PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yuan, PW; Bartlam, M; Lou, ZY; Chen, SD; Zhou, J; He, XJ; Lv, ZY; Ge, RW; Li, XM; Deng, T; Fodor, E; Rao, ZH; Liu, YF				Yuan, Puwei; Bartlam, Mark; Lou, Zhiyong; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Ge, Ruowen; Li, Xuemei; Deng, Tao; Fodor, Ervin; Rao, Zihe; Liu, Yingfang			Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site	NATURE			English	Article							RNA-POLYMERASE; PA SUBUNIT; A VIRUS; TERMINAL REGION; CAP-BINDING; REPLICATION; PROTEIN; PB2; IDENTIFICATION; RESIDUES	The heterotrimeric influenza virus polymerase, containing the PA, PB1 and PB2 proteins, catalyses viral RNA replication and transcription in the nucleus of infected cells. PB1 holds the polymerase active site(1) and reportedly harbours endonuclease activity(2), whereas PB2 is responsible for cap binding(2-4). The PA amino terminus is understood to be the major functional part of the PA protein and has been implicated in several roles, including endonuclease(5) and protease activities(6) as well as viral RNA/complementary RNA promoter binding(7). Here we report the 2.2 angstrom (angstrom) crystal structure of the N-terminal 197 residues of PA, termed PA(N), from an avian influenza H5N1 virus. The PA(N) structure has an alpha/beta architecture and reveals a bound magnesium ion coordinated by a motif similar to the (P) DXN(D/E) XK motif characteristic of many endonucleases. Structural comparisons and mutagenesis analysis of the motif identified in PA(N) provide further evidence that PA(N) holds an endonuclease active site. Furthermore, functional analysis with in vivo ribonucleoprotein reconstitution and direct in vitro endonuclease assays strongly suggest that PA(N) holds the endonuclease active site and has critical roles in endonuclease activity of the influenza virus polymerase, rather than PB1. The high conservation of this endonuclease active site among influenza strains indicates that PA(N) is an important target for the design of new anti-influenza therapeutics.	[Yuan, Puwei; Chen, Shoudeng; Zhou, Jie; He, Xiaojing; Lv, Zongyang; Li, Xuemei; Rao, Zihe; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark; Deng, Tao; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Lou, Zhiyong; Li, Xuemei; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Deng, Tao; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Nankai University; Tsinghua University; National University of Singapore; University of Oxford	Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	raozh@xtal.tsinghua.edu.cn; liuy@ibp.ac.cn	chen, shoudeng/AAX-8738-2021; chen, shoudeng/G-3556-2012; Ge, Ruowen/D-8352-2012; HE, XIAOJING/A-6040-2013; Lv, Zongyang/M-9307-2018; Rao, Zihe/HCH-6944-2022	chen, shoudeng/0000-0002-7634-2141; Ge, Ruowen/0000-0002-0750-7336; Lv, Zongyang/0000-0002-8862-113X; Bartlam, Mark/0000-0001-5173-5080; Fodor, Ervin/0000-0003-3249-196X	National Natural Science Foundation of China [30599432, 30221003, 30721003]; Ministry of Science and Technology International Cooperation [2006DFB32420]; Ministry of Science and Technology 863 Project [2006AA02A314, 2006AA02A322]; Ministry of Science and Technology 973 Project [2006CB504300, 2007CB914300]; Medical Research Council [G0700848]; MRC [G0700848] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Cooperation; Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China); Ministry of Science and Technology 973 Project(National Basic Research Program of China); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Chen and K. Yu for providing the A/goose/Guangdong/1/96 influenza PA gene, R. Zhang and A. Joachimiak for assistance with data collection, and G. G. Brownlee for providing materials and for valuable advice. This work was supported by the National Natural Science Foundation of China (grant numbers 30599432, 30221003 and 30721003), the Ministry of Science and Technology International Cooperation Project (2006DFB32420), the Ministry of Science and Technology 863 Project (2006AA02A314 and 2006AA02A322), the Ministry of Science and Technology 973 Project (2006CB504300 and 2007CB914300) and the Medical Research Council (G0700848).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blok V, 1996, J GEN VIROL, V77, P1025, DOI 10.1099/0022-1317-77-5-1025; BROWNLEE GG, 1995, NUCLEIC ACIDS RES, V23, P2641, DOI 10.1093/nar/23.14.2641; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Naffakh N, 2001, VIROLOGY, V285, P244, DOI 10.1006/viro.2001.0956; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; NIETO A, 1992, VIRUS RES, V24, P65, DOI 10.1016/0168-1702(92)90031-4; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perales B, 2000, J VIROL, V74, P1307, DOI 10.1128/JVI.74.3.1307-1312.2000; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	35	386	418	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					909	U12		10.1038/nature07720	http://dx.doi.org/10.1038/nature07720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194458				2022-12-28	WOS:000265182500047
J	Mehta, R; Zhu, R				Mehta, Ravi; Zhu, Rui (Juliet)			Blue or Red? Exploring the Effect of Color on Cognitive Task Performances	SCIENCE			English	Article							REGULATORY FOCUS; CUES; PREVENTION; PROMOTION	Existing research reports inconsistent findings with regard to the effect of color on cognitive task performances. Some research suggests that blue or green leads to better performances than red; other studies record the opposite. Current work reconciles this discrepancy. We demonstrate that red (versus blue) color induces primarily an avoidance (versus approach) motivation (study 1, n = 69) and that red enhances performance on a detail-oriented task, whereas blue enhances performance on a creative task (studies 2 and 3, n = 208 and 118). Further, we replicate these results in the domains of product design (study 4, n = 42) and persuasive message evaluation (study 5, n = 161) and show that these effects occur outside of individuals' consciousness (study 6, n = 68). We also provide process evidence suggesting that the activation of alternative motivations mediates the effect of color on cognitive task performances.	[Mehta, Ravi; Zhu, Rui (Juliet)] Univ British Columbia, Sauder Sch Business, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Zhu, R (corresponding author), Univ British Columbia, Sauder Sch Business, 2053 Main Mall, Vancouver, BC V6T 1Z2, Canada.	juliet.zhu@sauder.ubc.ca			Social Sciences and Humanities Research Council	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work benefited from financial support from the Social Sciences and Humanities Research Council to R.J.Z. We thank J. Meyers-Levy and K. D. Vohs for very helpful comments on earlier drafts of this paper. Research assistance from P. Behmardi, S. Ho, and S. Park is greatly appreciated.	Aslam M. M., 2006, J MARK COMMUN, V12, P15, DOI DOI 10.1080/13527260500247827; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BRAUN CC, 1995, ERGONOMICS, V38, P2207, DOI 10.1080/00140139508925263; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Friedman RS, 2005, J PERS SOC PSYCHOL, V88, P263, DOI 10.1037/0022-3514.88.2.263; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Koch S, 2008, COGNITION, V109, P133, DOI 10.1016/j.cognition.2008.07.014; KWALLEK N, 1990, APPL ERGON, V21, P275, DOI 10.1016/0003-6870(90)90197-6; Moreau CP, 2005, J CONSUM RES, V32, P13, DOI 10.1086/429597; Naz K., 2004, COLL STUDENT J, V38, P396; Schwarz N., 1990, HDB MOTIVATION COGNI, P527, DOI DOI 10.2307/2072281; Soldat AS, 1997, SOC COGNITION, V15, P55, DOI 10.1521/soco.1997.15.1.55; Stone NJ, 2003, J ENVIRON PSYCHOL, V23, P63, DOI 10.1016/S0272-4944(02)00107-X; THOMPSON E, 1992, BEHAV BRAIN SCI, V15, P1, DOI 10.1017/S0140525X00067248; Williams DJ, 2007, THEOR ISS ERGON SCI, V8, P1, DOI 10.1080/14639220500484419; Zhu R, 2007, J CONSUM RES, V34, P89, DOI 10.1086/513049	25	395	410	13	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1226	1229		10.1126/science.1169144	http://dx.doi.org/10.1126/science.1169144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19197022				2022-12-28	WOS:000263687600042
J	Cuchacovich, RS; Espinoza, LR				Cuchacovich, Raquel S.; Espinoza, Luis R.			Ustekinumab for psoriatic arthritis	LANCET			English	Editorial Material							THERAPY; EXPRESSION; EFFICACY; SAFETY		[Cuchacovich, Raquel S.; Espinoza, Luis R.] Louisiana State Univ, Hlth Sci Ctr, Rheumatol Sect, Dept Med, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Espinoza, LR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Rheumatol Sect, Dept Med, New Orleans, LA 70112 USA.	Lespin1@lsuhsc.edu						Candia L, 2007, J RHEUMATOL, V34, P374; Cuchacovich R, 2008, JCR-J CLIN RHEUMATOL, V14, P353, DOI 10.1097/RHU.0b013e318190dd88; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Genovese MC, 2007, J RHEUMATOL, V34, P1040; GOTTLIEB A, 2009, LANCET          0212, DOI DOI 10.1016/S0140-6736(09)60140-9; Helliwell PS, 2008, J RHEUMATOL, V35, P472; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Saketkoo LA, 2008, J RHEUMATOL, V35, P369; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972	12	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					605	606		10.1016/S0140-6736(09)60141-0	http://dx.doi.org/10.1016/S0140-6736(09)60141-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19217153				2022-12-28	WOS:000263563500004
J	Nikolaev, A; McLaughlin, T; O'Leary, DDM; Tessier-Lavigne, M				Nikolaev, Anatoly; McLaughlin, Todd; O'Leary, Dennis D. M.; Tessier-Lavigne, Marc			APP binds DR6 to trigger axon pruning and neuron death via distinct caspases	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; PROGRAMMED CELL-DEATH; BAX-DEFICIENT MICE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; COMMISSURAL AXONS; GENE-EXPRESSION; FAMILY-MEMBERS; TNF RECEPTOR; DEGENERATION	Naturally occurring axonal pruning and neuronal cell death help to sculpt neuronal connections during development, but their mechanistic basis remains poorly understood. Here we report that beta-amyloid precursor protein ( APP) and death receptor 6 ( DR6, also known as TNFRSF21) activate a widespread caspase- dependent self- destruction program. DR6 is broadly expressed by developing neurons, and is required for normal cell body death and axonal pruning both in vivo and after trophic- factor deprivation in vitro. Unlike neuronal cell body apoptosis, which requires caspase 3, we show that axonal degeneration requires caspase 6, which is activated in a punctate pattern that parallels the pattern of axonal fragmentation. DR6 is activated locally by an inactive surface ligand( s) that is released in an active form after trophic- factor deprivation, and we identify APP as a DR6 ligand. Trophic- factor deprivation triggers the shedding of surface APP in a beta-secretase ( BACE)- dependent manner. Loss- and gain- of- function studies support a model in which a cleaved amino- terminal fragment of APP ( N- APP) binds DR6 and triggers degeneration. Genetic support is provided by a common neuromuscular junction phenotype in mutant mice. Our results indicate that APP and DR6 are components of a neuronal self- destruction pathway, and suggest that an extracellular fragment of APP, acting via DR6 and caspase 6, contributes to Alzheimer's disease.	[Nikolaev, Anatoly; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [McLaughlin, Todd; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Roche Holding; Genentech; Salk Institute	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com		Nikolaev, Anatoly/0000-0003-2818-5839	Genentech; National Eye Institute [R01 EY07025]; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Axel, C. Bargmann, B. de Strooper, V. Dixit, C. Henderson, J. Lewcock, R. Scheller, R. Vassar, R. Watts, and members of the M. T.- L. laboratory for helpful discussions and suggestions, and critical reading of the manuscript, and A. Bruce for making the diagrams. We thank P. Hass and members of his laboratory (Genentech) for generation and purification of the DR6 ectodomain and APP(1-286), and W.-C. Liang and Y. Wu (Genentech) for binding experiments with purified proteins. Supported by Genentech (A.N. and M.T.-L.) and National Eye Institute grant R01 EY07025 (D.D.M.O.'L.).	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Chiang LW, 2001, P NATL ACAD SCI USA, V98, P2814, DOI 10.1073/pnas.051630598; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edwards PD, 2007, J MED CHEM, V50, P5912, DOI 10.1021/jm070829p; Finn JT, 2000, J NEUROSCI, V20, P1333; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perez RG, 1997, J NEUROSCI, V17, P9407; PETTMANN B, 1988, J NEUROSCI, V8, P3624; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schmidt CS, 2003, J EXP MED, V197, P51, DOI 10.1084/jem.20020617; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; VANGOOL D, 1995, DEMENTIA, V6, P63, DOI 10.1159/000106923; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; White FA, 1998, J NEUROSCI, V18, P1428; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441	59	795	843	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					981	U1		10.1038/nature07767	http://dx.doi.org/10.1038/nature07767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225519	Green Accepted			2022-12-28	WOS:000263425400036
J	Borgatti, SP; Mehra, A; Brass, DJ; Labianca, G				Borgatti, Stephen P.; Mehra, Ajay; Brass, Daniel J.; Labianca, Giuseppe			Network Analysis in the Social Sciences	SCIENCE			English	Review							INNOVATION	Over the past decade, there has been an explosion of interest in network research across the physical and social sciences. For social scientists, the theory of networks has been a gold mine, yielding explanations for social phenomena in a wide variety of disciplines from psychology to economics. Here, we review the kinds of things that social scientists have tried to explain using social network analysis and provide a nutshell description of the basic assumptions, goals, and explanatory mechanisms prevalent in the field. We hope to contribute to a dialogue among researchers from across the physical and social sciences who share a common interest in understanding the antecedents and consequences of network phenomena.	[Borgatti, Stephen P.; Mehra, Ajay; Brass, Daniel J.; Labianca, Giuseppe] Univ Kentucky, LINKS Ctr Network Res Business, Gatton Coll Business & Econ, Lexington, KY 40506 USA	University of Kentucky	Borgatti, SP (corresponding author), Univ Kentucky, LINKS Ctr Network Res Business, Gatton Coll Business & Econ, Lexington, KY 40506 USA.	sborgatti@uky.edu; ajay.mehra@uky.edu; dbrass@uky.edu; joe.labianca@uky.edu	Labianca, Giuseppe/K-6074-2015; Labianca, Giuseppe/G-8878-2012; Blanchet, karl/F-4678-2012; 白, 纯歌/V-1853-2017	Labianca, Giuseppe/0000-0002-9412-8421; Labianca, Giuseppe/0000-0002-9412-8421; Borgatti, Stephen/0000-0002-5776-5579	Defense Threat Reduction Agency [HDTRA1-08-1-0002-P00002]; Gatton College of Business and Economics at the University of Kentucky	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Gatton College of Business and Economics at the University of Kentucky	We thank A. Caster, R. Chase, L. Freeman, and B. Wellman for their help in improving thismanuscript. This work was funded in part by grant HDTRA1-08-1-0002-P00002 from the Defense Threat Reduction Agency and by the Gatton College of Business and Economics at the University of Kentucky.	Borgatti SP, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P241; Bott E., 2014, FAM SOC NETWORK; BOYD JP, 1969, J MATH PSYCHOL, V6, P139, DOI 10.1016/0022-2496(69)90032-7; BRASS DJ, 1984, ADMIN SCI QUART, V29, P518, DOI 10.2307/2392937; BROWN R, 1952, STRUCTURE FUNCTION P; Burt R.S., 2005, BROKERAGE CLOSURE IN; Burt R.S., 1983, CORPORATE PROFITS CO; Burt R. S, 1992, STRUCTURAL HOLES; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Cross R., 2004, HIDDEN POWER SOCIAL; DAVIS G, 1997, MODERN AGR, V1, P18; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; FISCHER CS, 1948, DWELL FRIENDS; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Freeman LC, 2004, DEV SOCIAL NETWORK A; Giddens A., 1976, NEW RULES SOCIOLOGIC; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HOLLINGSHEAD CE, 1949, ELMTOWNS YOUTH; Krackhardt D, 1999, J PERS SOC PSYCHOL, V76, P770, DOI 10.1037/0022-3514.76.5.770; LEAVITT HJ, 1951, J ABNORM SOC PSYCH, V46, P38, DOI 10.1037/h0057189; Levy J.A., 2002, SOCIAL NETWORKS HLTH; Lin N, 1999, ANNU REV SOCIOL, V25, P467, DOI 10.1146/annurev.soc.25.1.467; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moreno J. L., 1934, WHO SHALL SURVIVE; Nadel S. F., 1957, THEORY SOCIAL STRUCT; Newman MEJ., 2006, STRUCTURE DYNAMICS N; PADGETT JF, 1993, AM J SOCIOL, V98, P1259, DOI 10.1086/230190; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988; Sageman M, 2004, UNDERSTANDING TERROR NETWORKS, P1; SHAW ME, 1964, ADV EXP SOC PSYCHOL, V1, P111, DOI 10.1016/S0065-2601(08)60050-7; Shipilov AV, 2008, ADMIN SCI QUART, V53, P73, DOI 10.2189/asqu.53.1.73; Wellman B, 1996, ANNU REV SOCIOL, V22, P213, DOI 10.1146/annurev.soc.22.1.213; WHITE H, 1963, ANATOMY KINSHIP MATH; YAMAGISHI T, 1988, AM J SOCIOL, V93, P833, DOI 10.1086/228826	37	2093	2183	69	1153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					892	895		10.1126/science.1165821	http://dx.doi.org/10.1126/science.1165821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213908	Green Submitted			2022-12-28	WOS:000263295400030
J	Hafed, ZM; Goffart, L; Krauzlis, RJ				Hafed, Ziad M.; Goffart, Laurent; Krauzlis, Richard J.			A Neural Mechanism for Microsaccade Generation in the Primate Superior Colliculus	SCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; COVERT ATTENTION; TARGET SELECTION; VISUAL-CORTEX; NEURONS; INACTIVATION; FIXATION; TRACKING; STRIATE; PURSUIT	During fixation, the eyes are not still but often exhibit microsaccadic movements. The function of microsaccades is controversial, largely because the neural mechanisms responsible for their generation are unknown. Here, we show that the superior colliculus ( SC), a retinotopically organized structure involved in voluntary- saccade target selection, plays a causal role in microsaccade generation. Neurons in the foveal portion of the SC increase their activity before and during microsaccades with sizes of only a few minutes of arc and exhibit selectivity for the direction and amplitude of these movements. Reversible inactivation of these neurons significantly reduces microsaccade rate without otherwise compromising fixation. These results, coupled with computational modeling of SC activity, demonstrate that microsaccades are controlled by the SC and explain the link between microsaccades and visual attention.	[Hafed, Ziad M.; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Goffart, Laurent] Univ Aix Marseille 1, CNRS, Inst Neurosci Cognit Mediterranee, UMR 6193, F-13402 Marseille, France	Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hafed, ZM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zhafed@salk.edu	Goffart, Laurent/AEX-7821-2022	Goffart, Laurent/0000-0001-8767-1867; Richard, Krauzlis/0000-0002-1826-0447	NIH [EY12212]; Agence Nationale de la Recherche; RETINAE; NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); RETINAE; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by NIH grant EY12212 and Agence Nationale de la Recherche grant RETINAE. We thank K. Nielsen and V. Ciaramitaro for helpful comments.	Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Hafed ZM, 2008, J NEUROSCI, V28, P9426, DOI 10.1523/JNEUROSCI.1313-08.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	27	281	284	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					940	943		10.1126/science.1166112	http://dx.doi.org/10.1126/science.1166112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213919	Green Accepted			2022-12-28	WOS:000263295400044
J	Hohnloser, SH; Crijns, HJGM; van Eickels, M; Gaudin, C; Page, RL; Torp-Pedersen, C; Connolly, SJ				Hohnloser, Stefan H.; Crijns, Harry J. G. M.; van Eickels, Martin; Gaudin, Christophe; Page, Richard L.; Torp-Pedersen, Christian; Connolly, Stuart J.		ATHENA Investigators	Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; RHYTHM; PREVENTION; AMIODARONE; HOSPITALIZATION; FLUTTER; AGENT; HEART	Background Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation. Methods We conducted a multicenter trial to evaluate the use of dronedarone in 4628 patients with atrial fibrillation who had additional risk factors for death. Patients were randomly assigned to receive dronedarone, 400 mg twice a day, or placebo. The primary outcome was the first hospitalization due to cardiovascular events or death. Secondary outcomes were death from any cause, death from cardiovascular causes, and hospitalization due to cardiovascular events. Results The mean follow- up period was 21 +/- 5 months, with the study drug discontinued prematurely in 696 of the 2301 patients ( 30.2%) receiving dronedarone and in 716 of the 2327 patients ( 30.8%) receiving placebo, mostly because of adverse events. The primary outcome occurred in 734 patients ( 31.9%) in the dronedarone group and in 917 patients ( 39.4%) in the placebo group, with a hazard ratio for dronedarone of 0.76 ( 95% confidence interval [ CI], 0.69 to 0.84; P< 0.001). There were 116 deaths ( 5.0%) in the dronedarone group and 139 ( 6.0%) in the placebo group ( hazard ratio, 0.84; 95% CI, 0.66 to 1.08; P = 0.18). There were 63 deaths from cardiovascular causes ( 2.7%) in the dronedarone group and 90 ( 3.9%) in the placebo group ( hazard ratio, 0.71; 95% CI, 0.51 to 0.98; P = 0.03), largely due to a reduction in the rate of death from arrhythmia with dronedarone. The dronedarone group had higher rates of bradycardia, QT- interval prolongation, nausea, diarrhea, rash, and an increased serum creatinine level than the placebo group. Rates of thyroid- and pulmonary- related adverse events were not significantly different between the two groups. Conclusion Dronedarone reduced the incidence of hospitalization due to cardiovascular events or death in patients with atrial fibrillation. (ClinicalTrials. gov number, NCT00174785.).	[Hohnloser, Stefan H.] Univ Frankfurt, Dept Cardiol, Frankfurt, Germany; [van Eickels, Martin; Gaudin, Christophe] Sanofi Aventis, Frankfurt, Germany; [Crijns, Harry J. G. M.] Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands; [Page, Richard L.] Univ Washington, Seattle, WA 98195 USA; [Torp-Pedersen, Christian] Univ Copenhagen, Gentofte Hosp, Hellerup, Denmark; [Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Goethe University Frankfurt; Sanofi-Aventis; Maastricht University; Maastricht University Medical Centre (MUMC); University of Washington; University of Washington Seattle; University of Copenhagen; Herlev & Gentofte Hospital; McMaster University; Population Health Research Institute	Hohnloser, SH (corresponding author), JW Goethe Univ Hosp, Div Clin Electrophysiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	hohnloser@em.uni-frankfurt.de	Boldueva, Svetlana/AAH-3862-2019; Page, Richard L./L-5501-2014; Torp-Pedersen, Christian/E-5931-2013; Kaab, Stefan/H-3915-2012; Heidbuchel, Hein/C-2331-2019; Ručka, David/O-6785-2017	Boldueva, Svetlana/0000-0002-1898-084X; Page, Richard L./0000-0001-5603-1330; Heidbuchel, Hein/0000-0001-9301-8127; Ručka, David/0000-0002-3564-9788; Lanas, Fernando/0000-0003-3595-9759	Sanofi-Aventis; Cardiome; ARYx Therapeutics; Bristol-Myers Squibb; St. Jude Medical; Medacorp; AstraZeneca; Chugai Pharmaceuticals; Astellas; Pfizer	Sanofi-Aventis(Sanofi-Aventis); Cardiome; ARYx Therapeutics; Bristol-Myers Squibb(Bristol-Myers Squibb); St. Jude Medical(St. Jude Medical); Medacorp; AstraZeneca(AstraZeneca); Chugai Pharmaceuticals; Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer)	Dr. Hohnloser reports receiving consulting fees from SanofiAventis, Cardiome, ARYx Therapeutics, and Bristol-Myers Squibb, research grants from Sanofi-Aventis and St. Jude Medical, and lecture fees from Sanofi-Aventis, St. Jude Medical, and BristolMyers Squibb; and Dr. Crijns, consulting fees from Medacorp, AstraZeneca, Sanofi- Aventis, and Cardiome, research grants from AstraZeneca and St. Jude Medical, and lecture fees from AstraZeneca, Sanofi-Aventis, and Chugai Pharmaceuticals. Dr. van Eickels and Dr. Gaudin report being employees of Sanofi- Aventis and owning shares in the company. Dr. Page reports receiving consulting fees from Sanofi- Aventis, Astellas, and Pfizer; Dr. Torp- Pedersen, consulting fees from Sanofi- Aventis and Cardiome, research grants from Sanofi-Aventis, and lecture fees from Sanofi- Aventis and Cardiome; and Dr. Connolly, consulting fees and research grants from Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.	Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Cairns JA, 1997, LANCET, V349, P1776; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Gautier P., 1997, European Heart Journal, V18, P269; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hohnloser SH, 2008, J CARDIOVASC ELECTR, V19, P69, DOI 10.1111/j.1540-8167.2007.01016.x; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Sun W, 1999, CIRCULATION, V100, P2276, DOI 10.1161/01.CIR.100.22.2276; Sun W, 2002, J CARDIOVASC PHARM, V39, P677, DOI 10.1097/00005344-200205000-00008; Tschuppert Y, 2007, BRIT J CLIN PHARMACO, V64, P785, DOI 10.1111/j.1365-2125.2007.02998.x; Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A; Wegener FT, 2006, J CARDIOVASC ELECTR, V17, pS17, DOI 10.1111/j.1540-8167.2006.00583.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zareba KM, 2006, DRUG TODAY, V42, P75, DOI 10.1358/dot.2006.42.2.925346	18	780	828	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					668	678		10.1056/NEJMoa0803778	http://dx.doi.org/10.1056/NEJMoa0803778			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213680				2022-12-28	WOS:000263260500004
J	Landgren, O; Albitar, M; Ma, WL; Abbasi, F; Hayes, RB; Ghia, P; Marti, GE; Caporaso, NE				Landgren, Ola; Albitar, Maher; Ma, Wanlong; Abbasi, Fatima; Hayes, Richard B.; Ghia, Paolo; Marti, Gerald E.; Caporaso, Neil E.			B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HODGKINS-DISEASE; MUTATIONAL STATUS; NATURAL-HISTORY; IMMUNOGLOBULIN; BLOOD; MBL; CLL; CLASSIFICATION; EXPRESSION; RECEPTOR	Background Otherwise healthy persons with a small number of B- cell clones circulating in the peripheral blood have been designated as having monoclonal B- cell lymphocytosis ( MBL). Hospital- based series indicate an excess risk of progression from MBL to chronic lymphocytic leukemia ( CLL). In this prospective cohort study, we tested the hypothesis that CLL is always preceded by MBL. Methods Among 77,469 healthy adults who were enrolled in the nationwide, population- based Prostate, Lung, Colorectal, and Ovarian ( PLCO) Cancer Screening Trial, we identified 45 subjects in whom CLL was subsequently diagnosed ( up to 6.4 years later) through the collection of a peripheral- blood sample. Using six- color flow cytometry ( with antibodies CD45, CD19, CD5, CD10, kappa, and lambda) and immunoglobulin heavy-chain gene rearrangement by reverse- transcriptase - polymerase- chain- reaction assay, we determined the association between MBL and subsequent CLL and characterized the immunoglobulin gene repertoire of the prediagnostic B- cell clones. Results On the basis of either flow- cytometric or molecular analysis, 44 of 45 patients with CLL ( 98%; 95% confidence interval [ CI], 88 to 100) had a prediagnostic B- cell clone; in 41 patients ( 91%; 95% CI, 79 to 98), the presence of the B- cell clone was confirmed by both methods. The presence of immunoglobulin heavy- chain variable ( IGHV) genes was determined in 35 of 45 prediagnostic clones ( 78%). Of these clones, 16 ( 46%) were IGHV3 subgroup genes ( including 6 [ 17%] IGHV3- 23 genes) and 9 ( 26%) were IGHV4 subgroup genes ( including 4 [ 11%] IGHV4- 34 genes). Furthermore, 27 of 35 of the IGHV sequences ( 77%) had mutations, with similar distributions after stratification either below or above the median time between the collection of the prediagnostic blood sample and the subsequent CLL diagnosis. Conclusions In peripheral blood obtained up to 77 months before a CLL diagnosis, prediagnostic B- cell clones were present in 44 of 45 patients with CLL.	[Landgren, Ola; Hayes, Richard B.; Caporaso, Neil E.] NCI, Canc Res Ctr, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Marti, Gerald E.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Albitar, Maher; Ma, Wanlong] Nichols Inst, Quest Diagnost, San Juan Capistrano, CA USA; [Ghia, Paolo] Univ Vita Salute San raffaele, Unit & Lab Lymphoid Malignancies, Dept Oncol, Milan, Italy; [Ghia, Paolo] Ist Sci San Raffaele, Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); Nichols Institute; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landgren, O (corresponding author), NCI, Canc Res Ctr, Div Canc Epidemiol & Genet, NIH, Bldg 10,Rm 13N240,10 Center Dr, Bethesda, MD 20892 USA.	landgreo@mail.nih.gov	Ghia, Paolo/K-7138-2016	Ghia, Paolo/0000-0003-3750-7342; Hayes, Richard/0000-0002-0918-661X	Intramural Research Program of the National Cancer Institute; Italian Association for Cancer Research; CLL Global Research Foundation; NATIONAL CANCER INSTITUTE [ZIACP005803, ZIABC011352] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); CLL Global Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Christine Berg and Philip Prorok of the Division of Cancer Prevention, National Cancer Institute; the Screening Center investigators and staff of the PLCO Cancer Screening Trial; Tom Riley and the staff of Information Management Services; Barbara O'Brien and the staff of Westat; Ruth Pfeiffer of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, for statistical help; Kostas Stamatopoulos of Thessaloniki, Greece, for his most helpful advice and suggestions; and the patients who made this study possible.	BINET JL, 1990, BRIT J HAEMATOL, V76, P45; Carbone A, 1998, BLOOD, V92, P2220; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; de Tute R, 2006, LEUKEMIA, V20, P728, DOI 10.1038/sj.leu.2404116; GARNIER JL, 1995, TRANSPLANT P, V27, P1785; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghia P, 2004, BLOOD, V103, P2337, DOI 10.1182/blood-2003-09-3277; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; GOLDIN LR, 2009, HAEMATOLOGI IN PRESS; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; HAN T, 1984, BLOOD, V64, P244; Hayes RB, 2005, MUTAT RES-FUND MOL M, V592, P147, DOI 10.1016/j.mrfmmm.2005.06.013; Hayes RB, 2002, CANCER EPIDEM BIOMAR, V11, P1496; Jaffe ES, 2001, WHO CLASSIFICATION T; Jamroziak K, 2006, PHARMACOL REP, V58, P720; Kipps TJ, 2007, BEST PRACT RES CL HA, V20, P415, DOI 10.1016/j.beha.2007.04.001; Landgren O, 2006, BLOOD, V108, P292, DOI 10.1182/blood-2005-11-4620; Landgren O, 2007, BRIT J HAEMATOL, V139, P717, DOI 10.1111/j.1365-2141.2007.06866.x; Landgren O, 2007, BRIT J HAEMATOL, V139, P791, DOI 10.1111/j.1365-2141.2007.06859.x; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; Linet MS, 2007, BRIT J HAEMATOL, V139, P672, DOI 10.1111/j.1365-2141.2007.06847.x; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Messmer BT, 2004, BLOOD, V103, P3490, DOI 10.1182/blood-2003-10-3407; MONTSERRAT E, 1988, NOUV REV FR HEMATOL, V30, P359; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Rawstron AC, 2002, BLOOD, V100, P635, DOI 10.1182/blood.V100.2.635; Rawstron AC, 2004, J BIOL REG HOMEOS AG, V18, P155; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rawstron AC, 2007, BRIT J HAEMATOL, V139, P724, DOI 10.1111/j.1365-2141.2007.06863.x; Ries L MD, 2008, SEER CANC STAT REV 1; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Shanafelt TD, 2008, LEUKEMIA RES, V32, P1458, DOI 10.1016/j.leukres.2007.11.030; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227; Tomita Y, 1996, CANCER, V77, P186, DOI 10.1002/(SICI)1097-0142(19960101)77:1<186::AID-CNCR30>3.0.CO;2-#; VOGT RF, 1995, P US PUBL HLTH SERV, P19	36	233	244	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					659	667		10.1056/NEJMoa0806122	http://dx.doi.org/10.1056/NEJMoa0806122			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213679	Green Accepted			2022-12-28	WOS:000263260500003
J	Chou, R; Fu, RW; Carrino, JA; Deyo, RA				Chou, Roger; Fu, Rongwei; Carrino, John A.; Deyo, Richard A.			Imaging strategies for low-back pain: systematic review and meta-analysis	LANCET			English	Article							PRIMARY-CARE PATIENTS; LUMBAR SPINE; PATIENT EXPECTATIONS; CLINICAL GUIDELINES; EUROPEAN GUIDELINES; RADIOGRAPHY; MANAGEMENT; RADICULOPATHY; HETEROGENEITY; DISABILITY	Background Some clinicians do lumbar imaging routinely or in the absence of historical or clinical features suggestive Of serious low-back problems. We investigated the effects of routine, immediate lumbar imaging versus usual clinical Care without immediate imaging on clinical outcomes in patients with low-back pain and no indication of serious underlying conditions. Methods We analysed randomised controlled trials that compared immediate lumbar imaging (radiography, MRI, or CT) versus usual clinical care without immediate imaging for low-back pain. These trials reported pain or function (primary outcomes), quality of life, mental health, overall patient-reported improvement (based on various scales), and patient satisfaction in care received. Six trials (n=1804) met inclusion criteria. Study quality was assessed by two independent reviewers with criteria adapted from the Cochrane Back Review Group. Meta-analyses were done with a random effects model. Findings We did not record significant differences between immediate lumbar imaging and usual care without 3 months, standardised mean difference 0.19, immediate imaging for primary outcomes at either short-term (lip to 95% CI -0 . 01 to 0 . 39 for pain and 0 . 11, -0.29 to 0.50 for function, negative values favour routine imaging) or long-term (6-12 months, -0.04,-0.15 to 0.07 For pain and 0 . 01, -0.17 to 0 . 19 for function) follow-up. Other outcomes did not differ significantly. Trial quality, use of different imaging methods, and duration of low-back pain did not affect the results, but analyses were limited by small numbers of trials. Results are most applicable to acute or subacute low-back pain assessed in primary-care settings. Interpretation Lumbar imaging for low-back pain without indications of serious underlying conditions does not improve clinical outcomes. Therefore, clinicians should refrain from routine, immediate lumbar imaging in patients with acute or subacute low-back pain and without features suggesting a serious underlying condition. Funding American Pain Society.	[Chou, Roger; Fu, Rongwei; Deyo, Richard A.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Carrino, John A.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Chou, Roger] Johns Hopkins Univ, Sch Med, Oregon Evidence Based Practice Ctr, Baltimore, MD USA; [Chou, Roger] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Fu, Rongwei] Johns Hopkins Univ, Sch Med, Dept Publ Hlth & Prevent Med, Baltimore, MD USA; [Deyo, Richard A.] Johns Hopkins Univ, Sch Med, Dept Family Med, Baltimore, MD USA	Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; BIGOS SJ, CLIN PRACTICE GUIDEL; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Carey TS, 1996, ANN INTERN MED, V125, P807, DOI 10.7326/0003-4819-125-10-199611150-00004; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1986, J GEN INTERN MED, V1, P20, DOI 10.1007/BF02596320; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Djais N, 2005, APLAR J RHEUM, V8, P45, DOI DOI 10.1111/j.1479-8077.2005.00122.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gilbert FJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Gilbert FJ, 2004, RADIOLOGY, V231, P343, DOI 10.1148/radiol.2312030886; Gillan MGC, 2001, RADIOLOGY, V220, P393, DOI 10.1148/radiology.220.2.r01au06393; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jarvik JG, 1997, RADIOLOGY, V204, P447, DOI 10.1148/radiology.204.2.9240534; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kendrick D, 2001, Health Technol Assess, V5, P1; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Kerry S, 2002, BRIT J GEN PRACT, V52, P469; KERRY S, 2000, HEALTH TECHNOL ASSES, V4, P1; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Maitino AJ, 2003, RADIOLOGY, V227, P113, DOI 10.1148/radiol.2272020617; Miller P, 2002, SPINE, V27, P2291, DOI 10.1097/00007632-200210150-00021; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; ROCKEY PH, 1978, J FAM PRACTICE, V7, P455; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Song FJ, 1999, J CLIN EPIDEMIOL, V52, P725, DOI 10.1016/S0895-4356(99)00066-9; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; Verbeek J, 2004, SPINE, V29, P2309, DOI 10.1097/01.brs.0000142007.38256.7f; Willson TC, 2001, APPL SOIL ECOL, V16, P63, DOI 10.1016/S0929-1393(00)00077-9	50	347	360	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					463	472		10.1016/S0140-6736(09)60172-0	http://dx.doi.org/10.1016/S0140-6736(09)60172-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200918				2022-12-28	WOS:000263132800029
J	Crame, JA				Crame, J. Alistair			EVOLUTION Time's Stamp on Modern Biogeography	SCIENCE			English	Editorial Material							DIVERSITY; DIVERSIFICATION; EXTINCTION; HISTORY		[Crame, J. Alistair] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Crame, JA (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	jacr@bas.ac.uk			NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Bush AM, 2004, PALEOBIOLOGY, V30, P666, DOI 10.1666/0094-8373(2004)030<0666:RBFDCT>2.0.CO;2; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Krug AZ, 2009, SCIENCE, V323, P767, DOI 10.1126/science.1164905; LAROY J, 2001, P NATL ACAD SCI USA, V98, P6261; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; SIGNOR PW, 1990, ANNU REV ECOL SYST, V21, P509, DOI 10.1146/annurev.es.21.110190.002453; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1	11	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					720	721		10.1126/science.1169410	http://dx.doi.org/10.1126/science.1169410			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EV	19197045				2022-12-28	WOS:000263066800026
J	McNab, F; Varrone, A; Farde, L; Jucaite, A; Bystritsky, P; Forssberg, H; Klingberg, T				McNab, Fiona; Varrone, Andrea; Farde, Lars; Jucaite, Aurelija; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel			Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training	SCIENCE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; PREFRONTAL CORTEX; MODULATION; DEPLETION; CHILDREN	Working memory is a key function for human cognition, dependent on adequate dopamine neurotransmission. Here we show that the training of working memory, which improves working memory capacity, is associated with changes in the density of cortical dopamine D1 receptors. Fourteen hours of training over 5 weeks was associated with changes in both prefrontal and parietal D1 binding potential. This plasticity of the dopamine D1 receptor system demonstrates a reciprocal interplay between mental activity and brain biochemistry in vivo.	[McNab, Fiona; Bystritsky, Paulina; Forssberg, Hans; Klingberg, Torkel] Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden; [Varrone, Andrea; Farde, Lars; Jucaite, Aurelija] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm Brain Inst, Stockholm, Sweden; [Farde, Lars; Jucaite, Aurelija] AstraZeneca Res & Dev, Sodertalje, Sweden	Karolinska Institutet; Karolinska Institutet; AstraZeneca	Klingberg, T (corresponding author), Karolinska Inst, Neuropediat Unit, Dept Woman & Child Hlth, Stockholm Brain Inst, Stockholm, Sweden.	torkel.klingberg@ki.se	Forssberg, Hans/A-2944-2009	Klingberg, Torkel/0000-0002-3175-2171; Forssberg, Hans/0000-0003-2069-6618	Swedish Foundation for Strategic Research; Swedish Research Council; VINNOVA ( the Swedish Governmental Agency for Innovation Systems); Knut and Alice Wallenberg Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA ( the Swedish Governmental Agency for Innovation Systems)(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	The authors thank C. Halldin, K. Kolaas, G. Lei, J. Macoveanu, and members of the Karolinska Institutet PET center for assistance in the PET measurements. This work was supported by the Swedish Foundation for Strategic Research, Swedish Research Council, VINNOVA (the Swedish Governmental Agency for Innovation Systems), and Knut and Alice Wallenberg Foundation.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Guo NN, 2003, NEUROPSYCHOPHARMACOL, V28, P1703, DOI 10.1038/sj.npp.1300224; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laruelle M, 1998, Q J NUCL MED, V42, P211; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Muller U, 1998, J NEUROSCI, V18, P2720; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	27	363	384	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					800	802		10.1126/science.1166102	http://dx.doi.org/10.1126/science.1166102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197069				2022-12-28	WOS:000263066800052
J	Rowland, JM; Emlen, DJ				Rowland, J. Mark; Emlen, Douglas J.			Two Thresholds, Three Male Forms Result in Facultative Male Trimorphism in Beetles	SCIENCE			English	Article							HORN LENGTH DIMORPHISM; SEXUAL-DIMORPHISM; SCARAB BEETLE; BODY-SIZE; EVOLUTION; COLEOPTERA; TACTICS; MODELS	Male animals of many species deploy conditional reproductive strategies that contain distinct alternative phenotypes. Such facultatively expressed male tactics are assumed to be due to a single developmental threshold mechanism switching between the expression of two alternative phenotypes. However, we discovered a clade of dung beetles that commonly expresses two threshold mechanisms, resulting in three alternative phenotypes (male trimorphism). Once recognized, we found trimorphism in other beetle families that involves different types of male weapons. Evidence that insects assumed to be dimorphic can express three facultative male forms suggests that we need to adjust how we think about animal mating systems and the evolution of conditional strategies.	[Rowland, J. Mark] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of New Mexico; University of Montana System; University of Montana	Rowland, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rowland@unm.edu			NSF [IOS-0642409]	NSF(National Science Foundation (NSF))	We thank S. Spector, T. Larsen, A. Solis, T. Gardner, J. Louzada, P. Skelley, D. Almquist, C. Gillett, D. Edmonds, D. Lewis, L. Herman, T. Fincher, M. Barclay, C. O'Brien, J. Prena, F. Genier, G. and J. Lewallern, R. Veal, D. Heinicke, and B. Raber for providing critical samples; assistance of the Scarabaeine Research Network; K. Bright, W. Eberhard, E. Greene, A. Kodric- Brown, T. Maginnis, E. McCullough, C. Qualls, and two anonymous reviewers for ideas and comments on the manuscript; J. Driver and the University of Montana Electron Microscopy facility for the weevil images; and the NSF (IOS-0642409) (to D.J.E.) for funding.	Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.1111/j.1558-5646.1991.tb05262.x; Eberhard WG, 2000, P ROY SOC B-BIOL SCI, V267, P1129, DOI 10.1098/rspb.2000.1118; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2005, AM NAT, V166, pS42, DOI 10.1086/444599; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; HAZEL WN, 1990, P ROY SOC B-BIOL SCI, V242, P181, DOI 10.1098/rspb.1990.0122; HUNT J, 2001, P ROY SOC LOND B BIO, V26, P2409; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845, DOI 10.1093/aesa/91.6.845; Iguchi Yutaka, 2000, Kogane, V1, P21; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; Kelly CD, 2008, BEHAV ECOL, V19, P1018, DOI 10.1093/beheco/arn058; Kotiaho JS, 2001, BEHAV ECOL, V12, P553, DOI 10.1093/beheco/12.5.553; Maddison DR, 2000, MACCLADE 4 0 ANAL PH; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2006, AM NAT, V168, P711, DOI 10.1086/509051; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Moore JC, 2004, BEHAV ECOL, V15, P735, DOI 10.1093/beheco/arh069; OLIVEIRA RF, 2008, ALTERNATIVE REPROD T, P507; Plaistow SJ, 2004, BEHAV ECOL, V15, P534, DOI 10.1093/beheco/arh029; Price DL, 2007, INSECT SYST EVOL, V38, P1, DOI 10.1163/187631207788784058; RASMUSSEN JL, 1994, J INSECT BEHAV, V7, P67, DOI 10.1007/BF01989828; Rowland JM, 2005, EVOL ECOL RES, V7, P421; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Tomkins JL, 2005, AM NAT, V165, P389, DOI 10.1086/427732; West-Eberhard Mary Jane, 2003, pi	34	59	62	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					773	776		10.1126/science.1167345	http://dx.doi.org/10.1126/science.1167345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197062				2022-12-28	WOS:000263066800044
J	Winkelmayer, WC; Liu, J; Brookhart, MA				Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan			Altitude and All-Cause Mortality in Incident Dialysis Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-DISEASE; HIF-1	Context Patients undergoing dialysis at higher altitude receive lower erythropoietin doses, yet achieve higher hemoglobin concentrations. Increased iron availability caused by activation of hypoxia- induced factors at higher altitude may explain this finding. Hypoxia- induced factors are also involved in other pathways that may affect morbidity and mortality. Objective To study whether mortality differed by altitude in patients initiating dialysis. Design, Setting, and Participants Retrospective cohort of patients initiating dialysis in the United States between 1995 and 2004. Patients were stratified by the average elevation of their residential zip code. Covariates included age, sex, race, Medicaid coverage, dialysis modality, comorbidities, and reported laboratory measurements. We constructed proportional hazards models of all- cause mortality, stratifying by year, and censoring patients at 5 years from first dialysis, at the end of the database ( December 31, 2004), or loss to follow- up. We also compared age- and sex- adjusted standardized mortality rates of US patients receiving dialysis with the general population. Main Outcome Measure Mortality from any cause. Results A total of 804 812 patients initiated dialysis and were followed up for a median of 1.78 years. Crude mortality rates per 1000 person- years were 220.1 at an altitude lower than 76 m ( <250 ft), 221.2 from 76 through 609 m ( 250- 1999 ft), 214.6 from 610 through 1218 m ( 2000- 3999 ft), 184.9 from 1219 through 1828 m ( 4000 to 5999 ft), and 177.2 at an altitude higher than 1828 m ( > 6000 ft). After multivariable adjustment, compared with patients living at an altitude of lower than 76 m, the relative mortality rates were 0.97 ( 95% confidence interval [ CI], 0.96- 0.98) for those living from 76 through 609 m; 0.93 ( 95% CI, 0.91- 0.95), from 610 through 1218 m; 0.88 ( 95% CI, 0.84- 0.91), from 1219 through 1828 m, and 0.85 ( 95% CI, 0.79-0.92) higher than 1828 m. Age- and sex- standardized mortality decreased more with altitude in patients receiving dialysis than in the general population. Conclusions Altitude was inversely associated with all- cause mortality among US patients receiving dialysis.	[Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.; Liu, Jun; Brookhart, M. Alan] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Winkelmayer, Wolfgang C.] Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Winkelmayer, WC (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3-030, Boston, MA 02120 USA.	wwinkelmayer@partners.org			American Heart Association [0535232N]; National Institute on Aging [AG-027400]; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Winkelmayer is supported by Scientist Development Grant 0535232N from the American Heart Association. Dr Brookhart is supported by career development award AG-027400 from the National Institute on Aging.	Baibas N, 2005, J EPIDEMIOL COMMUN H, V59, P274, DOI 10.1136/jech.2004.025510; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; *CDC WONDER, COMPR MORT FIL 1999; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; REGENSTEINER JG, 1985, JAMA-J AM MED ASSOC, V253, P3124, DOI 10.1001/jama.253.21.3124; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265	11	47	49	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					508	512		10.1001/jama.2009.84	http://dx.doi.org/10.1001/jama.2009.84			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190315	Bronze			2022-12-28	WOS:000262992400020
J	Tiner, R				Tiner, Richard			Relationships with the drug industry: Focus on better information	BRITISH MEDICAL JOURNAL			English	Editorial Material									Assoc British Pharmaceut Ind, London SW1A 2DY, England		Tiner, R (corresponding author), Assoc British Pharmaceut Ind, 12 Whitehall, London SW1A 2DY, England.	rtiner@abpi.org.uk						[Anonymous], ELECT MED COMPENDIUM; *NHS CHOIC, MED GUID	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2009	338								b252	10.1136/bmj.b252	http://dx.doi.org/10.1136/bmj.b252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19193617				2022-12-28	WOS:000263876200009
J	Junker, JP; Ziegler, F; Rief, M				Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias			Ligand-Dependent Equilibrium Fluctuations of Single Calmodulin Molecules	SCIENCE			English	Article							FORCE SPECTROSCOPY; MECHANICAL STABILITY; APO-CALMODULIN; PROTEIN; BINDING; KINETICS; ADHESION; AFFINITY	Single- molecule force spectroscopy allows superb mechanical control of protein conformation. We used a custom- built low- drift atomic force microscope to observe mechanically induced conformational equilibrium fluctuations of single molecules of the eukaryotic calcium- dependent signal transducer calmodulin ( CaM). From this data, the ligand dependence of the full energy landscape can be reconstructed. We find that calcium ions affect the folding kinetics of the individual CaM domains, whereas target peptides stabilize the already folded structure. Single- molecule data of full length CaM reveal that a wasp venom peptide binds noncooperatively to CaM with 2: 1 stoichiometry, whereas a target enzyme peptide binds cooperatively with 1: 1 stoichiometry. If mechanical load is applied directly to the target peptide, real- time binding/ unbinding transitions can be observed.	[Rief, Matthias] Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Junker, Jan Philipp; Ziegler, Fabian; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Munich, Germany	University of Munich; Technical University of Munich	Rief, M (corresponding author), Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany.	mrief@ph.tum.de	Junker, Jan Philipp/A-9754-2010	Junker, Jan Philipp/0000-0002-2826-8290	Deutsche Forschungsgemeinschaft [RI 990/3-1]; International Graduate School "Materials Science of Complex Interfaces	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School "Materials Science of Complex Interfaces	We thank P. M. Bayley for inspiring discussions and A. Bausch, H. Gaub, M. Bertz, and M. Schlierf for helpful comments on the manuscript. This work was supported by Deutsche Forschungsgemeinschaft grant RI 990/3-1. J.P.J. was supported by the International Graduate School "Materials Science of Complex Interfaces."	Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Best RB, 2008, J AM CHEM SOC, V130, P3706, DOI 10.1021/ja0762691; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; LINSE S, 1986, FEBS LETT, V199, P28, DOI 10.1016/0014-5793(86)81217-0; MALENCIK DA, 1983, BIOCHEM BIOPH RES CO, V114, P50, DOI 10.1016/0006-291X(83)91592-9; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munoz V, 2007, ANNU REV BIOPH BIOM, V36, P395, DOI 10.1146/annurev.biophys.36.040306.132608; Ng SP, 2007, P NATL ACAD SCI USA, V104, P9633, DOI 10.1073/pnas.0609901104; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	26	169	172	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					633	637		10.1126/science.1166191	http://dx.doi.org/10.1126/science.1166191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179531				2022-12-28	WOS:000262862800043
J	Hawkes, N				Hawkes, Nigel			NICE goes global	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						DRUMMOND MF, 2008, NEW GUIDELINES EC EV; European Observatory on Health Systems and Policies, 2008, HLTH TECHN ASS HLTH; HARRIS G, 2008, NY TIMES        1202	3	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 28	2009	338								b103	10.1136/bmj.b103	http://dx.doi.org/10.1136/bmj.b103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EM	19176677				2022-12-28	WOS:000263205500016
J	Kendall, T; Pilling, S; Tyrer, P; Duggan, C; Burbeck, R; Meader, N; Taylor, C				Kendall, Tim; Pilling, Stephen; Tyrer, Peter; Duggan, Conor; Burbeck, Rachel; Meader, Nicholas; Taylor, Clare			Borderline and antisocial personality disorders: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE		[Kendall, Tim; Meader, Nicholas; Taylor, Clare] Royal Coll Psychiatrists, Res & Training Unit, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Sheffield Hlth & Social Care Trust, Sheffield S10 3TH, S Yorkshire, England; [Pilling, Stephen; Burbeck, Rachel] UCL, Natl Collaborating Ctr Mental Hlth, British Psychol Soc CORE, Subdept Clin Hlth Psychol, London WC1E 7HB, England; [Pilling, Stephen] UCL, Ctr Outcomes Res & Effectiveness, London WC1E 7HB, England; [Pilling, Stephen] Camden & Islington Fdn Trust, London NW1 0PE, England; [Tyrer, Peter] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Tyrer, Peter] W London Mental Hlth NHS Trust, Southall UB1 3EU, Middx, England; [Duggan, Conor] Univ Nottingham, Nottingham NG7 2RD, England; [Duggan, Conor] Nottinghamshire Healthcare Trust, Nottingham NG3 6AA, England	University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London; University of Nottingham	Kendall, T (corresponding author), Royal Coll Psychiatrists, Res & Training Unit, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	Tim.Kendall@shsc.nhs.uk		France, Rachel/0000-0001-5287-332X; Meader, Nicholas/0000-0001-9332-6605				Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; Castillo H., 2000, MENTAL HLTH LEARNING, V4, P53; Coid J, 2006, BRIT J PSYCHIAT, V188, P423, DOI 10.1192/bjp.188.5.423; Crawford M., 2007, LEARNING LESSONS MUL; Department of Health, 2003, PERS DIS NO LONG DIA; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Gross R, 2002, ARCH INTERN MED, V162, P53, DOI 10.1001/archinte.162.1.53; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Hart S. D., 1999, HARE PSYCHOPATHY CHE; HOM N, 2007, J MENT HEALTH, V16, P255; Moran P, 2000, ACTA PSYCHIAT SCAND, V102, P52, DOI 10.1034/j.1600-0447.2000.102001052.x; National Institute for Mental Health in England (NIMHE), 2003, PERS DIS NO LONG DIA; Robins L. N., 1991, PSYCHIAT DISORDERS A, P258; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Tyrer P, 2003, J PERS DISORD, V17, P263, DOI 10.1521/pedi.17.3.263.22152; Tyrer P, 1996, AM J PSYCHIAT, V153, P1593; Webster C.D., 1997, HCR 20 ASSESSING RIS; Zanarini MC, 2004, J CLIN PSYCHIAT, V65, P28, DOI 10.4088/jcp.v65n0105	18	40	40	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2009	338								b93	10.1136/bmj.b93	http://dx.doi.org/10.1136/bmj.b93			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EM	19176682				2022-12-28	WOS:000263205500006
J	Kim, AH; Puram, SV; Bilimoria, PM; Ikeuchi, Y; Keough, S; Wong, M; Rowitch, D; Bonni, A				Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Wong, Michael; Rowitch, David; Bonni, Azad			A Centrosomal Cdc20-APC Pathway Controls Dendrite Morphogenesis in Postmitotic Neurons	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; MAMMALIAN BRAIN; AXONAL GROWTH; UBIQUITINATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; DEGRADATION; MECHANISMS; COMPONENTS	The ubiquitin ligase anaphase-promoting complex (APC) recruits the coactivator Cdc20 to drive mitosis in cycling cells. However, the nonmitotic functions of Cdc20-APC have remained unexplored. We report that Cdc20-APC plays an essential role in dendrite morphogenesis in postmitotic neurons. Knockdown of Cdc20 in cerebellar slices and in postnatal rats in vivo profoundly impairs the formation of granule neuron dendrite arbors in the cerebellar cortex. Remarkably, Cdc20 is enriched at the centrosome in neurons, and the centrosomal localization is critical for Cdc20-dependent dendrite development. We also find that the centrosome-associated protein histone deacetylase 6 (HDAC6) promotes the poly-ubiquitination of Cdc20, stimulates the activity of centrosomal Cdc20-APC, and drives the differentiation of dendrites. These findings define a postmitotic function for Cdc20-APC in the morphogenesis of dendrites in the mammalian brain. The identification of a centrosomal Cdc20-APC ubiquitin signaling pathway holds important implications for diverse biological processes, including neuronal connectivity and plasticity.	[Kim, Albert H.; Puram, Sidharth V.; Bilimoria, Parizad M.; Ikeuchi, Yoshiho; Keough, Samantha; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puram, Sidharth V.; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Bilimoria, Parizad M.; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kim, Albert H.] Childrens Hosp, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Wong, Michael; Rowitch, David] Univ Calif San Francisco, Howard Hughes Med Inst, Inst Regenerat Med, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Rowitch, David] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; ikeuchi, yoshiho/C-1713-2014; Kim, Albert H./HGF-0057-2022	ikeuchi, yoshiho/0000-0002-2829-3840; Puram, Sidharth/0000-0003-3543-889X; Rowitch, David/0000-0002-0079-0060	National Institutes of Health [NS051255, NS41021]; National Research Service; National Cancer Institute; Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255, R01NS041021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Science Foundation; Albert J Ryan Foundation; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grants NS051255 and NS41021 (A. B.), a Ruth L. Kirschstein National Research Service Award research fellowship, the National Cancer Institute, and Brain Science Foundation grant (A. H. K.), the Albert J Ryan Foundation (P. B.), and a Human Frontier Science Program Long-Term Fellowship (Y.I.). We thank members of the Bonni laboratory for helpful discussions and critical reading of the manuscript.	ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gillingham AK, 2000, EMBO REP, V1, P524; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Hasskarl J, 2004, ONCOGENE, V23, P1930, DOI 10.1038/sj.onc.1207310; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2003, J NEUROSCI, V23, P1649; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	32	150	152	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					322	336		10.1016/j.cell.2008.11.050	http://dx.doi.org/10.1016/j.cell.2008.11.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167333	Bronze, Green Accepted			2022-12-28	WOS:000262648800020
J	Lee, K; Sridhar, D; Patel, M				Lee, Kelley; Sridhar, Devi; Patel, Mayur			Trade and Health 2 Bridging the divide: global governance of trade and health	LANCET			English	Article							ACCESS	The main institutions responsible for governing international trade and health-the World Trade Organization (WTO), which replaced the General Agreement on Tariffs and Trade (GATT) in 1995, and WHO-were established after World War 2. For many decades the two institutions operated in isolation, with little cooperation between them. The growth and expansion of world trade over the past half century amid economic globalisation, and the increased importance of health issues to the functioning of a more interconnected world, brings the two domains closer together on a broad range of issues. Foremost is the capacity of each to govern their respective domains, and their ability to cooperate in tackling issues that lie at the intersection of trade and health. This paper discusses how the governance of these two areas relate to one another, and how well existing institutions work together.	[Lee, Kelley] Univ London London Sch Hyg & Trop Med, Ctr Global Change & Hlth, London WC1E 7HT, England; [Sridhar, Devi] Univ Oxford All Souls Coll, Dept Polit & Int Relat, Oxford OX1 4AL, England; [Patel, Mayur] Univ Oxford, Dept Int Dev, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford	Lee, K (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Global Change & Hlth, Keppel St, London WC1E 7HT, England.	kelley.lee@lshtm.ac.uk			NATIONAL CANCER INSTITUTE [R01CA091021] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA091021-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*ACTIONAID, 2006, UND INFL EXP UND COR; Bermudez J, 2004, INTELLECTUAL PROPERT; BRUNDTLAND GH, 2001, WHO WTO WORKSH DIFF; CHAN M, 2007, HLTH DIPLOMACY 21 CE; CORREA C, 2007, FINANCIAL TIMES 0524; Correa CM, 2006, B WORLD HEALTH ORGAN, V84, P399, DOI 10.2471/BLT.05.023432; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; Fidler DP, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P294; Ford N, 2003, LANCET, V361, P3, DOI 10.1016/S0140-6736(03)12173-3; *GAO, 2007, GAO071198, P53; GARWOOD P, 2007, INTELLECTUAL PR 1010; *GATT, 1994, UR ROUND AGR AGR APP; Hardon A, 2003, LANCET, V361, P6, DOI 10.1016/S0140-6736(03)12177-0; HUEICHIH N, 2007, SCRIPTED, V4, P368; KHOR M, 2007, WHO DG REGRETS REPOR; LEE K, 2007, GLOBALIZATION GLOBAL; *OXF, 2007, SIGN AW FUT TRAD INV; PATEL M, 2007, WORKING PAPER SERIES; Pauwelyn J, 1999, J INT ECON LAW, V2, P641; SHABALALA D, 2007, EUROPEAN APPROACH IN; SIHANYA B, 2005, PATENTS PARALLEL IMP; SINGH S, 1999, TRIPS WHOS REVISED D; Tuerk E, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P265; *UNCTAD, 2007, TRAD DEV REP, P55; *UNDP, 2005, INT COOP CROSSR UN H; *US MISS EU, 2008, PAN FINDS EU BAN HOR; *WHO, 1997, GLO ACC DRUGS IMPL W; *WHO, 2008, TRAD HLTH; World Health Organization/World Trade Organization (WHO/WTO), 2002, WTO AGR PUBL HLTH JO; *WTO, 2007, WORLD TRAD REP 2007, P332; WTO, 2001, 4 MIN C WTO	31	52	52	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					416	422		10.1016/S0140-6736(08)61776-6	http://dx.doi.org/10.1016/S0140-6736(08)61776-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19167060	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000262912100033
J	Tillman, K; Burton, B; Jacques, LB; Phurrough, SE				Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.			Compendia and Anticancer Therapy Under Medicare	ANNALS OF INTERNAL MEDICINE			English	Article							INVESTIGATIONAL THERAPY	In 1993, Congress directed the Medicare program to refer to 3 existing published compendia, American Medical Association Drug Evaluations (AMA-DE), United States Pharmacopoeia Drug Information for the Health Professional (USP-DI), and American Hospital Formulary Service Drug Information (AHFS-DI), to identify unlabeled but medically accepted uses of drugs and biologicals in anticancer chemotherapy regimens. Public discussion during the preceding years had centered on whether to designate unlabeled uses of anticancer treatments as experimental and thus outside the scope of Medicare benefits. American Medical Association Drug Evaluations and USP-DI subsequently ceased publication, and the Medicare program faced increasing calls to revise the list of acceptable compendia, as authorized in the statute. In 2007, the Centers for Medicare & Medicaid Services used its regulatory authority to establish a publicly transparent process to revise the list. The Centers for Medicare & Medicaid Services considered 5 requests in 2008 and added National Comprehensive Cancer Network Drugs and Biologics Compendium, DRUGDEX, and Clinical Pharmacology to the list of compendia. DrugPoints was not added, and AMA-DE was removed. Because of the potential for conflicts of interest to lead to biased judgments, the 2008 Medicare Improvements for Patients and Providers Act has a provision that explicitly prohibits inclusion of compendia that do not have a publicly transparent process for evaluating therapies and identifying potential conflicts of interest.	[Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Tillman, K (corresponding author), Ctr Medicare & Medicaid Serv, Mailstop C1-09-06,7500 Secur Blvd, Baltimore, MD 21244 USA.	katherine.tillman@cms.hhs.gov						Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; ARONSON FR, 1990, J NATL CANCER I, V82, P1434, DOI 10.1093/jnci/82.17.1434; *CLIN PHARM, ED POL SUMM; *CTR MED MED SERV, THOMS MICR DRUGPOINT; *CTR MED MED SERV, CLIN PHARM COMP REV; *CTR MED MED SERV, THOMS MICR DRUGDEX C; *CTR MED MED SERV, NCCN COMP REV REQ; *CTR MED MED SERV, AMA DE COMP REV REQ; MCINTOSH H, 1990, J NATL CANCER I, V82, P996, DOI 10.1093/jnci/82.12.996; *NAT COMP CANC NET, NCCN EXP DISCL POL; *THOMS REUT HEALTH, THOMS MICR CONFL INT	11	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					348	+		10.7326/0003-4819-150-5-200903030-00109	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221368				2022-12-28	WOS:000264051700007
J	Brunner, DO; De Zanche, N; Frohlich, J; Paska, J; Pruessmann, KP				Brunner, David O.; De Zanche, Nicola; Froehlich, Juerg; Paska, Jan; Pruessmann, Klaas P.			Travelling-wave nuclear magnetic resonance	NATURE			English	Article							HUMAN MRI; NMR; COILS; 9.4T	Nuclear magnetic resonance(1,2) (NMR) is one of the most versatile experimental methods in chemistry, physics and biology(3), providing insight into the structure and dynamics of matter at the molecular scale. Its imaging variant - magnetic resonance imaging(4,5) (MRI) - is widely used to examine the anatomy, physiology and metabolism of the human body. NMRsignal detection is traditionally based on Faraday induction(6) in one or multiple radio- frequency resonators(7-10) that are brought into close proximity with the sample. Alternative principles involving structured-material flux guides(11), superconducting quantum interference devices(12), atomic magnetometers(13), Hall probes(14) or magnetoresistive elements(15) have been explored. However, a common feature of all NMR implementations until now is that they rely on close coupling between the detector and the object under investigation. Here we show that NMR can also be excited and detected by long-range interaction, relying on travelling radio- frequency waves sent and received by an antenna. One benefit of this approach is more uniform coverage of samples that are larger than the wavelength of the NMR signal - an important current issue in MRI of humans at very high magnetic fields. By allowing a significant distance between the probe and the sample, travelling- wave interaction also introduces new possibilities in the design of NMR experiments and systems.	[Brunner, David O.; De Zanche, Nicola; Pruessmann, Klaas P.] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Brunner, David O.; De Zanche, Nicola; Froehlich, Juerg; Paska, Jan; Pruessmann, Klaas P.] ETH, Lab Electromagnet Fields & Microwave Elect, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pruessmann, KP (corresponding author), Univ Zurich, Inst Biomed Engn, Gloriastr 35, CH-8092 Zurich, Switzerland.	pruessmann@biomed.ee.ethz.ch	Pruessmann, Klaas P/H-5385-2018; De Zanche, Nicola/B-3953-2011	Pruessmann, Klaas P/0000-0003-0009-8362; De Zanche, Nicola/0000-0003-4424-8430; Frohlich, Jurg/0000-0002-5923-3410	Swiss National Science Foundation [116400]; Velux Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden)	We thank N. van den Berg and A. Trabesinger for discussions. We are also grateful to P. Boesiger for his leading role in creating the 7T facility. This work was funded in part by the Swiss National Science Foundation (Project 116400) and by the Velux Foundation. Technical support from Philips Healthcare is also gratefully acknowledged.	ARMSTRONG JA, 1962, PHYS REV, V128, P606; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; BALANIS CA, 2005, ANTENNA THEORY ANAL, pCH14; BLOCH F, 1946, PHYS REV, V70, P474, DOI 10.1103/PhysRev.70.474; Bock NA, 2003, MAGNET RESON MED, V49, P158, DOI 10.1002/mrm.10326; Boero G, 2001, APPL PHYS LETT, V79, P1498, DOI 10.1063/1.1399306; Bogdanov G, 2002, MAGNET RESON MED, V47, P579, DOI 10.1002/mrm.10083; Boyd R. W., 2003, NONLINEAR OPTICS; CHRIST A, 2007, 8 INT C EUR BIOELECT; DAY EP, 1972, PHYS REV LETT, V29, P540, DOI 10.1103/PhysRevLett.29.540; Gulla AF, 2004, CONCEPT MAGN RESON B, V22B, P15, DOI 10.1002/cmr.b.20014; HAHN EL, 1950, PHYS REV, V77, P297, DOI 10.1103/PhysRev.77.297.2; HARPEN MD, 1993, MAGNET RESON MED, V30, P489, DOI 10.1002/mrm.1910300412; HAYES CE, 1985, J MAGN RESON, V63, P622, DOI 10.1016/0022-2364(85)90257-4; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; KUMAR A, 1975, J MAGN RESON, V18, P69, DOI 10.1016/0022-2364(75)90224-3; KURNIT NA, 1964, PHYS REV LETT, V13, P567, DOI 10.1103/PhysRevLett.13.567; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; MCCALL SL, 1969, PHYS REV, V183, P457, DOI 10.1103/PhysRev.183.457; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Savukov IM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123001; TROPP J, 1989, J MAGN RESON, V82, P51, DOI 10.1016/0022-2364(89)90164-9; VAUGHAN JT, 1994, MAGNET RESON MED, V32, P206, DOI 10.1002/mrm.1910320209; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; Verpillat F, 2008, P NATL ACAD SCI USA, V105, P2271, DOI 10.1073/pnas.0712129105; Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849	28	138	151	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					994	U2		10.1038/nature07752	http://dx.doi.org/10.1038/nature07752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225521	Green Accepted			2022-12-28	WOS:000263425400038
J	Rauchway, E				Rauchway, Eric			Recession Watch: Work for the greater good	NATURE			English	Editorial Material									[Rauchway, Eric] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Rauchway, E (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	earauchway@ucdavis.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					959	960		10.1038/457959a	http://dx.doi.org/10.1038/457959a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225501				2022-12-28	WOS:000263425400019
J	Molyneux, DH				Molyneux, David H.			10 years of success in addressing lymphatic filariasis	LANCET			English	Editorial Material							DISEASES; ACHIEVE		[Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	david.molyneux@liv.ac.uk						Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; WHO, 2006, PREV CHEM HUM HELM; *WHO, 2008, 61 WORLD HLTH ASS MA; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333	11	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					529	530		10.1016/S0140-6736(09)60181-1	http://dx.doi.org/10.1016/S0140-6736(09)60181-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217976				2022-12-28	WOS:000263333600011
J	Prandoni, P				Prandoni, Paolo			Prophylaxis of catheter-related thrombosis in cancer patients	LANCET			English	Editorial Material							CENTRAL VENOUS CATHETERS; CENTRAL VEIN CATHETER; RISK-FACTORS; PREVENTION; THROMBOPROPHYLAXIS; WARFARIN		[Prandoni, Paolo] Univ Padua, Dept Cardiothorac & Vasc Sci, Thromboembolism Unit, I-35122 Padua, Italy	University of Padua	Prandoni, P (corresponding author), Univ Padua, Dept Cardiothorac & Vasc Sci, Thromboembolism Unit, I-35122 Padua, Italy.	paoloprandoni@tin.it						BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; Carrier M, 2007, J THROMB HAEMOST, V5, P2552, DOI 10.1111/j.1538-7836.2007.02751.x; Chaukiyal P, 2008, THROMB HAEMOSTASIS, V99, P38, DOI 10.1160/TH07-07-0446; Couban S, 2005, J CLIN ONCOL, V23, P4063, DOI 10.1200/JCO.2005.10.192; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Monreal M, 1996, THROMB HAEMOSTASIS, V75, P251; Verso M, 2005, J CLIN ONCOL, V23, P4057, DOI 10.1200/JCO.2005.06.084; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; Verso M, 2008, INTERN EMERG MED, V3, P117, DOI 10.1007/s11739-008-0125-3; Young AM, 2009, LANCET, V373, P567, DOI 10.1016/S0140-6736(09)60205-1	12	10	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					523	524		10.1016/S0140-6736(09)60178-1	http://dx.doi.org/10.1016/S0140-6736(09)60178-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217973				2022-12-28	WOS:000263333600007
J	Young, AM; Billingham, LJ; Begum, G; Kerr, DJ; Hughes, AI; Rea, DW; Shepherd, S; Stanley, A; Sweeney, A; Wilde, J; Wheatley, K				Young, Annie M.; Billingham, Lucinda J.; Begum, Gulnaz; Kerr, David J.; Hughes, Ana I.; Rea, Daniel W.; Shepherd, Stephen; Stanley, Andrew; Sweeney, Ann; Wilde, Jonathan; Wheatley, Keith		WARP Collaborat Grp UK	Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial	LANCET			English	Article							CENTRAL VEIN CATHETER; MOLECULAR-WEIGHT HEPARIN; RISK-FACTORS; DOUBLE-BLIND; THROMBOSIS; PREVENTION; THROMBOEMBOLISM; COMPLICATIONS; PROPHYLAXIS	Background The role and dose of anticoagulants in thromboprophylaxis for patients with cancer receiving chemotherapy through central venous catheters (CVCs) is controversial. We therefore assessed whether warfarin reduces catheter-related thrombosis compared with no warfarin and whether the dose of warfarin determines the thromboprophylactic effect. Methods In 68 clinical centres in the UK, we randomly assigned 1590 patients aged at least 16 years with cancer who were receiving chemotherapy through CVCs to no warfarin, fixed-dose warfarin 1 mg per day, or dose-adjusted warfarin per day to maintain an international normalised ratio between 1. 5 and 2. 0. Clinicians who were certain of the benefit of warfarin randomly assigned patients to fixed-dose or dose-adjusted warfarin groups. The primary outcome was the rate of radiologically proven, symptomatic catheter- related thrombosis. Analysis was by intention to treat. This trial is 14 registered as an International Standard Randomised Controlled Trial, number I SRCTN 50312145. Findings Compared with no warfarin (n=404), warfarin (n=408; 324 [79%] on fixed-dose and 84 [21%] on dose-adjusted) did not reduce the rate of catheter- related thromboses (24 [6%] vs 24 [6%]; relative risk 0 . 99, 95% Cl 0 . 57-1.72, p=0 . 98). However, compared with fixed-dose warfarin (n=471), dose-adjusted warfarin (n=473) was superior in the prevention of catheter- related thromboses (13 [3%] vs 34 [7%]; 0 . 38, 0.20-0.71, p=0 . 002). Major bleeding events were rare; an excess was noted with warfarin compared with no warfarin (7 vs 1, p=0. 07) and with dose-adjusted warfarin compared with fixed-dose warfarin (16 vs 7, p=0.09). A combined endpoint of thromboses and major bleeding showed no difference between comparisons. We did not note a survival benefit in either comparison. Interpretation The findings show that prophylactic warfarin compared with no warfarin is not associated with a reduction in symptomatic catheter- related or other thromboses in patients with cancer and therefore we should consider newer treatments. Funding Medical Research Council and Cancer Research UK.	[Young, Annie M.; Billingham, Lucinda J.; Begum, Gulnaz; Hughes, Ana I.; Rea, Daniel W.; Sweeney, Ann] Univ Birmingham, Res UK Clin Trials Unit, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Wheatley, Keith] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Begum, Gulnaz] Univ Birmingham, Birmingham, W Midlands, England; [Begum, Gulnaz] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Kerr, David J.] Univ Oxford, Oncol Clin Trials Off, Oxford, England; [Shepherd, Stephen] Gloucestershire Oncol Ctr, Cheltenham, Glos, England; [Stanley, Andrew] City Hosp, Birmingham, W Midlands, England; [Wilde, Jonathan] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Warwick; University of Oxford; University of Birmingham; University of Birmingham	Young, AM (corresponding author), Univ Birmingham, Res UK Clin Trials Unit, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.	a.young@bham.ac.uk	Young, Annie/AAK-3708-2020	Billingham, Lucinda/0000-0001-8581-4262	The Medical Research Council; Cancer Research UK; Medical Research Council [G0800808] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Medical Research Council funded the clinical research fellowship and Cancer Research UK funded data management.	Akl EA, 2007, COCHRANE DB SYST REV, V3; BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; Boraks P, 1998, BRIT J HAEMATOL, V101, P483, DOI 10.1046/j.1365-2141.1998.00732.x; Couban S, 2005, J CLIN ONCOL, V23, P4063, DOI 10.1200/JCO.2005.10.192; Heaton DC, 2002, INTERN MED J, V32, P84, DOI 10.1046/j.1445-5994.2002.00171.x; Hutten BA, 2000, J CLIN ONCOL, V18, P3078, DOI 10.1200/JCO.2000.18.17.3078; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Kuter DJ, 2004, ONCOLOGIST, V9, P207, DOI 10.1634/theoncologist.9-2-207; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Levine M, 2005, J CLIN ONCOL, V23, P4006, DOI 10.1200/JCO.2005.12.901; Monreal M, 1996, THROMB HAEMOSTASIS, V75, P251; PARK K, 1999, P AN M AM SOC CLIN, P2330; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Rose AJ, 2007, J GEN INTERN MED, V22, P997, DOI 10.1007/s11606-007-0228-y; Verso M, 2005, J CLIN ONCOL, V23, P4057, DOI 10.1200/JCO.2005.06.084; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; Verso M, 2008, INTERN EMERG MED, V3, P117, DOI 10.1007/s11739-008-0125-3; WalshMcMonagle D, 1997, CANCER-AM CANCER SOC, V80, P649, DOI 10.1002/(SICI)1097-0142(19970815)80:4<649::AID-CNCR1>3.0.CO;2-I; Wheatley K, 2005, BLOOD, V106, p267A, DOI 10.1182/blood.V106.11.909.909	21	109	118	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					567	574		10.1016/S0140-6736(09)60205-1	http://dx.doi.org/10.1016/S0140-6736(09)60205-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217991	Green Submitted			2022-12-28	WOS:000263333600035
J	Hsieh, D; Xia, Y; Wray, L; Qian, D; Pal, A; Dil, JH; Osterwalder, J; Meier, F; Bihlmayer, G; Kane, CL; Hor, YS; Cava, RJ; Hasan, MZ				Hsieh, D.; Xia, Y.; Wray, L.; Qian, D.; Pal, A.; Dil, J. H.; Osterwalder, J.; Meier, F.; Bihlmayer, G.; Kane, C. L.; Hor, Y. S.; Cava, R. J.; Hasan, M. Z.			Observation of Unconventional Quantum Spin Textures in Topological Insulators	SCIENCE			English	Article							PHASE; STATE; WELLS	A topologically ordered material is characterized by a rare quantum organization of electrons that evades the conventional spontaneously broken symmetry- based classification of condensed matter. Exotic spin- transport phenomena, such as the dissipationless quantum spin Hall effect, have been speculated to originate from a topological order whose identification requires a spin- sensitive measurement, which does not exist to this date in any system. Using Mott polarimetry, we probed the spin degrees of freedom and demonstrated that topological quantum numbers are completely determined from spin texture- imaging measurements. Applying this method to Sb and Bi1-xSbx, we identified the origin of its topological order and unusual chiral properties. These results taken together constitute the first observation of surface electrons collectively carrying a topological quantum Berry's phase and definite spin chirality, which are the key electronic properties component for realizing topological quantum computing bits with intrinsic spin Hall- like topological phenomena.	[Hsieh, D.; Xia, Y.; Wray, L.; Pal, A.; Hasan, M. Z.] Princeton Univ, Joseph Henry Labs Phys, Dept Phys, Princeton, NJ 08544 USA; [Xia, Y.; Hasan, M. Z.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA; [Wray, L.] Lawrence Berkeley Lab, Adv Light Source, Stanford, CA 94305 USA; [Dil, J. H.; Meier, F.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Dil, J. H.; Osterwalder, J.; Meier, F.] Univ Zurich Irchel, Inst Phys, CH-8057 Zurich, Switzerland; [Bihlmayer, G.] Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany; [Kane, C. L.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Helmholtz Association; Research Center Julich; University of Pennsylvania; Princeton University	Hasan, MZ (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Dept Phys, Princeton, NJ 08544 USA.	mzhasan@princeton.edu	Kane, Charles L/A-1035-2007; HASAN, M. Zahid/D-8237-2012; Bihlmayer, Gustav/G-5279-2013; San Hor, Yew/S-1429-2017; Dil, Hugo/F-6995-2012; Qian, Dong/O-1028-2015	Bihlmayer, Gustav/0000-0002-6615-1122; San Hor, Yew/0000-0002-1417-4357; Dil, Hugo/0000-0002-6016-6120; Wray, L. Andrew/0000-0001-8977-0201	NSF [DMR-0605066, DMR-0819860]; Princeton University; Basic Energy Sciences of the U. S; Department of Energy [DE-FG-02-05ER46200]; Swiss Light Source; Paul Scherrer Institute, Villigen, Switzerland;  [Villigen, Switzerland]	NSF(National Science Foundation (NSF)); Princeton University(Princeton University); Basic Energy Sciences of the U. S(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Swiss Light Source(European Commission); Paul Scherrer Institute, Villigen, Switzerland; 	We thank J. Teo for providing the SS band calculations of antimony (Sb); A. Fedorov, L. Patthey, and D.- H. Lu for beamline assistance; and D. Haldane, B. I. Halperin, N. P. Ong, D. A. Huse, F. Wilczek, P. W. Anderson, D. C. Tsui, J. E. Moore, L. Fu, L. Balents, D.- H. Lee, S. Sachdev, P. A. Lee, and X.- G. Wen for stimulating discussions. C. L. K. was supported by NSF grant DMR-0605066. The spin-resolved ARPES experiments are supported by NSF through the Center for Complex Materials (DMR-0819860) and Princeton University; the use of synchrotron X-ray facilities (ALS-LBNL, Berkeley, and SSRL-SLAC, Stanford) is supported by the Basic Energy Sciences of the U. S. Department of Energy (DE-FG-02-05ER46200) and by the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland.	Ashcroft N.W., 1976, SOLID STATE PHYS; Avron JE, 2003, PHYS TODAY, V56, P38, DOI 10.1063/1.1611351; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; GAY TJ, 1992, REV SCI INSTRUM, V63, P1635, DOI 10.1063/1.1143371; Hirahara T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.153305; Hoesch M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.241401; Hoesch M, 2002, J ELECTRON SPECTROSC, V124, P263, DOI 10.1016/S0368-2048(02)00058-0; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hufner S., 1995, PHOTOELECTRON SPECTR; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Leek PJ, 2007, SCIENCE, V318, P1889, DOI 10.1126/science.1149858; LENOIR B, 1996, INT C THERM, V15, P1; LIU Y, 1995, PHYS REV B, V52, P1566, DOI 10.1103/PhysRevB.52.1566; Meier F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165431; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Nagaosa N, 2007, SCIENCE, V318, P758, DOI 10.1126/science.1150199; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Sugawara K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.046411; Teo JCY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045426; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wen X. G., 1990, International Journal of Modern Physics B, V4, P239, DOI 10.1142/S0217979290000139	29	976	986	12	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					919	922		10.1126/science.1167733	http://dx.doi.org/10.1126/science.1167733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213915	Green Submitted, Green Accepted			2022-12-28	WOS:000263295400038
J	Carver, BS; Tran, J; Chen, ZB; Carracedo-Perez, A; Alimonti, A; Nardella, C; Gopalan, A; Scardino, PT; Cordon-Cardo, C; Gerald, W; Pandolfi, PP				Carver, Brett S.; Tran, Jennifer; Chen, Zhenbang; Carracedo-Perez, Arkaitz; Alimonti, Andrea; Nardella, Caterina; Gopalan, Anuradha; Scardino, Peter T.; Cordon-Cardo, Carlos; Gerald, William; Pandolfi, Pier Paolo			ETS rearrangements and prostate cancer initiation	NATURE			English	Letter							GENE FUSIONS; TMPRSS2		[Carver, Brett S.; Tran, Jennifer; Chen, Zhenbang; Carracedo-Perez, Arkaitz; Alimonti, Andrea; Nardella, Caterina; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; [Gopalan, Anuradha; Gerald, William; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Carver, Brett S.; Scardino, Peter T.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Urol, New York, NY 10021 USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Chen, Zhenbang; Alimonti, Andrea; Nardella, Caterina; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Chen, Zhenbang; Alimonti, Andrea; Nardella, Caterina; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Carver, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; Alimonti, Andrea/J-4150-2012	Carracedo, Arkaitz/0000-0001-5957-1260; Nardella, Caterina/0000-0002-1901-7916; Alimonti, Andrea/0000-0002-9362-2313	NATIONAL CANCER INSTITUTE [R01CA082328, U01CA084292, P50CA092629] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084292-10, R01 CA082328-12, U01 CA084292, P50 CA092629-10, P50 CA092629, R01 CA082328] Funding Source: Medline; NIMHD NIH HHS [R01 MD004038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tu JJ, 2007, MODERN PATHOL, V20, P921, DOI 10.1038/modpathol.3800903	4	79	85	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					E1	E1		10.1038/nature07738	http://dx.doi.org/10.1038/nature07738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212347	Green Accepted			2022-12-28	WOS:000263266700036
J	Stothard, KJ; Tennant, PWG; Bell, R; Rankin, J				Stothard, Katherine J.; Tennant, Peter W. G.; Bell, Ruth; Rankin, Judith			Maternal Overweight and Obesity and the Risk of Congenital Anomalies A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NEURAL-TUBE DEFECTS; BODY-MASS INDEX; SERUM ALPHA-FETOPROTEIN; GESTATIONAL DIABETES-MELLITUS; BIRTH-DEFECTS; HEART-DEFECTS; SPINA-BIFIDA; CARDIOVASCULAR-DISEASE; CARDIAC-MALFORMATIONS; AFFECTED PREGNANCIES	Context Evidence suggests an association between maternal obesity and some congenital anomalies. Objective To assess current evidence of the association between maternal overweight, maternal obesity, and congenital anomaly. Data Sources MEDLINE, EMBASE, CINAHL, and Scopus ( January 1966 through May 2008) were searched for English- language studies using a list of keywords. Reference lists from relevant review articles were also searched. Study Selection Observational studies with an estimate of prepregnancy or early pregnancy weight or body mass index ( BMI) and data on congenital anomalies were considered. Of 1944 potential articles, 39 were included in the systematic review and 18 in the meta- analysis. Data Extraction and Synthesis Information was extracted on study design, quality, participants, congenital anomaly groups and subtypes, and risk estimates. Pooled odds ratios ( ORs) comparing risk among overweight, obese, and recommended- weight mothers ( defined by BMI) were determined for congenital anomaly groups and subtypes for which at least 150 cases had been reported in the literature. Results Pooled ORs for overweight and obesity were calculated for 16 and 15 anomaly groups or subtypes, respectively. Compared with mothers of recommended BMI, obese mothers were at increased odds of pregnancies affected by neural tube defects ( OR, 1.87; 95% confidence interval [ CI], 1.62- 2.15), spina bifida ( OR, 2.24; 95% CI, 1.86- 2.69), cardiovascular anomalies ( OR, 1.30; 95% CI, 1.12- 1.51), septal anomalies ( OR, 1.20; 95% CI, 1.09- 1.31), cleft palate ( OR, 1.23; 95% CI, 1.03- 1.47), cleft lip and palate ( OR, 1.20; 95% CI, 1.03- 1.40), anorectal atresia ( OR, 1.48; 95% CI, 1.12- 1.97), hydrocephaly ( OR, 1.68; 95% CI, 1.192.36), and limb reduction anomalies ( OR, 1.34; 95% CI, 1.03- 1.73). The risk of gastroschisis among obese mothers was significantly reduced ( OR, 0.17; 95% CI, 0.10- 0.30). Conclusions Maternal obesity is associated with an increased risk of a range of structural anomalies, although the absolute increase is likely to be small. Further studies are needed to confirm whether maternal overweight is also implicated.	[Stothard, Katherine J.; Tennant, Peter W. G.; Bell, Ruth; Rankin, Judith] Univ Newcastle, Inst Hlth & Soc, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Rankin, J (corresponding author), Univ Newcastle, Inst Hlth & Soc, Fac Med Sci, 4th Floor,William Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.m.rankin@ncl.ac.uk	Stothard, Katherine/F-2566-2015	Stothard, Katherine/0000-0002-8779-8857; Tennant, Peter/0000-0003-1555-069X	BDF Newlife; National Institute of Health Research (UK Department of Health)	BDF Newlife; National Institute of Health Research (UK Department of Health)(National Institute for Health Research (NIHR))	Dr Stothard received funding from BDF Newlife. Dr Rankin received funding from a Personal Award Scheme Career Scientist Award from the National Institute of Health Research (UK Department of Health).	Anderson JL, 2005, EPIDEMIOLOGY, V16, P87, DOI 10.1097/01.ede.0000147122.97061.bb; BECERRA JE, 1990, PEDIATRICS, V85, P1; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; BRADBURN MJ, 2003, STATA TECHNICAL B, V44, P4; *CALF BIRTH DEF MO, REG DAT 1999 2003 LI; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Carmichael SL, 2007, PAEDIATR PERINAT EP, V21, P210, DOI 10.1111/j.1365-3016.2007.00809.x; Casanueva E, 2000, NUTR RES, V20, P1389, DOI 10.1016/S0271-5317(00)80020-2; Cedergren M, 2005, CLEFT PALATE-CRAN J, V42, P367, DOI 10.1597/04-012.1; Cedergren M, 2002, ACTA PAEDIATR, V91, P222, DOI 10.1080/080352502317285252; Cedergren MI, 2006, EUR J OBSTET GYN R B, V125, P211, DOI 10.1016/j.ejogrb.2005.07.006; Cedergren MI, 2002, SCAND J WORK ENV HEA, V28, P12, DOI 10.5271/sjweh.641; Cedergren MI, 2003, OBES RES, V11, P1065, DOI 10.1038/oby.2003.146; Centers for Disease Control and Prevention, 2007, BEH RISK FACT SURV S; CHAN A, 1995, BRIT J OBSTET GYNAEC, V102, P370, DOI 10.1111/j.1471-0528.1995.tb11287.x; Chauhan SP, 2001, AM J OBSTET GYNECOL, V185, P349, DOI 10.1067/mob.2001.116729; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feldman B, 1999, FETAL DIAGN THER, V14, P185, DOI 10.1159/000020916; Garcia-Patterson A, 2004, DIABETOLOGIA, V47, P509, DOI 10.1007/s00125-004-1337-3; HADDOW JE, 1982, BRIT J OBSTET GYNAEC, V89, P93, DOI 10.1111/j.1471-0528.1982.tb04646.x; HADDOW JE, 1993, TERATOLOGY, V47, P225, DOI 10.1002/tera.1420470306; Hendricks KA, 2001, EPIDEMIOLOGY, V12, P630, DOI 10.1097/00001648-200111000-00009; HERON M, DEATHS PRELIMINARY D; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honein MA, 2003, BIRTH DEFECTS RES A, V67, P572, DOI 10.1002/bdra.10077; Hotzel D, 1986, Bibl Nutr Dieta, P36; *I MED, 1990, NUTR PREGN, P5; JOHNSON AM, 1990, AM J OBSTET GYNECOL, V163, P9, DOI 10.1016/S0002-9378(11)90655-3; Kallen K, 1998, AM J EPIDEMIOL, V147, P1103, DOI 10.1093/oxfordjournals.aje.a009408; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452; Lam PK, 1999, EPIDEMIOLOGY, V10, P717, DOI 10.1097/00001648-199911000-00012; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Martinez-Frias ML, 2005, DIABETIC MED, V22, P775, DOI 10.1111/j.1464-5491.2005.01492.x; METZGER BE, 1991, DIABETES, V40, P99, DOI 10.2337/diab.40.2.S99; Mikhail LN, 2002, J NATL MED ASSOC, V94, P695; Moore LL, 2000, EPIDEMIOLOGY, V11, P689, DOI 10.1097/00001648-200011000-00013; NAEYE RL, 1990, AM J CLIN NUTR, V52, P273, DOI 10.1093/ajcn/52.2.273; Nuthalapaty FS, 2004, CLIN OBSTET GYNECOL, V47, P898, DOI 10.1097/01.grf.0000135358.34673.48; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Organization WH, 1998, WELLB MEAS PRIM HLTH; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Queisser-Luft A, 1998, ULTRASCHALL MED, V19, P40, DOI 10.1055/s-2007-1000457; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Ray JG, 2005, OBSTET GYNECOL, V105, P261, DOI 10.1097/01.AOG.0000151988.84346.3e; RICHARDS ID, 1969, BRIT J PREV SOC MED, V23, P218; Robinson H, 2003, OBSTET GYNECOL, V101, P24, DOI 10.1016/S0029-7844(02)02448-1; Rossner S, 1990, ACTA OBSTET GYN SCAN, V69, P475, DOI 10.3109/00016349009013321; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shaw GM, 2008, EPIDEMIOLOGY, V19, P616, DOI 10.1097/EDE.0b013e3181761fa3; Shaw GM, 2000, PAEDIATR PERINAT EP, V14, P234, DOI 10.1046/j.1365-3016.2000.00274.x; Shaw GM, 2000, TERATOLOGY, V61, P376, DOI 10.1002/(SICI)1096-9926(200005)61:5<376::AID-TERA9>3.0.CO;2-J; Shaw GM, 2003, AM J CLIN NUTR, V78, P972, DOI 10.1093/ajcn/78.5.972; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Shaw GM, 2002, AM J MED GENET, V107, P253, DOI 10.1002/ajmg.10164; Shaw GM, 2001, INT J EPIDEMIOL, V30, P60, DOI 10.1093/ije/30.1.60; STEICHEN T, 2003, STATA TECHNICAL B, V61, P11; STEICHEN TJ, 2003, STATA J, V11, P3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SUTTON AJ, BMJ; TOWNER D, 1995, DIABETES CARE, V18, P1446, DOI 10.2337/diacare.18.11.1446; van Hoorn J, 2002, AUST NZ J OBSTET GYN, V42, P29; Velie EM, 2006, PAEDIATR PERINAT EP, V20, P219, DOI 10.1111/j.1365-3016.2006.00722.x; WALD N, 1981, BRIT J OBSTET GYNAEC, V88, P1094, DOI 10.1111/j.1471-0528.1981.tb01759.x; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Waller DK, 2003, BIRTH DEFECTS RES A, V67, P73, DOI 10.1002/bdra.10003; WALLER DK, 1994, AM J OBSTET GYNECOL, V170, P541, DOI 10.1016/S0002-9378(94)70224-1; Watkins ML, 1996, EPIDEMIOLOGY, V7, P507, DOI 10.1097/00001648-199609000-00009; Watkins ML, 2003, PEDIATRICS, V111, P1152; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Werler MM, 1996, JAMA-J AM MED ASSOC, V275, P1089, DOI 10.1001/jama.275.14.1089; WOLFE HM, 1990, OBSTET GYNECOL, V76, P339; World Health Organization, COR HLTH IND; World Health Organization, OB OV	79	765	785	0	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					636	650		10.1001/jama.2009.113	http://dx.doi.org/10.1001/jama.2009.113			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211471				2022-12-28	WOS:000263229000028
J	Kochen, MM; Blozik, E; Scherer, M				Kochen, Michael M.; Blozik, Eva; Scherer, Martin			Imaging for low-back pain	LANCET			English	Editorial Material							EUROPEAN GUIDELINES; GENERAL-PRACTICE; MEDIA CAMPAIGN; MANAGEMENT; DIAGNOSIS; BELIEFS; CARE		[Kochen, Michael M.; Blozik, Eva; Scherer, Martin] Univ Gottingen, Dept Gen Practice, D-37073 Gottingen, Germany	University of Gottingen	Kochen, MM (corresponding author), Univ Gottingen, Dept Gen Practice, D-37073 Gottingen, Germany.	mkochen@gwdg.de	Chenot, Jean-Francois/F-8241-2011	Chenot, Jean-Francois/0000-0001-8877-2950				Balague F, 2007, LANCET, V369, P726, DOI 10.1016/S0140-6736(07)60340-7; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Buchbinder R, 2007, SPINE, V32, pE156, DOI 10.1097/01.brs.0000256885.00681.00; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Fullen BM, 2007, EUR J PAIN, V11, P614, DOI 10.1016/j.ejpain.2006.09.007; Gibson JN, 2005, COCHRANE DB SYST REV, V4; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Mortimer M, 2003, SCAND J PUBLIC HEALT, V31, P194, DOI 10.1080/14034940210134086; Schers H, 2000, BRIT J GEN PRACT, V50, P640; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2	14	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					436	437		10.1016/S0140-6736(09)60149-5	http://dx.doi.org/10.1016/S0140-6736(09)60149-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200903				2022-12-28	WOS:000263132800005
J	Feinmann, J				Feinmann, Jane			Patient Safety Safety first	BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Soar J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b220; Westaby S, 2007, BRIT MED J, V335, P759, DOI 10.1136/bmj.39318.644549.AE	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 6	2009	338								b420	10.1136/bmj.b420	http://dx.doi.org/10.1136/bmj.b420			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414PA	19201809				2022-12-28	WOS:000263876500004
J	Boebinger, GS				Boebinger, Gregory S.			PHYSICS An Abnormal Normal State	SCIENCE			English	Editorial Material							LA2-XSRXCUO4; SUPERCONDUCTOR; RESISTIVITY; DEPENDENCE; CRYSTALS		[Boebinger, Gregory S.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL USA	State University System of Florida; Florida State University	Boebinger, GS (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL USA.	gsb@magnet.fsu.edu						Ando Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267001; ANDO Y, 1995, PHYS REV LETT, V75, P4662, DOI 10.1103/PhysRevLett.75.4662; Balakirev FF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017004; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Cooper RA, 2009, SCIENCE, V323, P603, DOI 10.1126/science.1165015; Gegenwart P, 2004, PHYSICA C, V408, P157, DOI 10.1016/j.physc.2004.02.070; Mackenzie AP, 1996, PHYS REV B, V53, P5848, DOI 10.1103/PhysRevB.53.5848; MARTIN S, 1990, PHYS REV B, V41, P846, DOI 10.1103/PhysRevB.41.846; MARTIN S, 1988, PHYS REV LETT, V60, P2194, DOI 10.1103/PhysRevLett.60.2194; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; STORMER HL, 1988, PHYS REV B, V38, P2472, DOI 10.1103/PhysRevB.38.2472; TAKAGI H, 1992, PHYS REV LETT, V69, P2975, DOI 10.1103/PhysRevLett.69.2975; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0	14	9	10	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					590	591		10.1126/science.1168952	http://dx.doi.org/10.1126/science.1168952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179517				2022-12-28	WOS:000262862800028
J	MacArthur, C; Jolly, K; Ingram, L; Freemantle, N; Dennis, CL; Hamburger, R; Brown, J; Chambers, J; Khan, K				MacArthur, Christine; Jolly, Kate; Ingram, Lucy; Freemantle, Nick; Dennis, Cindy-Lee; Hamburger, Ros; Brown, Julia; Chambers, Jackie; Khan, Khalid			Antenatal peer support workers and initiation of breast feeding: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-INCOME; COUNSELORS; EFFICACY	Objective To assess the effectiveness of an antenatal service using community based breastfeeding peer support workers on initiation of breast feeding. Design Cluster randomised controlled trial. Setting Community antenatal clinics in one primary care trust in a multiethnic, deprived population. Participants 66 antenatal clinics with 2511 pregnant women: 33 clinics including 1140 women were randomised to receive the peer support worker service and 33 clinics including 1371 women were randomised to receive standard care. Intervention An antenatal peer support worker service planned to comprise a minimum of two contacts with women to provide advice, information, and support from approximately 24 weeks' gestation within the antenatal clinic or at home. The trained peer support workers were of similar ethnic and sociodemographic backgrounds to their clinic population. Main outcome measure Initiation of breast feeding obtained from computerised maternity records of the hospitals where women from the primary care trust delivered. Results The sample was multiethnic, with only 9.4% of women being white British, and 70% were in the lowest 10th for deprivation. Most of the contacts with peer support workers took place in the antenatal clinics. Data on initiation of breast feeding were obtained for 2398 of 2511 ( 95.5%) women ( 1083/ 1140 intervention and 1315/ 1371 controls). The groups did not differ for initiation of breast feeding: 69.0% ( 747/ 1083) in the intervention group and 68.1% ( 896/ 1315) in the control groups; cluster adjusted odds ratio 1.11 ( 95% confidence interval 0.87 to 1.43). Ethnicity, parity, and mode of delivery independently predicted initiation of breast feeding, but randomisation to the peer support worker service did not. Conclusion A universal service for initiation of breast feeding using peer support workers provided within antenatal clinics serving a multiethnic, deprived population was ineffective in increasing initiation rates. Trial registration Current Controlled Trials ISRCTN16126175.	[MacArthur, Christine; Jolly, Kate; Ingram, Lucy; Freemantle, Nick] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Dennis, Cindy-Lee] Univ Toronto, Toronto, ON, Canada; [Hamburger, Ros; Brown, Julia; Chambers, Jackie] Heart Birmingham Teaching Primary Care Trust, Birmingham, W Midlands, England; [Khan, Khalid] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Khan, Khalid] Birmingham Womens Hosp, Birmingham, W Midlands, England	University of Birmingham; University of Toronto; University of Birmingham; Birmingham Women's Hospital	Jolly, K (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	c.b.jolly@bham.ac.uk	Khan, Khalid S/AAT-8824-2020; Jolly, Kate/AAA-1341-2019; Dennis, Cindy-Lee/ABA-2860-2020; MacArthur, Christine/ABA-8601-2021	Khan, Khalid S/0000-0001-5084-7312; Jolly, Kate/0000-0002-6224-2115; Dennis, Cindy-Lee/0000-0002-0135-7242; MacArthur, Christine/0000-0003-0434-2158; Freemantle, Nick/0000-0001-5807-5740	Heart of Birmingham Teaching Primary Care Trust	Heart of Birmingham Teaching Primary Care Trust	Heart of Birmingham Teaching Primary Care Trust.	Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; [Anonymous], 2002, INFANT FEEDING 2000; Bolling K, 2007, INFANT FEEDING SURVE; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Cattaneo A, 2005, PUBLIC HEALTH NUTR, V8, P39, DOI 10.1079/PHN2005660; Chapman DJ, 2004, ARCH PEDIAT ADOL MED, V158, P897, DOI 10.1001/archpedi.158.9.897; Collet D., 1991, MODELLING BINARY DAT, V2nd; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Dyson L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001688.pub2; Dyson L., 2006, PROMOTION BREASTFEED, P242; Fairbank L., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4250; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Guise Jeanne-Marie, 2003, Ann Fam Med, V1, P70, DOI 10.1370/afm.56; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; MacArthur C, 2002, LANCET, V359, P378, DOI 10.1016/S0140-6736(02)07596-7; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Muirhead PE, 2006, BRIT J GEN PRACT, V56, P191; TAYLOR B, MATERNITY MORTALITY	18	40	41	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2009	338								b131	10.1136/bmj.b131	http://dx.doi.org/10.1136/bmj.b131			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EQ	19181730	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000263206000002
J	Blow, N				Blow, Nathan			Glycobiology: A spoonful of sugar	NATURE			English	Editorial Material																		Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Hwang GM, 2008, IEEE SENS J, V8, P2074, DOI 10.1109/JSEN.2008.2007663; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Wang CC, 2007, NATURE, V446, P896, DOI 10.1038/nature05730	4	43	46	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					617	622		10.1038/457617a	http://dx.doi.org/10.1038/457617a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177129				2022-12-28	WOS:000262852200049
J	Laughlin, G; Deming, D; Langton, J; Kasen, D; Vogt, S; Butler, RP; Rivera, E; Meschiari, S				Laughlin, Gregory; Deming, Drake; Langton, Jonathan; Kasen, Daniel; Vogt, Steve; Butler, Robert Paul; Rivera, Eugenio; Meschiari, Stefano			Rapid heating of the atmosphere of an extrasolar planet	NATURE			English	Article							SPITZER-SPACE-TELESCOPE; HD 189733B; EVOLUTION; EMISSION	Near- infrared observations of more than a dozen 'hot-Jupiter' extrasolar planets have now been reported(1-5). These planets display a wide diversity of properties, yet all are believed to have had their spin periods tidally spin- synchronized with their orbital periods, resulting in permanent star- facing hemispheres and surface flow patterns that are most likely in equilibrium. Planets in significantly eccentric orbits can enable direct measurements of global heating that are largely independent of the details of the hydrodynamic flow(6). Here we report 8-mu m photometric observations of the planet HD 80606b during a 30- hour interval bracketing the periastron passage of its extremely eccentric 111.4- day orbit. As the planet received its strongest irradiation ( 828 times larger than the flux received at apastron) its maximum 8- mm brightness temperature increased from 800 K to 1,500K over a six- hour period. We also detected a secondary eclipse for the planet, which implies an orbital inclination of i approximate to 90 degrees, fixes the planetary mass at four times the mass of Jupiter, and constrains the planet's tidal luminosity. Our measurement of the global heating rate indicates that the radiative time constant at the planet's 8- mu m photosphere is similar to 4.5 h, in comparison with 3 - 5 days in Earth's stratosphere(7).	[Laughlin, Gregory; Langton, Jonathan; Kasen, Daniel; Vogt, Steve; Rivera, Eugenio; Meschiari, Stefano] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Deming, Drake] NASA, Goddard Space Flight Ctr, Planetary Syst Branch, Greenbelt, MD 20771 USA; [Butler, Robert Paul] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Carnegie Institution for Science	Laughlin, G (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA.	laughlin@ucolick.org	Vogt, Steven/AAC-3358-2021; Butler, Robert Paul/B-1125-2009; Kasen, Daniel/I-3443-2015	Butler, Robert Paul/0000-0003-1305-3761; Meschiari, Stefano/0000-0002-2930-0416; Kasen, Daniel/0000-0002-5981-1022	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank P. Bodenheimer, D. Charbonneau, J. Fortney, N. Iro and H. Knutson for discussions. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory (JPL), California Institute of Technology (Caltech), under contract to NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech.	Bodenheimer P, 2003, ASTROPHYS J, V592, P555, DOI 10.1086/375565; Burkert A, 2005, ASTROPHYS J, V618, P512, DOI 10.1086/425955; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Cho JYK, 2003, ASTROPHYS J, V587, pL117, DOI 10.1086/375016; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Ivanov PB, 2007, MON NOT R ASTRON SOC, V376, P682, DOI 10.1111/j.1365-2966.2007.11463.x; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; LANGTON J, ASTROPHYS J UNPUB; Langton J, 2008, ASTROPHYS J, V674, P1106, DOI 10.1086/523957; Naef D, 2001, ASTRON ASTROPHYS, V375, pL27, DOI 10.1051/0004-6361:20010853; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; Press W., 1992, NUMERICAL RECIPES FO; Queloz D, 2000, ASTRON ASTROPHYS, V359, pL13; ROWE JF, 2007, ASTROPHYS J UNPUB; SALBY ML, 1996, FUNDAMENTALS ATMOSPH, P248; Showman AP, 2008, ASTROPHYS J, V682, P559, DOI 10.1086/589325; WINN J, 2000, ASTROPHYS J, V631, P1215; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598	25	86	86	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					562	564		10.1038/nature07649	http://dx.doi.org/10.1038/nature07649			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177124				2022-12-28	WOS:000262852200036
J	Kelly, CP				Kelly, Ciaran P.			A 76-Year-Old Man With Recurrent Clostridium difficile-Associated Diarrhea Review of C difficile Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOXIN-A; SACCHAROMYCES-BOULARDII; ANTIBODY-RESPONSE; INTRAVENOUS IMMUNOGLOBULIN; PSEUDOMEMBRANOUS COLITIS; RISK-FACTORS; VANCOMYCIN; VACCINE; STRAIN	Clostridium difficile infection (CDI) is a common and increasingly severe nosocomial infectious disease. The case of Mr S, a 76-year-old man with multiple recurrences of CDI, illustrates the difficulties in treating recurrent disease and the way it complicates the management of other medical conditions. Risk factors for CDI include antimicrobial use, hospital admission, advancing age, and severe underlying disease. A clinical diagnosis of CDI is usually confirmed by identifying C difficile toxins in a stool sample. Evidence supports metronidazole, 500 mg every 6 hours for 10 to 14 days, as the treatment of choice for mild to moderately severe CDI. Oral vancomycin, 125 mg every 6 hours for 10 to 14 days, is recommended for severe CDI, for which it is more effective than metronidazole. Recurrent CDI occurs in more than 20% of patients when metronidazole or vancomycin treatment is discontinued. Few studies have evaluated treatment options for recurrent CDI, but a prolonged, tapering, and pulse-dosed regimen of oral vancomycin is commonly used. Careful attention to antimicrobial stewardship and infection control practices is essential to curb this nosocomial, iatrogenic disease.	[Kelly, Ciaran P.] Beth Israel Deaconess Med Ctr, Celiac Ctr, Boston, MA 02215 USA; [Kelly, Ciaran P.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Kelly, CP (corresponding author), Beth Israel Deaconess Med Ctr, Celiac Ctr, 330 Brookline Ave,East DA 601, Boston, MA 02215 USA.	ckelly2@bidmc.harvard.edu						Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Aboudola S, 2003, INFECT IMMUN, V71, P1608, DOI 10.1128/IAI.71.3.1608-1610.2003; Alfa MJ, 2002, DIAGN MICR INFEC DIS, V43, P257, DOI 10.1016/S0732-8893(02)00413-3; ANAND A, 1993, CLIN INFECT DIS, V17, P109, DOI 10.1093/clinids/17.1.109; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; *CDCP, UND CLOSTR DIFF PAT; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Drudy D, 2007, CLIN MICROBIOL INFEC, V13, P298, DOI 10.1111/j.1469-0691.2006.01634.x; Follmar KE, 2008, SURG INFECT, V9, P195, DOI 10.1089/sur.2006.089; Gerding DN, 2008, CLIN INFECT DIS, V46, pS32, DOI 10.1086/521860; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Greenstein AJ, 2008, SURGERY, V143, P623, DOI 10.1016/j.surg.2007.12.008; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; HIERHOLZER WJ, 1995, AM J INFECT CONTROL, V23, P87; HIRSCHHORN LR, 1994, J INFECT DIS, V169, P127, DOI 10.1093/infdis/169.1.127; ISSACK MI, 1990, LANCET, V335, P610, DOI 10.1016/0140-6736(90)90400-Y; Izadnia F, 1998, DIGEST DIS SCI, V43, P2055, DOI 10.1023/A:1018811331596; Jaber MR, 2008, AM J GASTROENTEROL, V103, P3195, DOI 10.1111/j.1572-0241.2008.02198.x; Jaber MR, 2008, AM J GASTROENTEROL, V103, P3204; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Johnson S, 2007, CLIN INFECT DIS, V44, P846, DOI 10.1086/511870; Juang P, 2007, AM J INFECT CONTROL, V35, P131, DOI 10.1016/j.ajic.2006.06.007; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; KREUTZER EW, 1978, JOHNS HOPKINS MED J, V143, P67; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Kyne L, 1998, BIODRUGS, V10, P173, DOI 10.2165/00063030-199810030-00001; Kyne L, 2001, GUT, V49, P152, DOI 10.1136/gut.49.1.152; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie T, 2007, 47 ANN INT C ANT AG; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Mylonaki M, 2004, EUR J GASTROEN HEPAT, V16, P775, DOI 10.1097/01.meg.0000131040.38607.09; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P1443, DOI 10.1111/j.1572-0241.2007.01780.x; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; SEAL D, 1987, EUR J CLIN MICROBIOL, V6, P51, DOI 10.1007/BF02097191; Segarra-Newnham M, 2007, ANN PHARMACOTHER, V41, P1212, DOI 10.1345/aph.1K110; Sougioultzis S, 2005, GASTROENTEROLOGY, V128, P764, DOI 10.1053/j.gastro.2004.11.004; Stamper PD, 2009, J CLIN MICROBIOL, V47, P373, DOI 10.1128/JCM.01613-08; Stepan Crenguta, 2007, Expert Rev Gastroenterol Hepatol, V1, P295, DOI 10.1586/17474124.1.2.295; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; TEASLEY DG, 1983, LANCET, V2, P1043; TEDESCO FJ, 1985, AM J GASTROENTEROL, V80, P867; TRIADAFILOPOULOS G, 1991, GASTROENTEROLOGY, V101, P685, DOI 10.1016/0016-5085(91)90526-Q; *UK NAT STAT, CLOSTR DIFF NUMB DEA; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Warny M, 2003, MICROBIAL PATHOGENESIS AND THE INTESTINAL EPITHELIAL CELL, P503; Wilcox MH, 1998, J HOSP INFECT, V38, P93, DOI 10.1016/S0195-6701(98)90062-7; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; 1979, CAN MED ASS J, V121, P1193; [No title captured]	77	64	65	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 4	2009	301	9					954	962		10.1001/jama.2009.171	http://dx.doi.org/10.1001/jama.2009.171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413HQ	19190304				2022-12-28	WOS:000263784600025
J	Fox, RO				Fox, Robert O.			Frederic Richards (1925-2009) Obituary	NATURE			English	Biographical-Item									[Fox, Robert O.] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Fox, RO (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	rofox@utmb.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					976	976		10.1038/457976a	http://dx.doi.org/10.1038/457976a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225517	Bronze			2022-12-28	WOS:000263425400034
J	Xu, ZY; Wei, W; Gagneur, J; Perocchi, F; Clauder-Munster, S; Camblong, J; Guffanti, E; Stutz, F; Huber, W; Steinmetz, LM				Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Camblong, Jurgi; Guffanti, Elisa; Stutz, Francoise; Huber, Wolfgang; Steinmetz, Lars M.			Bidirectional promoters generate pervasive transcription in yeast	NATURE			English	Article							GENOME-WIDE TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; ANTISENSE TRANSCRIPTION; TILING ARRAYS; IDENTIFICATION; RESOLUTION; NUCLEOSOMES; POLYMERASE; LANDSCAPE; MAP	Genome- wide pervasive transcription has been reported in many eukaryotic organisms(1-7), revealing a highly interleaved transcriptome organization that involves hundreds of previously unknown non- codingRNAs(8). These recently identified transcripts either exist stably in cells ( stable unannotated transcripts, SUTs) or are rapidly degraded by the RNA surveillance pathway ( cryptic unstable transcripts, CUTs). One characteristic of pervasive transcription is the extensive overlap of SUTs and CUTs with previously annotated features, which prompts questions regarding how these transcripts are generated, and whether they exert function(9). Single- gene studies have shown that transcription of SUTs and CUTs can be functional, through mechanisms involving the generated RNAs10,11 or their generation itself(12-14). So far, a complete transcriptome architecture including SUTs and CUTs has not been described in any organism. Knowledge about the position and genome- wide arrangement of these transcripts will be instrumental in understanding their function(8,15). Here we provide a comprehensive analysis of these transcripts in the context of multiple conditions, a mutant of the exosome machinery and different strain backgrounds of Saccharomyces cerevisiae. We show that both SUTs and CUTs display distinct patterns of distribution at specific locations. Most of the newly identified transcripts initiate from nucleosome- free regions ( NFRs) associated with the promoters of other transcripts ( mostly protein- coding genes), or from NFRs at the 3 ' ends of protein- coding genes. Likewise, about half of all coding transcripts initiate from NFRs associated with promoters of other transcripts. These data change our view of how a genome is transcribed, indicating that bidirectionality is an inherent feature of promoters. Such an arrangement of divergent and overlapping transcripts may provide a mechanism for local spreading of regulatory signals - that is, coupling the transcriptional regulation of neighbouring genes by means of transcriptional interference or histone modification.	[Xu, Zhenyu; Wei, Wu; Gagneur, Julien; Perocchi, Fabiana; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Camblong, Jurgi] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Guffanti, Elisa; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Huber, Wolfgang] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Geneva; European Molecular Biology Laboratory (EMBL)	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Wei, Wu/AAC-8285-2020; Stutz, Françoise C/N-4329-2017	Wei, Wu/0000-0001-5643-8739; Clauder-Muenster, Sandra/0000-0002-9530-2938; Huber, Wolfgang/0000-0002-0474-2218; perocchi, fabiana/0000-0002-1102-6500; Steinmetz, Lars/0000-0002-3962-2865; Gagneur, Julien/0000-0002-8924-8365	National Institutes of Health; Deutsche Forschungsgemeinschaft; SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SystemsX fellowship; Roche fellowship; SNF; NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Akhtar, A. Ladurner, S. Blandin, R. Aiyar, E. Mancera and E. Fritsch for comments on the manuscript, J. Toedling for discussion and for the template of the website, C. Girardot for data submission to ArrayExpress, N. Proudfoot for access to experimental equipment, and the contributors to the Bioconductor (www.bioconductor.org) and R (http://www.r-project.org) projects for their software. This work was supported by grants to L.M.S. from the National Institutes of Health and Deutsche Forschungsgemeinschaft, by a SystemsX fellowship to E.G., by a Roche fellowship to J.C. and by grants to F.S. from SNF and NCCR Frontiers in Genetics.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	30	668	681	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1033	U7		10.1038/nature07728	http://dx.doi.org/10.1038/nature07728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169243	Green Accepted			2022-12-28	WOS:000263425400047
J	Shojania, KG; Levinson, W				Shojania, Kaveh G.; Levinson, Wendy			Clinicians in Quality Improvement A New Career Pathway in Academic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIAN ORDER ENTRY; HEALTH-CARE; PROMOTION; EDUCATORS; SYSTEMS; FACULTY; SCHOOLS		[Shojania, Kaveh G.; Levinson, Wendy] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Shojania, Kaveh G.; Levinson, Wendy] Univ Toronto, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Shojania, KG (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Room D470,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	kaveh.shojania@utoronto.ca	Mikhailova, Elena/G-8352-2014	Mikhailova, Elena/0000-0002-5280-6327				*ACCR COUNC GRAD M, ED PHYS 21 CENT; Ash JS, 2004, J AM MED INFORM ASSN, V11, P95, DOI 10.1197/jamia.M1427; Atasoylu AA, 2003, J GEN INTERN MED, V18, P711, DOI 10.1046/j.1525-1497.2003.10425.x; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Boonyasai RT, 2007, JAMA-J AM MED ASSOC, V298, P1023, DOI 10.1001/jama.298.9.1023; Cutler DM, 2005, HEALTH AFFAIR, V24, P1654, DOI 10.1377/hlthaff.24.6.1654; Fleming VM, 2005, JAMA-J AM MED ASSOC, V294, P1101, DOI 10.1001/jama.294.9.1101; Grol R, 2008, BMJ-BRIT MED J, V336, P74, DOI 10.1136/bmj.39413.486944.AD; Howell LP, 2007, ACAD MED, V82, P704, DOI 10.1097/ACM.0b013e318067489e; Levinson W, 1999, NEW ENGL J MED, V341, P840, DOI 10.1056/NEJM199909093411111; Levinson W, 2006, ACAD MED, V81, P568, DOI 10.1097/01.ACM.0000225223.45701.da; Simpson D, 2004, ACAD MED, V79, P783, DOI 10.1097/00001888-200408000-00014; Zeidel ML, 2002, AM J MED, V112, P165, DOI 10.1016/S0002-9343(01)01099-3	13	63	63	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					766	768		10.1001/jama.2009.140	http://dx.doi.org/10.1001/jama.2009.140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224754				2022-12-28	WOS:000263370100020
J	Pletcher, MJ; Lazar, L; Bibbins-Domingo, K; Moran, A; Rodondi, N; Coxson, P; Lightwood, J; Williams, L; Goldman, L				Pletcher, Mark J.; Lazar, Lawrence; Bibbins-Domingo, Kirsten; Moran, Andrew; Rodondi, Nicolas; Coxson, Pamela; Lightwood, James; Williams, Lawrence; Goldman, Lee			Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HOSPITAL CARDIAC-ARREST; BYPASS GRAFT-SURGERY; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; CHOLESTEROL LEVELS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; MORTALITY	Background: Lipid-lowering therapy is costly but effective at reducing coronary heart disease (CHD) risk. Objective: To assess the cost-effectiveness and public health impact of Adult Treatment Panel III (ATP III) guidelines and compare with a range of risk- and age-based alternative strategies. Design: The CHD Policy Model, a Markov-type cost-effectiveness model. Data Sources: National surveys ( 1999 to 2004), vital statistics ( 2000), the Framingham Heart Study ( 1948 to 2000), other published data, and a direct survey of statin costs ( 2008). Target Population: U. S. population age 35 to 85 years. Time Horizon: 2010 to 2040. Perspective: Health care system. Intervention: Lowering of low-density lipoprotein cholesterol with HMG-CoA reductase inhibitors (statins). Outcome Measure: Incremental cost-effectiveness. Results of Base-Case Analysis: Full adherence to ATP III primary prevention guidelines would require starting (9.7 million) or intensifying (1.4 million) statin therapy for 11.1 million adults and would prevent 20 000 myocardial infarctions and 10 000 CHD deaths per year at an annual net cost of $3.6 billion ($42 000/QALY) if low-intensity statins cost $2.11 per pill. The ATP III guidelines would be preferred over alternative strategies if society is willing to pay $50 000/QALY and statins cost $1.54 to $2.21 per pill. At higher statin costs, ATP III is not cost-effective; at lower costs, more liberal statin-prescribing strategies would be preferred; and at costs less than $0.10 per pill, treating all persons with low-density lipoprotein cholesterol levels greater than 3.4 mmol/L ( > 130 mg/dL) would yield net cost savings. Results of Sensitivity Analysis: Results are sensitive to the assumptions that LDL cholesterol becomes less important as a risk factor with increasing age and that little disutility results from taking a pill every day. Limitation: Randomized trial evidence for statin effectiveness is not available for all subgroups. Conclusion: The ATP III guidelines are relatively cost-effective and would have a large public health impact if implemented fully in the United States. Alternate strategies may be preferred, however, depending on the cost of statins and how much society is willing to pay for better health outcomes.	[Pletcher, Mark J.] Univ Calif San Francisco, San Francisco, CA 94107 USA; Columbia Univ, New York, NY USA; Univ Lausanne, Lausanne, Switzerland; Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California San Francisco; Columbia University; University of Lausanne; Harvard University; Brigham & Women's Hospital	Pletcher, MJ (corresponding author), Univ Calif San Francisco, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu		Rodondi, Nicolas/0000-0001-9083-6896	Medical Research Institute; Swanson Family Fund; Framingham Heart Study and Framingham Offspring Study; National Heart, Lung, and Blood Institute.	Medical Research Institute; Swanson Family Fund; Framingham Heart Study and Framingham Offspring Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Flight Attendants' Medical Research Institute and the Swanson Family Fund. The Framingham Heart Study and Framingham Offspring Study are conducted and supported by the National Heart, Lung, and Blood Institute.	Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; American Heart Association, 2006, HEART DIS STROK STAT; [Anonymous], 2000, NAT HLTH INT SURV; [Anonymous], 2006, REL BAS RES VAL SCAL; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bureau of Labor Statistics, 2008, CONS PRIC IND; *CA OFF STAT HLTH, 2001, CAL PAT DISCH DAT JA; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; *CDCP, 2002, YEAR 2000 VIT STAT M; *CDCP, 2006, GMWK307 DEATHS 39 SE; Centers for Disease Control and Prevention, 2008, NAT HLTH INT SURV; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Choudhury L, 1999, AM J MED, V107, P254, DOI 10.1016/S0002-9343(99)00218-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CTR MED MED SERV, 1999, PERS HLTH CAR SPEND; Davidson MH, 2005, AM J CARDIOL, V96, P556, DOI 10.1016/j.amjcard.2005.04.019; *DEP HLTH HUM SERV, 2005, FRAM HEART STUD; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P221, DOI 10.1001/jama.298.2.221; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Franco OH, 2007, INT J TECHNOL ASSESS, V23, P71, DOI 10.1017/S0266462307051598; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Goldberg RJ, 1998, AM J CARDIOL, V82, P1311, DOI 10.1016/S0002-9149(98)00633-X; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Goldman L, 1999, J AM COLL CARDIOL, V34, P768, DOI 10.1016/S0735-1097(99)00260-0; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; GURWITZ JH, 1991, AM J EPIDEMIOL, V134, P948, DOI 10.1093/oxfordjournals.aje.a116179; HAMILTON VH, 1995, JAMA-J AM MED ASSOC, V273, P1032, DOI 10.1001/jama.273.13.1032; *HEALTHC COST UT P, 2006, NAT IMP SAMPL NIS; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; ILLINGWORTH DR, 1994, CLIN THER, V16, P366; Jacobson TA, 2006, AM J CARDIOL, V97, p44C, DOI 10.1016/j.amjcard.2005.12.009; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Kendrach MG, 2004, ANN PHARMACOTHER, V38, P1286, DOI 10.1345/aph.1D391; Krumholz HM, 2001, J AM COLL CARDIOL, V38, P453, DOI 10.1016/S0735-1097(01)01395-X; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Kuisma M, 1997, ANN EMERG MED, V30, P69, DOI 10.1016/S0196-0644(97)70114-8; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Marchetti M, 2001, AM J MED, V111, P130, DOI 10.1016/S0002-9343(01)00793-8; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Marshall T, 2003, BMJ-BRIT MED J, V327, P1264, DOI 10.1136/bmj.327.7426.1264; McFayden JE, 2005, INT DRUG PRICE INDIC; Mihaylova B, 2006, BMJ-BRIT MED J, V333, P1145, DOI 10.1136/bmj.38993.731725.BE; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NAGHAVI M, 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; *NAT HEART LUNG BL, 2005, 3 REP EXP PAN DET EV; *OFF STAT HLTH PLA, 2008, HOSP FIN DAT COST CH; Packer M, 1999, AM J CARDIOL, V83, p1A; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Persell SD, 2006, J GEN INTERN MED, V21, P171, DOI [10.1111/j.1525-1497.2006.00323.x, 10.1007/s11606-006-0253-2]; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pharoah PDP, 1996, BMJ-BRIT MED J, V312, P1443, DOI 10.1136/bmj.312.7044.1443; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Ramachandran Sud, 2003, Prev Cardiol, V6, P17, DOI 10.1111/j.1520-037X.2003.00561.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rieves D, 2000, AM J CARDIOL, V85, P147, DOI 10.1016/S0002-9149(99)00652-9; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tolman KG, 2002, AM J CARDIOL, V89, P1374, DOI 10.1016/S0002-9149(02)02355-X; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; U. S. Census Bureau, US INT PROJ AG SEX R; *US CENS BUR, 2002, DET TABL SEX AG; *US CENS BUR, 1998, STAT ABSTR US AV COS; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; van Domburg RT, 2002, EUR HEART J, V23, P543, DOI 10.1053/euhj.2001.2821; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Westfall JM, 2001, MED CARE, V39, P459, DOI 10.1097/00005650-200105000-00006; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	81	141	146	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					243	U42		10.7326/0003-4819-150-4-200902170-00005	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00005			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221376				2022-12-28	WOS:000263562500003
J	Stoltz, DB; Whitfield, JB				Stoltz, Donald B.; Whitfield, James B.			VIROLOGY Making Nice with Viruses	SCIENCE			English	Editorial Material							PARASITOID WASP; INSECT; PARTICLES; EVOLUTION; HOST		[Stoltz, Donald B.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Whitfield, James B.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	Dalhousie University; University of Illinois System; University of Illinois Urbana-Champaign	Stoltz, DB (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.	dstoltz@dal.ca; jwhitfie@life.uiuc.edu						Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; BARONDESS JJ, 1990, NATURE, V346, P871, DOI 10.1038/346871a0; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; EDSON KM, 1981, SCIENCE, V211, P582, DOI 10.1126/science.7455695; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; KRELL PJ, 1979, J VIROL, V29, P1118, DOI 10.1128/JVI.29.3.1118-1130.1979; KRELL PJ, 1980, VIROLOGY, V101, P408, DOI 10.1016/0042-6822(80)90454-7; NORTON WN, 1975, CELL TISSUE RES, V162, P195; ROTHERAM S, 1967, NATURE, V214, P700, DOI 10.1038/214700a0; Stoltz D., 1992, Journal of Hymenoptera Research, V1, P125; Stoltz D B, 1979, Adv Virus Res, V24, P125, DOI 10.1016/S0065-3527(08)60393-0; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; Wang Y, 2007, ARCH VIROL, V152, P519, DOI 10.1007/s00705-006-0872-2	14	21	21	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					884	885		10.1126/science.1169808	http://dx.doi.org/10.1126/science.1169808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213903	Green Submitted			2022-12-28	WOS:000263295400025
J	Zaanen, J				Zaanen, Jan			PHYSICS Fast Electrons Tie Quantum Knots	SCIENCE			English	Editorial Material							PHASE; INSULATOR; WELLS		[Zaanen, Jan] Leiden Univ, Inst Lorentz, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Inst Lorentz, POB 9506, NL-2300 RA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; ISHIKAWA Y, 1984, J PHYS SOC JPN, V53, P2726, DOI 10.1143/JPSJ.53.2726; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Moore JE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186805; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; QI XL, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1167747; SKYRME THR, 1962, NUCL PHYS, V31, P556, DOI 10.1016/0029-5582(62)90775-7	12	14	14	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					888	890		10.1126/science.1169344	http://dx.doi.org/10.1126/science.1169344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213906				2022-12-28	WOS:000263295400028
J	Nicholls, H				Nicholls, Henry			Darwin 200: A flight of fancy	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					790	791		10.1038/457790a	http://dx.doi.org/10.1038/457790a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212386	Bronze			2022-12-28	WOS:000263266700018
J	Oganov, AR; Chen, JH; Gatti, C; Ma, YZ; Ma, YM; Glass, CW; Liu, ZX; Yu, T; Kurakevych, OO; Solozhenko, VL				Oganov, Artem R.; Chen, Jiuhua; Gatti, Carlo; Ma, Yanzhang; Ma, Yanming; Glass, Colin W.; Liu, Zhenxian; Yu, Tony; Kurakevych, Oleksandr O.; Solozhenko, Vladimir L.			Ionic high-pressure form of elemental boron	NATURE			English	Article							CRYSTAL-STRUCTURE; STABILITY; DENSITY	Boron is an element of fascinating chemical complexity. Controversies have shrouded this element since its discovery was announced in 1808: the new 'element' turned out to be a compound containing less than 60 - 70% of boron, and it was not until 1909 that 99% pure boron was obtained(1). And although we now know of at least 16 polymorphs(2), the stable phase of boron is not yet experimentally established even at ambient conditions(3). Boron's complexities arise from frustration: situated between metals and insulators in the periodic table, boron has only three valence electrons, which would favour metallicity, but they are sufficiently localized that insulating states emerge. However, this subtle balance between metallic and insulating states is easily shifted by pressure, temperature and impurities. Here we report the results of high- pressure experiments and ab initio evolutionary crystal structure predictions(4,5) that explore the structural stability of boron under pressure and, strikingly, reveal a partially ionic high-pressure boron phase. This new phase is stable between 19 and 89 GPa, can be quenched to ambient conditions, and has a hitherto unknown structure ( space group Pnnm, 28 atoms in the unit cell) consisting of icosahedral B(12) clusters and B(2) pairs in a NaCl- type arrangement. We find that the ionicity of the phase affects its electronic bandgap, infrared adsorption and dielectric constants, and that it arises from the different electronic properties of the B(2) pairs and B(12) clusters and the resultant charge transfer between them.	[Oganov, Artem R.; Chen, Jiuhua] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Oganov, Artem R.; Ma, Yanming; Glass, Colin W.] ETH, Crystallog Lab, Dept Mat, CH-8093 Zurich, Switzerland; [Oganov, Artem R.] Moscow MV Lomonosov State Univ, Dept Geol, Moscow 119992, Russia; [Chen, Jiuhua; Yu, Tony] Florida Int Univ, Ctr Study Matter & Extreme Condit, Miami, FL 33199 USA; [Chen, Jiuhua; Yu, Tony] Florida Int Univ, Dept Mech & Mat Engn, Miami, FL 33199 USA; [Chen, Jiuhua] SUNY Stony Brook, Inst Mineral Phys, Stony Brook, NY 11794 USA; [Chen, Jiuhua] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Gatti, Carlo] CNR, ISTM, I-20133 Milan, Italy; [Ma, Yanzhang] Texas Univ Technol, Dept Mech Engn, Lubbock, TX 79409 USA; [Ma, Yanming] Jilin Univ, Natl Lab Superhard Mat, Changchun 130012, Peoples R China; [Liu, Zhenxian] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; [Kurakevych, Oleksandr O.; Solozhenko, Vladimir L.] Univ Paris 13, LPMTM, CNRS, F-93430 Villetaneuse, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Swiss Federal Institutes of Technology Domain; ETH Zurich; Lomonosov Moscow State University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); Jilin University; Carnegie Institution for Science; Centre National de la Recherche Scientifique (CNRS); Universite Paris 13	Oganov, AR (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	artem.oganov@sunysb.edu	Glass, Colin/E-2377-2014; Ma, Yanming/A-7297-2008; Gatti, Carlo/AAA-8211-2020; Solozhenko, Vladimir L./E-1975-2011; Oganov, Artem R/A-1213-2008; Kurakevych, Oleksandr O/A-5105-2008; Oganov, Artem R./O-8234-2019; Oganov, Artem R./AAA-1478-2021; , Carlo/B-7410-2009; Ma, Yanming/ABE-8450-2020	Glass, Colin/0000-0003-0192-1808; Ma, Yanming/0000-0003-3711-0011; Solozhenko, Vladimir L./0000-0002-0881-9761; Oganov, Artem R/0000-0001-7082-9728; Kurakevych, Oleksandr O/0000-0002-1249-5325; Oganov, Artem R./0000-0001-7082-9728; , Carlo/0000-0002-0047-1596; Ma, Yanzhang/0000-0002-8215-7962	Swiss National Science Foundation [200021-111847/1]; ETH Research Equipment Programme; NSF [EAR0711321, DMR-0619215]; DOE [DE-FG02-07ER46461, DE-FC03-03NA00144]; Agence Nationale de la Recherche [ANR-05-BLAN-0141)]; US Department of Energy [DE-AC02-98CH10886]; COMPRES [EAR 06-49658]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Research Equipment Programme; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Agence Nationale de la Recherche(French National Research Agency (ANR)); US Department of Energy(United States Department of Energy (DOE)); COMPRES(National Science Foundation (NSF))	A.R.O. acknowledges the Swiss National Science Foundation (grant 200021-111847/1) and the ETH Research Equipment Programme for support of this work. J.C. and T.Y. were supported by the NSF (grant EAR0711321) and the DOE (contract DE-FG02-07ER46461), Yanzhang Ma was funded by the DOE (agreement DE-FC03-03NA00144) and the NSF (grant DMR-0619215), and O.O.K. and V.L.S. were supported by the Agence Nationale de la Recherche (grant ANR-05-BLAN-0141). The use of the NSLS at Brookhaven National Laboratory was supported by the US Department of Energy under contract DE-AC02-98CH10886, and high pressure beamlines at the NSLS were supported by COMPRES under NSF cooperative agreement EAR 06-49658. Calculations were performed at CSCS ( Manno), ETH Zurich, and the Joint Supercomputer Centre of the Russian Academy of Sciences.	AMBERGER E, 1971, J LESS-COMMON MET, V23, P21, DOI 10.1016/0022-5088(71)90004-X; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BLOC, 1990, K9OMS MOL QUANTUM TH; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brazlikin VV, 2004, J MATER RES, V19, P1643, DOI 10.1557/JMR.2004.0224; Chase MW, 1998, J PHYS CHEM REF DATA, V9, DOI [10.18434/T42S31, DOI 10.18434/T42S31]; Douglas BE, 2006, STRUCTURE CHEM CRYST; Dovesi R., 2006, CRYSTAL06 USERS MANU; Eremets MI, 2001, SCIENCE, V293, P272, DOI 10.1126/science.1062286; Glass CW, 2006, COMPUT PHYS COMMUN, V175, P713, DOI 10.1016/j.cpc.2006.07.020; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Haussermann U, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.065701; Hayami W, 1999, PHYS REV B, V60, P1523, DOI 10.1103/PhysRevB.60.1523; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Ma YZ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174116; Masago A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104102; McMahon MI, 2006, CHEM SOC REV, V35, P943, DOI 10.1039/b517777b; Oganov AR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210932; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PETRYANOVSOKOLO.IV, 1983, POPULAR LIB ELEMENTS, pCH5; Sanz DN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.245501; Solozhenko VL, 2006, CR CHIM, V9, P1472, DOI 10.1016/j.crci.2006.07.003; van Setten MJ, 2007, J AM CHEM SOC, V129, P2458, DOI 10.1021/ja0631246; VLASSE M, 1979, J SOLID STATE CHEM, V28, P289, DOI 10.1016/0022-4596(79)90080-X; Wells A. F., 1986, STRUCTURAL INORGANIC; WERHEIT H, 1993, PHYS STATUS SOLIDI B, V176, P415, DOI 10.1002/pssb.2221760215; Will G, 2001, Z ANORG ALLG CHEM, V627, P2100, DOI 10.1002/1521-3749(200109)627:9<2100::AID-ZAAC2100>3.0.CO;2-G	27	657	671	8	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					863	867		10.1038/nature07736	http://dx.doi.org/10.1038/nature07736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182772	Green Submitted			2022-12-28	WOS:000263266700041
J	McKay, CP				McKay, Christopher P.			PLANETARY SCIENCE Biologically Reversible Exploration	SCIENCE			English	Editorial Material							MARS; EARTH		[McKay, Christopher P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McKay, CP (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	christopher.mckay@nasa.gov						Barengoltz J, 2005, AEROSP CONF PROC, P253; Boston P J, 2003, Gravit Space Biol Bull, V16, P121; *COSPAR, 2003, COSPAR INF B, V156, P24; Kminek G, 2003, RADIAT RES, V159, P722, DOI 10.1667/0033-7587(2003)159[0722:RLFTVO]2.0.CO;2; Marinova MM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002306; McKay C.P., 2001, PLANET REP, V21, P4; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; McKay CP, 2004, PLOS BIOL, V2, P1260, DOI 10.1371/journal.pbio.0020302; *NAT RES COUNC, 2006, PREV FORW CONT MARS, P362; Schuerger AC, 2003, ICARUS, V165, P253, DOI 10.1016/S0019-1035(03)00200-8; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791	12	16	18	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					718	718		10.1126/science.1167987	http://dx.doi.org/10.1126/science.1167987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197043	Green Submitted			2022-12-28	WOS:000263066800024
J	Bach, PB				Bach, Peter B.			Smoking as a Factor in Causing Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOBACCO-CONTROL; SETTLEMENT; RISK		[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave,Box 44, New York, NY 10065 USA.							[Anonymous], 1952, CANC CARTON READERS; Bain C, 2004, JNCI-J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143; Campaign for Tobacco-Free Kids, STAT CIG TAX RAT RAN; Doll R, 1999, AM J PUBLIC HEALTH, V89, P1798, DOI 10.2105/AJPH.89.12.1798; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Gross CP, 2002, NEW ENGL J MED, V347, P1080, DOI 10.1056/NEJMsa012743; Grossman M, 1997, PUBLIC HEALTH REP, V112, P290; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Horn L, 2008, J CLIN ONCOL, V26, P3268, DOI 10.1200/JCO.2008.16.8260; Lai SH, 2000, J ADDICT DIS, V19, P11, DOI 10.1300/J069v19n04_02; Samet JM, 2007, EPIDEMIOLOGY, V18, P649, DOI 10.1097/EDE.0b013e3181271afa; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; *US SURG GEN ASS C, 1964, 1103 US PHS OFF SURG; Warner K., 2006, TOBACCO CONTROL POLI; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	15	13	17	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					539	541		10.1001/jama.2009.57	http://dx.doi.org/10.1001/jama.2009.57			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190320	Bronze			2022-12-28	WOS:000262992400026
J	Toon, PD				Toon, Peter D.			Practice Pointer "I need a note, doctor": dealing with requests for medical reports about patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England	University of London; Queen Mary University London	Toon, PD (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England.	p.d.toon@qmul.ac.uk						[Anonymous], 2006, REP ADV DRUG REACT G; BISCONCIN M, 2006, EUROPEAN TXB FAMILY, P51; *BMA PROF FEES COM, 2007, INS REP GUID MED PRA; Brabazon ED, 2008, EPIDEMIOL INFECT, V136, P241, DOI 10.1017/S0950268807008230; *BRIT MED ASS, 2004, ASS MENT CAP GUID DO; GLEN S, 2004, BRIT J SPORT MED, V34, P375; Hitchen L, 2006, BRIT MED J, V332, P1109, DOI 10.1136/bmj.332.7550.1109; *HLTH PROF COUNC, 2006, INF PROPS REG DOCT I; MCCORMICK A, 1993, COMMUN DIS REP CDR R, V3, P1; Moncrieff G, 2008, BRIT MED J, V336, P508, DOI 10.1136/bmj.39503.459572.59; *ROY COLL GEN PRAC, 2002, MAK DIFF RED BURD GE; Sawney P, 2002, BRIT J GEN PRACT, V52, P217; TOON PD, 1986, LANCET, V1, P1196; TOON PD, 1999, OCCAS PAP COLL GEN P, pR1	14	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2009	338								b175	10.1136/bmj.b175	http://dx.doi.org/10.1136/bmj.b175			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414OX	19190014				2022-12-28	WOS:000263876200002
J	Bao, L; Cai, T; Koenig, K; Fang, K; Han, J; Wang, J; Liu, Q; Ding, L; Cui, LL; Luo, Y; Wang, YF; Li, LM; Wu, NL				Bao, Lei; Cai, Tianfan; Koenig, Kathy; Fang, Kai; Han, Jing; Wang, Jing; Liu, Qing; Ding, Lin; Cui, Lili; Luo, Ying; Wang, Yufeng; Li, Lieming; Wu, Nianle			PHYSICS Learning and Scientific Reasoning	SCIENCE			English	Editorial Material							THINKING; MIDDLE		[Bao, Lei; Han, Jing; Wang, Jing; Liu, Qing; Ding, Lin] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Cai, Tianfan; Wang, Yufeng] Beijing Jiaotong Univ, Dept Phys, Beijing 100044, Peoples R China; [Koenig, Kathy] Wright State Univ, Dept Phys, Dayton, OH 45435 USA; [Fang, Kai] Tongji Univ, Dept Phys, Shanghai 200092, Peoples R China; [Cui, Lili] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Luo, Ying] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China; [Li, Lieming; Wu, Nianle] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China	University System of Ohio; Ohio State University; Beijing Jiaotong University; University System of Ohio; Wright State University Dayton; Tongji University; University System of Maryland; University of Maryland Baltimore County; Beijing Normal University; Tsinghua University	Bao, L (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	bao.15@osu.edu	Ding, Lin/C-6257-2009; Fang, Kai/M-1201-2015	Ding, Lin/0000-0002-6450-9856; Ding, Lin/0000-0002-4888-0479				ADEY P, 1990, J RES SCI TEACH, V27, P267, DOI 10.1002/tea.3660270309; Adey P., 1994, REALLY RAISING STAND; Benford R., 2001, RELATIONSHIPS EFFECT; BLOOM BENJAMIN S., 1956, HDB 1 COGNITIVE DOMA; Chen Z, 1999, CHILD DEV, V70, P1098, DOI 10.1111/1467-8624.00081; Ding L, 2006, PHYS REV SPEC TOP-PH, V2, DOI 10.1103/PhysRevSTPER.2.010105; Elby A, 1999, AM J PHYS, V67, pS52, DOI 10.1119/1.19081; Facione P., 1991, USING CALIFORNIA CRI; Gerber BL, 2001, INT J SCI EDUC, V23, P535, DOI 10.1080/095006901750162892; Hehn J, 2006, PHYS TODAY, V59, P37, DOI 10.1063/1.2186280; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; Iyengar R, 2008, SCIENCE, V319, P1189, DOI 10.1126/science.1149875; Kuhn D, 2004, J COGN DEV, V5, P261, DOI 10.1207/s15327647jcd0502_5; Lawson A. E., 1978, J RES SCI TEACH, V15, P11, DOI [10.1002/tea.3660150103, DOI 10.1002/TEA.3660150103]; Lawson A. E., 1995, SCI TEACHING DEV THI; Linn MC, 2006, SCIENCE, V313, P1049, DOI 10.1126/science.1131408; MAREK EA, 1997, LEARNING CYCLE ELEME; National Research Council, 1996, NAT SCI ED STAND, DOI [10.17226/4962, DOI 10.17226/4962]; National Research Council (NRC), 2002, LEARN UND IMPR ADV S; NISBETT RE, 1987, SCIENCE, V238, P625, DOI 10.1126/science.3672116; SCHOENFELD AH, 1988, EDUC PSYCHOL, V23, P145, DOI 10.1207/s15326985ep2302_5; SINGER H, 2005, AM LAB REPORT; VanLehn K., 1989, FDN COGNITIVE SCI, P1; Zheng AY, 2008, SCIENCE, V319, P414, DOI 10.1126/science.1147852; Zimmerman C, 2007, DEV REV, V27, P172, DOI 10.1016/j.dr.2006.12.001; 2000, CLASSROOM TEST SCI R	26	117	124	10	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					586	587		10.1126/science.1167740	http://dx.doi.org/10.1126/science.1167740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	400JB	19179514				2022-12-28	WOS:000262862800025
J	Westwood, MA; Flett, AS; Riding, P; Moon, JC				Westwood, Mark A.; Flett, Andrew S.; Riding, Phil; Moon, James C.			How to webcast lectures and conferences	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Westwood, Mark A.; Moon, James C.] Univ Coll London Hosp NHS Trust, Heart Hosp, Dept Cardiol, London W1G 8PH, England; [Flett, Andrew S.] London Chest Hosp, London E2 9JX, England; [Riding, Phil; Moon, James C.] UCL, London WC1E 6BT, England; [Moon, James C.] Soc Cardiovasc Magnet Resonance, Mt Royal, NJ 08061 USA	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; Queen Mary University London; University of London; University College London	Moon, JC (corresponding author), Univ Coll London Hosp NHS Trust, Heart Hosp, Dept Cardiol, London W1G 8PH, England.	james.moon@uclh.nhs.uk	Moon, James/AAA-9905-2020; Moon, James C/F-1031-2014	Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 30	2009	338								b31	10.1136/bmj.b31	http://dx.doi.org/10.1136/bmj.b31			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EQ	19181731				2022-12-28	WOS:000263206000005
J	Attia, E; Walsh, BT				Attia, Evelyn; Walsh, B. Timothy			Behavioral Management for Anorexia Nervosa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED FAMILY; EATING-DISORDERS; BULIMIA-NERVOSA; ADOLESCENT; HOSPITALIZATION; PREVALENCE; INPATIENT; PATTERNS; THERAPY; WEIGHT		[Attia, Evelyn; Walsh, B. Timothy] Columbia Univ Coll Phys & Surg, Unit 98, Eating Disorders Res Unit, Dept Psychiat, New York, NY 10032 USA; [Attia, Evelyn; Walsh, B. Timothy] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Attia, E (corresponding author), Columbia Univ Coll Phys & Surg, Unit 98, Eating Disorders Res Unit, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	ea12@columbia.edu			Eli Lilly; Pfizer; Abbott Laboratories; AstraZeneca	Eli Lilly(Eli Lilly); Pfizer(Pfizer); Abbott Laboratories(Abbott Laboratories); AstraZeneca(AstraZeneca)	Dr. Attia reports receiving grant support from Eli Lilly and Pfizer; and Dr. Walsh, grant support from Abbott Laboratories and AstraZeneca. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2006, AM J PSYCHIAT; Attia E, 2001, J Psychiatr Pract, V7, P157, DOI 10.1097/00131746-200105000-00003; Bissada H, 2008, AM J PSYCHIAT, V165, P1281, DOI 10.1176/appi.ajp.2008.07121900; Bulik CM, 2007, ANNU REV NUTR, V27, P263, DOI 10.1146/annurev.nutr.27.061406.093713; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; CRISP AH, 1991, BRIT J PSYCHIAT, V159, P325, DOI 10.1192/bjp.159.3.325; ECKERT ED, 1995, PSYCHOL MED, V25, P143, DOI 10.1017/S0033291700028166; Eisler I, 2007, J CHILD PSYCHOL PSYC, V48, P552, DOI 10.1111/j.1469-7610.2007.01726.x; Golden Neville H, 2004, Int J Adolesc Med Health, V16, P131; Gordon R.A., 2000, EATING DISORDERS ANA; Guarda A. S., 2003, HDB EATING DISORDERS, P297; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kaye W, 2008, PHYSIOL BEHAV, V94, P121, DOI 10.1016/j.physbeh.2007.11.037; Keys A, 1950, BIOL HUMAN STARVATIO; Lask B, 2005, INT J EAT DISORDER, V38, P269, DOI 10.1002/eat.20163; Le Grande D, 2005, J AM ACAD CHILD PSY, V44, P41, DOI 10.1097/01.chi.0000145373.68863.85; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Lock J, 2013, TREATMENT MANUAL ANO, V2nd; McIntosh VVW, 2005, AM J PSYCHIAT, V162, P741, DOI 10.1176/appi.ajp.162.4.741; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; National Institute for Clinical Excellence, 2004, NICE CLIN GUID; Offord A, 2006, EUR EAT DISORD REV, V14, P377, DOI 10.1002/erv.687; PERTSCHUK MJ, 1981, BIOL PSYCHIAT, V16, P539; Pike KM, 2003, AM J PSYCHIAT, V160, P2046, DOI 10.1176/appi.ajp.160.11.2046; Robergeau K, 2006, J ADOLESCENT HEALTH, V39, P806, DOI 10.1016/j.jadohealth.2006.08.003; Simon J, 2005, PSYCHOL MED, V35, P1543, DOI 10.1017/S0033291705004708; Striegel-Moore RH, 2000, INT J EAT DISORDER, V27, P381; STRIEGELMOORE RH, 1998, CLIN PSYCHOL REV, V18, P447; Strober M, 2000, AM J PSYCHIAT, V157, P393, DOI 10.1176/appi.ajp.157.3.393; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Wade TD, 2008, PSYCHOSOM MED, V70, P239, DOI 10.1097/PSY.0b013e31815c40f1; Walsh BT, 2007, JAMA-J AM MED ASSOC, V298, P2008; Walsh BT, 2006, JAMA-J AM MED ASSOC, V296, P934; Walsh BT, 2006, JAMA-J AM MED ASSOC, V295, P2605, DOI 10.1001/jama.295.22.2605; Wiseman CV, 2001, INT J EAT DISORDER, V30, P69, DOI 10.1002/eat.1055	36	75	77	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					500	506		10.1056/NEJMct0805569	http://dx.doi.org/10.1056/NEJMct0805569			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399PS	19179317				2022-12-28	WOS:000262812400009
J	Drazen, JM; Desai, NR; Green, P				Drazen, Jeffrey M.; Desai, Nihar R.; Green, Philip			Fighting On.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Desai, Nihar R.; Green, Philip] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital			Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	9	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					444	445		10.1056/NEJMp0809496	http://dx.doi.org/10.1056/NEJMp0809496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179313				2022-12-28	WOS:000262812400003
J	Subak, LL; Wing, R; West, DS; Franklin, F; Vittinghoff, E; Creasman, JM; Richter, HE; Myers, D; Burgio, KL; Gorin, AA; Macer, J; Kusek, JW; Grady, D				Subak, Leslee L.; Wing, Rena; West, Delia Smith; Franklin, Frank; Vittinghoff, Eric; Creasman, Jennifer M.; Richter, Holly E.; Myers, Deborah; Burgio, Kathryn L.; Gorin, Amy A.; Macer, Judith; Kusek, John W.; Grady, Deborah		PRIDE Investigators	Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; STRESS-INCONTINENCE; STYLE INTERVENTION; FOLLOW-UP; SURGERY; HEALTH; PREVENTION; DIARY; RISK	Background: Obesity is an established and modifiable risk factor for urinary incontinence, but conclusive evidence for a beneficial effect of weight loss on urinary incontinence is lacking. Methods: We randomly assigned 338 overweight and obese women with at least 10 urinary-incontinence episodes per week to an intensive 6-month weight-loss program that included diet, exercise, and behavior modification (226 patients) or to a structured education program (112 patients). Results: The mean (+/-SD) age of the participants was 53+/-11 years. The body-mass index (BMI) (the weight in kilograms divided by the square of the height in meters) and the weekly number of incontinence episodes as recorded in a 7-day diary of voiding were similar in the intervention group and the control group at baseline (BMI, 36+/-6 and 36+/-5, respectively; incontinence episodes, 24+/-18 and 24+/-16, respectively). The women in the intervention group had a mean weight loss of 8.0% (7.8 kg), as compared with 1.6% (1.5 kg) in the control group (P<0.001). After 6 months, the mean weekly number of incontinence episodes decreased by 47% in the intervention group, as compared with 28% in the control group (P=0.01). As compared with the control group, the intervention group had a greater decrease in the frequency of stress-incontinence episodes (P=0.02), but not of urge-incontinence episodes (P=0.14). A higher proportion of the intervention group than of the control group had a clinically relevant reduction of 70% or more in the frequency of all incontinence episodes (P<0.001), stress-incontinence episodes (P=0.009), and urge-incontinence episodes (P=0.04). Conclusions: A 6-month behavioral intervention targeting weight loss reduced the frequency of self-reported urinary-incontinence episodes among overweight and obese women as compared with a control group. A decrease in urinary incontinence may be another benefit among the extensive health improvements associated with moderate weight reduction. (ClinicalTrials.gov number, NCT00091988.) N Engl J Med 2009;360:481-90.	[Subak, Leslee L.; Vittinghoff, Eric; Creasman, Jennifer M.; Macer, Judith; Grady, Deborah] Univ Calif San Francisco, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; [Wing, Rena] Miriam Hosp, Providence, RI 02906 USA; [Wing, Rena; Myers, Deborah] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [West, Delia Smith] Univ Arkansas Med Sci, Coll Publ Hlth, Little Rock, AR 72205 USA; [Franklin, Frank; Richter, Holly E.; Burgio, Kathryn L.] Univ Alabama Birmingham, Birmingham, AL USA; [Burgio, Kathryn L.] Dept Vet Affairs, Ctr Geriatr Res Educ & Clin, Birmingham, AL USA; [Gorin, Amy A.] Univ Connecticut, Storrs, CT USA; [Kusek, John W.] NIDDKD, Bethesda, MD 20892 USA; [Grady, Deborah] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; Lifespan Health Rhode Island; Miriam Hospital; Brown University; University of Arkansas System; University of Arkansas Medical Sciences; University of Alabama System; University of Alabama Birmingham; Geriatric Research Education & Clinical Center; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Subak, LL (corresponding author), Univ Calif San Francisco, Womens Hlth Clin Res Ctr, 1635 Divisadero St,Suite 600, San Francisco, CA 94115 USA.	subakl@obgyn.ucsf.edu	West, Delia Smith/GWV-5839-2022	West, Delia Smith/0000-0002-4375-2785; Richter, Holly E/0000-0001-7741-5771	National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK067860, U01 DK067861, U01 DK067862]; Office of Research on Women's Health; Pfizer; Bionovo; Astellas; GlaxoSmithKline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK067862, U01DK067861, K24DK080775, U01DK067860] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Pfizer(Pfizer); Bionovo; Astellas(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (U01 DK067860, U01 DK067861, and U01 DK067862) and from the Office of Research on Women's Health.; Dr. Subak reports serving on an advisory board for Pfizer and receiving grant support from Pfizer; Dr. Grady, receiving grant support from Bionovo; Dr. Kusek, owning stock in Eli Lilly, Pfizer, and deCODE Genetics; and Dr. Burgio, serving on an advisory board for Pfizer, receiving grant support from Pfizer, and receiving advisory-board fees from Astellas and GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.; The views expressed are those of the authors and do not necessarily represent the official views of the NIDDK or the National Institutes of Health.	Abrams P, 1988, Scand J Urol Nephrol Suppl, V114, P5; Albo M, 2007, J UROLOGY, V177, P1810, DOI 10.1016/j.juro.2007.01.032; Blissmer B, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-43; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; BUMP RC, 1992, AM J OBSTET GYNECOL, V167, P392, DOI 10.1016/S0002-9378(11)91418-5; Burgio KL, 2007, OBSTET GYNECOL, V110, P1034, DOI 10.1097/01.AOG.0000285483.22898.9c; Burgio KL, 2006, NEUROUROL URODYNAM, V25, P411, DOI 10.1002/nau.20243; Burgio KL, 2002, JAMA-J AM MED ASSOC, V288, P2293, DOI 10.1001/jama.288.18.2293; Burgio KL, 1989, STAYING DRY PRACTICA; Cummings JM, 2000, INT UROGYNECOL J PEL, V11, P41, DOI 10.1007/s001920050008; Danforth KN, 2006, AM J OBSTET GYNECOL, V194, P339, DOI 10.1016/j.ajog.2005.07.051; DEITEL M, 1988, J AM COLL NUTR, V7, P147, DOI 10.1080/07315724.1988.10720232; Espeland M, 2007, DIABETES CARE, V30, P1374; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; GRIMBY A, 1993, AGE AGEING, V22, P82, DOI 10.1093/ageing/22.2.82; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; HUNSKAAR S, 1991, J AM GERIATR SOC, V39, P378, DOI 10.1111/j.1532-5415.1991.tb02903.x; HUNSKAAR S, 1992, J AM GERIATR SOC, V40, P976, DOI 10.1111/j.1532-5415.1992.tb02002.x; Karlsson J, 1998, INT J OBESITY, V22, P113, DOI 10.1038/sj.ijo.0800553; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Miller ER, 2002, HYPERTENSION, V40, P612, DOI 10.1161/01.HYP.0000037217.96002.8E; Nygaard I, 2000, INT UROGYNECOL J, V11, P15, DOI 10.1007/PL00004021; Reid FM, 2007, NEUROUROL URODYNAM, V26, P123, DOI 10.1002/nau.20303; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Subak LL, 2005, J UROLOGY, V174, P190, DOI 10.1097/01.ju.0000162056.30326.83; Subak LL, 2002, INT UROGYNECOL J PEL, V13, P40, DOI 10.1007/s001920200008; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Townsend MK, 2007, OBSTET GYNECOL, V110, P346, DOI 10.1097/01.AOG.0000270121.15510.57; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2006, OBESITY, V14, P737; Waetjen LE, 2007, AM J EPIDEMIOL, V165, P309, DOI 10.1093/aje/kwk018; Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8; WING RR, 1984, J PSYCHOSOM RES, V28, P189, DOI 10.1016/0022-3999(84)90019-9; WYMAN JF, 1988, OBSTET GYNECOL, V71, P812	36	353	364	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					481	490		10.1056/NEJMoa0806375	http://dx.doi.org/10.1056/NEJMoa0806375			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179316	Green Accepted			2022-12-28	WOS:000262812400007
J	Anderson, TM; vonHoldt, BM; Candille, SI; Musiani, M; Greco, C; Stahler, DR; Smith, DW; Padhukasahasram, B; Randi, E; Leonard, JA; Bustamante, CD; Ostrander, EA; Tang, H; Wayne, RK; Barsh, GS				Anderson, Tovi M.; vonHoldt, Bridgett M.; Candille, Sophie I.; Musiani, Marco; Greco, Claudia; Stahler, Daniel R.; Smith, Douglas W.; Padhukasahasram, Badri; Randi, Ettore; Leonard, Jennifer A.; Bustamante, Carlos D.; Ostrander, Elaine A.; Tang, Hua; Wayne, Robert K.; Barsh, Gregory S.			Molecular and Evolutionary History of Melanism in North American Gray Wolves	SCIENCE			English	Article							COAT COLOR; GENETIC-BASIS; DIFFERENTIATION; INTROGRESSION; PATTERNS; SEQUENCE; GENOME; BLACK; WOLF; WILD	Morphological diversity within closely related species is an essential aspect of evolution and adaptation. Mutations in the Melanocortin 1 receptor (Mc1r) gene contribute to pigmentary diversity in natural populations of fish, birds, and many mammals. However, melanism in the gray wolf, Canis lupus, is caused by a different melanocortin pathway component, the K locus, that encodes a beta-defensin protein that acts as an alternative ligand for Mc1r. We show that the melanistic K locus mutation in North American wolves derives from past hybridization with domestic dogs, has risen to high frequency in forested habitats, and exhibits a molecular signature of positive selection. The same mutation also causes melanism in the coyote, Canis latrans, and in Italian gray wolves, and hence our results demonstrate how traits selected in domesticated species can influence the morphological diversity of their wild relatives.	[Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Anderson, Tovi M.; Candille, Sophie I.; Tang, Hua; Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [vonHoldt, Bridgett M.; Stahler, Daniel R.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 91302 USA; [Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Greco, Claudia; Randi, Ettore] Ist Nazl Fauna Selvat, I-40064 Ozzano Dell Emilia, BO, Italy; [Stahler, Daniel R.; Smith, Douglas W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [Padhukasahasram, Badri; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Leonard, Jennifer A.] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Ostrander, Elaine A.] NHGRI, Bethesda, MD 20892 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of Calgary; Italian Institute for Environmental Protection & Research (ISPRA); United States Department of the Interior; Cornell University; Uppsala University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	Musiani, Marco/ABB-9387-2021; Greco, Claudia/ABA-6030-2020; Leonard, Jennifer/A-7894-2010	Musiani, Marco/0000-0002-6097-5841; Leonard, Jennifer/0000-0003-0291-7819; Bustamante, Carlos D./0000-0002-4187-7920; Greco, Claudia/0000-0002-8678-0890; Ostrander, Elaine/0000-0001-6075-9738	NIH; NSF; Swedish Research Council; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from NIH (G.S.B.), NSF (R.K.W., D.R.S., and D.W.S.), and the Swedish Research Council (J. A.L.). We are grateful to H. Chen and S. Schmutz for advice, to H. Manuel for technical assistance, and to members of the U.S. Department of Agriculture Wildlife Services and private citizens for assistance with sample collection. Sequences generated in this study are deposited in GenBank under accession numbers FJ609634 to FJ609641.	Andersson L, 2003, ANN NY ACAD SCI, V994, P313, DOI 10.1111/j.1749-6632.2003.tb03195.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Gipson PS, 2002, WILDLIFE SOC B, V30, P821; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; JOLICOEUR P, 1959, EVOLUTION, V13, P283, DOI 10.1111/j.1558-5646.1959.tb03016.x; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Majerus M, 1998, MELANISM EVOLUTION A; Mech LD., 1998, WOLVES DENALI; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Peterson RO, 1984, WILDLIFE MONOGR, P3; Randi E, 2002, CONSERV GENET, V3, P31; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tang H, 2002, GENETICS, V161, P447; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913	29	294	308	1	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1339	1343		10.1126/science.1165448	http://dx.doi.org/10.1126/science.1165448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19197024	Green Accepted			2022-12-28	WOS:000263876700041
J	Legge, D; Sanders, D; Mccoy, D				Legge, David; Sanders, David; McCoy, David			Trade and health: the need for a political economic analysis	LANCET			English	Editorial Material									[Legge, David] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia; [Sanders, David] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; UCL, Ctr Int Hlth & Dev, London, England	La Trobe University; University of the Western Cape; University of London; University College London	Legge, D (corresponding author), La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia.	D.Legge@latrobe.edu.au		Sanders, David/0000-0003-1094-7655				Blouin C, 2009, LANCET, V373, P502, DOI 10.1016/S0140-6736(08)61777-8; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; People's Health Movement Medact and Global Equity Gauge Alliance, 2008, GLOB HLTH WATCH 2 AL; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X; WHO, 2008, PHARMAFORUM 0121	5	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					527	529		10.1016/S0140-6736(08)61761-4	http://dx.doi.org/10.1016/S0140-6736(08)61761-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19167057	Green Submitted			2022-12-28	WOS:000263333600010
J	Potter, A; Fox, K; Cook, S; Punjabi, P; Connolly, S				Potter, Andrew; Fox, Kevin; Cook, Stuart; Punjabi, Prakash; Connolly, Susan			Collapse while jogging and a mimic of milk	LANCET			English	Editorial Material							CHYLOPERICARDIUM		[Potter, Andrew; Fox, Kevin; Connolly, Susan] Charing Cross Hosp, Dept Cardiol, London, England; [Cook, Stuart] Natl Heart & Lung Inst, MRC, Ctr Clin Sci, London, England; [Punjabi, Prakash] Hammersmith Hosp, Dept Cardiothorac Surg, London, England	Imperial College London; Imperial College London; Imperial College London	Potter, A (corresponding author), Royal Free Hosp, Dept Acute Med, 2nd Floor,Pond St, London NW3 2QG, England.	apotter1980@hotmail.com	Punjabi, Prakash P/AAG-8724-2019	Punjabi, Prakash P/0000-0002-6587-1603				Dib C, 2008, J THORAC CARDIOV SUR, V136, P650, DOI 10.1016/j.jtcvs.2008.03.033; Koksel Oguz, 2007, J Trauma, V63, pE13, DOI 10.1097/TA.0b013e3180d0a46b; Wurnig PN, 2000, ANN THORAC SURG, V70, P1662, DOI 10.1016/S0003-4975(00)01921-4	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					602	602		10.1016/S0140-6736(09)60208-7	http://dx.doi.org/10.1016/S0140-6736(09)60208-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217994				2022-12-28	WOS:000263333600039
J	Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Postlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rucklinger, E; Greil, R				Gnant, Michael; Mlineritsch, Brigitte; Schippinger, Walter; Luschin-Ebengreuth, Gero; Poestlberger, Sabine; Menzel, Christian; Jakesz, Raimund; Seifert, Michael; Hubalek, Michael; Bjelic-Radisic, Vesna; Samonigg, Hellmut; Tausch, Christoph; Eidtmann, Holger; Steger, Guenther; Kwasny, Werner; Dubsky, Peter; Fridrik, Michael; Fitzal, Florian; Stierer, Michael; Rucklinger, Ernst; Greil, Richard		ABCSG-12 Trial Investigators	Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	44th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 30-JUN 03, 2008	Chicago, IL	Amer Soc Clin Oncol			BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; DELTA T-CELLS; POSTMENOPAUSAL WOMEN; ADJUVANT THERAPY; AUSTRIAN BREAST; BONE LOSS; SOLID TUMORS; TAMOXIFEN; METASTASES; RECEPTOR	Background Ovarian suppression plus tamoxifen is a standard adjuvant treatment in premenopausal women with endocrine- responsive breast cancer. Aromatase inhibitors are superior to tamoxifen in postmenopausal patients, and preclinical data suggest that zoledronic acid has antitumor properties. Methods We examined the effect of adding zoledronic acid to a combination of either goserelin and tamoxifen or goserelin and anastrozole in premenopausal women with endocrineresponsive early breast cancer. We randomly assigned 1803 patients to receive goserelin ( 3.6 mg given subcutaneously every 28 days) plus tamoxifen ( 20 mg per day given orally) or anastrozole ( 1 mg per day given orally) with or without zoledronic acid ( 4 mg given intravenously every 6 months) for 3 years. The primary end point was disease- free survival; recurrence- free survival and overall survival were secondary end points. Results After a median follow- up of 47.8 months, 137 events had occurred, with disease- free survival rates of 92.8% in the tamoxifen group, 92.0% in the anastrozole group, 90.8% in the group that received endocrine therapy alone, and 94.0% in the group that received endocrine therapy with zoledronic acid. There was no significant difference in disease- free survival between the anastrozole and tamoxifen groups ( hazard ratio for disease progression in the anastrozole group, 1.10; 95% confidence interval [ CI], 0.78 to 1.53; P = 0.59). The addition of zoledronic acid to endocrine therapy, as compared with endocrine therapy without zoledronic acid, resulted in an absolute reduction of 3.2 percentage points and a relative reduction of 36% in the risk of disease progression ( hazard ratio, 0.64; 95% CI, 0.46 to 0.91; P = 0.01); the addition of zoledronic acid did not significantly reduce the risk of death ( hazard ratio, 0.60; 95% CI, 0.32 to 1.11; P = 0.11). Adverse events were consistent with known drug- safety profiles. Conclusions The addition of zoledronic acid to adjuvant endocrine therapy improves disease- free survival in premenopausal patients with estrogen- responsive early breast cancer. (ClinicalTrials. gov number, NCT00295646.).	[Gnant, Michael; Jakesz, Raimund; Seifert, Michael; Steger, Guenther; Dubsky, Peter; Fitzal, Florian] Med Univ Vienna, A-1090 Vienna, Austria; [Stierer, Michael] Hanusch Hosp, Vienna, Austria; [Rucklinger, Ernst] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria; [Mlineritsch, Brigitte; Menzel, Christian; Greil, Richard] Paracelsus Med Univ Salzburg, Salzburg, Austria; [Schippinger, Walter; Luschin-Ebengreuth, Gero; Bjelic-Radisic, Vesna; Samonigg, Hellmut] Med Univ Graz, Graz, Austria; [Poestlberger, Sabine; Tausch, Christoph] Hosp Sisters Mercy, Linz, Austria; [Fridrik, Michael] Gen Hosp Linz, Linz, Austria; [Hubalek, Michael] Med Univ Innsbruck, Innsbruck, Austria; [Kwasny, Werner] Wiener Neustadt Gen Hosp, Wiener Neustadt, Austria; [Eidtmann, Holger] Univ Schleswig Holstein, Kiel, Germany	Medical University of Vienna; WGKK - Hanusch Hospital; Paracelsus Private Medical University; Medical University of Graz; Kepler University Hospital; Medical University of Innsbruck; University of Kiel; Schleswig Holstein University Hospital	Gnant, M (corresponding author), Med Univ Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	michael.gnant@meduniwien.ac.at	Hubalek, Michael/ABD-8041-2021; Gnant, Michael/AAN-7054-2020; Schoppmann, Sebastian F./K-1530-2017	Gnant, Michael/0000-0003-1002-2118; Schoppmann, Sebastian F./0000-0002-1725-7086; Keckstein, Joerg/0000-0002-3943-3300; Fridrik, Michael A./0000-0003-4073-4191; Bachleitner-Hofmann, Thomas/0000-0002-4201-8247				AFT R, 2008, J CLIN ONCOL S, V26, pS46; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1996, Lancet, V348, P1189; Aviles A, 2007, MED ONCOL, V24, P227, DOI 10.1007/BF02698044; Bria E, 2006, CANCER-AM CANCER SOC, V106, P2337, DOI 10.1002/cncr.21886; Brufsky A, 2008, ONCOLOGIST, V13, P503, DOI 10.1634/theoncologist.2007-0206; Brufsky A, 2007, J CLIN ONCOL, V25, P829, DOI 10.1200/JCO.2005.05.3744; Bundred NJ, 2008, CANCER-AM CANCER SOC, V112, P1001, DOI 10.1002/cncr.23259; COX DR, 1972, J R STAT SOC B, V34, P187; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Cuzick J, 2007, LANCET, V369, P1711; Daubine F, 2007, J NATL CANCER I, V99, P322, DOI 10.1093/jnci/djk054; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Diel IJ, 1998, NEW ENGL J MED, V339, P357, DOI 10.1056/NEJM199808063390601; Diel IJ, 2007, CRIT REV ONCOL HEMAT, V64, P198, DOI 10.1016/j.critrevonc.2007.07.005; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Forward DP, 2004, BRIT J CANCER, V90, P590, DOI 10.1038/sj.bjc.6601557; Gnant M, 2008, LANCET ONCOL, V9, P840, DOI 10.1016/S1470-2045(08)70204-3; Gnant MFX, 2007, J CLIN ONCOL, V25, P820, DOI 10.1200/JCO.2005.02.7102; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2007, ANN ONCOL, V18, P1917; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Ha TC, 2007, BRIT J CANCER, V96, P1796, DOI 10.1038/sj.bjc.6603661; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Hirsh V, 2008, J THORAC ONCOL, V3, P228, DOI 10.1097/JTO.0b013e3181651c0e; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Jakesz R, 2002, J CLIN ONCOL, V20, P4621, DOI 10.1200/JCO.2002.09.112; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jakesz R, 2008, JNCI-J NATL CANCER I, V100, P226; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Jonat W, 2007, LANCET ONCOL, V8, P6; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kunzmann V, 2000, BLOOD, V96, P384; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; LIN A, 2008, 6 EUR BREAST CANC C; Lipton A, 2008, CANCER-AM CANCER SOC, V113, P193, DOI 10.1002/cncr.23529; Mystakidou K, 2005, MED ONCOL, V22, P195, DOI 10.1385/MO:22:2:195; RACK BK, 2007, 30 ANN SAN ANT BREAS; REINER A, 1990, CANCER RES, V50, P7057; Rosen LS, 2001, CANCER J, V7, P377; Santini D, 2007, CLIN CANCER RES, V13, P4482, DOI 10.1158/1078-0432.CCR-07-0551; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Weitzman R, 2007, CRIT REV ONCOL HEMAT, V62, P148, DOI 10.1016/j.critrevonc.2006.12.005; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Wolff AC, 2006, J CLIN ONCOL, V24, P4949, DOI 10.1200/JCO.2006.07.9160; ZAGHLOUL MS, 2008, J CLIN ONCOL S, V26, pS257; [No title captured]	52	831	867	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					679	691		10.1056/NEJMoa0806285	http://dx.doi.org/10.1056/NEJMoa0806285			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	405YQ	19213681				2022-12-28	WOS:000263260500005
J	Kumar, G; Tang, HX; Schroers, J				Kumar, Golden; Tang, Hong X.; Schroers, Jan			Nanomoulding with amorphous metals	NATURE			English	Article							IMPRINT LITHOGRAPHY; MECHANICAL-BEHAVIOR; NANOIMPRINT LITHOGRAPHY; GLASS; TRANSITION; ALLOYS; NI	Nanoimprinting promises low- cost fabrication of micro- and nano-devices by embossing features from a hard mould onto thermoplastic materials, typically polymers with low glass transition temperature(1). The success and proliferation of such methods critically rely on the manufacturing of robust and durable master moulds(2). Silicon- based moulds are brittle(3) and have limited longevity(4). Metal moulds are stronger than semiconductors, but patterning of metals on the nano-metre scale is limited by their finite grain size. Amorphous metals ( metallic glasses) exhibit superior mechanical properties and are intrinsically free from grain size limitations. Here we demonstrate direct nanopatterning of metallic glasses by hot embossing, generating feature sizes as small as 13 nm. After subsequently crystallizing the as-formed metallic glass mould, we show that another amorphous sample of the same alloy can be formed on the crystallized mould. In addition, metallic glass replicas can also be used as moulds for polymers or other metallic glasses with lower softening temperatures. Using this 'spawning' process, we can massively replicate patterned surfaces through direct moulding without using conventional lithography. We anticipate that our findings will catalyse the development of micro- and nanoscale metallic glass applications that capitalize on the outstanding mechanical properties, microstructural homogeneity and isotropy, and ease of thermoplastic forming exhibited by these materials(5-7).	[Kumar, Golden; Tang, Hong X.; Schroers, Jan] Yale Univ, New Haven, CT 06511 USA	Yale University	Schroers, J (corresponding author), Yale Univ, New Haven, CT 06511 USA.	jan.schroers@yale.edu	kumar, golden/F-5443-2010; Kumar, Golden/AAP-9823-2021; Tang, Hong/D-1587-2009		US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	We thank T. A. Waniuk and C. S. O'Hern for reading of the manuscript and E. R. Dufresne for discussion. This work was supported by the US National Science Foundation under the Material Processing and Manufacturing programme.	Barbero DR, 2007, ADV FUNCT MATER, V17, P2419, DOI 10.1002/adfm.200600710; Basrour S, 2000, MAT SCI ENG A-STRUCT, V288, P270, DOI 10.1016/S0921-5093(00)00868-6; CHEN HS, 1968, J CHEM PHYS, V48, P2560, DOI 10.1063/1.1669483; Chou SY, 2002, NATURE, V417, P835, DOI 10.1038/nature00792; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Chou SY, 1997, J VAC SCI TECHNOL B, V15, P2897, DOI 10.1116/1.589752; Dalla Torre F, 2005, SCRIPTA MATER, V53, P23, DOI 10.1016/j.scriptamat.2005.03.026; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Haatainen T, 2006, MICROELECTRON ENG, V83, P948, DOI 10.1016/j.mee.2006.01.038; Heckele M, 2004, J MICROMECH MICROENG, V14, pR1, DOI 10.1088/0960-1317/14/3/R01; Hirai Y, 2002, JPN J APPL PHYS 1, V41, P4186, DOI 10.1143/JJAP.41.4186; Hua F, 2004, NANO LETT, V4, P2467, DOI 10.1021/nl048355u; Inoue A, 2003, NAT MATER, V2, P661, DOI 10.1038/nmat982; Johnson WL, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400053252; Kumar G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834712; Palm G, 2006, J ENG MATER-T ASME, V128, P559, DOI 10.1115/1.2345447; PATTERSON JP, 1978, MATER RES BULL, V13, P583, DOI 10.1016/0025-5408(78)90182-4; SAOTOME Y, 1994, 7 IEEE INT WORKSH MI, P343; Saotome Y, 2007, MATER SCI FORUM, V539-543, P2088, DOI 10.4028/www.scientific.net/MSF.539-543.2088; Schroers J, 2006, ADV MATER PROCESS, V164, P61; Schroers J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008374; Schroers J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255506; Schroers J, 2005, JOM-US, V57, P35, DOI 10.1007/s11837-005-0093-2; Schroers J, 2007, J MICROELECTROMECH S, V16, P240, DOI 10.1109/JMEMS.0007.892889; Schroers J, 2007, SCRIPTA MATER, V57, P341, DOI 10.1016/j.scriptamat.2007.04.033; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; Waniuk T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184203; Zankovych S, 2001, NANOTECHNOLOGY, V12, P91, DOI 10.1088/0957-4484/12/2/303	31	565	595	11	557	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					868	872		10.1038/nature07718	http://dx.doi.org/10.1038/nature07718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212407				2022-12-28	WOS:000263266700042
J	Wilensky, GR				Wilensky, Gail R.			HEALTH CARE 2009 Reforming Medicare's Physician Payment System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wilensky, Gail R.] MedPAC, Washington, DC USA									BERENSON R, 2007, OPTIONS IMPROVE QUAL; *MED PAYM ADV COMM, 2007, REPO C ASS ALT SUST; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658	3	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					653	655		10.1056/NEJMp0808003	http://dx.doi.org/10.1056/NEJMp0808003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213677				2022-12-28	WOS:000263260500001
J	Jackson, M				Jackson, Mark			Dust	LANCET			English	Editorial Material												m.a.jackson@exeter.ac.uk							0	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					453	453		10.1016/S0140-6736(09)60156-2	http://dx.doi.org/10.1016/S0140-6736(09)60156-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200905				2022-12-28	WOS:000263132800014
J	Cohen, A; Hall, MN				Cohen, Adiel; Hall, Michael N.			An Amino Acid Shuffle Activates mTORC1	CELL			English	Editorial Material							RAG GTPASES	The mammalian target of rapamycin complex 1 (mTORC1), which promotes cell growth, is regulated by specific nutrients such as the amino acid leucine. In this issue, Nicklin et al. (2009) describe a mechanism by which glutamine facilitates the uptake of leucine, leading to mTORC1 activation.	[Cohen, Adiel; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757				Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Krause U, 2002, EUR J BIOCHEM, V269, P3742, DOI 10.1046/j.1432-1033.2002.03069.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	9	41	44	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					399	401		10.1016/j.cell.2009.01.021	http://dx.doi.org/10.1016/j.cell.2009.01.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203575	Bronze			2022-12-28	WOS:000263120600010
J	Gong, KP; Du, F; Xia, ZH; Durstock, M; Dai, LM				Gong, Kuanping; Du, Feng; Xia, Zhenhai; Durstock, Michael; Dai, Liming			Nitrogen-Doped Carbon Nanotube Arrays with High Electrocatalytic Activity for Oxygen Reduction	SCIENCE			English	Article							CONDUCTING POLYMERS; MODIFIED ELECTRODES; NANOCOMPOSITE	The large- scale practical application of fuel cells will be difficult to realize if the expensive platinum- based electrocatalysts for oxygen reduction reactions ( ORRs) cannot be replaced by other efficient, low- cost, and stable electrodes. Here, we report that vertically aligned nitrogen- containing carbon nanotubes ( VA- NCNTs) can act as a metal- free electrode with a much better electrocatalytic activity, long- term operation stability, and tolerance to crossover effect than platinum for oxygen reduction in alkaline fuel cells. In air- saturated 0.1 molar potassium hydroxide, we observed a steady- state output potential of - 80 millivolts and a current density of 4.1 milliamps per square centimeter at - 0.22 volts, compared with - 85 millivolts and 1.1 milliamps per square centimeter at - 0.20 volts for a platinum- carbon electrode. The incorporation of electron- accepting nitrogen atoms in the conjugated nanotube carbon plane appears to impart a relatively high positive charge density on adjacent carbon atoms. This effect, coupled with aligning the NCNTs, provides a four- electron pathway for the ORR on VA- NCNTs with a superb performance.	[Gong, Kuanping; Du, Feng; Dai, Liming] Univ Dayton, Dept Chem Engn, Dayton, OH 45469 USA; [Gong, Kuanping; Du, Feng; Dai, Liming] Univ Dayton, Dept Mat Engn, Dayton, OH 45469 USA; [Xia, Zhenhai] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Durstock, Michael] USAF, Res Lab, RXBP, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; [Dai, Liming] Univ Dayton, Dept Chem, Dayton, OH 45469 USA; [Dai, Liming] Univ Dayton, Res Inst, Dayton, OH 45469 USA; [Dai, Liming] Univ Dayton, Inst Dev & Commercializat Adv Sensor Technol, Dayton, OH 45469 USA; [Dai, Liming] Wright Bros Inst, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University System of Ohio; University of Akron; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University of Dayton; University of Dayton; University of Dayton	Dai, LM (corresponding author), Univ Dayton, Dept Chem Engn, 300 College Pk, Dayton, OH 45469 USA.	ldai@udayton.edu	Dai, Liming/AAV-4376-2020	Dai, Liming/0000-0001-7536-160X; Xia, Zhenhai/0000-0002-0881-2906	Air Force Office of Scientific Research [FA9550-06-1-0384]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We gratefully acknowledge financial support for this work from the Air Force Office of Scientific Research (grant FA9550-06-1-0384). K. G. thanks L. Qu and J. Zhu for help with some initial work.	Arico AS, 2001, FUEL CELLS, V1, P133; Casellato U, 2006, ELECTROCHIM ACTA, V51, P5669, DOI 10.1016/j.electacta.2006.01.057; Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694; Chen ZW, 2007, ANGEW CHEM INT EDIT, V46, P4060, DOI 10.1002/anie.200700894; Cui HF, 2006, NANOTECHNOLOGY, V17, P2334, DOI 10.1088/0957-4484/17/9/043; DAI L, 2006, RECENT DEV CHEM PHYS; Dai LM, 2007, AUST J CHEM, V60, P472, DOI 10.1071/CH06470; Dai LM, 2003, CHEMPHYSCHEM, V4, P1150, DOI 10.1002/cphc.200300770; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; Fisch M, 2003, GAUSSIAN 03 REVISION; Gao M, 2000, ANGEW CHEM INT EDIT, V39, P3664, DOI 10.1002/1521-3773(20001016)39:20<3664::AID-ANIE3664>3.0.CO;2-Y; Gong KP, 2007, J PHYS CHEM C, V111, P1882, DOI 10.1021/jp0628636; Gooding JJ, 2007, ELECTROCHEM COMMUN, V9, P1677, DOI 10.1016/j.elecom.2007.03.023; GUPTA SL, 1986, P S LOAD LEV EN CONS, P207; Kongkanand A, 2006, LANGMUIR, V22, P2392, DOI 10.1021/la052753a; Panchalkarla LS, 2007, ACS NANO, V1, P494, DOI 10.1021/nn700230n; Shah RK, 2007, RECENT TRENDS FUEL C, P1; Shi Z, 2006, ELECTROCHIM ACTA, V51, P1905, DOI 10.1016/j.electacta.2005.07.006; Sljukic B, 2005, J IRAN CHEM SOC, V2, P1, DOI 10.1007/BF03245775; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Yang JB, 2008, CHEM COMMUN, P329, DOI 10.1039/b713096a; Yu EH, 2004, FUEL CELLS, V3, P169, DOI 10.1002/fuce.200330129; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569; Zhang MN, 2004, LANGMUIR, V20, P8781, DOI 10.1021/la048923l	27	5785	5921	146	6132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					760	764		10.1126/science.1168049	http://dx.doi.org/10.1126/science.1168049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197058				2022-12-28	WOS:000263066800040
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators II	CELL			English	Editorial Material							PROTEINS; FAMILY		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [5T32DE007306, T32 DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Dehmelt L, 2005, GENOME BIOL, V6; DeWard AD, 2008, CURR BIOL, V18, pR605, DOI 10.1016/j.cub.2008.06.001; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005	10	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3							566.e1	10.1016/j.cell.2009.01.011	http://dx.doi.org/10.1016/j.cell.2009.01.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203588	Green Accepted, Bronze			2022-12-28	WOS:000263120600025
J	Stewart, GS; Panier, S; Townsend, K; Al-Hakim, AK; Kolas, NK; Miller, ES; Nakada, S; Ylanko, J; Olivarius, S; Mendez, M; Oldreive, C; Wildenhain, J; Tagliaferro, A; Pelletier, L; Taubenheim, N; Durandy, A; Byrd, PJ; Stankovic, T; Taylor, AMR; Durocher, D				Stewart, Grant S.; Panier, Stephanie; Townsend, Kelly; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Miller, Edward S.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Oldreive, Ceri; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Taubenheim, Nadine; Durandy, Anne; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.; Durocher, Daniel			The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; 53BP1; GENE; ATM; REPAIR; MDC1; PATHWAY	The biological response to DNA double-strand breaks acts to preserve genome integrity. Individuals bearing inactivating mutations in components of this response exhibit clinical symptoms that include cellular radiosensitivity, immunodeficiency, and cancer predisposition. The archetype for such disorders is Ataxia-Telangiectasia caused by biallelic mutation in ATM, a central component of the DNA damage response. Here, we report that the ubiquitin ligase RNF168 is mutated in the RIDDLE syndrome, a recently discovered immuno-deficiency and radiosensitivity disorder. We show that RNF168 is recruited to sites of DNA damage by binding toubiquitylated histone H2A. RNF168 acts with UBC13 to amplify the RNF8-dependent histone ubiquitylation by targeting H2A-type histones and by promoting the formation of lysine 63-linked ubiquitin conjugates. These RNF168-dependent chromatin modifications orchestrate the accumulation of 53BP1 and BRCA1 to DNA lesions, and their loss is the likely cause of the cellular and developmental phenotypes associated with RIDDLE syndrome.	[Stewart, Grant S.; Townsend, Kelly; Miller, Edward S.; Oldreive, Ceri; Byrd, Philip J.; Stankovic, Tatjana; Taylor, A. Malcolm R.] Univ Birmingham, Canc Res UK, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Panier, Stephanie; Al-Hakim, Abdallah K.; Kolas, Nadine K.; Nakada, Shinichiro; Ylanko, Jarkko; Olivarius, Signe; Mendez, Megan; Wildenhain, Jan; Tagliaferro, Andrea; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Panier, Stephanie; Ylanko, Jarkko; Pelletier, Laurence; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Taubenheim, Nadine; Durandy, Anne] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France	Cancer Research UK; University of Birmingham; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stewart, GS (corresponding author), Univ Birmingham, Canc Res UK, Inst Canc Studies, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk; durocher@lunenfeld.ca	OsakaU/AAY-3661-2020; Pelletier, Laurence/F-8858-2013; Wildenhain, Jan/E-5597-2011; Wildenhain, Jan/Q-6596-2019; Durocher, Daniel/A-7733-2010; Panier, Stephanie/GVT-6365-2022; Durandy, Anne/H-7475-2017	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Durocher, Daniel/0000-0003-3863-8635; Durandy, Anne/0000-0001-7706-8466; Stankovic, Tatjana/0000-0002-3780-274X; Nakada, Shinichiro/0000-0001-9297-1565; Stewart, Grant/0000-0002-0960-3241				Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	562	589	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					420	434		10.1016/j.cell.2008.12.042	http://dx.doi.org/10.1016/j.cell.2008.12.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203578	Bronze			2022-12-28	WOS:000263120600013
J	Kao, SC; Wu, H; Xie, JM; Chang, CP; Ranish, JA; Graef, IA; Crabtree, GR				Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Ranish, Jeffrey A.; Graef, Isabella A.; Crabtree, Gerald R.			Calcineurin/NFAT Signaling Is Required for Neuregulin-Regulated Schwann Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; PERIPHERAL NERVOUS-SYSTEM; HEART DEVELOPMENT; AXONAL REGULATION; NUCLEAR FACTOR; MYELINATION; SURVIVAL; PROLIFERATION; NERVES; OCT-6	Schwann cells develop from multipotent neural crest cells and form myelin sheaths around axons that allow rapid transmission of action potentials. Neuregulin signaling through the ErbB receptor regulates Schwann cell development; however, the downstream pathways are not fully defined. We find that mice lacking calcineurin B1 in the neural crest have defects in Schwann cell differentiation and myelination. Neuregulin addition to Schwann cell precursors initiates an increase in cytoplasmic Ca2+, which activates calcineurin and the downstream transcription factors NFATc3 and c4. Purification of NFAT protein complexes shows that Sox10 is an NFAT nuclear partner and synergizes with NFATc4 to activate Krox20, which regulates genes necessary for myelination. Our studies demonstrate that calcineurin and NFAT are essential for neuregulin and ErbB signaling, neural crest diversification, and differentiation of Schwann cells.	[Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Chang, Ching-Pin; Graef, Isabella A.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Kao, Shih-Chu; Wu, Hai; Xie, Jianming; Chang, Ching-Pin; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98103 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Institute for Systems Biology (ISB)	Graef, IA (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	igraef@stanford.edu; crabtree@stanford.edu	Xie, Jianming/AAC-6359-2019; Xie, Jianming/G-6567-2012	Xie, Jianming/0000-0003-4112-650X; Kao, Shih-chu/0000-0002-6294-5494	NIH [NS046789, HD55391, AI60037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R37NS046789, R21NS061702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.A. Borres for insightful comments; K.J. Liu, Q. Lin, and J. Perrino for technical assistance; and J. I. Wu for critically reading this manuscript. G.R.C is an Investigator of HHMI. These studies were supported by grants from NIH (NS046789, HD55391, and AI60037) to G. R. C.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Ghislain J, 2002, DEVELOPMENT, V129, P155; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Srinivasan R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-117; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006	29	161	166	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					651	654		10.1126/science.1166562	http://dx.doi.org/10.1126/science.1166562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179536	Green Accepted			2022-12-28	WOS:000262862800048
J	La Rocca, M; Creager, KC; Galluzzo, D; Malone, S; Vidale, JE; Sweet, JR; Wech, AG				La Rocca, Mario; Creager, Kenneth C.; Galluzzo, Danilo; Malone, Steve; Vidale, John E.; Sweet, Justin R.; Wech, Aaron G.			Cascadia Tremor Located Near Plate Interface Constrained by S Minus P Wave Times	SCIENCE			English	Article							NON-VOLCANIC TREMOR; EPISODIC TREMOR; EARTHQUAKES; SUBDUCTION; JAPAN	Nonvolcanic tremor is difficult to locate because it does not produce impulsive phases identifiable across a seismic network. An alternative approach to identifying specific phases is to measure the lag between the S and P waves. We cross- correlate vertical and horizontal seismograms to reveal signals common to both, but with the horizontal delayed with respect to the vertical. This lagged correlation represents the time interval between vertical compressional waves and horizontal shear waves. Measurements of this interval, combined with location techniques, resolve the depth of tremor sources within +/-2 kilometers. For recent Cascadia tremor, the sources locate near or on the subducting slab interface. Strong correlations and steady S- P time differences imply that tremor consists of radiation from repeating sources.	[La Rocca, Mario; Galluzzo, Danilo] Ist Nazl Geofis & Vulcanol, Osserv Vesuviano, I-80124 Naples, Italy; [Creager, Kenneth C.; Malone, Steve; Vidale, John E.; Sweet, Justin R.; Wech, Aaron G.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Washington; University of Washington Seattle	La Rocca, M (corresponding author), Ist Nazl Geofis & Vulcanol, Osserv Vesuviano, Via Diocleziano 328, I-80124 Naples, Italy.	mlarocca@ov.ingv.it	Galluzzo, Danilo/I-4618-2017; Vidale, John/H-4965-2011	Galluzzo, Danilo/0000-0002-8952-9271; Vidale, John/0000-0002-3658-818X; La Rocca, Mario/0000-0002-2059-5350; Wech, Aaron/0000-0003-4983-1991	INGV; NSF; U.S. Geological Survey	INGV(Istituto Nazionale Geofisica e Vulcanologia (INGV)); NSF(National Science Foundation (NSF)); U.S. Geological Survey(United States Geological Survey)	Istituto Nazionale di Geofisica e Vulcanologia and IRIS/PASSCAL provided instruments for the arrays; other seismograms were provided by the Pacific Northwest Seismic Network. Discussions with T. Pratt, J. Gomberg, H. Houston, A. Ghosh, E. Del Pezzo and comments from two anonymous reviewers improved this manuscript. Funding was provided by INGV, NSF and the U.S. Geological Survey.	CROSSON RS, 1976, J GEOPHYS RES, V81, P3047, DOI 10.1029/JB081i017p03047; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Kao H, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003727; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kao H, 2004, GEOPHYS J INT, V157, P589, DOI 10.1111/j.1365-246X.2004.02276.x; La Rocca M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023974; La Rocca M, 2008, B SEISMOL SOC AM, V98, P620, DOI 10.1785/0120060185; McCausland W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024349; Melbourne TI, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021790; Miyazawa M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022539; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Preston LA, 2003, SCIENCE, V302, P1197, DOI 10.1126/science.1090751; Ramachandran K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004108; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2008, SCIENCE, V319, P186, DOI 10.1126/science.1150558; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shelly DR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001640; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Wech AG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035458; Wech AG, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031167	23	86	86	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					620	623		10.1126/science.1167112	http://dx.doi.org/10.1126/science.1167112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179527				2022-12-28	WOS:000262862800039
J	Rada, G				Rada, Gabriel			Immediate and delayed acupuncture reduced frequency and pain intensity of primary migraine or tension-type headaches	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Pontificia Univ Catolica Chile, Santiago, Chile	Pontificia Universidad Catolica de Chile	Rada, G (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.			Rada, Gabriel/0000-0003-2435-0710				MELCHART D, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001218	1	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-14	10.7326/0003-4819-150-2-200901200-02014	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172719				2022-12-28	WOS:000262655200032
J	Ishii, M; Egen, JG; Klauschen, F; Meier-Schellersheim, M; Saeki, Y; Vacher, J; Proia, RL; Germain, RN				Ishii, Masaru; Egen, Jackson G.; Klauschen, Frederick; Meier-Schellersheim, Martin; Saeki, Yukihiko; Vacher, Jean; Proia, Richard L.; Germain, Ronald N.			Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; CELL-MIGRATION; VASCULAR MATURATION; LYMPHOID ORGANS; TRANSGENIC MICE; T-CELLS; MARROW; EXPRESSION; COLLAGEN	Osteoclasts are the only somatic cells with bone-resorbing capacity and, as such, they have a critical role not only in normal bone homeostasis (called 'bone remodelling') but also in the pathogenesis of bone destructive disorders such as rheumatoid arthritis and osteoporosis(1). A major focus of research in the field has been on gene regulation by osteoclastogenic cytokines such as receptor activator of NF-kappa B-ligand (RANKL, also known as TNFSF11) and TNF-alpha, both of which have been well documented to contribute to osteoclast terminal differentiation(2,3). A crucial process that has been less well studied is the trafficking of osteoclast precursors to and from the bone surface, where they undergo cell fusion to form the fully differentiated multinucleated cells that mediate bone resorption. Here we report that sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood(4,5), induces chemotaxis and regulates the migration of osteoclast precursors not only in culture but also in vivo, contributing to the dynamic control of bone mineral homeostasis. Cells with the properties of osteoclast precursors express functional S1P(1) receptors and exhibit positive chemotaxis along an S1P gradient in vitro. Intravital two-photon imaging of bone tissues showed that a potent S1P(1) agonist, SEW2871, stimulated motility of osteoclast precursor-containing monocytoid populations in vivo. Osteoclast/monocyte (CD11b, also known as ITGAM) lineage-specific conditional S1P(1) knockout mice showed osteoporotic changes due to increased osteoclast attachment to the bone surface. Furthermore, treatment with the S1P(1) agonist FTY720 relieved ovariectomy-induced osteoporosis in mice by reducing the number of mature osteoclasts attached to the bone surface. Together, these data provide evidence that S1P controls the migratory behaviour of osteoclast precursors, dynamically regulating bone mineral homeostasis, and identifies a critical control point in osteoclastogenesis that may have potential as a therapeutic target.	[Ishii, Masaru; Egen, Jackson G.; Germain, Ronald N.] NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick; Meier-Schellersheim, Martin; Germain, Ronald N.] NIDDK, Program Syst Immunol & Infect Dis Modeling, NIAID, NIH, Bethesda, MD 20892 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Biol Imaging, Suita, Osaka 5650871, Japan; [Ishii, Masaru; Saeki, Yukihiko] Natl Osaka Minami Med Ctr, Dept Clin Res, Osaka 5868521, Japan; [Vacher, Jean] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Osaka University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Germain, RN (corresponding author), NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Proia, Richard L/A-7908-2012; Ishii, Masaru/D-2361-2009; Germain, Ronald/ABE-7090-2020; Klauschen, Frederick/C-5637-2015; Germain, Ronald N./Z-1945-2019	Klauschen, Frederick/0000-0002-9131-2389; Proia, Richard/0000-0003-0456-1270; Egen, Jackson/0000-0003-2053-0837	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; NIH; US Department of Health and Human Services; International Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; International Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank U. H. von Andrian and I. B. Mazo for their help with the technique of intravital skull bone imaging. We also thank Y. Takuwa and N. Sugimoto for discussions, and P. M. Murphy and S. Venkatesan for their help in imaging in vitro chemotaxis using the EZ-Taxiscan. This work was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH, US Department of Health and Human Services, and by a fellowship grant to M. I. from the International Human Frontier Science Program.	Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Tedesco-Silva H, 2007, TRANSPLANTATION, V84, P885, DOI 10.1097/01.tp.0000281385.26500.3b; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404	29	382	403	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					524	U8		10.1038/nature07713	http://dx.doi.org/10.1038/nature07713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204730	Green Accepted			2022-12-28	WOS:000264532400048
J	Cassidy, J				Cassidy, Jane			Medicine and the Media Jade, class, and cervical cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						Brown J, 1997, Popul Trends, P40; Brown J, 1997, POPUL TRENDS, V90, P49; Harris V, 1998, CANC REGISTRATION ST, P182; *NHS CERV SCREEN P, ANN REV 2008	4	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 18	2009	338								b691	10.1136/bmj.b691	http://dx.doi.org/10.1136/bmj.b691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CG	19224973				2022-12-28	WOS:000264052100009
J	Isaacs, SL; Jellinek, PS; Ray, WL				Isaacs, Stephen L.; Jellinek, Paul S.; Ray, Walker L.			The Independent Physician - Going, Going ...	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Isaacs, Stephen L.; Jellinek, Paul S.] Isaacs Jellinek, San Francisco, CA USA; [Ray, Walker L.] Phys Fdn, Boston, MA USA		Isaacs, SL (corresponding author), Isaacs Jellinek, San Francisco, CA USA.							Beasley JW, 2005, ANN FAM MED, V3, P500, DOI 10.1370/afm.369; Cunningham PJ, 2006, 13 CTR STUD HLTH SYS; Kikano GE, 1998, J FAM PRACTICE, V46, P499; Lowes R, 2000, Med Econ, V77, P80; LOWES R, 2000, MED ECON, V77, P89; LOWES R, 2000, MED ECON, V80, P95; Tollen L., 2008, PHYS ORG RELATION QU, V89	7	31	31	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					655	657		10.1056/NEJMp0808076	http://dx.doi.org/10.1056/NEJMp0808076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213678				2022-12-28	WOS:000263260500002
J	Hill, AVS; Shirley, M; Greenwood, BM				Hill, Adrian V. S.; Shirley, Martin; Greenwood, Brian M.			Jenner reborn: a new vaccine institute	LANCET			English	Editorial Material									[Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England; [Shirley, Martin] Inst Food Res, Inst Anim Hlth, Compton Lab, Newbury RG16 0NN, Berks, England; [Greenwood, Brian M.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Quadram Institute; University of London; London School of Hygiene & Tropical Medicine	Hill, AVS (corresponding author), Univ Oxford, Jenner Inst Labs, Oxford OX3 78DQ, England.	adrian.hill@ndm.ox.ac.uk			Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Fowler VL, 2008, VACCINE, V26, P1982, DOI 10.1016/j.vaccine.2008.02.012; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Nossal GJV, 2004, NAT IMMUNOL, V5, P457, DOI 10.1038/ni0504-457; POLLARD AJ, NAT REV IMM IN PRESS; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; WILKINSON E, 2008, BBC NEWS        0905	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					445	446		10.1016/S0140-6736(09)60150-1	http://dx.doi.org/10.1016/S0140-6736(09)60150-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19200904				2022-12-28	WOS:000263132800010
J	Gavrilets, S; Losos, JB				Gavrilets, Sergey; Losos, Jonathan B.			Adaptive Radiation: Contrasting Theory with Data	SCIENCE			English	Review							SYMPATRIC SPECIATION; SENSORY DRIVE; CICHLID FISH; EVOLUTIONARY; MODEL; DIVERSIFICATION; HYBRIDIZATION; CONSERVATION; POPULATION; DYNAMICS	Biologists have long been fascinated by the exceptionally high diversity displayed by some evolutionary groups. Adaptive radiation in such clades is not only spectacular, but is also an extremely complex process influenced by a variety of ecological, genetic, and developmental factors and strongly dependent on historical contingencies. Using modeling approaches, we identify 10 general patterns concerning the temporal, spatial, and genetic/ morphological properties of adaptive radiation. Some of these are strongly supported by empirical work, whereas for others, empirical support is more tentative. In almost all cases, more data are needed. Future progress in our understanding of adaptive radiation will be most successful if theoretical and empirical approaches are integrated, as has happened in other areas of evolutionary biology.	[Gavrilets, Sergey] Univ Tennessee, Dept Ecol & Evolutionary Biol, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Gavrilets, Sergey] Univ Tennessee, Dept Math, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Harvard University; Harvard University	Gavrilets, S (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	sergey@tiem.utk.edu			NSF [DEB-0519777)]; NIH [GM56693]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056693] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Birand, R. Glor, A. Harrison, L. Harmon, D Jablonski, L. Mahler, C. Marshall, and the anonymous reviewers for useful comments. Supported by the NSF (grant DEB-0519777) and the NIH (grant GM56693).	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Albertson RC, 2003, J HERED, V94, P291, DOI 10.1093/jhered/esg071; Bolnick DI, 2006, J THEOR BIOL, V241, P734, DOI 10.1016/j.jtbi.2006.01.009; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Chow SS, 2004, SCIENCE, V305, P84, DOI 10.1126/science.1096307; Christensen K, 2002, J THEOR BIOL, V216, P73, DOI 10.1006/jtbi.2002.2530; Coyne J.A., 2004, SPECIATION; Coyne JA, 2000, EVOLUTION, V54, P2166; DARWIN C, 1909, VOYAGE BOOGLE, P383; Dieckman U, 2004, ADAPTIVE SPECIATION; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Endler J.A., 1977, Monographs in Population Biology, pi; Erwin D.H., 1992, Historical Biology, V6, P133; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Fryer G, 1996, ENVIRON BIOL FISH, V45, P109, DOI 10.1007/BF00005225; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gavrilets S, 1999, P ROY SOC B-BIOL SCI, V266, P817, DOI 10.1098/rspb.1999.0711; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gavrilets Sergey, 2009, P102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Givnish T.J., 1997, MOL EVOLUTION ADAPTI; Grant P. R., 2008, WHY SPECIES MULTIPLY; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Ito HC, 2007, AM NAT, V170, pE96, DOI 10.1086/521229; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lack D., 1947, DARWINS FINCHES; LANDE R, 1991, GENETICS, V128, P443; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2002, AM NAT, V160, P147, DOI 10.1086/341557; Mayr E., 1963, ANIMAL SPECIES EVOLU; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Pie MR, 2005, AM NAT, V166, pE1, DOI 10.1086/430727; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Sepkoski J. J., 1985, PHANEROZOIC DIVERSIT; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; VALENTINE JW, 1983, EVOLUTION TIME SPACE, P201; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	59	488	498	1	484	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					732	737		10.1126/science.1157966	http://dx.doi.org/10.1126/science.1157966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197052				2022-12-28	WOS:000263066800033
J	Hausleiter, J; Meyer, T; Hermann, F; Hadamitzky, M; Krebs, M; Gerber, TC; McCollough, C; Martinoff, S; Kastrati, A; Schoemig, A; Achenbach, S				Hausleiter, Joerg; Meyer, Tanja; Hermann, Franziska; Hadamitzky, Martin; Krebs, Markus; Gerber, Thomas C.; McCollough, Cynthia; Martinoff, Stefan; Kastrati, Adnan; Schoemig, Albert; Achenbach, Stephan			Estimated Radiation Dose Associated With Cardiac CT Angiography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOMOGRAPHY CORONARY-ANGIOGRAPHY; MULTISLICE COMPUTED-TOMOGRAPHY; RADIOLOGY; COMMITTEE; EXPOSURE; QUALITY; HEART; RISK	Context Cardiac computed tomography ( CT) angiography ( CCTA) has emerged as a useful diagnostic imaging modality in the assessment of coronary artery disease. However, the potential risks due to exposure to ionizing radiation associated with CCTA have raised concerns. Objectives To estimate the radiation dose of CCTA in routine clinical practice as well as the association of currently available strategies with dose reduction and to identify the independent factors contributing to radiation dose. Design, Setting, and Patients A cross- sectional, international, multicenter, observational study ( 50 study sites: 21 university hospitals and 29 community hospitals) of estimated radiation dose in 1965 patients undergoing CCTA between February and December 2007. Linear regression analysis was used to identify independent predictors associated with dose. Main Outcome Measure Dose- length product ( DLP) of CCTA. Results The median DLP of 1965 CCTA examinations performed at 50 study sites was 885 mGy x cm ( interquartile range, 568- 1259 mGy x cm), which corresponds to an estimated radiation dose of 12 mSv ( or 1.2 x the dose of an abdominal CT study or 600 chest x- rays). A high variability in DLP was observed between study sites ( range of median DLPs per site, 331- 2146 mGy x cm). Independent factors associated with radiation dose were patient weight ( relative effect on DLP, 5%; 95% confidence interval [ CI], 4%- 6%), absence of stable sinus rhythm ( 10%; 95% CI, 2%- 19%), scan length ( 5%; 95% CI, 4%- 6%), electrocardiographically controlled tube current modulation (- 25%; 95% CI, - 23% to - 28%; applied in 73% of patients), 100- kV tube voltage (- 46%; 95% CI, - 42% to - 51%; applied in 5% of patients), sequential scanning (- 78%; 95% CI, - 77% to - 79%; applied in 6% of patients), experience in cardiac CT (- 1%; 95% CI, - 1% to 0%), number of CCTAs per month ( 0%; 95% CI, 0%- 1%), and type of 64- slice CT system ( for highest vs lowest dose system, 97%; 95% CI, 88%- 106%). Algorithms for dose reduction were not associated with deteriorated diagnostic image quality in this observational study. Conclusions Median doses of CCTA differ significantly between study sites and CT systems. Effective strategies to reduce radiation dose are available but some strategies are not frequently used. The comparable diagnostic image quality may support an increased use of dose- saving strategies in adequately selected patients.	[Hausleiter, Joerg; Meyer, Tanja; Hermann, Franziska; Hadamitzky, Martin; Krebs, Markus; Kastrati, Adnan; Schoemig, Albert] Tech Univ Munich, Dept Cardiol, Deutsch Herzzentrum Munchen, Klin Tech, D-80636 Munich, Germany; [Martinoff, Stefan] Tech Univ Munich, Dept Radiol & Nucl Med, Deutsch Herzzentrum Munchen, Klin Tech, D-80636 Munich, Germany; [Gerber, Thomas C.] Mayo Clin, Dept Cardiovasc Dis, Jacksonville, FL 32224 USA; [McCollough, Cynthia] Mayo Clin, Dept Radiol, Rochester, MN USA; [Achenbach, Stephan] Univ Klinikum Erlangen, Dept Cardiol, Med Klin 2, Erlangen, Germany	German Heart Centre Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Mayo Clinic; Mayo Clinic; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hausleiter, J (corresponding author), Tech Univ Munich, Dept Cardiol, Deutsch Herzzentrum Munchen, Klin Tech, Lazarettstr 36, D-80636 Munich, Germany.	hausleiter@dhm.mhn.de	Hausleiter, Jörg/V-4206-2019; , Kastrati/Y-2389-2019		Deutsches Herzzentrum Munchen; Klinik an der Technischen Universitat, Munich, Germany; German Bundesministerium fur Bildung und Forschung [BMBF, 01 EV 0708]	Deutsches Herzzentrum Munchen; Klinik an der Technischen Universitat, Munich, Germany; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The study was supported solely by an unrestricted research grant from Deutsches Herzzentrum Munchen, Klinik an der Technischen Universitat, Munich, Germany. Dr Achenbach was supported by grant BMBF, 01 EV 0708 from the German Bundesministerium fur Bildung und Forschung. None of the participating physicians received any compensation for study participation.	Bongartz G., 2004, EUROPEAN GUIDELINES; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Coles DR, 2006, J AM COLL CARDIOL, V47, P1840, DOI 10.1016/j.jacc.2005.11.078; Di Carli MF, 2006, J NUCL MED, V47, P1397; Diggle P., 1993, ANAL LONGITUDINAL DA; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Gallagher MJ, 2007, ANN EMERG MED, V49, P125, DOI 10.1016/j.annemergmed.2006.06.043; Gray JE, 2005, RADIOLOGY, V235, P354, DOI 10.1148/radiol.2352020016; Harrell FE., 1997, PREDICTING OUTCOMES; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Hoffmann U, 2006, J NUCL MED, V47, P797; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; Jakobs TF, 2002, EUR RADIOL, V12, P1081, DOI 10.1007/s00330-001-1278-x; Johns HE, 1983, PHYS RADIOLOGY; McCollough CH, 2000, MED PHYS, V27, P828, DOI 10.1118/1.598948; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Morin RL, 2003, CIRCULATION, V107, P917, DOI 10.1161/01.CIR.0000048965.56529.C2; R Development Core Team, 2007, R LANG ENV STAT COMP; Suess C, 2002, PEDIATR RADIOL, V32, P729, DOI 10.1007/s00247-002-0800-x	24	752	839	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					500	507		10.1001/jama.2009.54	http://dx.doi.org/10.1001/jama.2009.54			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190314	Bronze			2022-12-28	WOS:000262992400019
J	Licht-Strunk, E; Van Marwijk, HWJ; Hoekstra, T; Twisk, JWR; De Haan, M; Beekman, ATF				Licht-Strunk, E.; Van Marwijk, H. W. J.; Hoekstra, T.; Twisk, J. W. R.; De Haan, M.; Beekman, A. T. F.			Outcome of depression in later life in primary care: longitudinal cohort study with three years' follow-up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTITIONER; MAJOR DEPRESSION; OLDER PATIENTS; HEALTH SURVEY; PROGNOSIS; HISTORY; RISK; POPULATION; PREVALENCE; MANAGEMENT	Objectives To study the duration of depression, recovery over time, and predictors of prognosis in an older cohort (>= 55 years) in primary care. Design Longitudinal cohort study, with three years' follow-up. Setting 32 general practices in West Friesland, the Netherlands. Participants 234 patients aged 55 years or more with a prevalent major depressive disorder. Main outcome measures Depression at baseline and every six months using structured diagnostic interviews (primary care evaluation of mental disorders according to diagnoses in Diagnostic and Statistical Manual of Mental Disorders, fourth edition) and a measure of severity of symptoms (Montgomery Asberg depression rating scale). The main outcome measures were time to recovery and the likelihood of recovery at different time points. Multivariable analyses were used to identify variables predicting prognosis. Results The median duration of a major depressive episode was 18.0 months (95% confidence interval 12.8 to 23.1). 35% of depressed patients recovered within one year, 60% within two years, and 68% within three years. A poor outcome was associated with severity of depression at baseline, a family history of depression, and poorer physical functioning. During follow-up functional status remained limited in patients with chronic depression but not in those who had recovered. Conclusion Depression among patients aged 55 years or more in primary care has a poor prognosis. Using readily available prognostic factors (for example, severity of the index episode, a family history of depression, and functional decline) could help direct treatment to those at highest risk of a poor prognosis.	[Licht-Strunk, E.; Van Marwijk, H. W. J.; De Haan, M.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, NL-1081 BT Amsterdam, Netherlands; [Licht-Strunk, E.; Van Marwijk, H. W. J.; De Haan, M.; Beekman, A. T. F.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [Hoekstra, T.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, NL-1081 BT Amsterdam, Netherlands; [Twisk, J. W. R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Methodol & Appl Biostat, NL-1081 BT Amsterdam, Netherlands; [Beekman, A. T. F.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Licht-Strunk, E (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Boechorstr 7, NL-1081 BT Amsterdam, Netherlands.	e.licht@vumc.nl	Van Marwijk, Harm/K-6306-2013; Hoekstra, Trynke/AAG-5901-2020	Van Marwijk, Harm/0000-0001-6206-485X; Hoekstra, Trynke/0000-0002-0535-0056	The Netherlands Organisation for Health Research and Development [2200.0019]; Dutch Organization for Scientific Research [904.57.127]	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The data reported on were collected in the context of the West Friesland Study, which was financed by The Netherlands Organisation for Health Research and Development ( grant No 2200.0019) and the Dutch Organization for Scientific Research ( MW grant 904.57.127).	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Beekman ATF, 2002, ARCH GEN PSYCHIAT, V59, P605, DOI 10.1001/archpsyc.59.7.605; Bremmer MA, 2006, AM J GERIAT PSYCHIAT, V14, P523, DOI 10.1097/01.JGP.0000216172.31735.d5; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Chew-Graham CA, 2007, BRIT J GEN PRACT, V57, P364; Cole MG, 2006, AM J GERIAT PSYCHIAT, V14, P966, DOI 10.1097/01.JGP.0000224327.16963.9f; Cole MG, 1997, AM J GERIAT PSYCHIAT, V5, P4; Crabb R, 2006, J CLIN PSYCHOL, V62, P299, DOI 10.1002/jclp.20231; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsell Y, 1998, AGING MENT HEALTH, V2, P100, DOI 10.1080/13607869856795; Gilchrist G, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-28; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; KAFONEK S, 1989, J AM GERIATR SOC, V37, P29, DOI 10.1111/j.1532-5415.1989.tb01565.x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lenze EJ, 2005, J AM GERIATR SOC, V53, P569, DOI 10.1111/j.1532-5415.2005.53202.x; Licht-Strunk E, 2005, INT J GERIATR PSYCH, V20, P1013, DOI 10.1002/gps.1391; Licht-Strunk E, 2007, FAM PRACT, V24, P168, DOI 10.1093/fampra/cml071; Licht-Strunk E, 2009, J AFFECT DISORDERS, V114, P310, DOI 10.1016/j.jad.2008.06.006; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ojo F, 2007, J NATL MED ASSOC, V99, P412; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Peytremann-Bridevaux I, 2008, J AFFECT DISORDERS, V105, P247, DOI 10.1016/j.jad.2007.04.011; Raji MA, 2007, J GERIATR PSYCH NEUR, V20, P145, DOI 10.1177/0891988707303604; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Schulberg HC, 1998, INT J PSYCHIAT MED, V28, P421, DOI 10.2190/G23R-NGGN-K1P1-MQ8N; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stimpson JP, 2007, ANN EPIDEMIOL, V17, P313, DOI 10.1016/j.annepidem.2006.10.006; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; VERHAAK PFM, 1993, BRIT J GEN PRACT, V43, P203; Ware J, 1994, SF 36 PHYS MENTAL SU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	36	58	59	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2009	338								a3079	10.1136/bmj.a3079	http://dx.doi.org/10.1136/bmj.a3079			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19188214	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000263876200001
J	Yu, T; Eberly, JH				Yu, Ting; Eberly, J. H.			Sudden Death of Entanglement	SCIENCE			English	Review							QUANTUM ENTANGLEMENT; DECOHERENCE; DYNAMICS; ENVIRONMENT; INFORMATION; STATES	A new development in the dynamical behavior of elementary quantum systems is the surprising discovery that correlation between two quantum units of information called qubits can be degraded by environmental noise in a way not seen previously in studies of dissipation. This new route for dissipation attacks quantum entanglement, the essential resource for quantum information as well as the central feature in the Einstein- Podolsky- Rosen so- called paradox and in discussions of the fate of Schrodinger's cat. The effect has been labeled ESD, which stands for early- stage disentanglement or, more frequently, entanglement sudden death. We review recent progress in studies focused on this phenomenon.	[Yu, Ting] Stevens Inst Technol, Dept Phys & Engn Phys, Hoboken, NJ 07030 USA; [Eberly, J. H.] Univ Rochester, Rochester Theory Ctr, Rochester, NY 14627 USA; [Eberly, J. H.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA	Stevens Institute of Technology; University of Rochester; University of Rochester	Yu, T (corresponding author), Stevens Inst Technol, Dept Phys & Engn Phys, Hoboken, NJ 07030 USA.	ting.yu@stevens.edu; eberly@pas.rochester.edu	Yu, Ting/A-3616-2011		U.S. Army Research Office [48422-PH]; NSF [PHY06-01804, PHY07-58016]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-FG02-05ER15713]; Division Of Physics [0925174] Funding Source: National Science Foundation	U.S. Army Research Office; NSF(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	T.Y. and J.H.E. acknowledge grant support from the U.S. Army Research Office (48422-PH), the NSF (PHY06-01804 and PHY07-58016), and U.S. Department of Energy, Office of Basic Energy Sciences (DE-FG02-05ER15713).	Al-Qasimi A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012117; Almeida MP, 2007, SCIENCE, V316, P579, DOI 10.1126/science.1139892; Ann K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115307; Ban M, 2006, J PHYS A-MATH GEN, V39, P1927, DOI 10.1088/0305-4470/39/8/010; Bellomo B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160502; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Carvalho ARR, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012334; Cavalcanti D, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042328; Checinska A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052306; Cubitt TS, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052308; Daffer S, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062312; Diosi L, 2003, LECT NOTES PHYS, V622, P157; Dodd PJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052105; Dur W, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.180403; Eberly JH, 2007, SCIENCE, V316, P555, DOI 10.1126/science.1142654; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ficek Z, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.024304; Fine BV, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.153105; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Gordon G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110503; Halder M, 2007, NAT PHYS, V3, P692, DOI 10.1038/nphys700; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; Laurat J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.180504; Lidar DA, 2003, LECT NOTES PHYS, V622, P83; Maniscalco S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.090503; Mintert F, 2005, PHYS REP, V415, P207, DOI 10.1016/j.physrep.2005.04.006; Nha H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.120408; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Novais E, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012314; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Rajagopal AK, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.022116; Rau ARP, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/40002; Sainz I, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042313; Sainz I, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052307; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Shiokawa K, 2007, QUANTUM INF PROCESS, V6, P55, DOI 10.1007/s11128-006-0044-z; Simon C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052327; Viola L, 1998, PHYS REV A, V58, P2733, DOI 10.1103/PhysRevA.58.2733; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yonac M, 2007, J PHYS B-AT MOL OPT, V40, pS45, DOI 10.1088/0953-4075/40/9/S02; Yonac M, 2008, OPT LETT, V33, P270, DOI 10.1364/OL.33.000270; Yonac M, 2006, J PHYS B-AT MOL OPT, V39, pS621, DOI 10.1088/0953-4075/39/15/S09; Yu T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140404; Yu T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.140403; Yu T, 2006, OPT COMMUN, V264, P393, DOI 10.1016/j.optcom.2006.01.061; Yu T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.193306; Yu T, 2007, QUANTUM INF COMPUT, V7, P459; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715; Zyczkowski K, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012101	49	823	846	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					598	601		10.1126/science.1167343	http://dx.doi.org/10.1126/science.1167343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179521				2022-12-28	WOS:000262862800032
J	McKellar, SH; Matthews, LR				McKellar, Stephen H.; Matthews, L. Ray			Traumatic Diaphragmatic Rupture with Intrathoracic Liver Herniation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McKellar, Stephen H.] Mayo Clin, Rochester, MN 55905 USA; [Matthews, L. Ray] Morehouse Sch Med, Atlanta, GA 30310 USA	Mayo Clinic; Morehouse School of Medicine	McKellar, SH (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			mckellar, stephen/0000-0001-5173-5574					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					E7	E7		10.1056/NEJMicm050814	http://dx.doi.org/10.1056/NEJMicm050814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179310				2022-12-28	WOS:000262812400012
J	Sridharan, R; Tchieu, J; Mason, MJ; Yachechko, R; Kuoy, E; Horvath, S; Zhou, Q; Plath, K				Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Zhou, Qing; Plath, Kathrin			Role of the Murine Reprogramming Factors in the Induction of Pluripotency	CELL			English	Article							STEM-CELLS; TRANSCRIPTIONAL NETWORK; MOUSE; FIBROBLASTS; MYC; GENERATION; EXPRESSION; CIRCUITRY	Induced pluripotent stem (iPS) cells can be obtained from fibroblasts upon expression of Oct4, Sox2, Klf4, and c-Myc. To understand how these factors induce pluripotency, we carried out genome-wide analyses of their promoter binding and expression in iPS and partially reprogrammed cells. We find that target genes of the four factors strongly overlap in iPS and embryonic stem (ES) cells. In partially reprogrammed cells, many genes co-occupied by c-Myc and any of the other three factors already show an ES cell-like binding and expression pattern. In contrast, genes that are specifically co-bound by Oct4, Sox2, and Klf4 in ES cells and encode pluripotency regulators severely lack binding and transcriptional activation. Among the four factors, c-Myc promotes the most ES cell-like transcription pattern when expressed individually in fibroblasts. These data uncover temporal and separable contributions of the four factors during the reprogramming process and indicate that ectopic c-Myc predominantly acts before pluripotency regulators are activated.	[Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Horvath, Steve; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Plath, Kathrin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Tchieu, Jason; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sridharan, Rupa; Tchieu, Jason; Mason, Mike J.; Yachechko, Robin; Kuoy, Edward; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mason, Mike J.; Zhou, Qing] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Plath, Kathrin/0000-0001-7796-3372; Mason, Michael/0000-0002-5652-7739; Kuoy, Edward/0000-0003-4721-1254	California Institute of Regenerative Medicine (CIRM); NSF [DMS-0805491]; Kimmel Scholar Foundations; NIH Director's Young Innovator Award; CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Kimmel Scholar Foundations; NIH Director's Young Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Young Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephen Smale, Siavash Kurdistani, Bernadett Papp, Lars Dreier, Mark Chin, Bill Lowry, and Konrad Hochedlinger for critical reading of the manuscript. R. S. is supported by a training grant from the California Institute of Regenerative Medicine (CIRM), Q. Z. by a NSF grant (DMS-0805491), and K. P. by the V and Kimmel Scholar Foundations, the NIH Director's Young Innovator Award, and a CIRM Young Investigator Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	27	501	531	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					364	377		10.1016/j.cell.2009.01.001	http://dx.doi.org/10.1016/j.cell.2009.01.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167336	Green Accepted, Bronze			2022-12-28	WOS:000262648800023
J	Stiglitz, JE				Stiglitz, Joseph E.			Trade agreements and health in developing countries	LANCET			English	Editorial Material									[Stiglitz, Joseph E.] Columbia Univ, New York, NY 10027 USA	Columbia University	Stiglitz, JE (corresponding author), Columbia Univ, New York, NY 10027 USA.	jes322@columbia.edu						*EUR COMM, BIL TRAD REL, P2; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; *MED SANS FRONT, 2006, PEOPL NOT GETT TREAT, P2; *OFF US TRAD REPR, TRAD AGR, P2; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; SOEKIRMAN KD, 2008, ASIA PACIFIC J CLI S, V10, P557; STIGLITZ JE, 2006, MAKING GLOBALIZATION, P2; *UN DEV PROGR, 2003, MAK GLOB TRAD WORK P, P2; 2007, MED NEWS TODAY  0207, P2	10	28	28	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					363	365		10.1016/S0140-6736(08)61772-9	http://dx.doi.org/10.1016/S0140-6736(08)61772-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19167055	Green Published			2022-12-28	WOS:000262912100009
J	Harrison, SA; Tong, F				Harrison, Stephenie A.; Tong, Frank			Decoding reveals the contents of visual working memory in early visual areas	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; PERSISTENT ACTIVITY; NEURAL MECHANISMS; TEMPORAL CORTEX; MOTION TASK; CAPACITY; PERFORMANCE; CORRELATE; NEURONS	Visual working memory provides an essential link between perception and higher cognitive functions, allowing for the active maintenance of information about stimuli no longer in view(1,2). Research suggests that sustained activity in higher-order prefrontal, parietal, inferotemporal and lateral occipital areas supports visual maintenance(3-11), and may account for the limited capacity of working memory to hold up to 3-4 items(9-11). Because higher-order areas lack the visual selectivity of early sensory areas, it has remained unclear how observers can remember specific visual features, such as the precise orientation of a grating, with minimal decay in performance over delays of many seconds(12). One proposal is that sensory areas serve to maintain fine-tuned feature information(13), but early visual areas show little to no sustained activity over prolonged delays(14-16). Here we show that orientations held in working memory can be decoded from activity patterns in the human visual cortex, even when overall levels of activity are low. Using functional magnetic resonance imaging and pattern classification methods, we found that activity patterns in visual areas V1-V4 could predict which of two oriented gratings was held in memory with mean accuracy levels upwards of 80%, even in participants whose activity fell to baseline levels after a prolonged delay. These orientation-selective activity patterns were sustained throughout the delay period, evident in individual visual areas, and similar to the responses evoked by unattended, task-irrelevant gratings. Our results demonstrate that early visual areas can retain specific information about visual features held in working memory, over periods of many seconds when no physical stimulus is present.	[Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Tong, F (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	frank.tong@vanderbilt.edu			National Eye Institute; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R01EY017082] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Brady and B. Wolfe for technical support, and J. Gore and the Vanderbilt University Institute of Imaging Science for MRI support. This work was supported by a grant from the National Eye Institute, National Institutes of Health to F. T. and a postgraduate fellowship from the Natural Sciences and Engineering Research Council of Canada to S. A. H.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Roelfsema PR, 2005, TRENDS COGN SCI, V9, P226, DOI 10.1016/j.tics.2005.03.012; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	30	785	805	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					632	635		10.1038/nature07832	http://dx.doi.org/10.1038/nature07832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19225460	Green Accepted			2022-12-28	WOS:000264796200041
J	Teixeira, FK; Heredia, F; Sarazin, A; Roudier, F; Boccara, M; Ciaudo, C; Cruaud, C; Poulain, J; Berdasco, M; Fraga, MF; Voinnet, O; Wincker, P; Esteller, M; Colot, V				Teixeira, Felipe Karam; Heredia, Fabiana; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Ciaudo, Constance; Cruaud, Corinne; Poulain, Julie; Berdasco, Maria; Fraga, Mario F.; Voinnet, Olivier; Wincker, Patrick; Esteller, Manel; Colot, Vincent			A Role for RNAi in the Selective Correction of DNA Methylation Defects	SCIENCE			English	Article							EPIGENETIC INHERITANCE; ARABIDOPSIS; EPIGENOME; IV	DNA methylation is essential for silencing transposable elements and some genes in higher eukaryotes, which suggests that this modification must be tightly controlled. However, accidental changes in DNA methylation can be transmitted through mitosis (as in cancer) or meiosis, leading to epiallelic variation. We demonstrated the existence of an efficient mechanism that protects against transgenerational loss of DNA methylation in Arabidopsis. Remethylation is specific to the subset of heavily methylated repeats that are targeted by the RNA interference (RNAi) machinery. This process does not spread into flanking regions, is usually progressive over several generations, and faithfully restores wild-type methylation over target sequences in an RNAi-dependent manner. Our findings suggest an important role for RNAi in protecting genomes against long-term epigenetic defects.	[Teixeira, Felipe Karam; Heredia, Fabiana; Roudier, Francois; Boccara, Martine; Colot, Vincent] Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France; [Teixeira, Felipe Karam; Sarazin, Alexis; Roudier, Francois; Boccara, Martine; Colot, Vincent] Ecole Normale Super, CNRS, Dept Biol, UMR 8186, F-75230 Paris 05, France; [Ciaudo, Constance; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France; [Ciaudo, Constance] Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France; [Cruaud, Corinne; Poulain, Julie; Wincker, Patrick] CEA, Inst Genom, F-91057 Evry, France; [Berdasco, Maria; Fraga, Mario F.; Esteller, Manel] Ctr Nacl Invest Oncol, Lab Epigenet Canc, Madrid 28029, Spain	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Colot, V (corresponding author), Univ Evry Val Essonne, Inst Natl Rech Agron UMR 1165, CNRS, UMR 8114,Unite Rech Genom Vegetale, F-91057 Evry, France.	colot@biologie.ens.fr	Herédia, Fabiana/J-3999-2013; Fraga, Mario F/H-7824-2017; Ciaudo, Constance/A-2014-2012; Esteller, Manel/L-5956-2014	Herédia, Fabiana/0000-0002-6390-7545; Fraga, Mario F/0000-0001-8450-2603; Ciaudo, Constance/0000-0002-0857-4506; Esteller, Manel/0000-0003-4490-6093; Sarazin, Alexis/0000-0002-1869-5192; Cruaud, Corinne/0000-0002-4752-7278; Poulain, Julie/0000-0002-8744-3116; Voinnet, Olivier/0000-0001-6982-9544; Karam Teixeira, Felipe/0000-0001-7651-1657; Heredia, Fabiana/0000-0003-0057-7654	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil [Ph.D. studentship]; Network of Excellence (NoE) [postdoctoral fellowships]; Fondation pour la Recherche Medicale [postdoctoral fellowships]; Agence Nationale de la Recherche Programme Blanc (PolIV); Genoplante (EPIVAR); Genoscope; CNRS (PIME)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Network of Excellence (NoE); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Programme Blanc (PolIV)(French National Research Agency (ANR)); Genoplante (EPIVAR); Genoscope; CNRS (PIME)(Centre National de la Recherche Scientifique (CNRS))	We thank P. Audigier for plant care, A. Bulski for DNA samples, R. Martienssen for sharing unpublished observations, and E. Heard for critical reading of the manuscript. F.K.T. was supported by a Ph.D. studentship (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil) and F.H. and C.C. by postdoctoral fellowships [Network of Excellence (NoE) "The Epigenome" and Fondation pour la Recherche Medicale, respectively]. Grant support was from Agence Nationale de la Recherche Programme Blanc (PolIV), NoE "The Epigenome," Genoplante (EPIVAR), Genoscope, and CNRS (PIME). The Gene Expression Omnibus accession number for sRNA sequences is GSE13419.	Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Flintoft L, 2009, NAT REV GENET, V10, DOI 10.1038/nrg2565; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kakutani T, 1999, GENETICS, V151, P831; Kankel MW, 2003, GENETICS, V163, P1109; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	23	273	285	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1600	1604		10.1126/science.1165313	http://dx.doi.org/10.1126/science.1165313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19179494				2022-12-28	WOS:000264342300037
J	Browning, J				Browning, John			Recession Watch: Cut costs and sell what you can	NATURE			English	Editorial Material												jb@poyais.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					961	962		10.1038/457961a	http://dx.doi.org/10.1038/457961a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225503				2022-12-28	WOS:000263425400021
J	Poitrasson, F				Poitrasson, Franck			GEOCHEMISTRY Probes of the Ancient and the Inaccessible	SCIENCE			English	Editorial Material							IRON ISOTOPE FRACTIONATION; PLANETARY DIFFERENTIATION; FE; EARTH; METEORITES; ACCRETION; WEYER,S.		[Poitrasson, Franck] Univ Toulouse 1, Inst Rech Dev, Lab Mecanismes Transfert Geol, CNRS, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Poitrasson, F (corresponding author), Univ Toulouse 1, Inst Rech Dev, Lab Mecanismes Transfert Geol, CNRS, 14 Ave Edouard Belin, F-31400 Toulouse, France.	franck.poitrasson@lmtg.obs-mip.fr		Poitrasson, Franck/0000-0003-4097-2771				Anbar AD, 2005, GEOCHIM COSMOCHIM AC, V69, P825, DOI 10.1016/j.gca.2004.06.012; Beard BL, 2003, CHEM GEOL, V195, P87, DOI 10.1016/S0009-2541(02)00390-X; Beard BL, 2007, EARTH PLANET SC LETT, V256, P633, DOI 10.1016/j.epsl.2007.01.037; Li J, 2001, GEOCHIM COSMOCHIM AC, V65, P1821, DOI 10.1016/S0016-7037(00)00613-X; Poitrasson F, 2005, EARTH PLANET SC LETT, V234, P151, DOI 10.1016/j.epsl.2005.02.010; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Poitrasson F, 2007, EARTH PLANET SC LETT, V256, P484, DOI 10.1016/j.epsl.2007.01.039; Poitrasson F, 2009, EARTH PLANET SC LETT, V278, P376, DOI 10.1016/j.epsl.2008.12.025; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; Polyakov VB, 2009, SCIENCE, V323, P912, DOI 10.1126/science.1166329; Schoenberg R, 2006, EARTH PLANET SC LETT, V252, P342, DOI 10.1016/j.epsl.2006.09.045; Teng FZ, 2008, SCIENCE, V320, P1620, DOI 10.1126/science.1157166; Weyer S, 2007, EARTH PLANET SC LETT, V256, P638, DOI 10.1016/j.epsl.2007.01.038; Weyer S, 2008, SCIENCE, V320, P1600, DOI 10.1126/science.1160204; Williams HM, 2006, EARTH PLANET SC LETT, V250, P486, DOI 10.1016/j.epsl.2006.08.013	15	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					882	883		10.1126/science.1169281	http://dx.doi.org/10.1126/science.1169281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213901				2022-12-28	WOS:000263295400023
J	Kuiken, TA; Li, GL; Lock, BA; Lipschutz, RD; Miller, LA; Stubblefield, KA; Englehart, KB				Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.; Englehart, Kevin B.			Targeted Muscle Reinnervation for Real-time Myoelectric Control of Multifunction Artificial Arms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-MACHINE INTERFACE; PROSTHESIS CONTROL; AMPUTEES; NERVE; EMG; ELECTROMYOGRAM; STIMULATION; SCHEME	Context Improving the function of prosthetic arms remains a challenge, because access to the neural- control information for the arm is lost during amputation. A surgical technique called targeted muscle reinnervation ( TMR) transfers residual arm nerves to alternative-muscle sites. After reinnervation, these target muscles produce electromyogram( EMG) signals on the surface of the skin that can be measured and used to control prosthetic arms. Objective To assess the performance of patients with upper- limb amputation who had undergone TMR surgery, using a pattern- recognition algorithm to decode EMG signals and control prosthetic- arm motions. Design, Setting, and Participants Study conducted between January 2007 and January 2008 at the Rehabilitation Institute of Chicago among 5 patients with shoulder-disarticulation or transhumeral amputations who underwent TMR surgery between February 2002 and October 2006 and 5 control participants without amputation. Surface EMG signals were recorded from all participants and decoded using a pattern-recognition algorithm. The decoding program controlled the movement of a virtual prosthetic arm. All participants were instructed to perform various arm movements, and their abilities to control the virtual prosthetic arm were measured. In addition, TMR patients used the same control system to operate advanced arm prosthesis prototypes. Main Outcome Measure Performance metrics measured during virtual arm movements included motion selection time, motion completion time, and motion completion ("success") rate. Results The TMR patients were able to repeatedly perform 10 different elbow, wrist, and hand motions with the virtual prosthetic arm. For these patients, the mean motion selection and motion completion times for elbow and wrist movements were 0.22 seconds ( SD, 0.06) and 1.29 seconds ( SD, 0.15), respectively. These times were 0.06 seconds and 0.21 seconds longer than the mean times for control participants. For TMR patients, the mean motion selection and motion completion times for hand-grasp patterns were 0.38 seconds ( SD, 0.12) and 1.54 seconds ( SD, 0.27), respectively. These patients successfully completed a mean of 96.3% ( SD, 3.8) of elbow and wrist movements and 86.9% ( SD, 13.9) of hand movements within 5 seconds, compared with 100% ( SD, 0) and 96.7% ( SD, 4.7) completed by controls. Three of the patients were able to demonstrate the use of this control system in advanced prostheses, including motorized shoulders, elbows, wrists, and hands. Conclusion These results suggest that reinnervated muscles can produce sufficient EMG information for real- time control of advanced artificial arms.	[Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.] Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, Chicago, IL 60611 USA; [Kuiken, Todd A.; Li, Guanglin; Miller, Laura A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kuiken, Todd A.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Englehart, Kevin B.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; University of New Brunswick	Kuiken, TA (corresponding author), Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, 345 E Super St,Room 1309, Chicago, IL 60611 USA.	tkuiken@northwestern.edu	Miller, Laura A/E-1110-2011	Miller, Laura A/0000-0002-7271-6214; Li, Guanglin/0000-0001-9016-2617; Englehart, Kevin/0000-0003-4525-1121	Defense Advanced Research Projects Agency; Army Research Office; DEKA Integrated Solution Corp Prime [W911NF-06-C-001]; National Institute of Child Health and Human Development [R01 HD-043137, JHU-APL-DARPA 908090, N66001-06-C8006R01 HD0-044798]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043137, R01HD044798] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office; DEKA Integrated Solution Corp Prime; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Defense Advanced Research Projects Agency, Army Research Office, DEKA Integrated Solution Corp Prime contract W911NF-06-C-001, the National Institute of Child Health and Human Development grant R01 HD-043137, JHU-APL-DARPA contract 908090 under Prime Contract N66001-06-C8006R01 HD0-044798, and National Institute of Child Health and Human Development grant R01 HD-043137.	Ajiboye AB, 2005, IEEE T NEUR SYS REH, V13, P280, DOI 10.1109/TNSRE.2005.847357; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Duda R.O., 2000, PATTERN CLASSIFICATI; EDELL DJ, 1986, IEEE T BIO-MED ENG, V33, P203, DOI 10.1109/TBME.1986.325892; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Englehart K., 2003, TECHNOL DISAB, V15, P95; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; FARREL TR, 2007, THESIS NW U EVANSTON; HEFFTNER G, 1988, IEEE T BIO-MED ENG, V35, P230, DOI 10.1109/10.1370; Hijjawi JB, 2006, PLAST RECONSTR SURG, V118, P1573, DOI 10.1097/01.prs.0000242487.62487.fb; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Kuiken TA., 2003, TECHNOL DISABIL, V15, P105, DOI [10.3233/TAD-2003-15206, DOI 10.3233/TAD-2003-15206]; Kuiken Todd, 2006, Phys Med Rehabil Clin N Am, V17, P1, DOI 10.1016/j.pmr.2005.10.001; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; LOCK BA, 2005, MYOEL CONTR S AUG 15; O'Shaughnessy KD, 2008, J BONE JOINT SURG AM, V90A, P393, DOI 10.2106/JBJS.G.00268; PARKER PA, 1986, CRIT REV BIOMED ENG, V13, P283; Sears H., 1992, ATLAS LIMB PROSTHETI; Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466; WEIR RF, 2003, P 25 SILV ANN INT C; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	25	650	691	8	163	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					619	628		10.1001/jama.2009.116	http://dx.doi.org/10.1001/jama.2009.116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211469	Bronze, Green Accepted			2022-12-28	WOS:000263229000026
J	Miyahara, M; Hirayama, M; Yuta, A; Takeuchi, K; Inoki, T				Miyahara, Masazumi; Hirayama, Masahiro; Yuta, Atsushi; Takeuchi, Kazuhiko; Inoki, Tatsu			Too young to talk of vertigo?	LANCET			English	Editorial Material							MENIERES-DISEASE		[Miyahara, Masazumi; Inoki, Tatsu] Okanami Gen Hosp, Dept Pediat, Iga, Mie 5180842, Japan; [Hirayama, Masahiro] Mie Univ Hosp, Dept Pediat, Tsu, Mie, Japan; [Yuta, Atsushi; Takeuchi, Kazuhiko] Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tsu, Mie 514, Japan	Mie University; Mie University	Miyahara, M (corresponding author), Okanami Gen Hosp, Dept Pediat, 1734 Uenokuwamachi, Iga, Mie 5180842, Japan.	masazumi.m@k6.dion.ne.jp						Akagi H, 2001, INT J PEDIATR OTORHI, V61, P259, DOI 10.1016/S0165-5876(01)00576-6; da Costa SS, 2002, OTOLARYNG CLIN N AM, V35, P455, DOI 10.1016/S0030-6665(02)00028-2; FILIPO R, 1985, J LARYNGOL OTOL, V99, P193, DOI 10.1017/S0022215100096523; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; SADE J, 1984, ACTA OTO-LARYNGOL, V97, P33, DOI 10.3109/00016488409130962	5	24	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					516	516		10.1016/S0140-6736(09)60173-2	http://dx.doi.org/10.1016/S0140-6736(09)60173-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	19200919				2022-12-28	WOS:000263132800035
J	Songkhla, MN				Songkhla, Mongkol Na			Health before profits? Learning from Thailand's experience	LANCET			English	Editorial Material											Songkhla, MN (corresponding author), Ladprao 15, Bangkok 10900, Thailand.	mongkol@health.moph.go.th						ABBOTT F, 2007, ACCESS ESSENTIAL MED; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; FINK C, 2003, IMPLEMENTING DOHA MA; Gerhardsen Tove, 2007, INTELLECTUAL PR 0216; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; Tantivess S, 2008, INTRO GOVT USE PATEN; Tantivess S, 2008, HEALTH POLICY PLANN, V23, P328, DOI 10.1093/heapol/czn023; VELASQUEZ G, 2008, IMPROVING ACCESS MED; *WORLD TRAD ORG, 2001, MIN DECL WT MIN 01 D; World Trade Organization, UR ROUND AGR TRIPS 2	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					441	442		10.1016/S0140-6736(08)61737-7	http://dx.doi.org/10.1016/S0140-6736(08)61737-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19167059	Green Submitted			2022-12-28	WOS:000263132800008
J	Weinmann, L; Hock, J; Ivacevic, T; Ohrt, T; Mutze, J; Schwille, P; Kremmer, E; Benes, V; Urlaub, H; Meister, G				Weinmann, Lasse; Hoeck, Julia; Ivacevic, Tomi; Ohrt, Thomas; Muetze, Joerg; Schwille, Petra; Kremmer, Elisabeth; Benes, Vladimir; Urlaub, Henning; Meister, Gunter			Importin 8 Is a Gene Silencing Factor that Targets Argonaute Proteins to Distinct mRNAs	CELL			English	Article							MICRORNA-DEPENDENT LOCALIZATION; HUMAN-CELLS; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; PASSENGER-STRAND; MAMMALIAN-CELLS; PIWI PROTEINS; IN-VITRO; MIRNAS; COMPLEXES	Small regulatory RNAs including small interfering RNAs (siRNAs) and microRNAs ( miRNAs) guide Argonaute ( Ago) proteins to specific target RNAs leading to mRNA destabilization or translational repression. Here, we report the identification of Importin 8 (Imp8) as a component of miRNA-guided regulatory pathways. We show that Imp8 interacts with Ago proteins and localizes to cytoplasmic processing bodies ( P bodies), structures involved in RNA metabolism. Furthermore, we detect Ago2 in the nucleus of HeLa cells, and knockdown of Imp8 reduces the nuclear Ago2 pool. Using immunoprecipitations of Ago2-associated mRNAs followed by microarray analysis, we further demonstrate that Imp8 is required for the recruitment of Ago protein complexes to a large set of Ago2-associated target mRNAs, allowing for efficient and specific gene silencing. Therefore, we provide evidence that Imp8 is required for cytoplasmic miRNA-guided gene silencing and affects nuclear localization of Ago proteins.	[Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Lab RNA Biol, D-82152 Martinsried, Germany; [Weinmann, Lasse; Hoeck, Julia; Meister, Gunter] Max Planck Inst Biochem, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany; [Ohrt, Thomas; Muetze, Joerg; Schwille, Petra] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Ivacevic, Tomi; Benes, Vladimir] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spect Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); Max Planck Society	Meister, G (corresponding author), Max Planck Inst Biochem, Lab RNA Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	meister@biochem.mpg.de	Weinmann, Lasse/B-9839-2008; Schwille, Petra/A-4983-2010	Benes, Vladimir/0000-0002-0352-2547	Max Planck Society; Deutsche Forschungsgemeinschaft [Me2064/2-1]; European Union [LSHG-CT-2006-037900]; Deutsche Volkswagenstiftung [I/79308]; Boehringer Ingelheim Fonds	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Deutsche Volkswagenstiftung(Volkswagen); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank Keiichi Ozono for pGEX-Imp4, Erich Nigg for pcDNA3.1- RanWT, - RanQ69L, and - RanT24N, Olaf Stemmann for pCS2, Simone Heubes for recombinant RanWT and RanQ69L, and Susanna Nagel for technical advice. Further, we thank Dirk Go " rlich, Witold Filipowicz, Michael Doyle, Laura Riolobos, Thomas Gu " ttler, Sabine Ru " del, Michaela Beitzinger, and Christine Ender for helpful discussions, Thomas Tuschl and Tobias Walther for critical reading of the manuscript, Sabine Rottmu " ller and Bernd Haas for technical assistance, and Stefan Jentsch for support. Our research is funded by the Max Planck Society. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, Me2064/2-1), the European Union (LSHG-CT-2006-037900), and the Max Planck Society. T. O. is funded by Deutsche Volkswagenstiftung I/79308. L. W. received a fellowship from the Boehringer Ingelheim Fonds.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	53	239	255	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					496	507		10.1016/j.cell.2008.12.023	http://dx.doi.org/10.1016/j.cell.2008.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19167051	Bronze			2022-12-28	WOS:000263120600019
J	Walter, F; Riechers, D; Cox, P; Neri, R; Carilli, C; Bertoldi, F; Weiss, A; Maiolino, R				Walter, Fabian; Riechers, Dominik; Cox, Pierre; Neri, Roberto; Carilli, Chris; Bertoldi, Frank; Weiss, Axel; Maiolino, Roberto			A kiloparsec-scale hyper-starburst in a quasar host less than 1 gigayear after the Big Bang	NATURE			English	Article							MOLECULAR GAS; DUST EMISSION; NUCLEUS	The host galaxy of the quasar SDSS J114816.641525150.3 ( at redshift z = 6.42, when the Universe was less than a billion years old) has an infrared luminosity of 2.2 x 10(13) times that of the Sun(1,2), presumably significantly powered by a massive burst of star formation(3-6). In local examples of extremely luminous galaxies, such as Arp 220, the burst of star formation is concentrated in a relatively small central region of <100 pc radius(7,8). It is not known on which scales stars are forming in active galaxies in the early Universe, at a time when they are probably undergoing their initial burst of star formation. We do know that at some early time, structures comparable to the spheroidal bulge of the Milky Way must have formed. Here we report a spatially resolved image of [CII] emission of the host galaxy of J114816.641525150.3 that demonstrates that its star- forming gas is distributed over a radius of about 750 pc around the centre. The surface density of the star formation rate averaged over this region is similar to 1,000 M. year(-1) kpc-(2). This surface density is comparable to the peak in Arp 220, although about two orders of magnitude larger in area. This vigorous star- forming event is likely to give rise to a massive spheroidal component in this system.	[Walter, Fabian; Riechers, Dominik] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Riechers, Dominik] CALTECH, Pasadena, CA 91125 USA; [Cox, Pierre; Neri, Roberto] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Carilli, Chris] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Bertoldi, Frank] Argelander Inst Astron, D-53121 Bonn, Germany; [Weiss, Axel] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Maiolino, Roberto] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Monte Porzio Catone, Italy	Max Planck Society; California Institute of Technology; National Radio Astronomy Observatory (NRAO); University of Bonn; Max Planck Society; Istituto Nazionale Astrofisica (INAF)	Walter, F (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	walter@mpia.de		Maiolino, Roberto/0000-0002-4985-3819; Walter, Fabian/0000-0003-4793-7880; Weiss, Axel/0000-0003-4678-3939	MPG (Germany); INSU/CNRS ( France); IGN (Spain); NASA; Hubble Fellowship; Space Telescope Science Institute; Max-Planck Gesellschaft; Alexander von Humboldt Stiftung; Max-Planck-Forschungspreis	MPG (Germany)(Max Planck Society); INSU/CNRS ( France)(Centre National de la Recherche Scientifique (CNRS)); IGN (Spain); NASA(National Aeronautics & Space Administration (NASA)); Hubble Fellowship; Space Telescope Science Institute(Space Telescope Science Institute); Max-Planck Gesellschaft(Max Planck Society); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Max-Planck-Forschungspreis	This work is based on observations carried out with the IRAM Plateau de Bure Interferometer. IRAM is supported by MPG (Germany), INSU/ CNRS ( France) and IGN (Spain). D.R. acknowledges support from NASA through a Hubble Fellowship awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA. C.C. acknowledges support from the Max- Planck Gesellschaft and the Alexander von Humboldt Stiftung through the Max-Planck-Forschungspreis 2005. F.W. and D.R. appreciate the hospitality of the Aspen Center for Physics, where this manuscript was written.	Beelen A, 2006, ASTROPHYS J, V642, P694, DOI 10.1086/500636; Bertoldi F, 2003, ASTRON ASTROPHYS, V409, pL47, DOI 10.1051/0004-6361:20031345; Bertoldi F, 2003, ASTRON ASTROPHYS, V406, pL55, DOI 10.1051/0004-6361:20030710; Carilli CL, 2004, ASTRON J, V128, P997, DOI 10.1086/423295; DEKEL A, NATURE IN PRESS, DOI DOI 10.1038/NATURE07648; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Elmegreen BG, 1999, ASTROPHYS J, V517, P103, DOI 10.1086/307200; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Gao Y, 2004, ASTROPHYS J SUPPL S, V152, P63, DOI 10.1086/383003; Iono D, 2006, ASTROPHYS J, V645, pL97, DOI 10.1086/506344; Luhman ML, 1998, ASTROPHYS J, V504, pL11, DOI 10.1086/311562; Maiolino R, 2005, ASTRON ASTROPHYS, V440, pL51, DOI 10.1051/0004-6361:200500165; Malhotra S, 1997, ASTROPHYS J LETT, V491, P27; Omont A, 2001, ASTRON ASTROPHYS, V374, P371, DOI 10.1051/0004-6361:20010721; PSERGEL DN, 2007, ASTROPHYS J S, V170, P377; Riechers DA, 2007, ASTROPHYS J LETT, V671, pL13, DOI 10.1086/524871; Scoville NZ, 1997, ASTROPHYS J, V484, P702, DOI 10.1086/304368; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; STACEY GJ, 1991, ASTROPHYS J, V373, P423, DOI 10.1086/170062; Tacconi LJ, 2006, ASTROPHYS J, V640, P228, DOI 10.1086/499933; Thompson TA, 2005, ASTROPHYS J, V630, P167, DOI 10.1086/431923; TIELENS AGGM, 1985, ASTROPHYS J, V291, P722, DOI 10.1086/163111; Walter F, 2004, ASTROPHYS J, V615, pL17, DOI 10.1086/426017; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Walter F, 2008, ASTROPHYS SPACE SCI, V313, P313, DOI 10.1007/s10509-007-9634-1; WERNER MW, 1976, ASTROPHYS J, V204, P420, DOI 10.1086/154185; White RL, 2005, ASTRON J, V129, P2102, DOI 10.1086/429380; Wright EL, 2006, PUBL ASTRON SOC PAC, V118, P1711, DOI 10.1086/510102	29	194	195	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					699	701		10.1038/nature07681	http://dx.doi.org/10.1038/nature07681			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194445	Green Submitted			2022-12-28	WOS:000263064700035
J	Bikard, D; Patel, D; Le Mette, C; Giorgi, V; Camilleri, C; Bennett, MJ; Loudet, O				Bikard, David; Patel, Dhaval; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Bennett, Malcolm J.; Loudet, Olivier			Divergent Evolution of Duplicate Genes Leads to Genetic Incompatibilities Within A-thaliana	SCIENCE			English	Article							INBRED LINE POPULATIONS; ARABIDOPSIS-THALIANA; SPECIATION; DROSOPHILA; CONSEQUENCES; LOCI; REVEALS; MODEL	Genetic incompatibilities resulting from interactions between two loci represent a potential source of postzygotic barriers and may be an important factor in evolution when they impair the outcome of interspecific crosses. We show that, in crosses between strains of the plant Arabidopsis thaliana, loci interact epistatically, controlling a recessive embryo lethality. This interaction is explained by divergent evolution occurring among paralogs of an essential duplicate gene, for which the functional copy is not located at the same locus in different accessions. These paralogs demonstrate genetic heterogeneity in their respective evolutionary trajectories, which results in widespread incompatibility among strains. Our data suggest that these passive mechanisms, gene duplication and extinction, could represent an important source of genetic incompatibilities across all taxa.	[Bikard, David; Le Mette, Claire; Giorgi, Veronica; Camilleri, Christine; Loudet, Olivier] INRA, SGAP UR254, F-78026 Versailles, France; [Patel, Dhaval; Bennett, Malcolm J.] Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Div Plant Sci, Loughborough LE12 5RD, Leics, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Nottingham	Loudet, O (corresponding author), INRA, SGAP UR254, F-78026 Versailles, France.	loudet@versailles.inra.fr	Bikard, David/AAZ-3752-2021; Bennett, Malcolm/G-4004-2010; Loudet, Olivier/CAF-7559-2022; Patel, Dhaval/D-2745-2013; Bikard, David/L-2971-2015; Loudet, Olivier/K-8266-2012; Giorgi, Veronica/GQA-4191-2022	Bikard, David/0000-0002-5729-1211; Bennett, Malcolm/0000-0003-0475-390X; Bikard, David/0000-0002-5729-1211; Loudet, Olivier/0000-0003-3717-0137; Giorgi, Veronica/0000-0002-8917-3949	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering; Physical Sciences Research Council Centres for Integrative Systems Biology	INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project; University of Nottingham; Biotechnology and Biological Sciences Research Council/Engineering(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physical Sciences Research Council Centres for Integrative Systems Biology	We thank K. Bomblies and D. Weigel for providing F2 seeds for specific test crosses (Bay-0 x Cvi and Tsu-0 x Cvi), X. Mo for hpa1 seeds, and R. Mercier and F. Roux for discussion and critical reading of the manuscript. Funded partly by an INRA-Departement de Genetique et d'Amelioration des Plantes Innovative Project grant to C.C. and O.L. Funding by the University of Nottingham to D.P. and the Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Centres for Integrative Systems Biology program to M.J.B. Sequences have been deposited in GenBank under accessions FJ436446 and FJ436447.	Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1937; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kopp A, 2005, GENETICA, V125, P55, DOI 10.1007/s10709-005-4787-8; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mo XR, 2006, PLANT PHYSIOL, V141, P1425, DOI 10.1104/pp.106.084178; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Orr HA, 2001, EVOLUTION, V55, P1085; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180	33	198	201	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					623	626		10.1126/science.1165917	http://dx.doi.org/10.1126/science.1165917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179528				2022-12-28	WOS:000262862800040
J	Hoddinott, P; Britten, J; Prescott, GJ; Tappin, D; Ludbrook, A; Godden, DJ				Hoddinott, Pat; Britten, Jane; Prescott, Gordon J.; Tappin, David; Ludbrook, Anne; Godden, David J.			Effectiveness of policy to provide breastfeeding groups ( BIG) for pregnant and breastfeeding mothers in primary care: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PEER COACHING INTERVENTION; SUPPORT; RATES; SCOTLAND	Objective To assess the clinical effectiveness and cost effectiveness of a policy to provide breastfeeding groups for pregnant and breastfeeding women. Design Cluster randomised controlled trial with prospective mixed method embedded case studies to evaluate implementation processes. Setting Primary care in Scotland. Participants Pregnant women, breastfeeding mothers, and babies registered with 14 of 66 eligible clusters of general practices ( localities) in Scotland that routinely collect breastfeeding outcome data. Intervention Localities setup new breastfeeding groups to provide population coverage; control localities did not change group activity. Main outcome measures Primary outcome: any breast feeding at 6- 8 weeks from routinely collected data for two pre- trial years and two trial years. Secondary outcomes: any breast feeding at birth, 5- 7 days, and 8- 9 months; maternal satisfaction. Results Between 1 February 2005 and 31 January 2007, 9747 birth records existed for intervention localities and 9111 for control localities. The number of breastfeeding groups increased from 10 to 27 in intervention localities, where 1310 women attended, and remained at 10 groups in control localities. No significant differences in breastfeeding outcomes were found. Any breast feeding at 6- 8 weeks declined from 27% to 26% in intervention localities and increased from 29% to 30% in control localities (P= 0.08, adjusted for pre- trial rate). Any breast feeding at 6- 8 weeks increased from 38% to 39% in localities not participating in the trial. Women who attended breastfeeding groups were older ( P< 0.001) than women initiating breast feeding who did not attend and had higher income (P= 0.02) than women in the control localities who attended postnatal groups. The locality cost was 13 400 ( (euro)14 410; $ 20 144) a year. Conclusion A policy for providing breastfeeding groups in relatively deprived areas of Scotland did not improve breastfeeding rates at 6- 8 weeks. The costs of running groups would be similar to the costs of visiting women at home. Trial registration Current Controlled Trials ISRCTN44857041.	[Hoddinott, Pat; Britten, Jane; Godden, David J.] Univ Aberdeen, Ctr Rural Hlth, Hlth Sci Ctr, Inverness IV2 3JH, Scotland; [Prescott, Gordon J.] Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; [Tappin, David] Univ Glasgow, Royal Hosp Sick Children, Paediat Epidemiol & Community Hlth Unit, Sect Child Hlth, Glasgow G3 8SJ, Lanark, Scotland; [Ludbrook, Anne] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Glasgow; University of Aberdeen	Hoddinott, P (corresponding author), Univ Aberdeen, Ctr Rural Hlth, Hlth Sci Ctr, Inverness IV2 3JH, Scotland.	p.hoddinott@abdn.ac.uk	Hoddinott, Pat/F-9090-2011	Prescott, Gordon/0000-0002-9156-2361; Hoddinott, Pat/0000-0002-4372-9681	Chief Scientist's Office of the Scottish Government Health Directorate [CZH/4/156]; Health Economics Research Unit; University of Aberdeen; Chief Scientist Office [HERU1] Funding Source: researchfish	Chief Scientist's Office of the Scottish Government Health Directorate; Health Economics Research Unit; University of Aberdeen; Chief Scientist Office	The Chief Scientist's Office of the Scottish Government Health Directorate provided funding through a research grant (CZH/4/156). PH was funded through a primary care research career award, and the Health Economics Research Unit, University of Aberdeen received core funding. The funding body had no role in the study design, data collection, analysis, or writing of reports; it received interim progress reports at six and 18 months and a final report after three years.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bartington S, 2006, INT J EPIDEMIOL, V35, P1178, DOI 10.1093/ije/dyl155; Blyth R, 2002, BIRTH-ISS PERINAT C, V29, P278, DOI 10.1046/j.1523-536X.2002.00202.x; Bolling K, 2007, INFANT FEEDING SURVE; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Broadfoot M, 2005, ARCH DIS CHILD-FETAL, V90, P114, DOI 10.1136/adc.2003.041558; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Curtis L, 2006, UNIT COSTS HLTH SOCI; DEMOTT K, 2006, ROUTINE POSTNATAL CA; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Dyson L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001688.pub2; Gagnon AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002869.pub2; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; Hoddinott P, 2006, BIRTH-ISS PERINAT C, V33, P27, DOI 10.1111/j.0730-7659.2006.00071.x; Hoddinott P, 1999, BRIT MED J, V318, P30, DOI 10.1136/bmj.318.7175.30; Hoddinott P, 2007, CONTEMP CLIN TRIALS, V28, P232, DOI 10.1016/j.cct.2006.08.004; Hoddinott P, 2007, FAM PRACT, V24, P84, DOI 10.1093/fampra/cml061; Hoddinott P, 2006, BIRTH-ISS PERINAT C, V33, P139, DOI 10.1111/j.0730-7659.2006.00092.x; Horta BL, 2007, EVIDENCE LONG TERM E; IP S, 2007, 153 AG HEALTHC RES Q; *ISD SCOTL, 2008, BREASTF; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Leff E W, 1994, J Hum Lact, V10, P105, DOI 10.1177/089033449401000217; Lumley J., 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001055.PUB2; MCGUIRE M, 2004, BRIT J MIDWIFERY, V12, P674; *NHS SCOTL, COMM HLTH PARTN; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Reid M, 2002, BJOG-INT J OBSTET GY, V109, P1164; *SCOTT GOV STAT, 2008, SCOTT HOUS SURV; Scottish Executive, 2006, SCOTT IND MULT DEPR; Scottish Executive, 2005, HLTH ALL CHILDR 4 GU; Tappin DM, 2001, BRIT MED J, V322, P1335, DOI 10.1136/bmj.322.7298.1335; United Nations International Children Emergency Fund, 2008, GLOB STRAT INF YOUNG; Waterman H., 2001, HEALTH TECHNOL ASSES, V5, piii, DOI DOI 10.3310/hta5230.; World Health Organization/UNICEF, 2008, BAB FRIENDL HOSP IN	35	37	37	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2009	338								a3026	10.1136/bmj.a3026	http://dx.doi.org/10.1136/bmj.a3026			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EQ	19181729	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000263206000001
J	Fletcher, P				Fletcher, Phillip			A woman with ataxia	BRITISH MEDICAL JOURNAL			English	Editorial Material							PARANEOPLASTIC CEREBELLAR DEGENERATION; ANTI-HU; ANTINEURONAL ANTIBODIES; NEUROLOGIC DISORDERS; YO ANTIBODIES; CANCER; BREAST; TUMOR		[Fletcher, Phillip] St George Hosp, London, England	St Georges University London	Fletcher, P (corresponding author), St George Hosp, London, England.	fletcherphillip@hotmail.com			Medical Research Council [MR/J011274/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albert ML, 2000, ANN NEUROL, V47, P9; ANDERSON NE, 1988, ANN NEUROL, V24, P559, DOI 10.1002/ana.410240413; Ciardi M, 2003, CLIN INFECT DIS, V36, pE50, DOI 10.1086/345781; Dalmau J, 2006, HEMATOL ONCOL CLIN N, V20, P1319, DOI 10.1016/j.hoc.2006.09.011; Debes JD, 2007, DIGEST SURG, V24, P395, DOI 10.1159/000107782; Keime-Guibert F, 1999, NEUROLOGY, V53, P1719, DOI 10.1212/WNL.53.8.1719; Keime-Guibert F, 2000, J NEUROL NEUROSUR PS, V68, P479, DOI 10.1136/jnnp.68.4.479; Mathew RM, 2006, J NEUROL SCI, V250, P153, DOI 10.1016/j.jns.2006.06.029; Monstad SE, 2006, CLIN EXP IMMUNOL, V144, P53, DOI 10.1111/j.1365-2249.2006.03031.x; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; POSNER JB, 1995, NEUROLOGIC COMPLICAT, P53; Rojas I, 2000, NEUROLOGY, V55, P713, DOI 10.1212/WNL.55.5.713; Rojas-Marcos I, 2003, MEDICINE, V82, P216, DOI 10.1097/00005792-200305000-00007; Rousseau A, 2005, J NEURO-ONCOL, V71, P231, DOI 10.1007/s11060-004-1723-1; Shams'ili S, 2003, BRAIN, V126, P1409, DOI 10.1093/brain/awg133; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3	17	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 28	2009	338								b180	10.1136/bmj.b180	http://dx.doi.org/10.1136/bmj.b180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EM	19176660				2022-12-28	WOS:000263205500004
J	Lim, DA; Huang, YC; Swigut, T; Mirick, AL; Garcia-Verdugo, JM; Wysocka, J; Ernst, P; Alvarez-Buylla, A				Lim, Daniel A.; Huang, Yin-Cheng; Swigut, Tomek; Mirick, Anika L.; Manuel Garcia-Verdugo, Jose; Wysocka, Joanna; Ernst, Patricia; Alvarez-Buylla, Arturo			Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells	NATURE			English	Article							ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; SELF-RENEWAL; PROGENITORS; MICE; OLIGODENDROCYTES; PROLIFERATION; EXPRESSION; POLYCOMB	Epigenetic mechanisms that maintain neurogenesis throughout adult life remain poorly understood(1). Trithorax group (trxG) and Polycomb group (PcG) gene products are part of an evolutionarily conserved chromatin remodelling system that activate or silence gene expression, respectively(2). Although PcG member Bmi1 has been shown to be required for postnatal neural stem cell self-renewal(3,4), the role of trxG genes remains unknown. Here we show that the trxG member Mll1 (mixed-lineage leukaemia 1) is required for neurogenesis in the mouse postnatal brain. Mll1-deficient subventricular zone neural stem cells survive, proliferate and efficiently differentiate into glial lineages; however, neuronal differentiation is severely impaired. In Mll1-deficient cells, early proneural Mash1 (also known as Ascl1) and gliogenic Olig2 expression are preserved, but Dlx2, a key downstream regulator of subventricular zone neurogenesis, is not expressed. Overexpression of Dlx2 can rescue neurogenesis in Mll1-deficient cells. Chromatin immunoprecipitation demonstrates that Dlx2 is a direct target of MLL in subventricular zone cells. In differentiating wild-type subventricular zone cells, Mash1, Olig2 and Dlx2 loci have high levels of histone 3 trimethylated at lysine 4 (H3K4me3), consistent with their transcription. In contrast, in Mll1-deficient subventricular zone cells, chromatin at Dlx2 is bivalently marked by both H3K4me3 and histone 3 trimethylated at lysine 27 (H3K27me3), and the Dlx2 gene fails to properly activate. These data support a model in which Mll1 is required to resolve key silenced bivalent loci in postnatal neural precursors to the actively transcribed state for the induction of neurogenesis, but not for gliogenesis.	[Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Mirick, Anika L.; Ernst, Patricia] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46012, Spain; [Manuel Garcia-Verdugo, Jose] CIBERNED, Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46012, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; Dartmouth College; University of Valencia; CIBERNED; Prince Felipe Research Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus St M779, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu; abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Swigut, Tomek/0000-0002-7649-6781; Ernst, Patricia/0000-0001-7638-2939; Lim, Daniel/0000-0001-7221-3425; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award; Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH) [5R37-NS028478]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478] Funding Source: NIH RePORTER	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award(California Institute for Regenerative Medicine); Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Rubenstein for anti-DLX2 antibodies and the pCAG-Dlx2 plasmid, D. Rowitch for anti-OLIG2 antibodies, and Y. Dou and R. Roeder for anti-MLL1 antibodies. This work was supported by the Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons, Sandler Family Foundation, Northern California Institute for Research and Education, and the Clinical and Translational Research Institute at the University of California, San Francisco (D. A. L.), California Institute for Regenerative Medicine New Faculty Award and The Chicago Community Trust Searle Scholar Award (J. W.), and the Goldhirsch Foundation, J. G. Bowes Research Fund, and National Institutes of Health (NIH) 5R37-NS028478 (A. A.-B.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	31	285	292	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					529	U9		10.1038/nature07726	http://dx.doi.org/10.1038/nature07726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19212323	Green Accepted			2022-12-28	WOS:000264532400049
J	Hearn, EM; Patel, DR; Lepore, BW; Indic, M; van den Berg, B				Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert			Transmembrane passage of hydrophobic compounds through a protein channel wall	NATURE			English	Article							FATTY-ACID TRANSPORT; ESCHERICHIA-COLI; MULTIDRUG TRANSPORTER; MEMBRANE-PROTEIN; P-GLYCOPROTEIN; CYTOPLASMIC LEAFLET; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; FADL GENE	Membrane proteins that transport hydrophobic compounds have important roles in multi-drug resistance(1-3) and can cause a number of diseases(4,5), underscoring the importance of protein-mediated transport of hydrophobic compounds. Hydrophobic compounds readily partition into regular membrane lipid bilayers(6), and their transport through an aqueous protein channel is energetically unfavourable(3). Alternative transport models involving acquisition from the lipid bilayer by lateral diffusion have been proposed for hydrophobic substrates(3,4,7-12). So far, all transport proteins for which a lateral diffusion mechanism has been proposed function as efflux pumps. Here we present the first example of a lateral diffusion mechanism for the uptake of hydrophobic substrates by the Escherichia coli outer membrane long-chain fatty acid transporter FadL. A FadL mutant in which a lateral opening in the barrel wall is constricted, but which is otherwise structurally identical to wild-type FadL, does not transport substrates. A crystal structure of FadL from Pseudomonas aeruginosa shows that the opening in the wall of the beta-barrel is conserved and delineates a long, hydrophobic tunnel that could mediate substrate passage from the extracellular environment, through the polar lipopolysaccharide layer and, by means of the lateral opening in the barrel wall, into the lipid bilayer from where the substrate can diffuse into the periplasm. Because FadL homologues are found in pathogenic and biodegrading bacteria, our results have implications for combating bacterial infections and bioremediating xenobiotics in the environment.	[Hearn, Elizabeth M.; Patel, Dimki R.; Lepore, Bryan W.; Indic, Mridhu; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Insitutes of Health; NIH [1R01GM074824]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074824, F32GM079820] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of the National Synchrotron Light Source (NSLS) beamlines X6A and X29 for beam time and beamline support. We are grateful to P. Black and C. Petteys for the strain D10 and for their technical advice on the fatty acid transport assays. This work was supported by a training grant from the National Insitutes of Health (to E. M. H.) and by a NIH research grant (1R01GM074824 to B. v. d. B.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLACK PN, 1987, J BIOL CHEM, V262, P1412; BLACK PN, 1990, BIOCHIM BIOPHYS ACTA, V1046, P97, DOI 10.1016/0005-2760(90)90099-J; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; EATON RW, 1994, J BACTERIOL, V176, P7757, DOI 10.1128/JB.176.24.7757-7762.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GINSBURGH CL, 1984, J BIOL CHEM, V259, P8437; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kahng HY, 2000, J BACTERIOL, V182, P1232, DOI 10.1128/JB.182.5.1232-1242.2000; KUMAR GB, 1991, J BIOL CHEM, V266, P1348; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sun PD, 2002, ACTA CRYSTALLOGR D, V58, P1092, DOI 10.1107/S0907444902006510; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; van Veen HW, 1999, BBA-BIOMEMBRANES, V1461, P201, DOI 10.1016/S0005-2736(99)00172-8; VANBEILEN JB, 1992, MOL MICROBIOL, V6, P3121; VORUM H, 1992, BIOCHIM BIOPHYS ACTA, V1126, P135, DOI 10.1016/0005-2760(92)90283-2; WANG Y, 1995, MOL GEN GENET, V246, P570, DOI 10.1007/BF00298963; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330	41	106	114	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					367	U134		10.1038/nature07678	http://dx.doi.org/10.1038/nature07678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182779	Green Accepted			2022-12-28	WOS:000264285600047
J	Lieberman, MD; Eisenberger, NI				Lieberman, Matthew D.; Eisenberger, Naomi I.			NEUROSCIENCE Pains and Pleasures of Social Life	SCIENCE			English	Editorial Material							NEURAL BASIS; REWARD		[Lieberman, Matthew D.; Eisenberger, Naomi I.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lieberman, MD (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall, Los Angeles, CA 90095 USA.	lieber@ucla.edu	Lieberman, Matthew/ABD-8197-2020	Lieberman, Matthew/0000-0002-4447-7359				BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; O'Connor MF, 2008, NEUROIMAGE, V42, P969, DOI 10.1016/j.neuroimage.2008.04.256; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641	15	105	107	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					890	891		10.1126/science.1170008	http://dx.doi.org/10.1126/science.1170008			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213907				2022-12-28	WOS:000263295400029
J	Namiki, N; Iwata, T; Matsumoto, K; Hanada, H; Noda, H; Goossens, S; Ogawa, M; Kawano, N; Asari, K; Tsuruta, SI; Ishihara, Y; Liu, QH; Kikuchi, F; Ishikawa, T; Sasaki, S; Aoshima, C; Kurosawa, K; Sugita, S; Takano, T				Namiki, Noriyuki; Iwata, Takahiro; Matsumoto, Koji; Hanada, Hideo; Noda, Hirotomo; Goossens, Sander; Ogawa, Mina; Kawano, Nobuyuki; Asari, Kazuyoshi; Tsuruta, Sei-Itsu; Ishihara, Yoshiaki; Liu, Qinghui; Kikuchi, Fuyuhiko; Ishikawa, Toshiaki; Sasaki, Sho; Aoshima, Chiaki; Kurosawa, Kosuke; Sugita, Seiji; Takano, Tadashi			Farside Gravity Field of the Moon from Four-Way Doppler Measurements of SELENE (Kaguya)	SCIENCE			English	Article							LUNAR CRUST; IMPACT BASINS; CLEMENTINE; MASCONS; MISSION; SURFACE; PROSPECTOR; EVOLUTION; RELIEF; MODEL	The farside gravity field of the Moon is improved from the tracking data of the Selenological and Engineering Explorer (SELENE) via a relay subsatellite. The new gravity field model reveals that the farside has negative anomaly rings unlike positive anomalies on the nearside. Several basins have large central gravity highs, likely due to super-isostatic, dynamic uplift of the mantle. Other basins with highs are associated with mare fill, implying basalt eruption facilitated by developed faults. Basin topography and mantle uplift on the farside are supported by a rigid lithosphere, whereas basins on the nearside deformed substantially with eruption. Variable styles of compensation on the near- and farsides suggest that reheating and weakening of the lithosphere on the nearside was more extensive than previously considered.	[Namiki, Noriyuki] Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan; [Iwata, Takahiro] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsumoto, Koji; Hanada, Hideo; Noda, Hirotomo; Goossens, Sander; Kawano, Nobuyuki; Asari, Kazuyoshi; Tsuruta, Sei-Itsu; Ishihara, Yoshiaki; Liu, Qinghui; Kikuchi, Fuyuhiko; Ishikawa, Toshiaki; Sasaki, Sho] Natl Inst Nat Sci, Natl Astron Observ Japan, Mizusawa, Iwate 0230861, Japan; [Ogawa, Mina] Japan Aerosp Explorat Agcy, Tsukuba Space Ctr, Tsukuba, Ibaraki 3058505, Japan; [Aoshima, Chiaki] Fujitsu Ltd, Mihama Ku, Chiba 2618588, Japan; [Kurosawa, Kosuke] Univ Tokyo, Chiba 2778561, Japan; [Takano, Tadashi] Nihon Univ, Chiba 2748501, Japan	Kyushu University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Fujitsu Ltd; University of Tokyo; Nihon University	Namiki, N (corresponding author), Kyushu Univ, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	nori@geo.kyushu-u.ac.jp	Matsumoto, Koji/AAF-7825-2021; Goossens, Sander J/K-2526-2015; Kurosawa, Kosuke/N-2291-2015; Sugita, Seiji/GQI-1142-2022; Takano, Tadashi/AAP-9279-2020; Sasaki, Sho/S-3845-2019; Ishihara, Yoshiaki/A-8499-2011	Matsumoto, Koji/0000-0003-4319-1970; Goossens, Sander J/0000-0002-7707-1128; Kurosawa, Kosuke/0000-0003-4965-4585; Sugita, Seiji/0000-0001-6076-3614; Sasaki, Sho/0000-0002-7646-5248; Ishihara, Yoshiaki/0000-0002-0375-6300	Grants-in-Aid for Scientific Research [20244073] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ANANDA MP, 1977, J GEOPHYS RES, V103, P3709; Arai T, 2008, EARTH PLANETS SPACE, V60, P433, DOI 10.1186/BF03352808; Araki H, 2009, SCIENCE, V323, P897, DOI 10.1126/science.1164146; BELTON MJS, 1992, SCIENCE, V255, P570, DOI 10.1126/science.255.5044.570; Cook AC, 2000, J GEOPHYS RES-PLANET, V105, P12023, DOI 10.1029/1999JE001083; FLOBERGHAGEN R., 2002, LUNAR GRAVIMETRY REV; Gillis JJ, 2004, GEOCHIM COSMOCHIM AC, V68, P3791, DOI 10.1016/j.gca.2004.03.024; Iwata T., 2001, J GEOD SOC JPN, V47, P558; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kato M, 2008, ADV SPACE RES, V42, P294, DOI 10.1016/j.asr.2007.03.049; Kaula W.M., 1966, THEORY SATELLITE GEO; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Korenaga J, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005100; Korotev RL, 2003, GEOCHIM COSMOCHIM AC, V67, P4895, DOI 10.1016/j.gca.2003.08.001; Lemoine FGR, 1997, J GEOPHYS RES-PLANET, V102, P16339, DOI 10.1029/97JE01418; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; PHILLIPS RJ, 1972, J GEOPHYS RES, V77, P7106, DOI 10.1029/JB077i035p07106; Pike R.J., 1977, LUNAR PLANET SCI C, V3, P3427; Rybacki E, 2000, J GEOPHYS RES-SOL EA, V105, P26017, DOI 10.1029/2000JB900223; SOLOMON SC, 1982, J GEOPHYS RES, V87, P3975, DOI 10.1029/JB087iB05p03975; Spudis P.D., 1993, GEOLOGY MULTIRING IM; TAYLOR SR, 1975, LUNAR SCI POST APOLL; WHITFORDSTARK JL, 1982, MOON PLANETS, V26, P323, DOI 10.1007/BF00928015; Wilhelms D., 1987, GEOLOGIC HIST MOON, DOI [10.3133/pp1348, DOI 10.3133/PP1348]; WISE DU, 1970, J GEOPHYS RES, V75, P261, DOI 10.1029/JB075i002p00261; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	28	144	187	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					900	905		10.1126/science.1168029	http://dx.doi.org/10.1126/science.1168029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213911				2022-12-28	WOS:000263295400033
J	Budd, GE; Telford, MJ				Budd, Graham E.; Telford, Maximilian J.			The origin and evolution of arthropods	NATURE			English	Review							AMINO-ACID REPLACEMENTS; GENOME-WIDE ANALYSIS; BURGESS SHALE; PHYLOGENETIC ANALYSIS; HEAD SEGMENTATION; FOSSIL RECORD; ECDYSOZOA; CRUSTACEAN; SUPPORT; COELOMATA	The past two decades have witnessed profound changes in our understanding of the evolution of arthropods. Many of these insights derive from the adoption of molecular methods by systematists and developmental biologists, prompting a radical reordering of the relationships among extant arthropod classes and their closest non- arthropod relatives, and shedding light on the developmental basis for the origins of key characteristics. A complementary source of data is the discovery of fossils from several spectacular Cambrian faunas. These fossils form well- characterized groupings, making the broad pattern of Cambrian arthropod systematics increasingly consensual.	[Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	Uppsala University; University of London; University College London	Budd, GE (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	graham.budd@pal.uu.se; m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008	Telford, Maximilian J/0000-0002-3749-5620; Budd, Graham/0000-0001-9007-4369	Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]	Marie Curie Research Training Network ZOONET(European Commission)	We thank A. Daley for assistance with photography and R. Copley for critically reading an earlier draft. Our research is supported by the Marie Curie Research Training Network ZOONET (grant number MRTN-CT-2004-005624).	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; [Anonymous], 1861, ORIGIN SPECIES MEANS; BALLARD JWO, 1992, SCIENCE, V258, P1345, DOI 10.1126/science.1455227; BERGSTROM J, 1986, LETHAIA, V19, P241, DOI 10.1111/j.1502-3931.1986.tb00738.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Bowler PJ., 1996, LIFES SPLENDID DRAMA; Boxshall GA, 2007, ZOOTAXA, P313, DOI 10.11646/zootaxa.1668.1.16; Briggs DEG, 1999, PALAEONTOLOGY, V42, P953, DOI 10.1111/1475-4983.00104; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2003, INTEGR COMP BIOL, V43, P157, DOI 10.1093/icb/43.1.157; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Copley RR, 2004, EVOL DEV, V6, P164, DOI 10.1111/j.1525-142X.2004.04021.x; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Damen WGM, 2002, CURR BIOL, V12, P1711, DOI 10.1016/S0960-9822(02)01126-0; DUNLOP JA, 2005, ACTA ZOOL BULG S, V1, P9; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2004, CONTRIB ZOOL, V73, P207, DOI 10.1163/18759866-07303002; EERNISSE DJ, 1992, SYST BIOL, V41, P305, DOI 10.1093/sysbio/41.3.305; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Fayers SR, 2005, PALAEONTOLOGY, V48, P1117, DOI 10.1111/j.1475-4983.2005.00501.x; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; HOU XG, 1997, FOSSILS STRATA, V45; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Ivantsov A.Y., 2001, PALEONTOL J+, V35, P335; Jensen S, 2003, INTEGR COMP BIOL, V43, P219, DOI 10.1093/icb/43.1.219; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Manton, 1977, ARTHROPODA HABITS FU; MORRIS SC, 1987, NATURE, V326, P181, DOI 10.1038/326181a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Rogozin IB, 2007, MOL BIOL EVOL, V24, P2594, DOI 10.1093/molbev/msm218; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; SANDERS HL, 1957, SYST ZOOL, V6, P112, DOI 10.2307/2411750; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2099, DOI 10.1098/rspb.2007.0429; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; StOrmer L., 1944, SKR NORSKE VIDENS MN, V5, P1; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; TELFORD MJ, 1995, NATURE, V376, P123, DOI 10.1038/376123a0; Thomas RH, 1999, ACTA ZOOL-STOCKHOLM, V80, P193, DOI 10.1046/j.1463-6395.1999.00016.x; Ungerer P, 2008, P ROY SOC B-BIOL SCI, V275, P369, DOI 10.1098/rspb.2007.1391; Wagele JW, 1999, J ZOOL SYST EVOL RES, V37, P211; Waggoner BM, 1996, SYST BIOL, V45, P190, DOI 10.2307/2413615; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Webster BL, 2006, EVOL DEV, V8, P502, DOI 10.1111/j.1525-142X.2006.00123.x; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wilson HM, 2006, J PALEONTOL, V80, P638, DOI 10.1666/0022-3360(2006)80[638:JMFTLD]2.0.CO;2; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; Zheng J, 2007, MOL BIOL EVOL, V24, P2583, DOI 10.1093/molbev/msm207	77	134	142	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					812	817		10.1038/nature07890	http://dx.doi.org/10.1038/nature07890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212398				2022-12-28	WOS:000263266700030
J	Eldredge, N				Eldredge, Niles			What Darwin learned in medical school	LANCET			English	Editorial Material									[Eldredge, Niles] Amer Museum Nat Hist, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Eldredge, N (corresponding author), Amer Museum Nat Hist, New York, NY 10024 USA.							Browne Janet, 1995, C DARWIN VOYAGING; Desmond Adrian., 1991, DARWIN LIFE TORMENTE; Eldredge Niles, 2009, Evolution Education and Outreach, V2, P35, DOI 10.1007/s12052-008-0103-2	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					454	455		10.1016/S0140-6736(09)60158-6	http://dx.doi.org/10.1016/S0140-6736(09)60158-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19205083				2022-12-28	WOS:000263132800015
J	Tang, SW; Presgraves, DC				Tang, Shanwu; Presgraves, Daven C.			Evolution of the Drosophila Nuclear Pore Complex Results in Multiple Hybrid Incompatibilities	SCIENCE			English	Article							ADAPTIVE PROTEIN EVOLUTION; DOSAGE COMPENSATION; POSITIVE SELECTION; INVIABILITY GENE; LETHAL COMPLEX; MELANOGASTER; HITCHHIKING; SPECIATION; STERILITY; PATTERNS	Speciation often involves the evolution of incompatible gene interactions that cause sterility or lethality in hybrids between populations. These so- called hybrid incompatibilities occur between two or more functionally divergent loci. We show that the nucleoporin 160kDa ( Nup160) gene of the fruitfly Drosophila simulans is incompatible with one or more factors on the D. melanogaster X chromosome, causing hybrid lethality. Nup160 encodes a nuclear pore complex protein and shows evidence of adaptive evolution. Furthermore, the protein encoded by Nup160 directly interacts with that of another hybrid lethality gene, Nup96, indicating that at least two lethal hybrid incompatibility genes have evolved as byproducts of divergent coevolution among interacting components of the Drosophila nuclear pore complex.	[Tang, Shanwu; Presgraves, Daven C.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Presgraves, Daven C.] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA	University of Rochester; Harvard University	Tang, SW (corresponding author), Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14627 USA.				NIH [R01GM079543]; University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester; Radcliffe Institute for Advanced Study at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Drosophila Genome Resource Center for cloning vectors and the D. melanogaster Nup160 cDNA; the Bloomington Stock Center and the Exelixis Stock Collection at Harvard Medical School for fly stocks; and V. Cattani, P. Gerard, C. Meiklejohn, A. Orr, A. Sweigart, and two anonymous reviewers for comments. This work was supported by funds to D. C. P. from NIH grant R01GM079543, the University of Rochester, and the Radcliffe Institute for Advanced Study at Harvard University. Sequences have been deposited in GenBank under accession numbers FJ600378 to FJ600401.	Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Ashburner M., 2004, DROSOPHILA LAB HDB; Bachtrog D, 2008, GENETICS, V180, P1123, DOI 10.1534/genetics.107.084244; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2007, GENETICS, V176, P543, DOI 10.1534/genetics.107.072827; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Dobzhansky T., 1937; Fay JC, 2000, GENETICS, V155, P1405; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; KAPLAN NL, 1989, GENETICS, V123, P887; Levine MT, 2007, GENETICS, V177, P1959, DOI 10.1534/genetics.107.079459; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; ORR HA, 1995, GENETICS, V139, P1805; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Rodriguez MA, 2007, P NATL ACAD SCI USA, V104, P15412, DOI 10.1073/pnas.0707445104; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; TAJIMA F, 1989, GENETICS, V123, P585; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TURELLI M, 1995, GENETICS, V140, P389; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	36	115	120	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					779	782		10.1126/science.1169123	http://dx.doi.org/10.1126/science.1169123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197064	Green Accepted			2022-12-28	WOS:000263066800046
J	Bliuc, D; Nguyen, ND; Milch, VE; Nguyen, TV; Eisman, JA; Center, JR				Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.			Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OLDER WOMEN; EXCESS MORTALITY; VERTEBRAL FRACTURE; CLINICAL FRACTURES; PREDICT MORTALITY; ELDERLY-WOMEN; FOLLOW-UP; SURVIVAL; HOSPITALIZATION	Context There are few data on long- term mortality following osteoporotic fracture and fewer following subsequent fracture. Objectives To examine long- term mortality risk in women and men following all osteoporotic fractures and to assess the association of subsequent fracture with that risk. Design, Setting, and Participants Prospective cohort from the Dubbo Osteoporosis Epidemiology Study of community- dwelling women and men aged 60 years and older from Dubbo, Australia, who sustained a fracture between April 1989 and May 2007. Main Outcome Measures Age- and sex- specific standardized mortality ratios ( SMRs) compared with the overallDubbopopulation for hip, vertebral, major, and minor fractures. Results In women, there were 952 low- trauma fractures followed by 461 deaths, and in men, 343 fractures were followed by 197 deaths. Age- adjusted SMRs were increased following hip fractures ( SMRs, 2.43 [ 95% confidence interval [ CI], 2.02-2.93] and 3.51 [ 95% CI, 2.65- 4.66]), vertebral fractures ( SMRs, 1.82 [ 95% CI, 1.52-2.17] and 2.12 [ 95% CI, 1.66- 2.72]), major fractures ( SMRs, 1.65 [ 95% CI, 1.31-2.08] and 1.70 [ 95% CI, 1.23- 2.36]), and minor fractures ( SMRs, 1.42 [ 95% CI, 1.19- 1.70] and 1.33 [ 95% CI, 0.99- 1.80]) for both women and men, respectively. Mortality was increased for all ages for all fractures except minor fractures for which increased mortality was only apparent for those older than 75 years. Increased mortality risk persisted for 5 years for all fractures and up to 10 years for hip fractures. Increases in absolute mortality that were above expected, for 5 years after fracture, ranged from 1.3 to 13.2 per 100 person- years in women and from 2.7 to 22.3 per 100 person- years in men, depending on fracture type. Subsequent fracture was associated with an increased mortality hazard ratio of 1.91 ( 95% CI, 1.54- 2.37) in women and 2.99 ( 95% CI, 2.11- 4.24) in men. Mortality risk following a subsequent fracture then declined but beyond 5 years still remained higher than in the general population ( SMR, 1.41 [ 95% CI, 1.01- 1.97] and SMR, 1.78 [ 95% CI, 0.96- 3.31] for women and men, respectively). Predictors of mortality after any fragility fracture for both men and women included age, quadriceps weakness, and subsequent fracture but not comorbidities. Low bone mineral density, having smoked, and sway were also predictors for women and less physical activity for men. Conclusions In a sample of older women and men, all low- trauma fractures were associated with increased mortality risk for 5 to 10 years. Subsequent fracture was associated with increased mortality risk for an additional 5 years.	[Bliuc, Dana; Nguyen, D. Nguyen; Milch, Vivienne E.; Nguyen, Tuan V.; Eisman, John A.; Center, Jacqueline R.] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Center, JR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	j.center@garvan.org.au	Nguyen, Tuan V/B-6147-2008; Eisman, John A/C-2886-2014; Nguyen, Nguyen/D-1480-2010; Center, Jacqueline/AAY-8712-2021; Nguyen, Thao/GWN-0419-2022; Bliuc, Dana/Y-7240-2018; Nguyen, Nguyen/GVT-4511-2022	Nguyen, Tuan V/0000-0002-3246-6281; Center, Jacqueline/0000-0002-5278-4527; Bliuc, Dana/0000-0001-9682-2313; Milch, Vivienne/0000-0001-8834-0349	National Health and Medical Research Council [276413]; MBF Living Well Foundation; Ernst Heine Foundation; Amgen; Merck Sharp Dohme; Sanofi-Aventis; Servier; Novartis	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MBF Living Well Foundation; Ernst Heine Foundation; Amgen(Amgen); Merck Sharp Dohme(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Novartis(Novartis)	This study was supported in part by National Health and Medical Research Council (NHMRC) grant 276413. This study also received support from the MBF Living Well Foundation, the Ernst Heine Foundation; and untied grants from Amgen, Merck Sharp & Dohme, Sanofi-Aventis, Servier, and Novartis.	Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Empana JP, 2004, J AM GERIATR SOC, V52, P685, DOI 10.1111/j.1532-5415.2004.52203.x; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Forsen L, 1999, OSTEOPOROSIS INT, V10, P73, DOI 10.1007/s001980050197; Haentjens P, 2004, J BONE MINER RES, V19, P1933, DOI 10.1359/JBMR.040917; Hasserius R, 2005, CALCIFIED TISSUE INT, V76, P235, DOI 10.1007/s00223-004-2222-2; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Karagiannis A, 2006, CALCIFIED TISSUE INT, V78, P72, DOI 10.1007/s00223-005-0169-6; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; *OST AUSTR ACC EC, 2001, BURD BRITTL BON COST; Pongchaiyakul C, 2005, J BONE MINER RES, V20, P1349, DOI 10.1359/JBMR.050317; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; SIMONS LA, 1990, AUST NZ J MED, V20, P783, DOI 10.1111/j.1445-5994.1990.tb00423.x; Tosteson ANA, 2007, OSTEOPOROSIS INT, V18, P1463, DOI 10.1007/s00198-007-0429-6; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Trone DW, 2007, AM J EPIDEMIOL, V166, P1191, DOI 10.1093/aje/kwm206; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P1583, DOI 10.1007/s00198-007-0403-3; Woodward M., 1992, STATISTICIAN, V41, P185; 2006, BASE SAS 9 1 3 PROCE	35	1011	1051	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					513	521		10.1001/jama.2009.50	http://dx.doi.org/10.1001/jama.2009.50			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190316	Bronze			2022-12-28	WOS:000262992400021
J	Angell, M				Angell, Marcia			Relationships with the drug industry: Keep at arm's length	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Angell, M (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	marcia_angell@hms.harvard.edu						Angell M., 2004, TRUTH DRUG CO THEY D; Relman AS, 2008, JAMA-J AM MED ASSOC, V300, P1071, DOI 10.1001/jama.300.9.1071; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	3	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2009	338								b222	10.1136/bmj.b222	http://dx.doi.org/10.1136/bmj.b222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19193614				2022-12-28	WOS:000263876200006
J	Emerson, E				Emerson, Eric			Relative Child Poverty, Income Inequality, Wealth, and Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC CIRCUMSTANCES		[Emerson, Eric] Univ Lancaster, Div Hlth Res, Lancaster LA1 4YT, England; [Emerson, Eric] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Lancaster University; University of Sydney	Emerson, E (corresponding author), Univ Lancaster, Div Hlth Res, Lancaster LA1 4YT, England.	eric.emerson@lancaster.ac.uk		Emerson, Eric/0000-0002-1776-6032				[Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2004, LIFE COURSE APPROACH; Galobardes B, 2008, J EPIDEMIOL COMMUN H, V62, P387, DOI 10.1136/jech.2007.065508; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Graham H, 2007, UNEQUAL LIVES HLTH S; Irwin L, 2007, EARLY CHILD DEV POWE; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; UNICEF, 2007, CHILD POV PERSP OV C; *UNICEF, 2002, STAT WORLDS CHILDR 2; UNICEF, 2005, CHILD POV RICH COUNT; United Nations Development Programme, 2007, HUM DEV REP 2007 FIG; Whiteford P., 2007, OECD SOCIAL EMPLOYME, V51; Wilkinson R.G., 2005, IMPACT INEQUALITY MA	14	15	15	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					425	426		10.1001/jama.2009.8	http://dx.doi.org/10.1001/jama.2009.8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176444				2022-12-28	WOS:000262777200022
J	Met, R; Bipat, S; Legemate, DA; Reekers, JA; Koelemay, MJW				Met, Rosemarie; Bipat, Shandra; Legemate, Dink A.; Reekers, Jim A.; Koelemay, Mark J. W.			Diagnostic Performance of Computed Tomography Angiography in Peripheral Arterial Disease A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MULTIDETECTOR CT ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; LOWER-EXTREMITY ARTERIES; OCCLUSIVE DISEASE; ABDOMINAL-AORTA; ACCURACY; CONTRAST; TRIAL; BIAS	Context Computed tomography angiography ( CTA) is an increasingly attractive imaging modality for assessing lower extremity peripheral arterial disease ( PAD). Objective To determine the accuracy of CTA compared with intra- arterial digital subtraction angiography ( DSA) in differentiating extent of disease in patients with PAD. Data Sources and Study Selection Search of MEDLINE ( January 1966- August 2008), EMBASE ( January 1980- August 2008), and the Database of Abstracts of Reviews of Effectiveness for studies comparing CTA with intra- arterial DSA for PAD. Eligible studies compared multidetector CTA with intra- arterial DSA, included at least 10 patients with intermittent claudication or critical limb ischemia, aimed to detect more than 50% stenosis or arterial occlusion, and presented either 2 x 2 or 3 x 3 contingency tables (<= 50% stenosis vs > 50% stenosis or occlusion), or provided data allowing their construction. Data Extraction Two reviewers screened potential studies for inclusion and independently extracted study data. Methodological quality was assessed by using the QUADAS instrument. Data Synthesis Of 909 studies identified, 20 ( 2.2%) met the inclusion criteria. These 20 studies had a median sample size of 33 ( range, 16- 279) and included 957 patients, predominantly with intermittent claudication ( 68%). Methodological quality was moderate. Overall, the sensitivity of CTA for detecting more than 50% stenosis or occlusion was 95% ( 95% confidence interval [ CI], 92%- 97%) and specificity was 96% ( 95% CI, 93%- 97%). Computed tomography angiography correctly identified occlusions in 94% of segments, the presence of more than 50% stenosis in 87% of segments, and absence of significant stenosis in 96% of segments. Overstaging occurred in 8% of segments and understaging in 15%. Conclusion Computed tomography angiography is an accurate modality to assess presence and extent of PAD in patients with intermittent claudication; however, methodological weaknesses of examined studies prevent definitive conclusions from these data.	[Met, Rosemarie; Bipat, Shandra; Reekers, Jim A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1100 DD Amsterdam, Netherlands; [Legemate, Dink A.; Koelemay, Mark J. W.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Met, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, POB 22660,Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.	r.met@amc.uva.nl	Reekers, Jim/ABF-7580-2021					Albrecht T, 2007, AM J ROENTGENOL, V189, P702, DOI 10.2214/AJR.07.2333; Bipat S, 2007, ACAD RADIOL, V14, P974, DOI 10.1016/j.acra.2007.05.007; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bui Trung D, 2005, Vasc Endovascular Surg, V39, P481, DOI 10.1177/153857440503900604; Cai Song, 2007, Chinese Journal of Medical Imaging Technology, V23, P1022; Catalano C, 2004, RADIOLOGY, V231, P555, DOI 10.1148/radiol.2312020920; Collins R, 2007, BMJ-BRIT MED J, V334, P1257, DOI 10.1136/bmj.39217.473275.55; Edwards AJ, 2005, CLIN RADIOL, V60, P85, DOI 10.1016/j.crad.2004.07.011; Fraioli F, 2006, EUR RADIOL, V16, P137, DOI 10.1007/s00330-005-2812-z; Heijenbrok-Kal MH, 2007, RADIOLOGY, V245, P433, DOI 10.1148/radiol.2451061280; Heuschmid M, 2003, EUR J MED RES, V8, P389; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kallen A, 2008, AM J KIDNEY DIS, V51, P966, DOI 10.1053/j.ajkd.2007.12.036; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Laswed T, 2008, EUR RADIOL, V18, P263, DOI 10.1007/s00330-007-0749-0; LAWRENCE JA, 1995, RADIOLOGY, V194, P903, DOI 10.1148/radiology.194.3.7862999; Li G-C, 2008, J INTERV RADIOL, V17, P336; Li X-M, 2007, J INTERV RADIOL, V16, P371; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Martin ML, 2003, AM J ROENTGENOL, V180, P1085, DOI 10.2214/ajr.180.4.1801085; Mesurolle B, 2004, CLIN IMAG, V28, P252, DOI 10.1016/S0899-7071(03)00201-8; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ofer A, 2003, AM J ROENTGENOL, V180, P719, DOI 10.2214/ajr.180.3.1800719; Ota H, 2004, AM J ROENTGENOL, V182, P201, DOI 10.2214/ajr.182.1.1820201; Ouwendijk R, 2008, AM J ROENTGENOL, V190, P1349, DOI 10.2214/AJR.07.3359; Portugaller HR, 2004, EUR RADIOL, V14, P1681, DOI 10.1007/s00330-004-2289-1; Puls R, 2001, Rontgenpraxis, V54, P141; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Sarwar A, 2008, RADIOLOGY, V249, P301, DOI 10.1148/radiol.2483072003; Schernthaner R, 2008, EUR RADIOL, V18, P665, DOI 10.1007/s00330-007-0822-8; Schertler T, 2005, RADIOLOGY, V237, P649, DOI 10.1148/radiol.2372041861; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Sun ZH, 2006, J VASC INTERV RADIOL, V17, P1915, DOI 10.1097/01.RVI.0000248830.17550.50; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; *UN SCI COMM EFF A, 2000, SOURC EFF ION RAD RE, V2; Visser K, 2000, RADIOLOGY, V216, P67, DOI 10.1148/radiology.216.1.r00jl0367; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Willmann JK, 2005, RADIOLOGY, V236, P1083, DOI 10.1148/radiol.2362040895; Zhang Xiao-dan, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P96	44	200	212	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					415	424		10.1001/jama.301.4.415	http://dx.doi.org/10.1001/jama.301.4.415			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176443	Bronze			2022-12-28	WOS:000262777200021
J	Ho, RCM; Lam, SYW; Tan, ESL; Ng, PMY; Mak, A				Ho, Roger C. M.; Lam, Stanley Y. W.; Tan, Evangeline S. L.; Ng, Pamela M. Y.; Mak, Anselm			Amnesia, political ambition, and canned tuna	LANCET			English	Editorial Material							MERCURY		[Ho, Roger C. M.] Natl Univ Singapore, Dept Psychol Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Mak, Anselm] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Lam, Stanley Y. W.] Tan Tock Seng Hosp, Dept Med, Singapore, Singapore; [Tan, Evangeline S. L.] Singapore Gen Hosp, Dept Psychiat, Singapore 0316, Singapore	National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Singapore General Hospital	Ho, RCM (corresponding author), Natl Univ Singapore Hosp, Dept Psychol Med, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	pcmrhcm@nus.edu.sg	Ho, Roger/ABD-8859-2021; Ho, Roger C./ABD-9061-2021	Ho, Roger C./0000-0001-9629-4493				ESPINOZA EO, 1995, NEW ENGL J MED, V333, P803, DOI 10.1056/NEJM199509213331217; KANGYUM E, 1992, VET HUM TOXICOL, V34, P235; KATZ SA, 1992, J APPL TOXICOL, V12, P79, DOI 10.1002/jat.2550120203; Satoh H, 2000, IND HEALTH, V38, P153, DOI 10.2486/indhealth.38.153	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					352	352		10.1016/S0140-6736(09)60099-4	http://dx.doi.org/10.1016/S0140-6736(09)60099-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167574				2022-12-28	WOS:000262728100032
J	Maximov, A; Tang, J; Yang, XF; Pang, ZPP; Sudhof, TC				Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.			Complexin Controls the Force Transfer from SNARE Complexes to Membranes in Fusion	SCIENCE			English	Article							SYNAPTOTAGMIN-I FUNCTIONS; NEUROTRANSMITTER RELEASE; DISTINCT DOMAINS; EXOCYTOSIS; SENSOR	Trans- SNAP receptor ( SNARE, where SNAP is defined as soluble NSF attachment protein, and NSF is defined as N- ethylmaleimide- sensitive factor) complexes catalyze synaptic vesicle fusion and bind complexin, but the function of complexin binding to SNARE complexes remains unclear. Here we show that in neuronal synapses, complexin simultaneously suppressed spontaneous fusion and activated fast calcium ion- evoked fusion. The dual function of complexin required SNARE binding and also involved distinct amino- terminal sequences of complexin that localize to the point where trans- SNARE complexes insert into the fusing membranes, suggesting that complexin controls the force that trans- SNARE complexes apply onto the fusing membranes. Consistent with this hypothesis, a mutation in the membrane insertion sequence of the v- SNARE synaptobrevin/ vesicle- associated membrane protein ( VAMP) phenocopied the complexin loss- of- function state without impairing complexin binding to SNARE complexes. Thus, complexin probably activates and clamps the force transfer from assembled trans- SNARE complexes onto fusing membranes.	[Maximov, Anton; Tang, Jiong; Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yang, Xiaofei; Pang, Zhiping P.; Sudhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Rizo and L. Chen for advice and critical comments. This study was supported by an investigatorship to T. C. S. from the Howard Hughes Medical Institute.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	22	244	251	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					516	521		10.1126/science.1166505	http://dx.doi.org/10.1126/science.1166505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164751	Green Accepted			2022-12-28	WOS:000262587900046
J	Utzschneider, K; Kowdley, K				Utzschneider, Kristina; Kowdley, Kris			Pioglitazone reduced liver injury and improved fasting glucose in nonalcoholic steatohepatitis without diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POPULATION		[Utzschneider, Kristina; Kowdley, Kris] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Utzschneider, K (corresponding author), Univ Washington, Seattle, WA 98195 USA.		Kowdley, Kris/AAF-5202-2019		NIDDK NIH HHS [K24 DK002957] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002957] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; LEE RG, 1989, HUM PATHOL, V20, P594, DOI 10.1016/0046-8177(89)90249-9; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-9	10.7326/0003-4819-150-2-200901200-02009	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172714				2022-12-28	WOS:000262655200027
J	Ingolia, NT; Ghaemmaghami, S; Newman, JRS; Weissman, JS				Ingolia, Nicholas T.; Ghaemmaghami, Sina; Newman, John R. S.; Weissman, Jonathan S.			Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling	SCIENCE			English	Article							OPEN READING FRAMES; NON-AUG CODONS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; GENE-EXPRESSION; INITIATION; YEAST; MICRORNAS	Techniques for systematically monitoring protein translation have lagged far behind methods for measuring messenger RNA ( mRNA) levels. Here, we present a ribosome-profiling strategy that is based on the deep sequencing of ribosome-protected mRNA fragments and enables genome-wide investigation of translation with subcodon resolution. We used this technique to monitor translation in budding yeast under both rich and starvation conditions. These studies defined the protein sequences being translated and found extensive translational control in both determining absolute protein abundance and responding to environmental stress. We also observed distinct phases during translation that involve a large decrease in ribosome density going from early to late peptide elongation as well as widespread regulated initiation at non-adenine-uracil-guanine (AUG) codons. Ribosome profiling is readily adaptable to other organisms, making high-precision investigation of protein translation experimentally accessible.	[Ingolia, Nicholas T.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ingolia, NT (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	ingolia@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	NIH [AG10770]; Ruth L. Kirschstein National Research Service Award [GM080853]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Chu, J. deRisi, and K. Fischer for help with sequencing; D. Bartel, H. Guo, D. Herschlag, J. Hollien, S. Luo, and G. Schroth for helpful discussions of RNA methods; P. Walter and T. Aragon for the use of a density gradient fractionator; the 2008 Woods Hole Physiology course students for data analysis; and members of the Weissman lab, L. Lareau, and T. Ingolia for critical commentary on the manuscript. Sequencing data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE13750. This investigation was supported by a NIH P01 grant (AG10770) and a Ruth L. Kirschstein National Research Service Award (GM080853) (to N.T.I.) and by the Howard Hughes Medical Institute (to J.S.W.). N.T.I. and J.S.W. are the inventors on a patent application, assigned to the Regents of the University of California, on the ribosome profiling and sequencing library generation techniques described in this work. S.G. and J.R.S.N. developed a microarray-based approach that served as a proof of principle for the present studies; N.T.I. and J.S.W. designed the experiments; N.T.I. performed the experiments and analyzed the data; and N.T.I. and J.S.W. interpreted the results and wrote the manuscript.	Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; GRANT CM, 1995, NUCLEIC ACIDS RES, V23, P3980, DOI 10.1093/nar/23.19.3980; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; Zhang ZH, 2005, CURR GENET, V48, P77, DOI 10.1007/s00294-005-0001-x	35	2288	2414	12	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					218	223		10.1126/science.1168978	http://dx.doi.org/10.1126/science.1168978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19213877	Green Accepted			2022-12-28	WOS:000265024400037
J	Zhang, Q; Li, YL; Tsien, RW				Zhang, Qi; Li, Yulong; Tsien, Richard W.			The Dynamic Control of Kiss-And-Run and Vesicular Reuse Probed with Single Nanoparticles	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; READILY RELEASABLE POOL; HIPPOCAMPAL SYNAPSES; SYNAPTIC VESICLES; QUANTUM DOTS; FUSION PORE; TRANSMITTER RELEASE; EXOCYTOSIS; NEURONS	Vesicular secretion of neurotransmitter is essential for neuronal communication. Kiss-and-run is a mode of membrane fusion and retrieval without the full collapse of the vesicle into the plasma membrane and de novo regeneration. The importance of kiss-and-run during efficient neurotransmission has remained in doubt. We developed an approach for loading individual synaptic vesicles with single quantum dots. Their size and pH-dependent photoluminescence change allowed us to distinguish kiss-and-run from full-collapse fusion and to track single vesicles through multiple rounds of kiss-and-run and reuse, without perturbing vesicle cycling. Kiss-and-run dominated at the beginning of stimulus trains, reflecting the preference of vesicles with high release probability. Its incidence was increased by rapid firing, a response appropriate to shape the kinetics of neurotransmission during a wide range of firing patterns.	[Zhang, Qi; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Li, Yulong/0000-0002-9166-9919	Grass Foundation; National Institute of Mental Health; Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA025143] Funding Source: NIH RePORTER	Grass Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. C. Harata for help with high-frequency imaging and data analysis, R. J. Reimer and members of the Tsien lab for comments, J. W. Mulholland and J. J. Perrino for help with imaging, and X. Gao and M. Bruchez for consultation on quantum dots. Supported by grants from the Grass Foundation (Q.Z.), the National Institute of Mental Health, and the Burnett Family Fund (R.W.T.).	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Franks KM, 2003, J NEUROSCI, V23, P3186; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	39	252	257	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1448	1453		10.1126/science.1167373	http://dx.doi.org/10.1126/science.1167373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19213879	Green Accepted			2022-12-28	WOS:000264101700032
J	Schmitt, J; Romanos, M; Schmitt, NM; Meurer, M; Kirch, W				Schmitt, Jochen; Romanos, Marcel; Schmitt, Natalie M.; Meurer, Michael; Kirch, Wilhelm			Atopic Eczema and Attention-Deficit/Hyperactivity Disorder in a Population-Based Sample of Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DERMATITIS; ADHD		[Schmitt, Jochen; Meurer, Michael] Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany; [Romanos, Marcel] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Hosp Clin, Wurzburg, Germany; [Schmitt, Natalie M.; Kirch, Wilhelm] Tech Univ Dresden, Inst Clin Pharmacol, Med Fac Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmitt, J (corresponding author), Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany.	jochen.schmitt@uniklinikum-dresden.de	Romanos, Marcel/D-7695-2017	Romanos, Marcel/0000-0001-7628-8299				Birnbaum HG, 2005, CURR MED RES OPIN, V21, P195, DOI 10.1185/030079904X20303; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Pelsser LMJ, 2009, PEDIAT ALLERG IMM-UK, V20, P107, DOI 10.1111/j.1399-3038.2008.00749.x; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803	6	135	140	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					724	726		10.1001/jama.2009.136	http://dx.doi.org/10.1001/jama.2009.136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224748				2022-12-28	WOS:000263370100014
J	Muhlbauer, S; Binz, B; Jonietz, F; Pfleiderer, C; Rosch, A; Neubauer, A; Georgii, R; Boni, P				Muehlbauer, S.; Binz, B.; Jonietz, F.; Pfleiderer, C.; Rosch, A.; Neubauer, A.; Georgii, R.; Boeni, P.			Skyrmion Lattice in a Chiral Magnet	SCIENCE			English	Article							MNSI; PHASE; CRYSTALS; STATES	Skyrmions represent topologically stable field configurations with particle- like properties. We used neutron scattering to observe the spontaneous formation of a two- dimensional lattice of skyrmion lines, a type of magnetic vortex, in the chiral itinerant- electron magnet MnSi. The skyrmion lattice stabilizes at the border between paramagnetism and long- range helimagnetic order perpendicular to a small applied magnetic field regardless of the direction of the magnetic field relative to the atomic lattice. Our study experimentally establishes magnetic materials lacking inversion symmetry as an arena for new forms of crystalline order composed of topologically stable spin states.	[Muehlbauer, S.; Jonietz, F.; Pfleiderer, C.; Neubauer, A.; Georgii, R.; Boeni, P.] Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany; [Muehlbauer, S.; Georgii, R.] Tech Univ Munich, Forschungsneutronenquelle Heinz Maier Leibnitz FR, D-85748 Garching, Germany; [Binz, B.; Rosch, A.] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany	Technical University of Munich; Technical University of Munich; University of Cologne	Pfleiderer, C (corresponding author), Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany.	christian.pfleiderer@frm2.tum.de	Rosch, Achim/AAY-7730-2020; Georgii, Robert Heinrich/N-8891-2019; Rosch, Achim/A-2962-2009; Pfleiderer, Christian/P-3575-2014	Rosch, Achim/0000-0002-6586-5721; Georgii, Robert Heinrich/0000-0002-9366-4935; Rosch, Achim/0000-0002-6586-5721; Pfleiderer, Christian/0000-0001-7749-7965	Alexander-von-Humboldt foundation [SFB608]	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation)	We thank A. N. Bogdanov, S. Dunsiger, E. M. Forgan, C. Franz, M. Garst, M. Janoschek, H. Kolb, M. Laver, S. Legl, T. Lorenz, W. Munzer, T. Nattermann, J. Peters, U. K. Rossler, B. Russ, R. Schwikowski, A. Vishwanath, M. Vojta, W. Zwerger, and the team of FRM II for discussions and support and K. von Bergmann for stimulating discussions and help in preparing Fig. 3C. We gratefully acknowledge financial support by SFB608 and the Alexander-von-Humboldt foundation.	[Anonymous], 2007, PRINCIPLES CONDENSED; BAK P, 1980, J PHYS C SOLID STATE, V13, pL881, DOI 10.1088/0022-3719/13/31/002; Binz B, 2008, PHYSICA B, V403, P1336, DOI 10.1016/j.physb.2007.10.136; Binz B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207202; BOGDANOV A, 1994, J MAGN MAGN MATER, V138, P255, DOI 10.1016/0304-8853(94)90046-9; BOGDANOV AN, 1989, ZH EKSP TEOR FIZ+, V95, P178; Brazovskii S.A, 1975, JETP, V41, P85, DOI [10.1142/9789814317344_0016, DOI 10.1142/9789814317344_0016]; BREY L, 1995, PHYS REV LETT, V75, P2562, DOI 10.1103/PhysRevLett.75.2562; Fischer I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.024415; FORGAN EM, 1989, PHYS REV LETT, V62, P470, DOI 10.1103/PhysRevLett.62.470; GIGNOUX D, 1991, J MAGN MAGN MATER, V100, P99, DOI 10.1016/0304-8853(91)90815-R; Green AG, 2000, PHYS REV B, V61, P16299, DOI 10.1103/PhysRevB.61.R16299; Grelet E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.168301; Grigoriev SV, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224440; LEBECH B, 1995, J MAGN MAGN MATER, V140, P119, DOI 10.1016/0304-8853(94)01115-X; Lebech B., 1993, RECENT ADV MAGNETISM, P167; Levin M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220403; NAKANISHI O, 1980, SOLID STATE COMMUN, V35, P995, DOI 10.1016/0038-1098(80)91004-2; Pfleiderer C, 2007, SCIENCE, V316, P1871, DOI 10.1126/science.1142644; Pfleiderer C, 2004, NATURE, V427, P227, DOI 10.1038/nature02232; Pfleiderer C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.156406; Pfleiderer C, 2001, NATURE, V414, P427, DOI 10.1038/35106527; POLYAKOV AM, 1974, JETP LETT+, V20, P194; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Schmalian J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036405; Thessieu C, 1997, J PHYS-CONDENS MAT, V9, P6677, DOI 10.1088/0953-8984/9/31/019; THOOFT G, 1974, NUCL PHYS B, VB 79, P276	27	2867	2900	79	1237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					915	919		10.1126/science.1166767	http://dx.doi.org/10.1126/science.1166767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213914	Green Submitted			2022-12-28	WOS:000263295400037
J	Jefferson, T; Di Pietrantonj, C; Debalini, MG; Rivetti, A; Demicheli, V				Jefferson, T.; Di Pietrantonj, C.; Debalini, M. G.; Rivetti, A.; Demicheli, V.			Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFORMATION-SEEKING BEHAVIOR; CONFLICTS-OF-INTEREST; ELDERLY-PEOPLE; VACCINATION; ASSOCIATION; CONCLUSIONS; MORTALITY; BENEFITS; TRIALS; HEALTH	Objective To explore the relation between study concordance, take home message, funding, and dissemination of comparative studies assessing the effects of influenza vaccines. Design Systematic review without meta-analysis. Data extraction Search of the Cochrane Library, PubMed, Embase, and the web, without language restriction, for any studies comparing the effects of influenza vaccines against placebo or no intervention. Abstraction and assessment of quality of methods were carried out. Data synthesis We identified 259 primary studies ( 274 datasets). Higher quality studies were significantly more likely to show concordance between data presented and conclusions (odds ratio 16.35, 95% confidence interval 4.24 to 63.04) and less likely to favour effectiveness of vaccines (0.04, 0.02 to 0.09). Government funded studies were less likely to have conclusions favouring the vaccines (0.45, 0.26 to 0.90). A higher mean journal impact factor was associated with complete or partial industry funding compared with government or private funding and no funding (differences between means 5.04). Study size was not associated with concordance, content of take home message, funding, and study quality. Higher citation index factor was associated with partial or complete industry funding. This was sensitive to the exclusion from the analysis of studies with undeclared funding. Conclusion Publication in prestigious journals is associated with partial or total industry funding, and this association is not explained by study quality or size.	[Jefferson, T.; Di Pietrantonj, C.; Debalini, M. G.; Rivetti, A.; Demicheli, V.] ASL AL 20, Cochrane Vaccines Field, I-15100 Alessandria, Italy		Jefferson, T (corresponding author), ASL AL 20, Cochrane Vaccines Field, I-15100 Alessandria, Italy.	jefferson.tom@gmail.com	Di Pietrantonj, Carlo/AAK-1340-2020	Di Pietrantonj, Carlo/0000-0002-7302-5714	ASL AL, Alessandria, Piemonte, Italy	ASL AL, Alessandria, Piemonte, Italy	This study was funded by ASL AL, Alessandria, Piemonte, Italy. The funding source had no role in the study design, collection, analysis, and interpretation of results, in the writing of the report, or in the decision to submit the paper for publication.	Alper BS, 2004, J MED LIBR ASSOC, V92, P429; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; ALSNIELSEN B, 2004, 12 INT COCHR C OTT, P88; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Dawes M, 2003, INT J MED INFORM, V71, P9, DOI 10.1016/S1386-5056(03)00023-6; Ely JW, 1999, BRIT MED J, V319, P358, DOI 10.1136/bmj.319.7206.358; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Garfield E, 1999, CAN MED ASSOC J, V161, P979; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jefferson T, 2006, BMJ-BRIT MED J, V333, P912, DOI 10.1136/bmj.38995.531701.80; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Leopold SS, 2003, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000093888.12372.d9; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Saint S, 2000, J GEN INTERN MED, V15, P881, DOI 10.1046/j.1525-1497.2000.00202.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Tenopir C, 2007, J MED LIBR ASSOC, V95, P56; Thomas RE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub2; Wells G., 2005, NEWCASTLE OTTAWA SCA; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; WOOD L, 2006, 14 COCHR C OCT 23 26; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565	33	45	45	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2009	338								b354	10.1136/bmj.b354	http://dx.doi.org/10.1136/bmj.b354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZY	19213766	Green Published, hybrid			2022-12-28	WOS:000263976200003
J	Shubin, N; Tabin, C; Carroll, S				Shubin, Neil; Tabin, Cliff; Carroll, Sean			Deep homology and the origins of evolutionary novelty	NATURE			English	Review							GENE-EXPRESSION; EYE DEVELOPMENT; PECTORAL FIN; PAIRED FINS; LIMB; CUBOMEDUSAN; DIVERSITY; SUPPORTS; REVEALS; FOSSILS	Do new anatomical structures arise de novo, or do they evolve from pre- existing structures? Advances in developmental genetics, palaeontology and evolutionary developmental biology have recently shed light on the origins of some of the structures that most intrigued Charles Darwin, including animal eyes, tetrapod limbs and giant beetle horns. In each case, structures arose by the modification of pre- existing genetic regulatory circuits established in early metazoans. The deep homology of generative processes and cell- type specification mechanisms in animal development has provided the foundation for the independent evolution of a great variety of structures.	[Shubin, Neil] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Shubin, Neil] Field Museum Nat Hist, Chicago, IL 60605 USA; [Tabin, Cliff] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carroll, Sean] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Chicago; Field Museum of Natural History (Chicago); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Shubin, N (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu			National Science Foundation; National Geographic Society.; National Institutes of Health	National Science Foundation(National Science Foundation (NSF)); National Geographic Society.(National Geographic Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.S. is supported by grants from the National Science Foundation and the National Geographic Society. C.T. is supported by grants from the National Institutes of Health. S. C. is an investigator of the Howard Hughes Medical Institute.	Ahn DG, 2006, DEV BIOL, V295, P419, DOI 10.1016/j.ydbio.2006.04.288; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arrow G.J., 1951, HORNED BEETLES; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Darwin C., 1871, P475; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Erclik T, 2008, CURR BIOL, V18, P1278, DOI 10.1016/j.cub.2008.07.076; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gould SJ, 2002, STRUCTURE EVOLUTIONA; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hunt J, 2001, P ROY SOC B-BIOL SCI, V268, P2409, DOI 10.1098/rspb.2001.1758; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Moczek AP, 2006, HEREDITY, V97, P168, DOI 10.1038/sj.hdy.6800871; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moczek AP, 2006, EVOLUTION, V60, P2329, DOI 10.1111/j.0014-3820.2006.tb01868.x; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Oakley TH, 2003, TRENDS ECOL EVOL, V18, P623, DOI 10.1016/j.tree.2003.09.005; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; PEARSE JS, 1978, SCIENCE, V199, P458, DOI 10.1126/science.22934; PLACHETZKI DC, 2007, PLOS 1, V10, pE1054; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; SHUBIN N, 1995, EVOL BIOL, V28, P39; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; YAMASU T, 1976, CELL TISSUE RES, V170, P325, DOI 10.1007/BF00219415; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695	42	522	533	7	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					818	823		10.1038/nature07891	http://dx.doi.org/10.1038/nature07891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212399				2022-12-28	WOS:000263266700031
J	Sugden, A; Ash, C; Hanson, B; Zahn, L				Sugden, Andrew; Ash, Caroline; Hanson, Brooks; Zahn, Laura			Happy Birthday, Mr. Darwin Introduction	SCIENCE			English	Editorial Material																			0	5	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					727	727		10.1126/science.323.5915.727	http://dx.doi.org/10.1126/science.323.5915.727			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197050				2022-12-28	WOS:000263066800031
J	Cartwright, HN; Humphries, JA; Smith, LG				Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.			PAN1: A Receptor-Like Protein That Promotes Polarization of an Asymmetric Cell Division in Maize	SCIENCE			English	Article							STOMATAL DEVELOPMENT; KINASES; ARABIDOPSIS; MECHANISM; LEPRK2; PLANTS; LEAF	Polarization of cell division is essential for eukaryotic development, but little is known about how this is accomplished in plants. The formation of stomatal complexes in maize involves the polarization of asymmetric subsidiary mother cell ( SMC) divisions toward the adjacent guard mother cell ( GMC), apparently under the influence of a GMC- derived signal. We found that the maize pan1 gene promotes the premitotic polarization of SMCs and encodes a leucine- rich repeat receptor- like protein that becomes localized in SMCs at sites of GMC contact. PAN1 has an inactive kinase domain but is required for the accumulation of a membrane- associated phosphoprotein, suggesting a function for PAN1 in signal transduction. Our findings implicate PAN1 in the transmission of an extrinsic signal that polarizes asymmetric SMC divisions toward GMCs.	[Cartwright, Heather N.; Humphries, John A.; Smith, Laurie G.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Smith, LG (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgsmith@ucsd.edu		Cartwright, Heather/0000-0001-6639-5808	NSF [IOB-0544226]	NSF(National Science Foundation (NSF))	We thank A. Wright and F. Delgado for help with experiments and J. Bolado, J. Chory, and R. Boston for reagents. This work was supported by NSF grant IOB-0544226. pan1 gene and PAN1 protein sequences are available at GenBank (accession number FJ231525).	Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; CHO SO, 1990, PROTOPLASMA, V157, P154, DOI 10.1007/BF01322648; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gallagher K, 2000, CURR BIOL, V10, P1229, DOI 10.1016/S0960-9822(00)00730-2; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Panteris E, 2006, CELL MOTIL CYTOSKEL, V63, P696, DOI 10.1002/cm.20155; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; STEBBINS GL, 1960, DEV BIOL, V2, P477, DOI 10.1016/0012-1606(60)90050-6; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	18	91	100	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					649	651		10.1126/science.1161686	http://dx.doi.org/10.1126/science.1161686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179535				2022-12-28	WOS:000262862800047
J	Tannen, RL; Weiner, MG; Xie, DW				Tannen, Richard L.; Weiner, Mark G.; Xie, Dawei			Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; PROPENSITY SCORE; SIMULATION; MORTALITY; DISEASE; NEED; BIAS	Objectives To determine whether observational studies that use an electronic medical record database can provide valid results of therapeutic effectiveness and to develop new methods to enhance validity. Design Data from the UK general practice research database ( GPRD) were used to replicate previously performed randomised controlled trials, to the extent that was feasible aside from randomisation. Studies Six published randomised controlled trials. Main outcome measure Cardiovascular outcomes analysed by hazard ratios calculated with standard biostatistical methods and a new analytical technique, prior event rate ratio ( PERR) adjustment. Results In nine of 17 outcome comparisons, there were no significant differences between results of randomised controlled trials and database studies analysed using standard biostatistical methods or PERR analysis. In eight comparisons, Cox adjusted hazard ratios in the database differed significantly from the results of the randomised controlled trials, suggesting unmeasured confounding. In seven of these eight, PERR adjusted hazard ratios differed significantly from Cox adjusted hazard ratios, whereas in five they didn't differ significantly, and in three were more similar to the hazard ratio from the randomised controlled trial, yielding PERR results more similar to the randomised controlled trial than Cox ( P< 0.05). Conclusions Although observational studies using databases are subject to unmeasured confounding, our new analytical technique ( PERR), applied here to cardiovascular outcomes, worked well to identify and reduce the effects of such confounding. These results suggest that electronic medical record databases can be useful to investigate therapeutic effectiveness.	[Tannen, Richard L.; Weiner, Mark G.; Xie, Dawei] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Tannen, RL (corresponding author), Univ Penn, Sch Med, 295 John Morgan Bldg,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	tannen@mail.med.upenn.edu			National Institutes of Health [RO1-HL 073911]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health research grant RO1-HL 073911.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 1984, J AM COLL CARDIOL, V3, P114; Avorn J, 2007, NEW ENGL J MED, V357, P2219, DOI 10.1056/NEJMp0706892; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Black N, 1996, BRIT MED J, V312, P1215; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; CALIFF RM, 1986, CIRCULATION, V74, P1191, DOI 10.1161/01.CIR.74.6.1191; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Concato J, 2004, LANCET, V363, P1660, DOI 10.1016/S0140-6736(04)16285-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Deeks J J, 2003, Health Technol Assess, V7, piii; Fox KM, 2003, LANCET, V362, P782; Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; GRODSTEIN F, 1996, J ENGL J MED, V335, P453; GRUBER J, 1994, AM ECON REV, V84, P622; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; MacLehose R R, 2000, Health Technol Assess, V4, P1; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; McMahon AD, 2003, PHARMACOEPIDEM DR S, V12, P551, DOI 10.1002/pds.883; McMahon AD, 2001, AM J EPIDEMIOL, V154, P557, DOI 10.1093/aje/154.6.557; MEYER BD, J BUSINESS EC STAT, V13, P151; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Oakes JM, 2007, AM J EPIDEMIOL, V165, P1119, DOI 10.1093/aje/kwm072; PEDERSEN TR, 1994, LANCET, V344, P1383; POPCOCK SJ, 2000, NEW ENGL J MED, V342, P1907; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; RAGHUNATHAN TE, 1998, IVEWARE IMPUTATION V; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sacks HS, 2000, NEW ENGL J MED, V343, P1195; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Sturmer T, 2007, AM J EPIDEMIOL, V165, P1110, DOI 10.1093/aje/kwm074; Sukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278; Tannen RL, 2008, FERTIL STERIL, V90, P258, DOI 10.1016/j.fertnstert.2008.05.031; Tannen RL, 2008, PHARMACOEPIDEM DR S, V17, P671, DOI 10.1002/pds.1584; Tannen RL, 2007, J CLIN EPIDEMIOL, V60, P686, DOI 10.1016/j.jclinepi.2006.10.012; Tannen RL, 2007, HUM REPROD, V22, P1769, DOI 10.1093/humrep/dem031; Tannen RL, 2006, J CLIN EPIDEMIOL, V59, P254, DOI 10.1016/j.jclinepi.2005.08.008; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Weiner MG, 2008, PHARMACOEPIDEM DR S, V17, P661, DOI 10.1002/pds.1585; Weiner MG, 2008, MENOPAUSE, V15, P86, DOI 10.1097/gme.0b013e180413e45; Yusuf S, 2000, NEW ENGL J MED, V342, P145	59	99	100	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2009	338								b81	10.1136/bmj.b81	http://dx.doi.org/10.1136/bmj.b81			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EL	19174434	Green Published, hybrid			2022-12-28	WOS:000263205400002
J	Gertsman, I; Gan, L; Guttman, M; Lee, K; Speir, JA; Duda, RL; Hendrix, RW; Komives, EA; Johnson, JE				Gertsman, Ilya; Gan, Lu; Guttman, Miklos; Lee, Kelly; Speir, Jeffrey A.; Duda, Robert L.; Hendrix, Roger W.; Komives, Elizabeth A.; Johnson, John E.			An unexpected twist in viral capsid maturation	NATURE			English	Article							X-RAY CRYSTALLOGRAPHY; VIRUS MATURATION; COMMON ANCESTRY; COAT PROTEIN; BACTERIOPHAGES; TRANSITION; DYNAMICS; DOMAIN; MODEL; DNA	Lambda-like double-stranded (ds) DNA bacteriophage undergo massive conformational changes in their capsid shell during the packaging of their viral genomes. Capsid shells are complex organizations of hundreds of protein subunits that assemble into intricate quaternary complexes that ultimately are able to withstand over 50 atm of pressure during genome packaging(1). The extensive integration between subunits in capsids requires the formation of an intermediate complex, termed a procapsid, from which individual subunits can undergo the necessary refolding and structural rearrangements needed to transition to the more stable capsid. Although various mature capsids have been characterized at atomic resolution, no such procapsid structure is available for a dsDNA virus or bacteriophage. Here we present a procapsid X-ray structure at 3.65 angstrom resolution, termed prohead II, of the lambda-like bacteriophage HK97, the mature capsid structure of which was previously solved to 3.44 angstrom (ref. 2). A comparison of the two largely different capsid forms has unveiled an unprecedented expansion mechanism that describes the transition. Crystallographic and hydrogen/deuterium exchange data presented here demonstrate that the subunit tertiary structures are significantly different between the two states, with twisting and bending motions occurring in both helical and beta-sheet regions. We also identified subunit interactions at each three-fold axis of the capsid that are maintained throughout maturation. The interactions sustain capsid integrity during subunit refolding and provide a fixed hinge from which subunits undergo rotational and translational motions during maturation. Previously published calorimetric data of a closely related bacteriophage, P22, showed that capsid maturation was an exothermic process that resulted in a release of 90 kJ mol(-1) of energy(3). We propose that the major tertiary changes presented in this study reveal a structural basis for an exothermic maturation process probably present in many dsDNA bacteriophage and possibly viruses such as herpesvirus, which share the HK97 subunit fold(4).	[Gertsman, Ilya; Gan, Lu; Lee, Kelly; Speir, Jeffrey A.; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Gertsman, Ilya; Guttman, Miklos; Komives, Elizabeth A.; Johnson, John E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Scripps Research Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jackj@scripps.edu	Gan, Lu/F-8317-2011; Johnson, Johnson/HDL-9124-2022	Gan, Lu/0000-0002-8685-4896; Duda, Robert/0000-0002-9517-2731	NIH [RO1 AI40101, RO1 GM47795]; NIH Training Grant [GM08326]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM047795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Reddy for assistance with crystallographic studies and for discussions. We thank R. Huang for providing HK97 capsomer samples and for discussions, and T. Matsui for help with X-ray data collection. We thank B. Firek and C. Moyer for mutagenesis of the HK97 constructs used in the study. We also thank B. Szymczyma for material used in the study. We also thank I. Wilson for discussions. Wethank the staffs at beamlines 14-BMC and 23-ID- D of the Advanced Photon Source for assistance in data collection. This work was supported by NIH grants RO1 AI40101 (to J.E.J), RO1 GM47795 ( to R. W. H) and NIH Training Grant GM08326.	Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Conway JF, 2007, J STRUCT BIOL, V158, P224, DOI 10.1016/j.jsb.2006.11.006; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Croy CH, 2004, PROTEIN SCI, V13, P1767, DOI 10.1110/ps.04731004; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Kang SB, 2005, J MOL BIOL, V347, P935, DOI 10.1016/j.jmb.2005.02.021; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; Lee KK, 2008, STRUCTURE, V16, P1491, DOI 10.1016/j.str.2008.06.014; Lee KK, 2005, J MOL BIOL, V352, P723, DOI 10.1016/j.jmb.2005.07.024; Lee KK, 2004, J MOL BIOL, V340, P419, DOI 10.1016/j.jmb.2004.05.008; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; Tuma R, 1998, P NATL ACAD SCI USA, V95, P9885, DOI 10.1073/pnas.95.17.9885; Wikoff WR, 2006, J STRUCT BIOL, V153, P300, DOI 10.1016/j.jsb.2005.11.009; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537	31	98	101	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					646	U114		10.1038/nature07686	http://dx.doi.org/10.1038/nature07686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19204733	Green Accepted, Green Submitted			2022-12-28	WOS:000264796200044
J	Lee, P; Lee, DJ; Chan, C; Chen, SW; Ch'en, I; Jamora, C				Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Ch'en, Irene; Jamora, Colin			Dynamic expression of epidermal caspase 8 simulates a wound healing response	NATURE			English	Article							INFLAMMATORY SKIN-DISEASE; NF-KAPPA-B; STEM-CELLS; INNATE IMMUNITY; CUTTING EDGE; INTERLEUKIN-1-ALPHA; KERATINOCYTES; HOMEOSTASIS; ACTIVATION; CONTRIBUTE	Tissue homeostasis and regeneration are regulated by an intricate balance of seemingly competing processes-proliferation versus differentiation, and cell death versus survival(1). Here we demonstrate that the loss of epidermal caspase 8, an important mediator of apoptosis(2), recapitulates several phases of a wound healing response in the mouse. The epidermal hyperplasia in the caspase 8 null skin is the culmination of signals exchanged between epidermal keratinocytes, dermal fibroblasts and leukocytic cells. This reciprocal interaction is initiated by the paracrine signalling of interleukin 1 alpha (IL1 alpha), which activates both skin stem cell proliferation and cutaneous inflammation. The non-canonical secretion of IL1a is induced by a p38-MAPK-mediated upregulation of NALP3 (also known as NLRP3), leading to inflammasome assembly and caspase 1 activation. Notably, the increased proliferation of basal keratinocytes is counterbalanced by the growth arrest of suprabasal keratinocytes in the stratified epidermis by IL1 alpha-dependent NF kappa B signalling. Altogether, our findings illustrate how the loss of caspase 8 can affect more than programmed cell death to alter the local microenvironment and elicit processes common to wound repair and many neoplastic skin disorders.	[Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Jamora, Colin] Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Ch'en, Irene] Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Jamora, Colin] Dept Med Dermatol, La Jolla, CA 92093 USA		Jamora, C (corresponding author), Div Biol Sci, Sect Cell & Dev Biol, Nat Sci Bldg,Room 6311,9500 Gilman Dr,MC 0380, La Jolla, CA 92093 USA.	cjamora@ucsd.edu			National Institutes of Health (NIAMS) [5R01AR053185-03]; American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Hedrick, W. Havran, B. Yu, D. Witherden, A. Hoffmann, D. Stachura and members of the Jamora laboratory for providing reagents and helpful discussions. This work was supported by grants from the National Institutes of Health (NIAMS grant number 5R01AR053185-03) and the American Skin Association, and a Career Award from the Dermatology Foundation.	Al-Mashat HA, 2006, DIABETES, V55, P487, DOI 10.2337/diabetes.55.02.06.db05-1201; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; HAUSER C, 1986, J IMMUNOL, V136, P3317; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; HOHL D, 1991, J BIOL CHEM, V266, P6626; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yamanaka K, 2000, J IMMUNOL, V165, P997, DOI 10.4049/jimmunol.165.2.997	30	115	124	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					519	U7		10.1038/nature07687	http://dx.doi.org/10.1038/nature07687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204729	Green Accepted			2022-12-28	WOS:000264532400047
J	Neil, H; Malabat, C; d'Aubenton-Carafa, Y; Xu, ZY; Steinmetz, LM; Jacquier, A				Neil, Helen; Malabat, Christophe; d'Aubenton-Carafa, Yves; Xu, Zhenyu; Steinmetz, Lars M.; Jacquier, Alain			Widespread bidirectional promoters are the major source of cryptic transcripts in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; UNSTABLE TRANSCRIPTS; RNA; GENOME; GENE; TERMINATION; EXPRESSION; PATHWAY; POLYMERASE; INITIATION	Pervasive and hidden transcription is widespread in eukaryotes(1-4), but its global level, the mechanisms from which it originates and its functional significance are unclear. Cryptic unstable transcripts ( CUTs) were recently described as a principal class of RNA polymerase II transcripts in Saccharomyces cerevisiae(5). These transcripts are targeted for degradation immediately after synthesis by the action of the Nrd1 - exosome - TRAMP complexes(6,7). Although CUT degradation mechanisms have been analysed in detail, the genome- wide distribution at the nucleotide resolution and the prevalence of CUTs are unknown. Here we report the first high- resolution genomic map of CUTs in yeast, revealing a class of potentially functional CUTs and the intrinsic bidirectional nature of eukaryotic promoters. An RNA fraction highly enriched in CUTs was analysed by a 3 ' Long- SAGE ( serial analysis of gene expression) approach adapted to deep sequencing. The resulting detailed genomic map of CUTs revealed that they derive from extremely widespread and very well defined transcription units and do not result from unspecific transcriptional noise. Moreover, the transcription of CUTs predominantly arises within nucleosome- free regions, most of which correspond to promoter regions of bona fide genes. Some of the CUTs start upstream from messenger RNAs and overlap their 59 end. Our study of glycolysis genes, as well as recent results from the literature(8-11), indicate that such concurrent transcription is potentially associated with regulatory mechanisms. Our data reveal numerous new CUTs with such a potential regulatory role. However, most of the identified CUTs corresponded to transcripts divergent from the promoter regions of genes, indicating that they represent by- products of divergent transcription occurring at many and possibly most promoters. Eukaryotic promoter regions are thus intrinsically bidirectional, a fundamental property that escaped previous analyses because in most cases divergent transcription generates short- lived unstable transcripts present at very low steady- state levels.	[Neil, Helen; Malabat, Christophe; Jacquier, Alain] CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France; [d'Aubenton-Carafa, Yves] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL)	Jacquier, A (corresponding author), CNRS, Inst Pasteur, Unite Genet Interact Macromol, URA2171, F-75015 Paris, France.	alain.jacquier@pasteur.fr		Malabat, Christophe/0000-0003-2551-2355; Steinmetz, Lars/0000-0002-3962-2865; JACQUIER, ALAIN/0000-0001-5707-9184	Institut Pasteur; CNRS; ANR (CUT program); European Science Foundation (RNA quality program); National Institutes of Health; Deutsche Forschungsgemeinschaft	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (CUT program)(French National Research Agency (ANR)); European Science Foundation (RNA quality program)(European Science Foundation (ESF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank D. Libri for the gift of strains, D. Libri, C. Thermes, C. Saveanu and M. Fromont- Racine for discussions and for critical reading of the manuscript, staff of the Genoscope ( Evry) for sequencing, and A. Doyen, L. Decourty, S. Clauder- Muenster and T. Bahr-Ivacevic for technical assistance. This work was supported by the Institut Pasteur, the CNRS, the ANR (CUT program), the European Science Foundation (RNA quality program), and the National Institutes of Health and the Deutsche Forschungsgemeinschaft. H. N. is supported by the ANR (CUT program).	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Ito T, 2008, IUBMB LIFE, V60, P775, DOI 10.1002/iub.121; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCOTT EW, 1993, MOL CELL BIOL, V13, P543, DOI 10.1128/MCB.13.1.543; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	25	433	447	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1038	U8		10.1038/nature07747	http://dx.doi.org/10.1038/nature07747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169244				2022-12-28	WOS:000263425400048
J	Sachs, J				Sachs, Jeffrey			Recession Watch: Boost the developing world	NATURE			English	Editorial Material									[Sachs, Jeffrey] Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	sachs@columbia.edu							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					958	958		10.1038/457958a	http://dx.doi.org/10.1038/457958a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225500	Bronze			2022-12-28	WOS:000263425400017
J	Fellows, HJ; Dalton, HR				Fellows, Helen J.; Dalton, Harry R.			Picture quiz Jaundice and malaise in a middle aged man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY SCLEROSING CHOLANGITIS; LIVER-TRANSPLANTATION; DOMINANT STRICTURES		[Fellows, Helen J.] Royal Devon & Exeter Hosp, Intens Care Unit, Exeter EX2 5DW, Devon, England; [Dalton, Harry R.] Royal Cornwall Hosp, Truro TR1 3LJ, England; [Dalton, Harry R.] Peninsular Coll Med & Dent, Truro TR1 3LJ, England	University of Exeter; Royal Cornwall Hospital	Fellows, HJ (corresponding author), Royal Devon & Exeter Hosp, Intens Care Unit, Exeter EX2 5DW, Devon, England.			Dalton, Harry/0000-0001-7786-5457				Angulo P, 2000, AM J GASTROENTEROL, V95, P2333; Angulo P, 1999, HEPATOLOGY, V30, P325, DOI 10.1002/hep.510300101; Baluyut AR, 2001, GASTROINTEST ENDOSC, V53, P308, DOI 10.1067/mge.2001.112739; Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1016/j.gastro.2003.07.011; Bjornsson E, 2004, AM J GASTROENTEROL, V99, P502, DOI 10.1111/j.1572-0241.2004.04106.x; BLOOMER JR, 1975, ANN INTERN MED, V82, P310, DOI 10.7326/0003-4819-82-3-310; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; Burak K, 2004, AM J GASTROENTEROL, V99, P523, DOI 10.1111/j.1572-0241.2004.04067.x; CALNE R, 1993, SURG TODAY, V23, P1, DOI 10.1007/BF00308991; Campsen J, 2008, LIVER TRANSPLANT, V14, P181, DOI 10.1002/lt.21313; Chen W, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003626; DEWIT AWMV, 1995, AM J GASTROENTEROL, V90, P893; ESCORSELL A, 1994, J HEPATOL, V21, P787, DOI 10.1016/S0168-8278(94)80240-8; Jones EA, 1996, GUT, V38, P644, DOI 10.1136/gut.38.5.644; Kaya M, 2001, AM J GASTROENTEROL, V96, P1059; LANGNAS AN, 1990, AM J GASTROENTEROL, V85, P1136; LEE YM, 1995, NEW ENGL J MED, V332, P924, DOI 10.1056/NEJM199504063321406; MARSH JW, 1988, ANN SURG, V207, P21; Ponsioen CY, 1999, AM J GASTROENTEROL, V94, P2403; SCHOENFI.LJ, 1967, NATURE, V213, P93, DOI 10.1038/213093b0; Terg R, 2002, J HEPATOL, V37, P717, DOI 10.1016/S0168-8278(02)00318-5; VANTHIEL DH, 1995, AM J GASTROENTEROL, V90, P771	22	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2009	338								a3175	10.1136/bmj.a3175	http://dx.doi.org/10.1136/bmj.a3175			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CG	19224956				2022-12-28	WOS:000264052100010
J	Greenhalgh, T				Greenhalgh, Trisha			Patient and public involvement in chronic illness: beyond the expert patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT; CHRONIC DISEASE; EDUCATION-PROGRAMS; HEALTH-CARE; PEOPLE		UCL, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Bate P, 2004, QUAL SAF HEALTH CARE, V13, P62, DOI 10.1136/qshc.2003.006965; Baum F. E., 2007, NEW PUBLIC HLTH; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clarke J, 2005, CRIT SOC POLICY, V25, P447, DOI 10.1177/0261018305057024; Dieterich A, 2007, PATIENT EDUC COUNS, V67, P279, DOI 10.1016/j.pec.2007.03.017; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084; Friere P., 1974, ED CRITICAL CONSCIOU; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Levy Jennifer M, 2007, Anthropol Med, V14, P55, DOI 10.1080/13648470601106343; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Newbould J, 2006, CHRONIC ILLN, V2, P249, DOI 10.1179/174592006X157508; O'Donnell CA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-75; OMI S, 2007, PEOPLE CTR HLTH CARE; Osborne RH, 2008, NAT CLIN PRACT RHEUM, V4, P224, DOI 10.1038/ncprheum0765; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; St John of God Health Care, 2019, OUR VIS; WANLESS D, 2004, SECURING PUBLIC HLTH; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHO, 1997, JAK DECL LEAD HLTH P	24	85	85	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2009	338								b49	10.1136/bmj.b49	http://dx.doi.org/10.1136/bmj.b49			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CE	19223339	Green Submitted			2022-12-28	WOS:000264051900027
J	Llewellyn, DJ; Lang, IA; Langa, KM; Naughton, F; Matthews, FE				Llewellyn, David J.; Lang, Iain A.; Langa, Kenneth M.; Naughton, Felix; Matthews, Fiona E.			Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DEMENTIA; STROKE; HISTORY; HEALTH; INFARCTION; WORKERS	Objective To examine the association between a biomarker of exposure to secondhand smoke (salivary cotinine concentration) and cognitive impairment. Design Cross sectional analysis of a national population based study. Setting Stratified random sample of households throughout England. Participants 4809 non-smoking adults aged 50 years or more from the 1998, 1999, and 2001 waves of the Health Survey for England who also participated in the 2002 wave of the English Longitudinal Study ofAgeing and provided saliva samples for cotinine assay and a detailed smoking history. Main outcome measure Cognitive impairment as defined by the lowest 10% of scores on a battery of neuropsychological tests. Results Participants who did not smoke, use nicotine products, or have salivary cotinine concentrations of 14.1 ng/ml or more were divided into four equal size groups on the basis of cotinine concentrations. Compared with the lowest fourth of cotinine concentration (0.0-0.1 ng/ml) the odds ratios (95% confidence intervals) for cognitive impairment in the second (0.2-0.3 ng/ml), third (0.4-0.7 ng/ml), and highest fourths (0.8-13.5 ng/ml) were 1.08 (0.78 to 1.48), 1.13 (0.81 to 1.56), and 1.44 (1.07 to 1.94; P for trend 0.02), after adjustment for a wide range of established risk factors for cognitive impairment. A similar pattern of associations was observed for never smokers and former smokers. Conclusions Exposure to secondhand smoke may be associated with increased odds of cognitive impairment. Prospective nationally representative studies relating biomarkers of exposure to cognitive decline and risk of dementia are needed.	[Llewellyn, David J.; Naughton, Felix] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Langa, Kenneth M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Matthews, Fiona E.] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Cambridge; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; MRC Biostatistics Unit; University of Cambridge	Llewellyn, DJ (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.	dl355@medschl.cam.ac.uk	Matthews, Fiona/O-6932-2015; Llewellyn, David/AAZ-2859-2021; Lang, Iain A/B-8255-2008; Naughton, Felix/B-4177-2011	Matthews, Fiona/0000-0002-1728-2388; Llewellyn, David/0000-0002-2441-4246; Naughton, Felix/0000-0001-9790-2796; Langa, Kenneth/0000-0002-2798-1836	US National Institute on Aging; US National Institute on Aging [K08 AG019180, R01 AG027010]; Paul Beeson Physician Faculty Scholars in Aging Research award; Cancer Research UK [C1345/A5809]; Medical Research Council [U.1052.00.013]; Medical Research Council [G0400077, MC_U105292687] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG027010, K08AG019180] Funding Source: NIH RePORTER; MRC [G0400077, MC_U105292687] Funding Source: UKRI	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul Beeson Physician Faculty Scholars in Aging Research award; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The English Longitudinal Study of Ageing is funded by the US National Institute on Aging and a consortium of UK government departments. KML was supported by grants from the US National Institute on Aging ( K08 AG019180 and R01 AG027010) and a Paul Beeson Physician Faculty Scholars in Aging Research award. IAL is an academic specialty registrar in public health supported by the National Health Service South- West Region Public Health Training scheme. FN is supported by a grant from Cancer Research UK [ grant No C1345/A5809]. FEM is funded by the Medical Research Council [U.1052.00.013]. The sponsors played no part in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; BAUMAN KE, 1991, HEALTH PSYCHOL, V10, P282, DOI 10.1037/0278-6133.10.4.282; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Bernal-Pacheco O, 2007, J NEUROL SCI, V262, P60, DOI 10.1016/j.jns.2007.06.026; Boffetta P, 2006, MUTAT RES-GEN TOX EN, V608, P157, DOI 10.1016/j.mrgentox.2006.02.015; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; Dietrich DF, 2007, INT J EPIDEMIOL, V36, P834, DOI [10.1093/ije/dymo31, 10.1093/ije/dym031]; ERENS B, 1999, HLTH SURVEY ENGLAND; FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037/0022-006X.62.3.550; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedrich MJ, 2007, JAMA-J AM MED ASSOC, V298, P161, DOI 10.1001/jama.298.2.161; GANGULI M, 1993, J GERONTOL, V48, pM152, DOI 10.1093/geronj/48.4.M152; Hachinski V, 2007, STROKE, V38, P1396, DOI 10.1161/01.STR.0000260101.08944.e9; Hayashino Y, 2008, DIABETES CARE, V31, P732, DOI 10.2337/dc07-1905; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Huppert F.A., 2006, RETIREMENT HLTH RELA, P217; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; JARVIS MJ, 1987, LANCET, V1, P1324; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Jarvis MJ, 2001, TOB CONTROL, V10, P368, DOI 10.1136/tc.10.4.368; Koh HK, 2007, NEW ENGL J MED, V356, P1496, DOI 10.1056/NEJMp068279; Llewellyn DJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-12; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; OFSTEDAL M, 2005, DR006 HRS HLTH WORK; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Patterson C, 2007, ALZHEIMERS DEMENT, V3, P341, DOI 10.1016/j.jalz.2007.07.001; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; Richards M, 1999, NEUROLOGY, V53, P308, DOI 10.1212/WNL.53.2.308; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; RUSH D, 1989, ANN NY ACAD SCI, V562, P74, DOI 10.1111/j.1749-6632.1989.tb21008.x; Spinney L, 2007, LANCET, V369, P1507, DOI 10.1016/S0140-6736(07)60691-6; Taylor R, 2003, HLTH WEALTH LIFESTYL, P357; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; WILCOX RG, 1979, BRIT MED J, V2, P1026, DOI 10.1136/bmj.2.6197.1026; Woodward A, 2001, TOB CONTROL, V10, P383, DOI 10.1136/tc.10.4.383; Yolton K, 2005, ENVIRON HEALTH PERSP, V113, P98, DOI 10.1289/ehp.7210	43	68	70	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2009	338								b462	10.1136/bmj.b462	http://dx.doi.org/10.1136/bmj.b462			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415ZY	19213767	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000263976200006
J	Purugganan, MD; Fuller, DQ				Purugganan, Michael D.; Fuller, Dorian Q.			The nature of selection during plant domestication	NATURE			English	Review							RICE DOMESTICATION; WAXY GENE; EVOLUTION; ORIGINS; WHEAT; CROP; CULTIVATION; LOCUS; RATES; PROGENITOR	Plant domestication is an outstanding example of plant - animal co- evolution and is a far richer model for studying evolution than is generally appreciated. There have been numerous studies to identify genes associated with domestication, and archaeological work has provided a clear understanding of the dynamics of human cultivation practices during the Neolithic period. Together, these have provided a better understanding of the selective pressures that accompany crop domestication, and they demonstrate that a synthesis from the twin vantage points of genetics and archaeology can expand our understanding of the nature of evolutionary selection that accompanies domestication.	[Purugganan, Michael D.] NYU, Dept Biol, New York, NY 10003 USA; [Purugganan, Michael D.] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Fuller, Dorian Q.] UCL, Archaeol Inst, London WC1H 0PY, England	New York University; New York University; University of London; University College London	Purugganan, MD (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	mp132@nyu.edu	Fuller, Dorian Q/C-1908-2008; Fuller, Dorian/AAF-7400-2019	Fuller, Dorian Q/0000-0002-4859-080X; Fuller, Dorian/0000-0002-4859-080X	National Science Foundation Plant Genome Research Program; NERC [NE/G005540/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005540/1] Funding Source: researchfish	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank K. Olsen and S. Colledge for critical reading of the manuscript. Work in the Purugganan laboratory is funded in part by a grant from the National Science Foundation Plant Genome Research Program.	ANDERSON EDGAR, 1954, ANN MISSOURI BOT GARDEN, V41, P213, DOI 10.2307/2394604; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bogaard, 2004, NEOLITHIC FARMING CE, DOI DOI 10.4324/9780203358009; Bradbury LMT, 2005, MOL BREEDING, V16, P279, DOI 10.1007/s11032-005-0776-y; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; COLLEDGE S, 2006, ORIGINS SPREAD DOMES; Colledge S., 2005, EUR J ARCHAEOL, V8, P137, DOI [10.1177/1461957105066937, DOI 10.1177/1461957105066937]; CRAWFORD G, 1983, PALEOTHNOBOTANY KAME; D'Andrea AC, 2007, ANTIQUITY, V81, P686, DOI 10.1017/S0003598X00095661; D'Ennequin ML, 1999, J EVOLUTION BIOL, V12, P1138, DOI 10.1046/j.1420-9101.1999.00115.x; Darwin, 1859, ORIGINS SPECIES MEAN; Darwin C., 1858, J P LINNEAN SOC LOND, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; Darwin Ch., 1868, P411; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Fukunaga K, 2002, MOL GENET GENOMICS, V268, P214, DOI 10.1007/s00438-002-0728-8; Fuller DQ, 2006, ENVIRON ARCHAEOL, V11, P219, DOI 10.1179/174963106x123232; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Giles RJ, 2006, THEOR APPL GENET, V112, P1563, DOI 10.1007/s00122-006-0259-5; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; HAMMER K, 1984, Kulturpflanze, V32, P11; Hancock JF, 2005, ANN BOT-LONDON, V96, P953, DOI 10.1093/aob/mci259; Harlan Jack R., 1976, ORIGINS AFRICAN PLAN, P3, DOI DOI 10.1515/9783110806373.465; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harris DR, 1989, FORAGING FARMING EVO, P11; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; HILLMAN GC, 1990, BIOL J LINN SOC, V39, P39, DOI 10.1111/j.1095-8312.1990.tb01611.x; Hillman GC, 2000, VILLAGE EUPHRATES FO, P327; Hirano HY, 1998, MOL BIOL EVOL, V15, P978, DOI 10.1093/oxfordjournals.molbev.a026013; Iltis HH, 2000, ECON BOT, V54, P7, DOI 10.1007/BF02866598; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kreuz A, 2005, VEG HIST ARCHAEOBOT, V14, P237, DOI 10.1007/s00334-005-0080-0; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Olsen KM, 2002, GENETICS, V162, P941; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Prathepha P, 2009, GENET RESOUR CROP EV, V56, P13, DOI 10.1007/s10722-008-9337-7; Rindos D., 1984, ORIGINS AGR EVOLUTIO; SAKAMOTO S, 1996, REDEFINING NATURE EC, P215; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; SKOGLUND P, 1999, CURRENT SWEDISH ARCH, V7, P149; Smith BD, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P15; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Uga Y, 2003, THEOR APPL GENET, V107, P218, DOI 10.1007/s00122-003-1227-y; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; WILKE PJ, 1972, ANTIQUITY, V46, P203, DOI 10.1017/S0003598X0005362X; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Wills DM, 2007, GENETICS, V176, P2589, DOI 10.1534/genetics.107.075333; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yoshida S., 2002, VEGECULTURE E ASIA O, P31; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zheng YF, 2007, CHINESE SCI BULL, V52, P1654, DOI 10.1007/s11434-007-0258-1; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	74	551	576	9	336	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					843	848		10.1038/nature07895	http://dx.doi.org/10.1038/nature07895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212403				2022-12-28	WOS:000263266700035
J	Creppe, C; Malinouskaya, L; Volvert, ML; Gillard, M; Close, P; Malaise, O; Laguesse, S; Cornez, I; Rahmouni, S; Ormenese, S; Belachew, S; Malgrange, B; Chapelle, JP; Siebenlist, U; Moonen, G; Chariot, A; Nguyen, L				Creppe, Catherine; Malinouskaya, Lina; Volvert, Marie-Laure; Gillard, Magali; Close, Pierre; Malaise, Olivier; Laguesse, Sophie; Cornez, Isabelle; Rahmouni, Souad; Ormenese, Sandra; Belachew, Shibeshih; Malgrange, Brigitte; Chapelle, Jean-Paul; Siebenlist, Ulrich; Moonen, Gustave; Chariot, Alain; Nguyen, Laurent			Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of alpha-Tubulin	CELL			English	Article							FAMILIAL DYSAUTONOMIA; IN-VIVO; CEREBRAL-CORTEX; CELL-MIGRATION; HISTONE ACETYLTRANSFERASE; ACTIN CYTOSKELETON; FILAMIN-A; PROTEIN; RNA; TRANSPORT	The generation of cortical projection neurons relies on the coordination of radial migration with branching. Here, we report that the multisubunit histone acetyltransferase Elongator complex, which contributes to transcript elongation, also regulates the maturation of projection neurons. Indeed, silencing of its scaffold (Elp1) or catalytic subunit (Elp3) cell-autonomously delays the migration and impairs the branching of projection neurons. Strikingly, neurons defective in Elongator show reduced levels of acetylated alpha-tubulin. Reduction of alpha-tubulin acetylation via expression of a nonacetylatable alpha-tubulin mutant leads to comparable defects in cortical neurons and suggests that alpha-tubulin is a target of Elp3. This is further supported by the demonstration that Elp3 promotes acetylation and counteracts HDAC6-mediated deacetylation of this substrate in vitro. Our results uncover alpha-tubulin as a target of the Elongator complex and suggest that a tight regulation of its acetylation underlies the maturation of cortical projection neurons.	[Creppe, Catherine; Gillard, Magali; Close, Pierre; Cornez, Isabelle; Chapelle, Jean-Paul; Chariot, Alain] Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium; [Malinouskaya, Lina; Volvert, Marie-Laure; Malaise, Olivier; Laguesse, Sophie; Belachew, Shibeshih; Malgrange, Brigitte; Moonen, Gustave; Nguyen, Laurent] Univ Liege, CHU Sart Tilman, GIGA Neurosci, B-4000 Liege, Belgium; [Rahmouni, Souad] Univ Liege, CHU Sart Tilman, GIGA Infect Immun & Inflammat, B-4000 Liege, Belgium; [Ormenese, Sandra] Univ Liege, CHU Sart Tilman, GIGA Imaging & Flow Cytometry, B-4000 Liege, Belgium; [Belachew, Shibeshih; Moonen, Gustave] Univ Liege, CHU Sart Tilman, Dept Neurol, B-4000 Liege, Belgium; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chariot, A (corresponding author), Univ Liege, CHU Sart Tilman, GIGA Signal Transduct, B-4000 Liege, Belgium.	alain.chariot@ulg.ac.be; lnguyen@ulg.ac.be	Nguyen, Laurent/E-9882-2016; Malgrange, Brigitte/F-8384-2010; malgrange, brigitte/A-4887-2019; Belachew, Shibeshih/V-9185-2019	malgrange, brigitte/0000-0002-8957-2528; Belachew, Shibeshih/0000-0003-3976-1950; Laguesse, Sophie/0000-0002-9217-0087; Chariot, Alain/0000-0002-1691-4347; CLOSE, PIERRE/0000-0002-8844-9616; Nguyen, Laurent/0000-0002-8560-3008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000431] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Cau E, 1997, DEVELOPMENT, V124, P1611; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lom B, 1999, J NEUROSCI, V19, P9928; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mezey E, 2003, BRAIN RES, V983, P209, DOI 10.1016/S0006-8993(03)03090-7; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tabata H, 2003, J NEUROSCI, V23, P9996; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	50	372	381	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					551	564		10.1016/j.cell.2008.11.043	http://dx.doi.org/10.1016/j.cell.2008.11.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19185337	Bronze			2022-12-28	WOS:000263120600023
J	Stern, DL; Orgogozo, V				Stern, David L.; Orgogozo, Virginie			Is Genetic Evolution Predictable?	SCIENCE			English	Review							MORPHOLOGICAL EVOLUTION; DROSOPHILA-MELANOGASTER; FLOWERING TIME; BRISTLE NUMBER; ADAPTATION; DIFFERENCE; FRIGIDA; LOCUS; ARABIDOPSIS; POPULATION	Ever since the integration of Mendelian genetics into evolutionary biology in the early 20th century, evolutionary geneticists have for the most part treated genes and mutations as generic entities. However, recent observations indicate that all genes are not equal in the eyes of evolution. Evolutionarily relevant mutations tend to accumulate in hotspot genes and at specific positions within genes. Genetic evolution is constrained by gene function, the structure of genetic networks, and population biology. The genetic basis of evolution may be predictable to some extent, and further understanding of this predictability requires incorporation of the specific functions and characteristics of genes into evolutionary theory.	[Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Orgogozo, Virginie] Univ Paris 06, CNRS, F-75005 Paris, France	Howard Hughes Medical Institute; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dstern@princeton.edu; virginie.orgogozo@normalesup.org		Stern, David/0000-0002-1847-6483; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank two referees for helpful comments, P. Simpson for providing photographs and advice for Fig. 2, and CNRS for research funding for O.V.	Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Cooper TF, 2007, EVOLUTION, V61, P1495, DOI 10.1111/j.1558-5646.2007.00109.x; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; Gibert JM, 2005, DEV BIOL, V288, P194, DOI 10.1016/j.ydbio.2005.09.032; Gurganus MC, 1999, GENETICS, V152, P1585; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; LONG AD, 1995, GENETICS, V139, P1273; Macdonald SJ, 1999, GENETICS, V153, P1683; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; SCOTT DA, 1995, AM J HUM GENET, V57, P965; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; STEWART CB, 1987, COLD SPRING HARB SYM, V52, P891, DOI 10.1101/SQB.1987.052.01.097; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Yokoyama S, 1997, ANNU REV GENET, V31, P315, DOI 10.1146/annurev.genet.31.1.315; Yukilevich R, 2008, EVOLUTION, V62, P2215, DOI 10.1111/j.1558-5646.2008.00445.x; Zeng ZB, 2000, GENETICS, V154, P299	29	362	370	3	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					746	751		10.1126/science.1158997	http://dx.doi.org/10.1126/science.1158997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197055	Green Accepted			2022-12-28	WOS:000263066800036
J	Calonge, N; Petitti, DB; DeWitt, TG; Gordis, L; Gregory, KD; Harris, R; Kizer, KW; LeFevre, ML; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Siu, AL; Teutsch, SM; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Kizer, Kenneth W.; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.		US Preventive Serv Task Force	Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Update of the 2001 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for skin cancer. Methods: To update its recommendation, the USPSTF reviewed evidence published since 2001 on studies on screening effectiveness, the stage of detection by screening, and the accuracy of whole-body examination by primary care clinicians and self-examination by patients. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for skin cancer by primary care clinicians or by patient skin self-examination. (I statement)	[Calonge, Ned] USPSTF, Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Univ So Calif, Keck Sch Med, USPSTF, Sierra Madre, CA USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Gordis, Leon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Kizer, Kenneth W.] Natl Qual Forum, Washington, DC USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Moyer, Virginia A.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Siu, Albert L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Teutsch, Steven M.] Merck & Co Inc, West Point, PA USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MI USA	Colorado Department of Public Health & Environment; University of Southern California; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; University of Texas System; University of Texas Health Science Center Houston; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Merck & Company	Calonge, N (corresponding author), USPSTF, Colorado Dept Publ Hlth & Environm, Denver, CO USA.				Agency for Healthcare Research and Quality; USPSTF	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	*AM AC FAM PHYS, 2007, AAFP POL ACT SUMM RE; American Cancer Society, 2004, CANC FACTS FIG 2004; American College of Obstetricians and Gynecologists, 2003, Obstet Gynecol, V102, P1117; Berg AO, 2001, AM J PREV MED, V20, P44, DOI 10.1016/S0749-3797(01)00259-8; Chen SC, 2001, ARCH DERMATOL, V137, P1627; FEIGHTNER JW, 1994, CANADIAN TASK FORCE, P850; Ferrini RL, 1998, AM J PREV MED, V14, P80, DOI 10.1016/S0749-3797(97)00007-X; Geller AC, 2003, J AM ACAD DERMATOL, V48, P34, DOI 10.1067/mjd.2003.9; *NAT CANC I, 2005, SKIN CANC SCREEN PDQ; RIES LAG, SURVEILLANCE EPIDEMI; RIES LAG, 2005, SEER CANC STAT REV; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009	12	113	113	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					188	+		10.7326/0003-4819-150-3-200902030-00020	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00020			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189908				2022-12-28	WOS:000263029600005
J	Gottlieb, S				Gottlieb, Scott			Relationships with the drug industry: Build trust based on good science	BRITISH MEDICAL JOURNAL			English	Editorial Material							LITERACY		Amer Enterprise Unit, Washington, DC 20036 USA		Gottlieb, S (corresponding author), Amer Enterprise Unit, 1150 17th St NW, Washington, DC 20036 USA.	Scott.Gottlieb@mssm.edu						Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Sentell TL, 2006, J GEN INTERN MED, V21, P862, DOI 10.1111/j.1525-1497.2006.00538.x	3	0	0	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2009	338								b234	10.1136/bmj.b234	http://dx.doi.org/10.1136/bmj.b234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19193616				2022-12-28	WOS:000263876200008
J	Little, J; Higgins, JPT; Ioannidis, JPA; Moher, D; Gagnon, F; von Elm, E; Khoury, MJ; Cohen, B; Davey-Smith, G; Grimshaw, J; Scheet, P; Gwinn, M; Williamson, RE; Zou, GY; Hutchings, K; Johnson, CY; Tait, V; Wiens, M; Golding, J; van Duijn, C; McLaughlin, J; Paterson, A; Wells, G; Fortier, I; Freedman, M; Zecevic, M; King, R; Infante-Rivard, C; Stewart, AFR; Birkett, N				Little, Julian; Higgins, Julian P. T.; Ioannidis, John P. A.; Moher, David; Gagnon, France; von Elm, Erik; Khoury, Muin J.; Cohen, Barbara; Davey-Smith, George; Grimshaw, Jeremy; Scheet, Paul; Gwinn, Marta; Williamson, Robin E.; Zou, Guang Yong; Hutchings, Kim; Johnson, Candice Y.; Tait, Valerie; Wiens, Miriam; Golding, Jean; van Duijn, Cornelia; McLaughlin, John; Paterson, Andrew; Wells, George; Fortier, Isabel; Freedman, Matthew; Zecevic, Maja; King, Richard; Infante-Rivard, Claire; Stewart, Alex F. R.; Birkett, Nick			STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; HARDY-WEINBERG EQUILIBRIUM; SINGLE-NUCLEOTIDE POLYMORPHISM; POPULATION STRATIFICATION; GENOTYPING ERRORS; PROSTATE-CANCER; LARGE-SCALE; DISEASE ASSOCIATIONS; EMPIRICAL-EVALUATION; STATISTICAL-METHOD	Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information into the practice of medicine and public health. Assessment of the strengths and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results. The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the STrengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement and provides additions to 12 of the 22 items on the STROBE checklist. The additions concern population stratification, genotyping errors, modeling haplotype variation, Hardy-Weinberg equilibrium, replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative traits, statistical methods, relatedness, reporting of descriptive and outcome data, and issues of data volume that are important to consider in genetic association studies. The STREGA recommendations do not prescribe or dictate how a genetic association study should be designed but seek to enhance the transparency of its reporting, regardless of choices made during design, conduct, or analysis.	[Little, Julian] Univ Ottawa, Ottawa, ON K1H 8M5, Canada; Univ Toronto, Toronto, ON, Canada; Univ Western Ontario, London, ON, Canada; Robarts Res Inst, Toronto, ON, Canada; Canc Care Ontario, Toronto, ON, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; McGill Univ, Montreal, PQ, Canada; Genome Quebec Innovat Ctr, Montreal, PQ, Canada; Tufts Univ, Sch Med, Boston, MA 02111 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Cell Press, Cambridge, MA USA; Lancet Publishing Grp, New York, NY USA; Amer Coll Med Genet, Bethesda, MD USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Texas Houston, Houston, TX USA; MRC, Cambridge, England; Univ Bristol & Blackwell Publishing, Bristol, Avon, England; Springer Netherlands, Rotterdam, Netherlands; German Cochrane Ctr, Freiburg, Germany; Univ Bern, Bern, Switzerland; Univ Ioannina, Sch Med, GR-45110 Ioannina, Greece	University of Ottawa; University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Tufts University; Harvard University; Dana-Farber Cancer Institute; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health Science Center Houston; University of Bristol; Springer Nature; University of Bern; University of Ioannina	Little, J (corresponding author), Univ Ottawa, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jlittle@uottawa.ca	McLaughlin, John R/E-4577-2013; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011; Little, Julian/AAR-6117-2020; Higgins, Julian PT/H-4008-2011; Zou, Guangyong/K-6408-2013; Ioannidis, John P. A./G-9836-2011; Davey Smith, George/A-7407-2013	Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Little, Julian/0000-0001-5026-5531; Higgins, Julian PT/0000-0002-8323-2514; Zou, Guangyong/0000-0001-5773-4185; Davey Smith, George/0000-0002-1407-8314; Van Duijn, Cornelia/0000-0002-2374-9204; Stewart, Alexandre/0000-0003-2673-9164; Grimshaw, Jeremy/0000-0001-8015-8243; Johnson, Candice/0000-0002-2544-3110; Golding, Jean/0000-0003-2826-3307; s, hema/0000-0002-3440-9475; Moher, David/0000-0003-2434-4206; von Elm, Erik/0000-0002-7412-0406	Institutes of Genetics and of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research; Genome Canada; Biotechnology, Genomics and Population Health Branch, Public Health Agency of Canada; Affymetrix; DNA Genotek; TrialStat!; GeneSens; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	Institutes of Genetics and of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Biotechnology, Genomics and Population Health Branch, Public Health Agency of Canada; Affymetrix; DNA Genotek; TrialStat!; GeneSens; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Grant Support: By the Institutes of Genetics and of Nutrition, Metabolism and Diabetes, Canadian Institutes of Health Research; Genome Canada; Biotechnology, Genomics and Population Health Branch, Public Health Agency of Canada; Affymetrix; DNA Genotek; TrialStat!; and GeneSens.	Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2005, MED CLIN-BARCELONA, V125, P8, DOI 10.1016/S0025-7753(05)72203-X; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Ayres KL, 1998, HEREDITY, V80, P769, DOI 10.1046/j.1365-2540.1998.00360.x; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Begg CB, 2005, CANCER EPIDEM BIOMAR, V14, P1364, DOI 10.1158/1055-9965.EPI-05-0407; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BROWNING SR, 2008, HUM GENET; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Byrnes G, 2005, CANCER EPIDEM BIOMAR, V14, P1363, DOI 10.1158/1055-9965.EPI-05-0406; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cooper DN, 2002, HUM GENET, V110, P207, DOI 10.1007/s00439-001-0672-4; Crossman D, 2004, HEART, V90, P831, DOI 10.1136/hrt.2003.022871; Davidoff F, 2008, ANN INTERN MED, V149, P670, DOI 10.7326/0003-4819-149-9-200811040-00009; DeLisi LE, 2006, AM J MED GENET B, V141B, P319, DOI 10.1002/ajmg.b.30321; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dequeker E, 2001, NAT REV GENET, V2, P717, DOI 10.1038/35088588; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edland SD, 2004, STAT MED, V23, P169, DOI 10.1002/sim.1706; Ehm MG, 2005, HUM MOL GENET, V14, P2485, DOI 10.1093/hmg/ddi252; FRAMEWORK F, 2005, NAT GENET, V37, P1153; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Freimer NB, 2005, HUM MOL GENET, V14, P2481, DOI 10.1093/hmg/ddi251; GARCIA C, 2004, HUMAN GENOME EPIDEMI, P127; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; *GEN HLTH SOC WORK, 2004, GEN HLTH SOC EM ISS; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hall IP, 2005, THORAX, V60, P357, DOI 10.1136/thx.2005.040790; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hegele RA, 2002, ARTERIOSCL THROM VAS, V22, P1058, DOI 10.1161/01.ATV.0000026801.56080.14; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Higgins JPT, 2007, AM J EPIDEMIOL, V166, P863, DOI 10.1093/aje/kwm248; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Huang QQ, 2003, HUM GENET, V113, P253, DOI 10.1007/s00439-003-0965-x; Huizinga TWJ, 2004, ARTHRITIS RHEUM, V50, P2066, DOI 10.1002/art.20360; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; JAXENA K, 2007, SCIENCE, V316, P1331; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Khlat M, 2004, CANCER EPIDEM BIOMAR, V13, P1660; KHOURY MJ, 2004, HUMAN GENOME EPIDEMI, P3; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Lawrence RW, 2005, PHILOS T R SOC B, V360, P1589, DOI 10.1098/rstb.2005.1689; Lee W, 2007, BRIT J PSYCHIAT, V190, P204, DOI 10.1192/bjp.bp.106.027250; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Little J, 2003, AM J EPIDEMIOL, V157, P667, DOI 10.1093/aje/kwg048; LITTLE J, HUGENET HUGE REV HDB; LITTLE J, 2004, HUMAN GENOME EPIDEMI, P168; Lynch M, 1999, GENETICS, V152, P1753; Manly KF, 2005, IMMUNOGENETICS, V57, P549, DOI 10.1007/s00251-005-0025-x; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Millikan RC, 2001, J NATL CANCER I, V93, P156, DOI 10.1093/jnci/93.2.156; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Peters DL, 2003, CRIT CARE MED, V31, P1691, DOI 10.1097/01.CCM.0000065190.24116.A4; Pharoah PDP, 2005, CANCER EPIDEM BIOMAR, V14, P1362, DOI 10.1158/1055-9965.EPI-05-0405; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rebbeck TR, 2004, CANCER EPIDEM BIOMAR, V13, P1985; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romero R, 2002, AM J OBSTET GYNECOL, V187, P1299, DOI 10.1067/mob.2002.128319; ROTHMAN N, 1993, CANCER EPIDEM BIOMAR, V2, P299; Saito YA, 2006, AM J GASTROENTEROL, V101, P1379, DOI 10.1111/j.1572-0241.2006.00587.x; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shen H, 2005, J BONE MINER RES, V20, P365, DOI 10.1359/JBMR.041129; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoemaker J, 1998, GENETICS, V149, P2079; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; STEINBERG K, 2004, HUMAN GENOME EPIDEMI, P79; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x; Thomas DC, 2006, CANCER EPIDEM BIOMAR, V15, P595, DOI 10.1158/1055-9965.EPI-06-0146; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Uhlig K, 2007, AM J KIDNEY DIS, V49, P3, DOI 10.1053/j.ajkd.2006.10.012; van Duijn CM, 2003, EUR J EPIDEMIOL, V18, P285; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; VANHYLCKAMA V, 2004, EUR J HUM GENET, V12, P478; Vitali Sally H, 2005, Pediatr Crit Care Med, V6, pS74, DOI 10.1097/01.PCC.0000161572.12676.91; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2005, CANCER EPIDEM BIOMAR, V14, P1361, DOI 10.1158/1055-9965.EPI-05-0404; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P885; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wain HM, 2002, NUCLEIC ACIDS RES, V30, P169, DOI 10.1093/nar/30.1.169; Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003; Wedzicha JA, 2005, THORAX, V60, P357, DOI 10.1136/thx.2005.043802; Weinberg W., 1908, JAHRESH VER VATERL N, V64, P369; Weiss S. T., 2001, Pharmacogenomics Journal, V1, P157; Weiss ST, 2001, AM J RESP CRIT CARE, V164, P2014, DOI 10.1164/ajrccm.164.11.2110043b; Whittemore AS, 2005, CANCER EPIDEM BIOMAR, V14, P1359, DOI 10.1158/1055-9965.EPI-05-0403; Winker MA, 2006, J LAW MED ETHICS, V34, P520, DOI 10.1111/j.1748-720X.2006.00065.x; Wong MY, 2004, STAT MED, V23, P987, DOI 10.1002/sim.1662; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yesupriya A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-31; YU W, HUGE LIT FINDER HUGE; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zerhouni EA, 2008, SCIENCE, V322, P44, DOI 10.1126/science.1165490; Zhang WH, 2004, HUM GENET, V115, P157, DOI 10.1007/s00439-004-1122-x; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140; Zou GY, 2006, ANN HUM GENET, V70, P923, DOI [10.1111/j.1469-1809.2006.00267.x, 10.1111/j.1469-1809.2006.0267.x]	153	86	90	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					206	+		10.7326/0003-4819-150-3-200902030-00011	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00011			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189911	Green Published, Green Submitted			2022-12-28	WOS:000263029600008
J	Gerke, J; Lorenz, K; Cohen, B				Gerke, Justin; Lorenz, Kim; Cohen, Barak			Genetic Interactions Between Transcription Factors Cause Natural Variation in Yeast	SCIENCE			English	Article							COMMON HUMAN-DISEASES; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE TRAITS; POSITIVE REGULATOR; EVOLUTION; MEIOSIS; EPISTASIS; SPORULATION; LOCUS; IME1	Our understanding of the genetic basis of phenotypic diversity is limited by the paucity of examples in which multiple, interacting loci have been identified. We show that natural variation in the efficiency of sporulation, the program in yeast that initiates the sexual phase of the life cycle, between oak tree and vineyard strains is due to allelic variation between four nucleotide changes in three transcription factors: IME1, RME1, and RSF1. Furthermore, we identified that selection has shaped quantitative variation in yeast sporulation between strains. These results illustrate how genetic interactions between transcription factors are a major source of phenotypic diversity within species.	[Gerke, Justin; Lorenz, Kim; Cohen, Barak] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA	Washington University (WUSTL)	Cohen, B (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA.	cohen@genetics.wustl.edu		Lorenz, Kim/0000-0001-8674-2942	 [NSF-MCB-0543156];  [NHGRI-T32HG000045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kyro for technical assistance and J. Fay, B. Engle, H.-S. Kim, and M. Johnston for sharing reagents. We also thank J. Fay, S. Doniger, C. Hittinger, and members of the Cohen laboratory for helpful advice and discussions. Funded by NSF-MCB-0543156. J.P.G. has received support from NHGRI-T32HG000045. Sequences were deposited in GenBank accessions FJ446649 to FJ446698.	Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; KUPIEC M, 1997, MOL CELLULAR BIOL YE, V3, P889; Lu L, 2003, CURR GENET, V43, P263, DOI 10.1007/s00294-003-0398-z; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SMITH HE, 1993, GENETICS, V133, P775; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	42	152	152	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					498	501		10.1126/science.1166426	http://dx.doi.org/10.1126/science.1166426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164747	Green Accepted			2022-12-28	WOS:000262587900041
J	Zehn, D; Lee, SY; Bevan, MJ				Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.			Complete but curtailed T-cell response to very low-affinity antigen	NATURE			English	Article							LISTERIA-MONOCYTOGENES; PRECURSOR FREQUENCY; MEMORY; EFFECTOR; INFECTION; SELECTION; DIFFERENTIATION; RECOGNITION; ACTIVATION; EXPRESSION	After an infection, T cells that carry the CD8 marker are activated and undergo a characteristic kinetic sequence of rapid expansion, subsequent contraction and formation of memory cells(1-3). The pool of naive T-cell clones is diverse and contains cells bearing T-cell antigen receptors (TCRs) that differ in their affinity for the same antigen(4,5). How these differences in affinity affect the function and the response kinetics of individual T-cell clones was previously unknown. Here we show that during the in vivo response to microbial infection, even very weak TCR-ligand interactions are sufficient to activate naive T cells, induce rapid initial proliferation and generate effector and memory cells. The strength of the TCR ligand interaction critically affects when expansion stops, when the cells exit lymphoid organs and when contraction begins; that is, strongly stimulated T cells contract and exit lymphoid organs later than weakly stimulated cells. Our data challenge the prevailing view that strong TCR ligation is a prerequisite for CD8(+) T-cell activation. Instead, very weak interactions are sufficient for activation, but strong TCR ligation is required to sustain T-cell expansion. We propose that in response to microbial challenge, T-cell clones with a broad range of avidities for foreign ligands are initially recruited, and that the pool of T cells subsequently matures in affinity owing to the more prolonged expansion of high-affinity T-cell clones.	[Zehn, Dietmar; Lee, Sarah Y.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu			National Institutes of Health; Howard Hughes Medical Institute; Juvenile Diabetes Research Foundation; German Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gallegos for advice in making the recombinant Listeria, and X.- C. Pan, B. Dere, B. Paul and K. Rider for technical support. Financial support was received from the National Institutes of Health and the Howard Hughes Medical Institute ( M. J. B.), and from the Juvenile Diabetes Research Foundation and the German Research Foundation ( D. Z.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376	26	460	465	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					211	214		10.1038/nature07657	http://dx.doi.org/10.1038/nature07657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182777	Green Accepted			2022-12-28	WOS:000264059700045
J	Geanakoplos, J				Geanakoplos, John			Recession Watch: End the obsession with interest	NATURE			English	Editorial Material									[Geanakoplos, John] Yale Univ, New Haven, CT 06520 USA; [Geanakoplos, John] Santa Fe Inst, Santa Fe, NM 87501 USA	Yale University; The Santa Fe Institute	Geanakoplos, J (corresponding author), Yale Univ, New Haven, CT 06520 USA.	john.geanakoplos@yale.edu							0	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					963	963		10.1038/457963a	http://dx.doi.org/10.1038/457963a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225505	Bronze			2022-12-28	WOS:000263425400023
J	Digenio, AG; Mancuso, JP; Gerber, RA; Dvorak, RV				Digenio, Andres G.; Mancuso, James P.; Gerber, Robert A.; Dvorak, Roman V.			Comparison of Methods for Delivering a Lifestyle Modification Program for Obese Patients A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							WEIGHT; OVERWEIGHT; PHARMACOTHERAPY; INTERVENTION; RISK	Background: Physicians frequently prescribe medications for weight loss but offer minimal lifestyle counseling despite the additional benefits of combining both interventions. Objective: To compare 5 methods of delivering a lifestyle modification program to obese patients receiving sibutramine. Design: Randomized, 6-month, open-label study. Participants were assigned to intervention groups by using a computer-generated schedule of randomly permuted blocks. Block length was 5. Setting: 12 independent research clinics with experience running obesity trials. Patients: 376 patients with obesity ( body mass index >= 30 and < 40 kg/m(2)). Intervention: High-frequency face-to-face lifestyle modification counseling (HF-F2F) (n = 74), low-frequency face-to-face counseling (LF-F2F) ( n = 76), high-frequency telephone counseling (HFTEL) ( n = 76), high-frequency e-mail counseling (HF-EMAIL) ( n = 74), or no dietitian contact (self-help [ SELF]) ( n = 76). All participants received sibutramine, 10 mg/d; a lifestyle manual; and access to a weight-loss Web site. Measurements: Percentage change in body weight at 6 months was the primary outcome. Secondary end points included changes in waist circumference; lipid, glucose, and insulin levels; blood pressure; weight-related symptoms; and quality of life at 6 months. Results: At 6 months, the mean weight loss, relative to baseline, in the HF-F2F and HF-TEL groups was similar (8.9% [95% CI, 8.0% to 9.8%] and 7.7% [ CI, 6.8% to 8.7%]) and significantly greater than that in the other groups (LF-F2F, 6.4% [ CI, 5.4% to 7.3%]; HF-EMAIL, 5.9% [ CI, 5.0% to 6.8%]; and SELF, 5.2% [ CI, 4.3% to 6.1%]). All groups showed significant improvements in waist circumference, high-density lipoprotein cholesterol and triglyceride levels, and measures of quality of life and weight-related symptoms. There were no serious adverse events and no differences in minor events among groups. Limitation: Most participants were women, and the attrition rate was 30%. Conclusion: High-frequency telephone contact with a dietitian was similar to HF-F2F contact for supporting lifestyle modification in obese patients trying to lose weight. The findings might be used by providers and health systems to promote healthy lifestyle changes for their patients.	Pfizer, S Lyme, CT USA; Pfizer Global Res & Dev, Cardiovasc & Metab, New London, CT USA	Pfizer; Pfizer	Digenio, AG (corresponding author), POB 428, S Lyme, CT 06376 USA.	agdvdb@aol.com			Pfizer Global Research and Development.	Pfizer Global Research and Development.(Pfizer)	Pfizer Global Research and Development.	Donnelly JE, 2007, INT J OBESITY, V31, P1270, DOI 10.1038/sj.ijo.0803568; Harvey-Berino J, 2002, BEHAV MODIF, V26, P103, DOI 10.1177/0145445502026001006; Hellerstedt WL, 1997, AM J HEALTH PROMOT, V11, P177, DOI 10.4278/0890-1171-11.3.177; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Patrick DL, 2004, OBES RES, V12, P48, DOI 10.1038/oby.2004.8; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Stafford RS, 2003, ARCH INTERN MED, V163, P1046, DOI 10.1001/archinte.163.9.1046; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wylie-Rosett J, 2002, J AM DIET ASSOC, V102, P1065, DOI 10.1016/S0002-8223(02)80073-6	15	106	106	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					255	U54		10.7326/0003-4819-150-4-200902170-00006	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410FI	19221377				2022-12-28	WOS:000263562500004
J	Loewenberg, S				Loewenberg, Samuel			Lunch with The Lancet	LANCET			English	Editorial Material												mail@samloewenberg.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					537	537		10.1016/S0140-6736(09)60189-6	http://dx.doi.org/10.1016/S0140-6736(09)60189-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217978				2022-12-28	WOS:000263333600017
J	Smith, RD; Chanda, R; Tangcharoensathien, V				Smith, Richard D.; Chanda, Rupa; Tangcharoensathien, Viroj			Trade and Health 4 Trade in health-related services	LANCET			English	Article							FOREIGN DIRECT-INVESTMENT; SUB-SAHARAN AFRICA; PUBLIC-HEALTH; CARE WORKERS; MIGRATION; GLOBALIZATION; ORGANIZATION; CHALLENGES; POLICIES; NURSES	The supervision of a domestic health system in the context of the trade environment in the 21st century needs a sophisticated Understanding of how trade in health services affects, and will affect, a country's health system and policy. This notion places a premium on people engaged in the health sector understanding the importance of a comprehensive outlook on trade in health services. However, establishment of systematic comparative data for amounts of trade in health services is difficult to achieve, and most trade negotiations occur in isolation from health professionals. These difficulties compromise the ability of a health system to not just minimise the risks presented by trade in health services, but also to maximise the opportunities. We consider these issues by presenting the latest trends and developments in the worldwide delivery of health-care services, using the classification provided by the World Trade Organization for the General Agreement on Trade in Services. This classification covers four modes of service delivery: cross-border supply of services; consumption of services abroad; foreign direct investment, typically to establish a new hospital, clinic, or diagnostic facility; and the movement of health professionals. For every delivery mode we discuss the present magnitude and pattern of trade, main contributors to this trade, and key issues arising.	[Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; [Chanda, Rupa] Indian Inst Management, Bangalore, Karnataka, India; [Tangcharoensathien, Viroj] Thailand Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand	University of London; London School of Hygiene & Tropical Medicine; Indian Institute of Management (IIM System); Indian Institute of Management Bangalore; Ministry of Public Health - Thailand	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				Adlung R, 2001, B WORLD HEALTH ORGAN, V79, P352; Adlung R, 2006, INTERNATIONAL TRADE IN HEALTH SERVICES AND THE GATS: CURRENT ISSUES AND DEBATES, P83; Ahmad OB, 2005, BRIT MED J, V331, P43, DOI 10.1136/bmj.331.7507.43; [Anonymous], 2004, CAN MED ASSOC J, V170, P1523, DOI 10.1053/cmaj.1040604; ARUNANONDCHAI J, 2007, TRADE HLTH SERVICES; Bach S, 2004, B WORLD HEALTH ORGAN, V82, P624; Bach S., 2003, INT MIGRATION HLTH W; BLANCHARD JM, 2004, BRIDGING DIGITAL DIV; Blomstrom M, 1999, EUR ECON REV, V43, P915, DOI 10.1016/S0014-2921(98)00104-4; BLOUIN C, 2005, TRADE HLTH SERVICES; Blouin C, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P3; Buchan J, 2004, B WORLD HEALTH ORGAN, V82, P587; Buchan J., 2005, INT MIGRATION NURSES; Buchan J., 2004, INT RECRUITMENT HLTH; Burgos Arlene, 2004, JAPAN TIMES     0922; BURRILL G, 2007, BURRILL Q INDIA LIFE, V3; CHANDA R, 2007, FOREIGN DIRECT INVES; Chanda R., 2006, COMPETING GLOBAL TAL, P215; Chanda R., 2006, 30 OECD; Chanda R, 2006, INTERNATIONAL TRADE IN HEALTH SERVICES AND THE GATS: CURRENT ISSUES AND DEBATES, P245; CHENG M, 2001, INSIDE BATTLE ASIAS; Chikanda A., 2004, 4 U OXF CTR MIGR POL; Chinai R, 2007, B WORLD HEALTH ORGAN, V85, P164, DOI 10.2471/BLT.07.010307; *CLEARST, 2007, MED TOUR AS GROWTH I; *COMM EUR COMM, 2004, EHEALTH MAK HLTH CAR; Connell J, 2007, SOC SCI MED, V64, P1876, DOI 10.1016/j.socscimed.2006.12.013; *CONS UN TRUST SOC, 2007, BARR MOV HEALTHC PRO; Diallo K, 2004, B WORLD HEALTH ORGAN, V82, P601; DOVLO D, 2004, 44 HARV U; Eastwood JB, 2005, LANCET, V365, P1893, DOI 10.1016/S0140-6736(05)66623-8; Forgione D., 2006, J HLTH CARE FINANCE, V34, P27; GOBRECHT J, 2003, MEASURING TRADE HLTH; Hamilton K, 2004, GLOBAL TUG OF WAR HL; HILARY J, 2001, WRONG MODEL GATS TRA; *IND CAN, 2000, LIF SCI BRANCH HLTH; *INDR AP HOSP, 2008, NEWS SECT; Janjaroen W. S., 2002, TRADE HLTH SERVICES, P87; Kincade K, 1999, LASER FOCUS WORLD, V35, P69; Labonte R, 2007, HLTH EQUITABLE GLOBA; LUTHER DR, 1999, HLTH CARE SERVICES S; Markusen JR, 1999, EUR ECON REV, V43, P335, DOI 10.1016/S0014-2921(98)00048-8; MARTINEAU T, 2002, BRIEFING NOTE INT MI; Mensah K, 2005, SKILLS DRAIN HLTH PR; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; MUTCHNICK IS, 2005, HLTH AFFAIRS W, V5, P42; Oh H, 2005, J MED INTERNET RES, V7; OUTREVILLE J, 1998, UNCTAD INT TRADE HLT, P111; Pachanee CA, 2006, HEALTH POLICY PLANN, V21, P310, DOI 10.1093/heapol/czl017; Padarath A., 2003, 3 EQUINET; PANNARUNOTHAI TC, 1999, PUBLIC PRIVATE HOSP; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1; Price D, 1999, LANCET, V354, P1889, DOI 10.1016/S0140-6736(99)11060-2; Rice TT, 1996, HOSP HEALTH NETWORK, V70, P30; ROMANOW R, 2002, GLOBALIZATION CANADA; *SAV CHILDR, 2006, WHOS CHAR AFR AID NH; Schrecker T, 2004, INT J OCCUP ENV HEAL, V10, P409, DOI 10.1179/oeh.2004.10.4.409; Segouin C, 2005, INT J QUAL HEALTH C, V17, P277, DOI 10.1093/intqhc/mzi059; SIEG L, 2004, TAIPEI TIMES    1129; SINGH D, 2004, TRAD HLTH INT WORKSH; Smith RD, 2004, SOC SCI MED, V59, P2313, DOI 10.1016/j.socscimed.2004.03.021; Smith R, 2006, ELGAR ORIG REF, P164; Smith R, 2008, HEALTH ECON, V17, P1, DOI 10.1002/hec.1335; Smith R, 2006, INTERNATIONAL TRADE IN HEALTH SERVICES AND THE GATS: CURRENT ISSUES AND DEBATES, P1; Smith R, 2006, INTERNATIONAL TRADE IN HEALTH SERVICES AND THE GATS: CURRENT ISSUES AND DEBATES, P235; Smith RD, 2006, J EPIDEMIOL COMMUN H, V60, P650, DOI 10.1136/jech.2005.042648; Stilwell B, 2004, B WORLD HEALTH ORGAN, V82, P595; SUSENO U, 2001, IMPACT GLOBALIZATION; TANGCHAROENSATH.V, 2005, DEMAND SUPPLY MED SE; *UNCTAD, 2005, WORLD INV REP 2005 T; *USAID BUR AFR OFF, 2003, HLTH SECT HUM RES CR; VANDOOSSELAERE C, 2007, EUROHEALTH, V13, P1; WHO, 2006, WORLD HLTH REP; *WHO, 2005, MIGR HLTH PERS BAS M; Wibulpolprasert S, 2004, HUMAN RESOURCES HLTH, V2, P1; Yach D, 1998, AM J PUBLIC HEALTH, V88, P735, DOI 10.2105/AJPH.88.5.735; Yach D, 1998, AM J PUBLIC HEALTH, V88, P738, DOI 10.2105/AJPH.88.5.738	76	100	104	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					593	601		10.1016/S0140-6736(08)61778-X	http://dx.doi.org/10.1016/S0140-6736(08)61778-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19167053				2022-12-28	WOS:000263333600038
J	Clevers, H				Clevers, Hans			Inflammatory Bowel Disease, Stress, and the Endoplasmic Reticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LINKS		[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.				Agamyxis	Agamyxis	Dr. Clevers reports having an equity interest in Agamyxis. No potential conflict of interest relevant to this article was reported.	Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199	5	13	15	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					726	727		10.1056/NEJMcibr0809591	http://dx.doi.org/10.1056/NEJMcibr0809591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213688				2022-12-28	WOS:000263260500013
J	Leaver, M; Dominguez-Cuevas, P; Coxhead, JM; Daniel, RA; Errington, J				Leaver, M.; Dominguez-Cuevas, P.; Coxhead, J. M.; Daniel, R. A.; Errington, J.			Life without a wall or division machine in Bacillus subtilis	NATURE			English	Article							DIPHOSPHATE SYNTHASE ACTIVITY; STABLE L-FORM; ESCHERICHIA-COLI; CELL-DIVISION; PEPTIDOGLYCAN SYNTHESIS; GROWTH; SEQUENCE; GENOME; MREB; LICHENIFORMIS	The cell wall is an essential structure for virtually all bacteria, forming a tough outer shell that protects the cell from damage and osmotic lysis. It is the target of our best antibiotics. L- form strains are wall- deficient derivatives of common bacteria that have been studied for decades. However, they are difficult to generate and typically require growth for many generations on osmotically protective media with antibiotics or enzymes that kill walled forms. Despite their potential importance for understanding antibiotic resistance and pathogenesis, little is known about their basic cell biology or their means of propagation. We have developed a controllable system for generating L- forms in the highly tractable model bacterium Bacillus subtilis. Here, using genome sequencing, we identify a single point mutation that predisposes cells to grow without a wall. We show that propagation of L- forms does not require the normal FtsZ- dependent division machine but occurs by a remarkable extrusion- resolution mechanism. This novel form of propagation provides insights into how early forms of cellular life may have proliferated.	[Leaver, M.; Dominguez-Cuevas, P.; Daniel, R. A.; Errington, J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Coxhead, J. M.] Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Errington, J (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeff.errington@newcastle.ac.uk	Leaver, Mark/GLR-0282-2022; Daniel, Richard A./I-2850-2019; Errington, Jeff/G-1832-2011; Dominguez-Cuevas, Patricia/D-6608-2017	Daniel, Richard A./0000-0002-6483-5897; Errington, Jeff/0000-0002-6977-9388; Dominguez-Cuevas, Patricia/0000-0002-9343-091X	UK Biotechnology and Biological Sciences Research Council; EMBO Long-Term Fellowship	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank D. Swan for assistance with bioinformatics; A. Danchin for providing unpublished sequence data; E. J. Allan for providing the L- form strain that sparked our interest; T. Davey and V. Thompson of the Electron Microscopy Research Service of Newcastle University for technical assistance with electron microscopy; S. Gruber for help with quantitative real time PCR; J.-W. Veening and H. Murray for supplying strains and advice; and D. Claessen, K. Gerdes, H. Murray and W. Vollmer for critical reading of the manuscript. M. L. was supported by the UK Biotechnology and Biological Sciences Research Council. P.D.-C. was supported by an EMBO Long-Term Fellowship.	ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; ALLAN EJ, 1991, J APPL BACTERIOL, V70, P339, DOI 10.1111/j.1365-2672.1991.tb02946.x; ALLAN EJ, ADV APPL MI IN PRESS; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BURMEISTER HR, 1968, J BACTERIOL, V95, P1857, DOI 10.1128/JB.95.5.1857-1861.1968; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; DANIEL RA, 1993, J GEN MICROBIOL, V139, P361, DOI 10.1099/00221287-139-2-361; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; GILPIN RW, 1973, J BACTERIOL, V113, P486, DOI 10.1128/JB.113.1.486-499.1973; GILPIN RW, 1976, J BACTERIOL, V127, P1018, DOI 10.1128/JB.127.2.1018-1021.1976; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; JOLY A, 1993, J BIOL CHEM, V268, P26983; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; King J R, 1970, J Bacteriol, V102, P196; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moszer I, 2002, NUCLEIC ACIDS RES, V30, P62, DOI 10.1093/nar/30.1.62; Murray T, 1998, J BACTERIOL, V180, P4555, DOI 10.1128/JB.180.17.4555-4563.1998; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROGERS HJ, 1976, J BACTERIOL, V125, P556, DOI 10.1128/JB.125.2.556-564.1976; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; WARD JB, 1975, J BACTERIOL, V124, P668, DOI 10.1128/JB.124.2.668-678.1975; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WYRICK PB, 1973, J BACTERIOL, V116, P456, DOI 10.1128/JB.116.1.456-465.1973	35	193	195	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					849	853		10.1038/nature07742	http://dx.doi.org/10.1038/nature07742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212404				2022-12-28	WOS:000263266700038
J	Losos, JB; Ricklefs, RE				Losos, Jonathan B.; Ricklefs, Robert E.			Adaptation and diversification on islands	NATURE			English	Review							SPECIES-AREA RELATIONSHIP; ADAPTIVE RADIATION; CHARACTER DISPLACEMENT; OCEANIC ISLAND; ECOLOGICAL SPECIATION; SYMPATRIC SPECIATION; MOLECULAR EVIDENCE; TERRESTRIAL FAUNA; DARWINS FINCHES; CANARY-ISLANDS	Charles Darwin's travels on HMS Beagle taught him that islands are an important source of evidence for evolution. Because many islands are young and have relatively few species, evolutionary adaptation and species proliferation are obvious and easy to study. In addition, the geographical isolation of many islands has allowed evolution to take its own course, free of influence from other areas, resulting in unusual faunas and floras, often unlike those found anywhere else. For these reasons, island research provides valuable insights into speciation and adaptive radiation, and into the relative importance of contingency and determinism in evolutionary diversification.	[Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Harvard University; University of Missouri System; University of Missouri Saint Louis	Losos, JB (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu			National Science Foundation; National Geographic Society; Smithsonian Institution	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Smithsonian Institution(Smithsonian Institution)	For comments on drafts, we thank A. Berry, R. Gillespie, R. Glor, P. Grant, L. Harmon, C. Parent, T. Price, D. Schluter and R. Whittaker. The National Science Foundation, the National Geographic Society and the Smithsonian Institution have supported our research on island faunas. We are also grateful to numerous individuals and governmental institutions throughout the West Indies for logistical and other support in the field.	[Anonymous], NATURAL HIST MADAGAS; [Anonymous], 1861, ORIGIN SPECIES MEANS; Berry A, 2008, NATURE, V453, P1188, DOI 10.1038/4531188a; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carlquist S., 2003, TARWEEDS SILVERSWORD; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Chiba S, 2004, J EVOLUTION BIOL, V17, P131, DOI 10.1046/j.1420-9101.2004.00639.x; Conway Morris Simon, 2003, LIFES SOLUTION INEVI; Coyne JA, 2000, EVOLUTION, V54, P2166; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; Darwin Charles, 1845, J RES NATURAL HIST G; DAUGHERTY CH, 1993, TRENDS ECOL EVOL, V8, P437, DOI 10.1016/0169-5347(93)90006-B; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; DIAMOND JM, 1990, ECOLOGICAL RESTORATI, P3; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Emerson BC, 2005, EVOLUTION, V59, P586; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fryer G, 1996, ENVIRON BIOL FISH, V45, P109, DOI 10.1007/BF00005225; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Gifford ME, 2008, MOL PHYLOGENET EVOL, V49, P277, DOI 10.1016/j.ympev.2008.06.003; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Givnish Thomas J., 1997, P1; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Goldberg J, 2008, PHILOS T R SOC B, V363, P3319, DOI 10.1098/rstb.2008.0114; Gould S. J., 1989, WONDERFUL LIFE; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, THEORY ISLA IN PRESS; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Kambysellis Michael P., 1997, P475; Kirkendall LR, 2006, BIOL J LINN SOC, V89, P729, DOI 10.1111/j.1095-8312.2006.00698.x; Lack D., 1947, DARWINS FINCHES; Leigh EG, 2007, REV ECOL-TERRE VIE, V62, P105; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; LOSOS JB, THEORY ISLA IN PRESS; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; MAC ARTHUR ROBERT H., 1967; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E., 1963, ANIMAL SPECIES EVOLU; Meimberg H, 2006, MOL PHYLOGENET EVOL, V41, P566, DOI 10.1016/j.ympev.2006.05.037; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Nicholson KE, 2005, J BIOGEOGR, V32, P929, DOI 10.1111/j.1365-2699.2004.01222.x; Otte D., 1989, P482; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Rand A. S., 1969, Breviora, VNo. 319, P1; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; RICKLEFS RE, 1980, AUK, V97, P321; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHLUTER D, 1990, AM NAT, V136, P560, DOI 10.1086/285115; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shaw Kerry L., 1995, P39; SIMBERLOFF D, 1981, EVOLUTION, V35, P1206, DOI 10.1111/j.1558-5646.1981.tb04990.x; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Thorpe RS, 2008, PHILOS T R SOC B, V363, P3071, DOI 10.1098/rstb.2008.0077; WALLACE AR, 1881, ISLAND LIFE OR PHENO; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; WIENS JA, 1991, ECOLOGY, V72, P479, DOI 10.2307/2937189; Williams E.E., 1983, P326; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.1111/j.1558-5646.1959.tb02996.x; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	75	596	612	11	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					830	836		10.1038/nature07893	http://dx.doi.org/10.1038/nature07893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212401				2022-12-28	WOS:000263266700033
J	Rose, S				Rose, Steven			Darwin 200: Should scientists study race and IQ? NO: Science and society do not benefit	NATURE			English	Editorial Material									[Rose, Steven] Open Univ, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Rose, S (corresponding author), Open Univ, Milton Keynes MK7 6AA, Bucks, England.	S.P.R.Rose@open.ac.uk						JENSEN AR, 1969, HARVARD EDUC REV, V39, P1	1	30	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					786	788		10.1038/457786a	http://dx.doi.org/10.1038/457786a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406AF	19212384				2022-12-28	WOS:000263266700016
J	Blouin, C; Chopra, M; van der Hoeven, R				Blouin, Chantal; Chopra, Mickey; van der Hoeven, Ralph			Trade and Health 3 Trade and social determinants of health	LANCET			English	Article							NUTRITION TRANSITION; DEVELOPING-ECONOMIES; INCOME INEQUALITY; GLOBALIZATION; LIBERALIZATION; FOOD; POVERTY; OBESITY; MORTALITY; EPIDEMIC	The effects of trade and trade liberalisation on the social determinants of health are not well known. Here, we outline a conceptual framework of links between trade liberalisation and health outcomes, and review existing evidence for these by focusing on four key factors: income, inequality economic insecurity, and unhealthy diets. Even though trade liberalisation seems to have positive effects on economic growth, it is not sufficient to boost growth. in several countries, trade reforms have not translated into enhanced economic expansion because complementary policies are needed. Trade liberalisation and openness are associated with greater wage inequality and raised economic insecurity. Trade liberalisation has facilitated availability of highly processed, calorie-rich, nutrient-poor food in developing countries, but further research is needed to better understand the effects of trade on unhealthy diets. Policyrnakers and health professionals need to be aware that the global economy affects the health of populations and understand how risks associated with trade liberalisation can be mitigated.	[Blouin, Chantal] Carleton Univ, Ctr Trade Policy & Law, Ottawa, ON K1S 5B6, Canada; [Chopra, Mickey] S Africa Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [van der Hoeven, Ralph] Inst Social Studies, NL-2509 LS The Hague, Netherlands	Carleton University; South African Medical Research Council	Blouin, C (corresponding author), Carleton Univ, Ctr Trade Policy & Law, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	chantal_blouin@carleton.ca						AIROLA J, 2005, 1525 IZA I STUD LAB; ATTANASIO O, 2002, 9830 NBER; BENDAVID D, 1993, Q J ECON, V108, P653, DOI 10.2307/2118404; Beyer H, 1999, J DEV ECON, V59, P103, DOI 10.1016/S0304-3878(99)00007-3; Bloom DE, 2007, INT J EPIDEMIOL, V36, P498, DOI 10.1093/ije/dym079; BLOUIN C, 2007, 4 U OTT I POP HLTH; BOIX C, 2002, WORKSH GLOB EG RED S; Bolling C., 2001, FoodReview, V24, P23; BOURGUIGNON F, 2003, E ASIA INTEGRATES TR; Burgoon B, 2001, INT ORGAN, V55, P509, DOI 10.1162/00208180152507542; Cassels S, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-10; Chaloupka F, 1996, 5543 NBER; Chaloupka F, 1998, EC TOBACCO CONTROL O; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Chopra M, 2002, GLOBALIZATION DIETS, P1; Cline W.R., 2004, TRADE POLICY GLOBAL; Coitinho D, 2002, PUBLIC HEALTH NUTR, V5, P263, DOI 10.1079/PHN2001302; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cornia G. A, 2004, UNDERSTING GLOBAL, P169; Cornia GA, 2001, B WORLD HEALTH ORGAN, V79, P834; Cornia GA, GLOBALISATION HLTH I; Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710; DOLLAR D, 1992, ECON DEV CULT CHANGE, V40, P523, DOI 10.1086/451959; DOLLAR D, 2001, 2199 WORLD BANK; Evans M, 2001, B WORLD HEALTH ORGAN, V79, P856; FAO, 2004, STAT AGR COMM MARK 2; Feachem RGA, 2001, BRIT MED J, V323, P504, DOI 10.1136/bmj.323.7311.504; Garrett G, 1998, INT ORGAN, V52, P787, DOI 10.1162/002081898550752; GHOSE AK, 2003, JOBS INCOMES GLOBALI; Gunter BG, 2004, INT LABOUR REV, V143, P7; Guo XG, 1999, J NUTR, V129, P994, DOI 10.1093/jn/129.5.994; Harrison A, 1999, J DEV ECON, V59, P125, DOI 10.1016/S0304-3878(99)00008-5; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; Hawkes C, 2006, GLOBAL HLTH, V2(, P1; Hays JC, 2005, INT ORGAN, V59, P473, DOI 10.1017/S0020818305050150; HOEKMAN B, 2005, 3676 WORLD BANK; Hughes RG, 2005, ASIA PAC J CLIN NUTR, V14, P298; Kennedy G., 2004, FAO Food and Nutrition Paper, P1; Kose M.A., 2003, 0350 IMF; Labonte R, 2007, HLTH EQUITABLE GLOBA; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-5; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; MAMOON D, 2005, ED BIAS TRADE LIBERA; Marmot M, 2000, MORTALITY CRISIS TRA, P127; MILANOVIC B, 2005, 11046 NBER; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; Nestle M, 2006, NEW ENGL J MED, V354, P2527, DOI 10.1056/NEJMp068014; Ocampo JA, 1998, ECON J, V108, P1523, DOI 10.1111/1468-0297.00359; PAVCNIK N, 2002, 2982 WORLD BANK; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2006, FOOD POLICY, V31, P554, DOI 10.1016/j.foodpol.2006.02.008; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Ravallion M, 2006, WORLD DEV, V34, P1374, DOI 10.1016/j.worlddev.2005.10.015; Reardon T., 2004, Development Policy Review, V22, P515, DOI 10.1111/j.1467-7679.2004.00263.x; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; REGMI A, PROCESSED FOOD TRADE; Robertson R, 2000, WORLD ECON, V23, P827, DOI 10.1111/1467-9701.00305; RODRIGUEZ F, 2001, MACROECONOMICS ANN 2, P261; Rodrik D., 1999, 24 OV DEV COUNC; RODRIK D, 1998, 1789 CEPR; Rodrik Dani., 1997, HAS GLOBALIZATION GO; SACHS JD, 1995, BROOKINGS PAP ECO AC, P1; Sawaya A. L., 2004, 83 FAO UN, P253; Scheve K, 2004, AM J POLIT SCI, V48, P662; SCHMIDHUBER J, 2004, J AGR DEV EC, V1, P272; SCHULTZ JT, 2004, 83 FAO UN, P195; Shkolnikov Vladimir M., 2000, MORTALITY CRISIS TRA, P253; SMITH WJ, 2003, SOCIAL PROTECTION DI; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; TAYLOR A, 2001, TOBACCO CONTROL DEV; Torres R., 2001, SOCIALLY SUSTAINABLE; *UN, 2008, HIGH LEV TASK FORC G; van Ginneken W, 2003, INT LABOUR REV, V142, P277; VANDERHOEVEN R, EXTERNAL OPENNESS EM; WHO, 2003, DIET NUTR PREVENTION, V916; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Wilkinson Richard G, 2000, MIND GAP HIERARCHIES; Winters LA, 2006, AUST ECON REV, V39, P347, DOI 10.1111/j.1467-8462.2006.00425.x; Winters LA, 2004, J ECON LIT, V42, P72, DOI 10.1257/002205104773558056; Winters LA, 2004, ECON J, V114, pF4, DOI 10.1111/j.0013-0133.2004.00185.x; World Bank, 2005, EC GROWTH 1990S LEAR; World Commission on the Social Dimension of Globalization, 2004, FAIR GLOB CREAT OPP; [No title captured]	87	123	126	3	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					502	507		10.1016/S0140-6736(08)61777-8	http://dx.doi.org/10.1016/S0140-6736(08)61777-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19167058				2022-12-28	WOS:000263132800033
J	Stevenson, PA				Stevenson, P. A.			ECOLOGY The Key to Pandora's Box	SCIENCE			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; LOCUST; PHASE; BEHAVIOR; OCTOPAMINE; AGGRESSION; MODULATION; DROSOPHILA		[Stevenson, P. A.] Univ Leipzig, Inst Biol 2, Fac Biosci Psychol & Pharmacol, D-04103 Leipzig, Germany	Leipzig University	Stevenson, PA (corresponding author), Univ Leipzig, Inst Biol 2, Fac Biosci Psychol & Pharmacol, Talstr 33, D-04103 Leipzig, Germany.	stevenson@rz.uni-leipzig.de	Stevenson, Paul A/A-2048-2010					Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Edwards DH, 2002, BRAIN BEHAV EVOLUT, V60, P360, DOI 10.1159/000067789; HEN R, 1992, TRENDS PHARMACOL SCI, V13, P160, DOI 10.1016/0165-6147(92)90054-A; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; TYRER NM, 1984, J COMP NEUROL, V227, P313, DOI 10.1002/cne.902270303; Wicher Dieter, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P304, DOI 10.2174/187153007782794290	17	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					594	595		10.1126/science.1169280	http://dx.doi.org/10.1126/science.1169280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	400JB	19179520				2022-12-28	WOS:000262862800031
J	Duff, P; Barth, WH; Post, MD; Harris, NL; Riley, LE				Duff, Patrick; Barth, William H., Jr.; Post, Miriam D.; Harris, Nancy Lee; Riley, Laura E.			A Pregnant Woman with Fever after a Trip to Africa Systemic congenital cytomegalovirus infection and cytomegalovirus placentitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRENATAL-DIAGNOSIS; WOMEN; IMMUNITY; DISEASE; FETAL		[Duff, Patrick] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA; [Barth, William H., Jr.] Massachusetts Gen Hosp, Div Maternal Fetal Med, Boston, MA 02114 USA; [Post, Miriam D.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Barth, William H., Jr.] Harvard Univ, Sch Med, Dept Obstet, Boston, MA USA; [Barth, William H., Jr.] Harvard Univ, Sch Med, Dept Gynecol, Boston, MA USA; [Barth, William H., Jr.] Harvard Univ, Sch Med, Dept Reprod Biol, Boston, MA USA; [Post, Miriam D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Duff, P (corresponding author), Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA.							Azam AZ, 2001, OBSTET GYNECOL, V97, P443, DOI 10.1016/S0029-7844(00)01140-6; Baergen R.N, 2005, MANUAL BENIRSCHKE KA; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; DONNER C, 1993, OBSTET GYNECOL, V82, P481; Duff P, 2005, NEW ENGL J MED, V353, P1402, DOI 10.1056/NEJMe058172; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; Gilbert-Barness E., 2007, POTTERS PATHOLOGY FE, V2nd edn; Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039; Hammer SM, 2005, NEW ENGL J MED, V353, P1702, DOI 10.1056/NEJMcp051203; Hassan J, 2007, CLIN EXP IMMUNOL, V149, P205, DOI 10.1111/j.1365-2249.2007.03454.x; La Torre R, 2006, CLIN INFECT DIS, V43, P994, DOI 10.1086/507634; Lipitz S, 1997, OBSTET GYNECOL, V89, P763, DOI 10.1016/S0029-7844(97)00084-7; Markenson GR, 1998, SEMIN PERINATOL, V22, P309, DOI 10.1016/S0146-0005(98)80019-0; Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337	15	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					508	516		10.1056/NEJMcpc0807819	http://dx.doi.org/10.1056/NEJMcpc0807819			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179319				2022-12-28	WOS:000262812400013
J	Ping, PP				Ping, Peipei			Getting to the Heart of Proteomics.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ping, Peipei] Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ping, PP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NHLBI, Program Project Myocardial Ischemia Injury & Prot, Los Angeles, CA 90095 USA.			Ping, Peipei/0000-0003-3583-3881	NHLBI NIH HHS [R37 HL063901, P01 HL080111-04, P01 HL080111, R01 HL101228] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063901, R01HL101228, P01HL080111] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ping PP, 1997, CIRC RES, V81, P404, DOI 10.1161/01.RES.81.3.404; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; YTREHUS K, 1994, AM J PHYSIOL, V266, pH1145, DOI 10.1152/ajpheart.1994.266.3.H1145	5	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					532	534		10.1056/NEJMcibr0808487	http://dx.doi.org/10.1056/NEJMcibr0808487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179323	Green Accepted			2022-12-28	WOS:000262812400018
J	Yuan, HQ; Singleton, J; Balakirev, FF; Baily, SA; Chen, GF; Luo, JL; Wang, NL				Yuan, H. Q.; Singleton, J.; Balakirev, F. F.; Baily, S. A.; Chen, G. F.; Luo, J. L.; Wang, N. L.			Nearly isotropic superconductivity in (Ba,K)Fe2As2	NATURE			English	Article							UPPER CRITICAL-FIELD; FERMI-SURFACE	Superconductivity was recently observed(1-7) in iron- arsenic- based compounds with a superconducting transition temperature (T-c) as high as 56 K, naturally raising comparisons with the high-T-c copper oxides. The copper oxides have layered crystal structures with quasi- two- dimensional electronic properties, which led to speculation that reduced dimensionality ( that is, extreme anisotropy) is a necessary prerequisite for superconductivity at temperatures above 40 K ( refs 8, 9). Early work on the iron- arsenic compounds seemed to support this view(7,10). Here we report measurements of the electrical resistivity in single crystals of (Ba,K)Fe2As2 in a magnetic field up to 60 T. We find that the superconducting properties are in fact quite isotropic, being rather independent of the direction of the applied magnetic fields at low temperature. Such behaviour is strikingly different from all previously known layered superconductors(9,11), and indicates that reduced dimensionality in these compounds is not a prerequisite for 'high- temperature' superconductivity. We suggest that this situation arises because of the underlying electronic structure of the iron- arsenic compounds, which appears to be much more three dimensional than that of the copper oxides. Extrapolations of low- field single- crystal data incorrectly suggest a high anisotropy and a greatly exaggerated zero- temperature upper critical field.	[Yuan, H. Q.] Zhejiang Univ, Dept Phys, Hangzhou 310027, Peoples R China; [Yuan, H. Q.; Singleton, J.; Balakirev, F. F.; Baily, S. A.] Los Alamos Natl Lab, NHMFL, MS E536, Los Alamos, NM 87545 USA; [Chen, G. F.; Luo, J. L.; Wang, N. L.] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 10080, Peoples R China	Zhejiang University; United States Department of Energy (DOE); Los Alamos National Laboratory; Chinese Academy of Sciences	Yuan, HQ (corresponding author), Zhejiang Univ, Dept Phys, Hangzhou 310027, Peoples R China.	hqyuan@zju.edu.cn	Balakirev, Fedor/AAY-2860-2020; Balakirev, Fedor/AAS-6827-2020; Wang, Nan/GRY-3150-2022	Balakirev, Fedor/0000-0003-4887-5140; Balakirev, Fedor/0000-0003-4887-5140; 	DOE BES program 'Science in 100T'; NHMFL-UCGP; National Science Foundation of China; National Basic Research Program of China [973]; Chinese Academy of Sciences; PCSIRT; Ministry of Education of China	DOE BES program 'Science in 100T'(United States Department of Energy (DOE)); NHMFL-UCGP; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ministry of Education of China(Ministry of Education, China)	We acknowledge S. Riggs and J. Betts for experimental assistance and F. C. Zhang, P. Goddard and S. Blundell for discussions. Work at NHMFL- LANL is performed under the auspices of the National Science Foundation, Department of Energy and State of Florida. The experiments reported here are supported by the DOE BES program 'Science in 100T', the NHMFL-UCGP, the National Science Foundation of China, the National Basic Research Program of China (973 Program) and the Chinese Academy of Sciences. H.Q.Y. is also supported by PCSIRT of the Ministry of Education of China.	ALTARAWNEH M, 2008, DETERMINATION ANISOT; Anderson P. W., 1997, THEORY SUPERCONDUCTI; Ando Y, 1999, PHYS REV B, V60, P12475, DOI 10.1103/PhysRevB.60.12475; Chen GF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247002; CHEN GF, 2008, TRANSPORT ANISOTROPY; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Gurevich A, 2007, PHYSICA C, V456, P160, DOI 10.1016/j.physc.2007.01.008; HUANG O, 2008, MAGNETIC ORDER BAFE2; Hunte F, 2008, NATURE, V453, P903, DOI 10.1038/nature07058; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Li PC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.172508; Liu C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.177005; Nam MS, 1999, J PHYS-CONDENS MAT, V11, pL477, DOI 10.1088/0953-8984/11/43/102; Ni N, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014507; Ren ZA, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/57002; RIGGS SC, 2008, LOG T DIVERGENCE INS; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Sebastian SE, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/42/422203; Shrieffer J. R., 2006, HDB HIGH TEMPERATURE; Singleton J, 2002, CONTEMP PHYS, V43, P63, DOI 10.1080/00107510110108681; Singleton J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027004; Vedeneev SI, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014528; Wang C, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/67006	27	438	444	11	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					565	568		10.1038/nature07676	http://dx.doi.org/10.1038/nature07676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177125				2022-12-28	WOS:000262852200037
J	Pfisterer, M; Buser, P; Rickli, H; Gutmann, M; Erne, P; Rickenbacher, P; Vuillomenet, A; Jeker, U; Dubach, P; Beer, H; Yoon, SI; Suter, T; Osterhues, HH; Schieber, MM; Hilti, P; Schindler, R; Brunner-La Rocca, HP				Pfisterer, Matthias; Buser, Peter; Rickli, Hans; Gutmann, Marc; Erne, Paul; Rickenbacher, Peter; Vuillomenet, Andre; Jeker, Urs; Dubach, Paul; Beer, Hansjerg; Yoon, Se-Il; Suter, Thomas; Osterhues, Hans H.; Schieber, Michael M.; Hilti, Patrick; Schindler, Ruth; Brunner-La Rocca, Hans-Peter		TIME-CHF Investigators	BNP-Guided vs Symptom-Guided Heart Failure Therapy The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATRIURETIC PEPTIDE; EJECTION FRACTION; MANAGEMENT; PROGNOSIS; SURVIVAL; QUESTIONNAIRE; DIAGNOSIS; UPDATE; TRENDS	Context It is uncertain whether intensified heart failure therapy guided by N- terminal brain natriuretic peptide ( BNP) is superior to symptom- guided therapy. Objective To compare 18- month outcomes of N- terminal BNP - guided vs symptomguided heart failure therapy. Design, Setting, and Patients Randomized controlled multicenter Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure ( TIMECHF) of 499 patients aged 60 years or older with systolic heart failure ( ejection fraction <= 45%), New York Heart Association ( NYHA) class of II or greater, prior hospitalization for heart failure within 1 year, and N- terminal BNP level of 2 or more times the upper limit of normal. The study had an 18- month follow- up and it was conducted at 15 outpatient centers in Switzerland and Germany between January 2003 and June 2008. Intervention Uptitration of guideline- based treatments to reduce symptoms to NYHA class of II or less ( symptom- guided therapy) and BNP level of 2 times or less the upper limit of normal and symptoms to NYHA class of II or less ( BNP- guided therapy). Main Outcome Measures Primary outcomes were 18- month survival free of all- cause hospitalizations and quality of life as assessed by structured validated questionnaires. Results Heart failure therapy guided by N- terminal BNP and symptom- guided therapy resulted in similar rates of survival free of all- cause hospitalizations ( 41% vs 40%, respectively; hazard ratio [ HR], 0.91 [ 95% CI, 0.72- 1.14]; P=. 39). Patients' quality- of-life metrics improved over 18 months of follow- up but these improvements were similar in both the N- terminal BNP - guided and symptom- guided strategies. Compared with the symptom- guided group, survival free of hospitalization for heart failure, a secondary end point, was higher among those in the N- terminal BNP - guided group ( 72% vs 62%, respectively; HR, 0.68 [ 95% CI, 0.50- 0.92]; P=. 01). Heart failure therapy guided by N- terminal BNP improved outcomes in patients aged 60 to 75 years but not in those aged 75 years or older ( P <. 02 for interaction). Conclusion Heart failure therapy guided by N- terminal BNP did not improve overall clinical outcomes or quality of life compared with symptom- guided treatment. Trial Registration isrctn. org Identifier: ISRCTN43596477.	[Pfisterer, Matthias; Buser, Peter; Schindler, Ruth; Brunner-La Rocca, Hans-Peter] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Rickli, Hans] Kantonsspital, Dept Cardiol, St Gallen, Switzerland; [Gutmann, Marc] Univ Hosp Liestal, Dept Internal Med, Liestal, Switzerland; [Erne, Paul] Kantonsspital, Dept Internal Med, Luzern, Switzerland; [Rickenbacher, Peter] Univ Hosp Bruderholz, Dept Internal Med, Bruderholz, Switzerland; [Vuillomenet, Andre] Kantonsspital Aarau, Dept Internal Med, Aarau, Switzerland; [Jeker, Urs] Kantonales Spital Wolhusen, Dept Internal Med, Sursee, Switzerland; [Dubach, Paul] Kantonsspital Chur, Dept Internal Med, Chur, Switzerland; [Beer, Hansjerg] Kantonsspital, Dept Internal Med, Baden, Switzerland; [Yoon, Se-Il] Kantonales Spital Sursee, Dept Internal Med, Sursee, Switzerland; [Suter, Thomas] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Osterhues, Hans H.] Kreiskrankenhaus Lorrach, Dept Internal Med, Lorrach, Germany; [Schieber, Michael M.] Robert Bosch Krankenhaus, Dept Cardiol, Stuttgart, Germany; [Hilti, Patrick] Kantonsspital Solothurn, Dept Internal Med, Solothurn, Switzerland	University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); University of Bern; University Hospital of Bern; Bosch; Robert Bosch Krankenhaus	Pfisterer, M (corresponding author), Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland.	pfisterer@email.ch	Brunner-La Rocca, Hans-Peter/AAF-7330-2021	Beer, Jurg Hans/0000-0002-7199-0406	Horten Research Foundation; AstraZeneca Pharma; Novartis Pharma; Menarini Pharma; Pfizer Pharma; Servier; Roche Diagnostics; Roche Pharma; Merck Pharma	Horten Research Foundation; AstraZeneca Pharma(AstraZeneca); Novartis Pharma; Menarini Pharma(Menarini Group); Pfizer Pharma(Pfizer); Servier(Servier); Roche Diagnostics; Roche Pharma; Merck Pharma	This study was sponsored by the Horten Research Foundation (Lugano, Switzerland; >55% of the study's budget), as well as by smaller unrestricted grants from AstraZeneca Pharma, Novartis Pharma, Menarini Pharma, Pfizer Pharma, Servier, Roche Diagnostics, Roche Pharma, and Merck Pharma.	Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Brunner-La Rocca HP, 2006, AM HEART J, V151, P949, DOI 10.1016/j.ahj.2005.10.022; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Deedwania PC, 2004, EUR HEART J, V25, P1300, DOI 10.1016/j.ehj.2004.05.022; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; HALL C, 1994, CIRCULATION, V89, P1934, DOI 10.1161/01.CIR.89.5.1934; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hjalmarson A, 1999, LANCET, V353, P2001; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Khan SQ, 2008, J AM COLL CARDIOL, V51, P1857, DOI 10.1016/j.jacc.2008.01.041; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kosiborod M, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.019; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Muller-Nordhorn J, 2004, HEART, V90, P523, DOI 10.1136/hrt.2003.013995; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; RECTOR TS, 1993, AM J CARDIOL, V71, P1106, DOI 10.1016/0002-9149(93)90582-W; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; RICHARDS AM, 2008, EUR SOC CARD HEART F; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Shah MR, 2006, CIRCULATION, V114, P528; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	31	440	458	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					383	392		10.1001/jama.2009.2	http://dx.doi.org/10.1001/jama.2009.2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176440	Bronze			2022-12-28	WOS:000262777200018
J	Yang, JJ; Cheng, C; Yang, WJ; Pei, DQ; Cao, XY; Fan, YP; Pounds, SB; Neale, G; Trevino, LR; French, D; Campana, D; Downing, JR; Evans, WE; Pui, CH; Devidas, M; Bowman, WP; Camitta, BM; Willman, CL; Davies, SM; Borowitz, MJ; Carroll, WL; Hunger, SP; Relling, MV				Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Devidas, Meenakshi; Bowman, W. P.; Camitta, Bruce M.; Willman, Cheryl L.; Davies, Stella M.; Borowitz, Michael J.; Carroll, William L.; Hunger, Stephen P.; Relling, Mary V.			Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; CHILDRENS ONCOLOGY GROUP; CORONARY-ARTERY-DISEASE; P-GLYCOPROTEIN; RISK; METHOTREXATE; EXPRESSION; INTERLEUKIN-15; POLYMORPHISMS; IDENTIFICATION	Context Pediatric acute lymphoblastic leukemia ( ALL) is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable unexplained interindividual variability exists in treatment response. Objectives To assess the contribution of inherited genetic variation to therapy response and to identify germline single- nucleotide polymorphisms ( SNPs) associated with risk of minimal residual disease ( MRD) after remission induction chemotherapy. Design, Setting, and Patients Genome- wide interrogation of 476 796 germline SNPs to identify genotypes that were associated with MRD in 2 independent cohorts of children with newly diagnosed ALL: 318 patients in St Jude Total Therapy protocols XIIIB and XV and 169 patients in Children's Oncology Group trial P9906. Patients were enrolled between 1994 and 2006 and last follow- up was in 2006. Main Outcome Measures Minimal residual disease at the end of induction therapy, measured by flow cytometry. Results There were 102 SNPs associated with MRD in both cohorts ( median odds ratio, 2.18; P <=. 0125), including 5 SNPs in the interleukin 15 ( IL15) gene. Of these 102 SNPs, 21 were also associated with hematologic relapse ( P <. 05). Of 102 SNPs, 21 were also associated with antileukemic drug disposition, generally linking MRD eradication with greater drug exposure. In total, 63 of 102 SNPs were associated with early response, relapse, or drug disposition. Conclusion Host genetic variations are associated with treatment response for childhood ALL, with polymorphisms related to leukemia cell biology and host drug disposition associated with lower risk of residual disease.	[Yang, Jun J.; Cheng, Cheng; Yang, Wenjian; Pei, Deqing; Cao, Xueyuan; Fan, Yiping; Pounds, Stanley B.; Neale, Geoffrey; Trevino, Lisa R.; French, Deborah; Campana, Dario; Downing, James R.; Evans, William E.; Pui, Ching-Hon; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Devidas, Meenakshi] Univ Florida, Gainesville, FL USA; [Bowman, W. P.] Cook Childrens Med Ctr, Ft Worth, TX USA; [Camitta, Bruce M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Davies, Stella M.] Cincinnati Childrens Hosp & Med Ctr, Cincinnati, OH USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Carroll, William L.] NYU Med Ctr, New York, NY 10016 USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; State University System of Florida; University of Florida; Cook Children's Medical Center; Medical College of Wisconsin; University of New Mexico; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Medicine; New York University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl,MS313, Memphis, TN 38105 USA.	mary.relling@stjude.org	Pounds, Stanley B/N-2480-2018; Cheng, Cheng/N-8075-2018; Yang, Jun/B-6976-2008; Yang, Jun J./ABG-5646-2020; Relling, Mary/N-5032-2018; Devidas, Meenakshi/H-1170-2019; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012; Downing, James R./N-8102-2018	Pounds, Stanley B/0000-0002-9167-2114; Yang, Jun/0000-0002-0770-9659; Yang, Jun J./0000-0002-0770-9659; Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; 	National Institutes of Health [CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139]; National Institute of General Medical Sciences; Pharmacogenetics Research Network and Database [U01 GM61393, U01 GM61374]; NATIONAL CANCER INSTITUTE [R37CA036401, R01CA093552, P30CA021765, U10CA029139, U10CA098543, R29CA051001, R01CA051001, R01CA078224, R01CA060419, U10CA098413, R01CA086011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants CA 093552-02, CA 51001, CA 78224, CA 21765, CA R3736401, CA 60419, CA 086011, CA 98543, CA 29139, and National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Pharmacogenetics Research Network and Database grants U01 GM61393 and U01 GM61374 (http://www.pharmgkb.org) from the National Cancer Institute and NIGMS; by the American Lebanese Syrian Associated Charities; and by CureSearch.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Bleyer WA, 1997, J PEDIAT HEMATOL ONC, V19, P530, DOI 10.1097/00043426-199711000-00008; Borowitz MJ, 2003, LEUKEMIA, V17, P1566, DOI 10.1038/sj.leu.2403001; Bostrom BC, 2003, J PEDIAT HEMATOL ONC, V25, P114, DOI 10.1097/00043426-200302000-00006; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Carroll WL, 2006, PEDIATR BLOOD CANCER, V46, P570, DOI 10.1002/pbc.20722; Carroll WL, 2003, JAMA-J AM MED ASSOC, V290, P2061, DOI 10.1001/jama.290.15.2061; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Cheng C, 2004, STAT APPL GENET MOL, V3, P36; CONTER V, 1995, J CLIN ONCOL, V13, P2497, DOI 10.1200/JCO.1995.13.10.2497; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Davies SM, 2008, BLOOD, V111, P2984, DOI 10.1182/blood-2007-09-114082; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleury Isabelle, 2004, Am J Pharmacogenomics, V4, P331, DOI 10.2165/00129785-200404050-00006; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kishi S, 2004, BLOOD, V103, P67, DOI 10.1182/blood-2003-06-2105; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEU BL, 1995, CANCER CHEMOTH PHARM, V35, P432, DOI 10.1007/s002800050258; LEWIS AD, 1992, CANCER RES, V52, P4379; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Plasschaert SLA, 2004, CLIN PHARMACOL THER, V76, P220, DOI 10.1016/j.clpt.2004.05.007; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Relling MV, 1999, BLOOD, V93, P2817; RELLING MV, 1994, MOL PHARMACOL, V45, P352; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Sorich MJ, 2008, PLOS MED, V5, P646, DOI 10.1371/journal.pmed.0050083; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Szczepanski T, 2001, LANCET ONCOL, V2, P409, DOI 10.1016/S1470-2045(00)00418-6; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; van Asperen J, 2000, DRUG METAB DISPOS, V28, P264; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yates CR, 2003, PHARM RES-DORDR, V20, P1794, DOI 10.1023/B:PHAM.0000003377.39548.f6; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896; Zhou JB, 2007, BLOOD, V110, P1607, DOI 10.1182/blood-2006-09-045369	65	171	177	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					393	403		10.1001/jama.2009.7	http://dx.doi.org/10.1001/jama.2009.7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176441	Green Accepted			2022-12-28	WOS:000262777200019
J	Bartel, DP				Bartel, David P.			MicroRNAs: Target Recognition and Regulatory Functions	CELL			English	Review							UTR SEQUENCE MOTIF; POSTTRANSCRIPTIONAL REGULATION; MESSENGER-RNAS; C-ELEGANS; GENE-EXPRESSION; BINDING-SITES; K-BOX; LET-7; ACTIVATION; DIFFERENTIATION	MicroRNAs (miRNAs) are endogenous 23 nt RNAs that play important gene-regulatory roles in animals and plants by pairing to the mRNAs of protein-coding genes to direct their posttranscriptional repression. This review outlines the current understanding of miRNA target recognition in animals and discusses the widespread impact of miRNAs on both the expression and evolution of protein-coding genes.	[Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu	Huang, H/E-9490-2010; li, ran/K-1896-2012; Jackson, Benjamin L/C-4297-2012		National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank D. Baek, C. Burge, K. Farh, R. Friedman, A Grimson, B. Lewis, L. Lim, and other colleagues for their input and stimulating discussions, and members of the lab for helpful comments on this manuscript. Work on miRNAs in my lab is supported by the National Institutes of Health.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	112	15194	16054	85	2621	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					215	233		10.1016/j.cell.2009.01.002	http://dx.doi.org/10.1016/j.cell.2009.01.002			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167326	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000262648800012
J	D'Angelo, MA; Raices, M; Panowski, SH; Hetzer, MW				D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.			Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells	CELL			English	Article							OXIDATIVE STRESS RESISTANCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; GERM-LINE; ENVELOPE; DISEASE; PROTEIN; CYCLE; ORGANIZATION; LONGEVITY	In dividing cells, nuclear pore complexes (NPCs) disassemble during mitosis and reassemble into the newly forming nuclei. However, the fate of nuclear pores in postmitotic cells is unknown. Here, we show that NPCs, unlike other nuclear structures, do not turn over in differentiated cells. While a subset of NPC components, like Nup153 and Nup50, are continuously exchanged, scaffold nucleoporins, like the Nup107/160 complex, are extremely long-lived and remain incorporated in the nuclear membrane during the entire cellular life span. Besides the lack of nucleoporin expression and NPC turnover, we discovered an age-related deterioration of NPCs, leading to an increase in nuclear permeability and the leaking of cytoplasmic proteins into the nucleus. Our finding that nuclear "leakiness'' is dramatically accelerated during aging and that a subset of nucleoporins is oxidatively damaged in old cells suggests that the accumulation of damage at the NPC might be a crucial aging event.	[D'Angelo, Maximiliano A.; Raices, Marcela; Panowski, Siler H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		D'Angelo, Maximiliano/0000-0001-7025-0142	NIH [R01 GM057438 .]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dillin, P. Askjaer, B. Burke, J. Ellenberg, R. Foisner, M. Hengartner, Y. Gruenbaum, U. Kutay, and E. Schirmer for reagents; M. Downes for mammalian Q-PCR assays; J. Jepsen for isolation of rat brains; and the Hetzer lab, C. Hetzer-Egger, T. Hunter, W. Eckhart, F. Gage, and S. Pfaff for critical discussion and reading of the manuscript. This work was funded by the NIH R01 GM057438 grant.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; LOVTRUPREIN H, 1966, J CELL BIOL, V30, P405, DOI 10.1083/jcb.30.2.405; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Oeda T, 2001, HUM MOL GENET, V10, P2013, DOI 10.1093/hmg/10.19.2013; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Woulfe JM, 2007, NEUROPATH APPL NEURO, V33, P2, DOI 10.1111/j.1365-2990.2006.00819.x; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	44	363	369	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					284	295		10.1016/j.cell.2008.11.037	http://dx.doi.org/10.1016/j.cell.2008.11.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167330	Green Accepted, Bronze			2022-12-28	WOS:000262648800017
J	Das, A; Cherian, A; Chemmanam, T				Das, Abhijit; Cherian, Ajith; Chemmanam, Thomas			A fisherman who could not row	LANCET			English	Editorial Material									[Das, Abhijit; Cherian, Ajith; Chemmanam, Thomas] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India; [Chemmanam, Thomas] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Royal Melbourne Hospital	Das, A (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India.	abhijit.neuro@gmail.com	Cherian, Ajith/AAZ-1778-2021; Das, Abhijit/AAQ-1729-2020	Cherian, Ajith/0000-0001-8743-9793; 				Heatwole CR, 2007, NEUROTHERAPEUTICS, V4, P238, DOI 10.1016/j.nurt.2007.01.012; Miller TM, 2008, MUSCLE NERVE, V37, P293, DOI 10.1002/mus.20923; ROPPER AH, 2005, ADAMS VICTORS PRINCI, P1280; Sansone V, 2000, NEUROMUSCULAR DISORD, V10, P165, DOI 10.1016/S0960-8966(99)00097-8; VENABLES GS, 1978, J NEUROL NEUROSUR PS, V41, P1013, DOI 10.1136/jnnp.41.11.1013	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					432	432		10.1016/S0140-6736(09)60138-0	http://dx.doi.org/10.1016/S0140-6736(09)60138-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19186275				2022-12-28	WOS:000262912100035
J	Gao, P; Tchernyshyov, I; Chang, TC; Lee, YS; Kita, K; Ochi, T; Zeller, KI; De Marzo, AM; Van Eyk, JE; Mendell, JT; Dang, CV				Gao, Ping; Tchernyshyov, Irina; Chang, Tsung-Cheng; Lee, Yun-Sil; Kita, Kayoko; Ochi, Takafumi; Zeller, Karen I.; De Marzo, Angelo M.; Van Eyk, Jennifer E.; Mendell, Joshua T.; Dang, Chi V.			c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism	NATURE			English	Article							TUMOR-CELLS; PROTEIN; GROWTH; INHIBITION; APOPTOSIS; DATABASE; GENES; ACID	Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen(1,2). Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate(3). Glutamine, which is highly transported into proliferating cells(4,5), is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood(1,6). Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs(7,8) and stimulate cell proliferation(9), transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism(10). Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis(11). The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.	[Gao, Ping; Zeller, Karen I.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Tchernyshyov, Irina; Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Chang, Tsung-Cheng; Lee, Yun-Sil; Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Kita, Kayoko; Ochi, Takafumi] Teikyo Univ, Fac Pharmaceut Sci, Toxicol Lab, Kanagawa 2290195, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Teikyo University	Dang, CV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	pgao2@jhmi.edu; cvdang@jhmi.edu	Dang, Chi/Y-3375-2019; Chang, Tsung-Cheng/C-2761-2008; Zhang, Huafeng/A-7188-2012	Chang, Tsung-Cheng/0000-0003-4706-0468; Dang, Chi/0000-0002-4031-2522	NIH [NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236]; Rita Allen Foundation; Leukemia and Lymphoma Society; Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA051497, R01CA120185, R37CA051497, R01CA057341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors want to thank L. Blosser and A. Tam for their help in flow cytometry analysis, and H. Y. Zhang for her help with statistical analysis. This work was partially supported by NIH Awards NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236, Rita Allen Foundation, Leukemia and Lymphoma Society, and Sol Goldman Center for Pancreatic Cancer Research.	Anderson TJ, 2007, PROTEOMICS, V7, P1197, DOI 10.1002/pmic.200600374; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gallagher FA, 2008, MAGN RESON MED, V60, P253, DOI 10.1002/mrm.21650; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; MATSUNO T, 1986, J CELL PHYSIOL, V128, P397, DOI 10.1002/jcp.1041280308; Nikiforov MA, 2000, ONCOGENE, V19, P4828, DOI 10.1038/sj.onc.1203880; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Turner A, 2003, BIOCHEM J, V370, P403, DOI 10.1042/BJ20021360; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	30	1481	1548	6	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					762	U100		10.1038/nature07823	http://dx.doi.org/10.1038/nature07823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219026	Green Accepted			2022-12-28	WOS:000265193600041
J	Tateishi, K; Okada, Y; Kallin, EM; Zhang, Y				Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi			Role of Jhdm2a in regulating metabolic gene expression and obesity resistance	NATURE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL UNCOUPLING PROTEIN; ENERGY-BALANCE; BETA; THERMOGENESIS; TRANSCRIPTION; METHYLATION; ELEMENTS; MUSCLE; MICE	Recent studies indicate that the methylation state of histones can be dynamically regulated by histone methyltransferases and demethylases(1,2). The H3K9-specific demethylase Jhdm2a (also known as Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene activation and male germ cell development(3,4). Through disruption of the Jhdm2a gene in mice, here we demonstrate that Jhdm2a is critically important in regulating the expression of metabolic genes. The loss of Jhdm2a function results in obesity and hyperlipidemia in mice. We provide evidence that the loss of Jhdm2a function disrupts beta-adrenergic-stimulated glycerol release and oxygen consumption in brown fat, and decreases fat oxidation and glycerol release in skeletal muscles. We show that Jhdm2a expression is induced by beta-adrenergic stimulation, and that Jhdm2a directly regulates peroxisome proliferator-activated receptor alpha (Ppara) and Ucp1 expression. Furthermore, we demonstrate that beta-adrenergic activation-induced binding of Jhdm2a to the PPAR responsive element (PPRE) of the Ucp1 gene not only decreases levels of H3K9me2 (dimethylation of lysine 9 of histone H3) at the PPRE, but also facilitates the recruitment of Ppar gamma and Rxr alpha and their co-activators Pgc1 alpha (also known as Ppargc1a), CBP/p300 (Crebbp) and Src1 (Ncoa1) to the PPRE. Our studies thus demonstrate an essential role for Jhdm2a in regulating metabolic gene expression and normal weight control in mice.	[Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Tateishi, Keisuke; Okada, Yuki; Kallin, Eric M.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	UNC Clinical Nutrition Research Unit [DK56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	UNC Clinical Nutrition Research Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. M. Spiegelman for the HIB1B cells, L. Xia for construction of the targeting vector, K. E. Gardner for critical reading of the manuscript, D. Pump and K. Hua (UNC Clinical Nutrition Research Unit, DK56350) for calorimetry and MRI, and N. Takahashi for helpful comments. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bedu E, 2007, BIOCHEM BIOPH RES CO, V357, P877, DOI 10.1016/j.bbrc.2007.04.003; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lomax MA, 2007, ENDOCRINOLOGY, V148, P461, DOI 10.1210/en.2006-0918; Lopez D, 2003, MOL CELL ENDOCRINOL, V205, P169, DOI 10.1016/S0303-7207(02)00300-3; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	23	331	356	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					757	761		10.1038/nature07777	http://dx.doi.org/10.1038/nature07777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194461	Green Published, Green Accepted			2022-12-28	WOS:000265193600040
J	Schacherer, J; Shapiro, JA; Ruderfer, DM; Kruglyak, L				Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid			Comprehensive polymorphism survey elucidates population structure of Saccharomyces cerevisiae	NATURE			English	Article							QUANTITATIVE TRAIT; NUCLEOTIDE RESOLUTION; GENETIC DIVERSITY; GENOME EVOLUTION; DNA-SEQUENCES; YEAST; STRAINS; MAP	Comprehensive identification of polymorphisms among individuals within a species is essential both for studying the genetic basis of phenotypic differences and for elucidating the evolutionary history of the species. Large-scale polymorphism surveys have recently been reported for human(1), mouse(2) and Arabidopsis thaliana(3). Here we report a nucleotide-level survey of genomic variation in a diverse collection of 63 Saccharomyces cerevisiae strains sampled from different ecological niches (beer, bread, vineyards, immunocompromised individuals, various fermentations and nature) and from locations on different continents. We hybridized genomic DNA from each strain to whole-genome tiling microarrays and detected 1.89 million single nucleotide polymorphisms, which were grouped into 101,343 distinct segregating sites. We also identified 3,985 deletion events of length >200 base pairs among the surveyed strains. We analysed the genome-wide patterns of nucleotide polymorphism and deletion variants, and measured the extent of linkage disequilibrium in S. cerevisiae. These results and the polymorphism resource we have generated lay the foundation for genome-wide association studies in yeast. We also examined the population structure of S. cerevisiae, providing support for multiple domestication events as well as insight into the origins of pathogenic strains.	[Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016; Shapiro, Joshua/B-5948-2008	Ruderfer, Douglas M/0000-0002-2365-386X; Shapiro, Joshua/0000-0002-6224-0347	NIH [R37 MH059520, GM071508]; James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all the researchers and institutions, and especially J. Fay, for sharing yeast strains. We thank K. Dolinski and J. Matese for technical support and D. Gresham for comments on the manuscript. The authors acknowledge discussions with members of the Kruglyak and Botstein laboratories. This work was supported by NIH grant R37 MH059520 and a James S. McDonnell Foundation Centennial Fellowship to L. K., and NIH grant GM071508 to the Lewis- Sigler Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CARTER DM, NATURE UNPUB; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; FU YX, 1994, GENETICS, V138, P1375; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; MORTIMER RK, 1986, GENETICS, V113, P35; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pritchard JK, 2000, GENETICS, V155, P945; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1983, GENETICS, V105, P437; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	335	343	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					342	U103		10.1038/nature07670	http://dx.doi.org/10.1038/nature07670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212320	Green Accepted			2022-12-28	WOS:000264285600042
J	Hla, T; Im, DS				Hla, Timothy; Im, Dong-Soon			CELL BIOLOGY The ABCs of Lipophile Transport	SCIENCE			English	Editorial Material							MIGRATION; SPHINGOSINE-1-PHOSPHATE; ZEBRAFISH		[Hla, Timothy; Im, Dong-Soon] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Im, Dong-Soon] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	University of Connecticut; Pusan National University	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA.	hla@nso2.uchc.edu	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065; IM, DONG-SOON/0000-0001-8054-8946				Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640	9	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					883	884		10.1126/science.1170009	http://dx.doi.org/10.1126/science.1170009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213902				2022-12-28	WOS:000263295400024
J	Chen, CT; Doxsey, S				Chen, Chun-Ting; Doxsey, Stephen			A Last-Minute Rescue of Trapped Chromatin	CELL			English	Editorial Material							CYTOKINESIS; ANEUPLOIDY	Chromosome segregation and cytokinesis must be tightly coordinated to ensure that chromosomes are accurately partitioned between dividing cells. In this issue, Steigemann et al. (2009) report that Aurora B kinase promotes proper chromosome segregation by delaying abscission when chromatin is trapped between dividing cells.	[Chen, Chun-Ting; Doxsey, Stephen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Doxsey, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	stephen.doxsey@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Robinson DN, 1996, TRENDS CELL BIOL, V6, P474, DOI 10.1016/0962-8924(96)84945-2; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878	9	12	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					397	399		10.1016/j.cell.2009.01.028	http://dx.doi.org/10.1016/j.cell.2009.01.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203574	Bronze			2022-12-28	WOS:000263120600009
J	Kim, JB; Sebastiano, V; Wu, GM; Arauzo-Bravo, MJ; Sasse, P; Gentile, L; Ko, K; Ruau, D; Ehrich, M; van den Boom, D; Meyer, J; Hubner, K; Bernemann, C; Ortmeier, C; Zenke, M; Fleischmann, BK; Zaehres, H; Scholer, HR				Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Sasse, Philipp; Gentile, Luca; Ko, Kinarm; Ruau, David; Ehrich, Mathias; van den Boom, Dirk; Meyer, Johann; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zenke, Martin; Fleischmann, Bernd K.; Zaehres, Holm; Schoeler, Hans R.			Oct4-Induced Pluripotency in Adult Neural Stem Cells	CELL			English	Article							PRIMORDIAL GERM-CELLS; HUMAN FIBROBLASTS; SELF-RENEWAL; MOUSE; GENERATION; EXPRESSION; DERIVATION; INDUCTION; OCT4; MYC	The four transcription factors Oct4, Sox2, Klf4, and c-Myc can induce pluripotency in mouse and human fibroblasts. We previously described direct reprogramming of adult mouse neural stem cells (NSCs) by Oct4 and either Klf4 or c-Myc. NSCs endogenously express Sox2, c-Myc, and Klf4 as well as several intermediate reprogramming markers. Here we report that exogenous expression of the germline-specific transcription factor Oct4 is sufficient to generate pluripotent stem cells from adult mouse NSCs. These one-factor induced pluripotent stem cells (1F iPS) are similar to embryonic stem cells in vitro and in vivo. Not only can these cells can be efficiently differentiated into NSCs, cardiomyocytes, and germ cells in vitro, but they are also capable of teratoma formation and germline transmission in vivo. Our results demonstrate that Oct4 is required and sufficient to directly reprogram NSCs to pluripotency.	[Kim, Jeong Beom; Sebastiano, Vittorio; Wu, Guangming; Arauzo-Bravo, Marcos J.; Gentile, Luca; Ko, Kinarm; Huebner, Karin; Bernemann, Christof; Ortmeier, Claudia; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, NRW, Germany; [Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53105 Bonn, NRW, Germany; [Ruau, David; Zenke, Martin] RWTH Aachen Univ Med Sch, Inst Biomed Engn, Dept Cell Biol, D-52074 Aachen, NRW, Germany; [Ehrich, Mathias; van den Boom, Dirk] SEQUENOM Inc, San Diego, CA 92121 USA; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany	Max Planck Society; University of Bonn; RWTH Aachen University; Sequenom; Hannover Medical School	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, NRW, Germany.	office@mpi-muenster.mpg.de	Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/E-4908-2019; Sasse, Philipp/G-9866-2013; Gentile, Luca/L-4473-2014; , HS/AAB-4434-2019	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Gentile, Luca/0000-0002-7393-7502; Sasse, Philipp/0000-0002-8502-9472; , HS/0000-0003-2643-5136; Kim, Jeong Beom/0000-0001-6230-8826; Ehrich, Mathias/0000-0001-8415-0310; Wu, Guangming/0000-0003-1923-7609	Deutsche Forschungsgemeinschaft DFG [SPP1356, SPP1109]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank J. Muller-Keuker and S. Kolsch for critically reviewing the manuscript, M. Stehling for FACS analysis, B. Schafer for histology, C. Becker, B. Kratz, and B. Denecke for probe processing and array hybridization, F. Holst for technical help, and Dr. Toshio Kitamura for the pMX retroviral vector. The project was funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming.'' The microarray analyses were funded in part by a grant from the Deutsche Forschungsgemeinschaft DFG SPP1109. M. E. and D. v. d. B. are employees of SEQUENOM, Inc.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hubner K, 2006, METHOD ENZYMOL, V418, P284, DOI 10.1016/S0076-6879(06)18017-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Lee J, 2003, CANCER RES, V63, P8877; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McLaren A., 1981, GERM CELLS SOMA NEW; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weismann A., 1892, KEIMPLASMA THEORIE V; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	41	737	897	3	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					411	419		10.1016/j.cell.2009.01.023	http://dx.doi.org/10.1016/j.cell.2009.01.023			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203577	Bronze			2022-12-28	WOS:000263120600012
J	Schluter, D				Schluter, Dolph			Evidence for Ecological Speciation and Its Alternative	SCIENCE			English	Review							NATURAL-SELECTION; HISTORICAL CONTINGENCY; REPRODUCTIVE ISOLATION; DIVERGENT SELECTION; PARALLEL SPECIATION; PLANT SPECIATION; ADAPTATION; EVOLUTION; ORIGIN; STICKLEBACKS	Natural selection commonly drives the origin of species, as Darwin initially claimed. Mechanisms of speciation by selection fall into two broad categories: ecological and mutation- order. Under ecological speciation, divergence is driven by divergent natural selection between environments, whereas under mutation- order speciation, divergence occurs when different mutations arise and are fixed in separate populations adapting to similar selection pressures. Tests of parallel evolution of reproductive isolation, trait- based assortative mating, and reproductive isolation by active selection have demonstrated that ecological speciation is a common means by which new species arise. Evidence for mutation- order speciation by natural selection is more limited and has been best documented by instances of reproductive isolation resulting from intragenomic conflict. However, we still have not identified all aspects of selection, and identifying the underlying genes for reproductive isolation remains challenging.	[Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Schluter, D (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	schluter@zoology.ubc.ca		Schluter, Dolph/0000-0003-1683-7836	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank M. Arnegard, R. Barrett, A. Case, H. Hoekstra, M. Noor, P. Nosil, S. Otto, T. Price, L. Rieseberg, Rogers, A. Schluter, S. Via, M. Whitlock, J. Willis, and a reviewer for assistance and comments. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation.	[Anonymous], 1861, ORIGIN SPECIES MEANS; BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Coyne J.A., 2004, SPECIATION; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Dobzhansky T., 1937; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Hubbs CL, 1940, AM NAT, V74, P198, DOI 10.1086/280888; Kondrashov AS, 2003, EVOLUTION, V57, P151; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Levin DA, 2003, SYST BOT, V28, P5; Lexer C, 2004, NEW PHYTOL, V161, P225, DOI 10.1046/j.1469-8137.2003.00925.x; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Presgraves DC, 2007, CURR BIOL, V17, pR125, DOI 10.1016/j.cub.2006.12.030; Price T, 2008, SPECIATION BIRDS; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; RIESEBERG LH, 2008, COMMUNICATION; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2001, EVOLUTION, V55, P198; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x	45	978	998	13	646	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					737	741		10.1126/science.1160006	http://dx.doi.org/10.1126/science.1160006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197053				2022-12-28	WOS:000263066800034
J	Bach, PB				Bach, Peter B.			Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOTHERAPY; CARE; PRESCRIPTION; PAYMENT; REIMBURSEMENT; INTERFERON; HEALTH; COSTS; PRICE		[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave, New York, NY 10021 USA.							Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Bach PB, 2005, NEW ENGL J MED, V353, P2733, DOI 10.1056/NEJMp058249; Bach PB, 2005, J CLIN ONCOL, V23, P9041, DOI 10.1200/JCO.2005.03.6111; Bach PB, 2007, J CLIN ONCOL, V25, P187, DOI 10.1200/JCO.2006.08.6116; Berenson Alex, 2006, N Y Times Web, pC2; Berenson Robert A., 2006, MEDICARE PROSPECTIVE; Bowman J, 2006, HEALTH AFFAIR, V25, P1240, DOI 10.1377/hlthaff.25.5.1240; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; *CTR MED MED SERV, 2007, PROP DEC MEM ER STIM; Culliton BJ, 2008, HEALTH AFFAIR, V27, pW41, DOI 10.1377/hlthaff.27.1.w41; *DEP HHS, 2004, MED REIMB LUPR; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; FLAHERTY T, 2007, HME NEWS        0625; Garber AM, 2007, NEW ENGL J MED, V357, P1575, DOI 10.1056/NEJMp078204; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; *HOUS REPR, 2008, MED COMP BIDD MED EQ; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Kanavos P, 2003, HEALTH AFFAIR, V22, P16, DOI 10.1377/hlthaff.22.3.16; Lee TH, 2008, NEW ENGL J MED, V359, P333, DOI 10.1056/NEJMp0804261; LICHTENBERG FR, 2004, EXPANDING PHARM ARSE; LOHR KN, 1986, MED CARE, V24, pUS1; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; Schneeweiss S, 2002, J AM GERIATR SOC, V50, P521, DOI 10.1046/j.1532-5415.2002.50120.x; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WITTES RE, 2004, WASHINGTON POST 0615, pA23	34	295	299	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					626	633		10.1056/NEJMhpr0807774	http://dx.doi.org/10.1056/NEJMhpr0807774			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402QS	19176475				2022-12-28	WOS:000263028800012
J	Kapoor, R; Moseley, RH; Kapoor, JR; Crapo, LM; Saint, S				Kapoor, Roger; Moseley, Richard H.; Kapoor, John R.; Crapo, Lawrence M.; Saint, Sanjay			Needle in a Haystack	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOCRINE TUMORS; DIARRHEA; THERAPY; VIPOMA		[Kapoor, Roger; Kapoor, John R.; Crapo, Lawrence M.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Moseley, Richard H.; Saint, Sanjay] Univ Michigan Hlth Syst, Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; [Moseley, Richard H.; Saint, Sanjay] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; [Crapo, Lawrence M.] Santa Clara Valley Med Ctr, Div Endocrinol, Santa Clara, CA USA	Stanford University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Santa Clara Valley Medical Center	Kapoor, R (corresponding author), Stanford Univ, Sch Med, Dept Med, 300 Pasteur Dr,Rm S101,MC 5110, Stanford, CA 94305 USA.		Saint, Sanjay/AAF-5126-2019					BLOOM SR, 1988, ANN NY ACAD SCI, V527, P518; CAPELLA C, 1983, CANCER-AM CANCER SOC, V52, P1860, DOI 10.1002/1097-0142(19831115)52:10<1860::AID-CNCR2820521017>3.0.CO;2-F; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; KREJS GJ, 1987, AM J MED, V82, P37, DOI 10.1016/0002-9343(87)90425-6; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Moug SJ, 2006, PANCREATOLOGY, V6, P155, DOI 10.1159/000090257; Murray RD, 2008, J CLIN ENDOCR METAB, V93, P2957, DOI 10.1210/jc.2008-0027; O'Toole D, 2003, ENDOCR-RELAT CANCER, V10, P463, DOI 10.1677/erc.0.0100463; Panzuto F, 2006, ANN ONCOL, V17, P461, DOI 10.1093/annonc/mdj113; Park SK, 1996, BAILLIERE CLIN GASTR, V10, P673, DOI 10.1016/S0950-3528(96)90018-4; Smith SL, 1998, SURGERY, V124, P1050, DOI 10.1067/msy.1998.92005; VERNER JV, 1958, AM J MED, V25, P374, DOI 10.1016/0002-9343(58)90075-5; Warner RRP, 2005, GASTROENTEROLOGY, V128, P1668, DOI 10.1053/j.gastro.2005.03.078	13	2	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					616	621		10.1056/NEJMcps0805187	http://dx.doi.org/10.1056/NEJMcps0805187			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196679				2022-12-28	WOS:000263028800010
J	Savchenko, A				Savchenko, Alex			MATERIALS SCIENCE Transforming Graphene	SCIENCE			English	Editorial Material									[Savchenko, Alex] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Savchenko, A (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	a.k.savchenko@exeter.ac.uk						Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Laiko E. I., 1987, Soviet Physics - JETP, V66, P1258; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; NORMAN ROC, 1995, MODERN ORGANIC CHEM; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; PEPPER M, 1974, PHYS LETT A, VA 47, P71, DOI 10.1016/0375-9601(74)90111-X; Ryu S, 2008, NANO LETT, V8, P4597, DOI 10.1021/nl802940s; Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401; Wassmann T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096402	12	89	90	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					589	590		10.1126/science.1169246	http://dx.doi.org/10.1126/science.1169246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179516				2022-12-28	WOS:000262862800027
J	Bannard, O; Kraman, M; Fearon, DT				Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.			Secondary Replicative Function of CD8(+) T Cells That Had Developed an Effector Phenotype	SCIENCE			English	Article							MEMORY; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION	Models of the differentiation of memory CD8+ T cells that replicate during secondary infections differ over whether such cells had acquired effector function during primary infections. We created a transgenic mouse line that permits mapping of the fate of granzyme B (gzmB)- expressing CD8(+) T cells and their progeny by indelibly marking them with enhanced yellow fluorescent protein ( EYFP). Virus- specific CD8(+) T cells express gzmB within the first 2 days of a primary response to infection with influenza, without impairment of continued primary clonal expansion. On secondary infection, virus- specific CD8(+) T cells that became EYFP+ during a primary infection clonally expand as well as all virus- specific CD8(+) T cells. Thus, CD8(+) T cells that have acquired an effector phenotype during primary infection may function as memory cells with replicative function.	[Bannard, Oliver; Kraman, Matthew; Fearon, Douglas T.] Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Cambridge CB2 2QH, England	University of Cambridge	Fearon, DT (corresponding author), Univ Cambridge, Ctr Mrc, Wellcome Trust Immunol Unit, Dept Med, Hills Rd, Cambridge CB2 2QH, England.	dtf1000@cam.ac.uk		Kraman, Matthew/0000-0002-5040-0067	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank D. Winton for ROSA26EYFP mice, B. Crombrugghe for the CreER<SUP>12</SUP> construct, G. Eberl for the recombineering shuttle vector, and P. Digard and E. Hutchinson for help with viruses. This work was funded by the Wellcome Trust.	Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; HANSON RD, 1991, J BIOL CHEM, V266, P24433; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	13	126	128	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					505	509		10.1126/science.1166831	http://dx.doi.org/10.1126/science.1166831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164749	Green Accepted			2022-12-28	WOS:000262587900043
J	Olmschenk, S; Matsukevich, DN; Maunz, P; Hayes, D; Duan, LM; Monroe, C				Olmschenk, S.; Matsukevich, D. N.; Maunz, P.; Hayes, D.; Duan, L. -M.; Monroe, C.			Quantum Teleportation Between Distant Matter Qubits	SCIENCE			English	Article							PODOLSKY-ROSEN CHANNELS; ATOMIC QUBITS; COMMUNICATION; INTERFERENCE; ENTANGLEMENT; OPERATIONS; ENSEMBLES; PHOTON; STATE; LIGHT	Quantum teleportation is the faithful transfer of quantum states between systems, relying on the prior establishment of entanglement and using only classical communication during the transmission. We report teleportation of quantum information between atomic quantum memories separated by about 1 meter. A quantum bit stored in a single trapped ytterbium ion (Yb+) is teleported to a second Yb+ atom with an average fidelity of 90% over a replete set of states. The teleportation protocol is based on the heralded entanglement of the atoms through interference and detection of photons emitted from each atom and guided through optical fibers. This scheme may be used for scalable quantum computation and quantum communication.	[Olmschenk, S.; Matsukevich, D. N.; Maunz, P.; Hayes, D.; Monroe, C.] Univ Maryland, JQI, College Pk, MD 20742 USA; [Duan, L. -M.] Univ Michigan, FOCUS Ctr, Ann Arbor, MI 48109 USA; [Duan, L. -M.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Olmschenk, S.; Matsukevich, D. N.; Maunz, P.; Hayes, D.; Monroe, C.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park	Olmschenk, S (corresponding author), Univ Maryland, JQI, College Pk, MD 20742 USA.	smolms@umd.edu	Olmschenk, Steven/D-4960-2011; Matsukevich, Dzmitry/C-9134-2009; Monroe, Christopher R/G-8105-2011	Olmschenk, Steven/0000-0003-0105-7714; Matsukevich, Dzmitry/0000-0002-7679-0569; 	Intelligence Advanced Research Projects Activity (IARPA); NSF Physics at the Information Frontier; NSF Physics Frontier Center at JQI	Intelligence Advanced Research Projects Activity (IARPA); NSF Physics at the Information Frontier(National Science Foundation (NSF)); NSF Physics Frontier Center at JQI(National Science Foundation (NSF))	This work is supported by the Intelligence Advanced Research Projects Activity (IARPA) under Army Research Office contract, the NSF Physics at the Information Frontier program, and the NSF Physics Frontier Center at JQI.	Altepeter J. B., 2006, ADV ATOM MOL OPT PHY, V52, P105; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; BRAUNSTEIN SL, 1995, PHYS REV A, V51, pR1727, DOI 10.1103/PhysRevA.51.R1727; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Duan LM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062324; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Madsen MJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.040505; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Maunz P, 2007, NAT PHYS, V3, P538, DOI 10.1038/nphys644; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Riebe M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/211; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	29	329	339	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					486	489		10.1126/science.1167209	http://dx.doi.org/10.1126/science.1167209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164744	Green Published, Green Submitted			2022-12-28	WOS:000262587900037
J	Becker, G; Blum, HE				Becker, Gerhild; Blum, Hubert E.			Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus	LANCET			English	Article							MAJOR ABDOMINAL-SURGERY; MORPHINE-INDUCED DELAY; PHASE-III TRIAL; DOUBLE-BLIND; INDUCED CONSTIPATION; RECEPTOR ANTAGONIST; SUBCUTANEOUS METHYLNALTREXONE; ORAL METHYLNALTREXONE; TRANSIT-TIME; LAXATIVE USE	Peripherally acting p-opioid receptor antagonists methylnaltrexone and alvimopan are a new class of drugs designed to reverse opioid-induced side-effects on the gastrointestinal system without compromising pain relief This article gives an overview of the pharmacology, the efficacy, and adverse effects of these drugs. Both compounds seem to be generally well tolerated and effective for the treatment of opioid-related bowel dysfunction and postoperative ileus. Methylnaltrexone recently received approval by the US Food and Drug Administration (FDA) and the European Medicines Agency for treatment of opioid-related bowel dysfunction in patients with advanced illness. Alvimopan was recently approved by the FDA for treatment of postoperative ileus, but the use of the drug is restricted to inpatients because it has been associated with an increased rate of myocardial infarction. Further research should assess the effectiveness and safety of these drugs in clinical practice.	[Becker, Gerhild] Univ Hosp Freiburg, Dept Palliat Care, D-79106 Freiburg, Germany; [Blum, Hubert E.] Univ Hosp Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Becker, G (corresponding author), Univ Hosp Freiburg, Dept Palliat Care, Robert Koch Str 3, D-79106 Freiburg, Germany.	gerhild.becker@uniklinik-freiburg.de						Barr WH, 2000, CLIN PHARMACOL THER, V67, P91; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Beattie DT, 2007, N-S ARCH PHARMACOL, V375, P205, DOI 10.1007/s00210-007-0146-x; Becker G, 2007, J PAIN SYMPTOM MANAG, V34, P547, DOI 10.1016/j.jpainsymman.2006.12.018; Behm B, 2003, CLIN GASTROENTEROL H, V1, P71, DOI 10.1053/cgh.2003.50012; BROWN DR, 1985, NEUROPHARMACOLOGY, V24, P181, DOI 10.1016/0028-3908(85)90072-3; Buchler MW, 2008, ALIMENT PHARM THER, V28, P312, DOI 10.1111/j.1365-2036.2008.03696.x; Camilleri M, 2005, NEUROGASTROENT MOTIL, V17, P157, DOI 10.1111/j.1365-2982.2005.00640.x; De Ponti Fabrizio, 2002, Curr Opin Investig Drugs, V3, P614; De Schepper HU, 2004, NEUROGASTROENT MOTIL, V16, P383, DOI 10.1111/j.1365-2982.2004.00513.x; DeHaven-Hudkins DL, 2008, PHARMACOL THERAPEUT, V117, P162, DOI 10.1016/j.pharmthera.2007.09.007; Delaney CP, 2007, ANN SURG, V245, P355, DOI 10.1097/01.sla.0000232538.72458.93; Delaney CP, 2005, DIS COLON RECTUM, V48, P1114, DOI 10.1007/s10350-005-0035-7; Fakata Keri L, 2007, J Fam Pract, V56, pS3; Foss J, 2005, CLIN PHARMACOL THER, V77, pP74, DOI 10.1016/j.clpt.2004.12.175; FOSS J, 2005, PHARMACOTHERAPY, V25, P1504; FOSS J, 2005, PHARMACOTHERAPY, V25, P1505; Foss JF, 2008, CLIN PHARMACOL THER, V83, P770, DOI 10.1038/sj.clpt.6100292; Foss JF, 1996, LIFE SCI, V59, pPL235, DOI 10.1016/0024-3205(96)00451-1; Friedman JD, 2001, ANN PHARMACOTHER, V35, P85; Gomez-Flores R, 1998, ADV EXP MED BIOL, V437, P13; Gomez-Flores R, 2001, LIFE SCI, V68, P2675, DOI 10.1016/S0024-3205(01)01082-7; Gonenne J, 2005, CLIN GASTROENTEROL H, V3, P784, DOI 10.1016/S1542-3565(05)00434-9; Goodman AJ, 2007, CHEMMEDCHEM, V2, P1552, DOI 10.1002/cmdc.200700143; Herbert MK, 2008, CLIN NUTR, V27, P25, DOI 10.1016/j.clnu.2007.08.001; Herzog TJ, 2006, AM J OBSTET GYNECOL, V195, P445, DOI 10.1016/j.ajog.2006.01.039; Holzer P, 2004, NEUROSCI LETT, V361, P192, DOI 10.1016/j.neulet.2003.12.004; Holzer P, 2007, EXPERT OPIN INV DRUG, V16, P181, DOI 10.1517/13543784.16.2.181; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Karver S, 2007, GASTROENTEROLOGY, V132, pA478; Kehlet H, 2001, AM J SURG, V182, p3S, DOI 10.1016/S0002-9610(01)00781-4; Kirk L, 2008, ARCH SURG-CHICAGO, V143, P1098; Knowles CH, 2000, NEUROGASTROENT MOTIL, V12, P181; KOTAKE AN, 1989, XENOBIOTICA, V19, P1247, DOI 10.3109/00498258909043176; Kowalski J, 1998, NEUROPEPTIDES, V32, P287, DOI 10.1016/S0143-4179(98)90050-6; Kraft MD, 2007, AM J HEALTH-SYST PH, V64, pS13, DOI 10.2146/ajhp070430; Kurz A, 2003, DRUGS, V63, P649, DOI 10.2165/00003495-200363070-00003; Leslie JB, 2007, DRUG TODAY, V43, P611, DOI 10.1358/dot.2007.43.9.1086176; Liu SS, 2001, CLIN PHARMACOL THER, V69, P66, DOI 10.1067/mcp.2001.112680; Maron DJ, 2008, AM J THER, V15, P59, DOI 10.1097/MJT.0b013e31804c6f37; McNicol E, 2003, J PAIN, V4, P231, DOI 10.1016/S1526-5900(03)00556-X; McNicol ED, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006332.pub2; Murphy DB, 1997, ANESTHESIOLOGY, V87, P765, DOI 10.1097/00000542-199710000-00008; Narayan P, 2001, NEUROIMMUNOMODULAT, V9, P134, DOI 10.1159/000049017; Neary P, 2005, EXPERT OPIN INV DRUG, V14, P479, DOI 10.1517/13543784.14.4.479; Neyens Ron, 2007, J Pain Palliat Care Pharmacother, V21, P27; *NIH CLIN EXC, HLTH TECHN APPR METH; *P T COMM, ALV STUD HALT CARD P; Panchal SJ, 2007, INT J CLIN PRACT, V61, P1181, DOI 10.1111/j.1742-1241.2007.01415.x; Pappagallo M, 2001, AM J SURG, V182, p11S, DOI 10.1016/S0002-9610(01)00782-6; Paulson DM, 2005, J PAIN, V6, P184, DOI 10.1016/j.jpain.2004.12.001; Peeters TL, 2006, NEUROGASTROENT MOTIL, V18, P1, DOI 10.1111/j.1365-2982.2005.00749.x; Portenoy RK, 2008, J PAIN SYMPTOM MANAG, V35, P458, DOI 10.1016/j.jpainsymman.2007.12.005; Reichle FM, 2008, CURR OPIN INVEST DR, V9, P90; Rosow CE, 2007, CLIN PHARMACOL THER, V82, P48, DOI 10.1038/sj.clpt.6100164; RUSSELL J, 1982, EUR J PHARMACOL, V78, P255, DOI 10.1016/0014-2999(82)90026-7; Saad Richard, 2008, Expert Rev Gastroenterol Hepatol, V2, P497, DOI 10.1586/17474124.2.4.497; SAUNDERS WB, 2004, 39 AM SOC HLTH SYST; SCHMIDT WK, 2001, AM J SURG, V182, P27; Schmith VD, 2005, CLIN PHARMACOL THER, V77, pP49, DOI 10.1016/j.clpt.2004.12.080; SCHUG SA, 1992, J PAIN SYMPTOM MANAG, V7, P259, DOI 10.1016/0885-3924(92)90059-Q; Singleton PA, 2006, MICROVASC RES, V72, P3, DOI 10.1016/j.mvr.2006.04.004; Sternini C, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00553.x; Stewart David, 2007, Am J Ther, V14, P561, DOI 10.1097/MJT.0b013e31804bdf54; Sykes NP, 1998, PALLIATIVE MED, V12, P375, DOI 10.1191/026921698674125048; Taguchi A, 2001, NEW ENGL J MED, V345, P935, DOI 10.1056/NEJMoa010564; THOMAS J, 2003, P AN M AM SOC CLIN, V22, P729; THOMAS J, 2005, ASCO ANN M ORL FL MA; Thomas J, 2008, NEW ENGL J MED, V358, P2332, DOI 10.1056/NEJMoa0707377; Thomas J, 2008, J PAIN SYMPTOM MANAG, V35, P103, DOI 10.1016/j.jpainsymman.2007.01.017; Traut U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004930.pub3; Tuteja Ashok K, 2008, Expert Rev Gastroenterol Hepatol, V2, P727, DOI 10.1586/17474124.2.6.727; *US FDA, FDA APPR ENT HELP RE; VISCUSI E, 2005, P AM SOC ANESTH, V103, pA893; Viscusi ER, 2006, SURG ENDOSC, V20, P64, DOI 10.1007/s00464-005-0104-y; Webster L, 2008, PAIN, V137, P428, DOI 10.1016/j.pain.2007.11.008; Wittbrodt E., 2006, P & T, V31, P39; Wolff BG, 2004, ANN SURG, V240, P728, DOI 10.1097/01.sla.0000141158.27977.66; *WYETH PHARM, WYETH PROG BEG PHAS; Yuan CS, 2000, JAMA-J AM MED ASSOC, V284, P1383, DOI 10.1001/jama.284.11.1383; Yuan CS, 2006, EXPERT OPIN INV DRUG, V15, P541, DOI 10.1517/13543784.15.5.541; Yuan CS, 2005, J CLIN PHARMACOL, V45, P538, DOI 10.1177/0091270004273491; Yuan CS, 2000, CLIN PHARMACOL THER, V67, P398, DOI 10.1067/mcp.2000.105037; Yuan CS, 1997, CLIN PHARMACOL THER, V61, P467, DOI 10.1016/S0009-9236(97)90197-1; Yuan CS, 1999, PAIN, V83, P631, DOI 10.1016/S0304-3959(99)00162-1; Yuan CS, 2000, JAMA-J AM MED ASSOC, V283, P367, DOI 10.1001/jama.283.3.367; Yuan CS, 2002, J PHARMACOL EXP THER, V300, P118, DOI 10.1124/jpet.300.1.118; Yuan CS, 1996, CLIN PHARMACOL THER, V59, P469, DOI 10.1016/S0009-9236(96)90117-4; ZIMMERMAN DM, 1994, J MED CHEM, V37, P2262, DOI 10.1021/jm00041a003	89	78	84	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1198	1206		10.1016/S0140-6736(09)60139-2	http://dx.doi.org/10.1016/S0140-6736(09)60139-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19217656				2022-12-28	WOS:000264940600034
J	Abernethy, AP; Raman, G; Balk, EM; Hammond, JM; Orlando, LA; Wheeler, JL; Lau, J; McCrory, DC				Abernethy, Amy P.; Raman, Gowri; Balk, Ethan M.; Hammond, Julia M.; Orlando, Lori A.; Wheeler, Jane L.; Lau, Joseph; McCrory, Douglas C.			Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications	ANNALS OF INTERNAL MEDICINE			English	Review							METASTATIC BLADDER-CANCER; METHOTREXATE; GEMCITABINE; VINBLASTINE; DOXORUBICIN; CISPLATIN	Background: The Centers for Medicare & Medicaid Services limit coverage of cancer drugs for off-label indications to indications listed in specified compendia. Purpose: To assess whether compendia provide comprehensive, research-based, and timely information for off-label prescribing in oncology. Data Sources: 6 drug compendia, English-language literature searches of MEDLINE and the Cochrane Central Register of Controlled Trials from 2006 and 2008, and American Society of Clinical Oncology annual meeting abstracts from 2004 to 2007. Data Assessment: The compendia's stated methods, literature related to off-label indications of 14 cancer drugs in 2006, updated literature related to 1 off-label indication between 2006 and 2008, and completeness of compendia content and citations were assessed. Data Synthesis: The compendia's stated methods varied greatly from their actual practices. Compendia cited little of the available evidence, often neither the most recent nor that of highest methodological quality. Compendia differed in evidence cited, terminology, detail, presentation, and referencing. For the 14 off-label indications studied, the compendia differed in the indications included and whether and how they recommended particular agents for particular types of cancer. Update schedules varied, and documentation practices made it difficult to determine whether and when compendia content was updated. For 1 indication, compendia citations did not increase between 2006 and 2008 despite newly published articles. Limitations: The 2006 analysis was limited to 14 off-label indications; the 2008 update examined 1 indication. Only off-label indications for cancer drugs were included, and results cannot be generalized to noncancer drugs or indications. Conclusion: Oncologists rely on compendia for up-to-date access to evidence and reimbursement information for off-label indications. Current compendia lack transparency, cite little current evidence, and lack systematic methods to review or update evidence.	[Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med,Duke Ctr Clin Hlth Policy Res, Div Med Oncol,Duke Comprehens Canc Ctr, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Durham, NC USA; Tufts Med Ctr, Boston, MA USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Tufts Medical Center	Abernethy, AP (corresponding author), Duke Univ, Med Ctr, Dept Med,Duke Ctr Clin Hlth Policy Res, Div Med Oncol,Duke Comprehens Canc Ctr, Box 3436, Durham, NC 27710 USA.	amy.abernethy@duke.edu	Balk, Ethan/AAJ-2547-2020	Abernethy, Amy/0000-0001-6930-8722; Orlando, Lori/0000-0003-2534-7855; McCrory, Douglas/0000-0003-2093-0611	PHS HHS [290-02-0025] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abernethy AP, 2007, COMPENDIA COVERAGE O; *AM SOC HLTH SYST, 2006, AM HOSP FORM SERV DR; Amer Soc Clin Oncol, 2006, J CLIN ONCOL, V24, P3206, DOI 10.1200/JCO.2006.06.8940; [Anonymous], 2005, J ONCOL PRACT, V1, P102; ASCO supports government report, 1991, ONCOLOGY WILLISTON P, V5, p[29, 33]; *CTR MED MED SERV, 2008, COMP 1861 T 2 ANTICA; *FACTS COMP, 2006, DRUG FACTS COMP 2006; *GOLD STAND MULT, 2006, CLIN PHARM; KLASCO R, 2006, US PHARMACOPEIA DRUG; KLASCO RK, 2006, DRUGDEX SYSTEM; *NAT COMP CANC NET, 2006, NAT COMP CANC NETW D; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Roberts JT, 2006, ANN ONCOL, V17, pV118, DOI 10.1093/annonc/mdj965; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; 1991, ONCOLOGY WILLISTON P, V5, P33	16	84	87	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					336	+		10.7326/0003-4819-150-5-200903030-00107	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00107			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221366				2022-12-28	WOS:000264051700005
J	Gottlieb, A; Menter, A; Mendelsohn, A; Shen, YK; Li, S; Guzzo, C; Fretzin, S; Kunynetz, R; Kavanaugh, A				Gottlieb, Alice; Menter, Alan; Mendelsohn, Alan; Shen, Yaung-Kaung; Li, Shu; Guzzo, Cynthia; Fretzin, Scott; Kunynetz, Rod; Kavanaugh, Arthur			Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial	LANCET			English	Article							COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; JOINT DESTRUCTION; EFFICACY; SAFETY; INFLAMMATION; ADALIMUMAB; THERAPY; DISEASE; IL-17	Background Since some patients with psoriatic arthritis do not respond to typical drug treatments, alternatives are needed. Findings suggest that interleukins 12 and 23 might affect clinical symptoms and pathological joint changes of psoriatic arthritis. Ustekinumab is a human monoclonal antibody that inhibits receptor-binding of these cytokines. We aimed to assess the efficacy and safety of ustekinumab for psoriatic arthritis in this phase 11 study. Methods We undertook a double-blind, randomised, placebo-con trolled, crossover study at 24 sites in North America and Europe. Patients with active psoriatic arthritis were randomly allocated via interactive voice response system to either ustekinumab (90 mg or 63 mg) every week for 4 weeks (weeks 0-3) followed by placebo at weeks 12 and 16 (n=76; Group 1) or placebo (weeks 0-3) and ustekinumab (63 mg) at weeks 12 and 16 (n=70; Group 2). The first 1.2 weeks of the study were placebo-controlled. Masking was maintained to week 16 infusion, and patients were followed up to week 36. The primary endpoint was ACR20 response at week 12. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00267956. Findings At week 12, 32 (42%) patients in Group 1 and ten (14%) in Group 2 achieved the primary endpoint (difference 28% [95% C1 14.0-41-61; p=0.0002). Of 124 (85%) participants with psoriasis affecting 3% or more body surface area, 33 of 63 (52%) in Group 1 and three of 55 (5%) in Group 2 had a 75% or greater improvement in psoriasis area and severity index score at week 12 (47% [33.2-60.61; p<0.0001). During the placebo-controlled period (weeks 0-12), adverse events arose in 46 (61%) patients in Group 1 and 44 (63%) in Group 2; serious adverse events were recorded in three (4%) Group 2 patients (none in Group 1). Interpretation Ustekinumab significantly reduced signs and symptoms of psoriatic arthritis and diminished skin lesions compared with placebo, and the drug was well tolerated. Larger and longer term studies are needed to further characterise ustekinumab efficacy and safety for treatment of psoriatic arthritis. Funding Centocor.	[Gottlieb, Alice] Tufts Univ, Med Ctr, Dept Dermatol, Boston, MA 02111 USA; [Menter, Alan] Baylor Univ, Med Ctr, Dallas, TX USA; [Mendelsohn, Alan; Shen, Yaung-Kaung; Li, Shu; Guzzo, Cynthia] Centocor Res & Dev Inc, Malvern, PA USA; [Mendelsohn, Alan; Shen, Yaung-Kaung; Li, Shu; Guzzo, Cynthia] Centocor Ortho Biotech Serv LLC, Malvern, PA USA; [Fretzin, Scott] Dawes Fretzin Dermatol Grp, Indianapolis, IN USA; [Kunynetz, Rod] Ultranova Skincare, Barrie, ON, Canada; [Kavanaugh, Arthur] Univ Calif San Diego, La Jolla, CA 92093 USA	Tufts University; Baylor University; Baylor University Medical Center; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA; University of California System; University of California San Diego	Gottlieb, A (corresponding author), Tufts Univ, Med Ctr, Dept Dermatol, 800 Washington St, Boston, MA 02111 USA.	agottlieb@tuftsmedicalcenter.org	menter md, alan/A-8250-2009		Centocor Research and Development, Inc (Malvern, PA, USA)	Centocor Research and Development, Inc (Malvern, PA, USA)	Centocor Research and Development, Inc (Malvern, PA, USA) funded this study. We thank Michelle Perate and Mary Whitman of Centocor for writing and editorial support; and the following study investigators (listed alphabetically): S Adanis, Dermatology Associates, Calgary, AL, Canada; L Albrecht, Surrey, BC, Canada; D Cohen, Macon, CA, USA; R Gniaclecki, Bispebjerg Hospital, Copenhagen NV, Denmark; J Harshbarger, Carolina Arthritis Associates, Wilmington, NC, USA; R Kirsner, University of Miami Cedars Medical Center, Miami, FL, USA; P Knibbe, Intermountain Orthopaedics, Boise, ID, USA; K Kragballe, Aarmis University Hospital, Denmark; M Magliocco, UMDNJ RobertWood Johnson Medical School, New Brunswick, NJ, USA; A S Nayak, Sneeze Wheeze and itch Associates, Normal, IL, USA; A Ranki, Helsinki University Hospital, Helsinki, Finland; T Reunala, Tampere University Hospital, Tampere, Finland; Y Rosi-Helfrich, University of Michigan, Ann Arbor, MI, USA; L Skov, Gentofte Hospital, Hellerup, Denmark; B Strober, New York University Medical Center, New York, NY, USA; J Tan, Windsor Clinical Research, Windsor, ON, Canada; M Van Beek, University of Iowa, Iowa City, IA, USA; R Vender, Dermatrials Research, Hamilton, ON, Canada; N Wasel, Edmonton, AL, Canada; and I M Woodson, Woodson Dermatology, Las Vegas, NV, USA.	Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Antoni CE, 2005, ARTHRITIS RHEUM, V52, P1227, DOI 10.1002/art.20967; BOUMPAS DT, 2001, PRIMER RHEUMATIC DIS, P233; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; FRIES JF, 1982, J RHEUMATOL, V9, P789; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Genovese MC, 2007, J RHEUMATOL, V34, P1040; Gladman DD, 2007, ANN RHEUM DIS, V66, P163, DOI 10.1136/ard.2006.057901; Kavanaugh A, 2006, ANN RHEUM DIS, V65, P471, DOI 10.1136/ard.2005.040196; Kim WU, 2000, CLIN EXP IMMUNOL, V119, P175, DOI 10.1046/j.1365-2249.2000.01095.x; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Malfait AM, 1998, CLIN EXP IMMUNOL, V111, P377; McHugh NJ, 2003, RHEUMATOLOGY, V42, P778, DOI 10.1093/rheumatology/keg217; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Mease PJ, 2004, ANN RHEUM DIS, V63, P391; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Ribbens C, 2000, EUR CYTOKINE NETW, V11, P669; Ritchlin C, 1998, J RHEUMATOL, V25, P1544; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Szodoray P, 2007, RHEUMATOLOGY, V46, P417, DOI 10.1093/rheumatology/kel306; VANDERLINDEN MA, 2004, DIS ACTIVITY SCORES; VanRiel PLCM, 1996, BRIT J RHEUMATOL, V35, P4; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297	33	440	461	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					633	640		10.1016/S0140-6736(09)60140-9	http://dx.doi.org/10.1016/S0140-6736(09)60140-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19217154				2022-12-28	WOS:000263563500028
J	Waldman, SA; Hyslop, T; Schulz, S; Barkun, A; Nielsen, K; Haaf, J; Bonaccorso, C; Li, YY; Weinberg, DS				Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Barkun, Alan; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan; Weinberg, David S.			Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUANYLYL CYCLASE-C; II COLON-CANCER; STAGE-II; ADJUVANT CHEMOTHERAPY; PREDICT RECURRENCE; MESSENGER-RNA; DUKES-B; MICROMETASTASES; PROGNOSIS; THERAPY	Context The established relationship between lymph node metastasis and prognosis in colorectal cancer suggests that recurrence in 25% of patients with lymph nodes free of tumor cells by histopathology ( pN0) reflects the presence of occult metastases. Guanylyl cyclase 2C ( GUCY2C) is a marker expressed by colorectal tumors that could reveal occult metastases in lymph nodes and better estimate recurrence risk. Objective To examine the association of occult lymph node metastases detected by quantifying GUCY2C messenger RNA, using the reverse transcriptase - polymerase chain reaction, with recurrence and survival in patients with colorectal cancer. Design, Setting, and Participants Prospective study of 257 patients with pN0 colorectal cancer enrolled between March 2002 and June 2007 at 9 US and Canadian centers ( 7 academic medical centers and 2 community hospitals) provided 2570 fresh lymph nodes measuring 5 mm or larger for histopathology and GUCY2C messenger RNA analysis. Patients were followed up for a median of 24 months ( range, 2- 63 months) for disease recurrence or death. Main Outcome Measures Time to recurrence ( primary outcome) and diseasefree survival ( secondary outcome) relative to expression of GUCY2C in lymph nodes. Results Thirty- two patients ( 12.5%) had lymph nodes negative for GUCY2C ( pN0 [ mol-]), and all but 2 remained free of disease during follow- up ( recurrence rate, 6.3%; 95% confidence interval [ CI], 0.8%- 20.8%). Conversely, 225 patients ( 87.5%) had lymph nodes positive for GUCY2C ( pN0 [ mol +]), and 47 developed recurrent disease ( 20.9%; 95% CI, 15.8%- 26.8%) ( P=. 006). Multivariate analyses revealed that GUCY2C in lymph nodes was an independent marker of prognosis. Patients who were pN0 ( mol +) exhibited earlier time to recurrence ( adjusted hazard ratio, 4.66; 95% CI, 1.11- 19.57; P=. 04) and reduced disease- free survival ( adjusted hazard ratio, 3.27; 95% CI, 1.15-9.29; P=. 03). Conclusion Expression of GUCY2C in histologically negative lymph nodes appears to be independently associated with time to recurrence and disease- free survival in patients with pN0 colorectal cancer.	[Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Barkun, Alan] McGill Univ, Dept Med, Div Gastroenterol, Montreal, PQ, Canada; [Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA	Jefferson University; McGill University; Fox Chase Cancer Center	Waldman, SA (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, 132 S 10th St, Philadelphia, PA 19107 USA.	Scott.Waldman@jefferson.edu		Waldman, Scott/0000-0001-6619-175X	National Institutes of Health [CA75123, CA95026, CA112147]; Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE [R33CA112147, R21CA112147, R01CA095026, R01CA075123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA75123 and CA95026 (to Dr Waldman) and CA112147 (to Dr Hyslop) and by funding from the Targeted Diagnostic and Therapeutics Inc (to Dr Waldman). Dr Waldman is the Samuel M. V. Hamilton Endowed Professor of Thomas Jefferson University.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bilchik AJ, 2007, ANN SURG, V246, P568, DOI 10.1097/SLA.0b013e318155a9c7; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Brown HG, 2004, MODERN PATHOL, V17, P402, DOI 10.1038/modpathol.3800071; Cagir B, 1999, ANN INTERN MED, V131, P805, DOI 10.7326/0003-4819-131-11-199912070-00002; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Chervoneva I, 2007, STAT MED, V26, P5596, DOI 10.1002/sim.3127; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Frick GS, 2005, EXPERT REV MOL DIAGN, V5, P701, DOI 10.1586/14737159.5.5.701; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Groner RS, 2005, CANCER-AM CANCER SOC, V104, P395, DOI 10.1002/cncr.21170; HERRERAORNELAS L, 1987, ARCH SURG-CHICAGO, V122, P1253; Hitchcock CL, 1999, DIS COLON RECTUM, V42, P1046, DOI 10.1007/BF02236701; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Iddings D, 2006, ANN SURG ONCOL, V13, P1386, DOI 10.1245/s10434-006-9120-y; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nicastri DG, 2007, J MOL DIAGN, V9, P563, DOI 10.2353/jmoldx.2007.070032; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pitari GM, 2007, CLIN PHARMACOL THER, V82, P441, DOI 10.1038/sj.clpt.6100325; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Ratto C, 1999, DIS COLON RECTUM, V42, P143, DOI 10.1007/BF02237119; Schulz S, 2006, CLIN CANCER RES, V12, P4545, DOI 10.1158/1078-0432.CCR-06-0865; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Waldman SA, 2007, CLIN PHARMACOL THER, V82, P343, DOI 10.1038/sj.clpt.6100360; Waldman SA, 2007, CLIN PHARMACOL THER, V81, P3, DOI 10.1038/sj.clpt.6100032; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168	42	96	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					745	752		10.1001/jama.2009.141	http://dx.doi.org/10.1001/jama.2009.141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224751	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000263370100017
J	Dobbinson, SJ; White, V; Wakefield, MA; Jamsen, KM; White, V; Livingston, PM; English, DR; Simpson, JA				Dobbinson, Suzanne J.; White, Vanessa; Wakefield, Melanie A.; Jamsen, Kris M.; White, Victoria; Livingston, Patricia M.; English, Dallas R.; Simpson, Julie A.			Adolescents' use of purpose built shade in secondary schools: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SKIN-CANCER; SUN PROTECTION; AUSTRALIAN ADOLESCENTS; EXPOSURE; INTERVENTION; MELANOMA; RISK; CHILDHOOD; KNOWLEDGE; ATTITUDES	Objective To examine whether students use or avoid newly shaded areas created by shade sails installed at schools. Design Cluster randomised controlled trial with secondary schools as the unit of randomisation. Setting 51 secondary schools with limited available shade, in Australia, assessed over two spring and summer terms. Participants Students outside at lunch times. Intervention Purpose built shade sails were installed in winter 2005 at full sun study sites to increase available shade for students in the school grounds. Main outcome measure Mean number of students using the primary study sites during weekly observations at lunch time. Results Over the study period the mean change in students using the primary study site from pre-test to post-test was 2.63 (95% confidence interval 0.87 to 4.39) students in intervention schools and -0.03 (-1.16 to 1.09) students in control schools. The difference in mean change between groups was 2.67 (0.65 to 4.68) students (P=0.011). Conclusions Students used rather than avoided newly shaded areas provided by purpose built shade sails at secondary schools in this trial, suggesting a practical means of reducing adolescents' exposure to ultraviolet radiation. Trial registration Exempt.	[White, Vanessa] La Trobe Univ, Australian Inst Primary Care, Lincoln Ctr Res Ageing, Bundoora, Vic 3086, Australia; [Wakefield, Melanie A.; White, Victoria] Canc Council Victoria, Ctr Behav Res Canc, Melbourne, Vic 3053, Australia; [English, Dallas R.; Simpson, Julie A.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia	La Trobe University; Cancer Council Victoria; University of Melbourne		Suzanne.Dobbinson@cancervic.org.au	Simpson, Julie A/P-7299-2014; English, Dallas/AAH-5005-2019; Wakefield, Melanie/E-5019-2012	English, Dallas/0000-0001-7828-8188; White, Victoria/0000-0001-6619-8484; Dobbinson, Suzanne/0000-0001-7427-4379; Simpson, Julie/0000-0002-2660-2013	Australian National Health and Medical Research Council [ID 265902]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by a research project grant (ID 265902) from the Australian National Health and Medical Research Council. The building of the shade sails was covered by the research grant, and the manufacturer did not provide any funding to this study.	*AUSTR SUNSMART SC, 2002, AHPA 14 ANN C MAD FU; Bandura A., 1986, SOCIAL FDN THOUGHT A; Boldeman C, 2004, PHOTODERMATOL PHOTO, V20, P2, DOI 10.1111/j.1600-0781.2004.00069.x; Buller DB, 2006, AM J PREV MED, V30, P13, DOI 10.1016/j.amepre.2005.08.046; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DOBBINSON S, 2005, SUN PROTECTION SUNBU; Dobbinson SJ, 2000, HEALTH PROMOT J AUST, V10, P43; Dobbinson S, 2008, J AM ACAD DERMATOL, V59, P602, DOI 10.1016/j.jaad.2008.06.011; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; Geller AC, 2005, PEDIATR DERMATOL, V22, P112, DOI 10.1111/j.1525-1470.2005.22204.x; Gies P, 2004, PHOTOCHEM PHOTOBIOL, V80, P334, DOI 10.1562/2004-04-13-RA-138.1; Gies P, 1999, J Epidemiol, V9, pS115; HUGHES BR, 1993, BRIT J DERMATOL, V128, P412, DOI 10.1111/j.1365-2133.1993.tb00201.x; Kamin C S, 1993, J Cancer Educ, V8, P313; KATZ RC, 1991, J BEHAV MED, V14, P421, DOI 10.1007/BF00845117; KHLAT M, 1992, AM J EPIDEMIOL, V135, P1103, DOI 10.1093/oxfordjournals.aje.a116210; Kristjansson S, 2003, HEALTH EDUC RES, V18, P88, DOI 10.1093/her/18.1.88; Livingston PM, 2007, PREV MED, V44, P508, DOI 10.1016/j.ypmed.2007.02.015; Livingston PM, 2001, HEALTH EDUC RES, V16, P269, DOI 10.1093/her/16.3.269; Lowe JB, 1999, HEALTH EDUC BEHAV, V26, P396, DOI 10.1177/109019819902600309; Luke D, 2001, PUBLIC HEALTH REP, V116, P194, DOI 10.1093/phr/116.S1.194; MACKAY CA, 2002, P WORKSH HELD 26 28; MERMELSTEIN RJ, 1992, HEALTH PSYCHOL, V11, P371, DOI 10.1037/0278-6133.11.6.371; Moise AF, 1999, PHOTOCHEM PHOTOBIOL, V70, P269, DOI 10.1562/0031-8655(1999)070<0269:SEAS>2.3.CO;2; Montague M, 2001, HEALTH EDUC BEHAV, V28, P290, DOI 10.1177/109019810102800304; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; Murray DM, 1998, DESIGN ANAL GROUP RA; Oliveria SA, 2006, ARCH DIS CHILD, V91, P131, DOI 10.1136/adc.2005.086918; Olson AL, 2007, PEDIATRICS, V119, pE247, DOI 10.1542/peds.2006-1579; Parisi AV, 2000, PHOTODERMATOL PHOTO, V16, P19, DOI 10.1034/j.1600-0781.2000.160106.x; Saraiya M, 2004, AM J PREV MED, V27, P422, DOI 10.1016/j.amepre.2004.08.009; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; *SUNSMART SCH PROG, 1999, SEC SCH BEC SUNSM SO; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; WHO, 1986, 1 INT C HLTH PROM OT, DOI DOI 10.1093/HEAPRO/1.4.405	35	50	51	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2009	338								b95	10.1136/bmj.b95	http://dx.doi.org/10.1136/bmj.b95			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CE	19223344	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000264051900007
J	Polyakov, VB				Polyakov, Veniamin B.			Equilibrium Iron Isotope Fractionation at Core-Mantle Boundary Conditions	SCIENCE			English	Article							PLANETARY DIFFERENTIATION; MOSSBAUER-SPECTROSCOPY; TERRESTRIAL PLANETS; FE ISOTOPES; EARTH; GEOCHEMISTRY; SEGREGATION; METEORITES; PEROVSKITE; ACCRETION	The equilibrium iron isotope fractionation between lower mantle minerals and metallic iron at core- mantle boundary conditions can be evaluated from the high- pressure (57)Fe partial vibrational density of states determined by synchrotron inelastic nuclear resonant x- ray scattering spectroscopy using a diamond anvil. Ferropericlase [(Mg,Fe)O] and (Fe,Mg)SiO(3)-post-perovskite are enriched in heavy iron isotopes relative to metallic iron at ultrahigh pressures, as opposed to the equilibrium iron isotope fractionation between these compounds at low pressure. The enrichment of Earth and Moon basalts in heavy iron isotopes relative to those from Mars and asteroid Vesta can be explained by the equilibrium iron isotope fractionation during the segregation of Earth's core and the assumption that Earth was already differentiated before the Moon- forming "giant impact."	[Polyakov, Veniamin B.] Russian Acad Sci, Inst Expt Mineral, Moscow, Russia	Russian Academy of Sciences	Polyakov, VB (corresponding author), Russian Acad Sci, Inst Expt Mineral, Moscow, Russia.	polyakov@iem.ac.ru	Polyakov, Veniamin/N-9747-2015; Поляков, Вениамин Борисович/GQA-3247-2022	Polyakov, Veniamin/0000-0002-6718-580X; 				Beard BL, 2007, EARTH PLANET SC LETT, V256, P633, DOI 10.1016/j.epsl.2007.01.037; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Lin JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028099; Magna T, 2006, EARTH PLANET SC LETT, V243, P336, DOI 10.1016/j.epsl.2006.01.005; Mao HK, 2001, SCIENCE, V292, P914, DOI 10.1126/science.1057670; Mao WL, 2006, SCIENCE, V312, P564, DOI 10.1126/science.1123442; McCammon CA, 1998, PHYS CHEM MINER, V25, P292, DOI 10.1007/s002690050117; Poitrasson F, 2005, EARTH PLANET SC LETT, V234, P151, DOI 10.1016/j.epsl.2005.02.010; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Poitrasson F, 2007, EARTH PLANET SC LETT, V256, P484, DOI 10.1016/j.epsl.2007.01.039; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Polyakov VB, 1997, GEOCHIM COSMOCHIM AC, V61, P4213, DOI 10.1016/S0016-7037(97)00204-4; Polyakov VB, 1998, GEOCHIM COSMOCHIM AC, V62, P3077, DOI 10.1016/S0016-7037(98)00220-8; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; Polyakov VB, 2005, GEOCHIM COSMOCHIM AC, V69, P5531, DOI 10.1016/j.gca.2005.07.010; Roskosz M, 2006, EARTH PLANET SC LETT, V248, P851, DOI 10.1016/j.epsl.2006.06.037; Schoenberg R, 2006, EARTH PLANET SC LETT, V252, P342, DOI 10.1016/j.epsl.2006.09.045; Teng FZ, 2008, SCIENCE, V320, P1620, DOI 10.1126/science.1157166; Weyer S, 2007, EARTH PLANET SC LETT, V256, P638, DOI 10.1016/j.epsl.2007.01.038; Weyer S, 2005, EARTH PLANET SC LETT, V240, P251, DOI 10.1016/j.epsl.2005.09.023; Weyer S, 2008, SCIENCE, V320, P1600, DOI 10.1126/science.1160204; Weyer S, 2007, EARTH PLANET SC LETT, V259, P119, DOI 10.1016/j.epsl.2007.04.033; Wiechert U, 2007, EARTH PLANET SC LETT, V256, P360, DOI 10.1016/j.epsl.2007.01.007; Williams HM, 2006, EARTH PLANET SC LETT, V250, P486, DOI 10.1016/j.epsl.2006.08.013; Zhu XK, 2002, EARTH PLANET SC LETT, V200, P47, DOI 10.1016/S0012-821X(02)00615-5	26	90	94	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					912	914		10.1126/science.1166329	http://dx.doi.org/10.1126/science.1166329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213913				2022-12-28	WOS:000263295400036
J	Sreekumar, A; Poisson, LM; Rajendiran, TM; Khan, AP; Cao, Q; Yu, JD; Laxman, B; Mehra, R; Lonigro, RJ; Li, Y; Nyati, MK; Ahsan, A; Kalyana-Sundaram, S; Han, B; Cao, XH; Byun, J; Omenn, GS; Ghosh, D; Pennathur, S; Alexander, DC; Berger, A; Shuster, JR; Wei, JT; Varambally, S; Beecher, C; Chinnaiyan, AM				Sreekumar, Arun; Poisson, Laila M.; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Nyati, Mukesh K.; Ahsan, Aarif; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Byun, Jaeman; Omenn, Gilbert S.; Ghosh, Debashis; Pennathur, Subramaniam; Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.; Wei, John T.; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.			Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression	NATURE			English	Article							MOLECULAR-GENETICS; POLYCOMB; EZH2; EXPRESSION	Multiple, complex molecular events characterize cancer development and progression(1,2). Deciphering the molecular networks that distinguish organ- confined disease from metastatic disease may lead to the identification of critical biomarkers for cancer invasion and disease aggressiveness. Although gene and protein expression have been extensively profiled in human tumours, little is known about the global metabolomic alterations that characterize neoplastic progression. Using a combination of high- throughput liquid- and- gas- chromatography- based mass spectrometry, we profiled more than 1,126 metabolites across 262 clinical samples related to prostate cancer ( 42 tissues and 110 each of urine and plasma). These unbiased metabolomic profiles were able to distinguish benign prostate, clinically localized prostate cancer and metastatic disease. Sarcosine, an N- methyl derivative of the amino acid glycine, was identified as a differential metabolite that was highly increased during prostate cancer progression to metastasis and can be detected non- invasively in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells. Knockdown of glycine- N- methyl transferase, the enzyme that generates sarcosine from glycine, attenuated prostate cancer invasion. Addition of exogenous sarcosine or knockdown of the enzyme that leads to sarcosine degradation, sarcosine dehydrogenase, induced an invasive phenotype in benign prostate epithelial cells. Androgen receptor and the ERG gene fusion product coordinately regulate components of the sarcosine pathway. Here, by profiling the metabolomic alterations of prostate cancer progression, we reveal sarcosine as a potentially important metabolic intermediary of cancer cell invasion and aggressivity.	[Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Omenn, Gilbert S.; Pennathur, Subramaniam; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Lonigro, Robert J.; Nyati, Mukesh K.; Ghosh, Debashis; Pennathur, Subramaniam; Wei, John T.; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Poisson, Laila M.; Ghosh, Debashis] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.; Ahsan, Aarif] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Byun, Jaeman; Omenn, Gilbert S.; Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ghosh, Debashis] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Ghosh, Debashis] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.] Metabolon Inc, Durham, NC 27713 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Metabolon	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Wei, John T/E-8967-2012; Berger, Alvin/AAE-5353-2022; Cao, Qi/A-5517-2010	Cao, Qi/0000-0002-5140-3681; Ghosh, Debashis/0000-0001-6618-1316; Varambally, Sooryanarayana/0000-0002-2277-1127; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Omenn, Gilbert S./0000-0002-8976-6074	Early Detection Research Network; National Institutes of Health; MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [T32CA083654, K99CA129565, U01CA111275, R01CA133458] Funding Source: NIH RePORTER	Early Detection Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant(University of Michigan System); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Granger for help in manuscript preparation, J. Siddiqui and R. Varambally for help with the clinical database, and A. Vellaichamy and S. Pullela for technical assistance. We thank K. Pienta for access to metastatic prostate cancer samples from the University of Michigan Prostate SPORE rapid autopsy programme. This work is supported in part by the Early Detection Research Network (A.M.C., J.T.W.), National Institutes of Health (A.S., S.P., J.B., T.M.R., D.G., G.S.O. and A.M.C.) and an MTTC grant (G.S.O. and A.S.). A.M.C. is supported by a Clinical Translational Science Award from the Burroughs Welcome Foundation. A. S. is supported by a grant from the Fund for Discovery of the University of Michigan Comprehensive Cancer Center. L. M. P. is supported by the University of Michigan Cancer Biostatistics Training Grant. A. M. C and S. P. are supported by the Doris Duke Charitable Foundation.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	18	1645	1723	21	794	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					910	914		10.1038/nature07762	http://dx.doi.org/10.1038/nature07762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212411	Green Accepted, Green Published			2022-12-28	WOS:000263266700051
J	Houdusse, A; Carter, AP				Houdusse, Anne; Carter, Andrew P.			Dynein Swings into Action	CELL			English	Editorial Material							CYTOPLASMIC DYNEIN; DOMAIN	Motor proteins, such as dynein, use chemical energy from ATP hydrolysis to move along the cytoskeleton. Roberts et al. (2009) now describe the arrangement of subdomains in the motor domain of dynein and propose a model for how these regions function together in force generation.	[Houdusse, Anne] Ctr Rech, Inst Curie, Struct Motil Team, F-75248 Paris, France; [Houdusse, Anne] CNRS, UMR 144, F-75248 Paris, France; [Carter, Andrew P.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Carter, Andrew P.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Houdusse, A (corresponding author), Ctr Rech, Inst Curie, Struct Motil Team, F-75248 Paris, France.	anne.houdusse@curie.fr; cartera@cmp.ucsf.edu		houdusse, anne/0000-0002-8566-0336; Carter, Andrew/0000-0001-7292-5430				Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Ueno H, 2008, P NATL ACAD SCI USA, V105, P19702, DOI 10.1073/pnas.0808194105; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	8	10	10	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					395	396		10.1016/j.cell.2009.01.026	http://dx.doi.org/10.1016/j.cell.2009.01.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203573	Bronze			2022-12-28	WOS:000263120600008
J	Cardone, G; Purdy, JG; Cheng, NQ; Craven, RC; Steven, AC				Cardone, Giovanni; Purdy, John G.; Cheng, Naiqian; Craven, Rebecca C.; Steven, Alasdair C.			Visualization of a missing link in retrovirus capsid assembly	NATURE			English	Article							ROUS-SARCOMA-VIRUS; AMINO-TERMINAL DOMAIN; 3-DIMENSIONAL STRUCTURE; DIMERIZATION DOMAIN; CA PROTEIN; HIV-1 CORE; RESOLUTION; RECONSTRUCTIONS; ORGANIZATION; MODELS	For a retrovirus such as HIV to be infectious, a properly formed capsid is needed; however, unusually among viruses, retrovirus capsids are highly variable in structure. According to the fullerene conjecture, they are composed of hexamers and pentamers of capsid protein (CA), with the shape of a capsid varying according to how the twelve pentamers are distributed and its size depending on the number of hexamers. Hexamers have been studied in planar and tubular arrays, but the predicted pentamers have not been observed. Here we report cryo- electron microscopic analyses of two in- vitro- assembled capsids of Rous sarcoma virus. Both are icosahedrally symmetric: one is composed of 12 pentamers, and the other of 12 pentamers and 20 hexamers. Fitting of atomic models of the two CA domains into the reconstructions shows three distinct inter- subunit interactions. These observations substantiate the fullerene conjecture, show how pentamers are accommodated at vertices, support the inference that nucleation is a crucial morphologic determinant, and imply that electrostatic interactions govern the differential assembly of pentamers and hexamers.	[Cardone, Giovanni; Cheng, Naiqian; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Purdy, John G.; Craven, Rebecca C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	rcc6@psu.edu; stevena@mail.nih.gov		Cardone, Giovanni/0000-0003-4712-1451; Purdy, John/0000-0001-7460-7567	Intramural Research Program of NIAMS; IATAP Program; NIH [CA100322]; Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA100322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041166, ZIAAR027002] Funding Source: NIH RePORTER	Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); IATAP Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Penn State Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Flanagan for advice on protein purification and analytic methods and access to equipment, R. Meyers for assistance in electron microscopy at the Penn State College of Medicine and B. Heymann for advice on data analysis. This work was supported by the Intramural Research Program of NIAMS and the IATAP Program (A.C.S.), and funding from NIH grant CA100322, the Pennsylvania Department of Health and the Penn State Cancer Institute (R.C.C.).	Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Butan C, 2008, J MOL BIOL, V376, P1168, DOI 10.1016/j.jmb.2007.12.003; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cantele F, 2003, J STRUCT BIOL, V141, P84, DOI 10.1016/S1047-8477(02)00577-4; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Cheng N, 2002, J VIROL, V76, P7855, DOI 10.1128/JVI.76.15.7855-7859.2002; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kingston RL, 2001, J STRUCT BIOL, V136, P67, DOI 10.1006/jsbi.2001.4423; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lokhandwala PM, 2008, VIROLOGY, V376, P191, DOI 10.1016/j.virol.2008.03.001; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Mayo K, 2002, J MOL BIOL, V316, P667, DOI 10.1006/jmbi.2001.5354; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Vogt V. M., 1997, P27; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299	43	81	81	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					694	U3		10.1038/nature07724	http://dx.doi.org/10.1038/nature07724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194444	Green Accepted			2022-12-28	WOS:000263064700034
J	Gallia, GL; Sobotta, MH				Gallia, Gary L.; Sobotta, Michael H.			Traumatic Epidural Hematoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gallia, Gary L.; Sobotta, Michael H.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Gallia, GL (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					615	615		10.1056/NEJMicm0706764	http://dx.doi.org/10.1056/NEJMicm0706764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196678				2022-12-28	WOS:000263028800008
J	Cummings, JH; Mann, JI; Nishida, C; Vorster, HH				Cummings, J. H.; Mann, J. I.; Nishida, C.; Vorster, H. H.			Dietary fibre: an agreed definition	LANCET			English	Editorial Material									[Cummings, J. H.] Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland; [Mann, J. I.] Univ Otago, Edgar Natl Ctr Diabet Res, Dunedin, New Zealand; [Nishida, C.] WHO, Dept Nutr Hlth Dev, CH-1211 Geneva, Switzerland; [Vorster, H. H.] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa	University of Dundee; University of Otago; World Health Organization; North West University - South Africa	Cummings, JH (corresponding author), Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland.	j.h.cummings@dundee.ac.uk	Cummings, John/AAC-2007-2019					Cummings JH, 2007, EUR J CLIN NUTR, V61, pS5, DOI 10.1038/sj.ejcn.1602936; *FOOD STAND AG, 2002, MCC WIDD COMP FOODS; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; *UN FAO, 1998, 66 UN FAO	5	64	70	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					365	366		10.1016/S0140-6736(09)60117-3	http://dx.doi.org/10.1016/S0140-6736(09)60117-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19186261				2022-12-28	WOS:000262912100010
J	Burton, DC; Edwards, JR; Horan, TC; Jernigan, JA; Fridkin, SK				Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.			Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CATHETER-RELATED INFECTIONS; SURVEILLANCE SYSTEM; NOSOCOMIAL INFECTIONS; SAFETY NETWORK; RISK-FACTORS; PREVENTION; BACTEREMIA; IMPACT; INTERVENTION; TRANSMISSION	Context Concerns about rates of methicillin- resistant Staphylococcus aureus ( MRSA) health care - associated infections have prompted calls for mandatory screening or reporting in efforts to reduce MRSA infections. Objective To examine trends in the incidence of MRSA central line - associated blood-stream infections ( BSIs) in US intensive care units ( ICUs). Design, Setting, and Participants Data reported by hospitals to the Centers for Disease Control and Prevention ( CDC) from 1997- 2007 were used to calculate pooled mean annual central line - associated BSI incidence rates for 7 types of adult and non-neonatal pediatric ICUs. Percent MRSA was defined as the proportion of S aureus central line - associated BSIs that were MRSA. We used regression modeling to estimate percent changes in central line - associated BSI metrics over the analysis period. Main Outcome Measures Incidence rate of central line - associated BSIs per 1000 central line days; percent MRSA among S aureus central line - associated BSIs. Results Overall, 33 587 central line - associated BSIs were reported from 1684 ICUs representing 16 225 498 patient- days of surveillance; 2498 reported central line - associated BSIs ( 7.4%) were MRSA and 1590 ( 4.7%) were methicillin- susceptible S aureus ( MSSA). Of evaluated ICU types, surgical, nonteaching- affiliated medical- surgical, cardiothoracic, and coronary units experienced increases in MRSA central line - associated BSI incidence in the 1997- 2001 period; however, medical, teaching- affiliated medical-surgical, and pediatric units experienced no significant changes. From 2001 through 2007, MRSA central line - associated BSI incidence declined significantly in all ICU types except in pediatric units, for which incidence rates remained static. Declines in MRSA central line associated BSI incidence ranged from - 51.5% ( 95% CI, - 33.7% to - 64.6%; P <. 001) in nonteaching- affiliated medical- surgical ICUs ( 0.31 vs 0.15 per 1000 central line days) to - 69.2% ( 95% CI, - 57.9% to - 77.7%; P <. 001) in surgical ICUs ( 0.58 vs 0.18 per 1000 central line days). In all ICU types, MSSA central line - associated BSI incidence declined from 1997 through 2007, with changes in incidence ranging from - 60.1% ( 95% CI, - 41.2% to - 73.1%; P <. 001) in surgical ICUs ( 0.24 vs 0.10 per 1000 central line days) to - 77.7% ( 95% CI, - 68.2% to - 84.4%; P <. 001) in medical ICUs ( 0.40 vs 0.09 per 1000 central line days). Although the overall proportion of S aureus central line associated BSIs due to MRSA increased 25.8% ( P=. 02) in the 1997- 2007 period, overall MRSA central line - associated BSI incidence decreased 49.6% ( P <. 001) over this period. Conclusions The incidence of MRSA central line - associated BSI has been decreasing in recent years in most ICU types reporting to the CDC. These trends are not apparent when only percent MRSA is monitored.	[Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Burton, DC (corresponding author), Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Mailstop A-24,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	dburton@cdc.gov		Jernigan, John/0000-0001-8163-925X				Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; [Anonymous], 2005, MMWR MORB MORTAL WKL; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Ben-David D, 2008, AM J INFECT CONTROL, V36, P93, DOI 10.1016/j.ajic.2007.05.013; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Cimolai N, 2007, INFECT CONT HOSP EP, V28, P896, DOI 10.1086/519913; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Emori TG, 1998, INFECT CONT HOSP EP, V19, P308; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Gnass SA, 2004, INFECT CONT HOSP EP, V25, P675, DOI 10.1086/502461; Hageman JC, 2003, INFECT CONT HOSP EP, V24, P356, DOI 10.1086/502214; *HEALTHC ASS INF A, UK HLTH PROT AG SURV; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Karchmer AW, 2000, CLIN INFECT DIS, V31, pS139, DOI 10.1086/314078; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Mermel LA, 2001, EMERG INFECT DIS, V7, P197, DOI 10.3201/eid0702.010208; Mermel LA, 2007, J HOSP INFECT, V65, P30, DOI 10.1016/S0195-6701(07)60011-5; Meyer E, 2006, INFECT CONT HOSP EP, V27, P146, DOI 10.1086/500619; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Oztoprak N, 2006, AM J INFECT CONTROL, V34, P1, DOI 10.1016/j.ajic.2005.07.005; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; RAAD I, 1997, SUPPORT CARE CANCER, V7, P386; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Weber SG, 2007, AM J INFECT CONTROL, V35, P73, DOI 10.1016/j.ajic.2007.01.001	42	191	204	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					727	736		10.1001/jama.2009.153	http://dx.doi.org/10.1001/jama.2009.153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224749	Bronze			2022-12-28	WOS:000263370100015
J	Marino, AM; Pooser, RC; Boyer, V; Lett, PD				Marino, A. M.; Pooser, R. C.; Boyer, V.; Lett, P. D.			Tunable delay of Einstein-Podolsky-Rosen entanglement	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; QUANTUM; INFORMATION; PARADOX	Entangled systems display correlations that are stronger than can be obtained classically. This makes entanglement an essential resource for a number of applications, such as quantum information processing, quantum computing and quantum communications(1,2). The ability to control the transfer of entanglement between different locations will play a key role in these quantum protocols and enable quantum networks(3). Such a transfer requires a system that can delay quantum correlations without significant degradation, effectively acting as a short- term quantum memory. An important benchmark for such systems is the ability to delay Einstein - Podolsky - Rosen ( EPR) levels of entanglement and to be able to tune the delay. EPR entanglement is the basis for a number of quantum protocols, allowing the remote inference of the properties of one system ( to better than its standard quantum limit) through measurements on the other correlated system. Here we show that a four- wave mixing process based on a double- lambda scheme in hot Rb-85 vapour allows us to obtain an optically tunable delay for EPR entangled beams of light. A significant maximum delay, of the order of the width of the cross- correlation function, is achieved. The four- wave mixing also preserves the quantum spatial correlations of the entangled beams. We take advantage of this property to delay entangled images, making this the first step towards a quantum memory for images(4).	[Marino, A. M.; Pooser, R. C.; Boyer, V.; Lett, P. D.] Natl Inst Stand & Technol, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Marino, A. M.; Pooser, R. C.; Boyer, V.; Lett, P. D.] Univ Maryland, Gaithersburg, MD 20899 USA; [Boyer, V.] Univ Birmingham, MUARC, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University of Birmingham	Marino, AM (corresponding author), Natl Inst Stand & Technol, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	alberto.marino@nist.gov	Marino, Alberto/C-7193-2013	Boyer, Vincent/0000-0002-6900-8786; Pooser, Raphael/0000-0002-2922-453X; Marino, Alberto/0000-0001-5377-1122	Intelligence Community Postdoctoral Program; EPSRC [EP/E036473/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E036473/1] Funding Source: researchfish	Intelligence Community Postdoctoral Program; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C. P. is supported by the Intelligence Community Postdoctoral Program.	Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Bowen WP, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.012304; Boyd RW, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023801; Boyer V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143601; Boyer V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.143601; Boyer V, 2008, SCIENCE, V321, P544, DOI 10.1126/science.1158275; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Broadbent CJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133602; Camacho RM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153601; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; Collins OA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060502; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Galindo A, 2002, REV MOD PHYS, V74, P347, DOI 10.1103/RevModPhys.74.347; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Hetet G, 2008, OPT EXPRESS, V16, P7369, DOI 10.1364/OE.16.007369; Honda K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093601; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; McCormick CF, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.043816; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Sato T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.208101; Shuker M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.223601; Tan SM, 1999, PHYS REV A, V60, P2752, DOI 10.1103/PhysRevA.60.2752; Tordrup K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.040501; Vasilyev DV, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.020302; Vudyasetu PK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.123903	29	185	190	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					859	862		10.1038/nature07751	http://dx.doi.org/10.1038/nature07751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212406				2022-12-28	WOS:000263266700040
J	Thybo, H; Nielsen, CA				Thybo, H.; Nielsen, C. A.			Magma-compensated crustal thinning in continental rift zones	NATURE			English	Article							KENYA RIFT; LITHOSPHERIC STRUCTURE; CENTRAL-ASIA; BAIKAL; MONGOLIA; TECTONICS; INTRUSION; EVOLUTION; ATLANTIC; BASALTS	Continental rift zones are long, narrow tectonic depressions in the Earth's surface where the entire lithosphere has been modified in extension(1). Rifting can eventually lead to rupture of the continental lithosphere and creation of new oceanic lithosphere or, alternatively, lead to formation of wide sedimentary basins around failed rift zones. Conventional models of rift zones include three characteristic features: surface manifestation as an elongated topographic trough, Moho shallowing due to crustal thinning, and reduced seismic velocity in the uppermost mantle due to decompression melting or heating from the Earth's interior(2-4). Here we demonstrate that only the surface manifestation is observed at the Baikal rift zone, whereas the crustal and mantle characteristics can be ruled out by a new seismic profile across southern Lake Baikal in Siberia. Instead we observe a localized zone in the lower crust which has exceptionally high seismic velocity and is highly reflective. We suggest that the expected Moho uplift was compensated by magmatic intrusion into the lower crust, producing the observed high- velocity zone. This finding demonstrates a previously unknown role for magmatism in rifting processes with significant implications for estimation of stretching factors and modelling of sedimentary basins around failed rift structures.	[Thybo, H.; Nielsen, C. A.] Univ Copenhagen, Dept Geog & Geol, Oester Voldgade 10, DK-1350 Copenhagen K, Denmark	University of Copenhagen	Thybo, H (corresponding author), Univ Copenhagen, Dept Geog & Geol, Oester Voldgade 10, DK-1350 Copenhagen K, Denmark.	thybo@geo.ku.dk	Thybo, Hans/B-9292-2008	Thybo, Hans/0000-0002-3945-8065	Carlsberg Foundation; Danish Natural Science Research Council; Russian Academy of Sciences; Siberian Branch; Polish Academy of Sciences	Carlsberg Foundation(Carlsberg Foundation); Danish Natural Science Research Council(Danish Natural Science Research Council); Russian Academy of Sciences(Russian Academy of Sciences); Siberian Branch(Russian Academy of Sciences); Polish Academy of Sciences	This study received support from the Carlsberg Foundation and the Danish Natural Science Research Council. The field work at Lake Baikal further received support from the Russian Academy of Sciences, Siberian Branch, and the Polish Academy of Sciences. The seismic instruments were provided by the University of Copenhagen and the Technical University of Vienna. We acknowledge discussions with R.S. White on melting processes, and comments received from I. Artemieva, I. Reid and W. Stratford on earlier versions of the manuscript.	Achauer U, 2002, TECTONOPHYSICS, V358, P17, DOI 10.1016/S0040-1951(02)00415-8; Artemieva IM, 2001, J GEOPHYS RES-SOL EA, V106, P16387, DOI 10.1029/2000JB900439; Barry TL, 2003, J PETROL, V44, P55, DOI 10.1093/petrology/44.1.55; Delvaux D, 1997, TECTONOPHYSICS, V282, P1, DOI 10.1016/S0040-1951(97)00210-2; FURLONG KP, 1986, J GEOPHYS RES-SOLID, V91, P8285, DOI 10.1029/JB091iB08p08285; Gao SS, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020813; Gerya TV, 2007, PHYS EARTH PLANET IN, V160, P124, DOI 10.1016/j.pepi.2006.10.004; GREEN WV, 1991, NATURE, V354, P199, DOI 10.1038/354199a0; Ionov D, 2002, TECTONOPHYSICS, V351, P41, DOI 10.1016/S0040-1951(02)00124-5; Jin SG, 2007, EARTH PLANET SC LETT, V257, P486, DOI 10.1016/j.epsl.2007.03.011; KISELEV AI, 1987, TECTONOPHYSICS, V143, P235, DOI 10.1016/0040-1951(87)90093-X; Korenaga J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001030; Lyngsie SB, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004795; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; Moore TC, 1997, GEOL SOC AM BULL, V109, P746, DOI 10.1130/0016-7606(1997)109<0746:SASPIT>2.3.CO;2; Olsen K.H., 1995, CONTINENTAL RIFTS EV; Petit C, 1998, TECTONOPHYSICS, V296, P125, DOI 10.1016/S0040-1951(98)00140-1; Petit C, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001265; PRODEHL C, 1991, NATURE, V354, P223, DOI 10.1038/354223a0; Raum T, 2006, TECTONOPHYSICS, V415, P167, DOI 10.1016/j.tecto.2005.12.008; Ruppel C, 1995, J GEOPHYS RES-SOL EA, V100, P24187, DOI 10.1029/95JB02955; Suvorov VD, 2002, TECTONOPHYSICS, V351, P61, DOI 10.1016/S0040-1951(02)00125-7; TAPPONNIER P, 1979, J GEOPHYS RES, V84, P3425, DOI 10.1029/JB084iB07p03425; ten Brink US, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000300; Thybo H, 2000, GEOPHYS RES LETT, V27, P2745, DOI 10.1029/1999GL011294; WERNICKE B, 1985, CAN J EARTH SCI, V22, P108, DOI 10.1139/e85-009; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; White RS, 2008, NATURE, V452, P460, DOI 10.1038/nature06687; Wilson D, 2005, NATURE, V433, P851, DOI 10.1038/nature03297; WINDLEY BF, 1993, GEOLOGY, V21, P295, DOI 10.1130/0091-7613(1993)021<0295:MPEFAL>2.3.CO;2; Zhao DP, 2006, EARTH PLANET SC LETT, V243, P681, DOI 10.1016/j.epsl.2006.01.033; Zorin YA, 2003, TECTONOPHYSICS, V371, P153, DOI 10.1016/S0040-1951(03)00214-2	32	160	164	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					873	876		10.1038/nature07688	http://dx.doi.org/10.1038/nature07688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212408				2022-12-28	WOS:000263266700043
J	Kraemer, JD; Gostin, LO				Kraemer, John D.; Gostin, Lawrence O.			Science, Politics, and Values The Politicization of Professional Practice Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIOUS-DISEASES-SOCIETY; LYME-DISEASE		[Kraemer, John D.; Gostin, Lawrence O.] Georgetown Univ, Oneill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Oneill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Bowie WR, 2007, DRUGS, V67, P2661, DOI 10.2165/00003495-200767180-00002; Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1; CDC, 2008, LYM DIS TREATM PROGN; *CONN ATT GEN OFF, 2008, GEN INV REV FLAW LYM; Feder HM, 2008, NEW ENGL J MED, V358, P1084; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Halperin JJ, 2007, NEUROLOGY, V69, P91, DOI 10.1212/01.wnl.0000265517.66976.28; HARRIS JL, 2007, REEDSMITH HLTH LAW M, V11, P2; Klein JO, 2008, CLIN INFECT DIS, V47, P1197, DOI 10.1086/592247; *LYM DIS ASS, LDA AUT DOCT REF SYS; *NAT I ALL INF DIS, 2008, CHRON LYM DIS; *US HOUS REP COMM, 2003, POL SCI BUSH ADM; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	13	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					665	667		10.1001/jama.301.6.665	http://dx.doi.org/10.1001/jama.301.6.665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211474				2022-12-28	WOS:000263229000032
J	Schuckit, MA				Schuckit, Marc A.			Alcohol-use disorders	LANCET			English	Review							SUBSTANCE-USE DISORDERS; RECEPTOR GENE OPRM1; AT-RISK DRINKING; UNITED-STATES; DSM-IV; IDENTIFICATION TEST; BRIEF INTERVENTIONS; RELAPSE PREVENTION; LABORATORY MARKERS; DEPENDENT PATIENTS	Alcohol dependence and alcohol abuse or harmful use cause substantial morbidity and mortality. Alcohol-use disorders are associated with depressive episodes, severe anxiety, insomnia, suicide, and abuse of other drugs. Continued heavy alcohol use also shortens the onset of heart disease, stroke, cancers, and liver cirrhosis, by affecting the cardiovascular, gastrointestinal, and immune systems. Heavy drinking can also cause mild anterograde amnesias, temporary cognitive deficits, sleep problems, and peripheral neuropathy; cause gastroinestinal problems; decrease bone density and production of blood cells; and cause fetal alcohol syndrome. Alcohol-use disorders complicate assessment and treatment of other medical and psychiatric problems. Standard criteria for alcohol dependence-the more severe disorder-can be used to reliably identify people for whom drinking causes major physiological consequences and persistent impairment of quality of life and ability to function. Clinicians should routinely screen for alcohol disorders, using clinical interviews, questionnaires, blood tests, or a combination of these methods. Causes include environmental factors and specific genes that affect the risk of alcohol-use disorders, including genes for enzymes that metabolise alcohol, such as alcohol dehydrogenase and aldehyde dehydrogenase; those associated with disinhibition; and those that confer a low sensitivity to alcohol. Treatment can include motivational interviewing to help people to evaluate their situations, brief interventions to facilitate more healthy behaviours, detoxification to address withdrawal symptoms, cognitive-behavioural therapies to avoid relapses, and judicious use of drugs to diminish cravings or discourage relapses.	[Schuckit, Marc A.] VA San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Schuckit, Marc A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Schuckit, MA (corresponding author), VA San Diego Healthcare Syst, 3350 Jolla Village Dr, La Jolla, CA 92161 USA.	mschuckit@ucsd.edu			Veterans Affairs Research Service [NIAAA 2R01, NIAAA AA05526, NIAAA U10, NIAAA AA08401, NIAAA 5R01AA15760]; State of California; University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015760, R01AA005526, U10AA008401] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); State of California; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Veterans Affairs Research Service (NIAAA grants 2R01 AA05526, U10 AA08401, and 5ROIAA5760), and by funds provided by the, State of California for medical research oil alcohol and substance abuse through the University of California, San Francisco.	Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Alte D, 2003, J STUD ALCOHOL, V64, P75, DOI 10.15288/jsa.2003.64.75; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anton RF, 2006, ALCOHOL CLIN EXP RES, V30, P1878, DOI 10.1111/j.1530-0277.2006.00225.x; BABOR TF, 1992, ARCH GEN PSYCHIAT, V49, P599; Babor TF, 2006, ALCOHOL ALCOHOLISM, V41, P624, DOI 10.1093/alcalc/agl078; BARR C, 2005, ALCOHOL CLIN EXP RES, V27, P812; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Blednov YA, 2007, NEUROPSYCHOPHARMACOL, V32, P1570, DOI 10.1038/sj.npp.1301274; Bodin MC, 2006, J STUD ALCOHOL, V67, P139, DOI 10.15288/jsa.2006.67.139; Borghese CM, 2002, ALCOHOL CLIN EXP RES, V26, P1764, DOI 10.1097/01.ALC.0000042012.58231.D9; Bottlender M, 2005, DRUG ALCOHOL DEPEN, V80, P83, DOI 10.1016/j.drugalcdep.2005.03.011; Carroll KM, 2006, DRUG ALCOHOL DEPEN, V81, P301, DOI 10.1016/j.drugalcdep.2005.08.002; Clark DB, 2004, ADDICTION, V99, P5, DOI 10.1111/j.1360-0443.2004.00851.x; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Conroy DA, 2006, ALCOHOL CLIN EXP RES, V30, P1992, DOI 10.1111/j.1530-0277.2006.00245.x; Cook TAR, 2005, J STUD ALCOHOL, V66, P196, DOI 10.15288/jsa.2005.66.196; Cox WM, 2004, ALCOHOL ALCOHOLISM, V39, P130, DOI 10.1093/alcalc/agh035; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dickson PA, 2006, ALCOHOL CLIN EXP RES, V30, P1093, DOI 10.1111/j.1530-0277.2006.00128.x; Duranceaux NCE, 2006, ALCOHOL CLIN EXP RES, V30, P1470, DOI 10.1111/j.1530-0277.2006.00178.x; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Fatjo F, 2007, ALCOHOL CLIN EXP RES, V31, P1099, DOI 10.1111/j.1530-0277.2007.00404.x; Feeney GFX, 2006, ALCOHOL ALCOHOLISM, V41, P321, DOI 10.1093/alcalc/agl007; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; Gelernter J, 2007, ALCOHOL CLIN EXP RES, V31, P555, DOI 10.1111/j.1530-0277.2007.00339.x; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Harford TC, 2006, J STUD ALCOHOL, V67, P803, DOI 10.15288/jsa.2006.67.803; Hasin D, 1997, DRUG ALCOHOL DEPEN, V47, P217, DOI 10.1016/S0376-8716(97)00092-6; Hasin D, 1996, ADDICTION, V91, P1517; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heather N, 2000, J STUD ALCOHOL, V61, P561, DOI 10.15288/jsa.2000.61.561; Hietala J, 2006, ALCOHOL ALCOHOLISM, V41, P528, DOI 10.1093/alcalc/agl050; Hinckers AS, 2006, BIOL PSYCHIAT, V60, P282, DOI 10.1016/j.biopsych.2005.12.009; Ho MP, 2007, AM J MED SCI, V333, P53, DOI 10.1097/00000441-200701000-00007; Hughes JR, 2006, DRUG ALCOHOL DEPEN, V82, P91, DOI 10.1016/j.drugalcdep.2005.08.018; Humphreys K, 2007, ALCOHOL CLIN EXP RES, V31, P64, DOI 10.1111/j.1530-0277.2006.00273.x; IRWIN M, 1988, AM J PSYCHIAT, V145, P595; Johnson BA, 2006, ALCOHOL CLIN EXP RES, V30, P567, DOI 10.1111/j.1530-0277.2005.00066.x; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Johnston L. D., 2007, NIH PUBLICATION, VI; Jones KA, 2006, BEHAV GENET, V36, P627, DOI 10.1007/s10519-006-9075-6; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kaukonen JP, 2006, ALCOHOL ALCOHOLISM, V41, P345, DOI 10.1093/alcalc/agh259; Kendler KS, 2006, ALCOHOL CLIN EXP RES, V30, P1972, DOI 10.1111/j.1530-0277.2006.00243.x; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Kodituwakku PW, 2006, J STUD ALCOHOL, V67, P502, DOI 10.15288/jsa.2006.67.502; Krampe H, 2006, ALCOHOL CLIN EXP RES, V30, P86, DOI 10.1111/j.1530-0277.2006.00013.x; Kranzler HR, 2006, ALCOHOL CLIN EXP RES, V30, P272, DOI 10.1111/j.1530-0277.2006.00022.x; Krishnan-Sarin S, 2007, BIOL PSYCHIAT, V62, P694, DOI 10.1016/j.biopsych.2006.11.018; Krystal JH, 2006, ARCH GEN PSYCHIAT, V63, P957, DOI 10.1001/archpsyc.63.9.957; Kuperman S, 2005, ALCOHOL CLIN EXP RES, V29, P1869, DOI 10.1097/01.alc.0000183190.32692.c7; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Lemke S, 2005, J STUD ALCOHOL, V66, P756, DOI 10.15288/jsa.2005.66.756; Li TK, 2007, BIOL PSYCHIAT, V61, P1, DOI 10.1016/j.biopsych.2006.11.004; Lingford-Hughes AR, 2004, J PSYCHOPHARMACOL, V18, P293, DOI 10.1177/026988110401800321; Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4; Maisto SA, 2006, J STUD ALCOHOL, V67, P823, DOI 10.15288/jsa.2006.67.823; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Mann K, 2005, ADDICTION, V100, P797, DOI 10.1111/j.1360-0443.2005.01065.x; Mason BJ, 2006, J PSYCHIATR RES, V40, P383, DOI 10.1016/j.jpsychires.2006.02.002; McKellar JD, 2006, J STUD ALCOHOL, V67, P685, DOI 10.15288/jsa.2006.67.685; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Moos RH, 2000, ADDICTION, V95, P833, DOI 10.1046/j.1360-0443.2000.9568332.x; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Mundt MP, 2005, J STUD ALCOHOL, V66, P389, DOI 10.15288/jsa.2005.66.389; Nelson EC, 2004, ARCH GEN PSYCHIAT, V61, P257, DOI 10.1001/archpsyc.61.3.257; Niemela O, 2007, CLIN CHIM ACTA, V377, P39, DOI 10.1016/j.cca.2006.08.035; Norstrom T, 2004, ADDICTION, V99, P1274, DOI [10.1111/j.1360-0443.2004.00849.x, 10.1111/j.1360-0443.2004.00894.x]; Nurnberger JI, 2007, SCI AM, V296, P46, DOI 10.1038/scientificamerican0407-46; O'Malley SS, 2007, J CLIN PSYCHOPHARM, V27, P507, DOI 10.1097/jcp.0b013e31814ce50d; Palmieri VO, 2006, ADV EXP MED BIOL, V578, P125; Parker AJR, 2008, BMJ-BRIT MED J, V336, P496, DOI 10.1136/bmj.39483.457708.80; Pastor R, 2006, NEUROPSYCHOPHARMACOL, V31, P1489, DOI 10.1038/sj.npp.1300928; Peters TJ, 2006, ALCOHOL ALCOHOLISM, V41, P636, DOI 10.1093/alcalc/agl058; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Polednak AP, 2005, ALCOHOL ALCOHOLISM, V40, P234, DOI 10.1093/alcalc/agh150; Ramstedt M, 2004, ADDICTION, V99, P1255, DOI 10.1111/j.1360-0443.2004.00798.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Reoux JP, 2000, AM J ADDICTION, V9, P135; Rivara FP, 2004, J STUD ALCOHOL, V65, P530, DOI 10.15288/jsa.2004.65.530; ROMEROGOMEZ M, 2002, ALCOHOL RES, V7, P66; Rosenbloom MJ, 2007, J STUD ALCOHOL DRUGS, V68, P115, DOI 10.15288/jsad.2007.68.115; Rumpf HJ, 2006, ALCOHOL ALCOHOLISM, V41, P311, DOI 10.1093/alcalc/agl008; Rush A.J., 2000, HDB PSYCHIAT MEASURE; Sannibale C, 2005, DRUG ALCOHOL REV, V24, P475, DOI 10.1080/09595230500292912; Saremi A, 2001, J STUD ALCOHOL, V62, P294, DOI 10.15288/jsa.2001.62.294; Saxena S, 1997, ADDICTION, V92, pS43, DOI 10.1111/j.1360-0443.1997.tb03394.x; Schellenberg F, 2005, ALCOHOL ALCOHOLISM, V40, P531, DOI 10.1093/alcalc/agh194; Schuckit M., 2006, DRUG ALCOHOL ABUSE C; Schuckit M.A., 2002, NEUROPSYCHOPHARMACOL, P1399; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Schuckit MA, 2005, AM J PSYCHIAT, V162, P350, DOI 10.1176/appi.ajp.162.2.350; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; Schuckit MA, 2008, J PSYCHIATR RES, V42, P644, DOI 10.1016/j.jpsychires.2007.07.013; Schuckit MA, 2006, ADDICTION, V101, P76, DOI 10.1111/j.1360-0443.2006.01592.x; Schumann G, 2005, NERVENARZT, V76, P1355, DOI 10.1007/s00115-005-1917-6; Smith TL, 1999, ALCOHOL CLIN EXP RES, V23, P1772, DOI 10.1111/j.1530-0277.1999.tb04072.x; Srisurapanont M, 2005, INT J NEUROPSYCHOPH, V8, P267, DOI 10.1017/S1461145704004997; Stahlbrandt H, 2007, ALCOHOL CLIN EXP RES, V31, P458, DOI 10.1111/j.1530-0277.2006.00327.x; Stecker T, 2007, J STUD ALCOHOL DRUGS, V68, P510, DOI 10.15288/jsad.2007.68.510; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Szucs S, 2005, ADDICTION, V100, P536, DOI 10.1111/j.1360-0443.2005.01009.x; Teesson M, 2006, DRUG ALCOHOL DEPEN, V81, P149, DOI 10.1016/j.drugalcdep.2005.06.007; Thomson AD, 2006, ALCOHOL ALCOHOLISM, V41, P151, DOI 10.1093/alcalc/agh249; Timberlake DS, 2007, ALCOHOL CLIN EXP RES, V31, P1020, DOI 10.1111/j.1530-0277.2007.00383.x; Uyarel H, 2005, J STUD ALCOHOL, V66, P555, DOI 10.15288/jsa.2005.66.555; van den Wildenberg E, 2007, ALCOHOL CLIN EXP RES, V31, P1, DOI 10.1111/j.1530-0277.2006.00258.x; Van Reen E, 2006, ALCOHOL CLIN EXP RES, V30, P974, DOI 10.1111/j.1530-0277.2006.00111.x; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Verge C, 2006, WORLD J GASTROENTERO, V12, P5078, DOI 10.3748/wjg.v12.i31.5078; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; Witkiewitz K, 2008, J STUD ALCOHOL DRUGS, V69, P594, DOI 10.15288/jsad.2008.69.594; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	121	407	422	3	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					492	501		10.1016/S0140-6736(09)60009-X	http://dx.doi.org/10.1016/S0140-6736(09)60009-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19168210				2022-12-28	WOS:000263132800032
J	Fraser, C; Alm, EJ; Polz, MF; Spratt, BG; Hanage, WP				Fraser, Christophe; Alm, Eric J.; Polz, Martin F.; Spratt, Brian G.; Hanage, William P.			The Bacterial Species Challenge: Making Sense of Genetic and Ecological Diversity	SCIENCE			English	Review							STREPTOCOCCUS-PNEUMONIAE; MOLECULAR EVOLUTION; FUNDAMENTAL UNITS; GENOMIC ISLANDS; SEQUENCE; RECOMBINATION; DIFFERENTIATION; DIVERGENCE; SELECTION; ATLANTIC	The Bacteria and Archaea are the most genetically diverse superkingdoms of life, and techniques for exploring that diversity are only just becoming widespread. Taxonomists classify these organisms into species in much the same way as they classify eukaryotes, but differences in their biology- including horizontal gene transfer between distantly related taxa and variable rates of homologous recombination- mean that we still do not understand what a bacterial species is. This is not merely a semantic question; evolutionary theory should be able to explain why species exist at all levels of the tree of life, and we need to be able to define species for practical applications in industry, agriculture, and medicine. Recent studies have emphasized the need to combine genetic diversity and distinct ecology in an attempt to define species in a coherent and convincing fashion. The resulting data may help to discriminate among the many theories of prokaryotic species that have been produced to date.	[Fraser, Christophe; Spratt, Brian G.; Hanage, William P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Alm, Eric J.; Polz, Martin F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02139 USA	Imperial College London; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	c.fraser@imperial.ac.uk	Polz, Martin/ABE-7199-2020; Fraser, Christophe/A-8109-2008; Hanage, Bill/CAF-1813-2022	Fraser, Christophe/0000-0003-2399-9657; Polz, Martin/0000-0002-4975-2946	University Research Fellowships from the Royal Society; Wellcome Trust; U.S. Department of Energy Genomes to Life; NSF/National Institute of Environmental Health Sciences Woods Hole Centre for Oceans and Human Health; NSF Biological Oceanography Program; Moore Foundation; Medical Research Council [G0600719B] Funding Source: researchfish; Directorate For Geosciences [0911031] Funding Source: National Science Foundation	University Research Fellowships from the Royal Society(Royal Society of London); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy Genomes to Life(United States Department of Energy (DOE)); NSF/National Institute of Environmental Health Sciences Woods Hole Centre for Oceans and Human Health; NSF Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Moore Foundation(Gordon and Betty Moore Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Connor and S. Deeny for useful discussions. Supported by University Research Fellowships from the Royal Society (C.F. and W.P.H.), a program grant from the Wellcome Trust (B.G.S.), grants from the U.S. Department of Energy Genomes to Life program (M.F.P. and E.J.A.), and the NSF/National Institute of Environmental Health Sciences Woods Hole Centre for Oceans and Human Health, the NSF Biological Oceanography Program, and the Moore Foundation (M.F.P.).	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Cowan S. T., 1962, MICROBIAL CLASSIFICA, P433; Darwin Charles, 1985, ORIGIN SPECIES; Denef VJ, 2009, ENVIRON MICROBIOL, V11, P313, DOI 10.1111/j.1462-2920.2008.01769.x; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; FISHER RA, 1947, HEREDITY, V1, P143, DOI 10.1038/hdy.1947.11; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hoffmann KH, 2007, FEMS MICROBIOL LETT, V273, P224, DOI 10.1111/j.1574-6968.2007.00790.x; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; KIMURA M, 1976, TRENDS BIOCHEM SCI, V1, pN152, DOI 10.1016/0968-0004(76)90403-5; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; LEVIN BR, 1981, GENETICS, V99, P1; Majewski J, 1999, GENETICS, V152, P1459; Majewski J, 1999, GENETICS, V153, P1525; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; MILKMAN R, 1976, TRENDS BIOCHEM SCI, V1, pN152, DOI 10.1016/0968-0004(76)90402-3; Ochman H, 1987, ESCHERICHIA COLI SAL, P1649; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SMITH JM, 1991, P ROY SOC B-BIOL SCI, V245, P37, DOI 10.1098/rspb.1991.0085; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Vetsigian K, 2005, P NATL ACAD SCI USA, V102, P7332, DOI 10.1073/pnas.0502757102; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wilmes P, 2009, FEMS MICROBIOL REV, V33, P109, DOI 10.1111/j.1574-6976.2008.00144.x	42	283	289	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					741	746		10.1126/science.1159388	http://dx.doi.org/10.1126/science.1159388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197054				2022-12-28	WOS:000263066800035
J	McMorran, BJ; Marshall, VM; de Graaf, C; Drysdale, KE; Shabbar, M; Smyth, GK; Corbin, JE; Alexander, WS; Foote, SJ				McMorran, Brendan J.; Marshall, Vikki M.; de Graaf, Carolyn; Drysdale, Karen E.; Shabbar, Meriam; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.; Foote, Simon J.			Platelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to Infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; VIVAX MALARIA; BLOOD-CELLS; THROMBOCYTOPENIA; CHILDREN; PATHOLOGY; ANEMIA	Platelets play a critical role in the pathogenesis of malarial infections by encouraging the sequestration of infected red blood cells within the cerebral vasculature. But platelets also have well- established roles in innate protection against microbial infections. We found that purified human platelets killed Plasmodium falciparum parasites cultured in red blood cells. Inhibition of platelet function by aspirin and other platelet inhibitors abrogated the lethal effect human platelets exert on P. falciparum parasites. Likewise, platelet- deficient and aspirin- treated mice were more susceptible to death during erythrocytic infection with Plasmodium chabaudi. Both mouse and human platelets bind malarial- infected red cells and kill the parasite within. These results indicate a protective function for platelets in the early stages of erythrocytic infection distinct from their role in cerebral malaria.	[McMorran, Brendan J.; Drysdale, Karen E.; Shabbar, Meriam; Foote, Simon J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Marshall, Vikki M.; de Graaf, Carolyn; Smyth, Gordon K.; Corbin, Jason E.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [de Graaf, Carolyn] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; University of Melbourne	McMorran, BJ (corresponding author), Univ Tasmania, Menzies Res Inst, Private Bag 23, Hobart, Tas 7000, Australia.	brendan.mcmorran@utas.edu.au	Foote, Simon J/F-2802-2013; Smyth, Gordon/B-5276-2008	Smyth, Gordon/0000-0001-9221-2892; Foote, Simon/0000-0002-9142-2107; McMorran, Brendan/0000-0003-1845-8872	National Health and Medical Research Council of Australia [490037, 461219]; Australian Cancer Research Foundation; Howard Hughes Medical Institute; Human Research Ethics Committee (Tasmania) Network [H0009004]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Research Ethics Committee (Tasmania) Network	We thank M. Cozens for flow cytometry support; D. Senyschen, G. Panoschi, and F. Rodda for technical support; the Australian Red Cross Blood Service for providing purified red blood cells; S. Jackson for advice; R. Anders for providing the P. falciparum parasites; and C. Flowers for manuscript preparation. Funding support was from the National Health and Medical Research Council of Australia ( Program Grants 490037 and 461219), Australian Cancer Research Foundation, and Howard Hughes Medical Institute. Statistical Analysis. P values were calculated by means of two-tailed t tests, except where specifically mentioned. Ethics approval for animal experiments was received from the Royal Melbourne Hospital, Melbourne, Australia (2002.053), and University of Tasmania ( 0008702). Ethics approval for the platelet donations was received from Human Research Ethics Committee (Tasmania) Network (H0009004).	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Brass LF, 2007, PLATELETS, 2ND EDITION, P319, DOI 10.1016/B978-012369367-9/50778-3; Cattaneo M, 2007, PLATELETS, 2ND EDITION, P201, DOI 10.1016/B978-012369367-9/50772-2; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; DEGRAVES FJ, 1983, J PARASITOL, V69, P262, DOI 10.2307/3281215; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; HELLGREN U, 1989, B WORLD HEALTH ORGAN, V67, P197; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Jeremiah ZA, 2007, PLATELETS, V18, P469, DOI 10.1080/09537100701194871; Kakar A, 1999, DIAGN MICR INFEC DIS, V35, P243, DOI 10.1016/S0732-8893(99)00069-3; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lou JN, 1997, AM J PATHOL, V151, P1397; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Oh MD, 2001, AM J TROP MED HYG, V65, P143, DOI 10.4269/ajtmh.2001.65.143; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Rex S, 2007, PLATELETS, 2ND EDITION, P251, DOI 10.1016/B978-012369367-9/50775-8; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; WEISS HJ, 1968, J CLIN INVEST, V47, P2169, DOI 10.1172/JCI105903; Yeaman MR, 2007, PLATELETS, 2ND EDITION, P727, DOI 10.1016/B978-012369367-9/50802-8	25	184	191	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					797	800		10.1126/science.1166296	http://dx.doi.org/10.1126/science.1166296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197068				2022-12-28	WOS:000263066800051
J	Woolf, SH				Woolf, Steven H.			A Closer Look at the Economic Argument for Disease Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES TASK-FORCE; COST-EFFECTIVENESS; IMPACT		[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Dept Family Med, West Hosp, 1200 E Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Brown D., 2008, WASHINGTON POST 1007, pHE01; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Eden KB, 2002, ANN INTERN MED, V137, P208, DOI 10.7326/0003-4819-137-3-200208060-00015; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; Kahn R, 2008, DIABETES CARE, V31, P1686, DOI 10.2337/dc08-9022; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Satcher D, 2006, HEALTH AFFAIR, V25, P1009, DOI 10.1377/hlthaff.25.4.1009; Solberg LI, 2006, AM J PREV MED, V31, P62, DOI 10.1016/j.amepre.2006.03.013; The National Commission on Prevention Priorities, 2007, PREV CAR NAT PROF US; Trust for America's Health, 2008, ISSUE REPORT PREVENT; Zaza S, 2005, GUIDE COMMUNITY PREV; Zhou FJ, 2005, ARCH PEDIAT ADOL MED, V159, P1136, DOI 10.1001/archpedi.159.12.1136	15	61	63	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					536	538		10.1001/jama.2009.51	http://dx.doi.org/10.1001/jama.2009.51			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190319				2022-12-28	WOS:000262992400025
J	Coutts, G				Coutts, Gordon			Relationships with the drug industry: Collaboration to improve care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Schering Plough UK, Welwyn Garden City AL7 1TW, Herts, England	Merck & Company	Coutts, G (corresponding author), Schering Plough UK, Welwyn Garden City AL7 1TW, Herts, England.	gordon.coutts@spcorp.com						Abbasi K, 2003, BRIT MED J, V326, P1155, DOI 10.1136/bmj.326.7400.1155; Darzi A., 2008, HIGH QUALITY CARE AL; *DEP HLTH, MIN IND STRAT GROUP; DEPARTMENT HEALTH ASSOCIATION BRITISH PHARMACEUTICAL INDUSTRIES, 2008, MOV SPONS INT TOOLK; *EUR COMM, 2007, REP CURR PRACT REG P	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2009	338								b232	10.1136/bmj.b232	http://dx.doi.org/10.1136/bmj.b232			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19193615				2022-12-28	WOS:000263876200007
J	Hundt, S; Haug, U; Brenner, H				Hundt, Sabrina; Haug, Ulrike; Brenner, Hermann			Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection	ANNALS OF INTERNAL MEDICINE			English	Article							PROSPECTIVE MULTICENTER; SCREENING-PROGRAM; CANCER; COLONOSCOPY; NEOPLASIA; POPULATION; COLON; TIMES	Background: Different immunochemical fecal occult blood tests (FOBTs) have been proposed for noninvasive colorectal cancer screening. Large-scale, colonoscopy-based screening studies that allow evaluation of these tests for the detection of precursor lesions are scarce. Objective: To determine and compare performance characteristics of 6 qualitative immunochemical FOBTs for identifying colorectal adenomas among adults who attended screening colonoscopy examinations. Design: Prospective screening study from January 2006 to December 2007. Setting: 20 gastroenterology practices in Germany that did screening colonoscopy. Patients: 1319 participants at average risk for colorectal neoplasia who were undergoing screening colonoscopy (mean age, 63 years; 50% men). Measurements: 6 different qualitative immunochemical FOBTs were done with stool samples collected before bowel preparation for colonoscopy. Performance characteristics (sensitivity, specificity, predictive values, and likelihood ratios) of tests were measured by comparing test results with findings on colonoscopy. Technicians who read the tests were blinded to colonoscopy results, and colonoscopists were blinded to FOBT results. Results: Overall, 405 participants (31%) had an adenoma and 130 participants (10%) had an advanced adenoma. Performance characteristics varied widely among tests. For the 2 best-performing tests (immoCARE-C [ CAREdiagnostica, Voerde, Germany] and FOB advanced [ulti med, Ahrensburg, Germany]), the sensitivity for detection of advanced adenomas was 25% (95% CI, 18% to 34%) and 27% (CI, 20% to 35%), respectively; specificity was 97% (CI, 95% to 98%) and 93% (CI, 91% to 95%); and the positive likelihood ratio was 3.5 (CI, 2.2 to 5.4) and 2.5 (CI, 1.9 to 3.5). Limitation: The study differed from real-life conditions in that stool samples were not directly dissolved in a buffer-filled vial; instead, a small container was used and stool was frozen before testing. Conclusion: Qualitative immunochemical FOBTs could be an option for future colorectal cancer screening because they showed better performance characteristics for precursor lesions than guaiac-based FOBTs and are practical for mass screening. However, given the large differences in diagnostic performance among tests, careful evaluation of the different test variants is important.	[Hundt, Sabrina; Haug, Ulrike; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69115 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Haug, U (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Bergheimer Str 20, D-69115 Heidelberg, Germany.	u.haug@dkfz.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Haug, Ulrike/0000-0002-1886-2923	German Research Foundation (Deutsche Forschungsgemeinschaft) [793]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The German Research Foundation (Deutsche Forschungsgemeinschaft) within the framework of a PhD program (Graduiertenkolleg 793).	Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; FERLAY J, 2004, 5 IARC; FLEISHER M, 1991, ANN INTERN MED, V114, P875, DOI 10.7326/0003-4819-114-10-875; Fraser CG, 2006, LANCET ONCOL, V7, P127, DOI 10.1016/S1470-2045(05)70473-3; Greenberg PD, 2000, AM J GASTROENTEROL, V95, P1331; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Hope RL, 1996, GUT, V39, P722, DOI 10.1136/gut.39.5.722; JAFFE RM, 1975, ANN INTERN MED, V83, P824, DOI 10.7326/0003-4819-83-6-824; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Li SR, 2006, INT J CANCER, V118, P3078, DOI 10.1002/ijc.21774; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakama H, 1997, DIS COLON RECTUM, V40, P781, DOI 10.1007/BF02055432; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; NIV Y, 1990, J CLIN GASTROENTEROL, V12, P393, DOI 10.1097/00004836-199008000-00007; Wong BCY, 2003, ALIMENT PHARM THER, V18, P941, DOI 10.1046/j.1365-2036.2003.01783.x; Young GP, 2003, J MED SCREEN, V10, P123, DOI 10.1258/096914103769011012	23	270	276	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					162	+		10.7326/0003-4819-150-3-200902030-00005	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189905				2022-12-28	WOS:000263029600002
J	Parikh, SV				Parikh, Sagar V.			Antidepressants are not all created equal	LANCET			English	Editorial Material									[Parikh, Sagar V.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 2S8, Canada; [Parikh, Sagar V.] Univ Hlth Network, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Parikh, SV (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON M5T 2S8, Canada.	sagar.parikh@uhn.on.ca	Parikh, Sagar/X-3847-2019					Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cuijpers P, 2009, DEPRESS ANXIETY, V26, P279, DOI 10.1002/da.20519; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Nemeroff CB, 2008, BIOL PSYCHIAT, V63, P424, DOI 10.1016/j.biopsych.2007.06.027; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Petersen TJ, 2006, J PSYCHOPHARMACOL, V20, P19, DOI 10.1177/1359786806064314; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135	9	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					700	701		10.1016/S0140-6736(09)60047-7	http://dx.doi.org/10.1016/S0140-6736(09)60047-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19185343				2022-12-28	WOS:000263725400007
J	Ruth, T				Ruth, Thomas			Accelerating production of medical isotopes	NATURE			English	Editorial Material									[Ruth, Thomas] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Ruth, Thomas] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Ruth, T (corresponding author), TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.	truth@triumf.ca							0	73	73	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					536	537		10.1038/457536a	http://dx.doi.org/10.1038/457536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177112	Bronze			2022-12-28	WOS:000262852200023
J	Deeks, SG; Phillips, AN				Deeks, Steven G.; Phillips, Andrew N.			HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; MYOCARDIAL-INFARCTION; RISK; RATES; SUPPRESSION; ACTIVATION; MORTALITY		[Deeks, Steven G.] Univ Calif San Francisco, Posit Hlth Program, San Francisco Gen Hosp, San Francisco, CA 94131 USA; [Phillips, Andrew N.] UCL, HIV Epidemiol & Biostat Grp, Dept Primary Care & Populat Sci, London NW3 2PF, England; [Phillips, Andrew N.] UCL, Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of London; University College London; University of London; University College London	Deeks, SG (corresponding author), 995 Potero Ave, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807				Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Hsue Priscilla Y, 2008, Circulation, V118, pe41, DOI 10.1161/CIRCULATIONAHA.107.189626; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; KELLY CF, IN PRESS CLIN INFECT; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; McCutchan JA, 2007, AIDS, V21, P1109, DOI 10.1097/QAD.0b013e3280ef6acd; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Odden MC, 2007, ARCH INTERN MED, V167, P2213, DOI 10.1001/archinte.167.20.2213; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	25	460	471	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								a3172	10.1136/bmj.a3172	http://dx.doi.org/10.1136/bmj.a3172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EK	19171560				2022-12-28	WOS:000263205300005
J	Mckee, M; Suhrcke, M; Nolte, E; Lessof, S; Figueras, J; Duran, A; Menabde, N				McKee, Martin; Suhrcke, Marc; Nolte, Ellen; Lessof, Suszy; Figueras, Josep; Duran, Antonio; Menabde, Nata			Health systems, health, and wealth: a European perspective	LANCET			English	Editorial Material							MEDICAL-CARE; MORTALITY; SERVICES; GROWTH; TRENDS; DEATH		[McKee, Martin; Nolte, Ellen] Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1E 7HT, England; [Lessof, Suszy; Figueras, Josep] WHO, Reg Off Europe, European Observ Hlth Syst & Policies, Brussels, Belgium; [Suhrcke, Marc] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Menabde, Nata] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Duran, Antonio] Tecn Salud, Badalona, Spain	European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; World Health Organization; University of East Anglia; World Health Organization	Mckee, M (corresponding author), Univ London London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Suhrcke, Marc/AAE-9024-2019; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Nolte, Ellen/0000-0002-2289-117X; Suhrcke, Marc/0000-0001-7263-8626				ABELSMITH B, 1963, 17 WHO; ANAND S, 1993, J ECON PERSPECT, V7, P133, DOI 10.1257/jep.7.1.133; [Anonymous], 2001, MACR HLTH INV HLTH E; Arora S, 2001, J ECON HIST, V61, P699; *EUR COMM, GROWTH JOBS; FELDSTEIN MS, 1971, AM ECON REV, V61, P853; Figueras J., 2008, HLTH SYSTEMS HLTH WE; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Jones A., 2008, CAN CITIES THRIVE CH; Mackenbach J.P, 2007, EC IMPLICATIONS SOCI; MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106; MACKENBACH JP, 1988, SOC SCI MED, V27, P889, DOI 10.1016/0277-9536(88)90278-X; Martins J.O., 2005, OECD EC DEP WORKING; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; McKeown T., 1979, MED HIST, DOI DOI 10.1515/9781400854622; NEWHOUSE JP, 1977, J HUM RESOUR, V12, P115, DOI 10.2307/145602; Nolte E. M. McKee, 2004, DOES HEALTHCARE SAVE; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; PARKIN D, 1987, J HEALTH ECON, V6, P109, DOI 10.1016/0167-6296(87)90002-6; Sala-I-Martin X, 2004, AM ECON REV, V94, P813, DOI 10.1257/0002828042002570; Stahl T., 2006, HLTH ALL POLICIES PR; Suhrcke M, 2005, CONTRIBUTION HLTH EC; Suhrcke M, 2007, HLTH VITAL INVESTMEN; Suhrcke M, 2008, EC COSTS ILL HLTH EU; Wanless, 2002, SECURING OUR FUTURE; World Health Organization, 2000, WORLD HLTH REP 2000	27	26	26	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					349	351		10.1016/S0140-6736(09)60098-2	http://dx.doi.org/10.1016/S0140-6736(09)60098-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167573				2022-12-28	WOS:000262728100031
J	Brophy, JM				Brophy, James M.			n-3 polyunsaturated fatty acids reduced morbidity and mortality in chronic heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GUIDELINES; PREVENTION; CORONARY; DISEASE		McGill Univ, Montreal, PQ, Canada	McGill University	Brophy, JM (corresponding author), McGill Univ, Montreal, PQ, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				[Anonymous], 1986, LANCET, V1, P397; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-11	10.7326/0003-4819-150-2-200901200-02011	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172716				2022-12-28	WOS:000262655200029
J	Hill, MD				Hill, Michael D.			Alteplase given 3 to 4.5 hours after stroke reduced disability and improved global outcome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ECASS		Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Hill, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.		Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543				Dzialowski I, 2006, STROKE, V37, P973, DOI 10.1161/01.STR.0000206215.62441.56; Hacke W, 2004, LANCET, V363, P768	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-13	10.7326/0003-4819-150-2-200901200-02013	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172718				2022-12-28	WOS:000262655200031
J	Jani, K				Jani, Kalpesh			Laparoscopic surgery was more effective than medical management for chronic gastroesophageal reflux disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ESOPHAGITIS; THERAPY; TRIAL		Sigma Surg, Baroda, Gujarat, India		Jani, K (corresponding author), Sigma Surg, Baroda, Gujarat, India.							Mehta S, 2006, J GASTROINTEST SURG, V10, P1312, DOI 10.1016/j.gassur.2006.07.010; Robinson M, 1996, ANN INTERN MED, V124, P859, DOI 10.7326/0003-4819-124-10-199605150-00001; Romagnuolo J, 2002, ANN SURG, V236, P191, DOI 10.1097/00000658-200208000-00007	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-12	10.7326/0003-4819-150-2-200901200-02012	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172717				2022-12-28	WOS:000262655200030
J	Schneider, MC; Prosser, BE; Caesar, JJE; Kugelberg, E; Li, S; Zhang, Q; Quoraishi, S; Lovett, JE; Deane, JE; Sim, RB; Roversi, P; Johnson, S; Tang, CM; Lea, SM				Schneider, Muriel C.; Prosser, Beverly E.; Caesar, Joseph J. E.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Sim, Robert B.; Roversi, Pietro; Johnson, Steven; Tang, Christoph M.; Lea, Susan M.			Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates	NATURE			English	Article							MACULAR DEGENERATION; MENINGOCOCCAL DISEASE; ALTERNATIVE PATHWAY; MAXIMUM-LIKELIHOOD; COMPLEMENT; BINDING; LIPOPROTEIN; ANTIBODIES; GNA1870; REFINEMENT	The complement system is an essential component of the innate and acquired immune system(1), and consists of a series of proteolytic cascades that are initiated by the presence of microorganisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including complement factor H (fH; ref.2), a 155 kDa protein composed of 20 domains (termed complement control protein repeats). Many pathogens have evolved the ability to avoid immune-killing by recruiting host complement regulators(3) and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface(4). Here we present the structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, fH. The structure also indicates the molecular basis of the host-specificity of the interaction between fH and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.	[Prosser, Beverly E.; Caesar, Joseph J. E.; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Roversi, Pietro; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Schneider, Muriel C.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Sim, Robert B.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford; Imperial College London; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	c.tang@imperial.ac.uk; susan.lea@path.ox.ac.uk	Tuluc, Petronel/C-2527-2011; Johnson, Steven J/F-9182-2016; Lea, Susan M/B-7678-2009; Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Sim, Bob/A-1354-2008	Johnson, Steven J/0000-0002-7877-3543; Lea, Susan M/0000-0001-9287-8053; Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Sim, Bob/0000-0002-2855-7455; Deane, Janet/0000-0002-4863-0330; Lovett, Janet Eleanor/0000-0002-3561-450X; Kugelberg, Elisabeth/0000-0002-8302-3595	Wellcome Trust; Medical Research Council; Engineering and Physical Sciences Research; EMBO; Medical Research Council [G0601195, G0500367, G0400775] Funding Source: researchfish; MRC [G0500367, G0601195, G0400775] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Thanks are due to G. Bricogne and the Global Phasing Consortium for access to a beta version of autoSHARP and autoBUSTER, to the beamline staff of the European Synchrotron Radiation Source (particularly G. Leonard) and DIAMOND (UK), and to many members of the Laboratory of Molecular Biophysics, Oxford, and the Lea group for help with X-ray data collection. B. E. P. was funded by a Wellcome Trust studentship; P. R. and S. J. by Medical Research Council grants to S. M. L.; J. E. D. by a Wellcome Trust grant to SM.L.; and J. E. L. by an Engineering and Physical Sciences Research Grant to S. M. L. Work in C. M. T.'s laboratory is funded by the Wellcome Trust and the Medical Research Council. E. K. is an EMBO fellow.	Bahar M, 2006, ACTA CRYSTALLOGR D, V62, P1170, DOI 10.1107/S0907444906032197; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Feavers IM, 2000, NATURE, V404, P451, DOI 10.1038/35006546; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Jokiranta TS, 1996, FEBS LETT, V393, P297; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACHMANN PJ, 1990, BIOCHEM SOC T, V18, P1143, DOI 10.1042/bst0181143; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; SIM E, 1983, BIOSCIENCE REP, V3, P1119, DOI 10.1007/BF01120205; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	40	252	285	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					890	U9		10.1038/nature07769	http://dx.doi.org/10.1038/nature07769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19225461	Green Accepted			2022-12-28	WOS:000265182500043
J	Sunami, A; Kurokawa, K				Sunami, Atsushi; Kurokawa, Kiyoshi			Recession Watch: No time for nationalism	NATURE			English	Editorial Material									[Sunami, Atsushi; Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan	National Graduate Institute for Policy Studies	Sunami, A (corresponding author), Natl Grad Inst Policy Studies, Tokyo, Japan.	sunami-atsushi@grips.ac.jp							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					960	961		10.1038/457960a	http://dx.doi.org/10.1038/457960a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225502				2022-12-28	WOS:000263425400020
J	Kroshinsky, D; Stone, JH; Bloch, DB; Sepehr, A; Harris, NL; Seton, M; Robinson, D				Kroshinsky, Daniela; Stone, John H.; Bloch, Donald B.; Sepehr, Alireza; Harris, Nancy Lee; Seton, Margaret; Robinson, Dwight			A Woman with a Rash and Numbness and Pain in the Legs Lymphocyte-mediated vasculopathy, with fibrin microthrombi and vascular hyalinization (livedoid vasculopathy), secondary to SLE.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; PATIENT; UPDATE		[Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Stone, John H.; Bloch, Donald B.] Massachusetts Gen Hosp, Dept Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Sepehr, Alireza] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA; [Stone, John H.; Bloch, Donald B.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Sepehr, Alireza] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Kroshinsky, D (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020	Kroshinsky, Daniela/0000-0002-4781-9676; Bloch, Donald/0000-0002-6828-4754	Merck; ZymoGenetics	Merck(Merck & Company); ZymoGenetics	Dr. Stone reports receiving consulting fees from Merck and ZymoGenetics. No other potential conflict of interest relevant to this article was reported.	ALEGRE VA, 1989, BRIT J DERMATOL, V120, P419, DOI 10.1111/j.1365-2133.1989.tb04170.x; Anaya JM, 2006, CLIN DEV IMMUNOL, V13, P209, DOI 10.1080/17402520600876911; Anaya JM, 2006, J RHEUMATOL, V33, P2227; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Baker WF, 2008, HEMATOL ONCOL CLIN N, V22, P33, DOI 10.1016/j.hoc.2007.10.007; Bonilla E, 2007, CLIN IMMUNOL, V124, P18, DOI 10.1016/j.clim.2007.04.010; Callen JP, 2006, ARCH DERMATOL, V142, P1481, DOI 10.1001/archderm.142.11.1481; Cardoso R, 2007, INT J DERMATOL, V46, P431, DOI 10.1111/j.1365-4632.2007.03229.x; Cross LS, 2004, QJM-INT J MED, V97, P303, DOI 10.1093/qjmed/hch048; Daoud MS, 1997, BRIT J DERMATOL, V136, P706, DOI 10.1046/j.1365-2133.1997.6601645.x; Diogenes MJN, 2004, INT J DERMATOL, V43, P632, DOI 10.1111/j.1365-4632.2004.01939.x; Fiorentino DF, 2003, J AM ACAD DERMATOL, V48, P311, DOI 10.1067/mjd.2003.212; Fox RI, 2000, CURR OPIN RHEUMATOL, V12, P391, DOI 10.1097/00002281-200009000-00007; Gibbs MB, 2005, J AM ACAD DERMATOL, V52, P1009, DOI 10.1016/j.jaad.2004.11.051; Gill JM, 2003, AM FAM PHYSICIAN, V68, P2179; Hairston BR, 2006, ARCH DERMATOL, V142, P1413, DOI 10.1001/archderm.142.11.1413; Jorizzo JL, 1998, ARCH DERMATOL, V134, P491, DOI 10.1001/archderm.134.4.491; Krause I, 2007, LUPUS, V16, P176, DOI 10.1177/0961203306075977; Maessen-Visch MB, 1999, INT J DERMATOL, V38, P161, DOI 10.1046/j.1365-4362.1999.00581.x; Meiss F, 2006, EUR J DERMATOL, V16, P159; Nifli AP, 2006, J IMMUNOL METHODS, V311, P189, DOI 10.1016/j.jim.2006.02.004; Papiris SA, 2007, SEMIN RESP CRIT CARE, V28, P459, DOI 10.1055/s-2007-985667; Priori R, 2007, CLIN EXP RHEUMATOL, V25, P378; Ramos-Casals M, 2006, MEDICINE, V85, P95, DOI 10.1097/01.md.0000216817.35937.70; Ramos-Casals M, 2007, SEMIN ARTHRITIS RHEU, V36, P246, DOI 10.1016/j.semarthrit.2006.08.007; Sammaritano LR, 2005, SOUTH MED J, V98, P617, DOI 10.1097/01.smj.0000166748.90089.65; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Uthman IW, 2006, J RHEUMATOL, V33, P2379	28	22	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					711	720		10.1056/NEJMcpc0807822	http://dx.doi.org/10.1056/NEJMcpc0807822			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213685				2022-12-28	WOS:000263260500010
J	Hijazi, R; Taylor, D; Richardson, J				Hijazi, Ramzi; Taylor, David; Richardson, Joanna			Effect of topical alkane vapocoolant spray on pain with intravenous cannulation in patients in emergency departments: randomised double blind placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALLY SIGNIFICANT DIFFERENCE; ANALOG SCALE PAIN; VENOUS CANNULATION; ETHYL CHLORIDE; EMLA; PERCEPTION; ANESTHESIA; ANALGESIA; LIDOCAINE; SEVERITY	Objective To assess the efficacy, acceptability, and safety of a topical alkane vapocoolant in reducing pain during intravenous cannulation in adults. Design Randomised double blind placebo controlled trial. Setting Emergency department of a metropolitan teaching hospital. Participants 201 adult patients (54% male), mean (SD) age 58.2 (19.5) years, who required intravenous cannulation. Interventions Less than 15 seconds before cannulation, the skin area was sprayed with either water (control, n=98) or vapocoolant (intervention, n=103), from a distance of 12cm for 2 seconds. The intervention spray was a blend of propane, butane, and pentane. Main outcome measures Pain with cannulation and discomfort with spray, measured with a 100 mm visual analogue scale. Results Groups did not differ significantly in age, sex, indication for or site of cannulation, cannula size, or who cannulated the patient (P>0.05). Median (interquartile range) pain scores for cannulation in the control and intervention groups were 36 (19-51) and 12 (5-40) mm, respectively (P<0.001), and 59 (60%) and 33 (32%) reported pain scores >= 30 mm (P<0.001). Scores for spray discomfort also differed significantly (P<0.001) because of skewing to the right within the intervention group. The median discomfort scores, however, were 0 mm in both groups. Success rates for first cannulation attempt did not differ between groups (P=0.39). Thirty four (39%) and 62 (62%) patients said they would choose the spray they received for analgesia in the future (P=0.002). At follow-up at five days, two patients in the intervention group reported transient skin redness. Conclusions Topical alkane vapocoolant spray is effective, acceptable, and safe in reducing pain with peripheral intravenous cannulation in adults in the emergency department. Trial registration Australian Clinical Trials ACTRN12607000470493.	[Hijazi, Ramzi; Taylor, David] Univ Melbourne, Parkville, Vic 3052, Australia; [Taylor, David; Richardson, Joanna] Austin Hlth, Melbourne, Vic 3084, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Taylor, D (corresponding author), Univ Melbourne, Parkville, Vic 3052, Australia.	David.Taylor@austin.org.au			University of Melbourne, Victoria, Australia	University of Melbourne, Victoria, Australia(University of Melbourne)	This study was funded by an advanced medical science grant from the University of Melbourne, Victoria, Australia. There were no study sponsors. The authors were entirely independent from the funders. The funders had no role in the project.	ARMSTRONG P, 1990, CAN J ANAESTH, V37, P656, DOI 10.1007/BF03006485; Berthier F, 1998, AM J EMERG MED, V16, P132, DOI 10.1016/S0735-6757(98)90029-8; Biro P, 1997, Eur J Pain, V1, P37, DOI 10.1016/S1090-3801(97)90051-3; BJERRING P, 1989, BRIT J ANAESTH, V63, P655, DOI 10.1093/bja/63.6.655; Browne J, 1999, CAN J ANAESTH, V46, P1014, DOI 10.1007/BF03013194; EHRENSTROMREIZ G, 1983, ACTA ANAESTH SCAND, V27, P510, DOI 10.1111/j.1399-6576.1983.tb01997.x; Habif T., 2004, CLIN DERMATOLOGY; Harris T, 2001, EMERG MED J, V18, P175, DOI 10.1136/emj.18.3.175; Hartstein BH, 2008, EMERG MED J, V25, P257, DOI 10.1136/emj.2006.044776; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Norris William D, 2002, J R Nav Med Serv, V88, P62; Reis EC, 1998, PEDIATR ANN, V27, P375, DOI 10.3928/0090-4481-19980601-12; Rosier EM, 2002, PAIN, V98, P205, DOI 10.1016/S0304-3959(02)00048-9; Sado DM, 2005, J ROY SOC MED, V98, P158, DOI 10.1258/jrsm.98.4.158; SELBY IR, 1995, J ROY SOC MED, V88, P264; *SMITH NEPH HEALTH, 1996, AM; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Todd KH, 1996, ACAD EMERG MED, V3, P142, DOI 10.1111/j.1553-2712.1996.tb03402.x; Young B, 2002, WHEATERS FUNCTIONAL	20	40	40	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2009	338								b215	10.1136/bmj.b215	http://dx.doi.org/10.1136/bmj.b215			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZV	19208703	Green Published, hybrid			2022-12-28	WOS:000263975900003
J	Barbero, F; Thomas, JA; Bonelli, S; Balletto, E; Schonrogge, K				Barbero, Francesca; Thomas, Jeremy A.; Bonelli, Simona; Balletto, Emilio; Schonrogge, Karsten			Queen Ants Make Distinctive Sounds That Are Mimicked by a Butterfly Social Parasite	SCIENCE			English	Article							MACULINEA-REBELI; STRIDULATORY ORGAN; HOST-SPECIFICITY; HYMENOPTERA; SIGNALS; COMMUNICATION; CATERPILLARS; ECOLOGY	Ants dominate terrestrial ecosystems through living in complex societies whose organization is maintained via sophisticated communication systems. The role of acoustics in information exchange may be underestimated. We show that Myrmica schencki queens generate distinctive sounds that elicit increased benevolent responses from workers, reinforcing their supreme social status. Although fiercely defended by workers, ant societies are infiltrated by specialist insects that exploit their resources. Sounds produced by pupae and larvae of the parasitic butterfly Maculinea rebeli mimic those of queen ants more closely than those of workers, enabling them to achieve high status within ant societies. We conclude that acoustical mimicry provides another route for infiltration for similar to 10,000 species of social parasites that cheat ant societies.	[Barbero, Francesca; Thomas, Jeremy A.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Barbero, Francesca; Bonelli, Simona; Balletto, Emilio] Univ Turin, Dipartimento Biol Anim, Uomo Lab Zool, I-10123 Turin, Italy; [Thomas, Jeremy A.; Schonrogge, Karsten] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	UK Centre for Ecology & Hydrology (UKCEH); University of Turin; University of Oxford	Thomas, JA (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	jeremy.thomas@zoo.ox.ac.uk	Thomas, Jeremy/A-9619-2013; Barbero, Francesca/J-3555-2016; Schonrogge, Karsten/M-9935-2019	Barbero, Francesca/0000-0003-2667-0435; Schonrogge, Karsten/0000-0003-0122-6493; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; DEVRIES PJ, 1993, BIOL J LINN SOC, V49, P229, DOI 10.1111/j.1095-8312.1993.tb00902.x; Downey J.C., 1973, Bulletin Allyn Mus, VNo. 14, P1; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; Grasso DA, 1998, ITAL J ZOOL, V65, P167, DOI 10.1080/11250009809386741; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HILL CJ, 1993, J AUST ENTOMOL SOC, V32, P283; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; MARKL H, 1968, Z VERGL PHYSIOL, V60, P103, DOI 10.1007/BF00878447; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; Ruiz E, 2006, ANN SOC ENTOMOL FR, V42, P99, DOI 10.1080/00379271.2006.10697454; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Schurian Klaus G., 1994, Nachrichten des Entomologischen Vereins Apollo, V14, P339; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364	25	125	131	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					782	785		10.1126/science.1163583	http://dx.doi.org/10.1126/science.1163583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197065				2022-12-28	WOS:000263066800047
J	Burns, A; Iliffe, S				Burns, Alistair; Iliffe, Steve			Dementia	BRITISH MEDICAL JOURNAL			English	Review							PRIMARY-CARE; CAREGIVERS; HOME; INTERVENTIONS; DIAGNOSIS; SYMPTOMS; SERVICES; PEOPLE; HEALTH; TRIAL		[Burns, Alistair] Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England; [Burns, Alistair] Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England; [Iliffe, Steve] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of Manchester; Open University - UK; University of London; University College London	Burns, A (corresponding author), Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England.	alistair.burns@manchester.ac.uk		Iliffe, Stephen/0000-0003-2806-3997; Burns, Alistair/0000-0002-9837-0645				*ALZH SOC, 2007, DEM; Audit Commission, 2000, FORG ME NOT; Balestreri L, 2000, INT PSYCHOGERIATR, V12, P59, DOI 10.1017/S1041610200006773; Bertrand RM, 2006, J AGING HEALTH, V18, P534, DOI 10.1177/0898264306289620; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brodaty H, 2005, INT J GERIATR PSYCH, V20, P537, DOI 10.1002/gps.1322; Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Burns A, 2005, BRIT J PSYCHIAT, V187, P143, DOI 10.1192/bjp.187.2.143; Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; De Lepeleire J, 1998, FAM PRACT, V15, P431, DOI 10.1093/fampra/15.5.431; *DEP HLTH, NAT DEM STR IN PRESS; Downs M, 2006, BRIT MED J, V332, P692, DOI 10.1136/bmj.332.7543.692; Downs M, 2008, BMJ-BRIT MED J, V336, P225, DOI 10.1136/bmj.39429.434907.80; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gely-Nargeot Marie-Christine, 2003, Psychol Neuropsychiatr Vieil, V1, P45; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Grasel E, 2002, J AM GERIATR SOC, V50, P843, DOI 10.1046/j.1532-5415.2002.50209.x; Husband HJ, 1999, AGING MENT HEALTH, V3, P179, DOI 10.1080/13607869956352; ILIFFE S, 2005, DEMENTIA, V4, P12; Lavoie JP, 2005, AGING MENT HEALTH, V9, P25, DOI 10.1080/13607860412331323827; Mckillop James., 2004, DEMENTIA, V3, P117, DOI [10.1177/1471301204042332, DOI 10.1177/1471301204042332]; Milne A, 2008, INT PSYCHOGERIATR, V3, P431; National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence (NICE-SCIE), 2006, DEM SUPP PEOPL DEM T, V42; Robinson L., 2006, HLTH TECHNOLOGY ASSE, V10; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; THOMPSON LW, 1990, ALZHEIMERS DIS TREAT; Toseland RW, 2002, SOC SCI MED, V55, P1255, DOI 10.1016/S0277-9536(01)00240-4; *WHO, 2003, GLOB BURD DEM YEAR 2; WIMO, 2005, HLTH EC DEMENTIA DEM; Zanetti O, 1998, INT J GERIATR PSYCH, V13, P358, DOI 10.1002/(SICI)1099-1166(199806)13:6<358::AID-GPS772>3.0.CO;2-J	33	138	141	2	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 5	2009	338								b75	10.1136/bmj.b75	http://dx.doi.org/10.1136/bmj.b75			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OZ	19196746				2022-12-28	WOS:000263876400004
J	Kosaka, H; Inagaki, T; Rikitake, Y; Imamura, H; Mitsumori, Y; Edamatsu, K				Kosaka, Hideo; Inagaki, Takahiro; Rikitake, Yoshiaki; Imamura, Hiroshi; Mitsumori, Yasuyoshi; Edamatsu, Keiichi			Spin state tomography of optically injected electrons in a semiconductor	NATURE			English	Article							QUANTUM-DOT; SINGLE-ELECTRON; COHERENCE; MEMORY; BEATS	Spin is a fundamental property of electrons, with an important role in information storage(1-4). For spin- based quantum information technology, preparation and read- out of the electron spin state are essential functions(5-13). Coherence of the spin state is a manifestation of its quantum nature, so both the preparation and read- out should be spin- coherent. However, the traditional spin measurement technique based on Kerr rotation, which measures spin population using the rotation of the reflected light polarization that is due to the magneto- optical Kerr effect, requires an extra step of spin manipulation or precession to infer the spin coherence(14-20). Here we describe a technique that generalizes the traditional Kerr rotation approach to enable us to measure the electron spin coherence directly without needing to manipulate the spin dynamics, which allows for a spin projection measurement on an arbitrary set of basis states. Because this technique enables spin state tomography, we call it tomographic Kerr rotation. We demonstrate that the polarization coherence of light is transferred to the spin coherence of electrons, and confirm this by applying the tomographic Kerr rotation method to semiconductor quantum wells with precessing and non- precessing electrons. Spin state transfer and tomography offers a tool for performing basis- independent preparation and read- out of a spin quantum state in a solid.	[Kosaka, Hideo; Inagaki, Takahiro; Mitsumori, Yasuyoshi; Edamatsu, Keiichi] Tohoku Univ, Lab Nanoelect & Spintron, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan; [Kosaka, Hideo; Rikitake, Yoshiaki; Imamura, Hiroshi; Mitsumori, Yasuyoshi] CREST JST, Kawaguchi, Saitama 3320012, Japan; [Rikitake, Yoshiaki] Sendai Natl Coll Technol, Dept Informat Engn, Sendai, Miyagi 9893128, Japan; [Imamura, Hiroshi] AIST, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Tohoku University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Kosaka, H (corresponding author), Tohoku Univ, Lab Nanoelect & Spintron, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan.	kosaka@riec.tohoku.ac.jp	Imamura, Hiroshi/O-5748-2016	Imamura, Hiroshi/0000-0002-8372-9897	Strategic Information and Communications R & D Promotion Program; Ministry of Internal Affairs and Communications in Japan;  [SCOPE 41402001]	Strategic Information and Communications R & D Promotion Program; Ministry of Internal Affairs and Communications in Japan; 	This work was supported in part by the Strategic Information and Communications R & D Promotion Program (SCOPE No. 41402001) of the Ministry of Internal Affairs and Communications in Japan.	Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; BAUMBERG JJ, 1994, PHYS REV LETT, V72, P717, DOI 10.1103/PhysRevLett.72.717; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Dutt MVG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.227403; Greilich A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227401; Gupta JA, 2001, SCIENCE, V292, P2458, DOI 10.1126/science.1061169; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Kosaka H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709966; Kosaka H, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.045104; Kosaka H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096602; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Marie X, 1999, PHYS REV B, V60, P5811, DOI 10.1103/PhysRevB.60.5811; Meier F., 1984, OPTICAL ORIENTATION; Mikkelsen MH, 2007, NAT PHYS, V3, P770, DOI 10.1038/nphys736; Salis G, 2001, NATURE, V414, P619, DOI 10.1038/414619a; Vrijen R, 2001, PHYSICA E, V10, P569, DOI 10.1016/S1386-9477(00)00296-4; WU Y, 2007, PHYS REV LETT, V96; Wu YW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087402; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401; Young RJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/365; [No title captured]	25	84	84	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					702	705		10.1038/nature07729	http://dx.doi.org/10.1038/nature07729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194446				2022-12-28	WOS:000263064700036
J	Pitcher, T; Kalikoski, D; Pramod, G; Short, K				Pitcher, Tony; Kalikoski, Daniela; Pramod, Ganapathiraju; Short, Katherine			Not honouring the code	NATURE			English	Editorial Material									[Pitcher, Tony; Pramod, Ganapathiraju] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Kalikoski, Daniela] Fed Univ Rio Grande, Rio Grande, RS, Brazil; [Short, Katherine] WWF Int, CH-1196 Gland, Switzerland	University of British Columbia; Universidade Federal do Rio Grande; World Wildlife Fund	Pitcher, T (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada.	pitcher.t@gmail.com	Pramod, Ganapathiraju/AAI-5018-2020	Ganapathiraju, Pramod/0000-0001-8126-3432				AGNEW D, PLOS 1 IN PRESS; [Anonymous], 1995, COD COND RESP FISH; Esty D.C., 2006, PILOT ENV PERFORMANC; PITCHER TJ, 2006, FISHERIES CTR RES RE, V14; PITCHER TJ, 2009, SAFE CONDUCT 12 YEAR; Pitcher TJ, 1999, RAPFISH RAPID APPRAI	6	133	135	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					658	659		10.1038/457658a	http://dx.doi.org/10.1038/457658a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EA	19194431				2022-12-28	WOS:000263064700020
J	Steinbrook, R				Steinbrook, Robert			Physician-Industry Relations-Will Fewer Gifts Make a Difference?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												steinbrook@attglobal.net						Advanced Medical Technology Association, 2008, COD ETH INT HEALTHC; Association of American Medical Colleges, 2008, IND FUND MED ED REP; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Pharmaceutical Research and Manufacturers of America, 2008, COD INT HEALTHC PROF	5	21	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					557	559		10.1056/NEJMp0900143	http://dx.doi.org/10.1056/NEJMp0900143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402QS	19196671				2022-12-28	WOS:000263028800001
J	Petitti, DB; Teutsch, SM; Barton, MB; Sawaya, GF; Ockene, JK; DeWitt, T				Petitti, Diana B.; Teutsch, Steven M.; Barton, Mary B.; Sawaya, George F.; Ockene, Judith K.; DeWitt, Thomas		US Preventive Serv Task Force	Update on the Methods of the US Preventive Services Task Force: Insufficient Evidence	ANNALS OF INTERNAL MEDICINE			English	Article							DECISION-MAKING; SKIN-CANCER; STRENGTH; RECOMMENDATIONS; QUALITY; SYSTEMS	The U.S. Preventive Services Task Force (USPSTF) seeks to provide reliable and accurate evidence-based recommendations to primary care clinicians. However, clinicians indicate frustration with the lack of guidance provided by the USPSTF when the evidence is insufficient to make a recommendation. This article describes a new USPSTF plan to commission its Evidence-based Practice Centers to collect information in 4 domains pertinent to clinical decisions about prevention and to report this information routinely. The 4 domains are potential preventable burden, potential harm of the intervention, costs (both monetary and opportunity), and current practice. The process and rationale used to select these domains are presented, along with examples of how clinicians might use the information to guide clinical decision making when evidence is insufficient.	[Petitti, Diana B.] Arizona State Univ, Dept Biomed Informat, Phoenix, AZ 85041 USA; Merck & Co Inc, West Point, PA USA; Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA	Arizona State University; Arizona State University-Downtown Phoenix; Merck & Company; Agency for Healthcare Research & Quality; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Petitti, DB (corresponding author), Arizona State Univ, Dept Biomed Informat, Phoenix, AZ 85041 USA.							Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2005, HEALTH AFFAIR, V24, P102, DOI 10.1377/hlthaff.24.1.102; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Barton MB, 2007, ANN INTERN MED, V147, P123, DOI 10.7326/0003-4819-147-2-200707170-00171; Berg AO, 2004, ANN INTERN MED, V140, P738, DOI 10.7326/0003-4819-140-9-200405040-00014; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Bruce AJ, 2000, MAYO CLIN PROC, V75, P491; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V150, P188, DOI 10.7326/0003-4819-150-3-200902030-00020; Clancy CM, 2005, HEALTH AFFAIR, V24, P151, DOI 10.1377/hlthaff.24.1.151; Diederich S, 2000, CANCER, V89, P2457, DOI 10.1002/1097-0142(20001201)89:11+<2457::AID-CNCR22>3.0.CO;2-7; Djulbegovic B, 1999, MED HYPOTHESES, V53, P253, DOI 10.1054/mehy.1998.0020; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; FEINSTEIN AR, 1985, ARCH INTERN MED, V145, P1257, DOI 10.1001/archinte.145.7.1257; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2005, HEALTH AFFAIR, V24, P123, DOI 10.1377/hlthaff.24.1.123; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Krist AH, 2007, ANN FAM MED, V5, P120, DOI 10.1370/afm.622; Lomas J, 2005, CONCEPTUALIZING COMB; Merenstein D, 2004, JAMA-J AM MED ASSOC, V291, P15, DOI 10.1001/jama.291.1.15; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Steinberg EP, 2005, HEALTH AFFAIR, V24, P80, DOI 10.1377/hlthaff.24.1.80; Teutsch SM, 2005, MED DECIS MAKING, V25, P487, DOI 10.1177/0272989X05281156; Tucker JA, 2006, ADDICTION, V101, P918, DOI 10.1111/j.1360-0443.2006.01396.x; U.S. Preventive Services Task Force, 2003, GUID CLIN PREV SERV; US Preventive Services Task Force, 2008, AHRQ PUBL; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009; 2008, SWEDISH LUNG CANC SC	30	83	82	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					199	+		10.7326/0003-4819-150-3-200902030-00010	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402RA	19189910				2022-12-28	WOS:000263029600007
J	Best, RB; Hummer, G				Best, Robert B.; Hummer, Gerhard			BIOCHEMISTRY Unfolding the Secrets of Calmodulin	SCIENCE			English	Editorial Material							C-TERMINAL DOMAIN; SINGLE PROTEIN; DYNAMICS; MOLECULE; BINDING		[Best, Robert B.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Hummer, Gerhard] NIDDKD, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Best, RB (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gerhard.hummer@nih.gov	Hummer, Gerhard/A-2546-2013; Best, Robert/H-7588-2016	Hummer, Gerhard/0000-0001-7768-746X; Best, Robert/0000-0002-7893-3543	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029033, ZIADK029033, ZIADK029037] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK029033-08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Best RB, 2008, J PHYS CHEM B, V112, P5968, DOI 10.1021/jp075955j; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	16	9	9	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					593	594		10.1126/science.1169555	http://dx.doi.org/10.1126/science.1169555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179519	Green Accepted			2022-12-28	WOS:000262862800030
J	Strandberg, TE; Pitkala, KH; Tilvis, RS				Strandberg, Timo E.; Pitkala, Kaisu H.; Tilvis, Reijo S.			Cytomegalovirus Antibody Level and Mortality Among Community-Dwelling Older Adults With Stable Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							IMMUNOCOMPETENT PATIENTS; INFECTION; INFLAMMATION; IMPAIRMENT		[Strandberg, Timo E.] Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland; [Pitkala, Kaisu H.] Univ Cent Hosp Helsinki, Unit Gen Practice, Helsinki, Finland; [Tilvis, Reijo S.] Univ Cent Hosp Helsinki, Clin Internal Med & Geriatr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Strandberg, TE (corresponding author), Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland.	timo.strandberg@oulu.fi		Pitkala, Kaisu/0000-0001-9659-6985				Aiello AE, 2008, J GERONTOL A-BIOL, V63, P610, DOI 10.1093/gerona/63.6.610; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; Strandberg TE, 2001, AM HEART J, V142, P945, DOI 10.1067/mhj.2001.119609	6	81	82	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					380	382						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176439				2022-12-28	WOS:000262777200017
J	Kleinman, A				Kleinman, Arthur			Caregiving: the odyssey of becoming more human	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						Abel E. K., 2000, HEARTS WISDOM AM WOM; Alterra Aaron, 1999, CAREGIVER LIFE ALZHE; Kleinman Arthur, 2006, WHAT REALLY MATTERS; Reiff David, 2008, SWIMMING SEA DEATH S; Tronto J, 1993, MORAL BOUNDARIES	5	94	96	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					292	293		10.1016/S0140-6736(09)60087-8	http://dx.doi.org/10.1016/S0140-6736(09)60087-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19177629	Green Submitted			2022-12-28	WOS:000262728100014
J	Baehrecke, EH				Baehrecke, Eric H.			Autophagy SEPArates Germline and Somatic Cells	CELL			English	Editorial Material							NEURODEGENERATION; DEGRADATION	Cellular determinants of the germline selectively accumulate in germ cell precursors and influence cell fate during early development in many organisms. Zhang et al. (2009) now report that targeted autophagy mediated by the SEPA-1 protein depletes germplasm proteins from somatic cells during early development of the nematode.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	eric.baehrecke@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431, R56GM059136, R01GM059136] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059136-09, GM079431, R01 GM079431, GM059136, R56 GM059136, R01 GM079431-04, R01 GM059136] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x	8	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					207	208		10.1016/j.cell.2009.01.003	http://dx.doi.org/10.1016/j.cell.2009.01.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167322	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000262648800008
J	Barr, AJ; Ugochukwu, E; Lee, WH; King, ONF; Filippakopoulos, P; Alfano, I; Savitsky, P; Burgess-Brown, NA; Muller, S; Knapp, S				Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan			Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome	CELL			English	Article							RECEPTOR-TYPE-Z; CRYSTAL-STRUCTURE; RPTP-ALPHA; SUBSTRATE-SPECIFICITY; DIFFRACTION DATA; PTP-SIGMA; 1B; INHIBITOR; MECHANISM; GROWTH	Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-totoe'' dimerization model for RPTP gamma/zeta that is distinct from the "inhibitory wedge'' model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.	[Barr, Alastair J.; Ugochukwu, Emilie; Lee, Wen Hwa; King, Oliver N. F.; Filippakopoulos, Panagis; Alfano, Ivan; Savitsky, Pavel; Burgess-Brown, Nicola A.; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	University of Oxford; University of Oxford	Barr, AJ (corresponding author), Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	alastair.barr@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Knapp, Stefan/AAG-2347-2019; Lee, Wen Hwa/G-1250-2013; Lee, Wen Hwa/GZA-8183-2022	Knapp, Stefan/0000-0001-5995-6494; Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Barr, Alastair/0000-0001-7738-8419; Filippakopoulos, Panagis/0000-0002-1515-1317; Muller-Knapp, Susanne/0000-0003-2402-4157; Savitsky, Pavel/0000-0001-8584-7750; King, Oliver/0000-0002-6152-7207	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada; Glaxo Smith Kline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Glaxo Smith Kline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	We gratefully acknowledge all our colleagues at the SGC, in particular J. Elkins, C. Johansson, E. Salah, J. Eswaran, and T. Keates. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, Glaxo Smith Kline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barrett AC, 2006, EXP CLIN PSYCHOPHARM, V14, P1, DOI 10.1037/1064-1297.14.1.1; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Leslie AGW, 1992, RECENT CHANGES MOSFL; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Nakamura M, 2003, CANCER RES, V63, P737; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Sonnenburg ED, 2003, BIOCHEMISTRY-US, V42, P7904, DOI 10.1021/bi0340503; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Villa F, 2005, J BIOL CHEM, V280, P8180, DOI 10.1074/jbc.M412211200; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	55	345	368	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					352	363		10.1016/j.cell.2008.11.038	http://dx.doi.org/10.1016/j.cell.2008.11.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167335	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000262648800022
J	van Mantgem, PJ; Stephenson, NL; Byrne, JC; Daniels, LD; Franklin, JF; Fule, PZ; Harmon, ME; Larson, AJ; Smith, JM; Taylor, AH; Veblen, TT				van Mantgem, Phillip J.; Stephenson, Nathan L.; Byrne, John C.; Daniels, Lori D.; Franklin, Jerry F.; Fule, Peter Z.; Harmon, Mark E.; Larson, Andrew J.; Smith, Jeremy M.; Taylor, Alan H.; Veblen, Thomas T.			Widespread Increase of Tree Mortality Rates in the Western United States	SCIENCE			English	Article							CLIMATE-CHANGE; NORTH-AMERICA; LONG-TERM; FOREST; DROUGHT; GROWTH; DISTURBANCES; RESTORATION; DYNAMICS; FIRE	Persistent changes in tree mortality rates can alter forest structure, composition, and ecosystem services such as carbon sequestration. Our analyses of longitudinal data from unmanaged old forests in the western United States showed that background ( noncatastrophic) mortality rates have increased rapidly in recent decades, with doubling periods ranging from 17 to 29 years among regions. Increases were also pervasive across elevations, tree sizes, dominant genera, and past fire histories. Forest density and basal area declined slightly, which suggests that increasing mortality was not caused by endogenous increases in competition. Because mortality increased in small trees, the overall increase in mortality rates cannot be attributed solely to aging of large trees. Regional warming and consequent increases in water deficits are likely contributors to the increases in tree mortality rates.	[van Mantgem, Phillip J.; Stephenson, Nathan L.] Western Ecol Res Ctr, US Geol Survey, Three Rivers, CA 93271 USA; [Byrne, John C.] USDA Forest Serv, Rocky Mt Res Stn, Moscow, ID 83843 USA; [Daniels, Lori D.] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada; [Franklin, Jerry F.; Larson, Andrew J.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Fule, Peter Z.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Fule, Peter Z.] No Arizona Univ, Ecol Restorat Inst, Flagstaff, AZ 86011 USA; [Harmon, Mark E.] Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; [Smith, Jeremy M.; Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Taylor, Alan H.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA	United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service; University of British Columbia; University of Washington; University of Washington Seattle; Northern Arizona University; Northern Arizona University; Oregon State University; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	van Mantgem, PJ (corresponding author), Western Ecol Res Ctr, US Geol Survey, Arcata, CA 95521 USA.	pvanmantgem@usgs.gov; nstephenson@usgs.gov	Veblen, Thomas T./U-6461-2018; Noojipady, Praveen/B-2511-2010	Daniels, Lori/0000-0002-5015-8311	NSF's Long-term Studies Program [DEB-0218088]; Wind River Canopy Crane Program [PNW 08-DG- 11261952488]; USDA Forest Service's Pacific Northwest; Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF [DEB-0743498, BCS-0825823]; Natural Science and Engineering Research Council of Canada; U.S. National Park Service; U.S. Geological Survey	NSF's Long-term Studies Program(National Science Foundation (NSF)); Wind River Canopy Crane Program; USDA Forest Service's Pacific Northwest(United States Department of Agriculture (USDA)United States Forest Service); Pacific Southwest; Rocky Mountain research stations; McIntire-Stennis Cooperative Forestry Program; NSF(National Science Foundation (NSF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Park Service; U.S. Geological Survey(United States Geological Survey)	We thank the many people involved in establishing and maintaining the permanent forest plots; C. Allen, A. Das, J. Halofsky, J. Hicke, J. Lutz, and four anonymous reviewers for helpful comments on the manuscript; and J. Yee for essential statistical advice. The forest plots were funded by NSF's Long- term Studies Program (DEB- 0218088); the Wind River Canopy Crane Program through cooperative agreement PNW 08-DG- 11261952488 with the USDA Forest Service Pacific Northwest Research Station; various awards through the USDA Forest Service's Pacific Northwest, Pacific Southwest, and Rocky Mountain research stations and the McIntire-Stennis Cooperative Forestry Program; NSF awards DEB- 0743498 and BCS- 0825823; the Natural Science and Engineering Research Council of Canada; various awards through the U.S. National Park Service and U.S. Geological Survey (USGS). This work is a contribution of the Western Mountain Initiative (a USGS global change research project) and the Cordillera Forest Dynamics Network (CORFOR).	Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown RT, 2004, CONSERV BIOL, V18, P903, DOI 10.1111/j.1523-1739.2004.521_1.x; Diaz HF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GLO31253; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Fellows AW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033965; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Hicke JA, 2007, ECOL APPL, V17, P2387, DOI 10.1890/06-1951.1; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; McDonald G.I., 2001, WHITEBARK PINE COMMU, P193; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; Oliver C.D., 1990, FOREST STAND DYNAMIC; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	24	1193	1234	20	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					521	524		10.1126/science.1165000	http://dx.doi.org/10.1126/science.1165000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164752				2022-12-28	WOS:000262587900047
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch	NATURE			English	Article							MESSENGER-RNA; STRUCTURAL BASIS; BINDING; EXPRESSION; TRANSCRIPTION; RIBOSOME	The biosynthesis of several protein cofactors is subject to feedback regulation by riboswitches(1-3). Flavin mononucleotide (FMN)specific riboswitches(4,5), also known as RFN elements(6), direct expression of bacterial genes involved in the biosynthesis and transport of riboflavin (vitamin B-2) and related compounds. Here we present the crystal structures of the Fusobacterium nucleatum riboswitch bound to FMN, riboflavin and antibiotic roseoflavin(7). The FMN riboswitch structure, centred on an FMN-bound six-stem junction, does not fold by collinear stacking of adjacent helices, typical for folding of large RNAs. Rather, it adopts a butterfly-like scaffold, stapled together by opposingly directed but nearly identically folded peripheral domains. FMN is positioned asymmetrically within the junctional site and is specifically bound to RNA through interactions with the isoalloxazine ring chromophore and direct and Mg2+-mediated contacts with the phosphate moiety. Our structural data, complemented by binding and footprinting experiments, imply a largely pre-folded tertiary RNA architecture and FMN recognition mediated by conformational transitions within the junctional binding pocket. The inherent plasticity of the FMN-binding pocket and the availability of large openings make the riboswitch an attractive target for structure-based design of FMN-like antimicrobial compounds. Our studies also explain the effects of spontaneous and antibiotic-induced deregulatory mutations and provided molecular insights into FMN-based control of gene expression in normal and riboflavin-overproducing bacterial strains.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	the US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel of beamline X29 at the Brookhaven National Laboratory and beamline 24-ID-C at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank L. Jaeger (University of California, Santa Barbara) for discussions and O. Ouerfelli (Memorial Sloan-Kettering Cancer Center, New York) for the synthesis of iridium hexamine. D. J. P. was supported by funds from the National Institutes of Health.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Burgess Catherine M, 2006, Microb Cell Fact, V5, P24, DOI 10.1186/1475-2859-5-24; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; Feig A. L., 1999, RNA WORLD, P287; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serganov A, 1997, EUR J BIOCHEM, V246, P291, DOI 10.1111/j.1432-1033.1997.00291.x; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899	35	181	198	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					233	U10		10.1038/nature07642	http://dx.doi.org/10.1038/nature07642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19169240	Green Accepted			2022-12-28	WOS:000264059700050
J	Taylor, I				Taylor, Ian			Recession Watch: Learn to convince politicians	NATURE			English	Editorial Material												taylori@parliament.uk							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					958	959		10.1038/457958b	http://dx.doi.org/10.1038/457958b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225499				2022-12-28	WOS:000263425400018
J	Gerber, LR; Morissette, L; Kaschner, K; Pauly, D				Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin; Pauly, Daniel			ECOLOGY Should Whales Be Culled to Increase Fishery Yield?	SCIENCE			English	Editorial Material							DIVERSITY; ISSUE		[Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Morissette, Lyne] Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Kaschner, Kristin] Univ Freiburg, Inst Biol & Zool, Evolut Biol & Ecol Lab, Freiburg, Germany; [Pauly, Daniel] Univ British Columbia, Sea Around Us Project, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Arizona State University; Arizona State University-Tempe; University of Freiburg; University of British Columbia	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	Kaschner, Kristin/GQQ-6475-2022; Pauly, Daniel Marc/AAY-2316-2021	Gerber, Leah/0000-0002-6763-6842; Pauly, Daniel/0000-0003-3756-4793; Kaschner, Kristin/0000-0002-4061-626X				3rd Millennium Foundation, 2007, JAP VOT CONS OP INT; Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Bogstad Bjarte, 1997, Journal of Northwest Atlantic Fishery Science, V22, P317; BUSBY L, 2004, GLOBAL CORRUPTION RE, P76; Clapham PJ, 2007, MAR POLICY, V31, P314, DOI 10.1016/j.marpol.2006.09.004; Corkeron PJ, 2009, MAR ECOL PROG SER, V375, P305, DOI 10.3354/meps07882; Corkeron PJ, 2004, CONSERV BIOL, V18, P847, DOI 10.1111/j.1523-1739.2004.00255.x; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Gales NJ, 2005, NATURE, V435, P883, DOI 10.1038/435883a; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herrera GE, 2006, MAR POLICY, V30, P261, DOI 10.1016/j.marpol.2004.12.005; Higham JES, 2007, CONSERV BIOL, V21, P554, DOI 10.1111/j.1523-1739.2006.00580.x; Holt SJ, 2007, MAR POLLUT BULL, V54, P1081, DOI 10.1016/j.marpolbul.2007.05.011; Hoyt E, 2002, COAST MANAGE, V30, P381, DOI 10.1080/089207502900273; *IWC, 2002, ICES J MAR SCI, V4, P325; *IWC, 2008, S UT DUR RESS MAR VI; *IWC, 2008, SCI COMM REP 60 ANN; *IWC, 2006, CHAIRM REP INT WHAL; *IWC, 2004, ICES J MAR SCI S, V6, P413; Jann B., 2003, Journal of Cetacean Research and Management, V5, P125; KASCHNER K, 2005, STATE ANIMALS, V3, P95; KATONA S. K., 1990, REPORT INT WHALING C, P295; Komatsu M., 2001, TRUTH WHALING DISPUT; Miller AR, 2007, GLOBAL ENVIRON POLIT, V7, P69, DOI 10.1162/glep.2007.7.1.69; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PAULY D, 2008, SEA AROUND US PROJEC; Perrin WF, 2002, ENCY MARINE MAMMALS; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stefansson Gunnar, 1997, Journal of Northwest Atlantic Fishery Science, V22, P357; Stringer KD, 2006, DIPL STATECRAFT, V17, P547, DOI 10.1080/09592290600867636; Tamura T, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P143, DOI 10.1079/9780851996332.0143; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	37	48	49	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					880	881		10.1126/science.1169981	http://dx.doi.org/10.1126/science.1169981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213900				2022-12-28	WOS:000263295400022
J	Watts, G				Watts, Geoff			Feature Academic Medicine Beyond the impact factor	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Buxton M, 2000, PUBLIC MONEY MANAGE, V20, P29, DOI 10.1111/1467-9302.00233; *HIGH ED FUND COUN, RES EXC FRAM REF CON; *HIGH ED FUND COUN, 132008 HIGH ED FUND; Higher Education Funding Council, RES EXC FRAM; Royal Netherlands Academy of Arts and Sciences Council for Medical Sciences, 2002, SOC IMP APPL HLTH RE; Smith R, 2001, BRIT MED J, V323, P528, DOI 10.1136/bmj.323.7312.528; Watts G, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1805	7	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 13	2009	338								b553	10.1136/bmj.b553	http://dx.doi.org/10.1136/bmj.b553			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZZ	19218319				2022-12-28	WOS:000263976300005
J	Buckling, A; Maclean, RC; Brockhurst, MA; Colegrave, N				Buckling, Angus; Maclean, R. Craig; Brockhurst, Michael A.; Colegrave, Nick			The Beagle in a bottle	NATURE			English	Review							TERM EXPERIMENTAL EVOLUTION; HIGH MUTATION-RATES; ESCHERICHIA-COLI; EXPERIMENTAL POPULATIONS; PSEUDOMONAS-AERUGINOSA; ADAPTIVE RADIATION; SOCIAL-BEHAVIOR; ADAPTATION; DYNAMICS; COEVOLUTION	Why infer evolution when you can watch it happen in real time? This is the basic premise of using populations of fast- replicating microorganisms in test tubes to study evolution. The approach, known as experimental evolution, has provided a way of testing many of the key hypotheses that arose from the modern evolutionary synthesis. However, details of the unnatural histories of microorganisms in test tubes can be extrapolated only so far. Potential future directions for the approach include studying microbial evolution for its own sake under the most natural conditions possible in the test tube, and testing some qualitative theories of genome evolution.	[Buckling, Angus; Maclean, R. Craig] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3ZB, Merseyside, England; [Colegrave, Nick] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Oxford; University of Liverpool; University of Edinburgh	Buckling, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	angus.buckling@zoo.ox.ac.uk	Colegrave, Nick/F-3916-2010; Brockhurst, Michael A/A-6247-2009	Brockhurst, Michael/0000-0003-0362-820X; Buckling, Angus/0000-0003-1170-4604	Royal Society; Leverhulme Trust	Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust)	We thank the Royal Society and the Leverhulme Trust for funding.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-126; [Anonymous], EVOLUTION MODERN SYN; [Anonymous], 1861, ORIGIN SPECIES MEANS; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; BELL G, 2007, MECH EVOLUTION; Benmayor R, 2008, EVOLUTION, V62, P467, DOI 10.1111/j.1558-5646.2007.00268.x; Bjarnsholt T, 2007, PHILOS T R SOC B, V362, P1213, DOI 10.1098/rstb.2007.2046; Blount ZD, 2005, MOL MICROBIOL, V55, P312, DOI 10.1111/j.1365-2958.2004.04391.x; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Dallinger W. H., 1878, P R SOC LONDON, V27, P332, DOI [10.1098/rspl.1878.0055, DOI 10.1098/RSPL.1878.0055]; Darwin C., 1871, P475; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; DRAKE JW, 1991, ANNU REV GENET, V25, P125, DOI 10.1146/annurev.ge.25.120191.001013; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; Fisher R.A., 1930, GENETICAL THEORY NAT; Forde SE, 2007, AM NAT, V169, P794, DOI 10.1086/516848; Gause G. F., 1934, STRUGGLE EXISTENCE; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gratten J, 2008, SCIENCE, V319, P318, DOI 10.1126/science.1151182; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Harrison F, 2005, CURR BIOL, V15, P1968, DOI 10.1016/j.cub.2005.09.048; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; HELLING RB, 1987, GENETICS, V116, P349; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; Manefield M, 2005, ENVIRON MICROBIOL, V7, P715, DOI 10.1111/j.1462-2920.2004.00746.x; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; Mortlock RP, 1984, MICROORGANISMS MODEL; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ostrowski EA, 2008, P ROY SOC B-BIOL SCI, V275, P277, DOI 10.1098/rspb.2007.1244; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Thompson JD., 1994, COEVOLUTIONARY PROCE; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Wagner A., 2005, ROBUSTNESS EVOLVABIL; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	70	157	160	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					824	829		10.1038/nature07892	http://dx.doi.org/10.1038/nature07892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212400				2022-12-28	WOS:000263266700032
J	Ceci, S; Williams, WM				Ceci, Stephen; Williams, Wendy M.			Darwin 200: Should scientists study race and IQ? YES: The scientific truth must be pursuedYES: The scientific truth must be pursued	NATURE			English	Editorial Material									[Ceci, Stephen; Williams, Wendy M.] Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA	Cornell University	Ceci, S (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14853 USA.	sjc9@cornell.edu; wmw5@cornell.edu						Barnett SM, 2004, CONTEMP PSYCHOL, V49, P389, DOI 10.1037/004367; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; Flynn, 2007, WHAT IS INTELLIGENCE; Lynn R., 2006, IQ GLOBAL INEQUALITY; Lynn R., 2002, IQ WEALTH NATIONS	5	26	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					788	789		10.1038/457788a	http://dx.doi.org/10.1038/457788a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406AF	19212385	Bronze			2022-12-28	WOS:000263266700017
J	Kennedy, TJT; Regehr, G; Currie, R; Currie, E; Baker, GR; Lingard, L				Kennedy, Tara J. T.; Regehr, Glenn; Currie, Richard; Currie, Elizabeth; Baker, G. Ross; Lingard, Lorelei			Preserving professional credibility: grounded theory study of medical trainees' requests for clinical support	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To develop a conceptual framework of the influences on medical trainees' decisions regarding requests for clinical support from a supervisor. Design Phase 1: members of teaching teams in internal and emergency medicine were observed during regular clinical activities (216 hours) and subsequently completed brief interviews. Phase 2: 36 in depth interviews were conducted using videotaped vignettes to probe tacit influences on decisions to request support. Data collection and analysis used grounded theory methods. Setting Three teaching hospitals in an urban setting in Canada. Participants 124 members of teaching teams on general internal medicine wards and in the emergency department, comprising 31 attending physicians, 57 junior and senior residents, 28 medical students, and eight nurses. Purposeful sampling to saturation was conducted. Results Trainees' decisions about whether or not to seek clinical support were influenced by three issues: the clinical question (clinical importance, scope of practice), supervisor factors (availability, approachability), and trainee factors (skill, desire for independence, evaluation). Trainees perceived that requesting frequent/inappropriate support threatened their credibility and used rhetorical strategies to preserve credibility. These strategies included building a case for the importance of requests, saving requests for opportune moments, making a plan before requesting support, and targeting requests to specific team members. Conclusions Trainees consider not only clinical implications but also professional credibility when requesting support from clinical supervisors. Exposing the complexity of this process provides the opportunity to make changes to training programmes to promote timely supervision and provides a framework for further exploration of the impact of clinical training on quality of care of patients.	[Kennedy, Tara J. T.; Regehr, Glenn; Currie, Richard; Currie, Elizabeth; Lingard, Lorelei] Wilson Ctr Res Educ, Toronto, ON, Canada; [Kennedy, Tara J. T.] Bloorview Kids Rehab, Toronto, ON, Canada; [Kennedy, Tara J. T.] Stan Cassidy Ctr Rehabil, Fredericton, NB, Canada; [Regehr, Glenn; Currie, Richard; Currie, Elizabeth; Baker, G. Ross] Univ Toronto, Fac Med, Toronto, ON, Canada; [Regehr, Glenn] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Lingard, Lorelei] SickKids Learning Inst, Toronto, ON, Canada; [Lingard, Lorelei] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Kennedy, TJT (corresponding author), Wilson Ctr Res Educ, Toronto, ON, Canada.	tara.kennedy@utoronto.ca	Regehr, Glenn/K-4810-2016; Baker, Ross/B-5107-2012; Lingard, Lorelei/G-3322-2011; Baker, G. Ross/P-4867-2019	Regehr, Glenn/0000-0002-3144-331X; Baker, G. Ross/0000-0002-4107-7114	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR), which had no involvement in the research process. LL is supported by a CIHR New Investigators Award.	*AM ASS MED COLL, 2006, COMP RES PHYS THEIR; *AUSTR MED ASS, 2005, AMA POS STAT PREV ME; Bosk CL, 2003, FORGIVE REMEMBER MAN; Burke Kenneth, 1966, LANGUAGE SYMBOLIC AC; CHARMAZ K, 1954, SAGE HDB QUALITATIVE, P507; Charmaz Kathy., 2000, HDB QUALITATIVE RES, DOI DOI 10.1177/0891241609342193; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; *GEN MED COUN, 1997, NEW DOCT; *GEN MED COUNC, 2007, STAND TRAIN FDN; Ginsburg S, 2003, MED EDUC, V37, P350, DOI 10.1046/j.1365-2923.2003.01326.x; Ginsburg S, 2002, ACAD MED, V77, P516, DOI 10.1097/00001888-200206000-00007; Glaser B.G., 1965, AWARENESS DYING; Goswami D., 1985, WRITING NONACADEMIC; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Holden JD, 2001, J EVAL CLIN PRACT, V7, P65, DOI 10.1046/j.1365-2753.2001.00280.x; Kelle U, 2002, COMPUTER AIDED QUALI; Kennedy TJT, 2007, J GEN INTERN MED, V22, P1080, DOI 10.1007/s11606-007-0179-3; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Kennedy TJT, 2005, ACAD MED, V80, pS106, DOI 10.1097/00001888-200510001-00028; King E, 2006, J HOSP MED, V1, P296, DOI 10.1002/jhm.114; KONNER M, 1987, BECOMING DOCTOR; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Lincoln Y. S., 2005, SAGE HDB QUALITATIVE, DOI DOI 10.4135/9781849208550.N1; Lingard L, 2003, SOC SCI MED, V56, P603, DOI 10.1016/S0277-9536(02)00057-6; Lingard L, 1999, ACAD MED, V74, P507, DOI 10.1097/00001888-199905000-00015; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; POPE J, 2003, CBS NEWS        0929; *ROY COLL PHYS SUR, 2002, GEN STAND ACCR; SINCLAIR S, 1997, MAKING DOCTORS; SOMMERS PS, 1994, ACAD MED, V69, pS84, DOI 10.1097/00001888-199410000-00051; Strauss A., 1998, BASICS QUALITATIVE R; 2001, ACAD MED, V78, P112	32	114	115	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2009	338								b128	10.1136/bmj.b128	http://dx.doi.org/10.1136/bmj.b128			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZT	19204035	hybrid, Green Published			2022-12-28	WOS:000263975700001
J	Krug, AZ; Jablonski, D; Valentine, JW				Krug, Andrew Z.; Jablonski, David; Valentine, James W.			Signature of the End-Cretaceous Mass Extinction in the Modern Biota	SCIENCE			English	Article							LATITUDINAL DIVERSITY GRADIENT; RECENT BIVALVE FAUNAS; INDO-WEST PACIFIC; FOSSIL RECORD; MARINE REALM; DIVERSIFICATION; ORIGINATION; SPECIATION; EVOLUTION; PATTERNS	The long- term effects of mass extinctions on spatial and evolutionary dynamics have been poorly studied. Here we show that the evolutionary consequences of the end- Cretaceous [ Cretaceous/ Paleogene ( K/ Pg)] mass extinction persist in present- day biogeography. The geologic ages of genera of living marine bivalves show a significant break from a smooth exponential distribution, corresponding to the K/ Pg boundary. The break reflects a permanent increase in origination rates, intermediate between the Mesozoic rate and the post- extinction recovery pulse. This global rate shift is most clearly seen today in tropical bioprovinces and weakens toward the poles. Coupled with the modern geographic distributions of taxa originating before and after the K/ Pg boundary, this spatial pattern indicates that tropical origination rates after the K/ Pg event have left a permanent mark on the taxonomic and biogeographic structure of the modern biota, despite the complex Cenozoic history of marine environments.	[Krug, Andrew Z.; Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Valentine, James W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valentine, James W.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krug, AZ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.				NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank M. Foote, S. M. Kidwell, T. D. Price, K. Roy, and three anonymous reviewers for comments and M. Foote for programming assistance. This research was supported by NASA.	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Crame JA, 2002, PALEOBIOLOGY, V28, P184; Foote M, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P245; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; Nee S, 2004, PALEOBIOLOGY, V30, P172, DOI 10.1666/0094-8373(2004)030<0172:EMESMI>2.0.CO;2; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; PEASE CM, 1987, PALEOBIOLOGY, V13, P484; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Roy K, 2007, AM NAT, V170, pS71, DOI 10.1086/519403; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Vermeij G.J., 1987, EVOLUTION ESCALATION; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x	31	54	54	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					767	771		10.1126/science.1164905	http://dx.doi.org/10.1126/science.1164905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197060				2022-12-28	WOS:000263066800042
J	Moses, M				Moses, Melanie			Being Human: Engineering: Worldwide ebb	NATURE			English	Editorial Material									[Moses, Melanie] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of New Mexico	Moses, M (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	melaniem@unm.edu							0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2009	457	7230					660	661		10.1038/457660a	http://dx.doi.org/10.1038/457660a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EA	19194432	Bronze			2022-12-28	WOS:000263064700021
J	Koppel, DA				Koppel, David A.			Medicine and the Media Serious documentary or freak show?	BRITISH MEDICAL JOURNAL			English	Editorial Material									So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Koppel, DA (corresponding author), So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland.	David.Koppel@ggc.scot.nhs.uk							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 4	2009	338								b71	10.1136/bmj.b71	http://dx.doi.org/10.1136/bmj.b71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OY	19193688				2022-12-28	WOS:000263876300013
J	Lenzer, J				Lenzer, Jeanne			Feature Profile Jeffery Taubenberger: Back to the future	BRITISH MEDICAL JOURNAL			English	Biographical-Item												jeanne.lenzer@gmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 4	2009	338								b264	10.1136/bmj.b264	http://dx.doi.org/10.1136/bmj.b264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414OY	19193680				2022-12-28	WOS:000263876300003
J	Wolff, T; Tai, E; Miller, T				Wolff, Tracy; Tai, Eric; Miller, Therese			Screening for Skin Cancer: An Update of the Evidence for the U. S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							CUTANEOUS MELANOMA; SELF-EXAMINATION; HISTOPATHOLOGIC DIAGNOSIS; THINNER MELANOMAS; ACCURACY; LESIONS; DERMATOLOGISTS; POPULATION; PHYSICIANS	Background: Skin cancer is the most commonly diagnosed cancer in the United States. The majority of skin cancer is nonmelanoma cancer, either basal cell cancer or squamous cell cancer. The incidence of both melanoma and nonmelanoma skin cancer has been increasing over the past 3 decades. In 2001, the U.S. Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against routine screening for skin cancer by using whole-body skin examination for early detection of skin cancer. Purpose: To update the evidence of benefits and harms of screening for skin cancer in the general population. Data Sources: MEDLINE and Cochrane Library searches from 1 June 1999 to 9 August 2005 for English-language articles; recent systematic reviews; reference lists of retrieved articles; and expert suggestions. Study Selection: English-language studies were selected to answer the following key question: Does screening in asymptomatic persons with whole-body examination by a primary care clinician or by self-examination reduce morbidity and mortality from skin cancer? Randomized, controlled trials and case-control studies of screening for skin cancer were selected. One author selected English-language studies to answer the following contextual questions: Can screening with whole-body examination by primary care clinicians or by self-examination accurately detect skin cancer? Does screening with whole-body examination or by self-examination detect melanomas at an earlier stage (thinner lesions)? Data Extraction: All studies for the key question were reviewed, abstracted, and rated for quality by using predefined USPSTF criteria. Data Synthesis: No new evidence from controlled studies was found that addressed the benefit of screening for skin cancer with a whole-body examination by a physician. One article of fair quality, which reanalyzed data from a 1996 study identified for the 2001 report for the USPSTF, provides limited but insufficient evidence on the benefit of skin self-examination in the reduction of morbidity and mortality from melanoma. Limitations: Direct evidence linking skin cancer screening to improved health outcomes is lacking. Information is limited on the accuracy of screening by physicians or patients using real patients and lesions. Conclusion: The limited evidence prevents accurate estimation of the benefits of screening for skin cancer in the general primary care population.	[Wolff, Tracy; Tai, Eric; Miller, Therese] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Wolff, T (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.							Aitken JF, 2006, J AM ACAD DERMATOL, V54, P105, DOI 10.1016/j.jaad.2005.08.072; Aitken JF, 2002, J MED SCREEN, V9, P33, DOI 10.1136/jms.9.1.33; Berg AO, 2001, AM J PREV MED, V20, P44, DOI 10.1016/S0749-3797(01)00259-8; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Brady MS, 2000, CANCER-AM CANCER SOC, V89, P342, DOI 10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P; Branstrom R, 2002, J AM ACAD DERMATOL, V46, P667, DOI 10.1067/mjd.2002.120463; Brochez L, 2001, J AM ACAD DERMATOL, V44, P979, DOI 10.1067/mjd.2001.113442; Carli P, 2005, EUR J CANCER PREV, V14, P51, DOI 10.1097/00008469-200502000-00007; Carli P, 2004, CLIN EXP DERMATOL, V29, P593, DOI 10.1111/j.1365-2230.2004.01628.x; Carli P, 2003, ARCH DERMATOL, V139, P607, DOI 10.1001/archderm.139.5.607; Chen SC, 2001, ARCH DERMATOL, V137, P1627; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; de Gannes GC, 2004, J CUTAN MED SURG, V8, P103, DOI 10.1177/120347540400800205; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Elwood J M, 1994, J Med Screen, V1, P22; Epstein DS, 1999, JAMA-J AM MED ASSOC, V281, P640, DOI 10.1001/jama.281.7.640; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; Garner KL, 2000, PRIMARY CARE, V27, P447, DOI 10.1016/S0095-4543(05)70206-2; Geller AC, 2003, J AM ACAD DERMATOL, V48, P34, DOI 10.1067/mjd.2003.9; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2001, AM J PREV MED, V20, P47, DOI 10.1016/S0749-3797(01)00258-6; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; McPherson M, 2006, J AM ACAD DERMATOL, V54, P783, DOI 10.1016/j.jaad.2005.08.065; Muhn CY, 2000, J AM ACAD DERMATOL, V42, P754, DOI 10.1067/mjd.2000.104895; Oliveria SA, 2004, ARCH DERMATOL, V140, P57, DOI 10.1001/archderm.140.1.57; Rager EL, 2005, AM FAM PHYSICIAN, V72, P269	26	111	112	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					194	+		10.7326/0003-4819-150-3-200902030-00009	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189909				2022-12-28	WOS:000263029600006
J	Paterson, AH; Bowers, JE; Bruggmann, R; Dubchak, I; Grimwood, J; Gundlach, H; Haberer, G; Hellsten, U; Mitros, T; Poliakov, A; Schmutz, J; Spannagl, M; Tang, HB; Wang, XY; Wicker, T; Bharti, AK; Chapman, J; Feltus, FA; Gowik, U; Grigoriev, IV; Lyons, E; Maher, CA; Martis, M; Narechania, A; Otillar, RP; Penning, BW; Salamov, AA; Wang, Y; Zhang, LF; Carpita, NC; Freeling, M; Gingle, AR; Hash, CT; Keller, B; Klein, P; Kresovich, S; McCann, MC; Ming, R; Peterson, DG; Mehboob-ur-Rahman; Ware, D; Westhoff, P; Mayer, KFX; Messing, J; Rokhsar, DS				Paterson, Andrew H.; Bowers, John E.; Bruggmann, Remy; Dubchak, Inna; Grimwood, Jane; Gundlach, Heidrun; Haberer, Georg; Hellsten, Uffe; Mitros, Therese; Poliakov, Alexander; Schmutz, Jeremy; Spannagl, Manuel; Tang, Haibao; Wang, Xiyin; Wicker, Thomas; Bharti, Arvind K.; Chapman, Jarrod; Feltus, F. Alex; Gowik, Udo; Grigoriev, Igor V.; Lyons, Eric; Maher, Christopher A.; Martis, Mihaela; Narechania, Apurva; Otillar, Robert P.; Penning, Bryan W.; Salamov, Asaf A.; Wang, Yu; Zhang, Lifang; Carpita, Nicholas C.; Freeling, Michael; Gingle, Alan R.; Hash, C. Thomas; Keller, Beat; Klein, Patricia; Kresovich, Stephen; McCann, Maureen C.; Ming, Ray; Peterson, Daniel G.; Mehboob-ur-Rahman; Ware, Doreen; Westhoff, Peter; Mayer, Klaus F. X.; Messing, Joachim; Rokhsar, Daniel S.			The Sorghum bicolor genome and the diversification of grasses	NATURE			English	Article							RICE GENOME; WIDE ANALYSIS; MAIZE GENOME; CELL-WALLS; EVOLUTION; SEQUENCE; IDENTIFICATION; RECOMBINATION; DUPLICATION; REVEALS	Sorghum, an African grass related to sugar cane and maize, is grown for food, feed, fibre and fuel. We present an initial analysis of the similar to 730- megabase Sorghumbicolor ( L.) Moench genome, placing, 98% of genes in their chromosomal context using whole- genome shotgun sequence validated by genetic, physical and syntenic information. Genetic recombination is largely confined to about one- third of the sorghum genome with gene order and density similar to those of rice. Retrotransposon accumulation in recombinationally recalcitrant heterochromatin explains the similar to 75% larger genome size of sorghum compared with rice. Although gene and repetitive DNA distributions have been preserved since palaeopolyploidization similar to 70 million years ago, most duplicated gene sets lost one member before the sorghum - rice divergence. Concerted evolution makes one duplicated chromosomal segment appear to be only a few million years old. About 24% of genes are grass- specific and 7% are sorghum- specific. Recent gene and microRNA duplications may contribute to sorghum's drought tolerance.	[Paterson, Andrew H.; Bowers, John E.; Tang, Haibao; Wang, Xiyin; Feltus, F. Alex; Gingle, Alan R.; Peterson, Daniel G.; Mehboob-ur-Rahman] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Bruggmann, Remy; Bharti, Arvind K.; Messing, Joachim] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Dubchak, Inna; Hellsten, Uffe; Poliakov, Alexander; Chapman, Jarrod; Grigoriev, Igor V.; Otillar, Robert P.; Salamov, Asaf A.; Rokhsar, Daniel S.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel S.] Stanford Univ, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Haberer, Georg; Spannagl, Manuel; Martis, Mihaela; Wang, Yu; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Wang, Xiyin] Hebei Polytech Univ, Coll Sci, Tangshan 063000, Hebei, Peoples R China; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Feltus, F. Alex] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29631 USA; [Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Entwicklungs & Mol Biol Pflanzen, D-40225 Dusseldorf, Germany; [Lyons, Eric; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; [Maher, Christopher A.; Narechania, Apurva; Zhang, Lifang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Penning, Bryan W.; McCann, Maureen C.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Carpita, Nicholas C.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Hash, C. Thomas] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Klein, Patricia] Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; [Klein, Patricia] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Peterson, Daniel G.] Mississippi State Univ, Mississippi Genome Explorat Lab, Starkville, MS 39762 USA; [Mehboob-ur-Rahman] NIBGE, Faisalabad, Pakistan; [Ware, Doreen] USDA, NAA Robert Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Rutgers State University New Brunswick; United States Department of Energy (DOE); Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Berkeley; North China University of Science & Technology; University of Zurich; Clemson University; Heinrich Heine University Dusseldorf; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; Mississippi State University; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA)	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Bowers, John/AAD-7601-2019; McCann, Maureen C/T-9258-2017; Schmutz, Jeremy/N-3173-2013; Keller, Beat/K-3093-2019; Rahman, Mehboob-ur-/I-7983-2015; Grimwood, Jane/ABD-5737-2021; Mayer, Klaus FX/M-7941-2015; Tang, Haibao/A-6715-2011; Wicker, Thomas/Z-1978-2019; Bowers, John/B-9245-2009	McCann, Maureen C/0000-0001-6956-4216; Schmutz, Jeremy/0000-0001-8062-9172; Keller, Beat/0000-0003-2379-9225; Mayer, Klaus FX/0000-0001-6484-1077; Tang, Haibao/0000-0002-3460-8570; Bowers, John/0000-0001-8984-9796; Bowers, John/0000-0001-5693-2796; Peterson, Daniel/0000-0002-0274-5968; Haberer, Georg/0000-0002-6612-6939; Gundlach, Heidrun/0000-0002-6757-0943; Spannagl, Manuel/0000-0003-0701-7035; Penning, Bryan/0000-0002-0374-8693; Bruggmann, Remy/0000-0001-5629-6363; Gowik, Udo/0000-0002-8986-7318; Martis, Mihaela-Maria/0000-0001-7509-2446; , Thomas/0000-0002-6777-7135; Rokhsar, Daniel/0000-0002-8704-2224; Lyons, Eric/0000-0002-3348-8845; Messing, Joachim/0000-0001-8260-2643; Grigoriev, Igor/0000-0002-3136-8903; Feltus, Frank/0000-0002-2123-6114	US National Science Foundation [DBI-9872649, DBI-0115903, MCB-0450260, DBI-0321467]; International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy [DE-FG05-95ER20194]; German Federal Ministry of Education GABI initiative [0313117, 0314000C]; US Department of Agriculture-Agricultural Research Service	US National Science Foundation(National Science Foundation (NSF)); International Consortium for Sugarcane Biotechnology; National Sorghum Producers; John Simon Guggenheim Foundation; US Department of Energy(United States Department of Energy (DOE)); German Federal Ministry of Education GABI initiative; US Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We thank the US Department of Energy Joint Genome Institute Community Sequencing Program, J. Bristow, S. Lucas and the JGI production sequencing team for sequencing sorghum; and L. Lin for contributions to Fig. 1. We appreciate funding from the US National Science Foundation (NSF DBI-9872649, 0115903; MCB-0450260), International Consortium for Sugarcane Biotechnology, National Sorghum Producers, and a John Simon Guggenheim Foundation fellowship to A.H.P.; US Department of Energy (DE-FG05-95ER20194) to J.M.; German Federal Ministry of Education GABI initiative to MIPS (0313117 and 0314000C); NSF DBI-0321467 to A.N.; and US Department of Agriculture-Agricultural Research Service to C.A.M., L.Z. and D.W.	Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102; Bowers JE, 2003, GENETICS, V165, P367; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; Haas B, 2002, GENOME BIOL, V3; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Hamblin MT, 2005, GENETICS, V171, P1247, DOI 10.1534/genetics.105.041566; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hazen SP, 2003, PLANT PHYSIOL, V132, P263, DOI 10.1104/pp.103.020016; HUO N, 2007, GENOMICS, V8, P135; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lohithaswa HC, 2007, THEOR APPL GENET, V115, P237, DOI 10.1007/s00122-007-0559-4; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCann MC, 1991, CYTOSKELETAL BASIS P, P109; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Ming R, 2006, PL BRED RE, V27, P15; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; PATERSON AH, 1995, P NATL ACAD SCI USA, V92, P6127, DOI 10.1073/pnas.92.13.6127; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Swigonova Z, 2005, GENETICS, V169, P891, DOI 10.1534/genetics.104.034629; Swigonova Z, 2004, COMP FUNCT GENOM, V5, P281, DOI 10.1002/cfg.395; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Xu JH, 2008, P NATL ACAD SCI USA, V105, P14330, DOI 10.1073/pnas.0807026105; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022	50	1964	2255	7	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					551	556		10.1038/nature07723	http://dx.doi.org/10.1038/nature07723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19189423	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000262852200034
J	Dodek, P				Dodek, Peter			Review: Tight glucose control reduces septicemia, but not death, and increases hypoglycemia in critically ill adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Dodek, P (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.							Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; National Quality Forum, 2007, SER REP EV HEALTHC 2	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-5	10.7326/0003-4819-150-2-200901200-02005	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172710				2022-12-28	WOS:000262655200023
J	Dias, A; Bouvier, D; Crepin, T; McCarthy, AA; Hart, DJ; Baudin, F; Cusack, S; Ruigrok, RWH				Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.			The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit	NATURE			English	Article							RNA-POLYMERASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; CLEAVAGE; BINDING; SITES; PB2; TRANSCRIPTION; RECOGNITION	The influenza virus polymerase, a heterotrimer composed of three subunits, PA, PB1 and PB2, is responsible for replication and transcription of the eight separate segments of the viral RNA genome in the nuclei of infected cells. The polymerase synthesizes viral messenger RNAs using short capped primers derived from cellular transcripts by a unique 'cap-snatching' mechanism(1). The PB2 subunit binds the 59 cap of host pre-mRNAs(2-4), which are subsequently cleaved after 10-13 nucleotides by the viral endonuclease, hitherto thought to reside in the PB2 (ref. 5) or PB1 (ref. 2) subunits. Here we describe biochemical and structural studies showing that the amino-terminal 209 residues of the PA subunit contain the endonuclease active site. We show that this domain has intrinsic RNA and DNA endonuclease activity that is strongly activated by manganese ions, matching observations reported for the endonuclease activity of the intact trimeric polymerase(6,7). Furthermore, this activity is inhibited by 2,4-dioxo-4-phenylbutanoic acid, a known inhibitor of the influenza endonuclease(8). The crystal structure of the domain reveals a structural core closely resembling resolvases and type II restriction endonucleases. The active site comprises a histidine and a cluster of three acidic residues, conserved in all influenza viruses, which bind two manganese ions in a configuration similar to other two-metal-dependent endonucleases. Two active site residues have previously been shown to specifically eliminate the polymerase endonuclease activity when mutated(9). These results will facilitate the optimisation of endonuclease inhibitors(10-12) as potential new anti-influenza drugs.	[Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.] UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, F-38042 Grenoble 9, France; [McCarthy, Andrew A.; Hart, Darren J.; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL)	Cusack, S (corresponding author), UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMR 5233, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	cusack@embl.fr	McCarthy, Andrew A/A-5926-2013; Hart, Darren/C-4858-2015	McCarthy, Andrew A/0000-0003-4478-0136; Baudin, Florence/0000-0003-0816-0861; Cusack, Stephen/0000-0002-9324-0796; CREPIN, Thibaut/0000-0003-2663-1794; Hart, Darren/0000-0002-3502-2002	EU FLUPOL [SP5B-CT-2007-044263]; ANR FLU INTERPOL [ANR-06-MIME-014-02]; MENRT	EU FLUPOL; ANR FLU INTERPOL(French National Research Agency (ANR)); MENRT	We thank the ESRF, EMBL and MRC-France for access to synchrotron facilities and the Partnership for Structural Biology for an integrated structural biology environment. The work was partially funded by the EU FLUPOL contract (SP5B-CT-2007-044263) and the ANR FLU INTERPOL contract (ANR-06-MIME-014-02). A. D. has a PhD fellowship from the MENRT. We thank J.-L. Decout for advice about the inhibitor, E. Kowalinski and C. Swale for RNA transcripts, and C. Petosa and J. Perona for a critical reading of the manuscript.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304, DOI 10.1128/AAC.40.5.1304; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Knizewski L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-40; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Nishino T, 2001, STRUCTURE, V9, P197, DOI 10.1016/S0969-2126(01)00576-7; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SHI LC, 1995, VIROLOGY, V208, P38, DOI 10.1006/viro.1995.1127; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189, DOI 10.1128/AAC.40.5.1189; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352	30	543	585	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					914	918		10.1038/nature07745	http://dx.doi.org/10.1038/nature07745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19194459				2022-12-28	WOS:000265182500048
J	Yu, YC; Bultje, RS; Wang, XQ; Shi, SH				Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai			Specific synapses develop preferentially among sister excitatory neurons in the neocortex	NATURE			English	Article							RADIAL GLIAL-CELLS; CORTICAL-NEURONS; SYNAPTIC CONNECTIONS; CEREBRAL-CORTEX; VISUAL-CORTEX; RAT; PLASTICITY; CIRCUITS; LAYERS; MIGRATION	Neurons in the mammalian neocortex are organized into functional columns(1,2). Within a column, highly specific synaptic connections are formed to ensure that similar physiological properties are shared by neuron ensembles spanning from the pia to the white matter. Recent studies indicate that synaptic connectivity in the neocortex is sparse and highly specific(3-8) to allow even adjacent neurons to convey information independently(9-12). How this fine-scale microcircuit is constructed to create a functional columnar architecture at the level of individual neurons largely remains a mystery. Here we investigate whether radial clones of excitatory neurons arising from the same mother cell in the developing neocortex serve as a substrate for the formation of this highly specific microcircuit. We labelled ontogenetic radial clones of excitatory neurons in the mouse neocortex by in utero intraventricular injection of enhanced green fluorescent protein (EGFP)-expressing retroviruses around the onset of the peak phase of neocortical neurogenesis. Multiple-electrode whole-cell recordings were performed to probe synapse formation among these EGFP-labelled sister excitatory neurons in radial clones and the adjacent non-siblings during postnatal stages. We found that radially aligned sister excitatory neurons have a propensity for developing unidirectional chemical synapses with each other rather than with neighbouring non-siblings. Moreover, these synaptic connections display the same interlaminar directional preference as those observed in the mature neocortex. These results indicate that specific microcircuits develop preferentially within ontogenetic radial clones of excitatory neurons in the developing neocortex and contribute to the emergence of functional columnar micro-architectures in the mature neocortex.	[Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Bultje, Ronald S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org			March of Dimes Foundation; Whitehall Foundation; Klingenstein Foundation; DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. L. Joyner, J. Kaltschmidt, Y. Hayashi and Y. Chin for comments on the manuscript; and S. C. Noctor and F. H. Gage for providing the 293gp NIT - GFP retrovirus packaging cell line; and the Shi laboratory members for insightful discussion. We are grateful for support from the March of Dimes Foundation, the Whitehall Foundation, the Klingenstein Foundation, the DANA Foundation, the Autism Speaks Foundation, the National Alliance for Research on Schizophrenia and Depression (NARSAD) and the National Institutes of Health ( to S.-H. S.).	CEPKO CL, 1990, COLD SH Q B, V55, P265; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	30	227	229	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					501	U3		10.1038/nature07722	http://dx.doi.org/10.1038/nature07722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204731	Green Accepted			2022-12-28	WOS:000264532400043
J	Gillick, MR				Gillick, Muriel R.			Controlling Off-Label Medication Use	ANNALS OF INTERNAL MEDICINE			English	Article							DRUGS	Off-label prescribing may lead to innovative new uses of old medications, is essential in such fields as pediatrics, and avoids the lengthy and expensive process of modifying U. S. Food and Drug Administration (FDA) drug labeling. Using medications for unapproved indications, however, raises concerns about patient safety when the drugs have a high potential for toxicity and generates economic concerns when their cost is high. A possible means of controlling the use of off-label drugs is to focus on medications used off-label that are both expensive and potentially risky. These are principally biotechnology drugs, such as recombinant enzymes, cytokines, and monoclonal antibodies. This article suggests a 2-step process for controlling use of such drugs, analogous to that used for devices. Once a drug is FDA approved, it would undergo scrutiny using the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination method if its cost exceeds a specified benchmark-for example, $12 000, which is the average cost of a pacemaker. The CMS would pay only for off-label uses for which there is adequate evidence in its National Coverage Determination process. Other insurance companies would probably adopt the recommendations of CMS.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mgillick@partners.org						Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; [Anonymous], 2005, J ONCOL PRACT, V1, P102; Ansani N, 2006, AM J MED QUAL, V21, P255, DOI 10.1177/1062860606289020; Bennett WM, 2004, J AM SOC NEPHROL, V15, P830, DOI 10.1097/01.ASN.0000118323.41076.01; *BIOT IND ORG, GUID BIOT 2007; Boos J, 2003, ANN ONCOL, V14, P1, DOI 10.1093/annonc/mdg035; Centers for Medicare & Medicaid Services, 2021, MED COV DET PROC; *CTR MED MED SERV, NAT HLTH EXP 2007; EASTMAN P, 2005, ONCOLOGY TIMES, V27, P10; Eastman P., 2005, ONCOLOGY TIMES, V27, P8, DOI DOI 10.1097/01.COT.0000290944.45158.35; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Graves Julia E, 2007, J Am Acad Dermatol, V56, pe55, DOI 10.1016/j.jaad.2006.07.019; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Keenan PS, 2006, HEALTH AFFAIR, V25, P1260, DOI 10.1377/hlthaff.25.5.1260; Kocs D, 2003, AM J MANAG CARE, V9, P393; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Rader RA, 2008, NAT BIOTECHNOL, V26, P743, DOI 10.1038/nbt0708-743; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ramsey SD, 2007, J CLIN ONCOL, V25, P175, DOI 10.1200/JCO.2006.08.9805; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; Ward RM, 2002, PEDIATRICS, V110, P181; [No title captured]; 2003, HCUP FACT BOOK	26	52	56	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					344	347		10.7326/0003-4819-150-5-200903030-00108	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00108			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221367				2022-12-28	WOS:000264051700006
J	Sox, HC				Sox, Harold C.			Evaluating Off-Label Uses of Anticancer Drugs: Time for a Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SERVICES-TASK-FORCE; COMPENDIA; MEDICARE		Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Sox, HC (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; Eden J, 2008, KNOWING WHAT WORKS H; Gillick MR, 2009, ANN INTERN MED, V150, P344, DOI 10.7326/0003-4819-150-5-200903030-00108; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henney JE, 2006, ANN INTERN MED, V145, P305, DOI 10.7326/0003-4819-145-4-200608150-00013; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Tillman K, 2009, ANN INTERN MED, V150, P348, DOI 10.7326/0003-4819-150-5-200903030-00109; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218	8	13	14	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					353	354		10.7326/0003-4819-150-5-200903030-00110	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221369				2022-12-28	WOS:000264051700009
J	Conway, PH; Clancy, C				Conway, Patrick H.; Clancy, Carolyn			Transformation of Health Care at the Front Line	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY; PERFORMANCE		[Conway, Patrick H.; Clancy, Carolyn] US Dept HHS, Washington, DC 20201 USA; [Conway, Patrick H.; Clancy, Carolyn] Agcy Healthcare Res & Qual, Rockville, MD USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Ctr Hlth Care Qual, Cincinnati, OH USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Div Hlth Policy & Clin Effectiveness, Cincinnati, OH USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Div Gen Pediat, Cincinnati, OH USA	Agency for Healthcare Research & Quality; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Conway, PH (corresponding author), US Dept HHS, Humphrey Bldg,200 Independence Ave,Room 447D-3, Washington, DC 20201 USA.	patrick.conway@hhs.gov						*ACCR COUNC GRAD M, OUTC PROJ GEN COMP; [Anonymous], LONG TERM OUTL HLTH; BECKER C, 2008, MOD HEALTHCARE, V38, P38; Becker Cinda, 2008, Mod Healthc, V38, P32; Becker Cinda, 2008, Mod Healthc, V38, P36; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Hayward RA, 2008, JAMA-J AM MED ASSOC, V300, P255, DOI 10.1001/jama.2008.69; How S. K. H., 2008, PUBLIC VIEWS US HLTH; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, JAMA-J AM MED ASSOC, V298, P1800, DOI 10.1001/jama.298.15.1800; Vonnegut M, 2007, NEW ENGL J MED, V357, P2652, DOI 10.1056/NEJMp0706425; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403	16	67	67	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					763	765		10.1001/jama.2009.103	http://dx.doi.org/10.1001/jama.2009.103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224753				2022-12-28	WOS:000263370100019
J	Meinders, AJ; Elbers, P				Meinders, Arend-Jan; Elbers, Paul			Leukocytosis and Sublingual Microvascular Blood Flow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Meinders, Arend-Jan; Elbers, Paul] St Antonius Hosp, NL-3430 EM Nieuwegein, Netherlands	St. Antonius Hospital Utrecht	Meinders, AJ (corresponding author), St Antonius Hosp, NL-3430 EM Nieuwegein, Netherlands.	a.meinders@antonius.net	Elbers, Paul/M-1028-2019; Elbers, Paul/K-8259-2012; Elbers, Paul/AHA-0344-2022	Elbers, Paul/0000-0003-0447-6893; Elbers, Paul/0000-0003-0447-6893					0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					E9	E9		10.1056/NEJMicm066261	http://dx.doi.org/10.1056/NEJMicm066261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213676				2022-12-28	WOS:000263260500009
J	Peikes, D; Chen, A; Schore, J; Brown, R				Peikes, Deborah; Chen, Arnold; Schore, Jennifer; Brown, Randall			Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries 15 Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Research Meeting of the Academy-Health	JUN 09-10, 2008	Washington, DC	Acad Hlth			CONGESTIVE-HEART-FAILURE; SELF-MANAGEMENT PROGRAM; DISEASE MANAGEMENT; SENSITIVE CONDITIONS; CLINICAL-OUTCOMES; ELDERLY-PATIENTS; DISCHARGE; RISK; COMMUNICATION; OPPORTUNITIES	Context Medicare expenditures of patients with chronic illnesses might be reduced through improvements in care, patient adherence, and communication. Objective To determine whether care coordination programs reduced hospitalizations and Medicare expenditures and improved quality of care for chronically ill Medicare beneficiaries. Design, Setting, and Patients Eligible fee- for- service Medicare patients ( primarily with congestive heart failure, coronary artery disease, and diabetes) who volunteered to participate between April 2002 and June 2005 in 15 care coordination programs ( each received a negotiated monthly fee per patient from Medicare) were randomly assigned to treatment or control ( usual care) status. Hospitalizations, costs, and some quality- of- care outcomes were measured with claims data for 18 309 patients ( n= 178 to 2657 per program) from patients' enrollment through June 2006. A patient survey 7 to 12 months after enrollment provided additional quality- of- care measures. Interventions Nurses provided patient education and monitoring ( mostly via telephone) to improve adherence and ability to communicate with physicians. Patients were contacted twice per month on average; frequency varied widely. Main Outcome Measures Hospitalizations, monthly Medicare expenditures, patient-reported and care process indicators. Results Thirteen of the 15 programs showed no significant ( P <. 05) differences in hospitalizations; however, Mercy had 0.168 fewer hospitalizations per person per year ( 90% confidence interval [ CI], - 0.283 to - 0.054; 17% less than the control group mean, P=. 02) and Charlestown had 0.118 more hospitalizations per person per year ( 90% CI, 0.025- 0.210; 19% more than the control group mean, P=. 04). None of the 15 programs generated net savings. Treatment group members in 3 programs ( Health Quality Partners [ HQP], Georgetown, Mercy) had monthly Medicare expenditures less than the control group by 9% to 14% (-$ 84; 90% CI, -$ 171 to $ 4; P=. 12; -$ 358; 90% CI, -$ 934 to $ 218; P=. 31; and -$ 112; 90% CI, -$ 231 to $ 8; P=. 12; respectively). Savings offset fees for HQP and Georgetown but not for Mercy; Georgetown was too small to be sustainable. These programs had favorable effects on none of the adherence measures and only a few of many quality of care indicators examined. Conclusions Viable care coordination programs without a strong transitional care component are unlikely to yield net Medicare savings. Programs with substantial in-person contact that target moderate to severe patients can be cost- neutral and improve some aspects of care. Trial Registration clinicaltrials.gov Identifier: NCT00627029.	[Peikes, Deborah; Chen, Arnold; Schore, Jennifer; Brown, Randall] Mathematica Policy Res Inc, Princeton, NJ 08550 USA	Mathematica	Brown, R (corresponding author), Mathematica Policy Res Inc, 600 Alexander Pk, Princeton, NJ 08550 USA.	rbrown@mathematica-mpr.com						Alexander GC, 2003, JAMA-J AM MED ASSOC, V290, P953, DOI 10.1001/jama.290.7.953; American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Bell RA, 2001, ARCH INTERN MED, V161, P1977, DOI 10.1001/archinte.161.16.1977; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Brown AD, 2001, CAN J PUBLIC HEALTH, V92, P155, DOI 10.1007/BF03404951; BROWN R, 2007, EVALUATION MED COORD; Brown RS, 2001, RES DESIGN EVALUATIO; BROWN RS, 2000, DEMONSTRATION DESIGN; Burr J, 2003, SOUTH MED J, V96, P172, DOI 10.1097/01.SMJ.0000050680.55019.32; Castro CM, 2007, AM J HEALTH BEHAV, V31, pS85; CHEN A, 2007, FINAL REPORT C EVALU; Chen A., 2000, IDENTIFYING BEST PRA; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Coleman E A, 2001, Eff Clin Pract, V4, P49; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; *CTR MED MED SERV, DAT 2003 MED CURR BE, pCH1; *CTR MED MED SERV, FACT SHEET COMPL PHA; DeBusk RF, 2004, ANN INTERN MED, V141, P606, DOI 10.7326/0003-4819-141-8-200410190-00008; *DEP HHS, 2000, FED REGISTER, V65, P46466; Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3; Galbreath AD, 2004, CIRCULATION, V110, P3518, DOI 10.1161/01.CIR.0000148957.62328.89; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Kripalani S, 2008, MAYO CLIN PROC, V83, P529, DOI 10.4065/83.5.529; Leatherman S., 2005, QUALITY HLTH CARE ME; *LIFEMASTERS, OUTC DEL RES; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; Maniaci MJ, 2008, MAYO CLIN PROC, V83, P554, DOI 10.4065/83.5.554; *MATR HEALTHC HLTH, DIS MAN OUTC; Mattke S, 2007, AM J MANAG CARE, V13, P670; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Medicare Payment Advisory Commission, 2008, DAT HEALTHC SPEND ME; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Payment policy for inpatient readmissions, 2007, REP C PROM GREAT EFF, P103; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Powell CK, 2007, DIABETES EDUCATOR, V33, P144, DOI 10.1177/0145721706297452; Powell LH, 2008, AM HEART J, V156, P452, DOI 10.1016/j.ahj.2008.05.011; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Sanderson C, 2000, J Health Serv Res Policy, V5, P222; SHOJANIA KG, 2004, CLOS QUAL GAP CRIT A, V1; Sidorov J, 2002, DIABETES CARE, V25, P684, DOI 10.2337/diacare.25.4.684; Smith B, 2005, AM J MANAG CARE, V11, P701; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stewart S, 1999, AUST NZ J MED, V29, P220, DOI 10.1111/j.1445-5994.1999.tb00687.x; Stille CJ, 2005, ANN INTERN MED, V142, P700, DOI 10.7326/0003-4819-142-8-200504190-00038; Subramanian Usha, 2008, Congest Heart Fail, V14, P6, DOI 10.1111/j.1751-7133.2008.07174.x; Sylvia ML, 2008, DIS MANAGE, V11, P29, DOI 10.1089/dis.2008.111723; Thorpe KE, 2006, HEALTH AFFAIR, V25, pW378, DOI 10.1377/hlthaff.25.w378; Tsuyuki RT, 2001, ARCH INTERN MED, V161, P2337, DOI 10.1001/archinte.161.19.2337; Villagra VG, 2004, HEALTH AFFAIR, V23, P255, DOI 10.1377/hlthaff.23.4.255; Wheeler JRC, 2003, MED CARE, V41, P706; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	63	559	562	1	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					603	618		10.1001/jama.2009.126	http://dx.doi.org/10.1001/jama.2009.126			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	405MN	19211468	Bronze			2022-12-28	WOS:000263229000025
J	Poulton, J; Kennedy, S; Oakeshott, P; Wells, D				Poulton, Joanna; Kennedy, Stephen; Oakeshott, Pippa; Wells, Dagan			Preventing transmission of maternally inherited mitochondrial DNA diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRENATAL-DIAGNOSIS; MTDNA MUTATION; HETEROPLASMY; SEGREGATION; BOTTLENECK; VARIANT; MELAS; REDUCTION; SELECTION; OOCYTES		[Poulton, Joanna; Kennedy, Stephen; Wells, Dagan] Univ Oxford, Nuffield Dept Obstet, Oxford OX3 9DU, England; [Oakeshott, Pippa] Univ London St Georges Hosp, London SW17 0RE, England	University of Oxford; St Georges University London	Poulton, J (corresponding author), Univ Oxford, Nuffield Dept Obstet, Oxford OX3 9DU, England.	joanna.poulton@obs-gyn.ox.ac.uk	Kennedy, Stephen/B-8950-2009; Poulton, Joanna/AAB-4828-2021	Oakeshott, Pippa/0000-0003-2568-8211; Poulton, Joanna/0000-0002-2460-5587	Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres; MRC [G0500695] Funding Source: UKRI; Medical Research Council [G0500695] Funding Source: researchfish	Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	Black GCM, 1996, BRIT J OPHTHALMOL, V80, P915, DOI 10.1136/bjo.80.10.915; Bouchet C, 2006, J MED GENET, V43, P788, DOI 10.1136/jmg.2005.034140; Bredenoord AL, 2008, HUM REPROD, V23, P2392, DOI 10.1093/humrep/den290; Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P83, DOI 10.1093/humupd/dmm037; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; GUTIERREZMATEO C, 2008, FERTIL STERIL   1018; Harper JC, 2008, HUM REPROD, V23, P741, DOI 10.1093/humrep/dem354; Jacobs LJAM, 2005, MOL HUM REPROD, V11, P223, DOI 10.1093/molehr/gah152; Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; Marchington DR, 1997, AM J HUM GENET, V60, P408; POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366; Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; POULTON JMA, 2001, DEV MED CH NEUROL, V42, P6; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; ROGERS BJ, 1989, J ANDROL, V10, P275; Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sills ES, 2004, MED HYPOTHESES, V62, P612, DOI 10.1016/j.mehy.2003.10.008; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Weber K, 1997, AM J HUM GENET, V60, P373; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488	32	34	34	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2009	338								b94	10.1136/bmj.b94	http://dx.doi.org/10.1136/bmj.b94			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EQ	19181733				2022-12-28	WOS:000263206000010
J	Kim, S; De Vries, R; Ubel, P				Kim, Scott; De Vries, Raymond; Ubel, Peter			Pruning the regulatory tree	NATURE			English	Editorial Material							QUALITY IMPROVEMENT; BOARDS; CARE; COST		[Kim, Scott; De Vries, Raymond] Univ Michigan, Bioeth Program, Ann Arbor, MI 48109 USA; [Ubel, Peter] Univ Michigan, Ctr Behav & Decis Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kim, S (corresponding author), Univ Michigan, Bioeth Program, 300 N Ingalls St, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu		De Vries, Raymond/0000-0003-3087-3040				Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Hamburger P, 2004, SUPREME COURT REV, P271; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V299, P1005, DOI 10.1001/jama.299.9.1005; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; PRENTICE ED, 2002, I REV BOARD MANAGEME, P111; SINGER E, 1992, INT J PUBLIC OPIN R, V4, P256, DOI 10.1093/ijpor/4.3.256; Sugarman J, 2005, NEW ENGL J MED, V352, P1825, DOI 10.1056/NEJM200504283521723; Wagner TH, 2003, ACAD MED, V78, P638, DOI 10.1097/00001888-200306000-00019; Wendler D, 2005, JAMA-J AM MED ASSOC, V294, P826, DOI 10.1001/jama.294.7.826	10	37	37	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2009	457	7229					534	535		10.1038/457534a	http://dx.doi.org/10.1038/457534a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	400FA	19177111	Green Published			2022-12-28	WOS:000262852200022
J	Gray, RD; Drummond, AJ; Greenhill, SJ				Gray, R. D.; Drummond, A. J.; Greenhill, S. J.			Language Phylogenies Reveal Expansion Pulses and Pauses in Pacific Settlement	SCIENCE			English	Article							SOUTHEAST-ASIA; POPULATIONS; POLYNESIANS; EVOLUTION; CULTURE; ISLAND; MTDNA	Debates about human prehistory often center on the role that population expansions play in shaping biological and cultural diversity. Hypotheses on the origin of the Austronesian settlers of the Pacific are divided between a recent "pulse- pause" expansion from Taiwan and an older "slow- boat" diffusion from Wallacea. We used lexical data and Bayesian phylogenetic methods to construct a phylogeny of 400 languages. In agreement with the pulse- pause scenario, the language trees place the Austronesian origin in Taiwan approximately 5230 years ago and reveal a series of settlement pauses and expansion pulses linked to technological and social innovations. These results are robust to assumptions about the rooting and calibration of the trees and demonstrate the combined power of linguistic scholarship, database technologies, and computational phylogenetic methods for resolving questions about human prehistory.	[Gray, R. D.; Greenhill, S. J.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Drummond, A. J.] Univ Auckland, Dept Comp Sci, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Gray, RD (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland 1142, New Zealand.		Drummond, Alexei J/A-3209-2010; Greenhill, Simon/I-3554-2019; Greenhill, Simon/A-9555-2010; Greenhill, Simon J/B-3114-2011	Drummond, Alexei J/0000-0003-4454-2576; Greenhill, Simon/0000-0001-7832-6156; Greenhill, Simon J/0000-0001-7832-6156	Royal Society of New Zealand Marsden Fund; Bright Futures	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Bright Futures	We thank R. Blust, J. Lynch, J. Marck, C. Nickelsen, M. Ross, L. Sagart, and all contributors to the Austronesian Basic Vocabulary Database for their assistance with lexical data and cognate judgments. We gratefully acknowledge BeSTGRID (www.bestgrid.org) for Web hosting and A. Meade, M. Pagel, and the Centre for Advanced Computing and Emerging Technologies at the University of Reading for computational support. R. Blust, M. Corballis, R. Green, F. Jordan, M. Pagel, R. Ross, and M. Suchard commented on the manuscript. Funding was provided by the Royal Society of New Zealand Marsden Fund and a Bright Futures doctoral scholarship to S.G.	[Anonymous], 1997, GUNS GERMS STEEL; Atkinson Q, 2005, T PHILOL SOC, V103, P193, DOI 10.1111/j.1467-968X.2005.00151.x; BLUST R, 1993, OCEAN LINGUIST, V32, P241, DOI DOI 10.2307/3623195; Blust Robert, 1999, 8 INT C AUSTR LING, P31; Blust Robert A., 2005, CURRENT ISSUES PHILI, P31; Burley DV, 2001, P NATL ACAD SCI USA, V98, P11829, DOI 10.1073/pnas.181335398; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dyen Isidore, 1965, INT J AM LINGUISTICS; Embleton S. M., 1986, STAT HIST LINGUISTIC; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Grace GW, 1964, CURR ANTHROPOL, V5, P361, DOI 10.1086/200527; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray Russell D., 2007, Biological Theory, V2, P360, DOI 10.1162/biot.2007.2.4.360; Green R.C., 2003, PACIFIC ARCHAEOLOGY, P95; Green RC, 2008, ARCHAEOL OCEAN, V43, P49, DOI 10.1002/j.1834-4453.2008.tb00030.x; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Hurles ME, 2003, AM J HUM GENET, V72, P1282, DOI 10.1086/374827; Irwin G, 1998, J POLYNESIAN SOC, V107, P111; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kirch P., 2001, HAWAIKI ANCESTRAL PO; Lansing JS, 2007, P NATL ACAD SCI USA, V104, P16022, DOI 10.1073/pnas.0704451104; Lynch J., 2002, OCEANIC LANGUAGES; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; MELTON T, 1995, AM J HUM GENET, V57, P403; NICHOLLS GK, 2008, STAT SOC B, V70, P545; Nunn Patrick D., 2004, Archaeology in Oceania, V39, P139; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; PAWLEY A, 2002, EXAMINING FARMING LA, P251; Pawley A., 1994, AUSTRONESIAN TERMINO, P329; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Sagart L., 2005, PEOPLING E ASIA PUTT, P161, DOI DOI 10.4324/9780203343685_CHAPTER_9; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; WELSCH RL, 1992, AM ANTHROPOL, V94, P568, DOI 10.1525/aa.1992.94.3.02a00030	41	413	418	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					479	483		10.1126/science.1166858	http://dx.doi.org/10.1126/science.1166858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	396JL	19164742				2022-12-28	WOS:000262587900035
J	Moodley, Y; Linz, B; Yamaoka, Y; Windsor, HM; Breurec, S; Wu, JY; Maady, A; Bernhoft, S; Thiberge, JM; Phuanukoonnon, S; Jobb, G; Siba, P; Graham, DY; Marshall, BJ; Achtman, M				Moodley, Yoshan; Linz, Bodo; Yamaoka, Yoshio; Windsor, Helen M.; Breurec, Sebastien; Wu, Jeng-Yih; Maady, Ayas; Bernhoeft, Steffie; Thiberge, Jean-Michel; Phuanukoonnon, Suparat; Jobb, Gangolf; Siba, Peter; Graham, David Y.; Marshall, Barry J.; Achtman, Mark			The Peopling of the Pacific from a Bacterial Perspective	SCIENCE			English	Article							HELICOBACTER-PYLORI; HUMAN MIGRATIONS; MTDNA ANALYSIS; POPULATIONS; SETTLEMENT; SEQUENCE; ORIGIN; TRACES	Two prehistoric migrations peopled the Pacific. One reached New Guinea and Australia, and a second, more recent, migration extended through Melanesia and from there to the Polynesian islands. These migrations were accompanied by two distinct populations of the specific human pathogen Helicobacter pylori, called hpSahul and hspMaori, respectively. hpSahul split from Asian populations of H. pylori 31,000 to 37,000 years ago, in concordance with archaeological history. The hpSahul populations in New Guinea and Australia have diverged sufficiently to indicate that they have remained isolated for the past 23,000 to 32,000 years. The second human expansion from Taiwan 5000 years ago dispersed one of several subgroups of the Austronesian language family along with one of several hspMaori clades into Melanesia and Polynesia, where both language and parasite have continued to diverge.	[Moodley, Yoshan; Linz, Bodo; Bernhoeft, Steffie; Achtman, Mark] Max Planck Inst Infektionsbiol, Dept Mol Biol, D-10117 Berlin, Germany; [Yamaoka, Yoshio; Graham, David Y.] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio; Graham, David Y.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Windsor, Helen M.; Marshall, Barry J.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; [Breurec, Sebastien] Inst Pasteur, Dakar, Senegal; [Breurec, Sebastien] Inst Pasteur Nouvelle Caledonie, Noumea 98845, New Caledonia; [Wu, Jeng-Yih] Kaohsiung Med Univ, Dept Gastroenterol, Kaohsiung 80708, Taiwan; [Maady, Ayas] Repub Hosp 1, Dept Endoscopy, Kyzyl City 667003, Russia; [Thiberge, Jean-Michel] Inst Pasteur, F-75724 Paris, France; [Phuanukoonnon, Suparat; Siba, Peter] Papua New Guinea Inst Med Res, Goroka 441, Papua N Guinea; [Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	Max Planck Society; Baylor College of Medicine; Baylor College of Medicine; University of Western Australia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Kaohsiung Medical University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; PNG Institute Of Medical Research	Achtman, M (corresponding author), Max Planck Inst Infektionsbiol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	m.achtman@ucc.ie	Wu, Jeng-Yih/D-4520-2009; Graham, David/AAL-2165-2021; Maady, Ayas/T-4635-2019	Maady, Ayas/0000-0001-8863-6676; Marshall, Barry/0000-0003-4853-5015; Moodley, Yoshan/0000-0003-4216-2924; Achtman, Mark/0000-0001-6815-0070; Yamaoka, Yoshio/0000-0002-1222-5819	ERA-NET PathoGenoMics (project HELDIVNET); Science Foundation of Ireland [05/FE1/B882]; NIH [R01 DK62813]; Institut Pasteur and the Institut de Veille Sanitaire; Wellcome Trust and European Union; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER	ERA-NET PathoGenoMics (project HELDIVNET)(Academy of Finland); Science Foundation of Ireland(Science Foundation Ireland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur and the Institut de Veille Sanitaire; Wellcome Trust and European Union(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge C. Stamer for technical assistance, F. Balloux and D. Falush for helpful discussions, and J. Hey for advice on IMa. Support was provided by grants from the ERA-NET PathoGenoMics (project HELDIVNET) to M.A. and S.B., the Science Foundation of Ireland (05/FE1/B882) to M.A., the NIH ( grant R01 DK62813) to Y. Y., and the Institut Pasteur and the Institut de Veille Sanitaire to J.-M.T. This publication made use of the Helicobacter pylori Multi Locus Sequence Typing Web site (http://pubmlst.org/helicobacter/) developed by K. Jolley and sited at the University of Oxford. Each strain has an ID number, and the strains newly isolated here have the continuous block of IDs from 930 to 1242. The development of this site has been funded by the Wellcome Trust and European Union.	Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MELTON T, 1995, AM J HUM GENET, V57, P403; Pope KO, 2008, J BIOGEOGR, V35, P1, DOI 10.1111/j.1365-2699.2007.01797.x; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Spriggs MJT, 1996, PREHISTORIC MONGOLOI, P322; SYKES B, 1995, AM J HUM GENET, V57, P1463; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0	19	225	230	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					527	530		10.1126/science.1166083	http://dx.doi.org/10.1126/science.1166083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164753	Green Accepted			2022-12-28	WOS:000262587900049
J	Lamb, SE; Marsh, JL; Hutton, JL; Nakash, R; Cooke, MW				Lamb, S. E.; Marsh, J. L.; Hutton, J. L.; Nakash, R.; Cooke, M. W.		CAST Grp	Mechanical supports for acute, severe ankle sprain: a pragmatic, multicentre, randomised controlled trial	LANCET			English	Article							LIGAMENT; RUPTURES	Background Severe ankle sprains are a common presentation in emergency departments in the UK. We aimed to assess the effectiveness of three different mechanical supports (Aircast brace, Bledsoe boot, or 10-day below-knee cast) compared with that of a double-layer tubular compression bandage in promoting recovery after severe ankle sprains. Methods We did a pragmatic, multicentre randomised trial with blinded assessment of outcome. 584 participants with severe ankle sprain were recruited between April, 2003, and July, 2005, from eight emergency departments across the UK. participants were provided with a mechanical support within the first 3 days of attendance by a trained health-care professional, and given advice on reducing swelling and pain. Functional outcomes were measured over 9 months. The primary outcome was quality of ankle function at 3 months, measured using the Foot and Ankle Score; analysis was by intention to treat. This study is registered as an international Standard Randomised Controlled Trial, number ISRCTN37807450. Results Patients who received the below-knee cast had a more rapid recovery than those given the tubular compression bandage. We noted clinically important benefits at 3 months in quality of ankle function with the cast compared with tubular compression bandage (mean difference 9%; 95% C1 2.4-15 . 0), as well as in pain, symptoms, and activity The mean difference in quality of ankle function between Aircast brace and tubular compression bandage was 8%; 95% Cl 1 . 8-14.2, but there were little differences for pain, symptoms, and activity. Bledsoe boots offered no benefit over tubular compression bandage, which was the least effective treatment throughout the recovery period. There were no significant differences between tubular compression bandage and the other treatments at 9 months. Side-effects were rare with no discernible differences between treatments. Reported events (all treatments combined) were cellulitis (two cases), pulmonary embolus (two cases), and deep-vein thrombosis (three cases). Interpretation A short period of immobilisation in a below-knee cast or Aircast results in faster recovery than if the patient is only given tubular compression bandage. We recommend below-knee casts because they show the widest range of benefit. Funding National Co-ordinating Centre for Health Technology Assessment.	[Lamb, S. E.; Marsh, J. L.; Hutton, J. L.; Nakash, R.; Cooke, M. W.] Univ Warwick, Warwick Clin Trials Unit, Sch Med, Coventry CV4 7AL, W Midlands, England; [Lamb, S. E.] John Radcliffe Hosp, Kadoorie Crit Care Res Ctr, Oxford OX3 9DU, England	University of Warwick; University of Oxford	Lamb, SE (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Sch Med, Coventry CV4 7AL, W Midlands, England.	s.lamb@warwick.ac.uk	Williams, Mark/E-5647-2010	Lamb, Sarah/0000-0003-4349-7195	UK Department of Health; National Institute for Health Research [01/14/10] Funding Source: researchfish	UK Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by a grant from the UK Department of Health through its Health Technology Assessment Programme. The opinions and conclusions expressed here are those of the authors and do not necessarily reflect those ofthe UK National Health Service or the Department of Health.	BERGNER M, 1976, INT J HEALTH SERV, V6, P393, DOI 10.2190/RHE0-GGH4-410W-LA17; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooke MW, 2003, EMERG MED J, V20, P505, DOI 10.1136/emj.20.6.505; COOKE MW, HLTH TECHNO IN PRESS; CRICHTON K, 1995, INJURIES PELVIS LOWE; Egol KA, 2000, J BONE JOINT SURG BR, V82B, P246, DOI 10.1302/0301-620X.82B2.10039; Gerber JP, 1998, FOOT ANKLE INT, V19, P653, DOI 10.1177/107110079801901002; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Kannus P, 2003, SCAND J MED SCI SPOR, V13, P150, DOI 10.1034/j.1600-0838.2003.02225.x; Kerkhoffs G.M., 2002, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD003762, DOI 10.1002/14651858.CD003762]; Kerkhoffs GMMJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000380.pub2; Kerkhoffs GMMJ, 2003, ACTA ORTHOP SCAND, V74, P69, DOI 10.1080/00016470310013699; LAMB SE, 2005, BMC MUSCULOSKEL DIS, V13, P61; Machin D, 1997, SAMPLE SIZE TABLES C; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; *NHS, 2004, HLTH SURV ENGL 2004; Nicholl J P, 1991, Br J Sports Med, V25, P61; Office for National Statistics, 2001, CENS 2001; Pijnenburg ACM, 2000, J BONE JOINT SURG AM, V82A, P761, DOI 10.2106/00004623-200006000-00002; Renstrom PAFH, 1997, BRIT J SPORT MED, V31, P11, DOI 10.1136/bjsm.31.1.11; Roos EM, 2001, FOOT ANKLE INT, V22, P788, DOI 10.1177/107110070102201004; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Rubin DB, 1987, MULTIPLE IMPUTATION; SPANNAGEL U, 1993, SEMIN THROMB HEMOST, V19, P131; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; van der Wees PJ, 2006, AUST J PHYSIOTHER, V52, P27, DOI 10.1016/S0004-9514(06)70059-9; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; VERHAGEN RAW, 1995, ARCH ORTHOP TRAUM SU, V114, P92, DOI 10.1007/BF00422833; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	30	119	125	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					575	581		10.1016/S0140-6736(09)60206-3	http://dx.doi.org/10.1016/S0140-6736(09)60206-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217992				2022-12-28	WOS:000263333600036
J	Levy, MM; Rhodes, A				Levy, Mitchell M.; Rhodes, Andrew			The ongoing enigma of tight glucose control	LANCET			English	Editorial Material							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; SEPTIC SHOCK; HYDROCORTISONE; MANAGEMENT; MORTALITY		[Levy, Mitchell M.] Rhode Isl Hosp, Med Intens Care Unit, Providence, RI 02903 USA; [Rhodes, Andrew] St Georges Healthcare NHS Trust, London, England	Lifespan Health Rhode Island; Rhode Island Hospital; St Georges University London	Levy, MM (corresponding author), Rhode Isl Hosp, Med Intens Care Unit, Providence, RI 02903 USA.	Mitchell-levy@brown.edu	Rhodes, Andrew/G-4265-2011	Rhodes, Andrew/0000-0002-8737-574X				Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Otero RM, 2006, CHEST, V130, P1579, DOI 10.1378/chest.130.5.1579; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhandel M, 2007, NEURO-ONCOLOGY, V9, P502; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1	14	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					520	521		10.1016/S0140-6736(09)60045-3	http://dx.doi.org/10.1016/S0140-6736(09)60045-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19176239				2022-12-28	WOS:000263333600005
J	Pagel, M				Pagel, Mark			Natural selection 150 years on	NATURE			English	Article							EVOLUTION; SPECIATION; DROSOPHILA; LANGUAGE; DYNAMICS; ANIMALS; RISE		[Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Pagel, Mark] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Reading; The Santa Fe Institute	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.	m.pagel@reading.ac.uk			Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; [Anonymous], 1861, ORIGIN SPECIES MEANS; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Burt A, 2006, GENES CONFLICT BIOL; CAIN AJ, 1964, BIOL J LINN SOC, V36, P3; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Coyne J, 1996, SCIENCE, V272, P700, DOI 10.1126/science.272.5262.700; Darwin C., 1871, P475; Dawkins R., 2004, ANCESTORS TALE PILGR; Dawkins R., 1986, BLIND WATCHMAKER; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Gell-Mann M., 1994, QUARK JAGUAR ADVENTU; Gould S. J., 1989, WONDERFUL LIFE; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Kirschner M, 2005, PLAUSIBILITY LIFE RE; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; LUCAS JR, 1979, HIST J, V22, P313, DOI 10.1017/S0018246X00016848; Pagel M, 2008, NATURE, V452, P699, DOI 10.1038/452699a; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stringer Chris, 2005, COMPLETE WORLD HUMAN; Tattersall I, 2000, EVOL ANTHROPOL, V9, P2, DOI 10.1002/(SICI)1520-6505(2000)9:1<2::AID-EVAN2>3.0.CO;2-2	28	13	15	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2009	457	7231					808	811		10.1038/nature07889	http://dx.doi.org/10.1038/nature07889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212397				2022-12-28	WOS:000263266700029
J	Evans, JP				Evans, James P.			The Voyage Continues Darwin and Medicine at 200 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EVOLUTIONARY BIOLOGY		[Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu						[Anonymous], 1861, ORIGIN SPECIES MEANS; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DARWIN CR, 1863, COMMUNICATION   0131; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Nesse RM, 2008, B WORLD HEALTH ORGAN, V86, P83, DOI 10.2471/BLT.07.049601; Nesse RM, 2003, BIOSCIENCE, V53, P585, DOI 10.1641/0006-3568(2003)053[0585:EBITMS]2.0.CO;2; Nesse RM, 1998, SCI AM, V279, P86, DOI 10.1038/scientificamerican1198-86; Shubin N., 2008, YOUR INNER FISH JOUR; Slotten RA, 2004, HERETIC DARWINS COUR	9	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					663	665		10.1001/jama.2009.102	http://dx.doi.org/10.1001/jama.2009.102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211473				2022-12-28	WOS:000263229000031
J	Holmes, MV; Mehta, A; Morgan, MY				Holmes, Michael V.; Mehta, Atul; Morgan, Marsha Y.			Case report Hemiparesis in a 36 year old man	BRITISH MEDICAL JOURNAL			English	Editorial Material							POLYCYTHEMIA-VERA; ISCHEMIC-STROKE; YOUNG; ERYTHROCYTOSIS; DIAGNOSIS; ALCOHOL; POLYCYTHAEMIA/ERYTHROCYTOSIS		[Morgan, Marsha Y.] UCL, Sch Med, Dept Med, Ctr Hepatol, London NW3 2PF, England; [Holmes, Michael V.] St Thomas Hosp, Dept Clin Pharmacol, Clin Res Facil, London SE1 7EH, England; [Mehta, Atul] Royal Free Hampstead NHS Trust, Royal Free Hosp, Dept Haematol, London NW3 2QG, England	University of London; University College London; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Morgan, MY (corresponding author), UCL, Sch Med, Dept Med, Ctr Hepatol, Royal Free Campus, London NW3 2PF, England.	mymorgan@medsch.ucl.ac.uk	Morgan, Marsha Y/C-5909-2009; Mehta, Atul/GPC-7364-2022		MRC [G0802432] Funding Source: UKRI; Medical Research Council [G0802432] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Biswas M, 2003, J INTERN MED, V253, P481, DOI 10.1046/j.1365-2796.2003.01126.x; DERASMO E, 1988, ITAL J NEUROL SCI, V9, P573, DOI 10.1007/BF02337011; Feldmann E, 2005, STROKE, V36, P1881, DOI 10.1161/01.STR.0000177480.62341.6b; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; Gonthier A, 2004, REV NEUROL-FRANCE, V160, P1029, DOI 10.1016/S0035-3787(04)71140-6; GUSTIN DM, 2004, OXFORD TXB MED; Hillbom M, 1998, NEUROEPIDEMIOLOGY, V17, P281, DOI 10.1159/000026181; Johansson PL, 2005, BRIT J HAEMATOL, V129, P701, DOI 10.1111/j.1365-2141.2005.05517.x; LEE K, 1979, ACTA NEUROL SCAND, V59, P270; McMullin MF, 2008, INT J LAB HEMATOL, V30, P447, DOI 10.1111/j.1751-553X.2008.01102.x; McMullin MF, 2007, BRIT J HAEMATOL, V138, P821, DOI 10.1111/j.1365-2141.2007.06741.x; McMullin MF, 2005, BRIT J HAEMATOL, V130, P174, DOI 10.1111/j.1365-2141.2005.05535.x; Nightingale AL, 2004, STROKE, V35, P1574, DOI 10.1161/01.STR.0000129789.58837.e4; RIUNITI O, 1995, ANN INTERN MED, V123, P656, DOI 10.7326/0003-4819-123-9-199511010-00003; SMITH JFB, 1973, LANCET, V1, P637; WILKINS MR, 1985, BRIT MED J, V291, P1342, DOI 10.1136/bmj.291.6505.1342	17	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 11	2009	338								b90	10.1136/bmj.b90	http://dx.doi.org/10.1136/bmj.b90			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZX	19211628				2022-12-28	WOS:000263976100011
J	Forbes, AA; Powell, THQ; Stelinski, LL; Smith, JJ; Feder, JL				Forbes, Andrew A.; Powell, Thomas H. Q.; Stelinski, Lukasz L.; Smith, James J.; Feder, Jeffrey L.			Sequential Sympatric Speciation Across Trophic Levels	SCIENCE			English	Article							RHAGOLETIS-POMONELLA DIPTERA; APPLE MAGGOT FLY; HOST RACES; MATING BEHAVIOR; TEPHRITIDAE; DIVERSITY	A major cause for biodiversity may be biodiversity itself. As new species form, they may create new niches for others to exploit, potentially catalyzing a chain reaction of speciation events across trophic levels. We tested for such sequential radiation in the Rhagoletis pomonella ( Diptera: Tephritidae) complex, a model for sympatric speciation via host plant shifting. We report that the parasitic wasp Diachasma alloeum ( Hymenoptera: Braconidae) has formed new incipient species as a result of specializing on diversifying fly hosts, including the recently derived apple- infesting race of R. pomonella. Furthermore, we show that traits that differentially adapt R. pomonella flies to their host plants have also quickly evolved and serve as ecological barriers to reproduction, isolating the wasps. Speciation therefore cascades as the effects of new niche construction move across trophic levels.	[Forbes, Andrew A.; Powell, Thomas H. Q.; Feder, Jeffrey L.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Stelinski, Lukasz L.] Univ Florida, Ctr Agr Res & Educ, Dept Entomol & Nematol, Lake Alfred, FL 33850 USA; [Smith, James J.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Smith, James J.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	University of Notre Dame; State University System of Florida; University of Florida; Michigan State University; Michigan State University	Forbes, AA (corresponding author), Univ Calif Davis, Dept Entomol, 1 Shields Ave, Davis, CA 95616 USA.	aaforbes@ucdavis.edu	Powell, Thomas/B-8575-2013	Powell, Thomas/0000-0002-4780-5215; Forbes, Andrew/0000-0001-8332-6652	NSF; American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin	NSF(National Science Foundation (NSF)); American Museum of Natural History Theodore Roosevelt Fund Grant; Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	We thank M. Aluja, S. H. Berlocher, H. R. Dambroski, F. Footman, T. M. Forbes, E. Luecke, A. P. Michel, M. A. F. Noor, J. Rull, D. Schwarz, S. Velez, F. Wang, and R. A. Wharton for their technical, physical, intellectual, and moral support. Funded by a NSF doctoral dissertation improvement grant to A. A. F. and J. L. F., an American Museum of Natural History Theodore Roosevelt Fund Grant to A. A. F., and support to J. L. F. from the Wissenschaftskolleg zu Berlin. GenBank accession numbers for the mtDNA COI sequences are EU881512 to EU881682.	Abrahamson WG, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P188; Berlocher SH, 1999, HEREDITY, V83, P652, DOI 10.1038/sj.hdy.6885910; Berlocher SH, 2000, EVOLUTION, V54, P543, DOI 10.1111/j.0014-3820.2000.tb00057.x; Butterfield NJ, 2001, ECOLOGY CAMBRIAN REG; Coyne J.A., 2004, SPECIATION; Dilcher D, 2000, P NATL ACAD SCI USA, V97, P7030, DOI 10.1073/pnas.97.13.7030; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Erwin DH, 2005, SCIENCE, V308, P1752, DOI 10.1126/science.1113416; Feder Jeffrey L., 1998, P408; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1995, ECOLOGY, V76, P801, DOI 10.2307/1939346; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; FEDER JL, 1998, ENDLESS FORMS SPECIE; LaSalle J., 1991, Redia, V74, P315; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Price P. W., 1980, EVOLUTIONARY BIOL PA; PROKOPY RJ, 1971, CAN ENTOMOL, V103, P1405, DOI 10.4039/Ent1031405-10; PROKOPY RJ, 1972, CAN ENTOMOL, V104, P97, DOI 10.4039/Ent10497-1; Smith JJ, 1997, MOL PHYLOGENET EVOL, V7, P33, DOI 10.1006/mpev.1996.0374; Strong D., 1984, INSECTS PLANTS COMMU; TURLINGS TCJ, 1993, INSECT LEARNING ECOL, P398; Wharton R.A., 1978, Journal of the Washington Academy of Sciences, V68, P147	24	132	136	0	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					776	779		10.1126/science.1166981	http://dx.doi.org/10.1126/science.1166981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197063				2022-12-28	WOS:000263066800045
J	Marintchev, A; Edmonds, KA; Marintcheva, B; Hendrickson, E; Oberer, M; Suzuki, C; Herdy, B; Sonenberg, N; Wagner, G				Marintchev, Assen; Edmonds, Katherine A.; Marintcheva, Boriana; Hendrickson, Elthea; Oberer, Monika; Suzuki, Chikako; Herdy, Barbara; Sonenberg, Nahum; Wagner, Gerhard			Topology and Regulation of the Human eIF4A/4G/4H Helicase Complex in Translation Initiation	CELL			English	Article							BOX PROTEIN EIF4A; FACTOR 4G EIF4G; MESSENGER-RNA; CRYSTAL-STRUCTURE; BINDING; CAP; DOMAINS; FRAMEWORK; SITES	The RNA helicase eIF4A plays a key role in unwinding of mRNA and scanning during translation initiation. Free eIF4A is a poor helicase and requires the accessory proteins eIF4G and eIF4H. However, the structure of the helicase complex and the mechanisms of stimulation of eIF4A activity have remained elusive. Here we report the topology of the eIF4A/4G/4H helicase complex, which is built from multiple experimentally observed domain-domain contacts. Remarkably, some of the interactions are continuously rearranged during the ATP binding/hydrolysis cycle of the helicase. We show that the accessory proteins modulate the affinity of eIF4A for ATP by interacting simultaneously with both helicase domains and promoting either the closed, ATP-bound conformation or the open, nucleotide-free conformation. The topology of the complex and the spatial arrangement of the RNA-binding surfaces offer insights into their roles in stimulation of helicase activity and the mechanisms of mRNA unwinding and scanning.	[Oberer, Monika] Graz Univ, Inst Mol Biosci, Graz, Austria; [Herdy, Barbara; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Marintchev, Assen; Edmonds, Katherine A.; Hendrickson, Elthea; Suzuki, Chikako; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Graz; McGill University; Harvard University; Harvard Medical School	Marintchev, A (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	amarint@bu.edu; gerhard_wagner@hms.harvard.edu		Oberer, Monika/0000-0003-2525-9513; Marintchev, Assen/0000-0002-9901-3500	NATIONAL CANCER INSTITUTE [R01CA068262, R01CA127990, K01CA119107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015742, P41RR000995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038608, P41GM066360, P01GM047467] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA068262-13, K01 CA119107, R01 CA127990, R01 CA068262, K01CA119107, R01 CA068262-14, R01 CA068262-12, CA68262, R01 CA068262-11, R01 CA127990-03] Funding Source: Medline; NCRR NIH HHS [P41 RR000995-26, P41 RR000995-27, S10 RR015742-01] Funding Source: Medline; NIBIB NIH HHS [P41 EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467-179001, P01 GM047467-170011, R01 GM038608, P01 GM047467-170010, P41 GM066360-04, R01 GM038608-13, P01 GM047467, R01 GM038608-12, GM47467, P41 GM066360-05, R01 GM038608-11A2, P41 GM066360, P01 GM047467-179002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Feng PH, 2005, J VIROL, V79, P9651, DOI 10.1128/JVI.79.15.9651-9664.2005; Fersht A., 1999, STRUCTURE MECH PROTE, P125; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	33	172	175	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					447	460		10.1016/j.cell.2009.01.014	http://dx.doi.org/10.1016/j.cell.2009.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203580	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000263120600015
J	Marenzi, G; Assanelli, E; Campodonico, J; Lauri, G; Marana, I; De Metrio, M; Moltrasio, M; Grazi, M; Rubino, M; Veglia, F; Fabbiocchi, F; Bartorelli, AL				Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.			Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; RENAL DYSFUNCTION; CREATININE CLEARANCE; N-ACETYLCYSTEINE; PREDICTION; INSUFFICIENCY; FAILURE; IMPACT; MEDIA	Background: Contrast-induced nephropathy (CIN) frequently occurs in patients with acute ST-segment elevation myocardial infarction (STEMI) who are undergoing primary percutaneous coronary intervention, and CIN is associated with a more complicated clinical course and increased mortality. Objective: To investigate the association between absolute and weight- and creatinine-adjusted contrast volume, CIN incidence, and clinical outcome in the era of mechanical reperfusion of STEMI. Design: Prospective, observational study. Setting: A university cardiology center in Milan, Italy. Patients: 561 consecutive patients with STEMI who were undergoing primary percutaneous coronary intervention. Measurements: For each patient, the maximum contrast dose was calculated, according to the formula (5 X body weight [kg])/serum creatinine, and the contrast ratio, defined as the ratio between the contrast volume administered and the maximum dose calculated, was assessed. An increase in serum creatinine of more than 25% from baseline was defined as CIN. Results: 115 (20.5%) patients developed CIN. In-hospital mortality was higher among patients with CIN than those without CIN (21.4% vs. 0.9%; P < 0.001). The maximum contrast dose was exceeded in 130 (23%) patients. Patients who received more than the maximum contrast dose (contrast ratio >1) had a more complicated in-hospital clinical course and higher mortality rate (13% vs. 2.8%; P < 0.001) than did patients with a contrast ratio less than 1. Development of CIN was associated with both contrast volume and contrast ratio. Limitation: The association between contrast volume and outcomes was observed in a single center and could be due to comorbid conditions, disease severity, or an unknown factor. Conclusion: During primary percutaneous coronary intervention for STEMI, higher contrast volume is associated with higher rates of CIN and mortality; however, further study is needed to determine whether limiting contrast volume would improve patient outcome.	[Marenzi, Giancarlo; Assanelli, Emilio; Campodonico, Jeness; Lauri, Gianfranco; Marana, Ivana; De Metrio, Monica; Moltrasio, Marco; Grazi, Marco; Rubino, Mara; Veglia, Fabrizio; Fabbiocchi, Franco; Bartorelli, Antonio L.] Univ Milan, Ctr Cardiol Monzino, I-20138 Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan	Marenzi, G (corresponding author), Univ Milan, Ctr Cardiol Monzino, Via Parea 4, I-20138 Milan, Italy.	giancarlo.marenzi@ccfm.it	De Metrio, Monica/ABH-6561-2020; Grazi, Marco/ABH-5946-2020; Bartorelli, Antonio Luca/ABG-9593-2020; Rubino, Mara/K-1537-2016; Veglia, Fabrizio/K-1958-2016; Assanelli, Emilio/ABH-4902-2020; Bartorelli, Antonio/K-3955-2018; campodonico, jeness/AAC-2284-2022	Grazi, Marco/0000-0003-1518-3199; Rubino, Mara/0000-0001-7820-9814; Veglia, Fabrizio/0000-0002-9378-8874; Marenzi, Giancarlo/0000-0003-4410-4461; De Metrio, Monica/0000-0002-1955-747X	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino; Institute of Cardiology, University of Milan	Centro Cardiologico Monzino, Institute of Cardiology, University of Milan.	Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; Baumgart D, 1997, CATHETER CARDIO DIAG, V40, P241; BOURDILLON PD, 1985, J AM COLL CARDIOL, V6, P845, DOI 10.1016/S0735-1097(85)80493-9; Brodie BR, 1996, J AM COLL CARDIOL, V28, P319, DOI 10.1016/0735-1097(96)00152-0; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CRUZ C, 1986, RADIOLOGY, V158, P109, DOI 10.1148/radiology.158.1.3079623; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; DeGeare VS, 2000, AM J CARDIOL, V86, P30, DOI 10.1016/S0002-9149(00)00824-9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Heggunje PS, 2004, J AM COLL CARDIOL, V44, P1400, DOI 10.1016/j.jacc.2004.06.065; Jaumdally RJ, 2007, J THROMB THROMBOLYS, V23, P189, DOI 10.1007/s11239-006-9048-x; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Laskey WK, 2007, J AM COLL CARDIOL, V50, P584, DOI 10.1016/j.jacc.2007.03.058; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marenzi G, 2007, AM HEART J, V153, P755, DOI 10.1016/j.ahj.2007.02.018; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; MASON RA, 1985, JAMA-J AM MED ASSOC, V253, P1001, DOI 10.1001/jama.253.7.1001; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; MILLER DL, 1988, RADIOLOGY, V167, P607, DOI 10.1148/radiology.167.3.3363118; Moscucci M, 2005, J AM COLL CARDIOL, V46, P625, DOI 10.1016/j.jacc.2005.05.048; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Pradhan J, 2007, CORONARY ARTERY DIS, V18, P275, DOI 10.1097/MCA.0b013e328056dd46; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Solomon R, 2006, KIDNEY INT, V69, pS46, DOI 10.1038/sj.ki.5000374; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; TALIERCIO CP, 1986, ANN INTERN MED, V104, P501, DOI 10.7326/0003-4819-104-4-501; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Vlietstra RE, 1996, AM HEART J, V132, P1049, DOI 10.1016/S0002-8703(96)90021-6	38	251	271	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					170	+		10.7326/0003-4819-150-3-200902030-00006	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189906				2022-12-28	WOS:000263029600003
J	Sack, FD; Chen, JG				Sack, Fred D.; Chen, Jin-Gui			PLANT SCIENCE Pores in Place	SCIENCE			English	Editorial Material							ASYMMETRIC CELL-DIVISION; STOMATAL DEVELOPMENT; ARABIDOPSIS; DIFFERENTIATION; KINASES; LEAF		[Sack, Fred D.; Chen, Jin-Gui] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Sack, FD (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	fsack@interchange.ubc.ca; jingui@interchange.ubc.ca	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201				Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Cartwright HN, 2009, SCIENCE, V323, P649, DOI 10.1126/science.1161686; Gallagher K, 2000, CURR BIOL, V10, P1229, DOI 10.1016/S0960-9822(00)00730-2; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298	13	5	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					592	593		10.1126/science.1169553	http://dx.doi.org/10.1126/science.1169553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179518				2022-12-28	WOS:000262862800029
J	Giraudo, CG; Garcia-Diaz, A; Eng, WS; Chen, YH; Hendrickson, WA; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.; Melia, Thomas J.; Rothman, James E.			Alternative Zippering as an On-Off Switch for SNARE-Mediated Fusion	SCIENCE			English	Article							SYNAPTIC VESICLE CYCLE; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT DOMAINS; SYNAPTOTAGMIN-I; CA2+ SENSOR; COMPLEX; EXOCYTOSIS	Membrane fusion between vesicles and target membranes involves the zippering of a four- helix bundle generated by constituent helices derived from target- and vesicle- soluble N-ethylmaleimide- sensitive factor attachment protein receptors (SNAREs). In neurons, the protein complexin clamps otherwise spontaneous fusion by SNARE proteins, allowing neurotransmitters and other mediators to be secreted when and where they are needed as this clamp is released. The membrane- proximal accessory helix of complexin is necessary for clamping, but its mechanism of action is unknown. Here, we present experiments using a reconstituted fusion system that suggest a simple model in which the complexin accessory helix forms an alternative four- helix bundle with the target- SNARE near the membrane, preventing the vesicle- SNARE from completing its zippering.	[Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Melia, Thomas J.; Rothman, James E.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Eng, William S.; Chen, Yuhang; Hendrickson, Wayne A.] Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Giraudo, CG (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	claudio.giraudo@yale.edu; james.rothman@yale.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant to J.E.R.	Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; JONES A, 2008, O VERSION 12 0; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292	23	121	121	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					512	516		10.1126/science.1166500	http://dx.doi.org/10.1126/science.1166500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164750	Green Accepted			2022-12-28	WOS:000262587900045
J	Smith, RD; Correa, C; Oh, C				Smith, Richard D.; Correa, Carlos; Oh, Cecilia			Trade and Health 5 Trade, TRIPS, and pharmaceuticals	LANCET			English	Article							AFFORDABILITY; ACCESS; DRUGS	The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set global minimum standards for the protection of intellectual property, substantially increasing and expanding intellectual-property rights, and generated clear gains for the pharmaceutical industry and the developed world. The question of whether TRIPS generates gains for developing countries, in the form of increased exports, is addressed in this paper through consideration of the importance of pharmaceuticals in health-care trade, outlining the essential requirements, implications, and issues related to TRIPS, and TRIPS-plus, in which increased restrictions are imposed as part of bilateral free-trade agreements. TRIPS has not generated substantial gains for developing countries, but has further increased pharmaceutical trade in developed countries. The unequal trade between developed and developing countries (ie, exporting and importing high-value patented drugs, respectively) raises the issue of access to medicines, which is exacerbated by TRIPS-plus provisions, although many countries have not even enacted provision for TRIPS flexibilities. Therefore this paper focuses on options that are available to the health community for negotiation to their advantage under TRIPS, and within the presence of TRIPS-plus.	[Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Correa, Carlos] Univ Buenos Aires, Ctr Interdisciplinary Studies Ind Property & Econ, Buenos Aires, DF, Argentina; [Oh, Cecilia] UNDP Reg Ctr, Colombo, Sri Lanka	University of London; London School of Hygiene & Tropical Medicine; University of Buenos Aires	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				ABBOTT F, 2007, WORLD TRADE ORG ACCE; *AGCM, 2007, DEC A364 MERCK PRINC; ANDO G, 2006, PHARM MARKET MALAYSI; *ASEAN SECR, 2005, REG REP ASEAN ROCK F; Azmi IM, 2001, J WORLD INTELLECTUAL, V4, P947; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; BASU S, 2003, ZNET GLOBAL EC  0529; BLOUIN C, 2007, WHO SEARO M TRAD HLT; *BURR LIF SCI MED, 2007, BURR Q IND LIF SCI; Commission on Intellectual Property Rights, INT INT PROP RIGHTS; Correa CM, 2006, B WORLD HEALTH ORGAN, V84, P399, DOI 10.2471/BLT.05.023432; DEEPTI R, 2007, CHEM WEEK, P169; Dzung N.N, 2007, CHICAGO KENT J INTEL, V6, P138; Endeshaw A, 2005, J WORLD INTELLECT PR, V8, P211, DOI 10.1111/j.1747-1796.2005.tb00247.x; *FED TRAD COMM, 2002, GEN DRUG ENTR PRIOR; *GLOB TRAD INF SER, UK CUST EXC; Haakonsson SJ, 2007, DEV POLICY REV, V25, P71, DOI 10.1111/j.1467-7679.2007.00360.x; *KEI, 2007, KEI RES NOT 2007 REC; Kerry VB, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-3; Kinnon CM, 1998, WORLD HEALTH FORUM, V19, P397; KRAUS L, 2004, VANDERBILT J TRANSNA, V37, pL527; MILSTIEN J, B WHO, V84, P360; *MIN INT TRAD IND, 3 IND MAST 1996 2020; *MITI, 2007, IND PROF CHEM MAL TR; MUSUNGU SF, 2004, S PERSPECTIVES R APR; *MYLPO, 2008, CALC PAT STAT INT PR; Oh C., 2006, International Journal of Intellectual Property Management, V1, P22, DOI 10.1504/IJIPM.2006.011020; Oxfam International, 2007, 102 OXF INT; *PIR1BO, 2007, 200711 PIR1BO; Priapantja Priapantja, 2000, ASEAN WORKSH TRIPS A; Schaffer Gregory C., 2003, DEFENDING INTERESTS; Smith R., 2003, GLOBAL PUBLIC GOODS; Smith RD, 2004, B WORLD HEALTH ORGAN, V82, P385; SMITH RD, 2009, LANCET          0122; Steinbrook R, 2007, NEW ENGL J MED, V357, P1996, DOI 10.1056/NEJMp0706918; *UNCTAD, 2005, W MACK PROD VIEW PHA; USTR (Office of the United States Trade Representative), 2007, SPEC 301 REP; *WHO, 2006, COMM INT PROP INN PU; WILBULPROPRASER.S, 2001, WORKSH DIFF PRIC FIN	39	94	94	2	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					684	691		10.1016/S0140-6736(08)61779-1	http://dx.doi.org/10.1016/S0140-6736(08)61779-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19167054	Green Submitted			2022-12-28	WOS:000263563500033
J	Kurokawa, K; Banno, Y; Hara, S; Kondo, J				Kurokawa, Kiyoshi; Banno, Yashiro; Hara, Seigo; Kondo, James			Italian G8 Summit: a critical juncture for global health	LANCET			English	Editorial Material									[Kurokawa, Kiyoshi; Banno, Yashiro; Hara, Seigo; Kondo, James] Hlth Policy Inst, Tokyo 1000014, Japan; [Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan	National Graduate Institute for Policy Studies	Kurokawa, K (corresponding author), Hlth Policy Inst, Tokyo 1000014, Japan.	info@healthpolicy-institute.org						FUKUDA Y, 2008, OCC ANN M WORLD EC F; *HLTH POL I JAP, 2009, GLOB HLTH SUMM; *INT BANK REC DEV, 2008, GLOB MON REP 2008 MD; KORTON J, 2005, G8 GLOBAL HLTH GOVER; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; KUROKAWA K, 2008, GLOBAL FORUM UPDATE, V5, P1; *MIN FOR AFF JAP, 2008, CHAIRS SUMM; *MIN FOR AFF JAP, 2000, G8 COMM OK 2000 26 3; *MIN FOR AFF JAP, 2008, SUMM HOKK TOYAK SUMM; *NHK JAP BROADC CO, 2008, RESP VOIC AFR; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; *SCI COUNC JAP, 2008, JOINT SCI AC STAT GL; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; 2007, 2008 JAP G9 SUMM NGO	14	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					526	527		10.1016/S0140-6736(09)60180-X	http://dx.doi.org/10.1016/S0140-6736(09)60180-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217975				2022-12-28	WOS:000263333600009
J	Rowe, ML; Goldin-Meadow, S				Rowe, Meredith L.; Goldin-Meadow, Susan			Differences in Early Gesture Explain SES Disparities in Child Vocabulary Size at School Entry	SCIENCE			English	Article							KNOWLEDGE; HANDS	Children from low-socioeconomic status ( SES) families, on average, arrive at school with smaller vocabularies than children from high- SES families. In an effort to identify precursors to, and possible remedies for, this inequality, we videotaped 50 children from families with a range of different SES interacting with parents at 14 months and assessed their vocabulary skills at 54 months. We found that children from high- SES families frequently used gesture to communicate at 14 months, a relation that was explained by parent gesture use ( with speech controlled). In turn, the fact that children from high- SES families have large vocabularies at 54 months was explained by children's gesture use at 14 months. Thus, differences in early gesture help to explain the disparities in vocabulary that children bring with them to school.	[Rowe, Meredith L.; Goldin-Meadow, Susan] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Rowe, ML (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	rowemer@uchicago.edu			National Institute of Child Health and Human Development [K99HD055522, P01HD40605]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD040605] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD055522] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the National Institute of Child Health and Human Development: grants K99HD055522 to M. L. R. and P01HD40605 to S. G.- M. We thank J. Huttenlocher, S. Levine, W. Meadow, J. Rowe, and three anonymous reviewers for comments on earlier versions; the families for their participation; K. Brasky, L. Chang, E. Croft, K. Duboc, J. Griffin, S. Gripshover, K. Harden, L. King, C. Meanwell, E. Mellum, M. Nikolas, J. Oberholtzer, C. Rousch, L. Rissman, B. Seibel, M. Simone, K. Uttich, and J. Wallman for data collection/transcription; E. Sauer for gesture coding; and K. Schonwald and J. Voigt for administrative/technical assistance.	Anderson R. C., 1981, COMPREHENSION TEACHI, P77, DOI DOI 10.4236/PSYCH.2012.31007; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bornstein MH, 1998, J CHILD LANG, V25, P367, DOI 10.1017/S0305000998003456; Broaders SC, 2007, J EXP PSYCHOL GEN, V136, P539, DOI 10.1037/0096-3445.136.4.539; Butterworth G., 1988, THOUGHT LANGUAGE, P5; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Cook SW, 2006, J COGN DEV, V7, P211, DOI 10.1207/s15327647jcd0702_4; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Dunn L.M., 2009, PEABODY PICTURE VOCA; Farkas G, 2004, SOC SCI RES, V33, P464, DOI 10.1016/j.ssresearch.2003.08.001; Goldin-Meadow S, 2007, DEVELOPMENTAL SCI, V10, P778, DOI 10.1111/j.1467-7687.2007.00636.x; Griffin, 1998, PREVENTING READING D, DOI DOI 10.17226/6023; Hart B., 1995, MEANINGFUL DIFFERENC; Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E, 2003, MON PARENT, P147; HOFF E, 2003, HDB PARENTING, V2, P161; Iverson JM, 1999, COGNITIVE DEV, V14, P57, DOI 10.1016/S0885-2014(99)80018-5; Iverson JM, 2005, PSYCHOL SCI, V16, P367, DOI 10.1111/j.0956-7976.2005.01542.x; MCCARTNEY K, 2006, MONOGRAPHS SOC RES C, V71, P88; Namy LL, 2000, J NONVERBAL BEHAV, V24, P63, DOI 10.1023/A:1006601812056; Pan BA, 2005, CHILD DEV, V76, P763, DOI 10.1111/j.1467-8624.2005.00876.x; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rowe ML, 2009, DEVELOPMENTAL SCI, V12, P182, DOI 10.1111/j.1467-7687.2008.00764.x	24	261	268	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					951	953		10.1126/science.1167025	http://dx.doi.org/10.1126/science.1167025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213922	Green Published, Green Accepted			2022-12-28	WOS:000263295400047
J	Stutchbury, BJM; Tarof, SA; Done, T; Gow, E; Kramer, PM; Tautin, J; Fox, JW; Afanasyev, V				Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.; Tautin, John; Fox, James W.; Afanasyev, Vsevolod			Tracking Long-Distance Songbird Migration by Using Geolocators	SCIENCE			English	Article							STABLE-ISOTOPES; RANGES		[Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Tautin, John] Tom Ridge Environm Ctr, Purple Martin Conservat Assoc, Erie, PA 16505 USA; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	York University - Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Stutchbury, BJM (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	bstutch@yorku.ca			Natural Sciences and Engineering Research Council of Canada; National Geographic Society; Purple Martin Conservation Association; NERC [bas010013] Funding Source: UKRI; Natural Environment Research Council [bas010013] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Geographic Society(National Geographic Society); Purple Martin Conservation Association; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Graziano, R. Kresnik, T. MacIntosh, M. MacPherson, E. Pifer, T. Piraino, S. Puppi, C. Silverio, and C. Stanley for field assistance. For funding, we thank the Natural Sciences and Engineering Research Council of Canada, the National Geographic Society, the Purple Martin Conservation Association, and proceeds from (10).	Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stutchbury B., 2007, SILENCE SONGBIRDS; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Yong W, 1997, AUK, V114, P263, DOI 10.2307/4089167	10	340	369	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					896	896		10.1126/science.1166664	http://dx.doi.org/10.1126/science.1166664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213909				2022-12-28	WOS:000263295400031
J	Takahashi, H; Kato, M; Matsuura, M; Mobbs, D; Suhara, T; Okubo, Y				Takahashi, Hidehiko; Kato, Motoichiro; Matsuura, Masato; Mobbs, Dean; Suhara, Tetsuya; Okubo, Yoshiro			When Your Gain Is My Pain and Your Pain Is My Gain: Neural Correlates of Envy and Schadenfreude	SCIENCE			English	Article							BRAIN ACTIVITY; FMRI; BIAS	We often evaluate the self and others from social comparisons. We feel envy when the target person has superior and self- relevant characteristics. Schadenfreude occurs when envied persons fall from grace. To elucidate the neurocognitive mechanisms of envy and schadenfreude, we conducted two functional magnetic resonance imaging studies. In study one, the participants read information concerning target persons characterized by levels of possession and self- relevance of comparison domains. When the target person's possession was superior and self- relevant, stronger envy and stronger anterior cingulate cortex ( ACC) activation were induced. In study two, stronger schadenfreude and stronger striatum activation were induced when misfortunes happened to envied persons. ACC activation in study one predicted ventral striatum activation in study two. Our findings document mechanisms of painful emotion, envy, and a rewarding reaction, schadenfreude.	[Takahashi, Hidehiko; Suhara, Tetsuya] Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, Chiba 2638555, Japan; [Takahashi, Hidehiko; Matsuura, Masato] Tokyo Med & Dent Univ, Dept Life Sci & Bioinformat, Grad Sch Hlth Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Takahashi, Hidehiko] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan; [Mobbs, Dean] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138603, Japan	National Institutes for Quantum Science & Technology; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Keio University; University of Cambridge; Nippon Medical School	Takahashi, H (corresponding author), Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, 9-1, 4 Chome Anagawa, Chiba 2638555, Japan.	hidehiko@nirs.go.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare [H20-SYOGAI-011]; Japanese Ministry of Health, Labor, and Welfare; Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health [H20-KOKORO-025]; MRC (UK)	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully thank C. Frith for his valuable comments. This study was supported by a Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare (H20-SYOGAI-011) from the Japanese Ministry of Health, Labor, and Welfare, and a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H20-KOKORO-025) from the Japanese Ministry of Health, Labor, and Welfare. D.M. is support by MRC (UK).	Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Aristotle, 1981, ART RHETORIC; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Spinoza B., 2006, ETHICS; Eisenberg Nancy, 2007, Novartis Found Symp, V278, P71; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAZEAR EP, 1989, J POLIT ECON, V97, P561, DOI 10.1086/261616; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Mora Gonzalo Fernandez de la, 1987, EGALITARIAN ENVY POL; Nozick Robert, 1974, ANARCHY STATE UTOPIA; PARROTT WG, 1993, J PERS SOC PSYCHOL, V64, P906, DOI 10.1037/0022-3514.64.6.906; Rawls J., 1971, THEORY JUSTICE; Russell Bertrand., 1930, CONQUEST HAPPINESS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith RH, 1999, PERS SOC PSYCHOL B, V25, P1007, DOI 10.1177/01461672992511008; TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156	28	314	334	9	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					937	939		10.1126/science.1165604	http://dx.doi.org/10.1126/science.1165604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213918				2022-12-28	WOS:000263295400043
J	Dubrey, SW; Kohli, SK; Mehta, PA; Grocott-Mason, R				Dubrey, Simon W.; Kohli, Sanjay K.; Mehta, Paresh A.; Grocott-Mason, Richard			Picture quiz An unusual case of palpitations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ST-SEGMENT-ELEVATION; PAROXYSMAL ATRIAL-FIBRILLATION; BRUGADA-SYNDROME; MUTATION		[Dubrey, Simon W.; Kohli, Sanjay K.; Mehta, Paresh A.; Grocott-Mason, Richard] Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England		Kohli, SK (corresponding author), Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England.	skkohli@doctors.org.uk						BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; DONOHUE D, 2007, AM HEART HOSP J, V6, P48; Eckardt L, 2005, CIRCULATION, V111, P257, DOI 10.1161/01.CIR.0000153267.21278.8D; Francis J, 2008, J AM COLL CARDIOL, V51, P1149, DOI 10.1016/j.jacc.2007.10.062; Juang JM, 2004, CARDIOLOGY, V101, P157, DOI 10.1159/000076693; Junttila MJ, 2004, EUR HEART J, V25, P874, DOI 10.1016/j.ehj.2004.01.011; Kusano KF, 2008, J AM COLL CARDIOL, V51, P1169, DOI 10.1016/j.jacc.2007.10.060; Letsas KP, 2007, J CARDIOVASC MED, V8, P803, DOI 10.2459/JCM.0b013e3280112b21; Morita H, 2002, J AM COLL CARDIOL, V40, P1437, DOI 10.1016/S0735-1097(02)02167-8; Pfahnl AE, 2007, HEART RHYTHM, V4, P46, DOI 10.1016/j.hrthm.2006.09.031; Potet F, 2003, J CARDIOVASC ELECTR, V14, P200, DOI 10.1046/j.1540-8167.2003.02382.x; Sarkozy A, 2007, EUR HEART J, V28, P334, DOI 10.1093/eurheartj/ehl450; Yamada T, 2006, CIRC J, V70, P1574, DOI 10.1253/circj.70.1574; Yamada T, 2008, CIRC J, V72, P281, DOI 10.1253/circj.72.281	16	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2009	338								a3087	10.1136/bmj.a3087	http://dx.doi.org/10.1136/bmj.a3087			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZX	19211625				2022-12-28	WOS:000263976100001
J	Williams, J; Russell, I; Durai, D; Cheung, WY; Farrin, A; Bloor, K; Coulton, S; Richardson, G				Williams, John; Russell, Ian; Durai, Dharmaraj; Cheung, Wai Yee; Farrin, Amanda; Bloor, Karen; Coulton, Simon; Richardson, Gerry			Effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FLEXIBLE SIGMOIDOSCOPY; COST-EFFECTIVENESS; COLORECTAL-CANCER; ACCURACY; STATE	Objective To compare the clinical effectiveness of doctors and nurses in undertaking upper and lower gastrointestinal endoscopy. Design Pragmatic trial with Zelen's randomisation before consent to minimise distortion of existing practice. Setting 23 hospitals in the United Kingdom. In six hospitals, nurses undertook both upper and lower gastrointestinal endoscopy, yielding a total of 29 centres. Participants 67 doctors and 30 nurses. Of 4964 potentially eligible patients, we randomised 4128 (83%) and recruited 1888 (38%) from July 2002 to June 2003. Interventions Diagnostic upper gastrointestinal endoscopy and flexible sigmoidoscopy, undertaken with or without sedation, with the standard preparation, techniques, and protocols of participating hospitals. After referral for either procedure, patients were randomised between doctors and nurses. Main outcome measures Gastrointestinal symptom rating questionnaire (primary outcome), gastrointestinal endoscopy satisfaction questionnaire and state-trait anxiety inventory (all analysed by intention to treat); immediate and delayed complications; quality of examination and corresponding report; patients' preferences for operator; and new diagnoses at one year (all analysed according to who carried out the procedure). Results There was no significant difference between groups in outcome at one day, one month, or one year after endoscopy, except that patients were more satisfied with nurses after one day. Nurses were also more thorough than doctors in examining the stomach and oesophagus. While quality of life scores were slightly better in patients the doctor group, this was not statistically significant. Conclusions Diagnostic endoscopy can be undertaken safely and effectively by nurses. Trial registration International standard RCT 82765705	[Williams, John; Cheung, Wai Yee] Swansea Univ, Sch Med, Ctr Hlth Informat Res & Evaluat, Swansea SA2 8PP, W Glam, Wales; [Russell, Ian] Bangor Univ, N Wales Org Randomised Trials Hlth, Bangor, Gwynedd, Wales; [Durai, Dharmaraj] Wishaw Gen Hosp, Wishaw, Lanark, Scotland; [Farrin, Amanda] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Coulton, Simon] Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England	Swansea University; Bangor University; University of Leeds; University of Kent	Williams, J (corresponding author), Swansea Univ, Sch Med, Ctr Hlth Informat Res & Evaluat, Swansea SA2 8PP, W Glam, Wales.	j.g.williams@swansea.ac.uk	Russell, Ian T/H-1181-2012	Bloor, Karen/0000-0003-4852-9854; Coulton, Simon/0000-0002-7704-3274	NIHR Evaluation Trials and Studies Coordinating Centre; National Institute for Health Research [97/37/09] Funding Source: researchfish	NIHR Evaluation Trials and Studies Coordinating Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the NIHR Evaluation Trials and Studies Coordinating Centre.	*ASGE, 1999, GASTROINTEST ENDOSC, V49, P826; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; *BSG WORK PART, 1995, GUT, V36, P795; Cash BD, 1999, GASTROINTEST ENDOSC, V49, P163, DOI 10.1016/S0016-5107(99)70481-5; CHARLES D, 1983, STRATE TRAIT ANXIETY; Duthie GS, 1998, GUT, V43, P711, DOI 10.1136/gut.43.5.711; Faigel DO, 2006, GASTROINTEST ENDOSC, V63, pS3, DOI 10.1016/j.gie.2006.02.017; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; MAULE WF, 1994, NEW ENGL J MED, V330, P183, DOI 10.1056/NEJM199401203300307; Meaden C, 2006, ENDOSCOPY, V38, P553, DOI 10.1055/s-2006-925164; *MED RES COUNC, 2000, FRAM DEV EV RCTS COM; Pathmakanthan S, 2001, J ADV NURS, V36, P705, DOI 10.1046/j.1365-2648.2001.02021.x; Richardson G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b270; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; Schoenfeld PS, 1999, GASTROINTEST ENDOSC, V49, P158, DOI 10.1016/S0016-5107(99)70480-3; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Smale S, 2003, GUT, V52, P1090, DOI 10.1136/gut.52.8.1090; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Thomas-Gibson S, 2004, GUT, V53, pA8; Wallace MB, 1999, AM J MED, V107, P214, DOI 10.1016/S0002-9343(99)00225-9; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Wiklund I, 1998, GASTROINTEST ENDOSC, V47, P449, DOI 10.1016/S0016-5107(98)70243-3; Williams J, 2006, HEALTH TECHNOL ASSES, V10, P1; ZELEN M, 1990, STAT MED, V9, P645, DOI 10.1002/sim.4780090611	24	33	34	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2009	338								b231	10.1136/bmj.b231	http://dx.doi.org/10.1136/bmj.b231			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZV	19208714	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000263975900004
J	Doil, C; Mailand, N; Bekker-Jensen, S; Menard, P; Larsen, DH; Pepperkok, R; Ellenberg, J; Panier, S; Durocher, D; Bartek, J; Lukas, J; Lukas, C				Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Pepperkok, Rainer; Ellenberg, Jan; Panier, Stephanie; Durocher, Daniel; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins	CELL			English	Article							DNA; H2AX; CHECKPOINT; COMPLEX; BRCA1; PHOSPHORYLATION; UBIQUITYLATION; ORGANIZATION; ACETYLATION; RECOGNITION	DNA double-strand breaks (DSBs) not only interrupt the genetic information, but also disrupt the chromatin structure, and both impairments require repair mechanisms to ensure genome integrity. We showed previously that RNF8-mediated chromatin ubiquitylation protects genome integrity by promoting the accumulation of repair factors at DSBs. Here, we provide evidence that, while RNF8 is necessary to trigger the DSB-associated ubiquitylations, it is not sufficient to sustain conjugated ubiquitin in this compartment. We identified RNF168 as a novel chromatin-associated ubiquitin ligase with an ability to bind ubiquitin. We show that RNF168 interacts with ubiquitylated H2A, assembles at DSBs in an RNF8-dependent manner, and, by targeting H2A and H2AX, amplifies local concentration of lysine 63-linked ubiquitin conjugates to the threshold required for retention of 53BP1 and BRCA1. Thus, RNF168 defines a new pathway involving sequential ubiquitylations on damaged chromosomes and uncovers a functional cooperation between E3 ligases in genome maintenance.	[Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Doil, Carsten; Mailand, Niels; Bekker-Jensen, Simon; Menard, Patrice; Larsen, Dorthe Helena; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol Biophys Units, D-69117 Heidelberg, Germany; [Ellenberg, Jan] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Panier, Stephanie; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Danish Cancer Society; Danish Cancer Society; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lukas, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Bartek, Jiri/G-5870-2014; Larsen, Dorthe Helena/E-9771-2010; Durocher, Daniel/A-7733-2010; Larsen, Dorthe Helena/Z-6206-2019; Panier, Stephanie/GVT-6365-2022; Ellenberg, Jan/I-4688-2014	Larsen, Dorthe Helena/0000-0002-8280-1252; Durocher, Daniel/0000-0003-3863-8635; Larsen, Dorthe Helena/0000-0002-8280-1252; Ellenberg, Jan/0000-0001-5909-701X; Lukas, Claudia/0000-0001-7169-6883; Pepperkok, Rainer/0000-0002-9762-3583; Menard, Patrice/0000-0001-8844-3727; Bekker-Jensen, Simon/0000-0002-7308-4597; Lukas, Jiri/0000-0001-9087-506X	Danish Cancer Society; Danish National Research Foundation; European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation [R13-A1287]; Danish Research Council; John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF); National Genome Research Network [01GR0403]; European Commission Integrated Project Mitocheck [FP6-503464]	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; German Federal Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network; European Commission Integrated Project Mitocheck(European CommissionEuropean Commission Joint Research Centre)	We thank Junjie Chen, Stephen Jackson, Thanos Halazonetis, Ze'ev Ronai, Kim Newton, and Vishva M. Dixit for reagents; Mark R. Payne for help with statistical analysis; and Holger Erfle and Beate Neumann for assistance with the siRNA screen. This work was supported by the Danish Cancer Society, Danish National Research Foundation, European Commission Integrated Projects "DNA Repair'' and "GENICA,'' Lundbeck Foundation (R13-A1287), Danish Research Council, and the John and Birthe Meyer Foundation. J.E. and R. P. acknowledge support from the German Federal Ministry of Education and Research ( BMBF) grant within the National Genome Research Network (NGFN-1, SMP-RNAi, 01GR0403) and the European Commission Integrated Project Mitocheck (FP6-503464).	Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924	35	664	693	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					435	446		10.1016/j.cell.2008.12.041	http://dx.doi.org/10.1016/j.cell.2008.12.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203579	Bronze			2022-12-28	WOS:000263120600014
J	Lemstra, PJ				Lemstra, Piet J.			MATERIALS SCIENCE Confined Polymers Crystallize	SCIENCE			English	Editorial Material							SINGLE CRYSTALS; POLYETHYLENE		[Lemstra, Piet J.] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology	Lemstra, PJ (corresponding author), Eindhoven Univ Technol, Dolech 2, NL-5600 MB Eindhoven, Netherlands.	p.j.lemstra@tue.nl						Crawford GP, 2005, WILEY-SID SER DISPL, P1, DOI 10.1002/0470870508; FISCHER EW, 1957, Z NATURFORSCH PT A, V12, P753, DOI 10.1515/zna-1957-0912; Fischer H, 2003, MAT SCI ENG C-BIO S, V23, P763, DOI 10.1016/j.msec.2003.09.148; Janssen RAJ, 2005, MRS BULL, V30, P33, DOI 10.1557/mrs2005.6; KELLER A, 1957, PHILOS MAG, V2, P1171, DOI 10.1080/14786435708242746; TIAN M, 2004, THESIS EINDHOVEN U T; TILL PH, 1957, J POLYM SCI, V24, P301, DOI 10.1002/pol.1957.1202410616; Wang HP, 2009, SCIENCE, V323, P757, DOI 10.1126/science.1164601; Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a; Weber MF, 2000, SCIENCE, V287, P2451, DOI 10.1126/science.287.5462.2451	10	11	15	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					725	726		10.1126/science.1168242	http://dx.doi.org/10.1126/science.1168242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197049				2022-12-28	WOS:000263066800030
J	Thornalley, DJR; Elderfield, H; McCave, IN				Thornalley, David J. R.; Elderfield, Harry; McCave, I. Nick			Holocene oscillations in temperature and salinity of the surface subpolar North Atlantic	NATURE			English	Article							NORDIC SEAS; FORAMINIFERAL MG/CA; LABRADOR SEA; CLIMATE; VARIABILITY; CIRCULATION; WATER	The Atlantic meridional overturning circulation ( AMOC) transports warm salty surface waters to high latitudes, where they cool, sink and return southwards at depth. Through its attendant meridional heat transport, the AMOC helps maintain a warm northwestern European climate, and acts as a control on the global climate. Past climate fluctuations during the Holocene epoch (similar to 11,700 years ago to the present) have been linked with changes in North Atlantic Ocean circulation(1,2). The behaviour of the surface flowing salty water that helped drive overturning during past climatic changes is, however, not well known. Here we investigate the temperature and salinity changes of a substantial surface inflow to a region of deep- water formation throughout the Holocene. We find that the inflow has undergone millennial- scale variations in temperature and salinity ( similar to 3.5 degrees C and similar to 1.5 practical salinity units, respectively) most probably controlled by subpolar gyre dynamics. The temperature and salinity variations correlate with previously reported periods of rapid climate change(3). The inflow becomes more saline during enhanced freshwater flux to the subpolar North Atlantic. Model studies predict a weakening of AMOC in response to enhanced Arctic freshwater fluxes(4), although the inflow can compensate on decadal timescales by becoming more saline(5). Our data suggest that such a negative feedback mechanism may have operated during past intervals of climate change.	[Thornalley, David J. R.; Elderfield, Harry; McCave, I. Nick] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England	University of Cambridge	Thornalley, DJR (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, Wales.	d.thornalley@cantab.net	Thornalley, David/B-2451-2010; McCave, I. Nick/O-3992-2018; McCave, Nick N/G-7323-2016	McCave, I. Nick/0000-0002-4702-5489; McCave, Nick N/0000-0002-4702-5489	NERC Rapid Climate Change programme; Natural Environment Research Council [NER/T/S/2002/00436, NRCF010001, NE/C509531/1] Funding Source: researchfish; NERC [NRCF010001] Funding Source: UKRI	NERC Rapid Climate Change programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the crew of RV Charles Darwin 159; M. Greaves, A. Huckle and L. Booth for laboratory assistance; J. Rolfe and M. Hall for stable isotope analyses; J. Hillier for the Atlantic base map; and S. Crowhurst, T. Dokken, M. Schulz and L. Skinner for discussions. Radiocarbon dates were run by the UK Natural Environment Research Council ( NERC) radiocarbon laboratory. Labrador Sea data was provided by A. de Vernal. Funding was provided by the NERC Rapid Climate Change programme.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Barker S, 2005, QUATERNARY SCI REV, V24, P821, DOI 10.1016/j.quascirev.2004.07.016; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Blindheim J, 2005, GEOPH MONOG SERIES, V158, P11; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Came RE, 2007, GEOLOGY, V35, P315, DOI 10.1130/G23455A.1; CLEROUX C, EOS, V88; Cleroux C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001474; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Debret M, 2007, CLIM PAST, V3, P569, DOI 10.5194/cp-3-569-2007; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Ganssen GM, 2000, J GEOL SOC LONDON, V157, P693, DOI 10.1144/jgs.157.3.693; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Hansen B, 2000, PROG OCEANOGR, V45, P109, DOI 10.1016/S0079-6611(99)00052-X; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; LAMB HH, 1979, QUATERNARY RES, V11, P1, DOI 10.1016/0033-5894(79)90067-X; Lund DC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001008; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Oppo DW, 2003, NATURE, V422, P277, DOI 10.1038/422277b; Orvik KA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015002; Rosenheim BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021499; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Schmidt MW, 2006, NATURE, V443, P561, DOI 10.1038/nature05121; Schulz M, 2007, CLIM PAST, V3, P97, DOI 10.5194/cp-3-97-2007; Solignac S, 2004, QUATERNARY SCI REV, V23, P319, DOI 10.1016/j.quascirev.2003.06.003; *US NAT OC ATM ADM, 1998, NODC LEV WORLD OC AT	30	244	251	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					711	714		10.1038/nature07717	http://dx.doi.org/10.1038/nature07717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194447	Green Submitted			2022-12-28	WOS:000263064700038
J	Riker, RR; Shehabi, Y; Bokesch, PM; Ceraso, D; Wisemandle, W; Koura, F; Whitten, P; Margolis, BD; Byrne, DW; Ely, EW; Rocha, MG				Riker, Richard R.; Shehabi, Yahya; Bokesch, Paula M.; Ceraso, Daniel; Wisemandle, Wayne; Koura, Firas; Whitten, Patrick; Margolis, Benjamin D.; Byrne, Daniel W.; Ely, E. Wesley; Rocha, Marcelo G.		SEDCOM Study Grp	Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; ACTIVATED PROTEIN-C; PROLONGED SEDATION; DAILY INTERRUPTION; BRAIN-DYSFUNCTION; DELIRIUM; EFFICACY; SAFETY; MULTICENTER	Context gamma- Aminobutyric acid receptor agonist medications are the most commonly used sedatives for intensive care unit ( ICU) patients, yet preliminary evidence indicates that the alpha(2) agonist dexmedetomidine may have distinct advantages. Objective To compare the efficacy and safety of prolonged sedation with dexmedetomidine vs midazolam for mechanically ventilated patients. Design, Setting, and Patients Prospective, double- blind, randomized trial conducted in 68 centers in 5 countries between March 2005 and August 2007 among 375 medical/ surgical ICU patients with expected mechanical ventilation for more than 24 hours. Sedation level and delirium were assessed using the Richmond Agitation-Sedation Scale ( RASS) and the Confusion Assessment Method for the ICU. Interventions Dexmedetomidine ( 0.2- 1.4 mu g/ kg per hour [ n= 244]) or midazolam ( 0.02- 0.1 mg/ kg per hour [ n= 122]) titrated to achieve light sedation ( RASS scores between - 2 and + 1) from enrollment until extubation or 30 days. Main Outcome Measures Percentage of time within target RASS range. Secondary end points included prevalence and duration of delirium, use of fentanyl and open-label midazolam, and nursing assessments. Additional outcomes included duration of mechanical ventilation, ICU length of stay, and adverse events. Results There was no difference in percentage of time within the target RASS range ( 77.3% for dexmedetomidine group vs 75.1% for midazolam group; difference, 2.2% [ 95% confidence interval {CI}, - 3.2% to 7.5%]; P=. 18). The prevalence of delirium during treatment was 54% ( n= 132/ 244) in dexmedetomidine-treated patients vs 76.6% ( n= 93/ 122) in midazolam- treated patients ( difference, 22.6% [ 95% CI, 14% to 33%]; P <. 001). Median time to extubation was 1.9 days shorter in dexmedetomidine- treated patients ( 3.7 days [ 95% CI, 3.1 to 4.0] vs 5.6 days [ 95% CI, 4.6 to 5.9]; P=. 01), and ICU length of stay was similar ( 5.9 days [ 95% CI, 5.7 to 7.0] vs 7.6 days [ 95% CI, 6.7 to 8.6]; P=. 24). Dexmedetomidine-treated patients were more likely to develop bradycardia ( 42.2% [ 103/ 244] vs 18.9% [ 23/ 122]; P <. 001), with a nonsignificant increase in the proportion requiring treatment ( 4.9% [ 12/ 244] vs 0.8% [ 1/ 122]; P=. 07), but had a lower likelihood of tachycardia ( 25.4% [ 62/ 244] vs 44.3% [ 54/ 122]; P <. 001) or hypertension requiring treatment ( 18.9% [ 46/ 244] vs 29.5% [ 36/ 122]; P=. 02). Conclusions There was no difference between dexmedetomidine and midazolam in time at targeted sedation level in mechanically ventilated ICU patients. At comparable sedation levels, dexmedetomidine- treated patients spent less time on the ventilator, experienced less delirium, and developed less tachycardia and hypertension. The most notable adverse effect of dexmedetomidine was bradycardia. Trial Registration clinicaltrials.gov Identifier: NCT00216190.	[Riker, Richard R.] Maine Med Ctr, Inst Neurosci, Portland, ME 04102 USA; [Riker, Richard R.] Univ Vermont, Coll Med, Portland, ME USA; [Shehabi, Yahya] Univ New S Wales, Sch Clin, Randwick, NSW, Australia; [Bokesch, Paula M.; Wisemandle, Wayne] Hospira Inc, Lake Forest, IL USA; [Ceraso, Daniel] Univ Buenos Aires, Hosp Gen Agudos Juan A Fernandez, Buenos Aires, DF, Argentina; [Koura, Firas] Univ Kentucky, Coll Med, Hazard, KY USA; [Koura, Firas] Kentucky Lung Clin, Hazard, KY USA; [Whitten, Patrick] Univ Illinois, Coll Med, OSF St Francis Med Ctr, Peoria, IL 61656 USA; [Margolis, Benjamin D.] Resurrect W Suburban Hosp Med Ctr, Oak Pk, IL USA; [Byrne, Daniel W.; Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Ely, E. Wesley] Tennessee Valley Healthcare Syst VA VA GRECC, Vet Affairs Geriatr Res Educ Clin Ctr, Nashville, TN USA; [Rocha, Marcelo G.] Irmandade Santa Casa Misericordia, Porto Alegre, RS, Brazil	Maine Medical Center; University of Vermont; University of New South Wales Sydney; University of Buenos Aires; University of Kentucky; University of Illinois System; University of Illinois Peoria; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Riker, RR (corresponding author), Maine Med Ctr, Inst Neurosci, 22 Bramhall St, Portland, ME 04102 USA.	rikerr@mmc.org	Conrad, Steven/F-3257-2015; Riker, Richard/AAP-1760-2020; Byrne, Daniel/GRE-6302-2022; Ely, E. Wesley/Z-2018-2019	Conrad, Steven/0000-0002-4014-969X; Riker, Richard/0000-0002-0682-6204; Ely, E. Wesley/0000-0003-3957-2172; SHEHABI, Yahya/0000-0003-4707-7462; /0000-0002-4157-5148	Hospira Inc, Lake Forest, Illinois	Hospira Inc, Lake Forest, Illinois	This study was funded by Hospira Inc, Lake Forest, Illinois, which manufactures dexmedetomidine.	BAUER TM, 1995, LANCET, V346, P145, DOI 10.1016/S0140-6736(95)91209-6; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Bucknall TK, 2008, CRIT CARE MED, V36, P1444, DOI 10.1097/CCM.0b013e318168f82d; *CTR MED MED SERV, CMS PROP EXP QUAL PR; Dasta JF, 2004, ANN PHARMACOTHER, V38, P1130, DOI 10.1345/aph.1D615; de Wit M, 2008, CRIT CARE, V12, DOI 10.1186/cc6908; De Wolf AM, 2001, ANESTH ANALG, V93, P1205, DOI 10.1097/00000539-200111000-00031; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Gerlach AT, 2007, ANN PHARMACOTHER, V41, P245, DOI 10.1345/aph.1H314; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Guldbrand P, 2004, ACTA ANAESTH SCAND, V48, P944, DOI 10.1111/j.1399-6576.2004.00445.x; *HOSP INC, 2006, PROP PACK INS; Huupponen E, 2008, ACTA ANAESTH SCAND, V52, P289, DOI 10.1111/j.1399-6576.2007.01537.x; Jackson J.C., 2007, AM J RESP CRIT CARE, V175, pA22; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LEMESHOW S, 1994, CRIT CARE MED, V22, P1351, DOI 10.1097/00003246-199409000-00003; MALDONADO J, PSYCHOSOMAT IN PRESS; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Martin J, 2006, INTENS CARE MED, V32, P1137, DOI 10.1007/s00134-006-0214-6; MAZE M, 2004, ANESTHETIC PHARM PHY, P473; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nishina K, 1999, ANESTH ANALG, V88, P452, DOI 10.1097/00000539-199902000-00042; Nishina K, 1998, ANESTH ANALG, V86, P159, DOI 10.1097/00000539-199801000-00032; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; PATEL RP, CRIT CARE M IN PRESS; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Rhoney Denise H, 2003, J Intensive Care Med, V18, P139, DOI 10.1177/0885066603018003003; Riker RR, 2005, PHARMACOTHERAPY, V25, p8S, DOI 10.1592/phco.2005.25.5_Part_2.8S; RIKER RR, 2001, ANESTHESIOLOGY, V95, pA383; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2008, ANAESTH INTENS CARE, V36, P570, DOI 10.1177/0310057X0803600423; Shehabi Y, 2004, INTENS CARE MED, V30, P2188, DOI 10.1007/s00134-004-2417-z; SPENCER EM, 1992, INTENS CARE MED, V18, P415, DOI 10.1007/BF01694344; Venn RM, 2003, INTENS CARE MED, V29, P201, DOI 10.1007/s00134-002-1579-9	48	1004	1134	3	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					489	499		10.1001/jama.2009.56	http://dx.doi.org/10.1001/jama.2009.56			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19188334	Bronze			2022-12-28	WOS:000262992400018
J	Anderson, LL; Mao, XR; Scott, BA; Crowder, CM				Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael			Survival from Hypoxia in C-elegans by Inactivation of Aminoacyl-tRNA Synthetases	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; LIFE-SPAN; TRANSLATION; INHIBITION; PATHWAYS; COMPLEX; BRAIN; DEATH	Hypoxia is important in a wide range of biological processes, such as animal hibernation and cell survival, and is particularly relevant in many diseases. The sensitivity of cells and organisms to hypoxic injury varies widely, but the molecular basis for this variation is incompletely understood. Using forward genetic screens in Caenorhabditis elegans, we isolated a hypoxia- resistant reduction- of- function mutant of rrt- 1 that encodes an arginyl- transfer RNA ( tRNA) synthetase, an enzyme essential for protein translation. Knockdown of rrt- 1, and of most other genes encoding aminoacyl- tRNA synthetases, rescued animals from hypoxia- induced death, and the level of hypoxia resistance was inversely correlated with translation rate. The unfolded protein response was induced by hypoxia and was required for the hypoxia resistance of the reduction- of- function mutant of rrt- 1. Thus, translational suppression produces hypoxia resistance, in part by reducing unfolded protein toxicity.	[Anderson, Lori L.; Mao, Xianrong; Scott, Barbara A.; Crowder, C. Michael] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Crowder, C. Michael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crowder, CM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	crowderm@morpheus.wustl.edu			National Institute of Neurological Disorders and Stroke; Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award; NIH National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience of Brain Disorders Award; McKnight Endowment Fund for Neuroscience; American Heart Association Established Investigator Award(American Heart Association); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Mabon for early efforts on screen design, L. Metz for technical help, and M. Hansen for advice and strains. Supported by the National Institute of Neurological Disorders and Stroke, a Neuroscience of Brain Disorders Award from the McKnight Endowment Fund for Neuroscience, and an American Heart Association Established Investigator Award. Some of the strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2007, METHOD ENZYMOL, V435, P275, DOI 10.1016/S0076-6879(07)35014-3; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; LANDES C, 1995, BIOCHIMIE, V77, P194, DOI 10.1016/0300-9084(96)88125-9; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	25	75	82	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					630	633		10.1126/science.1166175	http://dx.doi.org/10.1126/science.1166175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179530	Green Accepted			2022-12-28	WOS:000262862800042
J	Madsen, MV; Gotzsche, PC; Hrobjartsson, A				Madsen, Matias Vested; Gotzsche, Peter C.; Hrobjartsson, Asbjorn			Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPARING PLACEBO; MULTICENTER; POWERLESS; OUTCOMES; NEEDLE	Objectives To study the analgesic effect of acupuncture and placebo acupuncture and to explore whether the type of the placebo acupuncture is associated with the estimated effect of acupuncture. Design Systematic review and meta- analysis of three armed randomised clinical trials. Data sources Cochrane Library, Medline, Embase, Biological Abstracts, and PsycLIT. Data extraction and analysis Standardised mean differences from each trial were used to estimate the effect of acupuncture and placebo acupuncture. The different types of placebo acupuncture were ranked from 1 to 5 according to assessment of the possibility of a physiological effect, and this ranking was meta- regressed with the effect of acupuncture. Data synthesis Thirteen trials ( 3025 patients) involving a variety of pain conditions were eligible. The allocation of patients was adequately concealed in eight trials. The clinicians managing the acupuncture and placebo acupuncture treatmentswere not blinded in any of the trials. One clearly outlying trial ( 70 patients) was excluded. A small difference was found between acupuncture and placebo acupuncture: standardised mean difference - 0.17 ( 95% confidence interval - 0.26 to - 0.08), corresponding to 4 mm ( 2 mm to 6 mm) on a 100 mm visual analogue scale. No statistically significant heterogeneity was present ( P= 0.10, I-2= 36%). A moderate difference was found between placebo acupuncture and no acupuncture: standardised mean difference - 0.42 (- 0.60 to - 0.23). However, considerable heterogeneity ( P< 0.001, I-2= 66%) was also found, as large trials reported both small and large effects of placebo. No association was detected between the type of placebo acupuncture and the effect of acupuncture ( P= 0.60). Conclusions A small analgesic effect of acupuncture was found, which seems to lack clinical relevance and cannot be clearly distinguished from bias. Whether needling at acupuncture points, or at any site, reduces pain independently of the psychological impact of the treatment ritual is unclear.	[Madsen, Matias Vested; Gotzsche, Peter C.; Hrobjartsson, Asbjorn] Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hrobjartsson, A (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	ah@cochrane.dk	Vested, Matias/HDN-3135-2022	Vested, Matias/0000-0002-5165-2725				Assefi NP, 2005, ANN INTERN MED, V143, P10, DOI 10.7326/0003-4819-143-1-200507050-00005; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Casimiro L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003788.pub2; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; GHIA JN, 1976, PAIN, V2, P285, DOI 10.1016/0304-3959(76)90006-3; Gotzsche PC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000193.pub2; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Green S, 2002, Cochrane Database Syst Rev, pCD003527; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hrobjartsson A, 2002, J CLIN EPIDEMIOL, V55, P430, DOI 10.1016/S0895-4356(01)00496-6; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Irnich D, 2002, SCHMERZ, V16, P93, DOI 10.1007/s004820100094; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; LEWIT K, 1979, PAIN, V6, P83, DOI 10.1016/0304-3959(79)90142-8; MELCHART D, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001218; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MELZACK R, 1976, ANAESTHESIST, V25, P204; Proctor ML., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002123; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; Trinh KV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004870.pub3; Vickers A, 1999, BRIT MED J, V319, P973, DOI 10.1136/bmj.319.7215.973	30	219	230	2	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2009	338								a3115	10.1136/bmj.a3115	http://dx.doi.org/10.1136/bmj.a3115			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EL	19174438	hybrid, Green Published			2022-12-28	WOS:000263205400001
J	Das, J; Ho, M; Zikherman, J; Govern, C; Yang, M; Weiss, A; Chakraborty, AK; Roose, JP				Das, Jayajit; Ho, Mary; Zikherman, Julie; Govern, Christopher; Yang, Ming; Weiss, Arthur; Chakraborty, Arup K.; Roose, Jeroen P.			Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; T-CELLS; POSITIVE FEEDBACK; DENDRITIC CELLS; SOS; SEVENLESS; GENE; TRANSDUCTION; REQUIREMENT; LYMPHOCYTES	Activation of Ras proteins underlies functional decisions in diverse cell types. Two molecules, RasGRP and SOS, catalyze Ras activation in lymphocytes. Binding of active Ras to SOS' allosteric pocket markedly increases SOS' activity establishing a positive feedback loop for SOS-mediated Ras activation. Integrating in silico and in vitro studies, we demonstrate that digital signaling in lymphocytes (cells are "on'' or "off'') is predicated upon feedback regulation of SOS. SOS' feedback loop leads to hysteresis in the dose-response curve, which can enable a capacity to sustain Ras activation as stimuli are withdrawn and exhibit "memory'' of past encounters with antigen. Ras activation via RasGRP alone is analog (graded increase in amplitude with stimulus). We describe how complementary analog (RasGRP) and digital (SOS) pathways act on Ras to efficiently convert analog input to digital output. Numerous predictions regarding the impact of our findings on lymphocyte function and development are noted.	[Zikherman, Julie; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ho, Mary; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Das, Jayajit; Govern, Christopher; Yang, Ming; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Div Rheumatol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu; arupc@mit.edu; jeroen.roose@ucsf.edu	Das, Jayajit/AAD-8502-2022; Das, Jayajit/E-2951-2011	Das, Jayajit/0000-0001-9649-4698; Zikherman, Julie/0000-0002-0873-192X; Roose, Jeroen/0000-0003-4746-2811	NIH Director's Pioneer [1PO1/AI071195/01]; Rosalind Russell Medical Research Center for Arthritis; NCI [K01CA113367]; Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE [K01CA113367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195] Funding Source: NIH RePORTER	NIH Director's Pioneer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalind Russell Medical Research Center for Arthritis; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthritis Foundation; Sandler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Kurosaki for DT40 lines and Dr. Dafna Bar-sagi for the H-RasG59E38 plasmid. We are grateful to Dr. DeFranco and members of the Weiss, Chakraborty, and Roose labs for critical reading of the manuscript. We apologize to colleagues we could not cite due to space constraints. Financial support: NIH Director's Pioneer Award and 1PO1/AI071195/01 (A. K. C.), the Howard Hughes Medical Institute as well as the Rosalind Russell Medical Research Center for Arthritis (A. W.), and the NCI (K01CA113367), Arthritis Foundation, and Sandler Foundation (J.P.R.).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BORTZ AB, 1975, J COMPUT PHYS, V17, P10, DOI 10.1016/0021-9991(75)90060-1; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gilbert JJ, 1996, J IMMUNOL, V156, P2054; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; WEISS A, 1987, J IMMUNOL, V138, P2169	39	281	285	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					337	351		10.1016/j.cell.2008.11.051	http://dx.doi.org/10.1016/j.cell.2008.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167334	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000262648800021
J	Piccini, JP; Newby, LK				Piccini, Jonathan P.; Newby, L. Kristin			Defibrillator therapy improved quality of life in CHF; amiodarone did not	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TACHYCARDIA		[Piccini, Jonathan P.; Newby, L. Kristin] Duke Clin Res Inst, Durham, NC USA	Duke University	Piccini, JP (corresponding author), Duke Clin Res Inst, Durham, NC USA.							Friedman PA, 2006, CIRCULATION, V113, P2871, DOI 10.1161/CIRCULATIONAHA.105.594531; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-10	10.7326/0003-4819-150-2-200901200-02010	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172715				2022-12-28	WOS:000262655200028
J	Lowther, SA; Curriero, FC; Kalish, BT; Shields, TM; Monze, M; Moss, WJ				Lowther, Sara A.; Curriero, Frank C.; Kalish, Brian T.; Shields, Timothy M.; Monze, Mwaka; Moss, William J.			Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey	LANCET			English	Article							ORAL-FLUID; ETHIOPIA; HETEROSKEDASTICITY; ELIMINATION; EPIDEMIC; OUTBREAK; RUBELLA; IMPACT	Background Measles control efforts are hindered by challenges in sustaining high vaccination coverage, waning immunity in HIV-1-infected children, and clustering of susceptible individuals. Our aim was to assess population immunity to measles virus after a mass vaccination campaign in a region with high HIV prevalence. Methods 3 years after a measles supplemental immunisation activity (SIA), we undertook a cross-sectional survey in Lusaka, Zambia. Households were randomly selected from a satellite image. Children aged 9 months to 5 years from selected households were eligible for enrolment. A questionnaire was administered to the children's caregivers to obtain information about measles vaccination history and history of measles. Oral fluid samples were obtained from children and tested for antibodies to measles virus and HIV-1 by EIA. Findings 1015 children from 668 residences provided adequate specimens. 853 (84%) children had a history of measles vaccination according to either caregiver report or immunisation card. 679 children (67%) had antibodies to measles virus, and 64 (6%) children had antibodies to HIV-1. Children with antibodies to HIV-1 were as likely to have no history of measles vaccination as those without antibodies to HIV-1 (odds ratio [OR] 1.17, 95% CI 0.57-2.41). Children without measles antibodies were more likely to have never received measles vaccine than those with antibodies (adjusted OR 2.50, 1.69-3.71). In vaccinated children, 33 (61%) of 54 children with antibodies to HIV-1 also had antibodies to measles virus, compared with 568 (71%) of 796 children without antibodies to HIV-1 (p=0.1). Interpretation 3 years after an SIA, population immunity to measles was insufficient to interrupt measles virus transmission. The use of oral fluid and satellite images for sampling are potential methods to assess population immunity and the timing of SIAs. Funding Thrasher Research Fund.	[Lowther, Sara A.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Shields, Timothy M.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Monze, Mwaka] Univ Teaching Hosp, Virol Lab, Lusaka, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zambia	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	wmoss@jhsph.edu			Thrasher Research Fund [02829-9]; National Eye Institute Training Grant [EY 07127]; National Institutes of Health; Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	Thrasher Research Fund; National Eye Institute Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	This work was supported by the Thrasher Research Fund (02829-9). SAL was supported by the National Eye Institute Training Grant (EY 07127), pre-doctoral Clinical Trials Training Program in Vision Research, National Institutes of Health, Department of Health and Human Services. We thank Cliansa Nkojiga-Mwangilwa for administrative assistance, the students and community health workers for assistance in undertaking the survey, the Tianjane Community Theater Group for creative and motivational performances as part ofthe community scusitisation activities, Felicity Cutts for contributions to die early conception of the study, and Greg Glass for expertise and support of the spatial analyses.	*CDC, 2003, MMWR-MORBID MORTAL W, V52, P1044; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P581; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1237; Cressie N., 2011, STAT SPATIO TEMPORAL; DIGGLE PJ, 2006, STAT ANAL SPATIAL PO; Enquselassie F, 2003, EPIDEMIOL INFECT, V130, P507, DOI 10.1017/S0950268803008446; FROOT KA, 1989, J FINANC QUANT ANAL, V24, P333, DOI 10.2307/2330815; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Hassidim A., 2008, Morbidity and Mortality Weekly Report, V57, P203; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Helfand RF, 2004, EPIDEMIOL INFECT, V132, P7, DOI 10.1017/S0950268803001547; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Kremer JR, 2005, CLIN DIAGN LAB IMMUN, V12, P668, DOI 10.1128/CDLI.12.5.668-670.2005; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Moss WJ, 2007, J INFECT DIS, V196, P347, DOI 10.1086/519169; Muller CP, 2007, VACCINE, V25, P1, DOI 10.1016/j.vaccine.2006.07.039; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; Nokes DJ, 2001, B WORLD HEALTH ORGAN, V79, P588; Ohuma EO, 2009, EPIDEMIOL INFECT, V137, P227, DOI 10.1017/S0950268808000848; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Ray Sandip Kumar, 2004, Indian Journal of Pediatrics, V71, P583, DOI 10.1007/BF02724116; Scott S, 2008, INT J EPIDEMIOL, V37, P356, DOI 10.1093/ije/dyn007; Setse RW, 2006, J TROP PEDIATRICS, V52, P324, DOI 10.1093/tropej/fmk002; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; Waller L.A., 2004, APPL SPATIAL STAT PU; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO, IMM SURV ASS MON ZAM; WHO, 2008, MMWR-MORBID MORTAL W, V57, P657; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization United Nations Children's Fund, 2001, MEASL MORT RED REG E; World Health Organization & United Nations Children's Fund, 2005, GLOB IMM VIS STRAT 2	33	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1025	1032		10.1016/S0140-6736(09)60142-2	http://dx.doi.org/10.1016/S0140-6736(09)60142-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19211140				2022-12-28	WOS:000264398200030
J	Saleh, MC; Tassetto, M; van Rij, RP; Goic, B; Gausson, V; Berry, B; Jacquier, C; Antoniewski, C; Andino, R				Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe; Andino, Raul			Antiviral immunity in Drosophila requires systemic RNA interference spread	NATURE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; PATHWAY; DSRNA; GENE; MELANOGASTER; VIRUSES; DICER-2; ENTRY	Multicellular organisms evolved sophisticated defence systems to confer protection against pathogens. An important characteristic of these immune systems is their ability to act both locally at the site of infection and at distal uninfected locations(1-4). In insects, such as Drosophila melanogaster, RNA interference (RNAi) mediates antiviral immunity(5-7). However, the antiviral RNAi defence in flies seems to be a local, cell-autonomous process, as flies are thought to be unable to generate a systemic RNAi response(8). Here we show that a recently defined double-stranded RNA(dsRNA) uptake pathway(9) is essential for effective antiviral RNAi immunity in adult flies. Mutant flies defective in this dsRNA uptake pathway were hypersensitive to infection with Drosophila C virus and Sindbis virus. Mortality in dsRNA-uptake-defective flies was accompanied by 100-to 10(5)-fold increases in viral titres and higher levels of viral RNA. Furthermore, inoculating naked dsRNA into flies elicited a sequence-specific antiviral immune response that required an intact dsRNA uptake pathway. These findings suggest that spread of dsRNA to uninfected sites is essential for effective antiviral immunity. Notably, infection with green fluorescent protein (GFP)-tagged Sindbis virus suppressed expression of host-encoded GFP at a distal site. Thus, similar to protein-based immunity in vertebrates, the antiviral RNAi response in flies also relies on the systemic spread of a virus-specific immunity signal.	[Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] Inst Pasteur, F-75015 Paris, France; [Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] CNRS, URA 2578, F-75015 Paris, France	University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	raul.andino@ucsf.edu	Saleh, Maria-Carla/ABC-2527-2021; BERRY, Bassam/D-1666-2009; Van Rij, Ronald/I-7073-2012; Antoniewski, Christophe/G-4519-2011	Saleh, Maria-Carla/0000-0001-8593-4117; Van Rij, Ronald/0000-0003-0221-4689; Antoniewski, Christophe/0000-0001-7709-2116; Dorey, valerie/0000-0002-9727-3448	NIH [AI40085, AI064738]; Institut Pasteur; CNRS; ANR; ARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064738, R01AI040085, R21AI040085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	d We are grateful to members of the Andino and the O'Farrell laboratories for discussion, technical support and advice on fly work. We thank J. Frydman, P. O'Farrell and M. Vignuzzi for discussions and comments on the manuscript. We also thank T. Cook for advice on the IR EcR eye phenotype, R. Carthew for providing the GMR. IR[white] and Dcr2 fly stocks and M. Siomi for the Ago2 fly stock. B. G. is a Manlio Cantarini fellow. B. B. is a Lebanese CNRSL Fellow. C. J. is a University of Paris VI and Ministere de la Recherche fellow. This work was financially supported by NIH grants AI40085 and AI064738 to R. A., the Institut Pasteur to M.-C. S. and C. A., and CNRS, ANR and ARC grants to C.	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roitt I., 2001, IMMUNOLOGY, V6th; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	24	205	220	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					346	U109		10.1038/nature07712	http://dx.doi.org/10.1038/nature07712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19204732	Green Accepted			2022-12-28	WOS:000264285600043
J	Pham, HH; O'Malley, AS; Bach, PB; Saiontz-Martinez, C; Schrag, D				Pham, Hoangmai H.; O'Malley, Ann S.; Bach, Peter B.; Saiontz-Martinez, Cynthia; Schrag, Deborah			Primary Care Physicians' Links to Other Physicians Through Medicare Patients: The Scope of Care Coordination	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE	Background: Primary care physicians are expected to coordinate care for their patients. Objective: To assess the number of physician peers providing care to the Medicare patients of a primary care physician. Design: Cross-sectional analysis of claims data. Setting: Fee-for-service Medicare in 2005. Participants: 2284 primary care physicians who responded to the 2004 to 2005 Community Tracking Study Physician Survey. Measurements: Primary patients for each physician were defined as beneficiaries for whom the physician billed for more evaluation and management visits than any other physician in 2005. The number of physician peers for each physician was the sum of other unique physicians that the index physician's primary patients visited plus other unique physicians who served as the primary physician for each of the index physician's nonprimary patients during 2005. Results: The typical primary care physician has 229 (interquartile range, 125 to 340) other physicians working in 117 ( interquartile range, 66 to 175) practices with which care must be coordinated, equivalent to an additional 99 physicians and 53 practices for every 100 Medicare beneficiaries managed by the primary care physician. When only the 31% of a primary care physician's primary patients who had 4 or more chronic conditions was considered, the median number of peers involved was still substantial ( 86 physicians in 36 practices). The number of peers varied with geographic region, practice type, and reliance on Medicaid revenues. Limitations: Estimates are based only on fee-for-service Medicare patients and physician peers, and the number of peers is therefore probably an underestimate. The modest response rate of the Community Tracking Study Physician Survey may bias results in unpredictable directions. Conclusion: In caring for his or her own primary and nonprimary patients during a single year, each primary care physician potentially must coordinate with a large number of individual physician colleagues who also provide care to these patients.	[Pham, Hoangmai H.] Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; Social & Sci Syst, Silver Spring, MD USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Social & Scientific Systems; Harvard University; Dana-Farber Cancer Institute	Pham, HH (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave SW,Suite 550, Washington, DC 20024 USA.	mpham@hschange.org			National Institute on Aging; American Medical Group Association; Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025687] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Medical Group Association; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging, American Medical Group Association, and the Robert Wood Johnson Foundation.	*AG HEALTHC RES QU, PUBL AG HEALTHC RES; Agency for Healthcare Research and Quality, CAHPS CLIN GROUP SUR; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barr M, 2008, ADV MED HOME PATIENT; Bartschat Wanda, 2006, J AHIMA, V77, p64A; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; *CTR STUD HLTH SYS, TECHN PUBL CTR STUD, V38; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; Kwait J, 2001, J URBAN HEALTH, V78, P468, DOI 10.1093/jurban/78.3.468; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Schrag D, 2006, MED CARE, V44, P560, DOI 10.1097/01.mlr.0000215811.68308.ae; Starfield B, 1998, PRIMARY CARE BALANCI; US Census Bureau, CENS REG DIV US; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503	20	162	162	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					236	U23		10.7326/0003-4819-150-4-200902170-00004	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221375	Green Accepted			2022-12-28	WOS:000263562500002
J	Adli, M; Kleinert, S; Lafont, A; Kahn, A; Ganten, D				Adli, Mazda; Kleinert, Sabine; Lafont, Antoine; Kahn, Axel; Ganten, Detlev			Shaping future health: Berlin Evolution of Medicine Summit	LANCET			English	Editorial Material									[Adli, Mazda; Ganten, Detlev] Charite, D-10117 Berlin, Germany; [Kleinert, Sabine] The Lancet, London NW1 7BY, England; [Lafont, Antoine; Kahn, Axel] Univ Paris 05, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UDICE-French Research Universities; Universite Paris Cite	Adli, M (corresponding author), Charite, D-10117 Berlin, Germany.	mazda.adli@charite.de	Adli, Mazda/GYV-2083-2022	Adli, Mazda/0000-0002-0993-5617				Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Beaglehole R, 2008, LANCET, V372, P1988, DOI 10.1016/S0140-6736(08)61558-5; Binstock RH, 2007, J ALZHEIMERS DIS, V12, P3; Feachem RGA, 2002, NATURE, V417, P695, DOI 10.1038/417695a; Louis MES, 2008, AM J PREV MED, V35, P527, DOI 10.1016/j.amepre.2008.08.023	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					519	520		10.1016/S0140-6736(09)60177-X	http://dx.doi.org/10.1016/S0140-6736(09)60177-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217972				2022-12-28	WOS:000263333600004
J	Hertel, J				Hertel, Jay			Immobilisation for acute severe ankle sprain	LANCET			English	Editorial Material							INJURIES		[Hertel, Jay] Univ Virginia, Charlottesville, VA 22904 USA	University of Virginia	Hertel, J (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.	jhertel@virginia.edu						Anandacoomarasamy A, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.011676; Braun BL, 1999, ARCH FAM MED, V8, P143, DOI 10.1001/archfami.8.2.143; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hubbard TJ, 2007, FOOT ANKLE INT, V28, P343, DOI 10.3113/FAI.2007.0343; Itay S., 1982, ORTHOP REV, V11, P73; Jones MH, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/BLO.0b01e31802f5468; Kerkhoffs GM, 2007, COCHRANE DB SYST REV, V2, pCD000380, DOI DOI 10.1002/14651858.CD000380.PUB2; Lamb SE, 2009, LANCET, V373, P575, DOI 10.1016/S0140-6736(09)60206-3; McKay GD, 2001, BRIT J SPORT MED, V35, P103, DOI 10.1136/bjsm.35.2.103; Valderrabano V, 2006, AM J SPORT MED, V34, P612, DOI 10.1177/0363546505281813; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; VERHAGEN RAW, 1995, ARCH ORTHOP TRAUM SU, V114, P92, DOI 10.1007/BF00422833; YEUNG MS, 1994, BRIT J SPORT MED, V28, P112, DOI 10.1136/bjsm.28.2.112	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					524	526		10.1016/S0140-6736(09)60179-3	http://dx.doi.org/10.1016/S0140-6736(09)60179-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217974				2022-12-28	WOS:000263333600008
J	Gekas, J; Gagne, G; Bujold, E; Douillard, D; Forest, JC; Reinharz, D; Rousseau, F				Gekas, Jean; Gagne, Genevieve; Bujold, Emmanuel; Douillard, Daniel; Forest, Jean-Claude; Reinharz, Daniel; Rousseau, Francois			Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; FETAL LOSS; UNITED-STATES; 1ST-TRIMESTER; WOMEN; RISK; DIAGNOSIS; SERUM; HEALTH; TESTS	Objectives To assess and compare the cost effectiveness of three different strategies for prenatal screening for Down's syndrome (integrated test, sequential screening, and contingent screenings) and to determine the most useful cut-off values for risk. Design Computer simulations to study integrated, sequential, and contingent screening strategies with various cut-offs leading to 19 potential screening algorithms. Data sources The computer simulation was populated with data from the Serum Urine and Ultrasound Screening Study (SURUSS), real unit costs for healthcare interventions, and a population of 110 948 pregnancies from the province of Quebec for the year 2001. Main outcome measures Cost effectiveness ratios, incremental cost effectiveness ratios, and screening options' outcomes. Results The contingent screening strategy dominated all other screening options: it had the best cost effectiveness ratio ($C26 833 per case of Down's syndrome) with fewer procedure related euploid miscarriages and unnecessary terminations (respectively, 6 and 16 per 100 000 pregnancies). It also outperformed serum screening at the second trimester. In terms of the incremental cost effectiveness ratio, contingent screening was still dominant: compared with screening based on maternal age alone, the savings were $C30 963 per additional birth with Down's syndrome averted. Contingent screening was the only screening strategy that offered early reassurance to the majority of women (77.81%) in first trimester and minimised costs by limiting retesting during the second trimester (21.05%). For the contingent and sequential screening strategies, the choice of cut-off value for risk in the first trimester test significantly affected the cost effectiveness ratios (respectively, from $C26 833 to $C37 260 and from $C35 215 to $C45 314 per case of Down's syndrome), the number of procedure related euploid miscarriages (from 6 to 46 and from 6 to 45 per 100 000 pregnancies), and the number of unnecessary terminations ( from 16 to 26 and from 16 to 25 per 100 000 pregnancies). Conclusions Contingent screening, with a first trimester cut-off value for high risk of 1 in 9, is the preferred option for prenatal screening of women for pregnancies affected by Down's syndrome.	[Gekas, Jean] Univ Laval, Fac Med, Ctr Rech CHUQ, Serv Genet Med,Unite Diagnost Prenatal, Quebec City, PQ G1K 7P4, Canada; [Gagne, Genevieve; Douillard, Daniel; Reinharz, Daniel] Univ Laval, Fac Med, Ctr Rech CHUQ, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada; [Bujold, Emmanuel] Univ Laval, Fac Med, Ctr Rech CHUQ, Unite Diagnost Prenatal,Dept Obstet Gynecol, Quebec City, PQ G1K 7P4, Canada; [Forest, Jean-Claude; Rousseau, Francois] Univ Laval, Fac Med, Ctr Rech CHUQ, Dept Med Biol,CanGeneTest Res Consortium Genet La, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University	Gekas, J (corresponding author), CHU Laval, Bur RC 9300, 2705 Boul Laurier, Quebec City, PQ G1V 4G2, Canada.	jean.gekas@mail.chuq.qc.ca						*AETMIS, 2003, 0301 AETMIS, V21, P84; [Anonymous], 2004, Obstet Gynecol, V104, P215; Asch A, 1999, AM J PUBLIC HEALTH, V89, P1649, DOI 10.2105/AJPH.89.11.1649; Ball RH, 2007, OBSTET GYNECOL, V110, P10, DOI 10.1097/01.AOG.0000263470.89007.e3; Benn P, 2005, PRENATAL DIAG, V25, P645, DOI 10.1002/pd.1215; Biggio JR, 2004, AM J OBSTET GYNECOL, V190, P721, DOI 10.1016/j.ajog.2003.09.028; Bishop AJ, 2004, BJOG-INT J OBSTET GY, V111, P775, DOI 10.1111/j.1471-0528.2004.00197.x; Boulware LE, 2008, AM J KIDNEY DIS, V51, P535, DOI 10.1053/j.ajkd.2008.01.006; Carroll JC, 1997, CAN MED ASSOC J, V156, P775; Caughey AB, 2005, GYNECOL OBSTET INVES, V60, P11, DOI 10.1159/000083480; Caughey AB, 2002, AM J OBSTET GYNECOL, V187, P1239, DOI 10.1067/mob.2002.127144; *CETS, 1999, 994 CETS RF, V18, P92; Chen YY, 2007, INT J TECHNOL ASSESS, V23, P138, DOI 10.1017/S0266462307051689; Cuckle HS, 1998, PRENATAL DIAG, V18, P1127, DOI 10.1002/(SICI)1097-0223(199811)18:11<1127::AID-PD419>3.3.CO;2-X; Drummond MF., 2005, METHODS EC EVALUATIO, V3 rd ed, P1; Egan JFX, 2002, AM J OBSTET GYNECOL, V187, P1230, DOI 10.1067/mob.2002.126980; FOREST JC, 2004, RAPPORT COMITE EXPER; Gekas J, 1999, PRENATAL DIAG, V19, P1, DOI 10.1002/(SICI)1097-0223(199901)19:1<1::AID-PD456>3.0.CO;2-S; Harris RA, 2004, LANCET, V363, P276, DOI 10.1016/S0140-6736(03)15385-8; Haute Autorite de Sante, 2007, EV STRAT DEP TRIS 21; Hoover S.V., 1989, SIMULATION PROBLEM S; Jackson L, 2003, PRENATAL DIAG, V23, P837, DOI 10.1002/pd.705; Kotaska A, 2007, J OBSTET GYNAECOL CA, V29, P499, DOI 10.1016/S1701-2163(16)35510-4; Kuppermann M, 1999, AM J PUBLIC HEALTH, V89, P160, DOI 10.2105/AJPH.89.2.160; Kuppermann M, 1999, PRENATAL DIAG, V19, P711, DOI 10.1002/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V; Lau TK, 2005, CURR OPIN OBSTET GYN, V17, P163, DOI 10.1097/01.gco.0000162187.99219.e0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Morris J, 2005, J MED SCREEN, V12, P202, DOI 10.1258/096914105775220679; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; *MSSS, 2003, BANQ DONN APR DRG AL; *MSSS, 2007, LAB BIOL MED MES PRO; *MSSS, 2007, REC 2001; *MSSS, 2005, SIFO SYST INF FIN OP; Mulvey S, 2003, PRENATAL DIAG, V23, P828, DOI 10.1002/pd.701; *NIH, 1979, NIH PUBL; Palomaki GE, 2006, OBSTET GYNECOL, V107, P367, DOI 10.1097/01.AOG.0000195061.48747.f4; Petrou S, 2004, LANCET, V363, P258, DOI 10.1016/S0140-6736(03)15416-5; Platt LD, 2004, OBSTET GYNECOL, V104, P661, DOI 10.1097/01.AOG.0000139832.79658.b9; *RAMQ, 2005, MAN MED SPEC, P607; *RAMQ, 2007, MAN MED SPEC LAB ET, P176; Reddy UM, 2007, OBSTET GYNECOL, V110, P2, DOI 10.1097/01.AOG.0000269044.84174.fc; Reddy UM, 2007, CLIN OBSTET GYNECOL, V50, P442, DOI 10.1097/GRF.0b013e31804c9b99; Resta RG, 2005, AM J MED GENET A, V133A, P31, DOI 10.1002/ajmg.a.30553; Ritchie K, 2005, BJOG-INT J OBSTET GY, V112, P866, DOI 10.1111/j.1471-0528.2005.00560.x; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Scott A, 2007, Issues Emerg Health Technol, P1; Snijders R, 1999, PRENATAL DIAG, V19, P1180, DOI 10.1002/(SICI)1097-0223(199912)19:12<1180::AID-PD732>3.0.CO;2-V; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Spencer K, 2004, ULTRASOUND OBST GYN, V24, P735, DOI 10.1002/uog.1768; Summers AM, 2007, J OBSTET GYNAECOL CA, V29, P146, DOI 10.1016/S1701-2163(16)32379-9; Sundberg K, 1997, LANCET, V350, P697, DOI 10.1016/S0140-6736(97)02449-5; Wald NJ, 2006, PRENATAL DIAG, V26, P769, DOI 10.1002/pd.1498; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Wyatt P, 2007, PRENATAL DIAG, V27, P186, DOI 10.1002/pd.1634	57	31	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2009	338								b138	10.1136/bmj.b138	http://dx.doi.org/10.1136/bmj.b138			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415ZZ	19218323	Green Published, hybrid			2022-12-28	WOS:000263976300002
J	Ono, T; Kumamoto, A; Nakagawa, H; Yamaguchi, Y; Oshigami, S; Yamaji, A; Kobayashi, T; Kasahara, Y; Oya, H				Ono, Takayuki; Kumamoto, Atsushi; Nakagawa, Hiromu; Yamaguchi, Yasushi; Oshigami, Shoko; Yamaji, Atsushi; Kobayashi, Takao; Kasahara, Yoshiya; Oya, Hiroshi			Lunar Radar Sounder Observations of Subsurface Layers Under the Nearside Maria of the Moon	SCIENCE			English	Article							EXPERIMENT ON-BOARD; SELENE SPACECRAFT; SERENITATIS; DEPOSITS; TECTONICS; BASALTS; REGION; BASIN	Observations of the subsurface geology of the Moon help advance our understanding of lunar origin and evolution. Radar sounding from the Kaguya spacecraft has revealed subsurface layers at an apparent depth of several hundred meters in nearside maria. Comparison with the surface geology in the Serenitatis basin implies that the prominent echoes are probably from buried regolith layers accumulated during the depositional hiatus of mare basalts. The stratification indicates a tectonic quiescence between 3.55 and 2.84 billion years ago; mare ridges were formed subsequently. The basalts that accumulated during this quiet period have a total thickness of only a few hundred meters. These observations suggest that mascon loading did not produce the tectonics in Serenitatis after 3.55 billion years ago. Global cooling probably dominated the tectonics after 2.84 billion years ago.	[Ono, Takayuki; Kumamoto, Atsushi; Nakagawa, Hiromu] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808578, Japan; [Yamaguchi, Yasushi; Oshigami, Shoko] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Yamaji, Atsushi] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Kobayashi, Takao] Korea Inst Geosci & Mineral Resources, Mineral Resources Res Div, Taejon 305350, South Korea; [Kasahara, Yoshiya] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Oya, Hiroshi] Fukui Univ Technol, Dept Space Sci & Technol, Fukui 9108505, Japan	Tohoku University; Nagoya University; Kyoto University; Korea Institute of Geoscience & Mineral Resources (KIGAM); Kanazawa University	Ono, T (corresponding author), Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808578, Japan.		KASAHARA, Yoshiya/E-7073-2015; Yamaji, Atsushi/ABB-2815-2021	KASAHARA, Yoshiya/0000-0002-9304-8235; Yamaji, Atsushi/0000-0001-8074-543X; Nakagawa, Hiromu/0000-0001-8166-0171; Yamaguchi, Yasushi/0000-0002-2554-1060; Kumamoto, Atsushi/0000-0002-3988-1488				BELL JF, 1995, ICARUS, V118, P51, DOI 10.1006/icar.1995.1177; Budney CJ, 1998, J GEOPHYS RES-PLANET, V103, P16855, DOI 10.1029/98JE01602; Campbell BA., 2002, RADAR REMOTE SENSING; DeHon R. A., 1976, P LUNAR PLANET SCI C, V3, P2729; Freed AM, 2001, J GEOPHYS RES-PLANET, V106, P20603, DOI 10.1029/2000JE001347; HEAD JW, 1979, MOON PLANETS, V21, P439, DOI 10.1007/BF00897836; Hiesinger H, 2000, J GEOPHYS RES-PLANET, V105, P29239, DOI 10.1029/2000JE001244; Kodama S, 2003, METEORIT PLANET SCI, V38, P1461, DOI 10.1111/j.1945-5100.2003.tb00251.x; MAXWELL TA, 1975, GEOL SOC AM BULL, V86, P1273, DOI 10.1130/0016-7606(1975)86<1273:DMAOOR>2.0.CO;2; MOORE HJ, 1974, P LUNAR PLANET SCI C, V5, P71; Ono T, 2000, EARTH PLANETS SPACE, V52, P629, DOI 10.1186/BF03351671; Ono T, 2008, EARTH PLANETS SPACE, V60, P321, DOI 10.1186/BF03352797; PEEPLES WJ, 1978, J GEOPHYS RES, V83, P3459, DOI 10.1029/JB083iB07p03459; PHILLIPS RJ, 1973, NASA SPEC PUBL, V330; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; QUAIDE W, 1975, MOON PLANETS, V13, P27, DOI 10.1007/BF00567506; Seu R, 2004, PLANET SPACE SCI, V52, P157, DOI 10.1016/j.pss.2003.08.024; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; SHARPTON VL, 1982, J GEOPHYS RES, V87, P983, DOI 10.1029/JB087iB13p10983; SOLOMON SC, 1979, J GEOPHYS RES, V84, P1667, DOI 10.1029/JB084iB04p01667; Staid MI, 2000, ICARUS, V145, P122, DOI 10.1006/icar.1999.6319; Watters TR, 2007, SCIENCE, V318, P1125, DOI 10.1126/science.1148112; WEILL DF, 1971, LUNAR SCI C, V2, P413; Weitz CM, 1998, J GEOPHYS RES-PLANET, V103, P22725, DOI 10.1029/98JE02027	25	121	131	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					909	912		10.1126/science.1165988	http://dx.doi.org/10.1126/science.1165988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213912				2022-12-28	WOS:000263295400035
J	Hutter, G; Nowak, D; Mossner, M; Ganepola, S; Mussig, A; Allers, K; Schneider, T; Hofmann, J; Kucherer, C; Blau, O; Blau, IW; Hofmann, WK; Thiel, E				Huetter, Gero; Nowak, Daniel; Mossner, Maximilian; Ganepola, Susanne; Muessig, Arne; Allers, Kristina; Schneider, Thomas; Hofmann, Joerg; Kuecherer, Claudia; Blau, Olga; Blau, Igor W.; Hofmann, Wolf K.; Thiel, Eckhard			Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; HIGH-RISK; INFECTION; LOAD; PERSISTENCE; POPULATION; LEUKEMIA	Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine 5 (CCR5). Homozygosity for a 32-bp deletion in the CCR5 allele provides resistance against HIV-1 acquisition. We transplanted stem cells from a donor who was homozygous for CCR5 delta32 in a patient with acute myeloid leukemia and HIV-1 infection. The patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy. This outcome demonstrates the critical role CCR5 plays in maintaining HIV-1 infection.	[Huetter, Gero; Nowak, Daniel; Mossner, Maximilian; Ganepola, Susanne; Muessig, Arne; Blau, Olga; Blau, Igor W.; Hofmann, Wolf K.; Thiel, Eckhard] Charite Univ Med Berlin, Dept Med 3, Dept Hematol Oncol & Transfus Med, D-12203 Berlin, Germany; [Allers, Kristina; Schneider, Thomas] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, D-12203 Berlin, Germany; [Hofmann, Joerg] Charite Univ Med Berlin, Inst Med Virol, D-12203 Berlin, Germany; [Kuecherer, Claudia] Robert Koch Inst, D-1000 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hutter, G (corresponding author), Charite Univ Med Berlin, Dept Med 3, Dept Hematol Oncol & Transfus Med, Charite Campus Benjamin Franklin,Hindenburgdamm 3, D-12203 Berlin, Germany.	gero.huetter@charite.de	Mossner, Maximilian/D-2292-2018; Franzeck, Fabian C/B-5055-2011	Mossner, Maximilian/0000-0001-9751-3803; Nowak, Daniel/0000-0001-7130-7921; Schneider, Thomas/0000-0003-1125-0518; Blau, Olga/0000-0002-4304-5079; Hofmann, Joerg/0000-0003-3966-515X	German Research Foundation [DFG KFO grant 104 1/1]	German Research Foundation(German Research Foundation (DFG))	We thank Alexander Schmidt, Petra Leuker, and Gerhard Ehninger (German Bone Marrow Center, Tubingen and Dresden, Germany) for their encouragement and cooperation regarding access of donor blood samples; Emil Morsch (Stefan Morsch Foundation, Birkenfeld, Germany) and Martin Meixner (Department of Biochemistry, Charit, Universitatsmedizin, Berlin) for performing sequencing; Stephan Fuhrmann and Mathias Streitz (Department of Immunology, Charit, Universitatsmedizin, Berlin) for providing HIV p24 antigens; Alexander Thielen (Max-Planck-Institut fur Informatik, Saarbrucken, Germany) for performing 454 ultradeep-sequencing data analysis; Lutz Uharek (Department of Hematology, Charit, Universitatsmedizin) for clinical supervision of the allogeneic stem- cell transplantation; and Martin Raftery ( Institute of Medical Virology, Charit, Universitatsmedizin, Berlin) for reading an earlier version of this article.	Anderson J, 2007, GENE THER, V14, P1287, DOI 10.1038/sj.gt.3302958; Ayash LJ, 2007, AM J HEMATOL, V82, P6, DOI 10.1002/ajh.20759; Blau IW, 2007, ANN HEMATOL, V86, P583, DOI 10.1007/s00277-007-0294-6; CASSOL S, 1991, J CLIN MICROBIOL, V29, P667, DOI 10.1128/JCM.29.4.667-671.1991; DAUMER M, 2008, 17 INT HIV DRUG RES; Delobel P, 2005, JAIDS-J ACQ IMM DEF, V38, P382, DOI 10.1097/01.qai.0000152835.17747.47; Delobel P, 2005, AIDS, V19, P1739, DOI 10.1097/01.aids.0000183125.93958.26; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Drosten C, 2001, J CLIN MICROBIOL, V39, P4302, DOI 10.1128/JCM.39.12.4302-4308.2001; Fackler OT, 1998, AIDS, V12, P139, DOI 10.1097/00002030-199802000-00003; Ganepola S, 2007, BONE MARROW TRANSPL, V39, P293, DOI 10.1038/sj.bmt.1705585; Huzicka I, 1999, MED HYPOTHESES, V52, P247, DOI 10.1054/mehy.1997.0638; Jubault V, 1998, AIDS, V12, P2358; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Manz RA, 2006, CURR TOP MICROBIOL, V305, P241, DOI 10.1007/3-540-29714-6_12; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Mueller MC, 2007, EUR J MED RES, V12, P441; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schmid C, 2002, DEUT MED WOCHENSCHR, V127, P2186, DOI 10.1055/s-2002-34946; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Sora F, 2002, EXP HEMATOL, V30, P279, DOI 10.1016/S0301-472X(01)00793-7; WAHREN B, 1984, J INFECT DIS, V150, P358, DOI 10.1093/infdis/150.3.358	23	1258	1340	3	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					692	698		10.1056/NEJMoa0802905	http://dx.doi.org/10.1056/NEJMoa0802905			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213682				2022-12-28	WOS:000263260500006
J	Bodnar, RJ				Bodnar, Robert J.			GEOLOGY Heavy Metals or Punk Rocks?	SCIENCE			English	Editorial Material							FLUIDS; DEPOSIT		[Bodnar, Robert J.] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Bodnar, RJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	rjb@vt.edu	Bodnar, Robert J/A-1916-2009					ANDERSON AJ, 1989, ECON GEOL, V84, P924, DOI 10.2113/gsecongeo.84.4.924; Davidson P, 2005, ECON GEOL, V100, P963, DOI 10.2113/100.5.963; GARVEN G, 1985, ECON GEOL, V80, P307, DOI 10.2113/gsecongeo.80.2.307; GIZE AP, 1987, ECON GEOL, V82, P457, DOI 10.2113/gsecongeo.82.2.457; Gunther D, 1998, J ANAL ATOM SPECTROM, V13, P263, DOI 10.1039/a707372k; Leach D.L., 2005, ONE 100 ANNIVERSARY, V105, P561, DOI [10.5382/AV100.18, DOI 10.5382/AV100.18]; Roedder E, 1960, COPENHAGEN, V16, P218; Roedder E., 1984, FLUID INCLUSIONS, V12; Simmons SF, 2006, SCIENCE, V314, P288, DOI 10.1126/science.1132866; Skinner B.J., 1997, GEOCHEMISTRY HYDROTH, P1; Wilkinson JJ, 2009, SCIENCE, V323, P764, DOI 10.1126/science.1164436; Yardley BWD, 2005, ECON GEOL, V100, P613, DOI 10.2113/100.4.613	12	9	13	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					724	725		10.1126/science.1166394	http://dx.doi.org/10.1126/science.1166394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197048				2022-12-28	WOS:000263066800029
J	Lazer, D; Pentland, A; Adamic, L; Aral, S; Barabasi, AL; Brewer, D; Christakis, N; Contractor, N; Fowler, J; Gutmann, M; Jebara, T; King, G; Macy, M; Roy, D; Van Alstyne, M				Lazer, David; Pentland, Alex; Adamic, Lada; Aral, Sinan; Barabasi, Albert-Laszlo; Brewer, Devon; Christakis, Nicholas; Contractor, Noshir; Fowler, James; Gutmann, Myron; Jebara, Tony; King, Gary; Macy, Michael; Roy, Deb; Van Alstyne, Marshall			SOCIAL SCIENCE Computational Social Science	SCIENCE			English	Editorial Material									[Lazer, David; Christakis, Nicholas; King, Gary] Harvard Univ, Cambridge, MA 02138 USA; [Pentland, Alex; Aral, Sinan; Roy, Deb; Van Alstyne, Marshall] MIT, Cambridge, MA 02139 USA; [Adamic, Lada; Gutmann, Myron] Univ Michigan, Ann Arbor, MI 48109 USA; [Aral, Sinan] NYU, New York, NY USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Boston, MA 02115 USA; [Brewer, Devon] Interdisciplinary Sci Res, Seattle, WA USA; [Contractor, Noshir] Northwestern Univ, Evanston, IL USA; [Fowler, James] Univ Calif San Diego, La Jolla, CA 92093 USA; [Jebara, Tony] Columbia Univ, New York, NY USA; [Macy, Michael] Cornell Univ, Ithaca, NY USA; [Van Alstyne, Marshall] Boston Univ, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; New York University; Northeastern University; Northwestern University; University of California System; University of California San Diego; Columbia University; Cornell University; Boston University	Lazer, D (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	david_lazer@harvard.edu	Gutmann, Myron/A-3618-2009; Barabasi, Albert-Laszlo/S-6474-2017; Christakis, Nicholas A/C-3205-2009; Fowler, James H/C-2750-2008; Contractor, Noshir/B-7456-2009; Contractor, Noshir/AAJ-8371-2020	Fowler, James H/0000-0001-7795-1638; Contractor, Noshir/0000-0002-9989-3018; Gutmann, Myron/0000-0002-6808-3573; Barabasi, Albert/0000-0002-4028-3522; Aral, Sinan/0000-0002-2762-058X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD045753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG031093-01, P01 AG031093] Funding Source: Medline; NICHD NIH HHS [P01 HD045753-01, P01 HD045753] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; ARAL S, 2007, P AC MAN C PHIL PA 3; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Barbaro M., 2006, NY TIMES; Cardie C, 2008, J INF TECHNOL POLITI, V5, P1, DOI 10.1080/19331680802149590; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; FELCH J, 2008, LOS ANGELES TIM 0829, pA31; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; JEBARA T, 2007, P EUR C MACH LEARN P; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; ROY D, 2009, P 28 ANN C COGN SCI; Stern P., 2007, PUTTING PEOPLE MAP P; Teevan J, 2008, ACM T INFORM SYST, V26, DOI 10.1145/1402256.1402258; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	17	1771	1862	43	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					721	723		10.1126/science.1167742	http://dx.doi.org/10.1126/science.1167742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EV	19197046	Green Submitted, Green Accepted			2022-12-28	WOS:000263066800027
J	Madhok, V; Falk, G; Fahey, T; Sullivan, FM				Madhok, Vishnu; Falk, Gavin; Fahey, Tom; Sullivan, Frank M.			Change Page Prescribe prednisolone alone for Bell's palsy diagnosed within 72 hours of symptom onset	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sullivan, Frank M.] Univ Dundee, Div Community Hlth Sci, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland; [Fahey, Tom] Royal Coll Surgeons Ireland, Dept Gen Practice, Dublin 2, Ireland	University of Dundee; Royal College of Surgeons - Ireland	Sullivan, FM (corresponding author), Univ Dundee, Div Community Hlth Sci, Tayside Ctr Gen Practice, Dundee DD2 4BF, Scotland.	f.m.sullivan@chs.dundee.ac.uk	Sullivan, Frank/L-8286-2019; Falk, Gavin A/D-7658-2013; Fahey, Tom/C-9367-2012; Sullivan, Frank m/A-7767-2009	Sullivan, Frank/0000-0002-6623-4964; Falk, Gavin A/0000-0003-1765-0838; Fahey, Tom/0000-0002-5896-5783; 				Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Salinas RA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001942.PUB2; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006	4	7	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2009	338								b255	10.1136/bmj.b255	http://dx.doi.org/10.1136/bmj.b255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414PA	19201807				2022-12-28	WOS:000263876500001
J	Roberts, AJ; Numata, N; Walker, ML; Kato, YS; Malkova, B; Kon, T; Ohkura, R; Arisaka, F; Knight, PJ; Sutoh, K; Burgess, SA				Roberts, Anthony J.; Numata, Naoki; Walker, Matt L.; Kato, Yusuke S.; Malkova, Bara; Kon, Takahide; Ohkura, Reiko; Arisaka, Fumio; Knight, Peter J.; Sutoh, Kazuo; Burgess, Stan A.			AAA plus Ring and Linker Swing Mechanism in the Dynein Motor	CELL			English	Article							DICTYOSTELIUM CYTOPLASMIC DYNEIN; ARMS IN-SITU; MOLECULAR MOTOR; ELECTRON-MICROSCOPY; NEGATIVE STAIN; RESOLUTION; FAMILY; DOMAIN; COORDINATION; MICROTUBULES	Dynein ATPases power diverse microtubule-based motilities. Each dynein motor domain comprises a ring-like head containing six AAA+ modules and N- and C-terminal regions, together with a stalk that binds microtubules. How these subdomains are arranged and generate force remains poorly understood. Here, using electron microscopy and image processing of tagged and truncated Dictyostelium cytoplasmic dynein constructs, we show that the heart of the motor is a hexameric ring of AAA+ modules, with the stalk emerging opposite the primary ATPase site (AAA1). The C-terminal region is not an integral part of the ring but spans between AAA6 and near the stalk base. The N- terminal region includes a lever-like linker whose N terminus swings by similar to 17 nm during the ATPase cycle between AAA2 and the stalk base. Together with evidence of stalk tilting, which may communicate changes in microtubule binding affinity, these findings suggest a model for dynein's structure and mechanism.	[Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Numata, Naoki; Kon, Takahide; Ohkura, Reiko; Sutoh, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Walker, Matt L.] MLW Consulting, Launceston PL15 9BB, Cornwall, England; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch, Yokohama, Kanagawa 2268501, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Leeds; University of Leeds; University of Tokyo; Tokyo Institute of Technology; Tokyo Institute of Technology	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	sutoh@bio.c.u-tokyo.ac.jp; s.a.burgess@leeds.ac.uk	Kon, Takahide/AAG-6975-2021	Kon, Takahide/0000-0002-1231-7609	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC (UK) [24/B19478, BB/E00928X/1]; BBSRC Japan Partnering Award; Wellcome Trust [078115/Z/05/Z, 080709/Z/06/Z]; BBSRC [BB/E00928X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00928X/1] Funding Source: researchfish	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Japan Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. N. A. Ranson, Dr. D. P. Mulvihill, and Dr. T. A. Edwards for comments on an earlier draft. This work was supported by a Grant-in-Aid for Scientific Research ( S) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to K. S.; by the BBSRC (UK) to P. J. K. (24/B19478) and to S. A. B. (BB/E00928X/1); a BBSRC Japan Partnering Award to P. J. K. and S. A. B.; and the Wellcome Trust to A. J. R. (078115/Z/05/Z) and B. M. (080709/Z/06/Z).	Burgess SA, 2004, J STRUCT BIOL, V146, P205, DOI 10.1016/j.jsb.2003.10.005; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Frank J, 2006, 3 DIMENSIONAL ELECT; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, J CELL SCI, V113, P2521; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupetti P, 2005, CELL MOTIL CYTOSKEL, V62, P69, DOI 10.1002/cm.20084; Meng X, 2006, J MOL BIOL, V357, P701, DOI 10.1016/j.jmb.2006.01.028; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mogami T, 2007, J BIOL CHEM, V282, P21639, DOI 10.1074/jbc.M701914200; Neuwald AF, 1999, GENOME RES, V9, P27; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Numata N, 2008, BIOCHEM SOC T, V36, P131, DOI 10.1042/BST0360131; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	48	162	163	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					485	495		10.1016/j.cell.2008.11.049	http://dx.doi.org/10.1016/j.cell.2008.11.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203583	hybrid, Green Published			2022-12-28	WOS:000263120600018
J	Nilewski, C; Geisser, RW; Carreira, EM				Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.			Total synthesis of a chlorosulpholipid cytotoxin associated with seafood poisoning	NATURE			English	Article							COUPLING-CONSTANTS; ADRIATIC MUSSELS; CHLOROSULFOLIPIDS; TOXINS; STEREOCHEMISTRY; OCHROMONAS; OXIDATION; SHELLFISH; LIPIDS	Each year, there are many cases of seafood poisoning in humans worldwide(1). Among the various toxins isolated that contribute to these poisonings(2,3), the chlorosulpholipids are particularly intriguing because of their structural and stereochemical complexity(4-12). The mechanism of biological activity remains unknown and, although chlorosulpholipids are associated with membranes in the organisms from which they are isolated, little is understood about their role within biological membranes. The lack of availability of the natural products has impaired more in-depth biochemical studies. So far, none of the chlorosulpholipids have been obtained from total synthesis, and efficient routes to their synthesis would be desirable for the preparation ofmaterial for pharmacological characterization and proper evaluation of the risk to human health. Despite the notable advances in the science of organic synthesis, reliable methods for stereoselective construction of polychlorinated acyclic substrates are lacking, although some preliminary investigations have appeared(13-15). Here we report the synthesis of a chlorosulpholipid cytotoxin, leading to confirmation of the proposed structure and the discovery of unanticipated reactivity of polychlorinated hydrocarbons. The concise synthetic approach should enable the preparation of material in sufficient quantities to facilitate biological studies.	[Nilewski, Christian; Geisser, Roger W.; Carreira, Erick M.] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Carreira, EM (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	carreira@org.chem.ethz.ch		Carreira, Erick/0000-0003-1472-490X	Swiss National Science Foundation; ETH Zurich; F. Hoffmann-La Roche; Eli Lilly; Boehringer Ingelheim	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); F. Hoffmann-La Roche(Hoffmann-La Roche); Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim)	We thank M.-O. Ebert for acquisition and discussion of the NMR data needed for J-based configuration analysis as well as W. B. Schweizer for the X-ray crystallographic analysis. C.N. thanks the Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie for a Kekule-Fellowship. This research was supported by the Swiss National Science Foundation and ETH Zurich. We are grateful for support for our program from F. Hoffmann-La Roche, Eli Lilly and Boehringer Ingelheim.	AHMED FE, 1991, J TOXICOL-TOXIN REV, V10, P263, DOI 10.3109/15569549109053858; CHA JK, 1984, TETRAHEDRON, V40, P2247, DOI 10.1016/0040-4020(84)80008-3; CHEN JL, 1994, J NAT PROD, V57, P524, DOI 10.1021/np50106a015; Ciminiello P, 2004, TETRAHEDRON, V60, P7093, DOI 10.1016/j.tet.2003.12.072; Ciminiello P, 2004, EUR J ORG CHEM, V2004, P2533, DOI 10.1002/ejoc.200300769; Ciminiello P, 2002, J AM CHEM SOC, V124, P13114, DOI 10.1021/ja0207347; Ciminiello P, 2001, J ORG CHEM, V66, P578, DOI 10.1021/jo001437s; ELOVSON J, 1969, P NATL ACAD SCI USA, V62, P957, DOI 10.1073/pnas.62.3.957; ELOVSON J, 1970, BIOCHEMISTRY-US, V9, P3110, DOI 10.1021/bi00818a002; HAINES TH, 1973, ANNU REV MICROBIOL, V27, P403, DOI 10.1146/annurev.mi.27.100173.002155; Hunter L, 2006, J AM CHEM SOC, V128, P16422, DOI 10.1021/ja066188p; Kang SH, 2005, CHEM REV, V105, P4537, DOI 10.1021/cr040608g; Kozminski W, 1997, J MAGN RESON, V124, P383, DOI 10.1006/jmre.1996.1016; MacCoss RN, 2003, TETRAHEDRON LETT, V44, P7779, DOI 10.1016/j.tetlet.2003.08.081; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; MERCER EI, 1974, PHYTOCHEMISTRY, V13, P1607, DOI 10.1016/0031-9422(74)80337-7; MERCER EI, 1975, PHYTOCHEMISTRY, V14, P1545, DOI 10.1016/0031-9422(75)85348-9; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; PADDONROW MN, 1982, J AM CHEM SOC, V104, P7162, DOI 10.1021/ja00389a045; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; PETERSON PE, 1967, J AM CHEM SOC, V89, P5902, DOI 10.1021/ja00999a029; PETERSON PE, 1971, TETRAHEDRON LETT, V12, P13; Schlama T, 1997, ANGEW CHEM INT EDIT, V36, P2342, DOI 10.1002/anie.199723421; Shibuya GM, 2008, J AM CHEM SOC, V130, P12514, DOI 10.1021/ja804167v; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yoshimitsu T, 2009, J ORG CHEM, V74, P696, DOI 10.1021/jo802093d	27	117	118	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					573	U76		10.1038/nature07734	http://dx.doi.org/10.1038/nature07734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	400FA	19177127				2022-12-28	WOS:000262852200039
J	Towse, A				Towse, Adrian			Should NICE's threshold range for cost per QALY be raised? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Towse, Adrian] Off Hlth Econ, London SW1A 2DY, England		Towse, A (corresponding author), Off Hlth Econ, London SW1A 2DY, England.	atowse@ohe.org	Towse, Adrian/M-3760-2014					[Anonymous], 2008, GUID METH TECHN APPR; APPLEBY J, HLTH POLICY IN PRESS; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; *DEP TRANSP, 2007, 12005 DEP TRANSP; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; *HOUS COMM HLTH SE, 2008, 1 REP SESS 2007 08, P103; MARTIN S, 2007, LINK HLTH CARE SPEND; MASON H, 2008, HLTH EC         1014; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; *NAT I HLTH CLIN E, 2008, NICES RESP COMM 1 RE; NICE, 2009, APPR LIF EXT END LIF; WILLIAMS A, 2002, COST EFFECTIVENESS T, P85; Williams I, 2008, HEALTH TECHNOL ASSES, V12, P1	13	55	55	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b181	10.1136/bmj.b181	http://dx.doi.org/10.1136/bmj.b181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EK	19171561				2022-12-28	WOS:000263205300011
J	Cuenda, A; Nebreda, AR				Cuenda, Ana; Nebreda, Angel R.			p38 delta and PKD1: Kinase Switches for Insulin Secretion	CELL			English	Editorial Material							CELL PROLIFERATION; ACTIVATION; PATHWAY; P38	Insufficient production of the hormone insulin by pancreatic beta cells results in diabetes. In this issue, Sumara et al. (2009) report key roles for the protein kinases p38 delta and PKD1 in the regulation of insulin secretion as well as in the survival of pancreatic beta cells.	[Cuenda, Ana] UAM, CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid 28049, Spain; [Nebreda, Angel R.] CNIO Spanish Natl Canc Ctr, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Oncologicas (CNIO)	Cuenda, A (corresponding author), UAM, CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Campus Cantoblanco, Madrid 28049, Spain.	acuenda@cnb.csic.es; anebreda@cnio.es	Nebreda, Angel Rodriguez/R-9594-2019					Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037	9	9	10	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					209	210		10.1016/j.cell.2009.01.005	http://dx.doi.org/10.1016/j.cell.2009.01.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167323	Bronze			2022-12-28	WOS:000262648800009
J	Diehn, M; Cho, RW; Lobo, NA; Kalisky, T; Dorie, MJ; Kulp, AN; Qian, DL; Lam, JS; Ailles, LE; Wong, MZ; Joshua, B; Kaplan, MJ; Wapnir, I; Dirbas, FM; Somlo, G; Garberoglio, C; Paz, B; Shen, J; Lau, SK; Quake, SR; Brown, JM; Weissman, IL; Clarke, MF				Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kalisky, Tomer; Dorie, Mary Jo; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Joshua, Benzion; Kaplan, Michael J.; Wapnir, Irene; Dirbas, Frederick M.; Somlo, George; Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie; Lau, Sean K.; Quake, Stephen R.; Brown, J. Martin; Weissman, Irving L.; Clarke, Michael F.			Association of reactive oxygen species levels and radioresistance in cancer stem cells	NATURE			English	Article							OXIDATIVE STRESS; IONIZING-RADIATION; MAMMARY-GLAND; SELF-RENEWAL; PROGENITORS; DIFFERENTIATION; IDENTIFICATION; GLUTATHIONE; ENRICHMENT; BIOLOGY	The metabolism of oxygen, although central to life, produces reactive oxygen species (ROS) that have been implicated in processes as diverse as cancer, cardiovascular disease and ageing. It has recently been shown that central nervous system stem cells(1,2) and haematopoietic stem cells and early progenitors(3-6) contain lower levels of ROS than their more mature progeny, and that these differences are critical for maintaining stem cell function. We proposed that epithelial tissue stem cells and their cancer stem cell (CSC) counterparts may also share this property. Here we show that normal mammary epithelial stem cells contain lower concentrations of ROS than their more mature progeny cells. Notably, subsets of CSCs in some human and murine breast tumours contain lower ROS levels than corresponding non-tumorigenic cells (NTCs). Consistent with ROS being critical mediators of ionizing-radiation-induced cell killing(7,8), CSCs in these tumours develop less DNA damage and are preferentially spared after irradiation compared to NTCs. Lower ROS levels in CSCs are associated with increased expression of free radical scavenging systems. Pharmacological depletion of ROS scavengers in CSCs markedly decreases their clonogenicity and results in radiosensitization. These results indicate that, similar to normal tissue stem cells, subsets of CSCs in some tumours contain lower ROS levels and enhanced ROS defences compared to their non-tumorigenic progeny, which may contribute to tumour radioresistance.	[Diehn, Maximilian; Cho, Robert W.; Lobo, Neethan A.; Kulp, Angela N.; Qian, Dalong; Lam, Jessica S.; Ailles, Laurie E.; Wong, Manzhi; Weissman, Irving L.; Clarke, Michael F.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Diehn, Maximilian; Dorie, Mary Jo; Brown, J. Martin] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Cho, Robert W.] Stanford Univ, Sch Med, Dept Pediat, Div Stem Cell Transplantat, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Wapnir, Irene; Dirbas, Frederick M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Clarke, Michael F.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Somlo, George] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Garberoglio, Carlos; Paz, Benjamin; Shen, Jeannie] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA; [Lau, Sean K.] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; City of Hope; City of Hope; City of Hope	Clarke, MF (corresponding author), Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Bowman, Angela/0000-0003-0980-8586; Diehn, Maximilian/0000-0003-2032-0581	National Institutes of Health; Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE [R01CA100225, U54CA126524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Foundation; Breast Cancer Research Foundation; Machiah foundation; American Society for Therapeutic Radiology and Oncology; Radiological Society of North America; Leonard B. Holman Research Pathway fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spitz for helpful discussions and D. Menke, D. Rossi, and J. Seita for technical assistance. This work was supported by grants from the National Institutes of Health (M. F. C., G. S. and I. L. W.), the Virginia and D. K. Ludwig Foundation (M. F. C. and I. L. W.), the Breast Cancer Research Foundation (M. F. C.), the Machiah foundation (T. K.), the American Society for Therapeutic Radiology and Oncology (M. D.), and the Radiological Society of North America (M. D.). M. D. is a recipient of the Leonard B. Holman Research Pathway fellowship.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Dorie Mary Jo, 1999, Neoplasia (New York), V1, P461, DOI 10.1038/sj.neo.7900060; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HAHN SM, 1994, CANCER RES, V54, pS2006; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; POWELL S, 1990, RADIOTHER ONCOL, V19, P95, DOI 10.1016/0167-8140(90)90123-E; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; WARD JF, 1985, RADIAT RES, V104, pS103, DOI 10.2307/3576637; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103	31	1762	1836	20	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					780	U123		10.1038/nature07733	http://dx.doi.org/10.1038/nature07733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194462	Green Accepted			2022-12-28	WOS:000265193600045
J	de Boer, AGEM; Taskila, T; Ojajarvi, A; van Dijk, FJH; Verbeek, JHAM				de Boer, Angela G. E. M.; Taskila, Taina; Ojajarvi, Anneli; van Dijk, Frank J. H.; Verbeek, Jos H. A. M.			Cancer Survivors and Unemployment A Meta-analysis and Meta-regression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; LONG-TERM SURVIVORS; HEMATOPOIETIC-CELL TRANSPLANTATION; BREAST-CANCER; EMPLOYMENT STATUS; PSYCHOSOCIAL FACTORS; ADULT SURVIVORS; WORK; HEALTH; RETURN	Context Nearly half of adult cancer survivors are younger than 65 years, but the association of cancer survivorship with employment status is unknown. Objective To assess the association of cancer survivorship with unemployment compared with healthy controls. Data Sources A systematic search of studies published between 1966 and June 2008 was conducted using MEDLINE, CINAHL, EMBASE, PsycINFO, and OSH- ROM databases. Study Selection Eligible studies included adult cancer survivors and a control group, and employment as an outcome. Data Extraction Pooled relative risks were calculated over all studies and according to cancer type. A Bayesian meta- regression analysis was performed to assess associations of unemployment with cancer type, country of origin, average age at diagnosis, and background unemployment rate. Results Twenty- six articles describing 36 studies met the inclusion criteria. The analyses included 20 366 cancer survivors and 157 603 healthy control participants. Studies included 16 from the United States, 15 from Europe, and 5 from other countries. Overall, cancer survivors were more likely to be unemployed than healthy control participants ( 33.8% vs 15.2%; pooled relative risk [ RR], 1.37; 95% confidence interval [ CI], 1.21-1.55). Unemployment was higher in breast cancer survivors compared with control participants ( 35.6% vs 31.7%; pooled RR, 1.28; 95% CI, 1.11- 1.49), as well as in survivors of gastrointestinal cancers ( 48.8% vs 33.4%; pooled RR, 1.44; 95% CI, 1.02- 2.05), and cancers of the female reproductive organs ( 49.1% vs 38.3%; pooled RR, 1.28; 95% CI, 1.17- 1.40). Unemployment rates were not higher for survivors of blood cancers compared with controls ( 30.6% vs 23.7%; pooled RR, 1.41; 95% CI, 0.95- 2.09), prostate cancers ( 39.4% vs 27.1%; pooled RR, 1.11; 95% CI, 1.00- 1.25), or testicular cancer ( 18.5% vs 18.1%; pooled RR, 0.94; 95% CI, 0.74- 1.20). For survivors in the United States, the unemployment risk was 1.5 times higher compared with survivors in Europe ( meta- RR, 1.48; 95% credibility interval, 1.15- 1.95). After adjustment for diagnosis, age, and background unemployment rate, this risk disappeared ( meta- RR, 1.24; 95% CI, 0.85- 1.83). Conclusion Cancer survivorship is associated with unemployment.	[de Boer, Angela G. E. M.; Taskila, Taina; van Dijk, Frank J. H.; Verbeek, Jos H. A. M.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1100 DE Amsterdam, Netherlands; [Taskila, Taina] Univ Birmingham, Primary Care Clin Sci, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Ojajarvi, Anneli] Finnish Inst Occupat Hlth Good Practices & Compet, Stat Serv, Helsinki, Finland; [Verbeek, Jos H. A. M.] Finnish Inst Occupat Hlth, Knowledge Transfer Team, Cochrane Occupat Hlth Field, Kuopio, Finland	University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health	de Boer, AGEM (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands.	a.g.deboer@amc.uva.nl	Verbeek, Jos H.A.M./F-8382-2013	Verbeek, Jos H.A.M./0000-0002-6537-6100; de Boer, Angela/0000-0003-1942-6848				Andrykowski MAA, 2005, J CLIN ONCOL, V23, P599, DOI 10.1200/JCO.2005.03.189; BLOOM JR, 1988, J PSYCHOSOC ONCOL, V6, P65, DOI DOI 10.1300/J077V06N03_05; Bradley C, 2005, MED DECIS MAKING, V25, P534, DOI 10.1177/0272989X05280556; Bradley CJ, 2007, CANCER INVEST, V25, P47, DOI 10.1080/07357900601130664; Bradley CJ, 2005, J NATL CANCER I, V97, P958, DOI 10.1093/jnci/dji171; Bradley CJ, 2005, J HEALTH ECON, V24, P137, DOI 10.1016/j.jhealeco.2004.07.003; Bradley CJ, 2002, HEALTH SERV RES, V37, P1309, DOI 10.1111/1475-6773.01041; Bradley CJ, 2002, J HEALTH ECON, V21, P757, DOI 10.1016/S0167-6296(02)00059-0; Bradley S, 2006, GYNECOL ONCOL, V100, P479, DOI 10.1016/j.ygyno.2005.08.023; Congdon P., 2014, APPL BAYESIAN MODELL; Currie J., 1999, HDB LABOR EC, V3, P3309, DOI DOI 10.1016/S1573-4463(99)30041-9; de Boer AGEM, 2008, BRIT J CANCER, V98, P1342, DOI 10.1038/sj.bjc.6604302; de Boer AGEM, 2006, CANCER, V107, P1, DOI 10.1002/cncr.21974; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorval M, 1998, J CLIN ONCOL, V16, P487, DOI 10.1200/JCO.1998.16.2.487; Drolet M, 2005, J CLIN ONCOL, V23, P8305, DOI 10.1200/JCO.2005.09.500; Drolet M, 2005, CAN MED ASSOC J, V173, P765, DOI 10.1503/cmaj.050178; DuMouchel W., 1990, STAT METHODOLOGY PHA, V104, P509; Eakin EG, 2006, CANCER EPIDEM BIOMAR, V15, P1969, DOI 10.1158/1055-9965.EPI-06-0122; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Feuerstein Michael, 2007, J Cancer Surviv, V1, P1, DOI 10.1007/s11764-006-0001-y; Gelman A., 2003, BAYESIAN DATA ANAL; Gudbergsson SB, 2007, ACTA ONCOL, V46, P534, DOI 10.1080/02841860601156132; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Helgeson VS, 2005, PSYCHO-ONCOLOGY, V14, P307, DOI 10.1002/pon.848; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffman B, 2005, CA-CANCER J CLIN, V55, P271, DOI 10.3322/canjclin.55.5.271; Hoffman RD, 2002, ARCH PHYS MED REHAB, V83, P177, DOI 10.1053/apmr.2002.27461; Joly F, 1996, J CLIN ONCOL, V14, P2444, DOI 10.1200/JCO.1996.14.9.2444; Joly F, 2002, J CLIN ONCOL, V20, P73, DOI 10.1200/JCO.20.1.73; Kennedy F, 2007, EUR J CANCER CARE, V16, P17, DOI 10.1111/j.1365-2354.2007.00729.x; Lauzier S, 2008, J NATL CANCER I, V100, P321, DOI 10.1093/jnci/djn028; Lee MK, 2008, BRIT J CANCER, V98, P708, DOI 10.1038/sj.bjc.6604236; Main DS, 2005, PSYCHO-ONCOLOGY, V14, P992, DOI 10.1002/pon.913; Majhail NS, 2007, BIOL BLOOD MARROW TR, V13, P1153, DOI 10.1016/j.bbmt.2007.06.003; Maunsell E, 2004, J NATL CANCER I, V96, P1813, DOI 10.1093/jnci/djh335; Nachreiner Nancy M, 2007, AAOHN J, V55, P290; Ojajarvi A, 2007, SCAND J WORK ENV HEA, V33, P325, DOI 10.5271/sjweh.1153; Park JH, 2008, J CLIN ONCOL, V26, P1302, DOI 10.1200/JCO.2007.14.2984; RAZAVI D, 1993, SUPPORT CARE CANCER, V1, P276, DOI 10.1007/BF00366050; Sabatino SA, 2006, CANCER-AM CANCER SOC, V106, P2466, DOI 10.1002/cncr.21879; Sawyer M., 2008, J SOCIO-ECON, V37, P718, DOI [10.1016/j.socec.2006.12.049, DOI 10.1016/J.SOCEC.2006.12.049]; Servaes P, 2002, CANCER-AM CANCER SOC, V95, P2017, DOI 10.1002/cncr.10891; Short PF, 2008, PSYCHO-ONCOLOGY, V17, P91, DOI 10.1002/pon.1194; Short PF, 2008, HEALTH SERV RES, V43, P193, DOI 10.1111/j.1475-6773.2007.00752.x; Short PF, 2005, CANCER, V103, P1292, DOI 10.1002/cncr.20912; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Smith T, 2007, CANCER-AM CANCER SOC, V109, P1, DOI 10.1002/cncr.22387; Spelten ER, 2003, EUR J CANCER, V39, P1562, DOI 10.1016/S0959-8049(03)00364-2; Spelten ER, 2002, PSYCHO-ONCOL, V11, P124, DOI 10.1002/pon.585; Spiegelhalter D.J., 1999, WINBUGS USER MANUAL; Steiner JF, 2008, PSYCHO-ONCOL, V17, P138, DOI 10.1002/pon.1204; Syrjala KL, 2005, J CLIN ONCOL, V23, P6596, DOI 10.1200/JCO.2005.12.674; Taskila T, 2007, ACTA ONCOL, V46, P446, DOI 10.1080/02841860701355048; Taskila-Abrandt T, 2005, PSYCHO-ONCOLOGY, V14, P221, DOI 10.1002/pon.838; Taskila-Abrandt T, 2004, EUR J CANCER, V40, P2488, DOI 10.1016/j.ejca.2004.06.031; VANDERWOUDEN JC, 1992, J OCCUP ENVIRON MED, V34, P1084, DOI 10.1097/00043764-199211000-00010; VANTULDER MW, 1994, ANN ONCOL, V5, P153, DOI 10.1093/oxfordjournals.annonc.a058768; Verbeek J, 2007, HDB CANC SURVIVORSHI; WEIS J, 1992, SOZ PRAVENTIV MED, V37, P85, DOI 10.1007/BF01322738; Weitzner MA, 1997, SUPPORT CARE CANCER, V5, P241, DOI 10.1007/s005200050067; Wettergren L, 2003, QUAL LIFE RES, V12, P545, DOI 10.1023/A:1025024008139; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	65	522	527	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					753	762		10.1001/jama.2009.187	http://dx.doi.org/10.1001/jama.2009.187			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	407MX	19224752	Bronze			2022-12-28	WOS:000263370100018
J	Kaiser, T; Moessner, J; Patel, K; McHutchison, JG; Tillmann, HL				Kaiser, Thorsten; Moessner, Joachim; Patel, Keyur; McHutchison, John G.; Tillmann, Hans L.			Case report Life threatening liver disease during treatment with monoclonal antibodies	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC HEPATITIS-B; ANTI-TNF-ALPHA; BONE-MARROW-TRANSPLANTATION; OF-THE-LITERATURE; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; CYTOTOXIC CHEMOTHERAPY; VIRUS REACTIVATION; INFLIXIMAB THERAPY; HBV INFECTION		[Kaiser, Thorsten; Moessner, Joachim; Tillmann, Hans L.] Univ Leipzig, Med Klin & Poliklin 2, D-04103 Leipzig, Germany; [Patel, Keyur; McHutchison, John G.; Tillmann, Hans L.] Duke Clin Res Inst, Durham, NC 27713 USA	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Duke University	Tillmann, HL (corresponding author), Univ Leipzig, Med Klin & Poliklin 2, D-04103 Leipzig, Germany.	hans.tillmann@duke.edu						Al-Taie OH, 1999, ANN HEMATOL, V78, P247, DOI 10.1007/s002770050510; Anelli MG, 2005, ARTHRITIS RHEUM-US, V52, P2519, DOI 10.1002/art.21216; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cornberg M, 2007, Z GASTROENTEROL, V45, P1281, DOI 10.1055/s-2007-963714; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; Eriksson C, 2005, ANN RHEUM DIS, V64, P403, DOI 10.1136/ard.2004.024182; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Iwai K, 2000, BONE MARROW TRANSPL, V25, P105, DOI 10.1038/sj.bmt.1702093; Jang JW, 2006, HEPATOLOGY, V43, P233, DOI 10.1002/hep.21024; Katz LH, 2008, J VIRAL HEPATITIS, V15, P89, DOI 10.1111/j.1365-2893.2007.00902.x; Kempinska A, 2005, CLIN INFECT DIS, V41, P1277, DOI 10.1086/496924; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lau GKK, 2002, HEPATOLOGY, V36, P702, DOI 10.1053/jhep.2002.35068; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Moses SE, 2006, J MED VIROL, V78, P1560, DOI 10.1002/jmv.20705; Nathan DM, 2006, J GASTROEN HEPATOL, V21, P1366, DOI 10.1111/j.1440-1746.2006.04559.x; Oniankitan O, 2004, J RHEUMATOL, V31, P107; Ozorio G, 2007, MED J AUSTRALIA, V187, P524, DOI 10.5694/j.1326-5377.2007.tb01396.x; Perceau G, 2006, BRIT J DERMATOL, V155, P1053, DOI 10.1111/j.1365-2133.2006.07451.x; Raftery G, 2007, RHEUMATOLOGY, V46, P1381, DOI 10.1093/rheumatology/kem082; Ramos-Casals M, 2008, BEST PRACT RES CL RH, V22, P847, DOI 10.1016/j.berh.2008.09.008; Roux CH, 2006, RHEUMATOLOGY, V45, P1294, DOI 10.1093/rheumatology/kel123; Sakellariou GT, 2007, CLIN RHEUMATOL, V26, P950, DOI 10.1007/s10067-006-0392-1; Schmilovitz-Weiss H, 2004, LIVER INT, V24, P547, DOI 10.1111/j.1478-3231.2004.0983.x; Tillmann HL, 2006, J VIRAL HEPATITIS, V13, P256, DOI 10.1111/j.1365-2893.2005.00695.x; Yeo W, 1999, J MED VIROL, V59, P263, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;263::AID-JMV1&gt;3.0.CO;2-X; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182	35	3	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 18	2009	338								b508	10.1136/bmj.b508	http://dx.doi.org/10.1136/bmj.b508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CG	19224957				2022-12-28	WOS:000264052100011
J	Volpp, KG; Troxel, AB; Pauly, MV; Glick, HA; Puig, A; Asch, DA; Galvin, R; Zhu, JS; Wan, F; DeGuzman, J; Corbett, E; Weiner, J; Audrain-McGovern, J				Volpp, Kevin G.; Troxel, Andrea B.; Pauly, Mark V.; Glick, Henry A.; Puig, Andrea; Asch, David A.; Galvin, Robert; Zhu, Jingsan; Wan, Fei; DeGuzman, Jill; Corbett, Elizabeth; Weiner, Janet; Audrain-McGovern, Janet			A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH; PERFORMANCE	Background Smoking is the leading preventable cause of premature death in the United States. Previous studies of financial incentives for smoking cessation in work settings have not shown that such incentives have significant effects on cessation rates, but these studies have had limited power, and the incentives used may have been insufficient. Methods We randomly assigned 878 employees of a multinational company based in the United States to receive information about smoking- cessation programs ( 442 employees) or to receive information about programs plus financial incentives ( 436 employees). The financial incentives were $ 100 for completion of a smoking- cessation program, $ 250 for cessation of smoking within 6 months after study enrollment, as confirmed by a biochemical test, and $ 400 for abstinence for an additional 6 months after the initial cessation, as confirmed by a biochemical test. Individual participants were stratified according to work site, heavy or nonheavy smoking, and income. The primary end point was smoking cessation 9 or 12 months after enrollment, depending on whether initial cessation was reported at 3 or 6 months. Secondary end points were smoking cessation within the first 6 months after enrollment and rates of participation in and completion of smoking- cessation programs. Results The incentive group had significantly higher rates of smoking cessation than did the information- only group 9 or 12 months after enrollment (14.7% vs. 5.0%, P< 0.001) and 15 or 18 months after enrollment (9.4% vs. 3.6%, P< 0.001). Incentive- group participants also had significantly higher rates of enrollment in a smoking- cessation program (15.4% vs. 5.4%, P< 0.001), completion of a smoking- cessation program (10.8% vs. 2.5%, P< 0.001), and smoking cessation within the first 6 months after enrollment (20.9% vs. 11.8%, P< 0.001). Conclusions In this study of employees of one large company, financial incentives for smoking cessation significantly increased the rates of smoking cessation. (ClinicalTrials. gov number, NCT00128375.).	[Volpp, Kevin G.; Pauly, Mark V.; Glick, Henry A.; Puig, Andrea; Asch, David A.] Univ Penn, Sch Med, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Pauly, Mark V.; Glick, Henry A.; Puig, Andrea; Asch, David A.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Troxel, Andrea B.; Wan, Fei] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Troxel, Andrea B.; Wan, Fei] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Ctr Hlth Equ Res & Promot, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Troxel, Andrea B.; Pauly, Mark V.; Glick, Henry A.; Asch, David A.; Zhu, Jingsan; DeGuzman, Jill; Weiner, Janet] Univ Penn, Ctr Hlth Incent, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Glick, Henry A.; Asch, David A.; Zhu, Jingsan; DeGuzman, Jill; Corbett, Elizabeth] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Audrain-McGovern, Janet] Univ Penn, Sch Med, Transdisciplinary Tobacco Use Res Ctr, Dept Psychiat, Philadelphia, PA 19104 USA; [Galvin, Robert] Gen Elect, Fairfield, CT USA; [Galvin, Robert] Yale Univ, Sch Med, New Haven, CT USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; General Electric; Yale University	Volpp, KG (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, 1232 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Weiner, Janet/0000-0001-5810-5807; Corbett, Elizabeth/0000-0002-3552-3181; Volpp, Kevin/0000-0003-1423-4599; Troxel, Andrea/0000-0002-1393-3075; Asch, David/0000-0002-7970-286X	Centers for Disease Control and Prevention [RO1 DP000100-01, RO1 DP001168-01]; Pennsylvania Department of Health; Aetna; Pfizer; General Electric; America's Health Insurance Plans; Merck; MedStar; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000100, R01DP001168] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pennsylvania Department of Health; Aetna; Pfizer(Pfizer); General Electric(General Electric); America's Health Insurance Plans; Merck(Merck & Company); MedStar; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by grants from the Centers for Disease Control and Prevention (RO1 DP000100-01 and RO1 DP001168-01) and from the Pennsylvania Department of Health, which specifically disclaims responsibility for any analyses, interpretations, or conclusions.; Dr. Volpp reports receiving lecture fees from Aetna and grant support from Aetna and Pfizer and owning equity in General Electric; Dr. Pauly, being a board member of Independent Health, owning equity in General Electric, receiving lecture fees from America's Health Insurance Plans, and receiving grant support from Merck and MedStar; Dr. Glick, owning equity in General Electric; and Dr. Galvin, owning equity in General Electric. No other potential conflict of interest relevant to this article was reported.; We thank Quincy Greene for his contributions to the analyses for this article and Donna Tomlinson, M. D., for assistance in implementing this study.	Aakko E, 1999, WMJ, V98, P14; Barbeau EM, 2001, AM J PUBLIC HEALTH, V91, P1412, DOI 10.2105/AJPH.91.9.1412; Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P642; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Donatelle RJ, 2004, NICOTINE TOB RES, V6, pS163, DOI 10.1080/14622200410001669196; Donatelle RJ, 2000, TOB CONTROL, V9, P67; Fiore M C, 2000, Respir Care, V45, P1200; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hennrikus DJ, 2002, AM J PUBLIC HEALTH, V92, P274, DOI 10.2105/AJPH.92.2.274; HEY K, 2005, COCHRANE DB SYST REV, V2; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jacob P, 2002, CANCER EPIDEM BIOMAR, V11, P1668; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Mariolis P., 2006, Morbidity and Mortality Weekly Report, V55, P1145; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; PAULY MV, 2002, HLTH BENEFITS WORK E; PROCHASKA JO, 1993, HEALTH PSYCHOL, V12, P399, DOI 10.1037/0278-6133.12.5.399; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Sindelar JL, 2008, HEALTH ECON, V17, P449, DOI 10.1002/hec.1350; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206; Volpp KG, 2006, CANCER EPIDEM BIOMAR, V15, P12, DOI 10.1158/1055-9965.EPI-05-0314; Westman EC, 1997, ARCH INTERN MED, V157, P335, DOI 10.1001/archinte.157.3.335; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0; 2002, MMWR MORB MORTAL WKL, V51, P300; 2005, MMWR MORB MORTAL WKL, V54, P625	27	544	547	2	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					699	709		10.1056/NEJMsa0806819	http://dx.doi.org/10.1056/NEJMsa0806819			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405YQ	19213683	Green Published			2022-12-28	WOS:000263260500007
J	Salomon, R; Webster, RG				Salomon, Rachelle; Webster, Robert G.			The Influenza Virus Enigma	CELL			English	Review							A H5N1 VIRUSES; PANDEMIC INFLUENZA; INTERSPECIES TRANSMISSION; CYTOKINE RESPONSES; HIGH VIRULENCE; PROTECTS MICE; HEMAGGLUTININ; RESISTANT; INFECTION; COMPLEX	Both seasonal and pandemic influenza continue to challenge both scientists and clinicians. Drug-resistant H1N1 influenza viruses have dominated the 2009 flu season, and the H5N1 avian influenza virus continues to kill both people and poultry in Eurasia. Here, we discuss the pathogenesis and transmissibility of influenza viruses and we emphasize the need to find better predictors of both seasonal and potentially pandemic influenza.	[Salomon, Rachelle; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.	robert.webster@stjude.org			NIAID NIH HHS [HHSN266200700005C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Budd A, 2007, ANTIMICROB AGENTS CH, V51, P2965, DOI 10.1128/AAC.00219-07; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fouchier RAM, 2003, VACCINE, V21, P1754, DOI 10.1016/S0264-410X(03)00067-7; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423, DOI 10.1111/j.1348-0421.2000.tb02516.x; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; LACKENBY A, 2008, EUROSURVEILLANCE, V13; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Watanabe T, 2008, J VIROL, V82, P2486, DOI 10.1128/JVI.01899-07; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	70	168	183	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					402	410		10.1016/j.cell.2009.01.029	http://dx.doi.org/10.1016/j.cell.2009.01.029			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203576	Green Accepted, Bronze			2022-12-28	WOS:000263120600011
J	Wang, HP; Keum, JK; Hiltner, A; Baer, E; Freeman, B; Rozanski, A; Galeski, A				Wang, Haopeng; Keum, Jong K.; Hiltner, Anne; Baer, Eric; Freeman, Benny; Rozanski, Artur; Galeski, Andrzej			Confined Crystallization of Polyethylene Oxide in Nanolayer Assemblies	SCIENCE			English	Article							CRYSTAL ORIENTATIONS; POLYMERIC MATERIALS; DIBLOCK COPOLYMER; BLOCK-COPOLYMER; FILMS; THIN	The design and fabrication of ultrathin polymer layers are of increasing importance because of the rapid development of nanoscience and nanotechnology. Confined, two- dimensional crystallization of polymers presents challenges and opportunities due to the long- chain, covalently bonded nature of the macromolecule. Using an innovative layer- multiplying coextrusion process to obtain assemblies with thousands of polymer nanolayers, we discovered a morphology that emerges as confined polyethylene oxide ( PEO) layers are made progressively thinner. When the thickness is confined to 20 nanometers, the PEO crystallizes as single, high- aspect- ratio lamellae that resemble single crystals. Unexpectedly, the crystallization habit imparts two orders of magnitude reduction in the gas permeability.	[Wang, Haopeng; Keum, Jong K.; Hiltner, Anne; Baer, Eric] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Freeman, Benny] Univ Texas Austin, Dept Chem Engn, Austin, TX 78758 USA; [Rozanski, Artur; Galeski, Andrzej] Polish Acad Sci, Ctr Mol & Macromol Studies, PL-90363 Lodz, Poland	Case Western Reserve University; University of Texas System; University of Texas Austin; Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences	Hiltner, A (corresponding author), Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.	ahiltner@case.edu	Keum, Jong Kahk/N-4412-2015; Freeman, Benny/G-5405-2016; Rozanski, Artur/GOP-0267-2022	Keum, Jong Kahk/0000-0002-5529-1373; Freeman, Benny/0000-0003-2779-7788; Rozanski, Artur/0000-0001-7545-6246; Galeski, Andrzej/0000-0003-3058-1312	NSF Center for Layered Polymeric Systems [DMR-0423914]	NSF Center for Layered Polymeric Systems(National Science Foundation (NSF))	This research was supported by the NSF Center for Layered Polymeric Systems (grant DMR-0423914).	BAER E, 1987, SCIENCE, V235, P1015, DOI 10.1126/science.3823866; Bassett D. C., 1981, PRINCIPLES POLYM MOR; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; Bernal-Lara TE, 2005, POLYMER, V46, P3043, DOI 10.1016/j.polymer.2005.01.055; Chen ZR, 1997, SCIENCE, V277, P1248, DOI 10.1126/science.277.5330.1248; CUSSLER EL, 1988, J MEMBRANE SCI, V38, P161, DOI 10.1016/S0376-7388(00)80877-7; Frank CW, 1996, SCIENCE, V273, P912, DOI 10.1126/science.273.5277.912; GEIL PH, 1963, POLYM SINGLE CRYSTAL; Goffri S, 2006, NAT MATER, V5, P950, DOI 10.1038/nmat1779; Hamley IW, 1996, MACROMOLECULES, V29, P8835, DOI 10.1021/ma960343a; Hiltner A, 2005, J POLYM SCI POL PHYS, V43, P1047, DOI 10.1002/polb.20349; Ho RM, 2004, MACROMOLECULES, V37, P5985, DOI 10.1021/ma0492869; Hsiao MS, 2008, MACROMOLECULES, V41, P8114, DOI 10.1021/ma801641w; Jin Y, 2004, J POLYM SCI POL PHYS, V42, P3380, DOI 10.1002/polb.20211; Li BB, 2007, LANGMUIR, V23, P2546, DOI 10.1021/la062563f; Liu RYF, 2004, MACROMOLECULES, V37, P6972, DOI 10.1021/ma049233r; Liu RYF, 2003, MACROMOL RAPID COMM, V24, P943, DOI 10.1002/marc.200300051; Ma Y, 2006, MACROMOLECULES, V39, P5159, DOI 10.1021/ma060798s; Mukai U, 1998, J APPL POLYM SCI, V70, P1985, DOI 10.1002/(SICI)1097-4628(19981205)70:10<1985::AID-APP14>3.0.CO;2-V; Napolitano S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205121; Reiter G., 2007, LECT NOTE PHYS, V714, P179; Sun YS, 2006, MACROMOLECULES, V39, P5782, DOI 10.1021/ma0608121; WEINKAUF DH, 1990, ACS SYM SER, V423, P60; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhu L, 2000, J AM CHEM SOC, V122, P5957, DOI 10.1021/ja000275e	25	289	302	11	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					757	760		10.1126/science.1164601	http://dx.doi.org/10.1126/science.1164601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197057				2022-12-28	WOS:000263066800039
J	Vanlemmens, C; Di Martino, V; Milan, C; Messner, M; Minello, A; Duvoux, C; Poynard, T; Perarnau, JM; Piquet, MAA; Pageaux, GP; Dharancy, S; Silvain, C; Hillaire, S; Thiefin, G; Vinel, JP; Hillon, P; Collin, E; Mantion, G; Miguet, JP				Vanlemmens, Claire; Di Martino, Vincent; Milan, Chantal; Messner, Michel; Minello, Anne; Duvoux, Christophe; Poynard, Thierry; Perarnau, Jean-Marc; Piquet, Marie-Anne Astrid; Pageaux, Georges-Philippe; Dharancy, Sebastien; Silvain, Christine; Hillaire, Sophie; Thiefin, Gerard; Vinel, Jean-Pierre; Hillon, Patrick; Collin, Estelle; Mantion, Georges; Miguet, Jean-Philippe		TRANSCIAL Study Grp	Immediate Listing for Liver Transplantation Versus Standard Care for Child-Pugh Stage B Alcoholic Cirrhosis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; SIMULATED CONTROLS; DISEASE; SURVIVAL; MORTALITY; METAANALYSIS; RECURRENCE; PREVENTION; HEPATITIS; EFFICACY	Background: Liver transplantation improves survival of patients with end-stage (Child-Pugh stage C) alcoholic cirrhosis, but its benefit for patients with stage B disease is uncertain. Objective: To compare the outcomes of patients with Child-Pugh stage B alcoholic cirrhosis who are immediately listed for liver transplantation with those of patients assigned to standard treatment with delay of transplantation until progression to stage C disease. Design: Randomized, controlled trial. Setting: 13 liver transplantation programs in France. Patients: 120 patients with Child-Pugh stage B alcoholic cirrhosis and no viral hepatitis, cancer, or contraindication to transplantation. Interventions: Patients were randomly assigned to immediate listing for liver transplantation (60 patients) or standard care (60 patients). Measurements: Overall and cancer-free survival over 5 years. Results: Sixty-eight percent of patients assigned to immediate listing for liver transplantation and 25% of those assigned to standard care received a liver transplant. All-cause death and cirrhosis-related death did not statistically differ between the 2 groups: 5-year survival was 58% (95% CI, 43% to 70%) for those assigned to immediate listing versus 69% (CI, 54% to 80%) for those assigned to standard care. In multivariate analysis, independent predictors of long-term survival were absence of ongoing alcohol consumption (hazard ratio, 7.604 [ CI, 2.395 to 24.154]), recovery from Child-Pugh stage C (hazard ratio, 7.633 [ CI, 2.392 to 24.390]), and baseline Child-Pugh score less than 8 (hazard ratio, 2.664 [ CI, 1.052 to 6.746]). Immediate listing for transplantation was associated with an increased risk for extrahepatic cancer: The 5-year cancer-free survival rate was 63% (CI, 43% to 77%) for patients who were immediately listed and 94% (CI, 81% to 98%) for those who received standard care. Limitation: Restriction of the study sample to alcoholic patients may limit the generalizability of results to other settings. Conclusion: Immediate listing for liver transplantation did not show a survival benefit compared with standard care for Child-Pugh stage B alcoholic cirrhosis. In addition, immediate listing for transplantation increased the risk for extrahepatic cancer.	[Vanlemmens, Claire] CHU Jean Minjoz, Serv Hepatol, F-25030 Besancon, France; Ctr Epidemiol Populat 106, Dijon, France; CHU Bocage, Dijon, France; CHU Pontchaillou, Rennes, France; CHU Henri Mondor, F-94010 Creteil, France; CHU Pitie Salpetriere, Paris, France; CHR Bon Sccours, Metz, France; CHU Caen, F-14000 Caen, France; CHU St Eloi, Montpellier, France; Univ Claude Huriez, CHR, Lille, France; CHU Jean Bernard, Poitiers, France; CHU Beaujon, Clichy, France; CHU Robert Debre, Reims, France; CHU Purpan, Toulouse, France	Universite de Franche-Comte; CHU Besancon; CHU Dijon Bourgogne; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; CHU de Toulouse	Di Martino, V (corresponding author), CHU Jean Minjoz, Serv Hepatol, 3 Blvd A Fleming, F-25030 Besancon, France.	vdimartino@chu-bcsancon.fr	Poynard, Thierry/C-1355-2010; Selves, Janick/M-7719-2014; Dharancy, Sebastien/M-4357-2018; Duvoux, Christophe/CAF-3432-2022; Mathurin, Philippe/A-9121-2018; Monnet, Elisabeth/E-1989-2017	Poynard, Thierry/0000-0002-3726-7230; Dharancy, Sebastien/0000-0002-8262-5607; Mathurin, Philippe/0000-0003-3447-2025; Di Martino, Vincent/0000-0002-2022-690X; Thiefin, Gerard/0000-0002-8626-8352; Thevenot, Thierry/0000-0003-3974-2784; Boudjema, Karim/0000-0002-3894-8767; Monnet, Elisabeth/0000-0002-3347-2579; Poynard, Thierry/0000-0002-2050-640X	French National Program for Clinical Research	French National Program for Clinical Research	The French National Program for Clinical Research.	Aggarwal A, 2001, CHEST, V119, P1489, DOI 10.1378/chest.119.5.1489; Bellamy COC, 2001, TRANSPLANTATION, V72, P619, DOI 10.1097/00007890-200108270-00010; Belle S H, 1997, Liver Transpl Surg, V3, P212, DOI 10.1053/jlts.1997.v3.ajlts0030212; Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Burroughs AK, 2006, LANCET, V367, P225, DOI 10.1016/S0140-6736(06)68033-1; Cales P, 2001, NEW ENGL J MED, V344, P23, DOI 10.1056/NEJM200101043440104; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; Duvoux C, 1999, TRANSPLANTATION, V67, P418, DOI 10.1097/00007890-199902150-00014; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; GRANT BF, 1992, ALCOHOL CLIN EXP RES, V16, P215, DOI 10.1111/j.1530-0277.1992.tb01366.x; Kuo PC, 1999, TRANSPLANTATION, V67, P1087, DOI 10.1097/00007890-199904270-00001; Lucey M R, 1997, Liver Transpl Surg, V3, P628; Merion RM, 2005, AM J TRANSPLANT, V5, P307, DOI 10.1111/j.1600-6143.2004.00703.x; Neuberger J, 1998, LIVER TRANSPLANT SUR, V4, pS51; *NIH CONS DEV C LI, 1984, HEPATOLOGY, V4, pS1; POYNARD T, 1994, LANCET, V344, P502, DOI 10.1016/S0140-6736(94)91897-X; Poynard T, 1999, J HEPATOL, V30, P1130, DOI 10.1016/S0168-8278(99)80269-4; Prince MI, 2002, POSTGRAD MED J, V78, P135, DOI 10.1136/pmj.78.917.135; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RAMOND MJ, 1992, NEW ENGL J MED, V326, P507, DOI 10.1056/NEJM199202203260802; SEARLES JS, 1990, ALCOHOL CLIN EXP RES, V14, P557, DOI 10.1111/j.1530-0277.1990.tb01199.x; SOARESWEISER K, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002232; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Stefanini GF, 1997, HEPATO-GASTROENTEROL, V44, P1356; Suc B, 2000, TRANSPLANTATION, V69, P515, DOI 10.1097/00007890-200002270-00009; Veldt BJ, 2002, J HEPATOL, V36, P93, DOI 10.1016/S0168-8278(01)00228-8; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	30	47	48	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					153	+		10.7326/0003-4819-150-3-200902030-00004	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189904				2022-12-28	WOS:000263029600001
J	de Souza, AC; de Carvalho, AM				de Souza, Antonio Carlos; de Carvalho, Adelino Moreira			Metallic Mercury Embolism to the Hand.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[de Souza, Antonio Carlos; de Carvalho, Adelino Moreira] Alzira Velano Hosp, BR-37130000 Unifenas Alfenas, MG, Brazil		de Souza, AC (corresponding author), Alzira Velano Hosp, BR-37130000 Unifenas Alfenas, MG, Brazil.			De Souza, Antonio Carlos/0000-0001-7318-9260					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					507	507		10.1056/NEJMicm040265	http://dx.doi.org/10.1056/NEJMicm040265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179318				2022-12-28	WOS:000262812400011
J	Alio, AP; Nana, PN; Salihu, HM				Alio, Amina P.; Nana, Philip N.; Salihu, Hamisu M.			Spousal violence and potentially preventable single and recurrent spontaneous fetal loss in an African setting: cross-sectional study	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; WOMEN; OUTCOMES; MISCARRIAGE; PREVALENCE; STILLBIRTH; PREGNANCY; HEALTH; ABUSE	Background Spousal violence is a global issue, with ramifications for the reproductive health of women. We aimed to investigate the effect of physical, sexual, and emotional violence on potentially preventable single and recurrent spontaneous fetal loss. Methods We analysed data from the Cameroon Demographic Health Survey. In the violence module of this survey, women were questioned about their experience of physical, emotional, and sexual violence inflicted by their spouses. Respondents were also asked about any stillbirths and spontaneous abortions. We measured risk for single and recurrent fetal loss with odds ratios, with adjustment for intracluster correlations as appropriate. We also estimated the proportion of preventable excess fetal loss at various levels of violence reduction. Findings 2562 women responded to the violence module. Those exposed to spousal violence (n=1307) were 50% more likely to experience at least one episode of fetal loss compared with women not exposed to abuse (odds ratio 1.5; 95% CI 1. 3-1 . 8). Recurrent fetal mortality was associated with all forms of spousal violence, but emotional violence had the strongest association (1 . 7; 1 . 2-2.3). If the prevalence of spousal abuse could be reduced to 50%, 25%, or entirely eliminated, preventable excess recurrent fetal demise would be 17%, 25%, and 33%, respectively. Interpretation Spousal violence increases the likelihood of single and repeated fetal loss. A large proportion of risk for recurrent fetal mortality is attributable to spousal violence and, therefore, is potentially preventable. Our findings support the idea of routine prenatal screening for spousal violence in the African setting, a region with the highest rate of fetal death in the world. Funding None.	[Alio, Amina P.] Univ S Florida, Dept Community & Family Hlth, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL 33612 USA; [Salihu, Hamisu M.] Univ S Florida, Dept Obstet & Gynecol, Tampa, FL 33612 USA; [Nana, Philip N.] Univ Yaounde, Dept Obstet & Gynecol, Yaounde, Cameroon	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Yaounde I	Alio, AP (corresponding author), Univ S Florida, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.	aalio@health.usf.edu						ADJETEY FNA, 1995, RIGHTS WOM NAT INT L, P26; Bowman CG, 2003, INT J LAW PSYCHIAT, V26, P473, DOI 10.1016/S0160-2527(03)00082-7; Boy A, 2004, INT J FERTIL WOMEN M, V49, P159; Curry MA, 1998, OBSTET GYNECOL, V92, P530, DOI 10.1016/S0029-7844(98)00258-0; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hadi A, 2000, J INTERPERS VIOLENCE, V15, P787, DOI 10.1177/088626000015008001; Hills, 1993, STAT MODELS EPIDEMIO; *INS ORC MACR, 2004, ENQ DEM SANT CAM 200; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; Jones RF, 1997, INT J GYNECOL OBSTET, V58, P43, DOI 10.1016/S0020-7292(97)02863-4; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Morland LA, 2008, J INTERPERS VIOLENCE, V23, P652, DOI 10.1177/0886260507313533; PEARCE TO, 1995, CONCEIVING NEW WORLD, P195; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rothman K., 1998, MODERN EPIDEMIOLOGY; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; Salihu HM, 2003, OBSTET GYNECOL, V102, P679, DOI 10.1016/S0029-7844(03)00768-3; Schroth HA, 2005, INT J CONFL MANAGE, V16, P102, DOI 10.1108/eb022925; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Szklo M., 2007, EPIDEMIOLOGY BASICS; WALKER A, 2002, PSYCHOL SEXUAL HLTH; Watts C, 2004, INT FAM PLAN PERSPEC, V30, P207, DOI 10.1363/3020704; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO DEP RHR, 2000, MON EV REPR HLTH IND; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; [No title captured]	30	52	52	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					318	324		10.1016/S0140-6736(09)60096-9	http://dx.doi.org/10.1016/S0140-6736(09)60096-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167571				2022-12-28	WOS:000262728100027
J	Kotwaliwale, CV; Dernburg, AF				Kotwaliwale, Chitra V.; Dernburg, Abby F.			Old Nuclei Spring New Leaks	CELL			English	Editorial Material							ORGANIZATION; CELLS	The nuclear pore complex (NPC) regulates the bidirectional movement of cell components across the nuclear envelope. In this issue, D'Angelo et al. (2009) demonstrate that the NPC loses essential protein subunits as cells age, resulting in increased nuclear permeability and potentially contributing to organismal aging.	[Kotwaliwale, Chitra V.; Dernburg, Abby F.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kotwaliwale, Chitra V.; Dernburg, Abby F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dernburg, Abby F.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Kotwaliwale, CV (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	chitra.kot@gmail.com; afdernburg@lbl.gov		Dernburg, Abby/0000-0001-8037-1079	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		CALLAN HG, 1950, PROC R SOC SER B-BIO, V137, P367, DOI 10.1098/rspb.1950.0047; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022	5	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					211	212		10.1016/j.cell.2009.01.004	http://dx.doi.org/10.1016/j.cell.2009.01.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167324	Bronze			2022-12-28	WOS:000262648800010
J	Horton, R				Horton, Richard			The global financial crisis: an acute threat to health	LANCET			English	Editorial Material									[Horton, Richard] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							*INT HLTH PARTN, 2008, HIGH LEV TASKF INN I; LEACH B, 2009, SUNDAY TELEGRAP 0118, P5; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1	3	53	54	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					355	356		10.1016/S0140-6736(09)60116-1	http://dx.doi.org/10.1016/S0140-6736(09)60116-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19186260				2022-12-28	WOS:000262912100004
J	Zheng, Y; Chaudhry, A; Kas, A; deRoos, P; Kim, JM; Chu, TT; Corcoran, L; Treuting, P; Klein, U; Rudensky, AY				Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Corcoran, Lynn; Treuting, Piper; Klein, Ulf; Rudensky, Alexander Y.			Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses	NATURE			English	Article							SELF-TOLERANCE; TARGET GENES; DIFFERENTIATION; FOXP3; LINEAGE; TH2; INTERLEUKIN-10; ADENOSINE; DISEASE; ABSENCE	In the course of infection or autoimmunity, particular transcription factors orchestrate the differentiation of T(H)1, T(H)2 or T(H)17 effector cells, the responses of which are limited by a distinct lineage of suppressive regulatory T cells (T-reg). T-reg cell differentiation and function are guided by the transcription factor Foxp3, and their deficiency due to mutations in Foxp3 results in aggressive fatal autoimmune disease associated with sharply augmented T(H)1 and T(H)2 cytokine production(1-3). Recent studies suggested that Foxp3 regulates the bulk of the Foxp3-dependent transcriptional program indirectly through a set of transcriptional regulators serving as direct Foxp3 targets(4,5). Here we show that in mouse T-reg cells, high amounts of interferon regulatory factor-4 (IRF4), a transcription factor essential for T(H)2 effector cell differentiation, is dependent on Foxp3 expression. We proposed that IRF4 expression endows T-reg cells with the ability to suppress T(H)2 responses. Indeed, ablation of a conditional Irf4 allele in T-reg cells resulted in selective dysregulation of T(H)2 responses, IL4-dependent immunoglobulin isotype production, and tissue lesions with pronounced plasma cell infiltration, in contrast to the mononuclear-cell-dominated pathology typical of mice lacking T-reg cells. Our results indicate that T-reg cells use components of the transcriptional machinery, promoting a particular type of effector CD4(+) T cell differentiation, to efficiently restrain the corresponding type of the immune response.	[Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zheng, Ye; Chaudhry, Ashutosh; Kas, Arnold; deRoos, Paul; Kim, Jeong M.; Chu, Tin-Tin; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Corcoran, Lynn] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Klein, Ulf] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Columbia University; Columbia University	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA.	rudenska@mskcc.org	Corcoran, Lynn M/C-9316-2013; Treuting, Piper M./AAB-2721-2019; Zheng, Ye/G-4866-2015	Treuting, Piper M./0000-0002-1812-1519; Zheng, Ye/0000-0001-5012-4309; Chaudhry, Ashutosh/0000-0003-3379-5236	CRI-Irvington Institute; Howard Hughes Medical Institute; National Institutes of Health	CRI-Irvington Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgements We thank K. Hilgner and K. Murphy for providing TH1, TH2 and TH0 gene expression data sets, B. Sullivan, R. Locksley, S. Quezada and J. Allison for critical reagents, K. Forbush and L. Karpik for expert technical assistance and mouse colony management, and R. Dalla- Favera for discussions. This work was supported by grants from the National Institutes of Health (A.Y.R.). Y. Z. and J. M. K. were supported by the CRI-Irvington Institute postdoctoral fellowship. A. Y. R. is an investigator with the Howard Hughes Medical Institute.	Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	30	686	704	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					351	U116		10.1038/nature07674	http://dx.doi.org/10.1038/nature07674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19182775	Green Accepted			2022-12-28	WOS:000264285600044
J	Steinbrook, R				Steinbrook, Robert			Health Care 2009: Health Care and the American Recovery and Reinvestment Act.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						BLUMENTHAL D, 2009, FEDERAL ROLE PROMOTI; SUNSHINE RA, 2009, COMMUNICATION   0121	2	161	163	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1057	1060		10.1056/NEJMp0900665	http://dx.doi.org/10.1056/NEJMp0900665			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417BW	19224738				2022-12-28	WOS:000264051000001
J	Kiboneka, A; Nyatia, RJ; Nabiryo, C; Anema, A; Cooper, CL; Fernandes, KA; Montaner, JSG; Mills, EJ				Kiboneka, Andrew; Nyatia, Ricky Jones; Nabiryo, Christine; Anema, Aranka; Cooper, Curtis L.; Fernandes, Kimberly Ann; Montaner, Julio S. G.; Mills, Edward J.			Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUALS; ADHERENCE; COUNTRIES; KAMPALA	Objective To measure the clinical and immunological outcomes of HIV positive adult patients receiving combination antiretroviral therapy in conflict affected northern Uganda. Design Prospective cohort study. Setting Gulu District, northern Uganda. Participants 1625 adults (aged over 14 years) receiving combination antiretroviral therapy. Main outcome measures Primary outcome: all cause mortality. Secondary outcomes: impact of covariates (sex, age, CD4 count at start, adherence, tuberculosis at start, duration of treatment, and internally displaced person status) on mortality. Results Sixty nine (4.2%) patients died during follow-up. The mortality incidence rate was 3.48 (95% confidence interval 2.66 to 4.31) per 100 person years. Patients started treatment with a median CD4 count of 157 (interquartile range 90-220) cells/mu l; most (1009; 63%) had World Health Organization stage 2 defined illness. Sixty two patients had pulmonary tuberculosis at the start of treatment. Of the 1521 patients with adherence data, 118 (7.8%) had adherence of less than 95% and 1403 (92.2%) had adherence of 95% or above. Conclusion Patients receiving combination antiretroviral therapy in conflict affected northern Uganda had a mortality comparable to that of patients in peaceful, low income settings and better adherence than patients in higher income settings. These favourable findings highlight the need to expand access to combination antiretroviral therapy in populations affected by armed conflict.	[Kiboneka, Andrew; Nabiryo, Christine; Mills, Edward J.] AIDS Support Org TASO, Kampala, Uganda; [Nyatia, Ricky Jones] TASO, Gulu, Uganda; [Anema, Aranka; Fernandes, Kimberly Ann; Montaner, Julio S. G.; Mills, Edward J.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Cooper, Curtis L.] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	B.C. Centre for Excellence in HIV/AIDS; University of Ottawa; Ottawa Hospital Research Institute	Mills, EJ (corresponding author), St Pauls Hosp, Room 627,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	emills@cfenet.ubc.ca	Kiboneka, Andrew/U-5381-2019; Montaner, Julio/K-7621-2012; Cooper, Curtis/M-9320-2019					Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chamla Dick D, 2007, Confl Health, V1, P12, DOI 10.1186/1752-1505-1-12; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Fabiani Massimo, 2007, Confl Health, V1, P3, DOI 10.1186/1752-1505-1-3; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Inter-Agency Standing Committee (IASC), 2003, GUID HIV AIDS INT EM; *JOINT UN PROGR HI, 2007, UN ACC SCAL PRIOR HI; Lutalo T, 2007, AIDS, V21, pS15, DOI 10.1097/01.aids.0000299406.44775.de; Mills EJ, 2007, CLIN INFECT DIS, V45, P916, DOI 10.1086/521249; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; *OCHA, 2006, NO UG BRIEF PAP; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Singh Sonal, 2007, Confl Health, V1, P1, DOI 10.1186/1752-1505-1-1; Spacek LA, 2006, CLIN INFECT DIS, V42, P252, DOI 10.1086/499044; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spiegel PB, 2004, DISASTERS, V28, P322, DOI 10.1111/j.0361-3666.2004.00261.x; Steering Committee for Humanitarian Response, 2004, SPHER PROJ HUM CHART; Tibaijuka, 2005, REPORT FACT FINDING; *UCDP, 2006, CUST REP ACT CONFL A; *UN HIGH COMM REF, STAT WORLDS REF 2006; *UN HIGH COMM REF, 2007, CLIN GUID ANT THER M; *UN HIGH COMM REF, 2007, ANT MED POL REF; *UN HIGH COMM REF, 2008, GLOB APP 2008 2009; *UN OCHA, 2007, CONS APP UG 2008; *WHO, 2006, ANT DRUGS EM ENGL FE; *WHO REP UG MIN HL, HLTH MORT SURV INT D; ZUCCA M, 2004, 15 INT AIDS C BANGK	29	25	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2009	338								b201	10.1136/bmj.b201	http://dx.doi.org/10.1136/bmj.b201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CE	19223338	Green Published, hybrid			2022-12-28	WOS:000264051900005
J	Fontanilla, D; Johannessen, M; Hajipour, AR; Cozzi, NV; Jackson, MB; Ruoho, AE				Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.			The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator	SCIENCE			English	Article							TRACE AMINES; BINDING-SITE; IN-VIVO; CHANNELS; IDENTIFICATION; TRYPTAMINES; MODULATION; TERMINALS; LIGANDS; MOUSE	The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma- 1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N, N- dimethyltryptamine ( DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma- 1 receptors and inhibited voltage- gated sodium ion ( Na+) channels in both native cardiac myocytes and heterologous cells that express sigma- 1 receptors. DMT induced hypermobility in wild- type mice but not in sigma- 1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma- 1 receptor.	[Fontanilla, Dominique; Cozzi, Nicholas V.; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; [Johannessen, Molly; Jackson, Meyer B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53706 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Pharmaceut Res Lab, Dept Chem, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Ruoho, AE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	aeruoho@wisc.edu	Cozzi, Nicholas/AAT-1633-2020		Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH [T32 GM08688, R01 MH065503, NS30016]; NIH Ruth L. Kirschstein National Research Service Award [F31 DA022932]; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA022932] Funding Source: NIH RePORTER	Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Corinna Burger laboratory for use of their mouse behavior equipment, and A. Paul and T. Mavlyutov for providing [<SUP>125</SUP>I] IAF and [<SUP>125</SUP>I]- IACoc, respectively. Supported by the Molecular and Cellular Pharmacology (MCP) Graduate Program training grant from NIH T32 GM08688 and by the NIH Ruth L. Kirschstein National Research Service Award (NRSA) (F31 DA022932) from the National Institute on Drug Abuse ( to D.F.). This work was funded by NIH grants R01 MH065503 ( to A. E. R.) and NS30016 ( to M. B. J.).	AXELROD J, 1961, SCIENCE, V134, P343, DOI 10.1126/science.134.3475.343; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Barker S A, 1981, Int Rev Neurobiol, V22, P83, DOI 10.1016/S0074-7742(08)60291-3; BEATON JM, 1984, MECH AGEING DEV, V25, P343, DOI 10.1016/0047-6374(84)90007-1; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BOUCHARD P, 1995, EUR J NEUROSCI, V7, P1952, DOI 10.1111/j.1460-9568.1995.tb00718.x; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; FRANZEN F, 1965, NATURE, V206, P1052, DOI 10.1038/2061052a0; GLENNON RA, 1994, J MED CHEM, V37, P1214, DOI 10.1021/jm00034a020; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Jacob MS, 2005, MED HYPOTHESES, V64, P930, DOI 10.1016/j.mehy.2004.11.005; JENNER P, 1980, BRIT J PHARMACOL, V69, P69, DOI 10.1111/j.1476-5381.1980.tb10884.x; JOHANNESSEN MA, 2007, ANN NEUR M SAN DIEG; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; KENNEDY C, 1990, NEUROSCIENCE, V35, P725, DOI 10.1016/0306-4522(90)90343-3; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; Matsumoto RR, 2000, EUR J PHARMACOL, V401, P155, DOI 10.1016/S0014-2999(00)00430-1; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; SAAVEDRA JM, 1972, SCIENCE, V175, P1365, DOI 10.1126/science.175.4028.1365; SU TP, 1986, LIFE SCI, V38, P2199; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	29	375	383	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					934	937		10.1126/science.1166127	http://dx.doi.org/10.1126/science.1166127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213917	Green Accepted			2022-12-28	WOS:000263295400042
J	Thathiah, A; Spittaels, K; Hoffmann, M; Staes, M; Cohen, A; Horre, K; Vanbrabant, M; Coun, F; Baekelandt, V; Delacourte, A; Fischer, DF; Pollet, D; De Strooper, B; Merchiers, P				Thathiah, Amantha; Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Horre, Katrien; Vanbrabant, Mieke; Coun, Frea; Baekelandt, Veerle; Delacourte, Andre; Fischer, David F.; Pollet, Dirk; De Strooper, Bart; Merchiers, Pascal			The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons	SCIENCE			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LIPID RAFTS; EXPRESSION; PRESENILIN; NICASTRIN; REQUIRES; GOLGI; PEN-2	Deposition of the amyloid-beta peptide is a pathological hallmark of Alzheimer's disease. A high- throughput functional genomics screen identified G protein- coupled receptor 3 ( GPR3), a constitutively active orphan G protein- coupled receptor, as a modulator of amyloid-beta production. Overexpression of GPR3 stimulated amyloid-beta production, whereas genetic ablation of GPR3 prevented accumulation of the amyloid-beta peptide in vitro and in an Alzheimer's disease mouse model. GPR3 expression led to increased formation and cell- surface localization of the mature gamma-secretase complex in the absence of an effect on Notch processing. GPR3 is highly expressed in areas of the normal human brain implicated in Alzheimer's disease and is elevated in the sporadic Alzheimer's disease brain. Thus, GPR3 represents a potential therapeutic target for the treatment of Alzheimer's disease.	[Fischer, David F.] BioFocus DPI, Galapagos Co, NL-2333 CR Leiden, Netherlands; [Delacourte, Andre] Jean Pierre Aubert Res Ctr, INSERM, Unit 837, F-59045 Lille, France; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Pollet, Dirk; Merchiers, Pascal] Galapagos, B-2800 Mechelen, Belgium; [Coun, Frea; Baekelandt, Veerle] Catholic Univ Louvain, Lab Neurobiol & Gene Therapy, Div Mol Med, B-3000 Louvain, Belgium	Galapagos NV; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Catholique Louvain; Galapagos NV; Universite Catholique Louvain	Fischer, DF (corresponding author), BioFocus DPI, Galapagos Co, Darwinweg 24, NL-2333 CR Leiden, Netherlands.	david.fischer@glpg.com; bart.destrooper@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Baekelandt, Veerle/ABB-9736-2020	De Strooper, Bart/0000-0001-5455-5819; Baekelandt, Veerle/0000-0001-8966-2921; Fischer, David/0000-0002-6690-0197; Horre, Katrien/0000-0002-6801-3137	Methusalem grant from the Flemish government [IWT990363, IWT010512, IWT030623]; Fund for Scientific Research (Flanders, Belgium); Federal Office for Scientific Affairs, Belgium [IUAP P6/43/]	Methusalem grant from the Flemish government; Fund for Scientific Research (Flanders, Belgium)(FWO); Federal Office for Scientific Affairs, Belgium	We acknowledge the contributions of W. Laenen, H. Klaassen, S. Hinnekint, S. de Vos, E. van Rossen, A. Van de Poel, M. De Raeymaeker, K. Thys, J. Vandersmissen, J. van der Schueren, R. Brown, K. Albert, V. Coose, K. Pittois, S. Theunissen, V. Hendrix, E. Maes, K. Craessaerts, J. Prennen, A. Deelder, P. Scheltens, and M. Mercken. We are grateful to G. Vassart and C. Ledent (Universit, Libre de Bruxelles, Brussels, Belgium) for the RT-GPR3 and RT-TSHr cDNA and assistance with cAMP assays, C. H. Berlot (Geisinger Medical Center, Danville, PA) for the GsDN and R280K cDNA, and Murat Bastepe (Harvard Medical School, Boston, MA) for the G<INF>s alpha</INF>-null mouse embryo fibroblasts. This project was supported by IWT990363, IWT010512, and IWT030623, a Methusalem grant from the Flemish government, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43/), Belgium. B. D. S. has been a paid consultant for Galapagos, a drug discovery company. Galapagos holds U. S. patent 7429459 on the GPR3 findings and the technology and library used in this study.	Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Saunders AJ, 1999, SCIENCE, V286; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	27	114	127	5	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					946	951		10.1126/science.1160649	http://dx.doi.org/10.1126/science.1160649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213921				2022-12-28	WOS:000263295400046
J	Rosenberg, RN; Stuve, O; Eagar, T				Rosenberg, Roger N.; Stuve, Olaf; Eagar, Todd			200 Years After Darwin (Reprinted from Archives of Neurology, vol 66, pg 153-155, 2009)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							GENOME-WIDE ASSOCIATION; ONSET ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; RISK; VARIANTS; RECEPTOR; ALLELES; ELEGANS; GENE; APOE		[Rosenberg, Roger N.; Stuve, Olaf; Eagar, Todd] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenberg, RN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	roger.rosenberg@utsouthwestern.edu						[Anonymous], 1861, ORIGIN SPECIES MEANS; Byun E, 2008, ARCH NEUROL-CHICAGO, V65, P337, DOI 10.1001/archneurol.2008.47; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; DARWIN C, 1858, J P LINNEAN SOC LOND, P46; DESMOND A, 1991, DARWIN; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rosenberg RN, 2009, ARCH NEUROL-CHICAGO, V66, P153, DOI 10.1001/archneurol.2008.580; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099	23	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					660	662		10.1001/jama.2009.80	http://dx.doi.org/10.1001/jama.2009.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19216097				2022-12-28	WOS:000263229000030
J	Benton, MJ				Benton, Michael J.			The Red Queen and the Court Jester: Species Diversity and the Role of Biotic and Abiotic Factors Through Time	SCIENCE			English	Review							EXTINCTION; DIVERSIFICATION; EVOLUTION; DYNAMICS; HISTORY; BIODIVERSITY; ORIGINATION; RICHNESS; LAND; LIFE	Evolution may be dominated by biotic factors, as in the Red Queen model, or abiotic factors, as in the Court Jester model, or a mixture of both. The two models appear to operate predominantly over different geographic and temporal scales: Competition, predation, and other biotic factors shape ecosystems locally and over short time spans, but extrinsic factors such as climate and oceanographic and tectonic events shape larger- scale patterns regionally and globally, and through thousands and millions of years. Paleobiological studies suggest that species diversity is driven largely by abiotic factors such as climate, landscape, or food supply, and comparative phylogenetic approaches offer new insights into clade dynamics.	[Benton, Michael J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	mike.benton@bristol.ac.uk	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824	Natural Environment Research Council; Royal Society	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London)	Thanks to S.J. Braddy, P.C.J. Donoghue, D. Jablonski, A. Purvis, M. Ruta, D.N. Schmidt, and anonymous referees for comments and to S. Powell for drafting the figures. Supported by the Natural Environment Research Council and the Royal Society.	Adamowicz SJ, 2008, P NATL ACAD SCI USA, V105, P4786, DOI 10.1073/pnas.0709378105; Alroy J, 2004, EVOL ECOL RES, V6, P1; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Benton MJ, 2001, GEOL J, V36, P211, DOI 10.1002/gj.877.abs; Bofarull AM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-97; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Eble GJ, 1999, GEOBIOS-LYON, V32, P223, DOI 10.1016/S0016-6995(99)80036-9; Finnegan S, 2008, PALEOBIOLOGY, V34, P318, DOI 10.1666/07008.1; Hunt G, 2005, ECOL LETT, V8, P739, DOI 10.1111/j.1461-0248.2005.00778.x; Isaac NJB, 2005, AM NAT, V165, P600, DOI 10.1086/429148; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Schmidt DN, 2004, SCIENCE, V303, P207, DOI 10.1126/science.1090592; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; VRBA ES, 1993, AM J SCI, V293A, P418, DOI 10.2475/ajs.293.A.418; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104	31	350	355	4	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					728	732		10.1126/science.1157719	http://dx.doi.org/10.1126/science.1157719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197051				2022-12-28	WOS:000263066800032
J	Shi, MG; Vivian, CJ; Lee, KJ; Ge, CM; Morotomi-Yano, K; Manzl, C; Bock, F; Sato, S; Tomomori-Sato, C; Zhu, RH; Haug, JS; Swanson, SK; Washburn, MP; Chen, DJ; Chen, BPC; Villunger, A; Florens, L; Du, CY				Shi, Mingan; Vivian, Carolyn J.; Lee, Kyung-Jong; Ge, Chunmin; Morotomi-Yano, Keiko; Manzl, Claudia; Bock, Florian; Sato, Shigeo; Tomomori-Sato, Chieri; Zhu, Ruihong; Haug, Jeffrey S.; Swanson, Selene K.; Washburn, Michael P.; Chen, David J.; Chen, Benjamin P. C.; Villunger, Andreas; Florens, Laurence; Du, Chunying			RETRACTED: DNA-PKcs-PIDDosome: A Nuclear Caspase-2-Activating Complex with Role in G2/M Checkpoint Maintenance (Retracted article. See vol. 145, pg. 161, 2011)	CELL			English	Article; Retracted Publication							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CELL-DEATH; IONIZING IRRADIATION; CASPASE-2; APOPTOSIS; ACTIVATION; DAMAGE; PHOSPHORYLATION; LOCALIZATION	Caspase-2 is unique among all the mammalian caspases in that it is the only caspase that is present constitutively in the cell nucleus, in addition to other cellular compartments. However, the functional significance of this nuclear localization is unknown. Here we show that DNA damage induced by gamma-radiation triggers the phosphorylation of nuclear caspase-2 at the S122 site within its prodomain, leading to its cleavage and activation. This phosphorylation is carried out by the nuclear serine/threonine protein kinase DNA-PKcs and promoted by the p53-inducible death-domain-containing protein PIDD within a large nuclear protein complex consisting of DNA-PKcs, PIDD, and caspase-2, which we have named the DNA-PKcs-PIDDosome. This phosphorylation and the catalytic activity of caspase-2 are involved in the maintenance of a G2/M DNA damage checkpoint and DNA repair mediated by the nonhomologous end-joining (NHEJ) pathway. The DNA-PKcs-PIDDosome thus represents a protein complex that impacts mammalian G2/M DNA damage checkpoint and NHEJ.	[Shi, Mingan; Vivian, Carolyn J.; Ge, Chunmin; Sato, Shigeo; Tomomori-Sato, Chieri; Zhu, Ruihong; Haug, Jeffrey S.; Swanson, Selene K.; Washburn, Michael P.; Florens, Laurence; Du, Chunying] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lee, Kyung-Jong; Morotomi-Yano, Keiko; Chen, David J.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Manzl, Claudia; Bock, Florian; Villunger, Andreas] Innsbruck Med Univ, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria	Stowers Institute for Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Innsbruck	Du, CY (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	cdu@stowers.org	Classen, Scott/AAY-8176-2020	Florens, Laurence/0000-0002-9310-6650; Tomomori-Sato, Chieri/0000-0002-2543-293X; Washburn, Michael/0000-0001-7568-2585; Vivian, Carolyn J./0000-0001-9598-0109	NATIONAL CANCER INSTITUTE [R01CA162804, P01CA092584, R37CA050519, R01CA050519] Funding Source: NIH RePORTER; Austrian Science Fund FWF [Y 212] Funding Source: Medline; NCI NIH HHS [P01-CA92584, P01 CA092584, R37 CA050519, R01 CA050519, R01 CA162804, CA50519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Brewerton SC, 2004, J STRUCT BIOL, V145, P295, DOI 10.1016/j.jsb.2003.11.024; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang XD, 2001, GENE DEV, V15, P2922; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	48	73	76	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					508	520		10.1016/j.cell.2008.12.021	http://dx.doi.org/10.1016/j.cell.2008.12.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203584	Bronze, Green Accepted			2022-12-28	WOS:000263120600020
J	Slotkin, RK; Vaughn, M; Borges, F; Tanurdzic, M; Becker, JD; Feijo, JA; Martienssen, RA				Slotkin, R. Keith; Vaughn, Matthew; Borges, Filipe; Tanurdzic, Milos; Becker, Joerg D.; Feijo, Jose A.; Martienssen, Robert A.			Epigenetic Reprogramming and Small RNA Silencing of Transposable Elements in Pollen	CELL			English	Article							MALE GAMETOPHYTE DEVELOPMENT; TISSUE-SPECIFIC CONTROL; DNA METHYLATION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MUTATOR TRANSPOSONS; INTERFERING RNA; H3 METHYLATION; FLAMENCO GENE; ARABIDOPSIS	The mutagenic activity of transposable elements (TEs) is suppressed by epigenetic silencing and small interfering RNAs (siRNAs), especially in gametes that could transmit transposed elements to the next generation. In pollen from the model plant Arabidopsis, we show that TEs are unexpectedly reactivated and transpose, but only in the pollen vegetative nucleus, which accompanies the sperm cells but does not provide DNA to the fertilized zygote. TE expression coincides with downregulation of the heterochromatin remodeler DECREASE IN DNA METHYLATION 1 and of many TE siRNAs. However, 21 nucleotide siRNAs from Athila retrotransposons are generated and accumulate in pollen and sperm, suggesting that siRNA from TEs activated in the vegetative nucleus can target silencing in gametes. We propose a conserved role for reprogramming in germline companion cells, such as nurse cells in insects and vegetative nuclei in plants, to reveal intact TEs in the genome and regulate their activity in gametes.	[Slotkin, R. Keith; Vaughn, Matthew; Tanurdzic, Milos; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Becker, Joerg D.; Feijo, Jose A.] Ctr Biol Desenvolvimento, Inst Gulbenkian Ciencia, P-2780901 Oeiras, Portugal; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Lisbon, MS, Portugal	Cold Spring Harbor Laboratory; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Becker, Jorg/A-5930-2011; Tanurdzic, Milos/A-5712-2012; Slotkin, R. Keith/H-6965-2013; Feijo, Jose A./ADM-0262-2022	Becker, Jorg/0000-0002-6845-6122; Tanurdzic, Milos/0000-0002-7564-0868; Slotkin, R. Keith/0000-0001-9582-3533; Feijo, Jose A./0000-0002-1100-5478; Borges, Filipe/0000-0002-7388-2118; Vaughn, Matthew/0000-0002-1384-4283	National Institutes of Health (NIH) [F32 CA125977]; National Science Foundation [DBI-0733857]; Robertson Research Fund; NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-BCM/61270/2004, PTDC/AGR-GPL/70592/2006]; NATIONAL CANCER INSTITUTE [F32CA125977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robertson Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Simorowski, M. Galli, T. Nawy, M. Bayer, and S. Hearn, for assistance with GUS staining and microscopy and T. Stokes, E. Richards, R. Gardner, T. Mulligan, Y. Fang, D. Spector, D. Lisch, and R. Schwab for providing tools and stocks. We additionally thank Dennis Stevenson ( New York Botanical Garden) for discussions. R. K. S. is a recipient of a National Institutes of Health (NIH) postdoctoral fellowship (F32 CA125977). This work was supported by grants from the National Science Foundation (DBI-0733857), the Robertson Research Fund, and the NIH (R01 GM067014) to R. A. M., as well as grants PPCDT/BIA-BCM/61270/2004 and PTDC/AGR-GPL/70592/2006 from Fundacao para a Ciencia e a Tecnologia (FCT) to J. D. B.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Becker JD, 2007, ANN BOT-LONDON, V100, P1117, DOI 10.1093/aob/mcm208; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; CALVI BR, 1994, EMBO J, V13, P1636, DOI 10.1002/j.1460-2075.1994.tb06427.x; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Casa AM, 2004, METH MOL B, V260, P175, DOI 10.1385/1-59259-755-6:175; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; EADY C, 1995, PLANT CELL, V7, P65, DOI 10.1105/tpc.7.1.65; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Galli M, 2003, GENETICS, V165, P2093; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Janousek B, 2000, PROTOPLASMA, V211, P116, DOI 10.1007/BF01279904; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MEYER E, 2007, EPIGENETICS, P127; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Okada T, 2006, PLANT MOL BIOL, V62, P503, DOI 10.1007/s11103-006-9036-8; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pasyukova E, 1997, MOL GEN GENET, V255, P115, DOI 10.1007/s004380050479; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; UEDA K, 1995, DEV BIOL, V169, P210, DOI 10.1006/dbio.1995.1138; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; YU S, 1989, PROTOPLASMA, V152, P29; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	59	707	730	2	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					461	472		10.1016/j.cell.2008.12.038	http://dx.doi.org/10.1016/j.cell.2008.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203581	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000263120600016
J	Worth, A; Irshad, T; Bhopal, R; Brown, D; Lawton, J; Grant, E; Murray, S; Kendall, M; Adam, J; Gardee, R; Sheikh, A				Worth, Allison; Irshad, Tasneem; Bhopal, Raj; Brown, Duncan; Lawton, Julia; Grant, Elizabeth; Murray, Scott; Kendall, Marilyn; Adam, James; Gardee, Rafik; Sheikh, Aziz			Vulnerability and access to care for South Asian Sikh and Muslim patients with life limiting illness in Scotland: prospective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPECIALIST PALLIATIVE CARE; HEALTH-CARE; ETHNIC DIVERSITY; SERVICES; CANCER; COMMUNITY; VIEWS; END; UK; PROFESSIONALS	Objectives To examine the care experiences of South Asian Sikh and Muslim patients in Scotland with life limiting illness and their families and to understand the reasons for any difficulties with access to services and how these might be overcome. Design Prospective, longitudinal, qualitative design using in-depth interviews. Setting Central Scotland. Participants 25 purposively selected South Asian Sikh and Muslim patients, 18 family carers, and 20 key health professionals. Results 92 interviews took place. Most services struggled to deliver responsive, culturally appropriate care. Barriers to accessing effective end of life care included resource constrained services; institutional and, occasionally, personal racial and religious discrimination; limited awareness and understanding among South Asian people of the role of hospices; and difficulty discussing death. The most vulnerable patients, including recent migrants and those with poor English language skills, with no family advocate, and dying of non-malignant diseases were at particularly high risk of inadequate care. Conclusions Despite a robust Scottish diversity policy, services for South Asian Sikh and Muslim patients with life limiting illness were wanting in many key areas. Active case management of the most vulnerable patients and carers, and "real time" support, from where professionals can obtain advice specific to an individual patient and family, are the approaches most likely to instigate noticeable improvements in access to high quality end of life care. Improving access to palliative care for all, particularly those with non-malignant illnesses, as well as focusing on the specific needs of ethnic minority groups, is required.	[Bhopal, Raj; Murray, Scott; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Brown, Duncan] St Columbas Hosp, Edinburgh, Midlothian, Scotland; [Adam, James] Marie Curie Hosp, Glasgow, Lanark, Scotland; [Gardee, Rafik] Natl Resource Ctr Ethn Minor Hlth, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department	Chief Scientist Office, Scottish Government Health Department. The research team is independent of the funders and the views expressed are those of the researchers, not the funding body.	Ahmed N, 2004, PALLIATIVE MED, V18, P525, DOI 10.1191/0269216304pm921oa; Bhopal R, 2007, ETHNICITY RACE HLTH; Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018; Carstairs V., 1991, DEPRIVATION HLTH SCO; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; CONILL C, 1990, CANCER, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U; Darzi A., 2008, HIGH QUALITY CARE AL; DAVIES E, 2004, PALLIATIVE CARE SOLI; Davies E, 2004, BETTER PALLIATIVE CA; Elkan R, 2007, EUR J CANCER CARE, V16, P109, DOI 10.1111/j.1365-2354.2006.00726.x; Equalities Review, 2007, FAIRN FREED FIN REP; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; Firth S, 2001, WIDER HORIZONS CARE; Gatrad AR, 2003, BRIT MED J, V327, P176, DOI 10.1136/bmj.327.7408.176; GATRAD R, 2007, PALLIATIVE CARE S AS; *GEN REG OFF SCOTL, 2008, SCOTL CENS 2001; Grande GE, 2006, AGE AGEING, V35, P267, DOI 10.1093/ageing/afj071; Gunaratnam Y., 2007, IMPROVING QUALITY PA; Higginson IJ, 1999, J PUBLIC HEALTH MED, V21, P22, DOI 10.1093/pubmed/21.1.22; HILL D, 1995, OPENING DOORS IMPROV; Jones K, 2005, J RES NURS, V10, P431, DOI 10.1177/174498710501000406; Kai J, 2001, MED EDUC, V35, P262, DOI 10.1046/j.1365-2923.2001.00880.x; Kai J, 2006, VALUING DIVERSITY RE; Kai J, 2007, PLOS MED, V4, P1766, DOI 10.1371/journal.pmed.0040323; Karim K, 2000, PALLIATIVE MED, V14, P471, DOI 10.1191/026921600701536390; Kendall M, 2007, BMJ-BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55; Kessler D, 2005, PALLIATIVE MED, V19, P105, DOI 10.1191/0269216305pm980oa; Koffman J, 2007, PALLIATIVE MED, V21, P145, DOI 10.1177/0269216306074639; Krakauer EL, 2002, J AM GERIATR SOC, V50, P182, DOI 10.1046/j.1532-5415.2002.50027.x; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Merrell J, 2006, HEALTH SOC CARE COMM, V14, P197, DOI 10.1111/j.1365-2524.2006.00610.x; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Nazroo JY, 1998, SOCIOL HEALTH ILL, V20, P710, DOI 10.1111/1467-9566.00126; NBCWN, 2008, WE CAR TOO PUTT BLAC; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; Owens A, 2004, HEALTH SOC CARE COMM, V12, P414, DOI 10.1111/j.1365-2524.2004.00511.x; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Richardson A, 2006, EUR J ONCOL NURS, V10, P93, DOI 10.1016/j.ejon.2005.05.002; ROBINSON LA, 1995, BRIT MED J, V311, P315, DOI 10.1136/bmj.311.7000.315; Sadiq A, 2008, CARING MUSLIM PATIEN, V2nd; Salway S., 2007, LONG TERM ILL HLTH P; *SCOTT EX, 2002, 200251 NHS HDL SCOTT; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Sheikh A, 2006, PLOS MED, V3, P166, DOI 10.1371/journal.pmed.0030049; Sheikh A, 2007, BRIT MED J, V334, P74, DOI 10.1136/bmj.39072.347720.68; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Sultana K, 2008, J ROY SOC MED, V101, P463, DOI 10.1258/jrsm.2008.080007; Szczepura A, 2005, POSTGRAD MED J, V81, P141, DOI 10.1136/pgmj.2004.026237; WEBB E, 2005, ARCH DIS CHILDHOOD-E, V90, P11; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031	53	76	76	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2009	338								b183	10.1136/bmj.b183	http://dx.doi.org/10.1136/bmj.b183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19190015	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000263876200003
J	del Rio, A; Perez-Jimenez, R; Liu, RC; Roca-Cusachs, P; Fernandez, JM; Sheetz, MP				del Rio, Armando; Perez-Jimenez, Raul; Liu, Ruchuan; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.			Stretching Single Talin Rod Molecules Activates Vinculin Binding	SCIENCE			English	Article							FORCE; PROTEIN; SITES; STABILITY; UBIQUITIN; COMPLEX; BUNDLE	The molecular mechanism by which a mechanical stimulus is translated into a chemical response in biological systems is still unclear. We show that mechanical stretching of single cytoplasmic proteins can activate binding of other molecules. We used magnetic tweezers, total internal reflection fluorescence, and atomic force microscopy to investigate the effect of force on the interaction between talin, a protein that links liganded membrane integrins to the cytoskeleton, and vinculin, a focal adhesion protein that is activated by talin binding, leading to reorganization of the cytoskeleton. Application of physiologically relevant forces caused stretching of single talin rods that exposed cryptic binding sites for vinculin. Thus in the talin- vinculin system, molecular mechanotransduction can occur by protein binding after exposure of buried binding sites in the talin-vinculin system. Such protein stretching may be a more general mechanism for force transduction.	[del Rio, Armando; Perez-Jimenez, Raul; Roca-Cusachs, Pere; Fernandez, Julio M.; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Liu, Ruchuan] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	Columbia University; National University of Singapore	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	del rio hernandez, armando e/N-4262-2013; Liu, Ruchuan/G-2279-2012; del Río Hernández, Armando E/D-3555-2012; Liu, Ruchuan/K-8376-2019; Roca-Cusachs, Pere/D-4309-2009; Perez-Jimenez, Raul/C-3085-2017	del rio hernandez, armando e/0000-0001-5062-8910; del Río Hernández, Armando E/0000-0001-5062-8910; Roca-Cusachs, Pere/0000-0001-6947-961X; Perez-Jimenez, Raul/0000-0001-7094-6799	NIH; Spanish Ministry of Science and Education; Marie Curie international fellowship; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Education(Spanish Government); Marie Curie international fellowship(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank D. Critchley and N. Bate for Vh and TR monomer constructs, C. Badilla-Fernandez for advisement with constructs, and V. Hytonen for contribution to Fig. 1. This work was supported by NIH grants to J.M.F. and M.P.S., an NIH award to A.d.R., a grant from the Spanish Ministry of Science and Education to R.P.-J.,and a Marie Curie international fellowship to P.R.-C.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890	25	1020	1028	9	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					638	641		10.1126/science.1162912	http://dx.doi.org/10.1126/science.1162912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179532	Green Accepted			2022-12-28	WOS:000262862800044
J	Diamond, LC; Reuland, DS				Diamond, Lisa C.; Reuland, Daniel S.			Describing Physician Language Fluency Deconstructing Medical Spanish	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT SATISFACTION; TEACHING SPANISH; ACCESS; CARE		[Diamond, Lisa C.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Diamond, Lisa C.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Diamond, Lisa C.] VA Med Ctr, West Haven, CT USA; [Reuland, Daniel S.] Univ N Carolina, Dept Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC USA	Palo Alto Medical Foundation Research Institute; Yale University; University of North Carolina; University of North Carolina Chapel Hill	Diamond, LC (corresponding author), Palo Alto Med Fdn, Res Inst, Ames Bldg,795 El Camino Real, Palo Alto, CA 94301 USA.	diamondl@pamfri.org		Reuland, Daniel/0000-0002-7839-6581; Diamond, Lisa/0000-0002-2175-6224	PHS HHS [T32 HP14001] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7; DuBard CA, 2008, AM J PUBLIC HEALTH, V98, P2021, DOI 10.2105/AJPH.2007.119008; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Jacobs EA, 2003, LANGUAGE BARRIERS HL; Jacobs EA, 2007, J GEN INTERN MED, V22, P306, DOI 10.1007/s11606-007-0357-3; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Mazor SS, 2002, ARCH PEDIAT ADOL MED, V156, P693, DOI 10.1001/archpedi.156.7.693; PRINCE D, 1995, ACAD EMERG MED, V2, P32, DOI 10.1111/j.1553-2712.1995.tb03076.x; REULAND DS, 2008, SOC GEN INT MED 31 A; Schenker Y, 2008, ANN INTERN MED, V149, P264, DOI 10.7326/0003-4819-149-4-200808190-00008; SHIN HB, 2003, LANGUAGE USE ENGLISH; Yoon J, 2004, J AM BOARD FAM PRACT, V17, P165, DOI 10.3122/jabfm.17.3.165	12	40	40	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					426	428		10.1001/jama.2009.6	http://dx.doi.org/10.1001/jama.2009.6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176445				2022-12-28	WOS:000262777200023
J	Garcia-Moreno, C				Garcia-Moreno, Claudia			Intimate-partner violence and fetal loss	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ADVERSE PREGNANCY OUTCOMES; HEALTH CONSEQUENCES; WEIGHT; WOMEN; ABUSE; INDIA; RISK		[Garcia-Moreno, Claudia] WHO, Dept Reprod Hlth & Res, CH-1227 Geneva, Switzerland	World Health Organization	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1227 Geneva, Switzerland.	garciamorenoc@who.int						Ahmed S, 2006, AM J PUBLIC HEALTH, V96, P1423, DOI 10.2105/AJPH.2005.066316; Alio AP, 2009, LANCET, V373, P318, DOI 10.1016/S0140-6736(09)60096-9; BERENSON AB, 1994, AM J OBSTET GYNECOL, V170, P1760; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; El-Mohandes AAE, 2008, OBSTET GYNECOL, V112, P611, DOI 10.1097/AOG.0b013e3181834b10; Garcia-Moreno C, 2005, WHO MULTI COUNTRY ST; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; Jejeebhoy SJ, 1998, STUD FAMILY PLANN, V29, P300, DOI 10.2307/172276; Lau Ying, 2007, J Midwifery Womens Health, V52, pe15, DOI 10.1016/j.jmwh.2006.09.001; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P634, DOI 10.1177/1077801208319283; Moraes CL, 2006, INT J GYNECOL OBSTET, V95, P254, DOI 10.1016/j.ijgo.2006.08.015; Murphy CC, 2001, CAN MED ASSOC J, V164, P1567; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x	14	10	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					278	279		10.1016/S0140-6736(09)60079-9	http://dx.doi.org/10.1016/S0140-6736(09)60079-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167560	Green Submitted			2022-12-28	WOS:000262728100007
J	Piddini, E; Vincent, JP				Piddini, Eugenia; Vincent, Jean-Paul			Interpretation of the Wingless Gradient Requires Signaling-Induced Self-Inhibition	CELL			English	Article							LONG-RANGE ACTION; MORPHOGEN GRADIENT; POSITIONAL INFORMATION; DISC DEVELOPMENT; SONIC HEDGEHOG; BETA-CATENIN; DROSOPHILA; ENCODES; AXIN; PROTEINS	In a classical view of development, a cell can acquire positional information by reading the local concentration of a morphogen independently of its neighbors. Accordingly, in Drosophila, the morphogen Wingless produced in the wing's prospective distal region activates target genes in a dose-dependent fashion to organize the proximodistal pattern. Here, we show that, in parallel, Wingless triggers two nonautonomous inhibitory programs that play an important role in the establishment of positional information. Cells flanking the source of Wingless produce a negative signal (encoded by notum) that inhibits Wingless signaling in nearby cells. Additionally, in response to Wingless, all prospective wing cells produce an unidentified signal that dampens target gene expression in surrounding cells. Thus, cells influence each other's response to Wingless through at least two modes of lateral inhibition. Without lateral inhibition, some cells acquire ectopic fates. Lateral inhibition may be a general mechanism behind the interpretation of morphogen gradients.	[Piddini, Eugenia; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk		Piddini, Eugenia/0000-0003-3901-076X	MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 1999, DEVELOPMENT, V126, P5309; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein T, 1999, DEVELOPMENT, V126, P913; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lawrence PA, 2001, NAT CELL BIOL, V3, pE151, DOI 10.1038/35083096; Liem KF, 2000, DEVELOPMENT, V127, P4855; Masland RH, 2005, CURR BIOL, V15, pR808, DOI 10.1016/j.cub.2005.09.023; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; MORATA G, 1977, DEV BIOL, V56, P227, DOI 10.1016/0012-1606(77)90266-4; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sato A, 1999, DEVELOPMENT, V126, P4421; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vincent JP, 2001, CURR BIOL, V11, pR851, DOI 10.1016/S0960-9822(01)00514-0; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu J, 2002, DEVELOPMENT, V129, P2411; XU T, 1993, DEVELOPMENT, V117, P1223; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	59	47	47	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					296	307		10.1016/j.cell.2008.11.036	http://dx.doi.org/10.1016/j.cell.2008.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167331	Bronze			2022-12-28	WOS:000262648800018
J	Zhang, YX; Yan, LB; Zhou, Z; Yang, PG; Tian, E; Zhang, K; Zhao, Y; Li, ZP; Song, B; Han, JH; Miao, L; Zhang, H				Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhang, Kai; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Miao, Long; Zhang, Hong			SEPA-1 Mediates the Specific Recognition and Degradation of P Granule Components by Autophagy in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GERM GRANULES; MOLECULAR MACHINERY; SELF-DIGESTION; MECHANISMS; MICE; NEURODEGENERATION; PROTEINS; DISEASE; P62	How autophagy, an evolutionarily conserved intracellular catabolic system for bulk degradation, selectively degrades protein aggregates is poorly understood. Here, we show that several maternally derived germ P granule components are selectively eliminated by autophagy in somatic cells during C. elegans embryogenesis. The activity of sepa-1 is required for the degradation of these P granule components and for their accumulation into aggregates, termed PGL granules, in autophagy mutants. SEPA-1 forms protein aggregates and is also a preferential target of autophagy. SEPA-1 directly binds to the P granule component PGL-3 and also to the autophagy protein LGG-1/Atg8. SEPA-1 aggregates consistently colocalize with PGL granules and with LGG-1 puncta. Thus, SEPA-1 functions as a bridging molecule in mediating the specific recognition and degradation of P granule components by autophagy. Our study reveals a mechanism for preferential degradation of protein aggregates by autophagy and emphasizes the physiological significance of selective autophagy during animal development.	[Zhang, Yuxia; Yan, Libo; Zhou, Zhi; Yang, Peiguo; Tian, E.; Zhao, Yu; Li, Zhipeng; Song, Bing; Han, Jinghua; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yan, Libo] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Yan, Libo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Kai; Miao, Long] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, H (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhanghong@nibs.ac.cn	Zhang, Yuxia/J-3449-2013; Yan, Libo/H-2328-2012; yan, libo/H-9533-2013; Zhang, Kai/M-9831-2017	Yan, Libo/0000-0002-4204-3397; Zhang, Kai/0000-0003-2962-3976; Zhang, Hong/0000-0002-3342-5377; YANG, PEIGUO/0000-0002-2334-5664; Miao, Long/0000-0002-0562-6681; Li, Zhipeng/0000-0001-8806-9667	National High Technology Projects 863 [2005AA210910]	National High Technology Projects 863	We thank Drs. Susan Strome and Xiaodong Wang for their helpful comments on the manuscript, Dr. David Hall for his advice on immuno EM, and Dr. Isabel Hanson for editing the manuscript. This work was supported by the National High Technology Projects 863 (2005AA210910).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hird SN, 1996, DEVELOPMENT, V122, P1303; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rowland AM, 2006, J NEUROSCI, V26, P1711, DOI 10.1523/JNEUROSCI.2279-05.2006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x	20	169	187	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					308	321		10.1016/j.cell.2008.12.022	http://dx.doi.org/10.1016/j.cell.2008.12.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167332	Bronze			2022-12-28	WOS:000262648800019
J	Mitchell-Boyask, R				Mitchell-Boyask, Robin			Plague and theatre in ancient Athens	LANCET			English	Editorial Material									[Mitchell-Boyask, Robin] Temple Univ, Dept Greek & Roman Classics, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mitchell-Boyask, R (corresponding author), Temple Univ, Dept Greek & Roman Classics, Philadelphia, PA 19122 USA.							Crawley Richard, 1996, LANDMARK THUCYDIDES, DOI 10.3201/eid0202.960220; Knox B. M. W., 1957, OEDIPUS THEBES SOPHO; LITTMAN RJ, 2006, AMPHORA, V5, P10; MitchellBoyask R, 2008, PLAGUE AND THE ATHENIAN IMAGINATION: DRAMA, HISTORY AND THE CULT OF ASCLEPIUS, P1; Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001	5	7	7	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					374	375		10.1016/S0140-6736(09)60123-9	http://dx.doi.org/10.1016/S0140-6736(09)60123-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	401BC	19189430				2022-12-28	WOS:000262912100014
J	Essers, MAG; Offner, S; Blanco-Bose, WE; Waibler, Z; Kalinke, U; Duchosal, MA; Trumpp, A				Essers, Marieke A. G.; Offner, Sandra; Blanco-Bose, William E.; Waibler, Zoe; Kalinke, Ulrich; Duchosal, Michel A.; Trumpp, Andreas			IFN alpha activates dormant haematopoietic stem cells in vivo	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; SELF-RENEWAL; INTERFERONS; NICHES; EXPRESSION; THERAPY; DISEASE; MICE	Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly reestablish homeostasis(1). The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFN alpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFN alpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFN alpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFN alpha/beta receptor (IFNAR)(2), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFN alpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFN alpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil(1,5), HSCs pre-treated (primed) with IFN alpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFN alpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFN alpha pathway in HSCs impairs their function, acute IFN alpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFN alpha on leukaemic cells(6,7), and raise the possibility for new applications of type I interferons to target cancer stem cells(8).	[Essers, Marieke A. G.; Trumpp, Andreas] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Essers, Marieke A. G.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Offner, Sandra; Blanco-Bose, William E.; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Waibler, Zoe; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Kalinke, Ulrich] TWINCORE Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Duchosal, Michel A.] Univ Lausanne Hosp, CHUV, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Trumpp, A (corresponding author), DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Essers, Marieke A.G./B-7758-2017; Trumpp, Andreas/Z-2141-2019	Essers, Marieke A.G./0000-0003-3117-1809; Trumpp, Andreas/0000-0002-6212-3466; Kalinke, Ulrich/0000-0003-0503-9564	Swiss National Science Foundation; Swiss Cancer League; EU; Deutsche Forschungsgemeinschaft [SFB432.B15]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to M. Aguet for discussions and advice throughout the project, and for providing mouse strains. We thank D. Tough for providing mouse recombinant IFN alpha 4, T. Pedrazzini, W. Stanford and M. Muller for mouse strains, K. Harshman and O. Hagenbuchle and the DAFL team for excellent service and help with the DNA microarrays. We thank C. Dubey and D. Aubry for animal husbandry, genetic screening and technical help, and J. Roberts for FACS sorting. We are grateful to A. Wilson for comments on the manuscript. M. A. G. E. is the recipient of an EMBO long-term fellowship. This work was supported by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 Program 'INTACT', the EU-FP7 Program 'EuroSyStem' and to UK from the Deutsche Forschungsgemeinschaft (SFB432.B15).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Atallah E, 2007, CURR OPIN HEMATOL, V14, P138; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hochhaus Andreas, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS1; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kujawski LA, 2007, CYTOKINE GROWTH F R, V18, P459, DOI 10.1016/j.cytogfr.2007.06.015; LERNER C, 1990, EXP HEMATOL, V18, P114; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200	30	930	951	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					904	U11		10.1038/nature07815	http://dx.doi.org/10.1038/nature07815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19212321				2022-12-28	WOS:000265182500046
J	Xiang, S; Cooper-Morgan, A; Jiao, XF; Kiledjian, M; Manley, JL; Tong, L				Xiang, Song; Cooper-Morgan, Amalene; Jiao, Xinfu; Kiledjian, Megerditch; Manley, James L.; Tong, Liang			Structure and function of the 5 '-> 3 ' exoribonuclease Rat1 and its activating partner Rai1	NATURE			English	Article							RNA-POLYMERASE-II; MESSENGER-RNA; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; MACROMOLECULAR STRUCTURES; PIN DOMAINS; PROTEIN; EXONUCLEASE; TURNOVER; NUCLEAR	The 5'-> 3' exoribonucleases (XRNs) comprise a large family of conserved enzymes in eukaryotes with crucial functions in RNA metabolism and RNA interference(1-5). XRN2, or Rat1 in yeast(6), functions primarily in the nucleus and also has an important role in transcription termination by RNA polymerase II (refs 7-14). Rat1 exoribonuclease activity is stimulated by the protein Rai1 (refs 15, 16). Here we report the crystal structure at 2.2 angstrom resolution of Schizosaccharomyces pombe Rat1 in complex with Rai1, as well as the structures of Rai1 and its murine homologue Dom3Z alone at 2.0 angstrom resolution. The structures reveal the molecular mechanism for the activation of Rat1 by Rai1 and for the exclusive exoribonuclease activity of Rat1. Biochemical studies confirm these observations, and show that Rai1 allows Rat1 to degrade RNAs with stable secondary structure more effectively. There are large differences in the active site landscape of Rat1 compared to related and PIN (PilT N terminus) domain-containing nucleases(17-20). Unexpectedly, we identified a large pocket in Rai1 and Dom3Z that contains highly conserved residues, including three acidic side chains that coordinate a divalent cation. Mutagenesis and biochemical studies demonstrate that Rai1 possesses pyrophosphohydrolase activity towards 5' triphosphorylated RNA. Such an activity is important for messenger RNA degradation in bacteria(21), but this is, to our knowledge, the first demonstration of this activity in eukaryotes and suggests that Rai1/Dom3Z may have additional important functions in RNA metabolism.	[Xiang, Song; Cooper-Morgan, Amalene; Manley, James L.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Jiao, Xinfu; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Columbia University; Rutgers State University New Brunswick	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Tong, Liang/0000-0002-0563-6468; Manley, James/0000-0002-8341-1459	NIH [GM077175, GM28983, GM67005]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077175, R01GM028983, R01GM067005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for setting up the X4A and X4C beamlines and H. Robinson for setting up the X29A beamline at the NSLS, and S. Jia for providing the S. pombe genome. This research is supported in part by grants from the NIH to L. T. (GM077175), J. L. M. (GM28983) and M. K. (GM67005).	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DeLano WL, 2002, PYMOL USERS MANUAL; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LAMZIN VS, 2001, CRYSTALLOGRAPHY BIOL, VF, P720; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Poole TL, 1997, BIOCHEM BIOPH RES CO, V235, P799, DOI 10.1006/bbrc.1997.6877; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Westmont K, 2004, URBAN AFF REV, V39, P522, DOI 10.1177/1078087404394009; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	42	144	148	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					784	U130		10.1038/nature07731	http://dx.doi.org/10.1038/nature07731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19194460	Green Accepted			2022-12-28	WOS:000265193600046
J	Guan, N; Fan, QF; Ding, J; Zhao, YM; Lu, JQ; Ai, Y; Xu, GB; Zhu, SN; Yao, C; Jiang, LN; Miao, J; Zhang, H; Zhao, D; Liu, XY; Yao, Y				Guan, Na; Fan, Qingfeng; Ding, Jie; Zhao, Yiming; Lu, Jingqiao; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong			Melamine-Contaminated Powdered Formula and Urolithiasis in Young Children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: A recent epidemic of melamine contamination of baby formula in China has been associated with the development of urinary tract stones, though the clinical manifestations and predisposing factors are incompletely delineated. Methods: We administered a questionnaire to the parents of children 36 months of age or younger who were being screened for a history of exposure to melamine and symptoms of, and possible predisposing factors for, urinary tract stones. In addition, we performed urinalysis, renal-function and liver-function tests, urinary tests for biochemical markers and the calcium:creatinine ratio, and ultrasonography. Powdered-milk infant formulas were classified as having a high melamine content (>500 ppm), a moderate melamine content (<150 ppm), or no melamine (0 ppm); no formulas contained between 150 and 500 ppm of melamine. Results: Contaminated formula was ingested by 421 of 589 children. Fifty had urinary stones, including 8 who had not received melamine-contaminated formula; 112 were suspected to have stones; and 427 had no stones. Among children with stones, 5.9% had hematuria and 2.9% had leukocyturia, percentages that did not differ significantly from those among children who were suspected to have stones or those who did not have stones. Serum creatinine, urea nitrogen, and alanine aminotransferase levels were normal in the 22 children with stones who were tested. Four of the 41 children (9.8%) who had stones and in whom urinary markers of glomerular function were measured had evidence of abnormalities; none had tubular dysfunction. Children exposed to high-melamine formula were 7.0 times as likely to have stones as those exposed to no-melamine formula. Preterm infants were 4.5 times as likely to have stones as term infants. Conclusions: Prematurity and exposure to melamine-contaminated formula were associated with urinary stones. Affected children lacked typical signs and symptoms of urolithiasis. N Engl J Med 2009;360:1067-74.	[Guan, Na; Fan, Qingfeng; Ding, Jie; Ai, Yi; Xu, Guobin; Zhu, Sainan; Yao, Chen; Jiang, Lina; Miao, Jing; Zhang, Han; Zhao, Dan; Liu, Xiaoyu; Yao, Yong] Peking Univ, Hosp 1, Beijing 100034, Peoples R China; [Zhao, Yiming; Lu, Jingqiao] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing 100034, Peoples R China	Peking University; Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, 1 Xi An Men Da Jie, Beijing 100034, Peoples R China.	djnc_5855@126.com	Fan, Qingfeng/F-4778-2012	Miao, Jing/0000-0003-0642-9740; Fan, Qingfeng/0000-0002-7100-7766	National Key Technology Research and Development Program of China	National Key Technology Research and Development Program of China(National Key Technology R&D Program)	Supported by a grant from the National Key Technology Research and Development Program of China.	Chertow GM, 1996, JAMA-J AM MED ASSOC, V276, P1732, DOI 10.1001/jama.276.21.1732; COWARD RJ, 2004, ARCH DIS CHILD, V89, P797; Coward RJM, 2003, ARCH DIS CHILD, V88, P962, DOI 10.1136/adc.88.11.962; GILSANZ V, 1985, RADIOLOGY, V154, P107, DOI 10.1148/radiology.154.1.3964925; Sun Ning, 2008, Zhonghua Er Ke Za Zhi, V46, P810; Thompson ME, 2008, VET PATHOL, V45, P417, DOI 10.1354/vp.45-3-417	6	203	233	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1067	1074		10.1056/NEJMoa0809550	http://dx.doi.org/10.1056/NEJMoa0809550			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19196669				2022-12-28	WOS:000264051000004
J	Buller, HR; ten Cate-Hoek, AJ; Hoes, AW; Joore, MA; Moons, KGM; Oudega, R; Prins, MH; Stoffers, HEJH; Toll, DB; van der Velde, EF; van Weert, HCPM				Buller, Harry R.; ten Cate-Hoek, Arina J.; Hoes, Arno W.; Joore, Manuela A.; Moons, Karel G. M.; Oudega, Ruud; Prins, Martin H.; Stoffers, Henri E. J. H.; Toll, Diane B.; van der Velde, Eit F.; van Weert, Henk C. P. M.		AMUSE	Safely Ruling Out Deep Venous Thrombosis in Primary Care	ANNALS OF INTERNAL MEDICINE			English	Article							SUSPECTED PULMONARY-EMBOLISM; DIAGNOSTIC WORK-UP; D-DIMER CONCENTRATION; SIMPLIFY D-DIMER; VEIN THROMBOSIS; CLINICAL PROBABILITY; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; DECISION RULE; MANAGEMENT	Background: Up to 90% of patients referred for ultrasonography with suspected deep venous thrombosis (DVT) of the leg do not have the disease. Objective: To evaluate the safety and efficiency of using a clinical decision rule that includes a point-of-care D-dimer assay at initial presentation in primary care to exclude DVT. Design: A prospective management study. Setting: Approximately 300 primary care practices in 3 regions of the Netherlands ( Amsterdam, Maastricht, and Utrecht). Patients: 1028 consecutive patients with clinically suspected DVT. Intervention: Patients were managed on the basis of the result of the clinical decision rule, which included a D-dimer result. Patients with a score of 3 or less were not referred for ultrasonography and received no anticoagulant treatment; patients with a score of 4 or more were referred for ultrasonography. Measurements: The primary outcome was symptomatic, objectively confirmed, venous thromboembolism during 3-month follow-up. Results: The mean age of the 1028 study patients was 58 years, and 37% of patients were men. A valid score was obtained in 1002 patients (98%). In 500 patients (49%), with a score of 3 or less, 7 developed venous thromboembolism within 3 months ( incidence, 1.4% [95% CI, 0.6% to 2.9%]). A total of 502 patients ( 49%) had a score of 4 or more; 3 did not have ultrasonography. Ultrasonography showed DVT in 125 patients (25%), for an overall prevalence in evaluable patients of 13% ( 125 of 1002). Of the 374 patients who had normal ultrasonography results, 4 developed venous thromboembolism within 3 months (1.1% [ CI, 0.3% to 2.7%]). Limitation: The study lacked a randomized design and relied on clinical follow-up to detect missed thrombotic disease. Conclusion: A diagnostic management strategy in primary care by using a simple clinical decision rule and a point-of-care D-dimer assay reduces the need for referral to secondary care of patients with clinically suspected DVT by almost 50% and is associated with a low risk for subsequent venous thromboembolic events.	Univ Amsterdam, Amsterdam, Netherlands; Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Prins, MH (corresponding author), Univ Limburg, Dept Epidemiol, P Debyepl 1, NL-6200 MD Maastricht, Netherlands.	mh.prins@epid.unimaas.nl	Stoffers, Henri E.J.H./N-3785-2019	Stoffers, Henri E.J.H./0000-0002-7908-5101	Netherlands Organization for Scientific Research.	Netherlands Organization for Scientific Research.(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research.	Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; ELF JL, 2008, THROMB RES; Goekoop RJ, 2007, THROMB HAEMOSTASIS, V97, P146, DOI 10.1160/TH06-09-0529; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Janes S, 2001, BRIT J HAEMATOL, V112, P1079, DOI 10.1046/j.1365-2141.2001.02607.x; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kilroy DA, 2003, EMERG MED J, V20, P29, DOI 10.1136/emj.20.1.29; Kraaijenhagen R A, 1997, Curr Opin Pulm Med, V3, P268, DOI 10.1097/00063198-199707000-00006; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Leclercq MGL, 2003, THROMB HAEMOSTASIS, V89, P97; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Ljungqvist M, 2008, EUR J INTERN MED, V19, P285, DOI 10.1016/j.ejim.2007.08.007; Neale D, 2004, EMERG MED J, V21, P663, DOI 10.1136/emj.2003.011049; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Parent F, 2007, THROMB RES, V120, P195, DOI 10.1016/j.thromres.2006.09.012; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Subramaniam Rathan M, 2006, Emerg Med Australas, V18, P457, DOI 10.1111/j.1742-6723.2006.00866.x; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; Toll DB, 2006, J FAM PRACTICE, V55, P613; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Velde EF, 2007, J THROMB HAEMOST, V5, P1327, DOI 10.1111/j.1538-7836.2007.02567.x; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	31	74	79	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					229	U13		10.7326/0003-4819-150-4-200902170-00003	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221374				2022-12-28	WOS:000263562500001
J	Ploss, A; Evans, MJ; Gaysinskaya, VA; Panis, M; You, HN; de Jong, YP; Rice, CM				Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.			Human occludin is a hepatitis C virus entry factor required for infection of mouse cells	NATURE			English	Article							EPITHELIAL TIGHT JUNCTIONS; COXSACKIEVIRUS ENTRY; REPLICATION; CD81; GLYCOPROTEINS; PROTEINS; CULTURE	Hepatitis C virus ( HCV) is a leading cause of liver disease worldwide. The development of much needed specific antiviral therapies and an effective vaccine has been hampered by the lack of a convenient small animal model. The determinants restricting HCV tropism to human and chimpanzee hosts are unknown. Replication of the viral RNA has been demonstrated in mouse cells(1,2), but these cells are not infectable with either lentiviral particles bearing HCV glycoproteins (HCVpp)(3) or HCV produced in cell culture ( HCVcc) ( A. P., M. E. and C. M. R., unpublished observations), suggesting that there is a block at the level of entry. Here we show, using an iterative complementary DNA library screening approach, that human occludin ( OCLN) is an essential HCV cell entry factor that is able to render murine cells infectable with HCVpp. Similarly, OCLN is required for the HCV- susceptibility of human cells, because its overexpression in uninfectable cells specifically enhanced HCVpp uptake, whereas its silencing in permissive cells impaired both HCVpp and HCVcc infection. In addition to OCLN, HCVpp infection of murine cells required expression of the previously identified HCV entry factors CD81 ( ref. 4), scavenger receptor class B type I ( SR- BI, also known as SCARB1) 5 and claudin- 1 (CLDN1)(6). Although the mouse versions of SR- BI and CLDN1 function at least as well as the human proteins in promoting HCV entry, both OCLN and CD81 must be of human origin to allow efficient infection. The species- specific determinants of OCLN were mapped to its second extracellular loop. The identification of OCLN as a new HCV entry factor further highlights the importance of the tight junction complex in the viral entry process, and provides an important advance towards efforts to develop small animal models for HCV.	[Ploss, Alexander; Evans, Matthew J.; Gaysinskaya, Valeriya A.; Panis, Maryline; You, Hana; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA; [de Jong, Ype P.] Mt Sinai Sch Med, Div Gastroenterol, New York, NY 10029 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@rockefeller.edu	Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Evans, Matthew/0000-0002-4991-3877	Greenberg Medical Research Institute; Ellison Medical Foundation; Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health; Ellison Medical Foundation Senior Scholar in Global Infectious Diseases; Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613] Funding Source: NIH RePORTER	Greenberg Medical Research Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Starr Foundation; Ronald A. Shellow Memorial Fund; Richard Salomon Family Foundation; Foundation for the National Institutes of Health; Grand Challenges in Global Health initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar in Global Infectious Diseases(Lawrence Ellison Foundation); Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships; Charles H. Revson Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Bowman, K. Mu, M. Hunter, J. Tassello and M. Holz for excellent technical assistance, J. L. Law and N. Shohdy for advice on siRNA experiments, T. von Hahn and A. J. Syder for helpful discussions and C. Murray for editing the manuscript. S. Mazel, C. Bare and X. Fan provided outstanding technical support. This work was supported by the Greenberg Medical Research Institute, the Ellison Medical Foundation, the Starr Foundation, the Ronald A. Shellow Memorial Fund, the Richard Salomon Family Foundation and funded in part by a Grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (to C.M.R.), and the National Institutes of Health (to M.J.E. and C.M.R.). C.M.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Diseases. A.P. and M.J.E. were supported by Kimberly Lawrence-Netter Cancer Research Discovery Fund Award Postdoctoral Fellowships. M.J.E. was also supported by the Charles H. Revson Postdoctoral Fellowship. We would like to thank P.D. Bieniasz and T. Hatziioannou for providing reagents, including the LMN8 retroviral plasmid, and expertise necessary for the cDNA library construction and screening. R. Tsien provided the mCherry fluorescent protein encoding plasmid, A. Miyawaki the Venus/YFP plasmid and D. W. Piston the Cerulean/CFP plasmid. Constructs expressing HCV glycoproteins of diverse genotypes and the JFH-1 subgenomic replicon cDNA were provided by J. Bukh and T. Wakita, respectively.	Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	19	693	739	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					882	886		10.1038/nature07684	http://dx.doi.org/10.1038/nature07684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182773	Green Accepted			2022-12-28	WOS:000263266700045
J	Sullivan, C; Sayre, SS; Leon, JB; Machekano, R; Love, TE; Porter, D; Marbury, M; Sehgal, AR				Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; Machekano, Rhoderick; Love, Thomas E.; Porter, David; Marbury, Marquisha; Sehgal, Ashwini R.			Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; FATTY-ACID CONTENT; HEMODIALYSIS-PATIENTS; MINERAL METABOLISM; MORTALITY RISK; PARATHYROID-HORMONE; DIETARY PHOSPHORUS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; SERUM PHOSPHORUS	Context High dietary phosphorus intake has deleterious consequences for renal patients and is possibly harmful for the general public as well. To prevent hyperphosphatemia, patients with end- stage renal disease limit their intake of foods that are naturally high in phosphorus. However, phosphorus- containing additives are increasingly being added to processed and fast foods. The effect of such additives on serum phosphorus levels is unclear. Objective To determine the effect of limiting the intake of phosphorus- containing food additives on serum phosphorus levels among patients with end- stage renal disease. Design, Setting, and Participants Cluster randomized controlled trial at 14 long-term hemodialysis facilities in northeast Ohio. Two hundred seventy- nine patients with elevated baseline serum phosphorus levels ( > 5.5 mg/ dL) were recruited between May and October 2007. Two shifts at each of 12 large facilities and 1 shift at each of 2 small facilities were randomly assigned to an intervention or control group. Intervention Intervention participants ( n= 145) received education on avoiding foods with phosphorus additives when purchasing groceries or visiting fast food restaurants. Control participants ( n= 134) continued to receive usual care. Main Outcome Measure Change in serum phosphorus level after 3 months. Results At baseline, there was no significant difference in serum phosphorus levels between the 2 groups. After 3 months, the decline in serum phosphorus levels was 0.6 mg/ dL larger among intervention vs control participants ( 95% confidence interval, - 1.0 to - 0.1 mg/ dL). Intervention participants also had statistically significant increases in reading ingredient lists ( P <. 001) and nutrition facts labels ( P =.04) but no significant increase in food knowledge scores ( P =.13). Conclusion Educating end- stage renal disease patients to avoid phosphorus-containing food additives resulted in modest improvements in hyperphosphatemia. Trial Registration clinicaltrials.gov Identifier: NCT00583570.	[Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; Porter, David; Marbury, Marquisha; Sehgal, Ashwini R.] Metrohlth Med Ctr, Div Nephrol, Cleveland, OH 44109 USA; [Machekano, Rhoderick; Love, Thomas E.; Sehgal, Ashwini R.] Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44109 USA; [Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; Porter, David; Marbury, Marquisha; Sehgal, Ashwini R.] Case Western Reserve Univ, Ctr Reducing Hlth Dispar, Cleveland, OH 44106 USA; [Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; Machekano, Rhoderick; Love, Thomas E.; Porter, David; Marbury, Marquisha; Sehgal, Ashwini R.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Sehgal, Ashwini R.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Sehgal, Ashwini R.] Case Western Reserve Univ, Dept Bioeth, Cleveland, OH 44106 USA	MetroHealth System; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sehgal, AR (corresponding author), Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	axs81@cwru.edu			National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland [DK51472]; Leonard C. Rosenberg Renal Research Foundation, Cleveland, Ohio; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051472] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leonard C. Rosenberg Renal Research Foundation, Cleveland, Ohio; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK51472 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, and by the Leonard C. Rosenberg Renal Research Foundation, Cleveland, Ohio.	Al Aly Z, 2004, AM J NEPHROL, V24, P422, DOI 10.1159/000080087; Albers MJ, 2008, J AM DIET ASSOC, V108, P367, DOI 10.1016/j.jada.2007.10.045; BELL RR, 1977, J NUTR, V107, P42, DOI 10.1093/jn/107.1.42; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Butt S, 2007, J RENAL NUTR, V17, P264, DOI 10.1053/j.jrn.2007.04.003; Calvo MS, 1996, J NUTR, V126, pS1168, DOI 10.1093/jn/126.suppl_4.1168S; CALVO MS, 1990, J CLIN ENDOCR METAB, V70, P1334, DOI 10.1210/jcem-70-5-1334; CALVO MS, 1993, J NUTR, V123, P1627, DOI 10.1093/jn/123.9.1627; Coates P.M., 2005, ENCY DIETARY SUPPLEM; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2007, ARCH INTERN MED, V167, P873, DOI 10.1001/archinte.167.9.873; Friesen R, 2006, J NUTR, V136, P2558, DOI 10.1093/jn/136.10.2558; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Goodman WG, 2004, SEMIN DIALYSIS, V17, P209, DOI 10.1111/j.0894-0959.2004.17308.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Karalis M, 2006, J RENAL NUTR, V16, P79, DOI 10.1053/j.jrn.2005.11.001; Kemi VE, 2006, BRIT J NUTR, V96, P545, DOI 10.1079/BJN20061838; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kimata N, 2005, NEPHROL DIAL TRANSPL, V20, P927, DOI 10.1093/ndt/gfh732; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lorenzo V, 2006, NEPHROL DIAL TRANSPL, V21, P459, DOI 10.1093/ndt/gfi213; Malluche HH, 2002, NEPHROL DIAL TRANSPL, V17, P1170, DOI 10.1093/ndt/17.7.1170; METZ JA, 1993, AM J CLIN NUTR, V58, P537, DOI 10.1093/ajcn/58.4.537; Moss J, 2006, ATHEROSCLEROSIS SUPP, V7, P57, DOI 10.1016/j.atherosclerosissup.2006.04.012; Murphy-Gutekunst Lisa, 2005, Nephrol Nurs J, V32, P443; *NAT KIDN FDN, KDOQL CLIN PRACT GUI; Ribeiro S, 1998, NEPHROL DIAL TRANSPL, V13, P2037, DOI 10.1093/ndt/13.8.2037; Rodriguez-Benot A, 2005, AM J KIDNEY DIS, V46, P68, DOI 10.1053/j.ajkd.2005.04.006; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; Sarathy S, 2008, J RENAL NUTR, V18, P466, DOI 10.1053/j.jrn.2008.05.007; Sax L, 2001, J AM COLL NUTR, V20, P271, DOI 10.1080/07315724.2001.10719047; Sehgal AR, 2008, J RENAL NUTR, V18, P256, DOI 10.1053/j.jrn.2007.12.002; Sherman RA, 2007, SEMIN DIALYSIS, V20, P16, DOI 10.1111/j.1525-139X.2007.00204.x; Sullivan CM, 2007, J RENAL NUTR, V17, P350, DOI 10.1053/j.jrn.2007.05.008; System USRD, 2016, AM J KIDNEY DIS; Teegarden D, 1998, AM J CLIN NUTR, V68, P749, DOI 10.1093/ajcn/68.3.749; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Uribarri J, 2003, SEMIN DIALYSIS, V16, P186, DOI 10.1046/j.1525-139X.2003.16037.x; Uribarri J, 2007, SEMIN DIALYSIS, V20, P295, DOI 10.1111/j.1525-139X.2007.00309.x; Wald R, 2008, AM J KIDNEY DIS, V52, P531, DOI 10.1053/j.ajkd.2008.05.020	44	205	221	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					629	635		10.1001/jama.2009.96	http://dx.doi.org/10.1001/jama.2009.96			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211470	Bronze			2022-12-28	WOS:000263229000027
J	Nicklin, P; Bergman, P; Zhang, BL; Triantafellow, E; Wang, H; Nyfeler, B; Yang, HD; Hild, M; Kung, C; Wilson, C; Myer, VE; MacKeigan, JP; Porter, JA; Wang, YK; Cantley, LC; Finan, PM; Murphy, LO				Nicklin, Paul; Bergman, Philip; Zhang, Bailin; Triantafellow, Ellen; Wang, Henry; Nyfeler, Beat; Yang, Haidi; Hild, Marc; Kung, Charles; Wilson, Christopher; Myer, Vic E.; MacKeigan, Jeffrey P.; Porter, Jeffrey A.; Wang, Y. Karen; Cantley, Lewis C.; Finan, Peter M.; Murphy, Leon O.			Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy	CELL			English	Article							P70 S6 KINASE; FUNCTIONAL-CHARACTERIZATION; GLUTAMINE-METABOLISM; GENE-EXPRESSION; RAG GTPASES; CELL-SIZE; SYSTEM L; PROTEIN; RAPAMYCIN; MUSCLE	Amino acids are required for activation of the mammalian target of rapamycin ( mTOR) kinase which regulates protein translation, cell growth, and autophagy. Cell surface transporters that allow amino acids to enter the cell and signal to mTOR are unknown. We show that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR. L-glutamine uptake is regulated by SLC1A5 and loss of SLC1A5 function inhibits cell growth and activates autophagy. The molecular basis for L-glutamine sensitivity is due to SLC7A5/SLC3A2, a bidirectional transporter that regulates the simultaneous efflux of L-glutamine out of cells and transport of L-leucine/EAA into cells. Certain tumor cell lines with high basal cellular levels of L-glutamine bypass the need for L-glutamine uptake and are primed for mTOR activation. Thus, L-glutamine flux regulates mTOR, translation and autophagy to coordinate cell growth and proliferation.	Novartis Inst BioMed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zhang, Bailin; Wang, Y. Karen] Novartis Inst BioMed Res, Analyt Sci, Cambridge, MA 02139 USA	Novartis; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Novartis	Murphy, LO (corresponding author), Novartis Inst BioMed Res, Dev & Mol Pathways, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	leon.murphy@novartis.com	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Wilson, Christopher/0000-0002-9146-522X; MacKeigan, Jeffrey/0000-0002-0198-5679	Novartis Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Stephen Helliwell, Dan Garza, Dmitri Wiederschain, Greg Michaud, Alex Huang, Leslie Pond, and John Westwick for support, comments, and advice; and to Alan Abrams for help with graphics; and Akos Szilvasi for help with confocal imaging. All authors ( except L. C. C.) are employees of Novartis Pharmaceuticals.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHRISTA L, 1994, GASTROENTEROLOGY, V106, P1312, DOI 10.1016/0016-5085(94)90024-8; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DECHELOTTE P, 1991, AM J PHYSIOL, V260, pG677, DOI 10.1152/ajpgi.1991.260.5.G677; EAGLE H, 1956, J BIOL CHEM, V218, P607; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; GEBHARDT R, 1995, CARCINOGENESIS, V16, P1673; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Holecek M, 2002, NUTRITION, V18, P130, DOI 10.1016/S0899-9007(01)00767-5; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; KOVACEVIC Z, 1972, CANCER RES, V32, P326; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nii T, 2001, BIOCHEM J, V358, P693, DOI 10.1042/0264-6021:3580693; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wolf DA, 1996, CANCER RES, V56, P5012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	59	1174	1234	9	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					521	534		10.1016/j.cell.2008.11.044	http://dx.doi.org/10.1016/j.cell.2008.11.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203585	Bronze, Green Accepted			2022-12-28	WOS:000263120600021
J	Mattson-DiCecca, AA; Farag, N; Reynolds, EE				Mattson-DiCecca, Anna A.; Farag, Nadine; Reynolds, Eileen E.			Update: A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Legro RS, 2007, JAMA-J AM MED ASSOC, V297, P509, DOI 10.1001/jama.297.5.509	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					532	532		10.1001/jama.2009.38	http://dx.doi.org/10.1001/jama.2009.38			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190317				2022-12-28	WOS:000262992400023
J	Smith, RD; Lee, K; Drager, N				Smith, Richard D.; Lee, Kelley; Drager, Nick			Trade and Health 6 Trade and health: an agenda for action	LANCET			English	Article								The processes of contemporary globalisation are creating ever-closer ties between individuals and populations across different countries. The health of a population, and the systems in place to deliver health care, are affected increasingly by factors beyond the population and health system. The Lancers Series on trade and health has provided an overview of these links between international trade, trade liberalisation, and health, and raised the key issues that face the health community. In this final paper in the Series, we call for a substantial and sustained effort by those within the health profession to engage with issues of trade, to strengthen institutional capacity in this area, and to place health higher on the agenda of trade negotiations. The rapid rise of trade agreements and treaties, as well as trade that occurs beyond these institutional boundaries, means that further action is required by a range of actors, including WHO, the World Bank, the World Trade Organization (WTO), regional agencies, foundations, national governments, civil society non-governmental organisations, and academics. The stewardship of a domestic health system in the 21st century requires a sophisticated understanding of how trade affects, and will affect, a country's health system and policy, to optimise opportunities to benefit health and health care while minimising the risks posed though the assertion of health goals in trade policy. To acheive this will place a premium on all those engaged in health to understand the importance of trade and to engage with their counterparts involved in trade and trade policy. We hope that this Series has prompted the reader to become involved in these efforts.	[Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England; [Smith, Richard D.; Lee, Kelley] Univ London London Sch Hyg & Trop Med, Ctr Global Change & Hlth, London WC1E 7HT, England; [Drager, Nick] WHO, Dept Eth Equ Trade & Human Rights, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Smith, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	Richard.Smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559	NCI NIH HHS [R01 CA091021-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA091021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Blouin C, 2009, LANCET, V373, P502, DOI 10.1016/S0140-6736(08)61777-8; CHANDA R, 2006, TRADE HLTH SERVICES; Chigas D, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P325; Dollar D, 2004, ECON J, V114, pF22, DOI 10.1111/j.0013-0133.2004.00186.x; Fidler DP, 2009, LANCET, V373, P325, DOI 10.1016/S0140-6736(08)61775-4; Fidler DP, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P294; GOBRECHT J, 2004, MEASURING TRADE HLTH; LABONTE R, 2003, DYING TRADE WHY GLOB, P1; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; SACHS J, 2002, NAT MED, V8, P89; Smith R, 2006, HEALTH ECON POLICY L, V1, P323, DOI 10.1017/S1744133106005019; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X	14	49	49	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					768	773		10.1016/S0140-6736(08)61780-8	http://dx.doi.org/10.1016/S0140-6736(08)61780-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19167056	Green Accepted			2022-12-28	WOS:000263725400036
J	Aiuti, A; Cattaneo, F; Galimberti, S; Benninghoff, U; Cassani, B; Callegaro, L; Scaramuzza, S; Andolfi, G; Mirolo, M; Brigida, I; Tabucchi, A; Carlucci, F; Eibl, M; Aker, M; Slavin, S; Al-Mousa, H; Al Ghonaium, A; Ferster, A; Duppenthaler, A; Notarangelo, L; Wintergerst, U; Buckley, RH; Bregni, M; Marktel, S; Valsecchi, MG; Rossi, P; Ciceri, F; Miniero, R; Bordignon, C; Roncarolo, M				Aiuti, Alessandro; Cattaneo, Federica; Galimberti, Stefania; Benninghoff, Ulrike; Cassani, Barbara; Callegaro, Luciano; Scaramuzza, Samantha; Andolfi, Grazia; Mirolo, Massimiliano; Brigida, Immacolata; Tabucchi, Antonella; Carlucci, Filippo; Eibl, Martha; Aker, Memet; Slavin, Shimon; Al-Mousa, Hamoud; Al Ghonaium, Abdulaziz; Ferster, Alina; Duppenthaler, Andrea; Notarangelo, Luigi; Wintergerst, Uwe; Buckley, Rebecca H.; Bregni, Marco; Marktel, Sarah; Valsecchi, Maria Grazia; Rossi, Paolo; Ciceri, Fabio; Miniero, Roberto; Bordignon, Claudio; Roncarolo, Maria-Grazia			Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; BLOOD-LYMPHOCYTES; THYMIC OUTPUT; ADA; RECONSTITUTION; ACTIVATION; EXPRESSION; CHILDHOOD; LEADS	Background: We investigated the long-term outcome of gene therapy for severe combined immunodeficiency (SCID) due to the lack of adenosine deaminase (ADA), a fatal disorder of purine metabolism and immunodeficiency. Methods: We infused autologous CD34+ bone marrow cells transduced with a retroviral vector containing the ADA gene into 10 children with SCID due to ADA deficiency who lacked an HLA-identical sibling donor, after nonmyeloablative conditioning with busulfan. Enzyme-replacement therapy was not given after infusion of the cells. Results: All patients are alive after a median follow-up of 4.0 years (range, 1.8 to 8.0). Transduced hematopoietic stem cells have stably engrafted and differentiated into myeloid cells containing ADA (mean range at 1 year in bone marrow lineages, 3.5 to 8.9%) and lymphoid cells (mean range in peripheral blood, 52.4 to 88.0%). Eight patients do not require enzyme-replacement therapy, their blood cells continue to express ADA, and they have no signs of defective detoxification of purine metabolites. Nine patients had immune reconstitution with increases in T-cell counts (median count at 3 years, 1.07 x 10(sup 9) per liter) and normalization of T-cell function. In the five patients in whom intravenous immune globulin replacement was discontinued, antigen-specific antibody responses were elicited after exposure to vaccines or viral antigens. Effective protection against infections and improvement in physical development made a normal lifestyle possible. Serious adverse events included prolonged neutropenia (in two patients), hypertension (in one), central-venous-catheter-related infections (in two), Epstein-Barr virus reactivation (in one), and autoimmune hepatitis (in one). Conclusions: Gene therapy, combined with reduced-intensity conditioning, is a safe and effective treatment for SCID in patients with ADA deficiency. (ClinicalTrials.gov numbers, NCT00598481 and NCT00599781.) N Engl J Med 2009;360:447-58.	[Aiuti, Alessandro; Cattaneo, Federica; Benninghoff, Ulrike; Cassani, Barbara; Callegaro, Luciano; Scaramuzza, Samantha; Andolfi, Grazia; Mirolo, Massimiliano; Brigida, Immacolata; Marktel, Sarah; Roncarolo, Maria-Grazia] Univ Milano Bicocca, HSR TIGET, I-20132 Milan, Italy; [Galimberti, Stefania; Valsecchi, Maria Grazia] Univ Milano Bicocca, Milan, Italy; [Bregni, Marco] Osped San Giuseppe, Milan, Italy; [Cattaneo, Federica] Ist Sci San Raffaele, I-20132 Milan, Italy; [Bordignon, Claudio; Roncarolo, Maria-Grazia] Univ Vita Salute San Raffaele, Milan, Italy; [Bordignon, Claudio] MolMed, Milan, Italy; [Aiuti, Alessandro; Rossi, Paolo] Univ Roma Tor Vergata, Rome, Italy; [Rossi, Paolo] Childrens Hosp Bambino Gesu, Rome, Italy; [Tabucchi, Antonella; Carlucci, Filippo] Univ Siena, I-53100 Siena, Italy; [Miniero, Roberto] Univ Turin, Turin, Italy; [Eibl, Martha] Immunol Tagesklin, Vienna, Austria; [Aker, Memet; Slavin, Shimon] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; [Al-Mousa, Hamoud; Al Ghonaium, Abdulaziz] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Ferster, Alina] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Brussels, Belgium; [Duppenthaler, Andrea] Univ Childrens Hosp, Bern, Switzerland; [Notarangelo, Luigi] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Wintergerst, Uwe] Univ Kinderklin Munchen, Munich, Germany; [Buckley, Rebecca H.] Duke Univ, Med Ctr, Durham, NC USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Milano-Bicocca; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Rome Tor Vergata; IRCCS Bambino Gesu; University of Siena; University of Turin; Hebrew University of Jerusalem; King Faisal Specialist Hospital & Research Center; Universite Libre de Bruxelles; University of Bern; University Hospital of Bern; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Munich; Duke University	Roncarolo, M (corresponding author), Univ Milano Bicocca, HSR TIGET, Via Olgettina 58, I-20132 Milan, Italy.	m.roncarolo@hsr.it	Scaramuzza, Samantha/AAN-2204-2020; Buckley, Rebecca/AAB-1578-2019; marktel, sarah/ABH-5549-2020; galimberti, stefania/H-2594-2012; Al-Mousa, Hamoud/AAS-4477-2020; rossi, paolo/D-6504-2012; Rossi, Paolo/K-5746-2016; Notarangelo, Luigi D/F-9718-2016; Tabucchi, Antonella/J-5949-2012; Cassani, Barbara/K-3871-2016; Valsecchi, Maria Grazia/K-8891-2016; AIUTI, ALESSANDRO/K-3918-2016	Scaramuzza, Samantha/0000-0003-2903-3650; Rossi, Paolo/0000-0003-2620-7918; Notarangelo, Luigi D/0000-0002-8335-0262; Cassani, Barbara/0000-0002-4115-8109; Valsecchi, Maria Grazia/0000-0001-5574-3504; AIUTI, ALESSANDRO/0000-0002-5398-1717; Wintergerst, Uwe/0000-0002-0785-0337; bregni, marco/0000-0002-3789-1199; RONCAROLO, Maria Grazia/0000-0002-2193-9186; marktel, sarah/0000-0002-3768-4288; Brigida, Immacolata/0000-0002-0338-2230; GALIMBERTI, STEFANIA/0000-0003-1504-7242	Telethon [TGT06F01] Funding Source: Medline	Telethon(Fondazione Telethon)		Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2002, NAT MED, V8, P423, DOI 10.1038/nm0502-423; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Albuquerque W, 2004, J PEDIATR-US, V144, P278, DOI 10.1016/j.jpeds.2003.10.055; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Booth C, 2007, CLIN IMMUNOL, V123, P139, DOI 10.1016/j.clim.2006.12.009; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Carlucci F, 2003, CLIN CHEM, V49, P1830, DOI 10.1373/clinchem.2003.021576; Cassani B, 2008, BLOOD, V111, P4209, DOI 10.1182/blood-2007-05-092429; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Engel BC, 2007, BLOOD, V109, P503, DOI 10.1182/blood-2006-06-031476; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Grunebaum E, 2006, JAMA-J AM MED ASSOC, V295, P508, DOI 10.1001/jama.295.5.508; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hershfield MS, 1998, SEMIN HEMATOL, V35, P291; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; Hirschorn R, 2006, PRIMARY IMMUNODEFICI, P169; Honig M, 2007, BLOOD, V109, P3595, DOI 10.1182/blood-2006-07-034678; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kohn DB, 2008, BONE MARROW TRANSPL, V41, P199, DOI 10.1038/sj.bmt.1705895; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Malacarne F, 2005, EUR J IMMUNOL, V35, P3376, DOI 10.1002/eji.200526248; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Muul LM, 2003, BLOOD, V101, P2563, DOI 10.1182/blood-2002-09-2800; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Rogers MH, 2001, J PEDIATR-US, V139, P44, DOI 10.1067/mpd.2001.115023; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763	33	713	743	1	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					447	458		10.1056/NEJMoa0805817	http://dx.doi.org/10.1056/NEJMoa0805817			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179314				2022-12-28	WOS:000262812400004
J	Raftery, J				Raftery, James			Should NICE's threshold range for cost per QALY be raised? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Raftery, James] Univ Southampton, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Southampton SO16 7PX, Hants, England.	raftery@soton.ac.uk						Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Barrett A, 2006, BRIT MED J, V333, P1118, DOI 10.1136/bmj.39008.624051.BE; *HOUS COMM HLTH CO, 2008, 1 REP SESS 2007 8, V1; MARTIN S, 2008, LINK HLTH CARE SPEND; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; *NICE, 2008, HLTH TECHN APPR APP; NICE, 2008, APPR LIF EXT END LIF; Raftery J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b67; Wells J, 2007, BRIT MED J, V334, P936, DOI 10.1136/bmj.39190.420081.94; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Woodroffe R, 2005, HEALTH TECHNOL ASSES, V9, P1	12	24	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b185	10.1136/bmj.b185	http://dx.doi.org/10.1136/bmj.b185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405EK	19171562				2022-12-28	WOS:000263205300010
J	Ekeberg, OM; Bautz-Holter, E; Tveita, EK; Juel, NG; Kvalheim, S; Brox, JI				Ekeberg, Ole M.; Bautz-Holter, Erik; Tveita, Einar K.; Juel, Niels G.; Kvalheim, Synnove; Brox, Jens I.			Subacromial ultrasound guided or systemic steroid injection for rotator cuff disease: randomised double blind study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOCAL CORTICOSTEROID INJECTION; SHOULDER PAIN; SUPERVISED EXERCISES; ARTHROSCOPIC SURGERY; IMPINGEMENT SYNDROME; CLINICAL-TRIAL; PHYSIOTHERAPY; BETAMETHASONE; TENDINITIS; DISORDERS	Objective To compare the effectiveness of ultrasound guided corticosteroid injection in the subacromial bursa with systemic corticosteroid injection in patients with rotator cuff disease. Design Double blind randomised clinical trial. Setting Outpatient clinic of a physical medicine and rehabilitation department in Oslo, Norway. Patients 106 patients with rotator cuff disease lasting at least three months. Interventions Ultrasound guided corticosteroid and lidocaine injection in the subacromial bursa and lidocaine injection in the gluteal region ( local group); corticosteroid and lidocaine injection in the gluteal region and ultrasound guided lidocaine injection in the subacromial bursa ( systemic group). Main outcome measures Difference in improvement in the overall shoulder pain and disability index score after six weeks. Results Six weeks after the intervention, the mean difference in improvement in overall shoulder pain and disability index score between the local group and the systemic group was - 5.2 ( 95% confidence interval - 13.9 to 3.5); it was - 4.1 (- 12.3 to 4.1, P= 0.32) after adjustment for baseline score. A small but statistically significant difference in improvement between groups occurred in favour of the local group for two secondary outcome measures: the Western Ontario rotator cuff index ( 8.1, 0.7 to 15.6) and change in main complaint ( 2.0, 0 to 4). Conclusions No important differences in short term outcomes were found between local ultrasound guided corticosteroid injection and systemic corticosteroid injection in rotator cuff disease. Trial registration Clinical trials NCT00640575.	[Ekeberg, Ole M.; Bautz-Holter, Erik; Tveita, Einar K.; Juel, Niels G.; Kvalheim, Synnove] Univ Oslo, Ulleval Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Ekeberg, Ole M.; Bautz-Holter, Erik; Tveita, Einar K.; Juel, Niels G.; Kvalheim, Synnove] Univ Oslo, Fac Med, N-0407 Oslo, Norway; [Brox, Jens I.] Univ Oslo, Rikshosp Univ Hosp & Med Fac, Dept Orthopaed Back Surg & Phys Med, N-0027 Oslo, Norway; [Brox, Jens I.] Univ Oslo, Fac Med, N-0027 Oslo, Norway; [Brox, Jens I.] Univ Bergen, Unifob Hlth, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen	Ekeberg, OM (corresponding author), Univ Oslo, Ulleval Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway.	o.m.ekeberg@medisin.uio.no	Zmistowski, Ben/AAI-7901-2020; Brox, Jens Ivar/N-1601-2018; Ekeberg, Ole M/AAL-1478-2021	Kvalheim, Synnoeve/0000-0002-1752-9328	The University of Oslo	The University of Oslo	The University of Oslo funded this study.	Alvarez CM, 2005, AM J SPORT MED, V33, P255, DOI 10.1177/0363546504267345; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; BARTOLOZZI A, 1994, CLIN ORTHOP RELAT R, P90; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022; Brox JI, 2003, BEST PRACT RES CL RH, V17, P33, DOI 10.1016/S1521-6942(02)00101-8; Brox JI, 1999, J SHOULDER ELB SURG, V8, P102, DOI 10.1016/S1058-2746(99)90001-0; BROX JI, 1993, BMJ-BRIT MED J, V307, P899, DOI 10.1136/bmj.307.6909.899; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Carette S, 2003, ARTHRITIS RHEUM, V48, P829, DOI 10.1002/art.10954; Chen MJL, 2006, AM J PHYS MED REHAB, V85, P31, DOI 10.1097/01.phm.0000184158.85689.5e; Croft P, 1996, BRIT MED J, V313, P601; de Hoyos JAG, 2004, PAIN, V112, P289, DOI 10.1016/j.pain.2004.08.030; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Ginn KA, 1997, PHYS THER, V77, P802, DOI 10.1093/ptj/77.8.802; Green S, 1998, ARTHRIT CARE RES, V11, P43, DOI 10.1002/art.1790110108; Gruson KI, 2008, J SHOULDER ELB SURG, V17, p118S, DOI 10.1016/j.jse.2007.07.009; Haahr JP, 2005, ANN RHEUM DIS, V64, P760, DOI 10.1136/ard.2004.021188; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Henkus HE, 2006, ARTHROSCOPY, V22, P277, DOI 10.1016/j.arthro.2005.12.019; HOLLINGWORTH GR, 1983, BRIT MED J, V287, P1339, DOI 10.1136/bmj.287.6402.1339; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Kirkley A, 2003, CLIN J SPORT MED, V13, P84, DOI 10.1097/00042752-200303000-00004; Koester MC, 2007, J AM ACAD ORTHOP SUR, V15, P3, DOI 10.5435/00124635-200701000-00002; LIRETTE R, 1992, CLIN ORTHOP RELAT R, P14; Naredo E, 2004, J RHEUMATOL, V31, P308; NEUSTADT DH, 1991, ARTHRITIS RHEUM-US, V34, P923, DOI 10.1002/art.1780340721; PARK HB, 2005, J BONE JOINT SURG AM, V87, P1446, DOI DOI 10.2106/JBJS.D.02335; Paul A, 2004, ANN RHEUM DIS, V63, P1293, DOI 10.1136/ard.2003.012088; Razmjou H, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-26; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Romeo AA, 1996, AM J SPORT MED, V24, P472, DOI 10.1177/036354659602400411; Schmitt JS, 2004, J CLIN EPIDEMIOL, V57, P1008, DOI 10.1016/j.jclinepi.2004.02.007; Speed CA, 2002, J BONE JOINT SURG BR, V84B, P509, DOI 10.1302/0301-620X.84B4.12318; Speed CA, 2007, BEST PRACT RES CL RH, V21, P333, DOI 10.1016/j.berh.2006.11.001; VALTONEN EJ, 1978, J INT MED RES, V6, P463, DOI 10.1177/030006057800600608; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; VANGSNESS CT, 1995, ARTHROSCOPY, V11, P180, DOI 10.1016/0749-8063(95)90064-0; VECCHIO P, 1995, BRIT J RHEUMATOL, V34, P440; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; WILLIAMS JW, 1995, J RHEUMATOL, V22, P727	43	93	94	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2009	338								a3112	10.1136/bmj.a3112	http://dx.doi.org/10.1136/bmj.a3112			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BU	19168537	Green Published, hybrid			2022-12-28	WOS:000263197900001
J	Ruiz-Canada, C; Kelleher, DJ; Gilmore, R				Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid			Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST Isoforms	CELL			English	Article							DIPEPTIDYL PEPTIDASE-I; ENDOPLASMIC-RETICULUM; RIBOPHORIN-I; LINKED GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRYPANOSOMA-BRUCEI; CATHEPSIN-C; PROTEIN; MEMBRANE; SUBUNIT	Asparagine-linked glycosylation of polypeptides in the lumen of the endoplasmic reticulum is catalyzed by the hetero-oligomeric oligosaccharyltransferase (OST). OST isoforms with different catalytic subunits (STT3A versus STT3B) and distinct enzymatic properties are coexpressed in mammalian cells. Using siRNA to achieve isoform-specific knockdowns, we show that the OST isoforms cooperate and act sequentially to mediate protein N-glycosylation. The STT3A OST isoform is primarily responsible for cotranslational glycosylation of the nascent polypeptide as it enters the lumen of the endoplasmic reticulum. The STT3B isoform is required for efficient cotranslational glycosylation of an acceptor site adjacent to the N-terminal signal sequence of a secreted protein. Unlike STT3A, STT3B efficiently mediates posttranslational glycosylation of a carboxyl-terminal glycosylation site in an unfolded protein. These distinct and complementary roles for the OST isoforms allow sequential scanning of polypeptides for acceptor sites to insure the maximal efficiency of N-glycosylation.	[Ruiz-Canada, Catalina; Kelleher, Daniel J.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Gilmore, R (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu			Public Health Services [GM 43768]; Ministerio de Educacion y Ciencia, Spain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Ministerio de Educacion y Ciencia, Spain(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Katherine High for providing the plasmid for FVII and Professor Konrad Sandhoff for the SAP D antisera. We also thank members of the Gilmore laboratory for helpful discussions. This work was supported by Public Health Services grant GM 43768 (R. G.) and a fellowship from the Ministerio de Educacion y Ciencia, Spain (C. R.-C.).	Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Horn M, 2002, PROTEIN SCI, V11, P933, DOI 10.1110/ps.2910102; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; NILSSON I, 1993, J BIOL CHEM, V268, P5798; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wrobe D, 2000, J INHERIT METAB DIS, V23, P63, DOI 10.1023/A:1005603014401; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	45	250	260	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					272	283		10.1016/j.cell.2008.11.047	http://dx.doi.org/10.1016/j.cell.2008.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167329	Green Accepted, Bronze			2022-12-28	WOS:000262648800016
J	Wu, JI; Lessard, J; Crabtree, GR				Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.			Understanding the Words of Chromatin Regulation	CELL			English	Article							REMODELING COMPLEX; POLYCOMB GROUP; HISTONE H3; BRG1; ISWI; EXPRESSION; SUBUNIT; DISRUPTION; PROTEINS; GENES	Recent studies indicate that chromatin regulatory complexes produce biological specificity in the way that letters produce meanings by combinations into words. Combinatorial assembly of chromatin regulatory complexes may be critical for maximizing the information content provided by arrays of histone modifications.	[Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA; [Wu, Jiang I.; Lessard, Julie; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94062 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94062 USA.	crabtree@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI060037-02, R01 AI060037-03, R01 AI060037-01, R01 AI060037-05, R01 AI060037, R01 AI060037-04] Funding Source: Medline; NICHD NIH HHS [R01 HD055391] Funding Source: Medline; NINDS NIH HHS [R01 NS046789-04, R01 NS046789-06, R01 NS046789-05, R01 NS046789-03, R01 NS046789, R01 NS046789-01, R01 NS046789-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akasaka T, 1996, DEVELOPMENT, V122, P1513; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NEIGEBORN L, 1984, GENETICS, V108, P845; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wong AKC, 2000, CANCER RES, V60, P6171; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	58	271	277	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					200	206		10.1016/j.cell.2009.01.009	http://dx.doi.org/10.1016/j.cell.2009.01.009			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167321	Bronze, Green Accepted			2022-12-28	WOS:000262648800007
J	Palmenberg, AC; Spiro, D; Kuzmickas, R; Wang, S; Djikeng, A; Rathe, JA; Fraser-Liggett, CM; Liggett, SB				Palmenberg, Ann C.; Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire; Rathe, Jennifer A.; Fraser-Liggett, Claire M.; Liggett, Stephen B.			Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution	SCIENCE			English	Article							ASTHMA; RECOMBINATION; INFECTIONS; FEATURES; VIRUSES; TRACT	Infection by human rhinovirus (HRV) is a major cause of upper and lower respiratory tract disease worldwide and displays considerable phenotypic variation. We examined diversity by completing the genome sequences for all known serotypes (n = 99). Superimposition of capsid crystal structure and optimal-energy RNA configurations established alignments and phylogeny. These revealed conserved motifs; clade-specific diversity, including a potential newly identified species (HRV-D); mutations in field isolates; and recombination. In analogy with poliovirus, a hypervariable 5' untranslated region tract may affect virulence. A configuration consistent with nonscanning internal ribosome entry was found in all HRVs and may account for rapid translation. The data density from complete sequences of the reference HRVs provided high resolution for this degree of modeling and serves as a platform for full genome-based epidemiologic studies and antiviral or vaccine development.	[Rathe, Jennifer A.; Liggett, Stephen B.] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire] J Craig Venter Inst, Rockville, MD 20850 USA; [Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Wisconsin System; University of Wisconsin Madison; J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012	Fraser, Claire/0000-0003-1462-2428; Liggett, Stephen B./0000-0002-0128-3669; Djikeng, Appolinaire/0000-0001-9271-3419	University of Maryland School of Medicine; NIH [U19-AI070503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	University of Maryland School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the University of Maryland School of Medicine internal funds and by NIH grant U19-AI070503. We thank A. Wolf and J.-Y. Sgro for implementation of the tree topology tests. The accession numbers for the hrv strains are FJ445111 to FJ445190 (see table S1).	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Barnard DL, 2006, CURR PHARM DESIGN, V12, P1379, DOI 10.2174/138161206776361129; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fleischer R, 2003, CLIN INFECT DIS, V37, P1722; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JACKSON RJ, 1996, TRANSLATIONAL CONTRO; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; KNOWLES N, COMMUNICATION; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin LR, 1996, J VIROL, V70, P2027, DOI 10.1128/JVI.70.3.2027-2031.1996; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; PALMENBERG AC, 2001, MOL BIOL PICORNAVIRU; Savolainen C, 2002, VIRUS RES, V85, P41, DOI 10.1016/S0168-1702(02)00016-3; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	26	328	348	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					55	59		10.1126/science.1165557	http://dx.doi.org/10.1126/science.1165557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19213880	Green Accepted			2022-12-28	WOS:000264802100029
J	Hedges, LO; Jack, RL; Garrahan, JP; Chandler, D				Hedges, Lester O.; Jack, Robert L.; Garrahan, Juan P.; Chandler, David			Dynamic Order-Disorder in Atomistic Models of Structural Glass Formers	SCIENCE			English	Article							SPATIALLY HETEROGENEOUS DYNAMICS; SUPERCOOLED LIQUIDS; TRANSITION; RELAXATION	The glass transition is the freezing of a liquid into a solid state without evident structural order. Although glassy materials are well characterized experimentally, the existence of a phase transition into the glass state remains controversial. Here, we present numerical evidence for the existence of a novel first-order dynamical phase transition in atomistic models of structural glass formers. In contrast to equilibrium phase transitions, which occur in configuration space, this transition occurs in trajectory space, and it is controlled by variables that drive the system out of equilibrium. Coexistence is established between an ergodic phase with finite relaxation time and a nonergodic phase of immobile molecular configurations. Thus, we connect the glass transition to a true phase transition, offering the possibility of a unified picture of glassy phenomena.	[Hedges, Lester O.; Jack, Robert L.; Chandler, David] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Garrahan, Juan P.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Jack, Robert L.] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England	University of California System; University of California Berkeley; University of Nottingham; University of Bath	Chandler, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chandler@cchem.berkeley.edu	Jack, Robert/M-4096-2014	Garrahan, Juan/0000-0002-0185-3924; Hedges, Lester/0000-0002-5624-0500	NSF [CHE-0543158, CHE-0626305]; U.S. Office of Naval Research [N00014-07-1-0689]; Engineering and Physical Sciences Research Council [GR/S54074/01]	NSF(National Science Foundation (NSF)); U.S. Office of Naval Research(Office of Naval Research); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	During the course of this work we have benefited from discussions with T. F. Miller III and F. van Wijland. The work was made possible through grants from the NSF (CHE-0543158 in the early stages for R.J. and D.C. and CHE-0626305 in the later stages for L.H. and D.C.), from the U.S. Office of Naval Research (N00014-07-1-0689 in the late stages for R.J.), and from the Engineering and Physical Sciences Research Council (GR/S54074/01 for J.P.G.).	Appignanesi GA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057801; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; BORGS C, 1992, PHYS REV LETT, V68, P1738, DOI 10.1103/PhysRevLett.68.1738; Bouchaud JP, 2004, J CHEM PHYS, V121, P7347, DOI 10.1063/1.1796231; Chandler D., 1987, INTRO MODERN STAT ME; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Doliwa B, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031506; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; Garrahan JP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195702; Glotzer SC, 2000, J NON-CRYST SOLIDS, V274, P342, DOI 10.1016/S0022-3093(00)00225-8; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; HANSEN JP, 2006, THEOYR SIMPLE LIQUID; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Jack RL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2374885; KIRKPATRICK TR, 1989, PHYS REV A, V40, P1045, DOI 10.1103/PhysRevA.40.1045; KIVELSON D, 1995, PHYSICA A, V219, P27, DOI 10.1016/0378-4371(95)00140-3; KOB W, 1994, PHYS REV LETT, V73, P1376, DOI 10.1103/PhysRevLett.73.1376; Landau D.P., 2000, GUIDE MONTE CARLO SI; Lecomte V, 2007, J STAT PHYS, V127, P51, DOI 10.1007/s10955-006-9254-0; Merolle M, 2005, P NATL ACAD SCI USA, V102, P10837, DOI 10.1073/pnas.0504820102; NAKANISHI H, 1982, PHYS REV LETT, V49, P1565, DOI 10.1103/PhysRevLett.49.1565; Reichman DR, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05013; Ritort F, 2003, ADV PHYS, V52, P219, DOI 10.1080/0001873031000093582; SCHMIDT-ROHR K, 1991, PHYS REV LETT, V66, P3020, DOI 10.1103/PhysRevLett.66.3020; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	28	306	307	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1309	1313		10.1126/science.1166665	http://dx.doi.org/10.1126/science.1166665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19197025				2022-12-28	WOS:000263876700033
J	Maki, DG				Maki, Dennis G.			Coming to Grips with Foodborne Infection - Peanut Butter, Peppers, and Nationwide Salmonella Outbreaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Maki, Dennis G.] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Centers for Disease Control and Prevention (CDC), 2008, INV OUTBR INF CAUS S; Centers for Disease Control and Prevention (CDC), 2009, INV UPD OUTBR SALM T; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Maki DG, 2006, NEW ENGL J MED, V355, P1952, DOI 10.1056/NEJMp068225; Osterholm MT, 2004, NEW ENGL J MED, V350, P1898, DOI 10.1056/NEJMsb032657	5	48	48	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					949	953		10.1056/NEJMp0806575	http://dx.doi.org/10.1056/NEJMp0806575			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19213675	Bronze			2022-12-28	WOS:000263824500001
J	Bokov, K; Steinberg, SV				Bokov, Konstantin; Steinberg, Sergey V.			A hierarchical model for evolution of 23S ribosomal RNA	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; ANGSTROM RESOLUTION; BOND FORMATION; SUBUNIT; BASE; SITE; ORIGIN	The emergence of the ribosome constituted a pivotal step in the evolution of life. This event happened nearly four billion years ago, and any traces of early stages of ribosome evolution are generally thought to have completely eroded away. Surprisingly, a detailed analysis of the structure of the modern ribosome reveals a concerted and modular scheme of its early evolution.	[Bokov, Konstantin; Steinberg, Sergey V.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Steinberg, SV (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	serguei.chteinberg@umontreal.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank L. Brakier-Gingras, A. Mankin, S. Michnick and I. Ponomarenko for advice and comments. This work was supported by a grant from NSERC.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; STILLMAN B, 2001, RIBOSOME; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	25	153	159	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					977	980		10.1038/nature07749	http://dx.doi.org/10.1038/nature07749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225518				2022-12-28	WOS:000263425400035
J	Vlasselaers, D; Milants, I; Desmet, L; Wouters, PJ; Vanhorebeek, I; van den Heuvel, I; Mesotten, D; Casaer, MP; Meyfroidt, G; Ingels, C; Muller, J; Van Cromphaut, S; Schetz, M; Van den Berghe, G				Vlasselaers, Dirk; Milants, Ilse; Desmet, Lars; Wouters, Pieter J.; Vanhorebeek, Ilse; van den Heuvel, Ingeborg; Mesotten, Dieter; Casaer, Michael P.; Meyfroidt, Geert; Ingels, Catherine; Muller, Jan; Van Cromphaut, Sophie; Schetz, Miet; Van den Berghe, Greet			Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study	LANCET			English	Article							CRITICALLY-ILL PATIENTS; BLOOD-GLUCOSE CONTROL; CRITICAL ILLNESS; STRESS HYPERGLYCEMIA; HYPOGLYCEMIA; CHILDREN; DEATH; CONSEQUENCES; SURGERY; IMPACT	Background Critically ill infants and children often develop hyperglycaemia, which is associated with adverse outcome; however, whether lowering blood glucose concentrations to age-adjusted normal fasting values improves outcome is unknown. We investigated the effect of targeting age-adjusted normoglycaemia with insulin infusion in critically ill infants and children on outcome. Methods In a prospective, randomised controlled study, we enrolled 700 critically ill patients, 317 infants (aged <1 year) and 383 children (aged >= 1 year), who were admitted to the paediatric intensive care unit (PICU) of the University Hospital of Leuven, Belgium. Patients were randomly assigned by blinded envelopes to target blood glucose concentrations of 2.8-4.4 mmol/L in infants and 3.9-5.6 mmol/L in children with insulin infusion throughout PICU stay (intensive group [n=349]), or to insulin infusion only to prevent blood glucose from exceeding 11 . 9 mmol/L (conventional group [n=351]). Patients and laboratory staff were blinded to treatment allocation. Primary endpoints were duration of PICU stay and inflammation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00214916. Findings Mean blood glucose concentrations were lower in the intensive group than in the conventional group (infants: 4.8 [SD 1. 2] mmol/L vs 6.4 [1.2] mmol/L, p<0.0001; children: 5.3 [1 . 1] mmol/L vs 8.2 [3.3] mmol/L, p<0.0001). Hypoglycaemia (defined as blood glucose <= 2.2 mmol/L) occurred in 87 (25%) patients in the intensive group (p<0 . 0001) versus five (1%) patients in the conventional group; hypoglycaemia defined as blood glucose less than 1. 7 mmol/L arose in 17 (5%) patients versus three (1%) (p=0 . 001). Duration of PICU stay was shortest in the intensively treated group (5.51 days [95% Cl 4.65-6.37] vs 6.15 days [5.25-7.05], p=0.017). The inflammatory response was attenuated at day 5, as indicated by lower C-reactive protein in the intensive group compared with baseline (-9 . 75 mg/L [95% Cl -19 . 93 to 0 . 43] vs 8 . 97 mg/L [-0 . 9 to 18.84], p=0. 007). The number of patients with extended (>rnedian) stay in PICU was 132 (38%) in the intensive group versus 165 (47%) in the conventional group (p=0.013). Nine (3%) patients died in the intensively treated group versus 20 (6%) in the conventional group (p=0 . 038). Interpretation Targeting of blood glucose concentrations to age-adjusted normal fasting concentrations improved short-term outcome of patients in PICU. The effect on long-term survival, morbidity, and neurocognitive development needs to be investigated. Funding Research Foundation (Belgium); Research Fund of the University of Leuven (Belgium) and the EU Information Society Technologies Integrated project "CLINICIP"; and Institute for Science and Technology (Belgium).	[Vlasselaers, Dirk; Milants, Ilse; Desmet, Lars; Wouters, Pieter J.; Vanhorebeek, Ilse; van den Heuvel, Ingeborg; Mesotten, Dieter; Casaer, Michael P.; Meyfroidt, Geert; Ingels, Catherine; Muller, Jan; Van Cromphaut, Sophie; Schetz, Miet; Van den Berghe, Greet] Catholic Univ Louvain, Dept Intens Care Med, Paediat Intens Care Unit, B-3000 Louvain, Belgium	Universite Catholique Louvain	Van den Berghe, G (corresponding author), Catholic Univ Louvain, Dept Intens Care Med, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium.	greet.vandenberghe@med.kuleuven.be	Van den Berghe, Greet/J-6788-2018; Mesotten, Dieter/ABE-4176-2020; Casaer, Michael/Y-7131-2019	Van den Berghe, Greet/0000-0002-5320-1362; Mesotten, Dieter/0000-0002-3258-4720; Casaer, Michael/0000-0002-7087-0795; Vanhorebeek, Ilse/0000-0002-5261-5192; Meyfroidt, Geert/0000-0003-4259-3935	Research Foundation-Flanders, Belgium (FWO) [G.0533.06]; Research Fund of the University of Leuven [OT/03/56, GOA/2007/14]; EU Information Society Technologies Integrated project "CLINICIP" [506965]; Institute for Science and Technology-Flanders, Belgium [IWT 070695]; Clinical Research Fund of the University Hospital Gasthuisberg; University of Leuven; Methusalern programme; Flemish Government	Research Foundation-Flanders, Belgium (FWO)(FWO); Research Fund of the University of Leuven; EU Information Society Technologies Integrated project "CLINICIP"(European Commission); Institute for Science and Technology-Flanders, Belgium; Clinical Research Fund of the University Hospital Gasthuisberg; University of Leuven(KU Leuven); Methusalern programme; Flemish Government(European Commission)	We thank the clinical fellows and the PICU nursing staff for excellent patient care and protocol compliance; Magaly Boussemaere, Nathalie Rubbens, Nele Nijs, and Mona Eerdekens for technical support; An Andries, Jenny Gielens, and Myriam Vandenbergh for secretarial help: and Peter Lauwers, Roger Bouillon, and Marc Van den Berghe for critical manuscript review. This research was fully supported by official research grants from the Research Foundation-Flanders, Belgium (FWO) (G.0533.06); the Research Fund of the University of Leuven (OT/03/56 and GOA/2007/14) and the EU Information Society Technologies Integrated project "CLINICIP" contract number 506965; and Institute for Science and Technology-Flanders, Belgium (IWT 070695). DV and GM are clinical PhD fellows and IV and SVC are post-doctoral fellows of the Research Foundation, Flanders, Belgium (FWO). DM is a post-doctoral fellow supported by the Clinical Research Fund of the University Hospital Gasthuisberg. GVdB, via the University of Leuven, receives structural research financing via the Methusalern programme, funded by the Flemish Government.	Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; BROWN TCK, 1980, AUST PAEDIATR J, V16, P28; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; Ellger B, 2006, DIABETES, V55, P1096, DOI 10.2337/diabetes.55.04.06.db05-1434; Ellger B, 2008, ENDOCRINOLOGY, V149, P3148, DOI 10.1210/en.2007-1558; Falcao G, 2008, PEDIATR CARDIOL, V29, P628, DOI 10.1007/s00246-007-9178-8; Falciglia M, 2007, CURR OPIN CLIN NUTR, V10, P498, DOI 10.1097/MCO.0b013e3281a3bf0a; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Genuth S, 2007, NEW ENGL J MED, V356, P1842; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Leteurtre S, 1999, MED DECIS MAKING, V19, P399, DOI 10.1177/0272989X9901900408; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; MEHTA N, 2006, PEDIAT CRITICAL CARE, P1069; PAGANA KD, 2003, MOSBYS DIAGNOSTIC LA, P457; Piper HG, 2006, PEDIATRICS, V118, P1176, DOI 10.1542/peds.2006-0347; Skillman HE, 2008, JPEN-PARENTER ENTER, V32, P520, DOI 10.1177/0148607108322398; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Su H, 2007, AM J PHYSIOL-ENDOC M, V293, pE629, DOI 10.1152/ajpendo.00221.2007; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Vriesendorp TM, 2006, CRIT CARE MED, V34, P2714, DOI 10.1097/01.CCM.0000241155.36689.91; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Yung M, 2008, PEDIATR CRIT CARE ME, V9, P147, DOI 10.1097/PCC.0b013e3181668c22	33	390	401	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					547	556		10.1016/S0140-6736(09)60044-1	http://dx.doi.org/10.1016/S0140-6736(09)60044-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19176240				2022-12-28	WOS:000263333600033
J	Kuhl, G; Briggs, DEG; Rust, J				Kuehl, Gabriele; Briggs, Derek E. G.; Rust, Jes			A Great-Appendage Arthropod with a Radial Mouth from the Lower Devonian Hunsruck Slate, Germany	SCIENCE			English	Article							BURGESS-SHALE; ANOMALOCARIS; PHYLOGENY; EVOLUTION; HEAD; MORPHOLOGY; HOMOLOGY; ORIGIN	Great- appendage arthropods, characterized by a highly modified anterior limb, were previously unknown after the Middle Cambrian. One fossil from the Lower Devonian Hunsruck Slate, Germany, extends the stratigraphic range of these arthropods by similar to 100 million years. Schinderhannes bartelsi shows an unusual combination of anomalocaridid and euarthropod characters, including a highly specialized swimming appendage. A cladistic analysis indicates that the new taxon is basal to crown- group euarthropods and that the great- appendage arthropods are paraphyletic. This new fossil shows that features of the anomalocaridids, including the multisegmented raptorial appendage and circular plated mouth, persisted long after the initial radiation of the euarthropods.	[Kuehl, Gabriele; Rust, Jes] Univ Bonn, Div Palaeontol, Steinmann Inst, D-53115 Bonn, Germany; [Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	University of Bonn; Yale University; Yale University	Kuhl, G (corresponding author), Univ Bonn, Div Palaeontol, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany.				German Science Foundation [PN RU 665/5-1]; Humboldt Foundation	German Science Foundation(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank the German Science Foundation (grant PN RU 665/5-1) and the Humboldt Foundation (Research Award to D.E.G.B.) for support; the Museum of Natural History in Mainz for access to the material; C. Bartels for information; G. Oleschinski for radiographs and photography; E. Groning for the reconstruction; and A. Maas, R. Willmann, G. D. Edgecombe, and two other reviewers for comments.	[Anonymous], 2002, METALLA; BARTELS C, 1998, FOSSILS HONSRUCK SLA; Bitsch J, 2007, ACTA ZOOL-STOCKHOLM, V88, P317, DOI 10.1111/j.1463-6395.2007.00284.x; BRIGGS DEG, 1979, PALAEONTOLOGY, V22, P77; Budd G.E., 1998, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; BUTTERFIELD NJ, 1995, LETHAIA, V28, P1, DOI 10.1111/j.1502-3931.1995.tb01587.x; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Dunlop JA, 2006, ACTA ZOOLOGICA BUL S, P9; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Kuhl G, 2008, PALAEONTOGR ABT A, V286, P123; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2223, DOI 10.1098/rspb.2007.0712; VAN ROY P., 2006, THESIS U GHENT GHENT; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Waloszek D, 2007, PALAEOGEOGR PALAEOCL, V254, P273, DOI 10.1016/j.palaeo.2007.03.027; Whittington H.B., 1971, Bull geol Surv Can, VNo. 209, P1; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	26	84	89	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					771	773		10.1126/science.1166586	http://dx.doi.org/10.1126/science.1166586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197061				2022-12-28	WOS:000263066800043
J	Chlebowski, RT; Kuller, LH; Prentice, RL; Stefanick, ML; Manson, JE; Gass, M; Aragaki, AK; Ockene, JK; Lane, DS; Sarto, GE; Rajkovic, A; Schenken, R; Hendrix, SL; Ravdin, PM; Rohan, TE; Yasmeen, S; Anderson, G				Chlebowski, Rowan T.; Kuller, Lewis H.; Prentice, Ross L.; Stefanick, Marcia L.; Manson, Joann E.; Gass, Margery; Aragaki, Aaron K.; Ockene, Judith K.; Lane, Dorothy S.; Sarto, Gloria E.; Rajkovic, Aleksandar; Schenken, Robert; Hendrix, Susan L.; Ravdin, Peter M.; Rohan, Thomas E.; Yasmeen, Shagufta; Anderson, Garnet		WHI Investigators	Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HORMONE-THERAPY; RECENT TRENDS; GROWTH-RATE; MAMMOGRAPHY; DECREASE; DECLINE; BENEFITS; TRIAL; RISKS; RATES	Background Following the release of the 2002 report of the Women's Health Initiative ( WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause- and- effect relation between hormone treatment and breast cancer. However, the cause of this decrease remains controversial. Methods We analyzed the results of the WHI randomized clinical trial - in which one study group received 0.625 mg of conjugated equine estrogens plus 2.5 mg of medroxyprogesterone acetate daily and another group received placebo - and examined temporal trends in breast- cancer diagnoses in the WHI observational- study cohort. Risk factors for breast cancer, frequency of mammography, and time- specific incidence of breast cancer were assessed in relation to combined hormone use. Results In the clinical trial, there were fewer breast- cancer diagnoses in the group receiving estrogen plus progestin than in the placebo group in the initial 2 years of the study, but the number of diagnoses increased over the course of the 5.6- year intervention period. The elevated risk decreased rapidly after both groups stopped taking the study pills, despite a similar frequency of mammography. In the observational study, the incidence of breast cancer was initially about two times as high in the group receiving menopausal hormones as in the placebo group, but this difference in incidence decreased rapidly in about 2 years, coinciding with year- to- year reductions in combined hormone use. During this period, differences in the frequency of mammography between the two groups were unchanged. Conclusions The increased risk of breast cancer associated with the use of estrogen plus progestin declined markedly soon after discontinuation of combined hormone therapy and was unrelated to changes in frequency of mammography.	[Chlebowski, Rowan T.] Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Prentice, Ross L.; Aragaki, Aaron K.; Anderson, Garnet] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Stefanick, Marcia L.] Stanford Ctr Res Dis Prevent, Stanford, CA USA; [Manson, Joann E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Manson, Joann E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gass, Margery] Univ Cincinnati, Cincinnati, OH USA; [Ockene, Judith K.] Univ Massachusetts, Fallon Clin, Worcester, MA 01605 USA; [Lane, Dorothy S.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Sarto, Gloria E.] Univ Wisconsin, Madison, WI USA; [Rajkovic, Aleksandar] Baylor Coll Med, Houston, TX 77030 USA; [Schenken, Robert] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA; [Hendrix, Susan L.] Wayne State Univ, Sch Med, Detroit, MI USA; [Hendrix, Susan L.] Hutzel Hosp, Detroit, MI 48201 USA; [Ravdin, Peter M.] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rohan, Thomas E.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Yasmeen, Shagufta] Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; Wayne State University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Davis	Chlebowski, RT (corresponding author), Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Los Angeles Biomed Res Inst, 1124 W Carson St, Torrance, CA 90502 USA.	rchlebowski@gmail.com	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Caan, Bette/0000-0002-5803-310X; Anderson, Garnet/0000-0001-5087-7837	National Heart, Lung, and Blood Institute [N01WH22110, N01WH24152, N01WH32100-2, N01WH32105-6, N01WH32108-9, N01WH32111-13, N01WH32115, N01WH32118-32119, N01WH32122, N01WH42107-26, N01WH42129-32, N01WH44221]; AstraZeneca; Novartis; Pfizer; Eli Lilly; Wyeth Pharmaceuticals; Abraxis; Organon; Upsher-Smith Laboratories; Procter Gamble; Meditrina Pharmaceuticals; Merck; Boehringer Ingelheim; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [N01WH32100, N01WH32118] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032122, N01WH032115, N01WH032100, N01WH042129, N01WH032111, N01WH022110, N01WH032105, N01WH032108, N01WH042107, N01WH032118] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Wyeth Pharmaceuticals(Wyeth); Abraxis; Organon; Upsher-Smith Laboratories(Randox Laboratories); Procter Gamble(Procter & Gamble); Meditrina Pharmaceuticals; Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grants from the National Heart, Lung, and Blood Institute ( N01WH22110, N01WH24152, N01WH32100-2, N01WH32105-6, N01WH32108-9, N01WH32111-13, N01WH32115, N01WH32118-32119, N01WH32122, N01WH42107- 26, N01WH42129-32, and N01WH44221). Dr. Chlebowski reports receiving consulting fees from AstraZeneca, Novartis, Pfizer, Eli Lilly, and Wyeth Pharmaceuticals, lecture fees from AstraZeneca, Novartis, and Abraxis, and grant support from Amgen, Eli Lilly, and Organon. Dr. Gass reports receiving consulting fees from Upsher-Smith Laboratories, Wyeth Pharmaceuticals, and Procter & Gamble and funding for multisite clinical trials from Procter & Gamble and Wyeth Pharmaceuticals. Dr. Rohan reports receiving consulting fees from legal firms regarding hormone- therapy issues. Dr. Hendrix reports receiving consulting fees from Meditrina Pharmaceuticals, lecture fees from Merck, and grant support from Boehringer Ingelheim and Organon. No other potential conflict of interest relevant to this article was reported.	Allemand H, 2008, B CANCER, V95, P11, DOI 10.1684/bdc.2008.0556; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; [Anonymous], 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Canfell K, 2008, MED J AUSTRALIA, V188, P641, DOI 10.5694/j.1326-5377.2008.tb01821.x; Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Haller DG, 2006, J CLIN ONCOL, V24, p149S; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Katalinic A, 2008, BREAST CANCER RES TR, V107, P427, DOI 10.1007/s10549-007-9566-z; Kerlikowske, 2007, JNCI-J NATL CANCER I, V99, P1493, DOI 10.1093/jnci/djm172; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; MacMahon B, 2008, EPIDEMIOLOGY, V19, P268, DOI 10.1097/EDE.0b013e31816334f5; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; *NAT CTR HLTH STAT, 2006, DHHS NATL CTR HLTH S; Ockene JK, 2005, JAMA-J AM MED ASSOC, V294, P183, DOI 10.1001/jama.294.2.183; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Rao Vijay M, 2008, J Am Coll Radiol, V5, P652, DOI 10.1016/j.jacr.2008.01.023; Ravdin PM, 2007, NEW ENGL J MED, V357, P513; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Robbins AS, 2007, J CLIN ONCOL, V25, P3437, DOI 10.1200/JCO.2007.11.4132; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ryerson AB, 2008, PREV MED, V47, P477, DOI 10.1016/j.ypmed.2008.06.010; Tilanus-Linthorst MMA, 2005, EUR J CANCER, V41, P1610, DOI 10.1016/j.ejca.2005.02.034; Vaidya JS, 2008, J NATL CANCER I, V100, P598, DOI 10.1093/jnci/djn080; Yasmeen S, 2003, JNCI-J NATL CANCER I, V95, P429, DOI 10.1093/jnci/95.6.429; Zahl PH, 2007, NEW ENGL J MED, V357, P510	35	328	334	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					573	587		10.1056/NEJMoa0807684	http://dx.doi.org/10.1056/NEJMoa0807684			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196674	Green Accepted			2022-12-28	WOS:000263028800004
J	Kesselheim, AS; Studdert, DM				Kesselheim, Aaron S.; Studdert, David M.			The Supreme Court, Preemption, and Malpractice Liability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017; Studdert, David/AAF-3116-2021	Kesselheim, Aaron/0000-0002-8867-2666; Studdert, David/0000-0003-0585-5537				*FOOD DRUG ADM, 2006, FED REGISTER, V71, P3936; National Practitioner Data Bank, PUBL US DAT FIL; Studdert D. M., 2007, J EMPIR LEGAL STUD, V4, P103	3	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					559	561		10.1056/NEJMp0809403	http://dx.doi.org/10.1056/NEJMp0809403			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402QS	19196672				2022-12-28	WOS:000263028800002
J	Jack, BW; Chetty, VK; Anthony, D; Greenwald, JL; Sanchez, GM; Johnson, AE; Forsythe, SR; O'Donnell, JK; Paasche-Orlow, MK; Manasseh, C; Martin, S; Culpepper, L				Jack, Brian W.; Chetty, Veerappa K.; Anthony, David; Greenwald, Jeffrey L.; Sanchez, Gail M.; Johnson, Anna E.; Forsythe, Shaula R.; O'Donnell, Julie K.; Paasche-Orlow, Michael K.; Manasseh, Christopher; Martin, Stephen; Culpepper, Larry			A Reengineered Hospital Discharge Program to Decrease Rehospitalization A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENTS AFTER-DISCHARGE; ADVERSE EVENTS; HEALTH LITERACY; PATIENT SAFETY; FOLLOW-UP; CARE; INTERVENTION; CONTINUITY; INPATIENT; SEVERITY	Background: Emergency department visits and rehospitalization are common after hospital discharge. Objective: To test the effects of an intervention designed to minimize hospital utilization after discharge. Design: Randomized trial using block randomization of 6 and 8. Randomly arranged index cards were placed in opaque envelopes labeled consecutively with study numbers, and participants were assigned a study group by revealing the index card. Setting: General medical service at an urban, academic, safety-net hospital. Patients: 749 English-speaking hospitalized adults (mean age, 49.9 years). Intervention: A nurse discharge advocate worked with patients during their hospital stay to arrange follow-up appointments, confirm medication reconciliation, and conduct patient education with an individualized instruction booklet that was sent to their primary care provider. A clinical pharmacist called patients 2 to 4 days after discharge to reinforce the discharge plan and review medications. Participants and providers were not blinded to treatment assignment. Measurements: Primary outcomes were emergency department visits and hospitalizations within 30 days of discharge. Secondary outcomes were self-reported preparedness for discharge and frequency of primary care providers' follow-up within 30 days of discharge. Research staff doing follow-up were blinded to study group assignment. Results: Participants in the intervention group (n = 370) had a lower rate of hospital utilization than those receiving usual care (n = 368) (0.314 vs. 0.451 visit per person per month; incidence rate ratio, 0.695 [95% CI, 0.515 to 0.937]; P = 0.009). The intervention was most effective among participants with hospital utilization in the 6 months before index admission (P = 0.014). Adverse events were not assessed; these data were collected but are still being analyzed. Limitation: This was a single-center study in which not all potentially eligible patients could be enrolled, and outcome assessment sometimes relied on participant report. Conclusion: A package of discharge services reduced hospital utilization within 30 days of discharge.	[Jack, Brian W.] Boston Univ, Sch Med, Dept Family Med, Boston Med Ctr, Boston, MA 02118 USA; Brown Univ, Alpert Med Sch, Pawtucket, RI USA	Boston Medical Center; Boston University; Brown University	Jack, BW (corresponding author), Boston Univ, Sch Med, Dept Family Med, Boston Med Ctr, 1 BMC Pl,Dowling 5 S, Boston, MA 02118 USA.	brian.jack@bmc.org	Paasche-Orlow, Michael/ABF-7919-2020; Martin, Stephen A/L-9381-2013	Paasche-Orlow, Michael/0000-0002-9276-7190; Martin, Stephen A/0000-0002-0356-5440; Culpepper, Larry/0000-0002-7655-0477; Manasseh, Christopher/0000-0001-5736-6589; Chetty, Veerappa/0000-0002-2640-3874; Jack, Brian/0000-0002-6497-2437	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; National Institutes of Health; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS015905, UC1HS014289] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081307] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute, National Institutes of Health.	Al-Rashed SA, 2002, BRIT J CLIN PHARMACO, V54, P657, DOI 10.1046/j.1365-2125.2002.01707.x; Andersen HE, 2000, STROKE, V31, P1038, DOI 10.1161/01.STR.31.5.1038; Anderson Cheryl, 2005, Congest Heart Fail, V11, P315, DOI 10.1111/j.1527-5299.2005.04458.x; Anthony D., 2005, ADV PATIENT SAFETY R; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Balaban RB, 2008, J GEN INTERN MED, V23, P1228, DOI 10.1007/s11606-008-0618-9; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Bula CJ, 2001, ARCH INTERN MED, V161, P2609, DOI 10.1001/archinte.161.21.2609; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Davis T C, 1993, Fam Med, V25, P391; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; EVANS RL, 1993, MED CARE, V31, P358, DOI 10.1097/00005650-199304000-00007; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Greenwald JL., 2007, J PATIENT SAF, V3, P97, DOI 10.1097/01.jps.0000236916.94696.12; Holland R, 2005, BMJ-BRIT MED J, V330, P293, DOI 10.1136/bmj.38338.674583.AE; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; LEVIT K, 2005, HCUP FACTS FIGURES S; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; MARQUIS KH, 1976, MED CARE, V14, P913, DOI 10.1097/00005650-197611000-00002; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; *NAT QUAL FOR, NAT QUAL FOR END CON; National Quality Forum (NQF), 2007, SAF PRACT BETT HEALT; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor M D, 1993, Image J Nurs Sch, V25, P73; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; PAASCHE O, 2007, MED MANAGEMENT VULNE, P101; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Siu AL, 1996, ARCH INTERN MED, V156, P76, DOI 10.1001/archinte.156.1.76; Therneau TM, 2000, MODELING SURVIVAL DA; Tsilimingras D, 2008, JT COMM J QUAL PATIE, V34, P85, DOI 10.1016/S1553-7250(08)34011-2; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; Wachter RM, 2004, NEW ENGL J MED, V350, P1935, DOI 10.1056/NEJMp038201; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	49	1069	1086	2	129	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2009	150	3					178	+		10.7326/0003-4819-150-3-200902030-00007	http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402RA	19189907	Green Accepted			2022-12-28	WOS:000263029600004
J	Oeffinger, KC; Ford, JS; Moskowitz, CS; Diller, LR; Hudson, MM; Chou, JF; Smith, SM; Mertens, AC; Henderson, TO; Friedman, DL; Leisenring, WM; Robison, LL				Oeffinger, Kevin C.; Ford, Jennifer S.; Moskowitz, Chaya S.; Diller, Lisa R.; Hudson, Melissa M.; Chou, Joanne F.; Smith, Stephanie M.; Mertens, Ann C.; Henderson, Tara O.; Friedman, Debra L.; Leisenring, Wendy M.; Robison, Leslie L.			Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH BELIEF MODEL; LONG-TERM SURVIVORS; HODGKINS-DISEASE; YOUNG-WOMEN; SCREENING PRACTICES; OVARIAN-CANCER; UNITED-STATES; SUPRADIAPHRAGMATIC RADIATION; FEMALE SURVIVORS; ADULT SURVIVORS	Context Women treated with chest radiation for a pediatric malignancy have a significantly increased risk of breast cancer at a young age and are recommended to have an annual screening mammogram starting at age 25 years or 8 years after radiation, whichever occurs last. Objective To characterize the breast cancer surveillance practices among female pediatric cancer survivors who were treated with chest radiation and identify correlates of screening. Design, Setting, and Participants Between June 2005 and August 2006, a 114-item questionnaire was administered to a random sample of 625 women aged 25 through 50 years who had survived pediatric cancer, who had been treated with chest radiation, and who were participating in the Childhood Cancer Survivor Study (CCSS), a North American cohort of long- term survivors diagnosed from 1970- 1986. Comparisons were made with similarly aged pediatric cancer survivors not treated with chest radiation ( n= 639) and the CCSS siblings cohort ( n= 712). Main Outcome Measure Screening mammogram within the previous 2 years. Results Of 1976 cancer survivors and siblings who were contacted, 87.9% participated. Among the 551 women with a history of chest radiation, 55% reported a screening mammogram in the past 2 years (ages 25- 39 years, 36.5%; 95% confidence interval [ CI], 31.0%-42.0%; ages 40- 50 years, 76.5%; 95% CI, 71.3%- 81.7%). In comparison, 40.5% of survivors without chest radiation and 37.0% of CCSS siblings reported a screening mammogram in the same time interval. Notably, among women with a history of chest radiation, 47.3% ( 95% CI; 41.6%- 53.0%) of those younger than 40 years had never had a mammogram and only 52.6% ( 95% CI; 46.4%- 58.8%) of women aged 40 through 50 years were being regularly screened ( 2 mammograms within 4 years). Screening rates were higher among women who reported a physician recommendation than those who did not ( ages 25- 39 years, 76.0% vs 17.6%; ages 40- 50 years, 87.3% vs 58.3%). In multivariate models, the association was particularly strong for younger women( ages25- 39 years, prevalence ratio [ PR], 3.0; 95% CI, 2.0- 4.0; ages 40- 50 years, PR, 1.3; 95% CI, 1.1- 1.6). Conclusions In this cohort of women who had childhood cancer treated with chest radiation, 63.5% of those aged 25 through 39 years and 23.5% of those aged 40 through 50 years had not had mammography screening for breast cancer within the previous 2 years despite a guideline recommendation that survivors of childhood cancer who were treated with chest radiation should undergo annual screening mammography.	[Oeffinger, Kevin C.; Ford, Jennifer S.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Ford, Jennifer S.] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA; [Moskowitz, Chaya S.; Chou, Joanne F.; Smith, Stephanie M.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Diller, Lisa R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hudson, Melissa M.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Hudson, Melissa M.; Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Mertens, Ann C.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Henderson, Tara O.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Friedman, Debra L.] Vanderbilt Ingram Canc Ctr, Dept Pediat, Nashville, TN USA; [Leisenring, Wendy M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Leisenring, Wendy M.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98104 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Emory University; University of Chicago; Vanderbilt University; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Oeffinger, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	oeffingk@mskcc.org	Hudson, Melissa M/N-4441-2018; Robison, Leslie/N-8122-2018	Hudson, Melissa M/0000-0001-6984-2407; Smith, Stephanie/0000-0002-3369-7516	NCI NIH HHS [R21 CA106972-02, U24 CA055727-07, U24 CA055727-10, U24 CA055727-09, R21 CA106972, U24 CA055727-11S1, U24-CA-55727, U24 CA055727-08, R21 CA106972-01, U24 CA055727-11, U24 CA055727-14, R21-CA-106972, U24 CA055727, U24 CA055727-11S2, U24 CA055727-12A1, U24 CA055727-13, U24 CA055727-06A1, R21 CA106972-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA055727, R21CA106972] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Absolom K, 2007, BREAST, V16, P590, DOI 10.1016/j.breast.2007.05.001; Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2; [Anonymous], 2006, SEER CANC STAT REV 1; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bloom JR, 2006, AM J CLIN ONCOL-CANC, V29, P258, DOI 10.1097/01.coc.0000209447.63640.5a; *CDCP, 2006, BEH RISK FACT SURV S; Children's Oncology Group, LONG TERM FOLL UP GU; Coughlin SS, 2004, CANCER CAUSE CONTROL, V15, P159, DOI 10.1023/B:CACO.0000019496.30145.62; CUMMINGS KM, 1978, HEALTH EDUC QUART, V6, P394, DOI 10.1177/109019818700600406; Cutuli B, 2001, RADIOTHER ONCOL, V59, P247, DOI 10.1016/S0167-8140(01)00337-1; DEGONZALEZ AB, J NATL CANC IN PRESS; Diller L, 2002, J CLIN ONCOL, V20, P2085, DOI 10.1200/JCO.2002.08.031; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Isaacs C, 2002, BREAST CANCER RES TR, V71, P103, DOI 10.1023/A:1013800409238; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; KING ES, 1990, AM J PUBLIC HEALTH, V80, P1386, DOI 10.2105/AJPH.80.11.1386; Kwong A, 2008, BREAST J, V14, P39, DOI 10.1111/j.1524-4741.2007.00524.x; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lee L, 2008, ANN ONCOL, V19, P62, DOI 10.1093/annonc/mdm440; Meissner HI, 2007, CANCER CAUSE CONTROL, V18, P61, DOI 10.1007/s10552-006-0078-7; Mertens AC, 2004, J CLIN EPIDEMIOL, V57, P933, DOI 10.1016/j.jclinepi.2004.01.005; Metayer C, 2000, J CLIN ONCOL, V18, P2435, DOI 10.1200/JCO.2000.18.12.2435; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Oeffinger KC, 2004, ANN FAM MED, V2, P61, DOI 10.1370/afm.26; Oeffinger KC, 2007, JAMA-J AM MED ASSOC, V297, P2762, DOI 10.1001/jama.297.24.2762; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Rakowski W, 1997, HEALTH PSYCHOL, V16, P433, DOI 10.1037/0278-6133.16.5.433; RAKOWSKI W, 1992, HEALTH PSYCHOL, V11, P111, DOI 10.1037/0278-6133.11.2.111; Rakowski W, 1997, PREV MED, V26, P664, DOI 10.1006/pmed.1997.0188; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; ROSENSTOCK IM, 1985, DIABETES CARE, V8, P610, DOI 10.2337/diacare.8.6.610; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sabatino SA, 2006, J GEN INTERN MED, V21, P285, DOI 10.1111/j.1525-1497.2006.00348.x; Sabatino SA, 2008, MED CARE, V46, P692, DOI 10.1097/MLR.0b013e31817893b1; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Simone J.V., 2003, CHILDHOOD CANC SURVI; Simone JV, 2001, J CLIN ONCOL, V19, P3161, DOI 10.1200/JCO.2001.19.13.3161; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Taylor AJ, 2007, INT J CANCER, V120, P384, DOI 10.1002/ijc.22261; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1428, DOI 10.1093/jnci/dji290; *US FDA, UPD TRENDS MAMM DOS; Vernon Sally W., 1999, Journal of the National Cancer Institute Monographs, P101; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Wolden SL, 1998, J CLIN ONCOL, V16, P536, DOI 10.1200/JCO.1998.16.2.536; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; Wu HY, 2007, BREAST CANCER RES TR, V101, P317, DOI 10.1007/s10549-006-9298-5; YAHALOM J, 1992, J CLIN ONCOL, V10, P1674, DOI 10.1200/JCO.1992.10.11.1674; Yeazel MW, 2004, CANCER-AM CANCER SOC, V100, P631, DOI 10.1002/cncr.20008; Young KC, 2005, BRIT J RADIOL, V78, P207, DOI 10.1259/bjr/41095952; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	58	93	93	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					404	414		10.1001/jama.2008.1039	http://dx.doi.org/10.1001/jama.2008.1039			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399CE	19176442	Green Accepted, Bronze			2022-12-28	WOS:000262777200020
J	Miles, SH; Freedman, AM				Miles, Steven H.; Freedman, Alfred M.			Medical ethics and torture: revising the Declaration of Tokyo	LANCET			English	Editorial Material									[Miles, Steven H.] Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA; [Freedman, Alfred M.] New York Med Coll, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; New York Medical College	Miles, SH (corresponding author), Univ Minnesota, Ctr Bioeth, 410 Church St, Minneapolis, MN 55455 USA.	miles001@umn.edu						*AM MED ASS, COD ETH E 2 067 TORT; *AM MED ASS COUNC, PHYS PART INT; *AM PSYCH ASS, PSYCH PART INT DET; American College of Physicians, ETH MAN; *AMN INT, DECL ROL HLTH PROF E; [Anonymous], 1995, NAZI DOCTORS NUREMBE; BLOCHE MG, 1986, JAMA-J AM MED ASSOC, V255, P2788, DOI 10.1001/jama.255.20.2788; Boyd JW, 2007, INT J HEALTH SERV, V37, P643, DOI 10.2190/HS.37.4.d; *BRIT MED ASS, MED PROF HUM RIGHTS; *COMM HUM RIGHTS, SCI HUM RIGHTS; DASSIN J, 1998, TORTURE BRAZIL, P37; *DEP DEF, 311509 DEP DEF; Hathaway OA, 2002, YALE LAW J, V111, P1935, DOI 10.2307/797642; Iacopino V, 1996, JAMA-J AM MED ASSOC, V276, P396, DOI 10.1001/jama.276.5.396; McLean G R, 2003, Dev World Bioeth, V3, P77, DOI 10.1111/1471-8847.00060; Miles S. M., 2006, OATH BETRAYED TORTUR; Miles Steven, 2007, US MILITARY MED WAR; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Reis C, 2004, JAMA-J AM MED ASSOC, V291, P1480, DOI 10.1001/jama.291.12.1480; Rejali D., 2007, TORTURE DEMOCRACY; *ROYAL COLL PHYS, RES COND PSYCH PART; STOVER E, 1985, BREAKING BODIES MIND; *UN, CONV TORT OTH CRUEL; *UN COMM HUM RIGHT, SIT DET GUANT BAY; United Nations, 1982, PRINC MED ETH REL RO; *WORLD MED ASS, DECL SUPP MED DOCT R; *WORLD MED ASS, STAT LIC PHYS FLEE P; *WORLD MED ASS, RES RESP PHYS DOC DE; *WORLD MED ASS, REG TIM ARM CONFL; World Medical Association, GUID MED DOCT TORT O; *WORLD PSYCH ASS, ETH STAND PSYCH PRAC	31	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					344	348		10.1016/S0140-6736(09)60097-0	http://dx.doi.org/10.1016/S0140-6736(09)60097-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167572				2022-12-28	WOS:000262728100030
J	Das, M; Sabio, G; Jiang, F; Rincon, M; Flavell, RA; Davis, RJ				Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Rincon, Mercedes; Flavell, Richard A.; Davis, Roger J.			Induction of Hepatitis by JNK-Mediated Expression of TNF-alpha	CELL			English	Article							TUMOR-NECROSIS-FACTOR; A-INDUCED HEPATITIS; SIGNAL-TRANSDUCTION PATHWAY; NECROTIC CELL-DEATH; CONCANAVALIN-A; IN-VIVO; LIVER-INJURY; INDUCED APOPTOSIS; INDUCED ACTIVATION; CRUCIAL ROLE	The c-Jun NH2-terminal kinase (JNK) signaling pathway has been implicated in the development of tumor necrosis factor (TNF)-dependent hepatitis. JNK may play a critical role in hepatocytes during TNF-stimulated cell death in vivo. To test this hypothesis, we examined the phenotype of mice with compound disruption of the Jnk1 and Jnk2 genes. Mice with loss of JNK1/2 expression in hepatocytes exhibited no defects in the development of hepatitis compared with control mice, whereas mice with loss of JNK1/2 in the hematopoietic compartment exhibited a profound defect in hepatitis that was associated with markedly reduced expression of TNF-alpha. These data indicate that JNK is required for TNF-alpha expression but not for TNF-alpha-stimulated death of hepatocytes. Indeed, TNF-alpha induced similar hepatic damage in both mice with hepatocyte-specific JNK1/2 deficiency and control mice. These observations confirm a role for JNK in the development of hepatitis but identify hematopoietic cells as the site of the essential function of JNK.	[Das, Madhumita; Sabio, Guadalupe; Jiang, Feng; Davis, Roger J.] Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; [Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Rincon, Mercedes] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Sabio, Guadalupe/H-9733-2015	Sabio, Guadalupe/0000-0002-2822-0625	NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA065861-14, R01 CA065861] Funding Source: Medline; NIAID NIH HHS [R01 AI051454] Funding Source: Medline; NIDDK NIH HHS [P30 DK 32520, P30 DK032520, P30 DK032520-26] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; EISSNER G, 1995, BLOOD, V86, P4184, DOI 10.1182/blood.V86.11.4184.bloodjournal86114184; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hatada S, 2005, CELL IMMUNOL, V233, P23, DOI 10.1016/j.cellimm.2005.03.003; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Louis H, 2002, GASTROENTEROLOGY, V122, P2001, DOI 10.1053/gast.2002.33620; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Morita A, 2003, HEPATOL RES, V27, P143, DOI 10.1016/S1386-6346(03)00206-7; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tagawa Y, 1998, EUR J IMMUNOL, V28, P4105, DOI 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.3.CO;2-#; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	69	109	111	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					249	260		10.1016/j.cell.2008.11.017	http://dx.doi.org/10.1016/j.cell.2008.11.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167327	Green Accepted, Bronze			2022-12-28	WOS:000262648800014
J	Biellik, RJ; Brown, DWG				Biellik, Robin J.; Brown, David W. G.			Measles mortality reduction in Africa	LANCET			English	Editorial Material							ORAL-FLUID		[Biellik, Robin J.] PATH, Immunizat Solut, F-01210 Ferney Voltaire, France; [Brown, David W. G.] Hlth Protect Agcy, Virus Reference Dept, London, England	Health Protection Agency	Biellik, RJ (corresponding author), PATH, Immunizat Solut, F-01210 Ferney Voltaire, France.	rbiellik@path.org						[Anonymous], 2007, WKLY EPIDEMIOL REC, V82, P418; Biellik R, 2002, LANCET, V359, P1564, DOI 10.1016/S0140-6736(02)08517-3; GURIS G, 2001, MODULE BEST PRACTICE; Kremer JR, 2005, CLIN DIAGN LAB IMMUN, V12, P668, DOI 10.1128/CDLI.12.5.668-670.2005; Lowther SA, 2009, LANCET, V373, P1025, DOI 10.1016/S0140-6736(09)60142-2; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; OHUMA EO, 2008, EPIDEMIOL INFECT, V10, P1; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; *WHO AFRO, 2008, REP 2 MEASL TECHN AD; 2008, WKLY EPIDEMIOL REC, V83, P229	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					984	985		10.1016/S0140-6736(09)60143-4	http://dx.doi.org/10.1016/S0140-6736(09)60143-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19211139				2022-12-28	WOS:000264398200006
J	Ahn, BY; Duoss, EB; Motala, MJ; Guo, XY; Park, SI; Xiong, YJ; Yoon, J; Nuzzo, RG; Rogers, JA; Lewis, JA				Ahn, Bok Y.; Duoss, Eric B.; Motala, Michael J.; Guo, Xiaoying; Park, Sang-Il; Xiong, Yujie; Yoon, Jongseung; Nuzzo, Ralph G.; Rogers, John A.; Lewis, Jennifer A.			Omnidirectional Printing of Flexible, Stretchable, and Spanning Silver Microelectrodes	SCIENCE			English	Article							PERIODIC STRUCTURES; ELECTRONICS; NANOPARTICLES; SILICON; FILM; INKS; CONDUCTIVITY; CIRCUITS; SOLAR; POWER	Flexible, stretchable, and spanning microelectrodes that carry signals from one circuit element to another are needed for many emerging forms of electronic and optoelectronic devices. We have patterned silver microelectrodes by omnidirectional printing of concentrated nanoparticle inks in both uniform and high-aspect ratio motifs with minimum widths of approximately 2 micrometers onto semiconductor, plastic, and glass substrates. The patterned microelectrodes can withstand repeated bending and stretching to large levels of strain with minimal degradation of their electrical properties. With this approach, wire bonding to fragile three-dimensional devices and spanning interconnects for solar cell and light-emitting diode arrays are demonstrated.	[Ahn, Bok Y.; Duoss, Eric B.; Motala, Michael J.; Guo, Xiaoying; Park, Sang-Il; Xiong, Yujie; Yoon, Jongseung; Nuzzo, Ralph G.; Rogers, John A.; Lewis, Jennifer A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Ahn, Bok Y.; Duoss, Eric B.; Guo, Xiaoying; Park, Sang-Il; Xiong, Yujie; Yoon, Jongseung; Rogers, John A.; Lewis, Jennifer A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Motala, Michael J.; Nuzzo, Ralph G.; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lewis, JA (corresponding author), Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.	jalewis@illinois.edu	GUO, XIAOYING/D-3140-2011; Lewis, Jennifer/HCH-4635-2022; Rogers, John/L-2798-2016; Xiong, Yujie/G-3203-2010; Duoss, Eric/AAW-3224-2021; huang, yonggang/O-6236-2019	Xiong, Yujie/0000-0002-1995-8257; Lewis, Jennifer/0000-0002-0280-2774; Duoss, Eric/0000-0002-5473-2528	U.S. Department of Energy, Materials Sciences and Engineering Division [DEFG-02-07ER46471]; Frederick Seitz Materials Research Laboratory (FSMRL) at the University of Illinois; Korean Research Foundation [postdoctoral fellowship]	U.S. Department of Energy, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Frederick Seitz Materials Research Laboratory (FSMRL) at the University of Illinois; Korean Research Foundation(National Research Foundation of Korea)	This material is based on work supported by the U.S. Department of Energy, Materials Sciences and Engineering Division under award no. DEFG-02-07ER46471, through the Frederick Seitz Materials Research Laboratory (FSMRL) at the University of Illinois. The authors gratefully acknowledge use of the FSMRL Central Facilities, including Center for Microanalysis of Materials. B.Y.A. thanks the Korean Research Foundation for the postdoctoral fellowship. We also thank C. Hansen, M. Xu, R. Shepherd, J. Bukowski, J. Carroll III, and J. Yoshikawa for useful discussions. J.A.L., B.Y.A., and E.B.D. submitted a U.S. patent application on this work entitled "Metal Nanoparticle Inks" on 3 October 2008.	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Ashley S, 2008, SCI AM, V299, P32, DOI 10.1038/scientificamerican0808-32; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879; Dobbelin M, 2007, CHEM MATER, V19, P2147, DOI 10.1021/cm070398z; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Harman G. G., 1997, WIRE BONDING MICROEL; Hosokawa M, 2007, NANOPARTICLE TECHNOL; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; LeMieux MC, 2008, SCIENCE, V321, P101, DOI 10.1126/science.1156588; Li Q, 2003, ADV MATER, V15, P1639, DOI 10.1002/adma.200305413; Li T, 2004, APPL PHYS LETT, V85, P3435, DOI 10.1063/1.1806275; Menard E, 2007, CHEM REV, V107, P1117, DOI 10.1021/cr050139y; Ouyang J, 2004, POLYMER, V45, P8443, DOI 10.1016/j.polymer.2004.10.001; Potyrallo RA, 2007, ANAL CHEM, V79, P45, DOI 10.1021/ac061748o; Pyatenko A, 2007, J PHYS CHEM C, V111, P7910, DOI 10.1021/jp071080x; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Ryu BH, 2005, COLLOID SURFACE A, V270, P345, DOI 10.1016/j.colsurfa.2005.09.005; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135; Subramanian V, 2005, P IEEE, V93, P1330, DOI 10.1109/JPROC.2005.850305; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Sun YG, 2007, ADV MATER, V19, P1897, DOI 10.1002/adma.200602223; van Osch THJ, 2008, ADV MATER, V20, P343, DOI 10.1002/adma.200701876; Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974; Yamamoto M, 2006, LANGMUIR, V22, P8581, DOI 10.1021/la0600245; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287	27	930	982	29	860	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1590	1593		10.1126/science.1168375	http://dx.doi.org/10.1126/science.1168375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19213878				2022-12-28	WOS:000264342300034
J	Gruer, L; Hart, CL; Gordon, DS; Watt, GCM				Gruer, Laurence; Hart, Carole L.; Gordon, David S.; Watt, Graham C. M.			Effect of tobacco smoking on survival of men and women by social position: a 28 year cohort study	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY HIGHER; RENFREW; PAISLEY; ENGLAND; WALES; DEPRIVATION; POPULATION; SCOTLAND; DISEASE; RISK	Objective To assess the impact of tobacco smoking on the survival of men and women in different social positions. Design A cohort observational study. Setting Renfrew and Paisley, two towns in west central Scotland. Participants 8353 women and 7049 men aged 45-64 years recruited in 1972-6 (almost 80% of the population in this age group). The cohort was divided into 24 groups by sex (male, female), smoking status (current, former, or never smokers), and social class (classes I + II, III non-manual, III manual, and IV + V) or deprivation category of place of residence. Main outcome measure Relative mortality (adjusted for age and other risk factors) in the different groups; Kaplan-Meier survival curves and survival rates at 28 years. Results Of those with complete data, 4387/7988 women and 4891/6967 men died over the 28 years. Compared with women in social classes I + II who had never smoked (the group with lowest mortality), the adjusted relative mortality of smoking groups ranged from 1.7 (95% confidence interval 1.3 to 2.3) to 4.2 (3.3 to 5.5). Former smokers' mortalities were closer to those of never smokers than those of smokers. By social class (highest first), age adjusted survival rates after 28 years were 65%, 57%, 53%, and 56% for female never smokers; 41%, 42%, 33%, and 35% for female current smokers; 53%, 47%, 38%, and 36% for male never smokers; and 24%, 24%, 19%, and 18% for male current smokers. Analysis by deprivation category gave similar results. Conclusions Among both women and men, never smokers had much better survival rates than smokers in all social positions. Smoking itself was a greater source of health inequality than social position and nullified women's survival advantage over men. This suggests the scope for reducing health inequalities related to social position in this and similar populations is limited unless many smokers in lower social positions stop smoking.	[Gruer, Laurence; Gordon, David S.] NHS Hlth Scotland, Glasgow G2 2AF, Lanark, Scotland; [Watt, Graham C. M.] Univ Glasgow, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland	University of Glasgow	Gruer, L (corresponding author), NHS Hlth Scotland, Glasgow G2 2AF, Lanark, Scotland.	Laurence.Gruer@health.scot.nhs.uk			NHS Health Scotland; King Edward Memorial Fund; Scottish Home and Health Department	NHS Health Scotland; King Edward Memorial Fund; Scottish Home and Health Department	LG and DSG are employees of NHS Health Scotland. CLH and GCMW are employees of the University of Glasgow. The analyses conducted by CLH were funded by NHS Health Scotland. The original Renfrew Paisley study was funded by the King Edward Memorial Fund and the Scottish Home and Health Department.	Carstairs V., 1991, DEPRIVATION HLTH SCO; *COMM SOC IN HLTH, 2007, ACH HLTH EQ ROOT CAU; *DEP HLTH, 2008, HLTH IN PROGR NEXT S; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fitzpatrick J, 2001, GEOGRAPHIC VARIATION; *GEN REF OFF, 1966, CLASS OCC 1966; *GEN REG OFF SCOTL, 2007, REG GEN ANN REV DEM; Gordon D, 1999, INEQUALITIES HLTH; Hanlon P, 2005, J PUBLIC HEALTH, V27, P199, DOI 10.1093/pubmed/fdi002; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Jarvis MJ., 1999, SOC DETERMINANTS HLT, V2, P224; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Marang-van de Mheen PJ, 1999, SOC SCI MED, V48, P1851, DOI 10.1016/S0277-9536(99)00071-4; Marang-van de Mheen PJ, 2000, PUBLIC HEALTH, V114, P117; *NAT STAT, 2006, REV REG GEN DEATHS E; *OFF NAT STAT, 2006, SMOK DRINK AD 2006; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; *SCOTT EX, 2004, BREATH FRESH AIR SCO; *SCOTT GOV, SCOTT HOUS SURV ANN; *SCOTT GOV, 2008, EQ WELL REP MIN WORK; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Taulbut M, 2008, TOBACCO SMOKING SCOT; Walsh D., 2008, AFTERSHOCK DEINDUSTR	25	45	46	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2009	338								b480	10.1136/bmj.b480	http://dx.doi.org/10.1136/bmj.b480			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CE	19224884	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000264051900006
J	Mitrovica, JX; Gomez, N; Clark, PU				Mitrovica, Jerry X.; Gomez, Natalya; Clark, Peter U.			The Sea-Level Fingerprint of West Antarctic Collapse	SCIENCE			English	Article									[Mitrovica, Jerry X.; Gomez, Natalya] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Clark, Peter U.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA	University of Toronto; Oregon State University	Mitrovica, JX (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.		Gomez, Natalya/AAU-4323-2020	Gomez, Natalya/0000-0002-2463-7917	Canadian Institute for Advanced Research; Natural Sciences and Engineering Research Council of Canada; John Simon Guggenheim Memorial Foundation; NSF	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); John Simon Guggenheim Memorial Foundation; NSF(National Science Foundation (NSF))	We thank the Canadian Institute for Advanced Research, the Natural Sciences and Engineering Research Council of Canada, the John Simon Guggenheim Memorial Foundation, and NSF for support.	IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Milne GA, 1996, GEOPHYS J INT, V126, pF13, DOI 10.1111/j.1365-246X.1996.tb04691.x; Mitrovica JX, 2001, NATURE, V409, P1026, DOI 10.1038/35059054	5	163	179	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					753	753		10.1126/science.1166510	http://dx.doi.org/10.1126/science.1166510			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197056				2022-12-28	WOS:000263066800037
J	Whitney, B				Whitney, Barbara			ASTRONOMY Forming Massive Stars	SCIENCE			English	Editorial Material									[Whitney, Barbara] Space Sci Inst, Boulder, CO 80301 USA		Whitney, B (corresponding author), Space Sci Inst, 4750 Walnut St,Suite 205, Boulder, CO 80301 USA.	bwhitney@spacescience.org						ADAMS FC, 1987, ASTROPHYS J, V312, P788, DOI 10.1086/164924; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; KAHN FD, 1974, ASTRON ASTROPHYS, V37, P149; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264	5	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					719	720		10.1126/science.1169667	http://dx.doi.org/10.1126/science.1169667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197044				2022-12-28	WOS:000263066800025
J	Lee, HJ; Jo, DY				Lee, Hyo Jin; Jo, Deog Yeon			A Smooth, Shiny Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Hyo Jin; Jo, Deog Yeon] Chungnam Natl Univ Hosp, Taejon 301721, South Korea	Chungnam National University; Chungnam National University Hospital	Lee, HJ (corresponding author), Chungnam Natl Univ Hosp, Taejon 301721, South Korea.	cymed@cnuh.co.kr		LEE, HYO JIN/0000-0001-8378-3001					0	3	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					E8	E8		10.1056/NEJMicm075733	http://dx.doi.org/10.1056/NEJMicm075733			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196670				2022-12-28	WOS:000263028800009
J	Cossairt, BM; Diawara, MC; Cummins, CC				Cossairt, Brandi M.; Diawara, Mariam-Celine; Cummins, Christopher C.			Facile Synthesis of AsP3	SCIENCE			English	Article							PHOSPHORUS		[Cossairt, Brandi M.; Cummins, Christopher C.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Diawara, Mariam-Celine] Univ Lyon 1, Ecole Normale Super Lyon, F-69364 Lyon 07, France	Massachusetts Institute of Technology (MIT); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cummins, CC (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave,Room 6-435, Cambridge, MA 02139 USA.	ccummins@mit.edu	Cummins, Christopher/J-2961-2014	Cummins, Christopher/0000-0003-2568-3269	NSF [CHE-719157]; Thermphos International; Massachusetts Institute of Technology	NSF(National Science Foundation (NSF)); Thermphos International; Massachusetts Institute of Technology	We thank the NSF (grant CHE-719157), Thermphos International, and the Massachusetts Institute of Technology for funding and N.A. Piro and H. A. Spinney for helpful discussions. Crystallographic parameters for (Na)[P<INF>3</INF>Nb(ODipp)<INF>3</INF>], Cl<INF>2</INF>Nb(ODipp)<INF>3</INF>(THF), and (AsP<INF>3</INF>)Mo(CO)<INF>3</INF>(PiPr<INF>3</INF>)<INF>2</INF> are available free of charge from the Cambridge Crystallographic Data Centre (CCDC 704466 to 704468).	Clark JR, 1997, INORG CHEM, V36, P3623, DOI 10.1021/ic970331l; Emsley J., 2000, 13 ELEMENT SORDID TA; Greenwood N.N., 1997, CHEM ELEMENTS; Groer T, 1998, ORGANOMETALLICS, V17, P5916, DOI 10.1021/om9806794; Manasreh O., 2005, SEMICONDUCTOR HETERO; OZIN GA, 1970, J CHEM SOC A, P2307, DOI 10.1039/j19700002307	6	82	82	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					602	602		10.1126/science.1168260	http://dx.doi.org/10.1126/science.1168260			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179522				2022-12-28	WOS:000262862800033
J	Zabolotnyy, VB; Inosov, DS; Evtushinsky, DV; Koitzsch, A; Kordyuk, AA; Sun, GL; Park, JT; Haug, D; Hinkov, V; Boris, AV; Lin, CT; Knupfer, M; Yaresko, AN; Buchner, B; Varykhalov, A; Follath, R; Borisenko, SV				Zabolotnyy, V. B.; Inosov, D. S.; Evtushinsky, D. V.; Koitzsch, A.; Kordyuk, A. A.; Sun, G. L.; Park, J. T.; Haug, D.; Hinkov, V.; Boris, A. V.; Lin, C. T.; Knupfer, M.; Yaresko, A. N.; Buechner, B.; Varykhalov, A.; Follath, R.; Borisenko, S. V.			(pi, pi) electronic order in iron arsenide superconductors	NATURE			English	Article							DENSITY-WAVE	The distribution of valence electrons in metals usually follows the symmetry of the underlying ionic lattice. Modulations of this distribution often occur when those electrons are not stable with respect to a new electronic order, such as spin or charge density waves. Electron density waves have been observed in many families of superconductors(1-3), and are often considered to be essential for superconductivity to exist(4). Recent measurements(5-9) seem to show that the properties of the iron pnictides(10,11) are in good agreement with band structure calculations that do not include additional ordering, implying no relation between density waves and superconductivity in these materials(12-15). Here we report that the electronic structure of Ba1-xKxFe2As2 is in sharp disagreement with those band structure calculations(12-15), and instead reveals a reconstruction characterized by a (pi, pi) wavevector. This electronic order coexists with superconductivity and persists up to room temperature (300 K).	[Zabolotnyy, V. B.; Inosov, D. S.; Evtushinsky, D. V.; Koitzsch, A.; Kordyuk, A. A.; Knupfer, M.; Buechner, B.; Borisenko, S. V.] IFW Dresden, Inst Solid State Res, D-01171 Dresden, Germany; [Inosov, D. S.; Sun, G. L.; Park, J. T.; Haug, D.; Hinkov, V.; Boris, A. V.; Lin, C. T.; Yaresko, A. N.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Kordyuk, A. A.] Natl Acad Sci Ukraine, Inst Met Phys, UA-03142 Kiev, Ukraine; [Boris, A. V.] Loughborough Univ Technol, Dept Phys, Loughborough LE11 3TU, Leics, England; [Varykhalov, A.; Follath, R.] Helmholtz Zentrum Berlin Mat & Energie, Elektronenspeicherring BESSY 2, D-12489 Berlin, Germany	Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden; Max Planck Society; National Academy of Sciences Ukraine; Loughborough University; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Borisenko, SV (corresponding author), IFW Dresden, Inst Solid State Res, POB 270116, D-01171 Dresden, Germany.	s.borisenko@ifw-dresden.de	Varykhalov, Andrei/I-3571-2013; Inosov, Dmytro S./B-6781-2008; Boris, Alexander/AAG-5662-2019; Borisenko, Sergey/G-6743-2012; Kordyuk, Alexander A/G-6502-2010; Büchner, Bernd/E-2437-2016; Hinkov, Vladimir/D-1495-2016; Park, Jitae T/G-1358-2016; Park, Jitae/F-5606-2011; Yaresko, Alexander/P-7978-2018	Varykhalov, Andrei/0000-0002-7901-3562; Inosov, Dmytro S./0000-0003-0639-2503; Borisenko, Sergey/0000-0002-5046-4829; Kordyuk, Alexander A/0000-0001-6737-9172; Büchner, Bernd/0000-0002-3886-2680; Park, Jitae T/0000-0001-6565-0192; Park, Jitae/0000-0001-6565-0192; Zabolotnyy, Volodymyr/0000-0002-7632-7312	Deutsche Forschungsgemeinschaft [KN393/4, BO 1912/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was supported, in part, by the Deutsche Forschungsgemeinschaft under grant numbers KN393/4 and BO 1912/2-1. We are grateful to I. Eremin, O. K. Andersen, L. Boeri, I. Mazin and M. Rumelli for discussions. We thank R. Hubel for technical support.	Borisenko SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.196402; Brouet V, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235104; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Chen H, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/17006; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; CHRISTIANSON AD, 2008, RESONANT SPIN EXCITA; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; EVTUSHINKY DV, 2008, MOMENTUM DEPENDENCE; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kawasaki S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.147001; Liu C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.177005; Lu DH, 2008, NATURE, V455, P81, DOI 10.1038/nature07263; MA F, 2008, ELECT BAND STRUCTURE; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Morosan E, 2006, NAT PHYS, V2, P544, DOI 10.1038/nphys360; Nekrasov IA, 2008, JETP LETT+, V88, P144, DOI 10.1134/S0021364008140166; RADTKE RJ, 1994, PHYS REV B, V50, P9554, DOI 10.1103/PhysRevB.50.9554; SINGH DJ, 2008, ELECT STRUCTURE DOPI; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; YANG LX, 2008, ELECT STRUCTURE EXOT; ZHANG Y, 2008, CORRELATION EFFECTS; Zhao L, 2008, CHINESE PHYS LETT, V25, P4402, DOI 10.1088/0256-307X/25/12/061	24	169	170	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					569	572		10.1038/nature07714	http://dx.doi.org/10.1038/nature07714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177126	Green Submitted			2022-12-28	WOS:000262852200038
J	Briffa, T; Hickling, S; Knuiman, M; Hobbs, M; Hung, J; Sanfilippo, FM; Jamrozik, K; Thompson, PL				Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Hung, J.; Sanfilippo, F. M.; Jamrozik, K.; Thompson, P. L.			Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CASE-FATALITY RATES; WESTERN-AUSTRALIA; UNSTABLE ANGINA; MEDICAL-CARE; EVENT RATES; TRENDS; MORTALITY; MORBIDITY; PROGNOSIS	Objective To examine trends in long term survival in patients alive 28 days after myocardial infarction and the impact of evidence based medical treatments and coronary revascularisation during or near the event. Design Population based cohort with 12 year follow- up. Setting Perth, Australia. Participants 4451 consecutive patients with a definite acute myocardial infarction according to the World Health Organization MONICA ( monitoring trends and determinants in cardiovascular disease) criteria admitted to hospital during 1984- 7, 1988- 90, and 1991- 3. Main outcome measures All cause mortality identified from official mortality records and the hospital morbidity data, with death from cardiovascular disease as a secondary end point. Results In the 1991- 3 cohort, 28 day survivors of acute myocardial infarction had a 7.6% absolute event reduction ( 95% confidence interval 4% to 11%) or a 28% lower relative risk reduction ( 16% to 38%), unadjusted for risk of death, over 12 years after the incident admission compared with the 1984- 7 cohort, similar to the survival of the 1988- 90 cohort. The improved survival for the 1991- 3 cohort persisted after adjustment for demographic factors, coronary risk factors, severity of disease, and event complications with an adjusted relative risk reduction of 26%( 14% to 37%), but this was not apparent after further adjustment for medical treatments in hospital and coronary revascularisation procedures within 12 months of the incident myocardial infarction. Conclusion The improving trends in 12 year survival after a definite acute myocardial infarction are associated with progressive use of evidence based treatments during the initial admission to hospital and in the 12 months after the event. These changes in the management of acute myocardial infarction are probably contributing to the continuing decline in mortality from coronary heart disease in Australia.	[Briffa, Tom; Hickling, S.; Knuiman, M.; Hobbs, M.; Sanfilippo, F. M.] Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia; [Hung, J.; Thompson, P. L.] Univ Western Australia, Sch Med & Pharmacol M503, Crawley, WA 6009, Australia; [Jamrozik, K.] Univ Adelaide, Sch Populat Hlth & Clin Sci NG45, Adelaide, SA 5005, Australia	University of Western Australia; University of Western Australia; University of Adelaide	Briffa, T (corresponding author), Univ Western Australia, Sch Populat Hlth M431, Crawley, WA 6009, Australia.	tom.briffa@uwa.edu.au	Knuiman, Matthew W/I-5549-2013; Thompson, Peter L/P-1071-2014; Sanfilippo, Frank M/H-9334-2013	Sanfilippo, Frank M/0000-0003-3639-0787; Hickling, Siobhan/0000-0001-8337-2894; Knuiman, Matthew/0000-0001-8874-2305	University of Western Australia; WHO MONICA	University of Western Australia; WHO MONICA	The study was supported by the University of Western Australia and the WHO MONICA project.	[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; Beaglehole R, 1997, AM J EPIDEMIOL, V145, P707, DOI 10.1093/aje/145.8.707; Botkin NF, 2006, AM HEART J, V151, P199, DOI 10.1016/j.ahj.2005.03.016; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; CZARN AOS, 1992, MED J AUSTRALIA, V157, P302, DOI 10.5694/j.1326-5377.1992.tb137179.x; Department of Health, 2000, NAT SERV FRAM NSF CO; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Herlitz J, 1996, CARDIOVASC DRUG THER, V10, P485, DOI 10.1007/BF00051115; Hobbs MS, 2008, EUR J CARDIOV PREV R, V15, P319, DOI 10.1097/HJR.0b013e3282f3c76b; Hobbs MST, 2004, HEART, V90, P1036, DOI 10.1136/hrt.2003.022160; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; JAMROZIK K, 2001, CARDIOVASCULAR DIS S, V17; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; MARTIN CA, 1987, J CHRON DIS, V40, P661, DOI 10.1016/0021-9681(87)90102-0; MARTIN CA, 1989, AM J EPIDEMIOL, V129, P655, DOI 10.1093/oxfordjournals.aje.a115182; MARTIN CA, 1986, J CHRON DIS, V39, P683, DOI 10.1016/0021-9681(86)90151-7; MCELDUFF P, 2000, 11 AIHW; MCGOVERN PG, 1992, CIRCULATION, V85, P172, DOI 10.1161/01.CIR.85.1.172; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Norman PE, 1998, BMJ-BRIT MED J, V317, P852, DOI 10.1136/bmj.317.7162.852; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; SALA J, 1995, EUR HEART J, V16, P779, DOI 10.1093/oxfordjournals.eurheartj.a060996; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Taylor R, 2006, EUR J CARDIOV PREV R, V13, P760, DOI 10.1097/01.hjr.0000220581.42387.d4; THOMPSON PL, 1991, J HYPERTENS, V9, pS35, DOI 10.1097/00004872-199112007-00009; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088	34	62	64	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2009	338								b36	10.1136/bmj.b36	http://dx.doi.org/10.1136/bmj.b36			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EK	19171564	Green Published, hybrid			2022-12-28	WOS:000263205300001
J	Kapp, C				Kapp, Clare			Barbara Hogan: South Africa's Minister of Health Profile	LANCET			English	Biographical-Item												clarekapp@hotmail.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					291	291		10.1016/S0140-6736(09)60086-6	http://dx.doi.org/10.1016/S0140-6736(09)60086-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19167563				2022-12-28	WOS:000262728100013
J	Teixeiro, E; Daniels, MA; Hamilton, SE; Schrum, AG; Bragado, R; Jameson, SC; Palmer, E				Teixeiro, Emma; Daniels, Mark A.; Hamilton, Sara E.; Schrum, Adam G.; Bragado, Rafael; Jameson, Stephen C.; Palmer, Ed			Different T Cell Receptor Signals Determine CD8(+) Memory Versus Effector Development	SCIENCE			English	Article							TRANSCRIPTION; LYMPHOCYTE; GENERATION; RESPONSES; SELECTION; DIVISION	Following infection, naive CD8(+) T cells bearing pathogen- specific T cell receptors ( TCRs) differentiate into a mixed population of short- lived effector and long- lived memory T cells to mediate an adaptive immune response. How the TCR regulates memory T cell development has remained elusive. Using a mutant TCR transgenic model, we found that point mutations in the TCR beta transmembrane domain (beta TMD) impair the development and function of CD8(+) memory T cells without affecting primary effector T cell responses. Mutant T cells are deficient in polarizing the TCR and in organizing the nuclear factor kappa B signal at the immunological synapse. Thus, effector and memory states of CD8(+) T cells are separable fates, determined by differential TCR signaling.	[Teixeiro, Emma; Daniels, Mark A.; Schrum, Adam G.; Palmer, Ed] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Teixeiro, Emma; Daniels, Mark A.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Sch Med,Ctr Cellular & Mol Immunol, Columbia, MO 65212 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55454 USA; [Hamilton, Sara E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Bragado, Rafael] Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain; [Schrum, Adam G.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA	University of Basel; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Teixeiro, E (corresponding author), Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	teixeiropernase@missouri.edu; ed.palmer@unibas.ch	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Daniels, Mark/0000-0002-5175-9901; Schrum, Adam/0000-0001-9276-1859	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society; Cancer Research Institute; Spanish Ministry of Science and Education (MEC) [BFU 2005-02807]; Novartis; Roche; Sybilla (EUFP7); Swiss National Science Foundation	Mission Enhancement Program, University of Missouri; Fundacion Ramon Areces, Spain; American Cancer Society(American Cancer Society); Cancer Research Institute; Spanish Ministry of Science and Education (MEC)(Spanish Government); Novartis(Novartis); Roche(Roche Holding); Sybilla (EUFP7)(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank D. Roubaty, B. Hausmann, V. Jaggin, G. E. Fernandez, H. Karauzum, M. Schmaler, and Z. Rajacic for technical assistance; R. Landmann-Suter for technical advice; and C. Pernas Pernas for helpful discussion. This work was supported by Mission Enhancement Program, University of Missouri (E.T. and M.A.D.) fellowships from the Fundacion Ramon Areces, Spain (E.T.), the American Cancer Society (S.E.H.), the Cancer Research Institute (M.A.D.), the Spanish Ministry of Science and Education (MEC) (BFU 2005-02807) (R.B.), Novartis, Roche, Sybilla (EUFP7) and the Swiss National Science Foundation (E.P.).	Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hettmann T, 2003, IMMUNOL LETT, V85, P297, DOI 10.1016/S0165-2478(02)00260-2; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Krieg C, 2007, NAT IMMUNOL, V8, P162, DOI 10.1038/ni1418; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Teixeiro E, 1999, EUR J IMMUNOL, V29, P745, DOI 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	23	150	153	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					502	505		10.1126/science.1163612	http://dx.doi.org/10.1126/science.1163612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164748				2022-12-28	WOS:000262587900042
J	Tremblay, ML				Tremblay, Michel L.			The PTP Family Photo Album	CELL			English	Editorial Material							TYROSINE; DIMERIZATION; INHIBITION; DOMAIN; WEDGE; ALPHA	Protein tyrosine phosphatases (PTPs) are central players in many biological processes. In this issue, Barr et al. (2009) analyze 22 different PTP structures to define their common and unique features. This effort provides key insights into the regulation of PTP activity that could lead to the development of new therapeutics.	Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3G 0B1, Canada		Tremblay, ML (corresponding author), Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	michel.tremblay@mcgill.ca						BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Noordman YE, 2008, BBA-MOL CELL RES, V1783, P275, DOI 10.1016/j.bbamcr.2007.10.023; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011	9	10	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 23	2009	136	2					213	214		10.1016/j.cell.2009.01.006	http://dx.doi.org/10.1016/j.cell.2009.01.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167325	Bronze			2022-12-28	WOS:000262648800011
J	Guttman, M; Amit, I; Garber, M; French, C; Lin, MF; Feldser, D; Huarte, M; Zuk, O; Carey, BW; Cassady, JP; Cabili, MN; Jaenisch, R; Mikkelsen, TS; Jacks, T; Hacohen, N; Bernstein, BE; Kellis, M; Regev, A; Rinn, JL; Lander, ES				Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Feldser, David; Huarte, Maite; Zuk, Or; Carey, Bryce W.; Cassady, John P.; Cabili, Moran N.; Jaenisch, Rudolf; Mikkelsen, Tarjei S.; Jacks, Tyler; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.			Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals	NATURE			English	Article							X-INACTIVATION CENTER; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; MOUSE OOCYTES; STEM-CELLS; GENOME; CHROMOSOME; INTERFERENCE; SEQUENCES; NOISE	There is growing recognition that mammalian cells produce many thousands of large intergenic transcripts(1-4). However, the functional significance of these transcripts has been particularly controversial. Although there are some well-characterized examples, most (>95%) show little evidence of evolutionary conservation and have been suggested to represent transcriptional noise(5,6). Here we report a new approach to identifying large non-coding RNAs using chromatin-state maps to discover discrete transcriptional units intervening known protein-coding loci. Our approach identified similar to 1,600 large multi-exonic RNAs across four mouse cell types. In sharp contrast to previous collections, these large intervening non-coding RNAs (lincRNAs) show strong purifying selection in their genomic loci, exonic sequences and promoter regions, with greater than 95% showing clear evolutionary conservation. We also developed a functional genomics approach that assigns putative functions to each lincRNA, demonstrating a diverse range of roles for lincRNAs in processes from embryonic stem cell pluripotency to cell proliferation. We obtained independent functional validation for the predictions for over 100 lincRNAs, using cell-based assays. In particular, we demonstrate that specific lincRNAs are transcriptionally regulated by key transcription factors in these processes such as p53, NF kappa B, Sox2, Oct4 (also known as Pou5f1) and Nanog. Together, these results define a unique collection of functional lincRNAs that are highly conserved and implicated in diverse biological processes.	[Guttman, Mitchell; Amit, Ido; Garber, Manuel; French, Courtney; Lin, Michael F.; Huarte, Maite; Zuk, Or; Mikkelsen, Tarjei S.; Hacohen, Nir; Bernstein, Bradley E.; Kellis, Manolis; Regev, Aviv; Rinn, John L.; Lander, Eric S.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Guttman, Mitchell; Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Jacks, Tyler; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Mikkelsen, Tarjei S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Huarte, Maite; Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Cabili, Moran N.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Carey, Bryce W.; Cassady, John P.; Jaenisch, Rudolf; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Bernstein, Bradley E.; Rinn, John L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rinn, JL (corresponding author), MIT & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	jrinn@broad.mit.edu	Huarte, Maite/J-6903-2014; Kellis, Manolis/ABE-7385-2020; Mikkelsen, Tarjei S/A-1306-2007	Huarte, Maite/0000-0003-3753-6493; Kellis, Manolis/0000-0001-7113-9630; Mikkelsen, Tarjei S/0000-0002-8133-3135; Rinn, John/0000-0002-7231-7539	Human Frontier Science Program Organization; Beth Israel Deaconess Medical Center; National Human Genome Research Institute; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); Beth Israel Deaconess Medical Center; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank our colleagues at the Broad Institute, especially J. P. Mesirov for discussions and statistical insights, X. Xie for statistical help with conservation analyses, J. Robinson for visualization help, M. Ku, E. Mendenhall and X. Zhang for help generating ChIP samples, and N. Novershtern and A. Levy for providing transcription factor lists. M. Guttman is a Vertex scholar, I. A. acknowledges the support of the Human Frontier Science Program Organization. This work was funded by Beth Israel Deaconess Medical Center, National Human Genome Research Institute, and the Broad Institute of MIT and Harvard.	Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	30	3061	3288	12	393	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					223	227		10.1038/nature07672	http://dx.doi.org/10.1038/nature07672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182780	Green Accepted, Green Submitted			2022-12-28	WOS:000264059700048
J	Mandel, MJ; Wollenberg, MS; Stabb, EV; Visick, KL; Ruby, EG				Mandel, Mark J.; Wollenberg, Michael S.; Stabb, Eric V.; Visick, Karen L.; Ruby, Edward G.			A single regulatory gene is sufficient to alter bacterial host range	NATURE			English	Article							VIBRIO-FISCHERI; SYMBIOTIC COLONIZATION; BIOFILM FORMATION; COMPARATIVE GENOMICS; EUPRYMNA-SCOLOPES; SEQUENCE; INTERFACE; EVOLUTION; ALIGNMENT; ISLANDS	Microbial symbioses are essential for the normal development and growth of animals(1-3). Often, symbionts must be acquired from the environment during each generation, and identification of the relevant symbiotic partner against a myriad of unwanted relationships is a formidable task(4). Although examples of this specificity are well-documented, the genetic mechanisms governing it are poorly characterized(5). Here we show that the two-component sensor kinase RscS is necessary and sufficient for conferring efficient colonization of Euprymna scolopes squid by bioluminescent Vibrio fischeri from the North Pacific Ocean. In the squid symbiont V. fischeri ES114, RscS controls light-organ colonization by inducing the Syp exopolysaccharide, a mediator of biofilm formation during initial infection. A genome-level comparison revealed that rscS, although present in squid symbionts, is absent from the fish symbiont V. fischeri MJ11. We found that heterologous expression of RscS in strain MJ11 conferred the ability to colonize E. scolopes in a manner comparable to that of natural squid isolates. Furthermore, phylogenetic analyses support an important role for rscS in the evolution of the squid symbiosis. Our results demonstrate that a regulatory gene can alter the host range of animal-associated bacteria. We show that, by encoding a regulator and not an effector that interacts directly with the host, a single gene can contribute to the evolution of host specificity by switching 'on' pre-existing capabilities for interaction with animal tissue.	[Mandel, Mark J.; Wollenberg, Michael S.; Ruby, Edward G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Visick, Karen L.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia; Loyola University Chicago	Mandel, MJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, 1550 Linden Dr, Madison, WI 53706 USA.	mmandel@wisc.edu		Mandel, Mark/0000-0001-6506-6711; Visick, Karen/0000-0002-2400-2591	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources; National Science Foundation Division of Integrative Organismal Systems; National Science Foundation CAREER Award; National Institute of General Medical Sciences; National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059690, F32GM078760, T32GM007215] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; National Institutes of Health - National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: P. Dunlap for sharing bacterial strains; N. Perna, J. Glasner, K. Geszvain, D. Baum, J. Johnson, M. Sarmiento and S. Ferriera for technical assistance; A. Wier, N. Bekiares, R. Gates and the Hawaii Institute of Marine Biology for animal facilities and care; J. McCosker and the Steinhart Aquarium for access to fish specimens; M. McFall- Ngai, H. Goodrich- Blair, C. Brennan and J. Troll for discussions; and L. Proctor for project support. MJ11 genome sequencing was funded by the Gordon and Betty Moore Foundation Marine Microbial Genome Sequencing Project; E. G. R. and co- workers are funded by the National Institutes of Health - National Center for Research Resources and the National Science Foundation Division of Integrative Organismal Systems; E. V. S. is funded by a National Science Foundation CAREER Award; K. L. V. is funded by the National Institute of General Medical Sciences; M. J. M. is funded by a National Institute of General Medical Sciences National Research Service Award Postdoctoral Fellowship; M. S. W. is funded by a National Science Foundation Predoctoral Fellowship and a National Institutes of Health Molecular Biosciences Training Grant to the University of Wisconsin.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Brinig MM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r81; Cowles CE, 2008, J BACTERIOL, V190, P4121, DOI 10.1128/JB.00123-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Foster JS, 2002, B MAR SCI, V70, P141; Geszvain K, 2008, FEMS MICROBIOL LETT, V285, P33, DOI 10.1111/j.1574-6968.2008.01209.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Groisman EA, 2005, MOL MICROBIOL, V56, P1, DOI 10.1111/j.1365-2958.2005.04564.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Mandel MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-138; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; RUBY EG, 1977, APPL ENVIRON MICROB, V34, P164, DOI 10.1128/AEM.34.2.164-169.1977; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Silhavy T. J., 1984, EXPT GENE FUSIONS; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STABB EV, 2001, RECENT ADV MARINE SC, P269; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2001, J BACTERIOL, V183, P835, DOI 10.1128/JB.183.3.835-842.2001; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x; Zwickl D, 2006, THESIS U TEXAS AUSTI	45	151	151	0	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					215	U7		10.1038/nature07660	http://dx.doi.org/10.1038/nature07660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19182778	Green Accepted			2022-12-28	WOS:000264059700046
J	Chen, J; Gu, DF; Huang, JF; Rao, DC; Jaquish, CE; Hixson, JE; Chen, CS; Chen, JC; Lu, FH; Hu, DS; Rice, T; Kelly, TN; Hamm, LL; Whelton, PK; He, J				Chen, Jing; Gu, Dongfeng; Huang, Jianfeng; Rao, Dabeeru C.; Jaquish, Cashell E.; Hixson, James E.; Chen, Chung-Shiuan; Chen, Jichun; Lu, Fanghong; Hu, Dongsheng; Rice, Treva; Kelly, Tanika N.; Hamm, L. Lee; Whelton, Paul K.; He, Jiang		GenSalt Collaborative Res Grp	Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study	LANCET			English	Article							SODIUM; HYPERTENSION; SYSTEM; PREVENTION; PREVALENCE; DISEASE; ADULTS; HEALTH	Background Since insulin resistance is thought to be the underlying mechanism for metabolic syndrome, affected individuals might be sensitive to a dietary sodium intervention. We aimed to examine the association between metabolic syndrome and salt sensitivity of blood pressure. Methods 1906 Chinese participants without diabetes, aged 16 years or more, were selected to receive a low-sodium diet (51.3 mmol per day) for 7 days followed by a high-sodium diet (307.8 mmol per day) for an additional 7 days. Participants were excluded from the analysis if metabolic risk factor information was missing or if they did not complete their dietary interventions. Blood pressure was measured at baseline and on days 2, 5, 6, and 7 of each intervention. Metabolic syndrome was defined as the presence of three or more of. abdominal obesity, raised blood pressure, high triglyceride concentration, low HDL cholesterol, or high glucose. High salt sensitivity was defined as a decrease in mean arterial blood pressure of more than 5 mm Hg during low-sodium or an increase of more than 5 mm Hg during high-sodium intervention. This study is registered with ClinicalTrials.gov, number NCT00721721. Findings Of the 1881 participants with information regarding metabolic syndrome, 283 had metabolic syndrome. 1853 participants completed the low-sodium diet and 1845 completed the high-sodium diet. Multivariable-adjusted mean changes in blood pressure were significantly greater in participants with metabolic syndrome than in those without on both low-sodium and high-sodium diets (p<0.0001 for all comparisons). Additionally, risk of salt sensitivity rose with increasing numbers of risk factors for metabolic syndrome. Compared with those with no risk factors participants with four or five had a 3.54-fold increased odds (95% CI 2.05-6.11) of high salt-sensitivity during the low-sodium and a 3.13-fold increased odds (1.80-5.43) of high salt-sensitivity during the high-sodium intervention. Interpretation These results suggest that metabolic syndrome enhances blood pressure response to sodium intake. Reduction in sodium intake could be an especially important component in reducing blood pressure in patients with multiple risk factors for metabolic syndrome. Funding National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.	[Chen, Jing; Hamm, L. Lee; He, Jiang] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70118 USA; [Chen, Jing; Hamm, L. Lee; He, Jiang] Tulane Univ, Tulane Hypertens & Renal Ctr Excellence, Sch Med, New Orleans, LA 70118 USA; [Chen, Jing; Chen, Chung-Shiuan; Kelly, Tanika N.; He, Jiang] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun] Chinese Acad Med Sci, Fuwai Hosp & Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Jing; Huang, Jianfeng; Chen, Jichun] Chinese Natl Ctr Cardiovasc Dis Control & Res, Beijing, Peoples R China; [Rao, Dabeeru C.; Rice, Treva] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Jaquish, Cashell E.] NHLBI, NIH, Bethesda, MD 20892 USA; [Hixson, James E.] Univ Texas, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Lu, Fanghong] Shandong Acad Med Sci, Shandong, Peoples R China; [Hu, Dongsheng] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou, Henan, Peoples R China; [Whelton, Paul K.] Loyola Univ Hlth Syst & Med Ctr, Maywood, IL USA	Tulane University; Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Zhengzhou University	Chen, J (corresponding author), Tulane Univ, Dept Med, Sch Med, 1430 Tulane Ave,SL45, New Orleans, LA 70118 USA.	jchen@tulane.edu	Rice, Treva K/D-1385-2009; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Rice, Treva/0000-0001-7452-2600; Hixson, James/0000-0002-0849-9315	National Heart, Lung, and Blood Institute [U01HL072507]; National Institutes of Health, Bethesda, MD, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	GenSalt is supported by a cooperative agreement project grant (U01HL072507) from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Barba G, 2007, J HYPERTENS, V25, P1465, DOI 10.1097/HJH.0b013e3281139ebd; Chan TYK, 2000, J AUTON PHARMACOL, V20, P37, DOI 10.1046/j.1365-2680.2000.00160.x; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chiolero A, 2001, NEPHROL DIAL TRANSPL, V16, P452, DOI 10.1093/ndt/16.3.452; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujita T, 2006, J RENIN-ANGIO-ALDO S, V7, P181, DOI 10.3317/jraas.2006.029; Galletti F, 1997, J HYPERTENS, V15, P1485, DOI 10.1097/00004872-199715120-00017; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hall JE, 1997, AM J HYPERTENS, V10, pS49, DOI 10.1016/S0895-7061(97)00075-7; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; Hoffmann IS, 2007, J HUM HYPERTENS, V21, P438, DOI 10.1038/sj.jhh.1002153; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; SHIMAMOTO K, 1994, HYPERTENSION, V23, pI29, DOI 10.1161/01.HYP.23.1_Suppl.I29; Strazzullo P, 2001, CLIN EXP HYPERTENS, V23, P25, DOI 10.1081/CEH-100001194; Strazzullo P, 2001, J HYPERTENS, V19, P2157, DOI 10.1097/00004872-200112000-00007; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; SULLIVAN JM, 1991, HYPERTENSION, V17, pI61, DOI 10.1161/01.HYP.17.1_Suppl.I61; TOLINS JP, 1994, KIDNEY INT, V46, P230, DOI 10.1038/ki.1994.264; Uzu T, 2006, J HYPERTENS, V24, P1627, DOI 10.1097/01.hjh.0000239299.71001.77; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481	30	189	205	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					829	835		10.1016/S0140-6736(09)60144-6	http://dx.doi.org/10.1016/S0140-6736(09)60144-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19223069	Green Accepted			2022-12-28	WOS:000263980900033
J	Mazzone, M; Dettori, D; de Oliveira, RL; Loges, S; Schmidt, T; Jonckx, B; Tian, YM; Lanahan, AA; Pollard, P; de Almodovar, CR; De Smet, F; Vinckier, S; Aragones, J; Debackere, K; Luttun, A; Wyns, S; Jordan, B; Pisacane, A; Gallez, B; Lampugnani, MG; Dejana, E; Simons, M; Ratcliffe, P; Maxwell, P; Carmeliet, P				Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; Tian, Ya-Min; Lanahan, Anthony A.; Pollard, Patrick; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Luttun, Aemout; Wyns, Sabine; Jordan, Benedicte; Pisacane, Alberto; Gallez, Bernard; Lampugnani, Maria Grazia; Dejana, Elisabetta; Simons, Michael; Ratcliffe, Peter; Maxwell, Patrick; Carmeliet, Peter			Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization	CELL			English	Article							INDUCIBLE FACTOR-I; VASCULAR NORMALIZATION; ANGIOGENESIS; VEGF; HYPOXIA; CADHERIN; CELLS; ACTIVATION; VESSELS; CANCER	A key function of blood vessels, to supply oxygen, is impaired in tumors because of abnormalities in their endothelial lining. PHD proteins serve as oxygen sensors and may regulate oxygen delivery. We therefore studied the role of endothelial PHD2 in vessel shaping by implanting tumors in PHD2(+/-) mice. Haplodeficiency of PHD2 did not affect tumor vessel density or lumen size, but normalized the endothelial lining and vessel maturation. This resulted in improved tumor perfusion and oxygenation and inhibited tumor cell invasion, intravasation, and metastasis. Haplodeficiency of PHD2 redirected the specification of endothelial tip cells to a more quiescent cell type, lacking filopodia and arrayed in a phalanx formation. This transition relied on HIF-driven upregulation of (soluble) VEGFR-1 and VE-cadherin. Thus, decreased activity of an oxygen sensor in hypoxic conditions prompts endothelial cells to readjust their shape and phenotype to restore oxygen supply. Inhibition of PHD2 may offer alternative therapeutic opportunities for anticancer therapy.	[Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Dettori, Daniela] Univ Turin, Sch Med, Canc Genet Lab, Inst Canc Res & Treatment, I-10060 Turin, Italy; [Tian, Ya-Min; Pollard, Patrick; Ratcliffe, Peter] Henry Wellcome Bldg Genom Med, Oxford OX3 7BN, England; [Lanahan, Anthony A.] Yale Univ, New Haven, CT 06510 USA; [Luttun, Aemout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Med Chem & Radiopharm UC Louvain, Biomed Magnet Resonance Unit, B-1000 Brussels, Belgium; [Pisacane, Alberto] Inst Canc Res & Treatment, Anat Pathol Unit, I-10060 Turin, Italy; [Lampugnani, Maria Grazia; Dejana, Elisabetta] Italian Fdn Canc Res, Inst Mol Oncol, Vasc Biol Unit, I-20139 Milan, Italy; [Maxwell, Patrick] UCL, Rayne Inst, London WC1E 6JJ, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Turin; University of Oxford; Yale University; KU Leuven; IFOM - FIRC Institute of Molecular Oncology; University of London; King's College London; University College London	Carmeliet, P (corresponding author), VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Simons, Michael/G-8553-2014; Pollard, Patrick/F-7516-2012; Maxwell, Patrick H/C-5557-2008; Carmeliet, Peter/AAQ-5140-2020; De Smet, Frederik/Q-7808-2016; Loges, Sonja/ABE-9868-2021; Schmidt, Thomas/Y-8431-2019; pisacane, alberto/AAB-9001-2020; Luttun, Aernout/AAZ-6540-2020	Simons, Michael/0000-0003-0348-7734; Pollard, Patrick/0000-0002-4459-4993; Maxwell, Patrick H/0000-0002-0338-2679; Carmeliet, Peter/0000-0001-7961-1821; De Smet, Frederik/0000-0002-6669-3335; Loges, Sonja/0000-0002-7650-8527; Schmidt, Thomas/0000-0002-7166-3675; pisacane, alberto/0000-0002-5143-8980; Luttun, Aernout/0000-0001-7902-9524; Lampugnani, Maria Grazia/0000-0002-4802-7064; Aragones Lopez, Julian/0000-0002-0193-4679; Ratcliffe, Peter/0000-0002-2853-806X; Mazzone, Massimiliano/0000-0001-8824-4015; Ruiz de Almodovar, Carmen/0000-0001-5975-7815; DEJANA, ELISABETTA/0000-0002-0007-0426; Debackere, Koen/0000-0002-7701-326X; Leite de Oliveira, Rodrigo/0000-0002-9696-2014	FWO [G0125.00, G0121.02]; British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER	FWO(FWO); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M. M. is supported by the European Molecular Biology Organization, R. L. O. by the Fonds Wetenschappelijk Onderzoek ( FWO), S. L. by the Deutsche Krebshilfe, T. S. by the Deutsche Forschungsgemeinschaft, C. R. A. by the Federation of European Biochemical Societies and the FWO, and A. L. by the FWO and a Katholieke Universiteit Leuven Center of Excellence grant. The authors thank Vesalius Research Center technicians for assistance. This work was supported by grants from (to P. C.) Methusalem, the FWO (G0125.00; G0121.02), the European Union (QLRT- 2001- 0195), the Concerted Research Activities (# GOA2001/ 09; GOA/2006/11), the Belgian Science Policy (IAP- P5/02), and (to P. H. M. and P. J. R.) the British Heart Foundation (Programme Grant). P. R. and P. M. are scientific cofounders of and hold equity in ReOx Ltd., a University spin-out company that aims to develop inhibitors of the HIF hydroxylases.	Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Nangaku M, 2007, ARTERIOSCL THROM VAS, V27, P2548, DOI 10.1161/ATVBAHA.107.148551; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200	41	594	615	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					839	851		10.1016/j.cell.2009.01.020	http://dx.doi.org/10.1016/j.cell.2009.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19217150	Bronze, Green Accepted			2022-12-28	WOS:000263930900008
J	Iglehart, JK				Iglehart, John K.			Health Care 2009: Expanding Coverage for Children -- The Democrats' Power and SCHIP Reauthorization.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; QUALITY											BOYD DJ, 2008, 74 NA ROCK I GOV; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Sack Kevin, 2009, NY TIMES, pA1; SIMPSON L, 2007, REAUTHORIZING SCHIP	5	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					855	857		10.1056/NEJMp0900461	http://dx.doi.org/10.1056/NEJMp0900461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	411CD	19196665				2022-12-28	WOS:000263624700003
J	Sena, G; Wang, XN; Liu, HY; Hofhuis, H; Birnbaum, KD				Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Hofhuis, Hugo; Birnbaum, Kenneth D.			Organ regeneration does not require a functional stem cell niche in plants	NATURE			English	Article							ROOT; EXPRESSION; SCARECROW; POLARITY	Plants rely on the maintenance of stem cell niches at their apices for the continuous growth of roots and shoots. However, although the developmental plasticity of plant cells has been demonstrated(1), it is not known whether the stem cell niche is required for organogenesis. Here we explore the capacity of a broad range of differentiating cells to regenerate an organ without the activity of a stem cell niche. Using a root-tip regeneration system in Arabidopsis thaliana to track the molecular and functional recovery of cell fates, we show that respecification of lost cell identities begins within hours of excision and that the function of specialized cells is restored within one day. Critically, regeneration proceeds in plants with mutations that fail to maintain the stem cell niche. These results show that stem-cell-like properties that mediate complete organ regeneration are dispersed in plant meristems and are not restricted to niches, which nonetheless seem to be necessary for indeterminate growth. This regenerative reprogramming of an entire organ without transition to a stereotypical stem cell environment has intriguing parallels to recent reports of induced transdifferentiation of specific cell types in the adult organs of animals(2,3).	[Sena, Giovanni; Wang, Xiaoning; Liu, Hsiao-Yun; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hofhuis, Hugo] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	New York University; Utrecht University	Birnbaum, KD (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, Silver Bldg,100 Washington Sq E, New York, NY 10003 USA.	ken.birnbaum@nyu.edu	Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038; hofhuis, hugo/0000-0001-7882-7380	National Institutes of Health [5R01GM078279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Scheres and R. Heidstra for mutant and reporter lines and for comments. We thank P. Doerner for the CYCB1;1::GFP reporter, J. Friml for the PINFORMED (PIN) reporter lines, and C. Desplan, T. Nawy, B. Bargmann and M. Gifford for comments. This work was supported by the National Institutes of Health grant 5R01GM078279 (K. D. B.)	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Beemster GTS, 2006, J PLANT RES, V119, P43, DOI 10.1007/s10265-005-0234-2; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; FELDMAN LJ, 1976, PLANTA, V128, P207, DOI 10.1007/BF00393230; FIGDOR W, 1907, JB WISS BOT, V44, P41; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; ROST TL, 1988, ANN BOT-LONDON, V61, P513, DOI 10.1093/oxfordjournals.aob.a087583; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sack FD, 1997, PLANTA, V203, pS63, DOI 10.1007/PL00008116; STEWARD FC, 1970, ANN BOT-LONDON, V34, P761, DOI 10.1093/oxfordjournals.aob.a084408; Thowfeequ S, 2007, DEV DYNAM, V236, P3208, DOI 10.1002/dvdy.21336; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	168	176	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1150	U110		10.1038/nature07597	http://dx.doi.org/10.1038/nature07597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19182776	Green Submitted, Green Accepted			2022-12-28	WOS:000263680100045
J	Mahajan, AP; Stemple, L; Shapiro, MF; King, JB; Cunningham, WE				Mahajan, Anish P.; Stemple, Lara; Shapiro, Martin F.; King, Jan B.; Cunningham, William E.			Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; 2006 CDC RECOMMENDATIONS; UNITED-STATES; ROUTINE; TRANSMISSION; VIRUS	In September 2006, the Centers for Disease Control and Prevention (CDC) released the "Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-care Settings" to improve screening and diagnosis. The CDC now recommends that all patients in all health care settings be offered opt-out HIV screening without separate written consent and prevention counseling. State law on HIV testing is widely assumed to be a barrier to implementing the recommendations. To help policymakers and providers better understand their own legal context and to correct possible misunderstandings about statutory compatibility, a state-by-state review ( including Washington, DC) of all statutes pertaining to HIV testing was performed and the consistency of these laws with the new recommendations was systematically assessed. Criteria were developed for classifying state statutory frameworks as consistent, neutral, or inconsistent with the new recommendations, and the implications for implementation of the CDC recommendations in these various legal contexts were examined. The statutory frameworks of 34 states and Washington, DC, were found to be either consistent with or neutral to the new CDC recommendations, which would enable full implementation. Statutory frameworks of 16 states were inconsistent with the new CDC recommendations, which would preclude implementation of 1 or more of the novel provisions without legislative change. In the 2 years since release of the recommendations, 9 states have passed new legislation to move from being inconsistent to consistent with the guidelines. State statutory laws are evolving toward greater compliance with the CDC recommendations. Policymakers, provider groups, consumer advocates, and other stakeholders should ensure that HIV screening practices comply with existing state law and work to amend inconsistent laws if they are interested in implementing the CDC recommendations.	[Mahajan, Anish P.] Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Los Angeles County Department of Public Health	Mahajan, AP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Robert Wood Johnson Clin Scholars Program, 911 Broxton Ave, Los Angeles, CA 90024 USA.	AnishMahajan@mednet.ucla.edu			Robert Wood Johnson Clinical Scholars Program; University of California Los Angeles Project EXPORT; National Institutes of Health [P20 MD 000182-06]; University of California Los Angeles; Drew Resource Centers for Minority Aging Research/ Center; Minority Elderly National Institutes of Health [P30AG021684]; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000182] Funding Source: NIH RePORTER	Robert Wood Johnson Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); University of California Los Angeles Project EXPORT(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles(University of California System); Drew Resource Centers for Minority Aging Research/ Center; Minority Elderly National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	By the Robert Wood Johnson Clinical Scholars Program ( Dr. Mahajan); Charles Drew/ University of California Los Angeles Project EXPORT National Institutes of Health grant P20 MD 000182-06 ( Drs. Shapiro and Cunningham); and University of California Los Angeles/Drew Resource Centers for Minority Aging Research/ Center for Health Improvement of Minority Elderly National Institutes of Health grant P30AG021684 ( Dr. Cunningham).	*AM CIV LIB UN, 2006, HIV ACT TELL NEW YOR; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Beckwith CG, 2005, CLIN INFECT DIS, V40, P1037, DOI 10.1086/428620; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; *CDCP, 2001, MMWR RECOMM REP, V50, P63; *CDCP, 2005, HIV AIDS SURV REP, V16, P16; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1110; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Garner B, 2006, BLACKS LAW DICT; Goldman J, 2008, AM J PUBLIC HEALTH, V98, P807, DOI 10.2105/AJPH.2007.121152; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hanssens C, 2007, CLIN INFECT DIS, V45, pS232, DOI 10.1086/522543; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Kaiser Family Foundation, 2006, SURV AM HIV AIDS; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lyons MS, 2007, PUBLIC HEALTH REP, V122, P579, DOI 10.1177/003335490712200504; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; *NAT HIV AIDS CLIN, 2007, STAT HIV TEST LAWS C; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Tarantola D, 2007, LANCET, V370, P202, DOI 10.1016/S0140-6736(07)61102-7; Wolf LE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001005; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004	32	55	55	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					263	U62		10.7326/0003-4819-150-4-200902170-00007	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410FI	19221378	Green Submitted, Green Accepted			2022-12-28	WOS:000263562500005
J	Williamson, CE; Saros, JE; Schindler, DW				Williamson, Craig E.; Saros, Jasmine E.; Schindler, David W.			CLIMATE CHANGE Sentinels of Change	SCIENCE			English	Editorial Material							TERRESTRIAL; LAKES		[Williamson, Craig E.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Saros, Jasmine E.] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Saros, Jasmine E.] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Schindler, David W.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University System of Ohio; Miami University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Alberta	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; jasmine.saros@maine.edu; d.schindler@ualberta.ca	Schindler, David/A-3752-2014					[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Johnson P. T. J., 2008, FRONT ECOL ENVIRON, V6, P357, DOI DOI 10.1890/070156; Kelly EN, 2006, P NATL ACAD SCI USA, V103, P19380, DOI 10.1073/pnas.0609798104; Lewis C.F.M., 2008, EOS T AM GEOPHYS UN, V89, P541, DOI DOI 10.1029/2008EO520001; Lewis CFM, 2001, GEOLOGY, V29, P743, DOI 10.1130/0091-7613(2001)029<0743:UDEDBM>2.0.CO;2; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Stow C.A., 2008, EOS T AM GEOPHYSICAL, V89, P389; van der Kamp G, 2008, CAN WATER RESOUR J, V33, P23, DOI 10.4296/cwrj3301023; von Wachenfeldt E, 2008, LIMNOL OCEANOGR, V53, P2416, DOI 10.4319/lo.2008.53.6.2416; Wilcox D.A., 2007, GEOL SURV CIRCULAR, P1, DOI [10.3133/cir1311, DOI 10.3133/CIR1311]; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	19	186	192	12	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					887	888		10.1126/science.1169443	http://dx.doi.org/10.1126/science.1169443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213905				2022-12-28	WOS:000263295400027
J	Eilken, HM; Nishikawa, SI; Schroeder, T				Eilken, Hanna M.; Nishikawa, Shin-Ichi; Schroeder, Timm			Continuous single-cell imaging of blood generation from haemogenic endothelium	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; EXPRESSION; ORIGIN; CD41; DIFFERENTIATION; VASCULOGENESIS; PROGENITORS; COMMITMENT	Despite decades of research, the identity of the cells generating the first haematopoietic cells in mammalian embryos is unknown(1). Indeed, whether blood cells arise from mesodermal cells, mesenchymal progenitors, bipotent endothelial - haematopoietic precursors or haemogenic endothelial cells remains controversial(2-9). Proximity of endothelial and blood cells at sites of embryonic haematopoiesis, as well as their similar gene expression, led to the hypothesis of the endothelium generating blood. However, owing to lacking technology(10) it has been impossible to observe blood cell emergence continuously at the single- cell level, and the postulated existence of haemogenic endothelial cells remains disputed(1). Here, using new imaging and cell- tracking methods, we show that embryonic endothelial cells can be haemogenic. By continuous long- term single- cell observation of mouse mesodermal cells generating endothelial cell and blood colonies, it was possible to detect haemogenic endothelial cells giving rise to blood cells. Living endothelial and haematopoietic cells were identified by simultaneous detection of morphology and multiple molecular and functional markers. Detachment of nascent blood cells from endothelium is not directly linked to asymmetric cell division, and haemogenic endothelial cells are specified from cells already expressing endothelial markers. These results improve our understanding of the developmental origin of mammalian blood and the potential generation of haematopoietic stem cells from embryonic stem cells.	[Eilken, Hanna M.; Schroeder, Timm] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Nishikawa, Shin-Ichi] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; RIKEN	Schroeder, T (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252	Deutsche Forschungsgemeinschaft; Leading Project for the Realization of Regenerative Medicine	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leading Project for the Realization of Regenerative Medicine	We are grateful to S. Nishikawa, M. A. Rieger, A. Hermann and M. Yoder for technical advice and discussions, M. Ogawa and H. Niwa for the VEVC2 and EB3 ESC lines, respectively, B. Schauberger for programming contributions, and A. Roth and C. Raithel for technical support. We thank M. Goetz, A. Hermann, M. A. Rieger and A. IJpenberg for critical reading of the manuscript. Part of this study was financed by the Deutsche Forschungsgemeinschaft to T. S. and by the Leading Project for the Realization of Regenerative Medicine to S.-I.N.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Choi K, 1998, DEVELOPMENT, V125, P725; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Guo RY, 2007, J CELL PHYSIOL, V211, P327, DOI 10.1002/jcp.20937; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	30	439	453	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					896	900		10.1038/nature07760	http://dx.doi.org/10.1038/nature07760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212410				2022-12-28	WOS:000263266700048
J	Freeman, MP				Freeman, Marlene P.			Person, Place, or Thing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mfreeman@partners.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					580	580		10.1001/jama.2009.114	http://dx.doi.org/10.1001/jama.2009.114			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211457				2022-12-28	WOS:000263229000001
J	Pagnini, F; Manzoni, GM; Castelnuovo, G				Pagnini, Francesco; Manzoni, Gian Mauro; Castelnuovo, Gianluca			Emotional Intelligence Training and Evaluation in Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Pagnini, Francesco] Univ Bergamo, Bergamo, Italy; [Manzoni, Gian Mauro; Castelnuovo, Gianluca] Ist Auxol Italiano, Oggebbio, Italy	University of Bergamo; IRCCS Istituto Auxologico Italiano	Pagnini, F (corresponding author), Univ Bergamo, Bergamo, Italy.	francesco.pagnini@unibg.it	Castelnuovo, Gianluca/AAC-1780-2019; Manzoni, Gian Mauro/L-3891-2019; Pagnini, Francesco/G-3808-2011	Castelnuovo, Gianluca/0000-0003-2633-9822; Manzoni, Gian Mauro/0000-0003-3384-0359; Pagnini, Francesco/0000-0003-1612-4211				Accreditation Council for Graduate Medical Education, PROGR DIR GUID COMM; Archinard M, 2000, J PSYCHIAT RES, V34, P261, DOI 10.1016/S0022-3956(00)00011-X; Grewal D, 2008, JAMA-J AM MED ASSOC, V300, P1200, DOI 10.1001/jama.300.10.1200; Pollak KI, 2007, J CLIN ONCOL, V25, P5748, DOI 10.1200/JCO.2007.12.4180	4	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					600	600		10.1001/jama.2009.81	http://dx.doi.org/10.1001/jama.2009.81			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211465				2022-12-28	WOS:000263229000019
J	Richardson, G; Bloor, K; Williams, J; Russell, I; Durai, D; Cheung, WY; Farrin, A; Coulton, S				Richardson, Gerry; Bloor, Karen; Williams, John; Russell, Ian; Durai, Dharmaraj; Cheung, Wai Yee; Farrin, Amanda; Coulton, Simon			Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET)	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To compare the cost effectiveness of nurses and doctors in performing upper gastrointestinal endoscopy and flexible sigmoidoscopy. Design As part of a pragmatic randomised trial, the economic analysis calculated incremental cost effectiveness ratios, and generated cost effectiveness acceptability curves to address uncertainty. Setting 23 hospitals in the United Kingdom. Participants 67 doctors and 30 nurses, with a total of 1888 patients, from July 2002 to June 2003. Intervention Diagnostic upper gastrointestinal endoscopy and flexible sigmoidoscopy carried out by doctors or nurses. Main outcome measure Estimated health gains in QALYs measured with EQ-5D. Probability of cost effectiveness over a range of decision makers' willingness to pay for an additional quality adjusted life year (QALY). Results Although differences did not reach traditional levels of significance, patients in the doctor group gained 0.015 QALYs more than those in the nurse group, at an increased cost of about 56 pound ((sic)59, $78) per patient. This yields an incremental cost effectiveness ratio of 3660 pound ((sic)3876, $5097) per QALY. Though there is uncertainty around these results, doctors are probably more cost effective than nurses for plausible values of a QALY. Conclusions Though upper gastrointestinal endoscopies and flexible sigmoidoscopies carried out by doctors cost slightly more than those by nurses and improved health outcomes only slightly, our analysis favours endoscopies by doctors. For plausible values of decision makers' willingness to pay for an extra QALY, endoscopy delivered by nurses is unlikely to be cost effective compared with endoscopy delivered by doctors. Trial registration International standard RCT 82765705	[Williams, John; Cheung, Wai Yee] Swansea Univ, Sch Med, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales; [Russell, Ian] Bangor Univ, Inst Med & Social Care Res, N Wales Org Randomised Trials Hlth, Bangor, Gwynedd, Wales; [Durai, Dharmaraj] Wishaw Gen Hosp, Wishaw, Lanark, Scotland; [Farrin, Amanda] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Coulton, Simon] Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England	Swansea University; Bangor University; University of Leeds; University of Kent		gar2@york.ac.uk	Russell, Ian T/H-1181-2012	Bloor, Karen/0000-0003-4852-9854	NIHR Evaluation Trials and Studies Coordinating Centre; National Institute for Health Research [97/37/09] Funding Source: researchfish	NIHR Evaluation Trials and Studies Coordinating Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the NIHR Evaluation Trials and Studies Coordinating Centre. All researchers are independent from this source of funding.	Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Curtis, 2003, UNIT COSTS HLTH SOCI; Dolan P., 1995, SOCIAL TARIFF EUROQO; FENWICK ECK, 2001, IMPROVING EFFICIENCY; Kind P, 1996, QUALITY LIFE PHARMAC; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; *MED RES COUNC, 2000, FRAM DEV EV RCTS COM; Pathmakanthan S, 2001, J ADV NURS, V36, P705, DOI 10.1046/j.1365-2648.2001.02021.x; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Sculpher M, 2005, HLTH POLICY EC OPPOR; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Williams J, 2006, HEALTH TECHNOL ASSES, V10, P1; Williams J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b231	16	21	21	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2009	338								b270	10.1136/bmj.b270	http://dx.doi.org/10.1136/bmj.b270			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	415ZV	19208715	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000263975900005
J	Hall, CB; Weinberg, GA; Iwane, MK; Blumkin, AK; Edwards, KM; Staat, MA; Auinger, P; Griffin, MR; Poehling, KA; Erdman, D; Grijalva, CG; Zhu, YW; Szilagyi, P				Hall, Caroline Breese; Weinberg, Geoffrey A.; Iwane, Marika K.; Blumkin, Aaron K.; Edwards, Kathryn M.; Staat, Mary A.; Auinger, Peggy; Griffin, Marie R.; Poehling, Katherine A.; Erdman, Dean; Grijalva, Carlos G.; Zhu, Yuwei; Szilagyi, Peter			The Burden of Respiratory Syncytial Virus Infection in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; HUMAN METAPNEUMOVIRUS; TRACT INFECTIONS; 1ST YEAR; INFLUENZA; HOSPITALIZATION; INFANTS; DISEASE; RATES; RSV	Background The primary role of respiratory syncytial virus ( RSV) in causing infant hospitalizations is well recognized, but the total burden of RSV infection among young children remains poorly defined. Methods We conducted prospective, population- based surveillance of acute respiratory infections among children under 5 years of age in three U. S. counties. We enrolled hospitalized children from 2000 through 2004 and children presenting as outpatients in emergency departments and pediatric offices from 2002 through 2004. RSV was detected by culture and reverse- transcriptase polymerase chain reaction. Clinical information was obtained from parents and medical records. We calculated population- based rates of hospitalization associated with RSV infection and estimated the rates of RSV- associated outpatient visits. Results Among 5067 children enrolled in the study, 919 ( 18%) had RSV infections. Overall, RSV was associated with 20% of hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. Average annual hospitalization rates were 17 per 1000 children under 6 months of age and 3 per 1000 children under 5 years of age. Most of the children had no coexisting illnesses. Only prematurity and a young age were independent risk factors for hospitalization. Estimated rates of RSV- associated office visits among children under 5 years of age were three times those in emergency departments. Outpatients had moderately severe RSV- associated illness, but few of the illnesses ( 3%) were diagnosed as being caused by RSV. Conclusions RSV infection is associated with substantial morbidity in U. S. children in both inpatient and outpatient settings. Most children with RSV infection were previously healthy, suggesting that control strategies targeting only high- risk children will have a limited effect on the total disease burden of RSV infection.	[Hall, Caroline Breese; Weinberg, Geoffrey A.; Blumkin, Aaron K.; Auinger, Peggy; Szilagyi, Peter] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY 14642 USA; [Iwane, Marika K.; Erdman, Dean] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Edwards, Kathryn M.; Poehling, Katherine A.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA; [Zhu, Yuwei] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Staat, Mary A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of Rochester; University of Rochester; Centers for Disease Control & Prevention - USA; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hall, CB (corresponding author), Univ Rochester, Sch Med & Dent, Div Infect Dis, Dept Pediat, 601 Elmwood Ave,Box 689, Rochester, NY 14642 USA.	caroline_hall@urmc.rochester.edu	Weinberg, Geoffrey A./W-7510-2019	Weinberg, Geoffrey A./0000-0002-3900-379X; Grijalva, Carlos/0000-0002-2329-7797	MedImmune; Astellas; GlaxoSmithKline; Merck; Pfizer; Wyeth; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [K01IP000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065805] Funding Source: NIH RePORTER	MedImmune(AstraZenecaMedimmune); Astellas(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Wyeth(Wyeth); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported through cooperative agreements with the CDC.; Dr. Hall reports receiving grant support and consulting fees from MedImmune; Dr. Weinberg, research support from Astellas and MedImmune and consulting fees from MedImmune; Dr. Staat, consulting fees or fees for serving on paid advisory boards from GlaxoSmithKline, Merck, and MedImmune, lecture fees from Merck, and research support from MedImmune; Dr. Griffin, grant support from MedImmune and Pfizer; and Dr. Grijalva, lecture fees from Wyeth. No other potential conflict of interest relevant to this article was reported.; The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the CDC.; We thank the children and their parents who participated in this study; all the members of the New Vaccine Surveillance Network, including Geraldine Lofthus, Kenneth Schnabel, Andrea Marino, Lynne Shelley, Jennifer Carnahan, Linda Anderson, Gladys Lathan, Charlene Freundlich, Christina Albertin, and Rebecca Martinez at the University of Rochester; John Williams, Diane Kent, Ann Clay, Ayesha Khan, Yi Wei Tang, Haijing Li, Jennifer Doersam, Amondrea Blackman, Nayleen Whitehead, Erin Keckley, and Jody Peters at Vanderbilt University; Linda Jamison, David Witte, David Bernstein, Emilie Grube, Vanessa Florian, Pamela Groen, and Joel Mortensen at the Cincinnati Children's Medical Center; and Ranee Seither, Aaron Curns, Larry Anderson, Carolyn B. Bridges, Benjamin Schwartz, Frances Walker, John Copeland, Alicia Fry, Jennifer Reuer, and John Zhang at the CDC.	Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Carbonell-Estrany Xavier, 2004, Pediatr Infect Dis J, V23, pS193, DOI 10.1097/01.inf.0000144664.31888.53; Casella G, 2002, STAT INFERENCE, P240; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; Comperat E, 2007, PROG UROL, V17, P5, DOI 10.1016/S1166-7087(07)92218-6; Englund J, 2005, J INFECT DIS, V191, P1036, DOI 10.1086/427998; Erdman DD, 2003, J CLIN MICROBIOL, V41, P4298, DOI 10.1128/JCM.41.9.4298-4303.2003; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Meissner HC, 2004, PEDIATR INFECT DIS J, V23, P284, DOI 10.1097/01.inf.0000121203.33560.f9; Miller EK, 2008, PEDIATRICS, V121, P1, DOI 10.1542/peds.2007-1053; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; *NAT I ALL INF DIS, 2002, JORD REP ACC DEV VAC; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nielsen HE, 2003, ACTA PAEDIATR, V92, P1314, DOI 10.1080/08035250310006304; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Peck AJ, 2005, PEDIATR INFECT DIS J, V24, P342, DOI 10.1097/01.inf.0000157250.95880.91; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Reeve CA, 2006, J PAEDIATR CHILD H, V42, P248, DOI 10.1111/j.1440-1754.2006.00849.x; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Rossi GA, 2007, EUR J PEDIATR, V166, P1267, DOI 10.1007/s00431-007-0418-y; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; von Linstow ML, 2008, EUR J PEDIATR, V167, P1125, DOI 10.1007/s00431-007-0643-4; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; WEINBERG GA, J PEDIAT IN PRESS; WELLIVER RC, 2004, PAEDIATR RESPIR REV, pS127	38	1358	1413	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					588	598		10.1056/NEJMoa0804877	http://dx.doi.org/10.1056/NEJMoa0804877			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196675	Green Accepted, Bronze			2022-12-28	WOS:000263028800005
J	Ndrepepa, G; Kastrati, A; Mehilli, J; Antoniucci, D; Schomig, A				Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Antoniucci, David; Schoemig, Albert			Mechanical Reperfusion and Long-term Mortality in Patients With Acute Myocardial Infarction Presenting 12 to 48 Hours From Onset of Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ndrepepa, Gjin; Kastrati, Adnan; Mehilli, Julinda; Schoemig, Albert] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Antoniucci, David] Azienda Osped Careggi, Florence, Italy	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Florence; Azienda Ospedaliero Universitaria Careggi	Ndrepepa, G (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Parodi G, 2006, AM HEART J, V152, P1133, DOI 10.1016/j.ahj.2006.08.007; Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865	4	40	47	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					487	488		10.1001/jama.2009.32	http://dx.doi.org/10.1001/jama.2009.32			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190313	Bronze			2022-12-28	WOS:000262992400017
J	Som, R; Wynne-Simmons, R; Islam, J; Lawman, S				Som, R.; Wynne-Simmons, R.; Islam, J.; Lawman, S.			Endgames Case report A chicken sandwich leading to intensive care	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; COMPLEMENT FACTOR-H; PLASMA-EXCHANGE; PATHOPHYSIOLOGY; CYCLOSPORINE; ANTIBIOTICS; ADULTS; HUS		[Som, R.; Wynne-Simmons, R.; Islam, J.; Lawman, S.] Royal Sussex Cty Hosp, Sussex Kidney Unit, Brighton BN2 5BE, E Sussex, England	University of Brighton	Som, R (corresponding author), Royal Sussex Cty Hosp, Sussex Kidney Unit, Brighton BN2 5BE, E Sussex, England.	rsom@doctors.org.uk		Islam, Jasmin/0000-0002-4369-6306; Islam, Jasmin/0000-0003-0005-014X				Abraham KA, 2000, TRANSPL INT, V13, P443, DOI 10.1007/s001470050727; Andreoli SP, 1999, CURR OPIN NEPHROL HY, V8, P459, DOI 10.1097/00041552-199907000-00010; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Bahloul M, 2007, J MAL VASCUL, V32, P75, DOI 10.1016/j.jmv.2007.03.001; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Coppo P, 2003, MEDICINE, V82, P27, DOI 10.1097/00005792-200301000-00003; Corrigan J J Jr, 2001, Pediatr Rev, V22, P365; Desch K, 2007, J AM SOC NEPHROL, V18, P2457, DOI 10.1681/ASN.2007010062; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Gerth J, 2007, CLIN NEPHROL, V68, P405; HAYWARD CPM, 1994, ARCH INTERN MED, V154, P982, DOI 10.1001/archinte.154.9.982; *HLTH PROT AG, 2008, E COL O157 H7; Lara PN, 1999, AM J MED, V107, P573, DOI 10.1016/S0002-9343(99)00286-7; Liu JX, 2001, J THROMB THROMBOLYS, V11, P261, DOI 10.1023/A:1011921122595; Matsumae T, 1996, CLIN NEPHROL, V45, P153; Moake JL, 1998, NEW ENGL J MED, V339, P1629, DOI 10.1056/NEJM199811263392210; MORELMAROGER L, 1979, KIDNEY INT, V15, P548, DOI 10.1038/ki.1979.70; NEILD GH, 1994, LANCET, V343, P398, DOI 10.1016/S0140-6736(94)91228-9; Panos GZ, 2006, ALIMENT PHARM THER, V24, P731, DOI 10.1111/j.1365-2036.2006.03036.x; PARMAR MS, 2008, E MED            DEC; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Razzaq S, 2006, AM FAM PHYSICIAN, V74, P991; RUST R, 2006, E MED            JUN; SHAPIRO W, 2007, E MED            JAN; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; Wen YK, 2006, CLIN NEPHROL, V66, P58	29	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 4	2009	338								b200	10.1136/bmj.b200	http://dx.doi.org/10.1136/bmj.b200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414OY	19193690				2022-12-28	WOS:000263876300001
J	Sniderman, AD; Furberg, CD				Sniderman, Allan D.; Furberg, Curt D.			Why Guideline-Making Requires Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RECOMMENDATIONS		[Sniderman, Allan D.] McGill Univ, McGill Univ Hlth Ctr, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ, Canada; [Furberg, Curt D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA	McGill University; Wake Forest University	Sniderman, AD (corresponding author), Royal Victoria Hosp, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allansniderman@hotmail.com						*AM MED ASS OFF QU, 1990, ATTR GUID DEV EV PRA; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; *COMM ADV PUBL HLT, 1990, CLIN PRACT GUID DIR; CONTOIS JH, CLIN CHEM IN PRESS; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; KASSIRER JP, 2005, TAKE MED COMPLICITY, P97; Kwan J, 2008, CAN J DIABETES, V32, P174, DOI 10.1016/S1499-2671(08)23007-8; Lenzer J, 2004, BRIT MED J, V329, P759, DOI 10.1136/bmj.329.7469.759-a; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; Psaty BM, 1999, BRIT MED J, V319, P589, DOI 10.1136/bmj.319.7210.589; Rosenzweig JL, 2008, J CLIN ENDOCR METAB, V93, P3671, DOI 10.1210/jc.2008-0222	14	161	164	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2009	301	4					429	431		10.1001/jama.2009.15	http://dx.doi.org/10.1001/jama.2009.15			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399CE	19176446				2022-12-28	WOS:000262777200024
J	Roach, PJ; Woodward, WH; Castleman, AW; Reber, AC; Khanna, SN				Roach, Patrick J.; Woodward, W. Hunter; Castleman, A. W., Jr.; Reber, Arthur C.; Khanna, Shiv N.			Complementary Active Sites Cause Size-Selective Reactivity of Aluminum Cluster Anions with Water	SCIENCE			English	Article							GOLD CLUSTERS	The reactions of metal clusters with small molecules often depend on cluster size. The selectivity of oxygen reactions with aluminum cluster anions can be well described within an electronic shell model; however, not all reactions are subject to the same fundamental constraints. We observed the size selectivity of aluminum cluster anion reactions with water, which can be attributed to the dissociative chemisorption of water at specific surface sites. The reactivity depends on geometric rather than electronic shell structure. Identical arrangements of multiple active sites in Al-16(-), Al-17(-), and Al-18(-) result in the production of H-2 from water.	[Roach, Patrick J.; Woodward, W. Hunter; Castleman, A. W., Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Roach, Patrick J.; Woodward, W. Hunter; Castleman, A. W., Jr.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Reber, Arthur C.; Khanna, Shiv N.] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University	Castleman, AW (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	awc@psu.edu	Reber, Arthur C/A-3698-2009; Roach, Patrick/G-5615-2012	Reber, Arthur C/0000-0003-1013-331X; 	Air Force Office of Scientific Research [FA9550-04-1-0066, FA9550-05-1-0186]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Supported by Air Force Office of Scientific Research grants FA9550-04-1-0066 and FA9550-05-1-0186.	Atkins PW., 1990, PHYS CHEM; Bergeron DE, 2005, SCIENCE, V307, P231, DOI 10.1126/science.1105820; Bergeron DE, 2004, SCIENCE, V304, P84, DOI 10.1126/science.1093902; Bonacic-Koutecky V, 2002, J CHEM PHYS, V117, P3120, DOI 10.1063/1.1492800; Burgel C, 2008, J AM CHEM SOC, V130, P1694, DOI 10.1021/ja0768542; Castleman AW, 2007, CHEM PHYS SOLID SURF, V12, P409, DOI 10.1016/S1571-0785(07)12010-1; Chretien S, 2004, J CHEM PHYS, V121, P3756, DOI 10.1063/1.1769366; COX DM, 1988, J PHYS CHEM-US, V92, P421, DOI 10.1021/j100313a036; Das U, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2150813; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Eley DD, 1940, NATURE, V146, P401, DOI 10.1038/146401d0; Guevara-Garcia A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1926279; Hakkinen H, 2003, ANGEW CHEM INT EDIT, V42, P1297, DOI 10.1002/anie.200390334; Jones NO, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2189218; KHANNA SN, 1995, PHYS REV B, V51, P13705, DOI 10.1103/PhysRevB.51.13705; KNIGHT WD, 1984, PHYS REV LETT, V53, P510, DOI 10.1103/PhysRevLett.53.510.2; LEUCHTNER RE, 1989, J CHEM PHYS, V91, P2753, DOI 10.1063/1.456988; Lippa TP, 1999, CHEM PHYS LETT, V305, P75, DOI 10.1016/S0009-2614(99)00330-9; Michaelides A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075409; Reber AC, 2007, J AM CHEM SOC, V129, P16098, DOI 10.1021/ja075998d; Reveles JU, 2006, P NATL ACAD SCI USA, V103, P18405, DOI 10.1073/pnas.0608781103; Roach PJ, 2007, P NATL ACAD SCI USA, V104, P14565, DOI 10.1073/pnas.0706613104; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Sun Q, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.053203; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; WOODALL JM, 2007, P 2 EN NAN INT C ASM	26	236	236	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					492	495		10.1126/science.1165884	http://dx.doi.org/10.1126/science.1165884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164745				2022-12-28	WOS:000262587900039
J	Crisp, MD; Arroyo, MTK; Cook, LG; Gandolfo, MA; Jordan, GJ; McGlone, MS; Weston, PH; Westoby, M; Wilf, P; Linder, HP				Crisp, Michael D.; Arroyo, Mary T. K.; Cook, Lyn G.; Gandolfo, Maria A.; Jordan, Gregory J.; McGlone, Matt S.; Weston, Peter H.; Westoby, Mark; Wilf, Peter; Linder, H. Peter			Phylogenetic biome conservatism on a global scale	NATURE			English	Article							GENUS OREOMYRRHIS APIACEAE; LONG-DISTANCE DISPERSAL; MOLECULAR PHYLOGENY; NEW-ZEALAND; NICHE CONSERVATISM; SEQUENCE DATA; SENSU-LATO; EVOLUTION; BIOGEOGRAPHY; CHLOROPLAST	How and why organisms are distributed as they are has long intrigued evolutionary biologists(1-4). The tendency for species to retain their ancestral ecology has been demonstrated in distributions on local and regional scales(5-7), but the extent of ecological conservatism over tens of millions of years and across continents has not been assessed(8-13). Here we show that biome stasis at speciation has outweighed biome shifts by a ratio of more than 25:1, by inferring ancestral biomes for an ecologically diverse sample of more than 11,000 plant species from around the Southern Hemisphere. Stasis was also prevalent in transocean colonizations. Availability of a suitable biome could have substantially influenced which lineages establish on more than one landmass, in addition to the influence of the rarity of the dispersal events themselves. Conversely, the taxonomic composition of biomes has probably been strongly influenced by the rarity of species' transitions between biomes. This study has implications for the future because if clades have inherently limited capacity to shift biomes(13), then their evolutionary potential could be strongly compromised by biome contraction as climate changes.	[Crisp, Michael D.] Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; [Arroyo, Mary T. K.] Univ Chile, Inst Ecol & Biodivers, Santiago, Chile; [Cook, Lyn G.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Gandolfo, Maria A.] Cornell Univ, Dept Plant Biol, LH Bailey Hortorium, Ithaca, NY 14853 USA; [Jordan, Gregory J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [McGlone, Matt S.] Landcare Res, Lincoln 7640, New Zealand; [Weston, Peter H.] Natl Herbarium New S Wales, Sydney, NSW 2000, Australia; [Westoby, Mark] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Linder, H. Peter] Univ Zurich, Inst Systemat Biol, CH-8008 Zurich, Switzerland	Australian National University; Universidad de Chile; University of Queensland; Cornell University; University of Tasmania; Landcare Research - New Zealand; Macquarie University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Zurich	Crisp, MD (corresponding author), Australian Natl Univ, Sch Bot & Zool, GPO Box 4, Canberra, ACT 0200, Australia.	mike.crisp@anu.edu.au	Crisp, Michael D/A-4888-2008; Linder, Hans Peter/F-5316-2010; Cook, Lyn/G-7336-2012; Jordan, Gregory/B-3932-2013	Crisp, Michael D/0000-0002-8255-6349; Cook, Lyn/0000-0002-3172-4920; Jordan, Gregory/0000-0002-6033-2766; Wilf, Peter/0000-0001-6813-1937; Westoby, Mark/0000-0001-7690-4530; Weston, Peter/0000-0001-8920-5376	Australian Research Council-New Zealand Research Network for Vegetation Function; US National Science Foundation	Australian Research Council-New Zealand Research Network for Vegetation Function(Australian Research Council); US National Science Foundation(National Science Foundation (NSF))	We thank the Australian Research Council-New Zealand Research Network for Vegetation Function for facilitating this collaboration. Participation by M. A. G. and P. W. was supported in part by a grant from the US National Science Foundation.	Aagesen L, 2005, PLANT SYST EVOL, V250, P197, DOI 10.1007/s00606-004-0204-5; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; Barker NP, 2007, PLANT SYST EVOL, V264, P135, DOI 10.1007/s00606-006-0479-9; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Barnes RW, 2001, AUST J BOT, V49, P301, DOI 10.1071/BT00036; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Berry PE, 2004, AM J BOT, V91, P601, DOI 10.3732/ajb.91.4.601; Bogler DJ, 2004, BOT REV, V70, P260, DOI 10.1663/0006-8101(2004)070[0260:MSSICE]2.0.CO;2; Bradford JC, 2002, ANN MO BOT GARD, V89, P491, DOI 10.2307/3298592; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Briggs BG, 2000, MONOCOTS SYSTEMATICS, P661; Burgoyne PM, 2005, J AFR EARTH SCI, V43, P13, DOI 10.1016/j.jafrearsci.2005.07.015; Bytebier B, 2007, MOL PHYLOGENET EVOL, V43, P75, DOI 10.1016/j.ympev.2006.08.014; Case AL, 2008, INT J PLANT SCI, V169, P141, DOI 10.1086/523368; Chandler GT, 2007, AUST SYST BOT, V20, P390, DOI 10.1071/SB07004; Chung KF, 2005, AM J BOT, V92, P2054, DOI 10.3732/ajb.92.12.2054; Chung KF, 2007, SYST BOT, V32, P671, DOI 10.1600/036364407782250517; Clements Mark A., 2002, Lindleyana, V17, P135; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Crayn DM, 2006, AM J BOT, V93, P1328, DOI 10.3732/ajb.93.9.1328; Crayn DM, 1998, AUST J BOT, V46, P187, DOI 10.1071/BT97019; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Crisp M, 2006, J BIOGEOGR, V33, P1332, DOI 10.1111/j.1365-2699.2006.01551.x; DARWIN CR, 1855, GARDENERS CHRONICLE, V21, P356; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Ford KA, 2007, TAXON, V56, P783, DOI 10.2307/25065861; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Goldblatt P, 2004, BOT J LINN SOC, V144, P41, DOI 10.1111/j.0024-4074.2004.00246.x; Goldblatt Peter, 2006, Aliso, V22, P399; Hallam A., 1994, OUTLINE PHANEROZOIC; Heenan PB, 1998, NEW ZEAL J BOT, V36, P53; Hershkovitz MA, 2006, PLANT SYST EVOL, V260, P1, DOI 10.1007/s00606-006-0428-7; Hershkovitz MA, 2006, MOL PHYLOGENET EVOL, V41, P594, DOI 10.1016/j.ympev.2006.05.003; Hill K.D., 1998, FLORA AUSTR, V48, P717; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; Hill RS, 2004, PHILOS T R SOC B, V359, P1537, DOI 10.1098/rstb.2004.1526; Hopper SD, 1999, BOT J LINN SOC, V131, P285, DOI 10.1111/j.1095-8339.1999.tb00770.x; Howarth DG, 2003, AM J BOT, V90, P915, DOI 10.3732/ajb.90.6.915; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Irwin H. S., 1982, The American Cassiinae: a synoptical revision of Leguminosae tribe Cassieae subtribe Cassiinae in the New World.; Jones D.L., 2002, AUSTR ORCHID REV, V4, P125; Jones DL., 2002, AUSTR ORCHID REV, V67, P3; Kadereit G, 2005, ORG DIVERS EVOL, V5, P59, DOI 10.1016/j.ode.2004.07.002; Kadereit G, 2006, TAXON, V55, P617, DOI 10.2307/25065639; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Knapp M, 2005, PLOS BIOL, V3, P38, DOI 10.1371/journal.pbio.0030014; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kores PJ, 2001, AM J BOT, V88, P1903, DOI 10.2307/3558366; Kron KA, 1999, PLANT SYST EVOL, V218, P55, DOI 10.1007/BF01087034; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Linder HP, 2005, NOVA ACT LC, V92, P29; Linder HP, 1995, CLADISTICS, V11, P5, DOI 10.1111/j.1096-0031.1995.tb00002.x; LINDER HP, 2000, GRASS SYSTEMATIC EVO, V2; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Manos PS, 1997, AM J BOT, V84, P1137, DOI 10.2307/2446156; Marazzi B, 2006, AM J BOT, V93, P288, DOI 10.3732/ajb.93.2.288; Mast AR, 2008, AM J BOT, V95, P843, DOI 10.3732/ajb.0700006; Mckenzie RJ, 2006, AM J BOT, V93, P1222, DOI 10.3732/ajb.93.8.1222; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Meudt HM, 2006, BIOL J LINN SOC, V87, P479, DOI 10.1111/j.1095-8312.2006.00584.x; Mitchell AD, 2000, NEW ZEAL J BOT, V38, P409; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; ORNLAND KE, 2008, BIOESSAYS, V30, P854; Orthia LA, 2005, AUST SYST BOT, V18, P133, DOI 10.1071/SB04028; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez F, 2006, AM J BOT, V93, P1029, DOI 10.3732/ajb.93.7.1029; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Plunkett GM, 2005, ANN MO BOT GARD, V92, P202; Plunkett GM, 2004, INT J PLANT SCI, V165, P861, DOI 10.1086/421855; Poole I, 1999, REV PALAEOBOT PALYNO, V107, P97, DOI 10.1016/S0034-6667(99)00013-5; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Pye MG, 2003, AUST SYST BOT, V16, P505, DOI 10.1071/SB02019; Qian H, 2004, J ECOL, V92, P253, DOI 10.1111/j.0022-0477.2004.00868.x; Quinn CJ, 2005, AUST SYST BOT, V18, P439, DOI 10.1071/SB05005; Quinn CJ, 2003, AUST SYST BOT, V16, P581, DOI 10.1071/SB03012; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Reeves G, 2001, AM J BOT, V88, P2074, DOI 10.2307/3558433; Renner SS, 2000, SYST BIOL, V49, P579, DOI 10.1080/10635159950127402; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Schonenberger J, 2003, AM J BOT, V90, P293, DOI 10.3732/ajb.90.2.293; Schuettpelz E, 2004, AM J BOT, V91, P247, DOI 10.3732/ajb.91.2.247; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; SIMPSON MG, 1990, ANN MO BOT GARD, V77, P722, DOI 10.2307/2399670; Smissen RD, 2003, AUST SYST BOT, V16, P301, DOI 10.1071/SB01032; Smissen RD, 2002, BOT J LINN SOC, V140, P15, DOI 10.1046/j.1095-8339.2002.00081.x; Steane DA, 2003, MOL PHYLOGENET EVOL, V28, P47, DOI 10.1016/S1055-7903(03)00028-9; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Stockey RA., 2005, MONOGRAPH CUPRESSACE, P54; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Sweeney PW, 2004, ANN MO BOT GARD, V91, P266; SWENSON U, 1995, PLANT SYST EVOL, V197, P149, DOI 10.1007/BF00984638; Thompson Joy, 1993, Telopea, V5, P427; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Treutlein J, 2005, PLANT BIOLOGY, V7, P79, DOI 10.1055/s-2004-830478; Verboom GA, 2003, EVOLUTION, V57, P1008, DOI 10.1111/j.0014-3820.2003.tb00312.x; Vinnersten A, 2003, AM J BOT, V90, P1455, DOI 10.3732/ajb.90.10.1455; Wagstaff SJ, 2006, TAXON, V55, P95, DOI 10.2307/25065531; Wagstaff SJ, 1999, AM J BOT, V86, P1346, DOI 10.2307/2656781; Wagstaff SJ, 2000, SYST BOT, V25, P134, DOI 10.2307/2666679; Weston Peter H., 2006, Telopea, V11, P314; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson P.G., 1984, FLORA AUSTR, V4, P81; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Winkworth RC, 2002, MOL PHYLOGENET EVOL, V24, P180, DOI 10.1016/S1055-7903(02)00210-5; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672	127	496	505	5	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					754	U90		10.1038/nature07764	http://dx.doi.org/10.1038/nature07764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219025				2022-12-28	WOS:000265193600039
J	Yang, GH				Yang, Gonghuan			Salt intake in individuals with metabolic syndrome	LANCET			English	Editorial Material							CHINA		[Yang, Gonghuan] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Yang, Gonghuan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100037, Peoples R China; [Yang, Gonghuan] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, GH (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China.	yanggh@chinacdc.cn						[Anonymous], 2002, CARD DEATH DIS CAN B; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Chinese Nutrition Society, 2008, CHIN DIET GUID; *FOOD STAND AG, STRAT PLAN 2005 2010; Food Standard Agency, 2006, REG IMP ASS SETT TAR; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Havas S, 2007, JAMA-J AM MED ASSOC, V298, P1439, DOI 10.1001/jama.298.12.1439; Katsuya T, 2003, HYPERTENS RES, V26, P521, DOI 10.1291/hypres.26.521; ROOS G, 2007, P NORD CONS POL RES; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Wang LD, 2005, COMPREHENSIVE REPORT; World Health Organization, 2006, RED SALT INT POP REP; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; [姚崇华 YAO Chonghua], 2007, [中国糖尿病杂志, Chinese Journal of Diabetes], V15, P332	15	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 7	2009	373	9666					792	794		10.1016/S0140-6736(09)60145-8	http://dx.doi.org/10.1016/S0140-6736(09)60145-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19223068				2022-12-28	WOS:000263980900008
J	Deller, AT; Bailes, M; Tingay, SJ				Deller, A. T.; Bailes, M.; Tingay, S. J.			Implications of a VLBI Distance to the Double Pulsar J0737-3039A/B	SCIENCE			English	Article							X-RAY-EMISSION; SYSTEM J0737-3039; MILLISECOND PULSAR; HIPPARCOS	The double pulsar J0737-3039A/B is a unique system with which to test gravitational theories in the strong-field regime. However, the accuracy of such tests will be limited by knowledge of the distance and relative motion of the system. Here we present very long baseline interferometry (VLBI) observations which reveal that the distance to PSR J0737-3039A/B is 1150(-160)(+220) parsecs, more than double previous estimates, and confirm its low transverse velocity (similar to 9 kilometers per second). Combined with a decade of pulsar timing, these results will allow tests of gravitational radiation emission theories at the 0.01% uncertainty level, putting stringent constraints on theories that predict dipolar gravitational radiation. They also allow insight into the system's formation and the source of its high-energy emission.	[Deller, A. T.; Bailes, M.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Tingay, S. J.] Curtin Univ Technol, Curtin Inst Radio Astron, Bentley, WA 6102, Australia	Swinburne University of Technology; Curtin University	Deller, AT (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, Mail H39,POB 218, Hawthorn, Vic 3122, Australia.	adeller@astro.swin.edu.au	Tingay, Steven J/B-5271-2013	Tingay, Steven J/0000-0002-8195-7562; Bailes, Matthew/0000-0003-3294-3081; Deller, Adam/0000-0001-9434-3837	Swinburne University of Technology [Chancellor's Research Scholarship]; Commonwealth Scientific and Industrial Research Organisation (CSIRO) [postgraduate scholarship]; Commonwealth of Australia	Swinburne University of Technology; Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Commonwealth of Australia(Australian Government)	We acknowledge discussions with M. Kramer and E. van den Heuvel. A.T.D. is supported via a Swinburne University of Technology Chancellor's Research Scholarship and a Commonwealth Scientific and Industrial Research Organisation (CSIRO) postgraduate scholarship. The Long Baseline Array is part of the Australia Telescope, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO.	ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; BECKER W, 2000, P IAU S, V195, P49; Blaauw A., 1961, BAN, V15, P265; Brisken WF, 2003, ASTROPHYS J, V593, pL89, DOI 10.1086/378184; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Champion DJ, 2008, SCIENCE, V320, P1309, DOI 10.1126/science.1157580; Chatterjee S, 2007, ASTROPHYS J, V670, P1301, DOI 10.1086/522298; DAMOUR T, 1991, ASTROPHYS J, V366, P501, DOI 10.1086/169585; Dias WS, 2005, ASTROPHYS J, V629, P825, DOI 10.1086/431456; Feast M. W., 1965, MONTHLY NOTICES ASTR, V130, P245; Grindlay JE, 2002, ASTROPHYS J, V581, P470, DOI 10.1086/344150; Holmberg J, 2004, MON NOT R ASTRON SOC, V352, P440, DOI 10.1111/j.1365-2966.2004.07931.x; Kalogera V, 2004, ASTROPHYS J, V601, pL179, DOI 10.1086/382155; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Kramer M, 1998, ASTROPHYS J, V501, P270, DOI 10.1086/305790; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Lyutikov M, 2004, MON NOT R ASTRON SOC, V353, P1095, DOI 10.1111/j.1365-2966.2004.08129.x; McLaughlin MA, 2004, ASTROPHYS J, V605, pL41, DOI 10.1086/392511; Mignard F, 2000, ASTRON ASTROPHYS, V354, P522; Pellizzoni A, 2008, ASTROPHYS J, V679, P664, DOI 10.1086/587053; Piran T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.051102; Possenti A, 2008, ASTROPHYS J, V680, P654, DOI 10.1086/587950; Shklovskii I. S., 1970, SOV ASTRON, V13, P562; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Willems B, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.043003	25	41	42	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1327	1329		10.1126/science.1167969	http://dx.doi.org/10.1126/science.1167969			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19197023	Green Submitted			2022-12-28	WOS:000263876700037
J	Douglas, JM				Douglas, John M., Jr.			Penicillin Treatment of Syphilis Clearing Away the Shadow on the Land	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONGENITAL-SYPHILIS; UNITED-STATES; ELIMINATION; TRIALS		[Douglas, John M., Jr.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div STD Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Douglas, JM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div STD Prevent, 1600 Clifton Rd NE,MS-E02, Atlanta, GA 30333 USA.	jyd3@cdc.gov						Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bai ZG, 2008, INT J STD AIDS, V19, P217, DOI 10.1258/ijsa.2007.007245; Borisenko KK, 1999, INT J STD AIDS, V10, P665, DOI 10.1258/0956462991913240; *CDCP, 2007, SEX TRANSM DIS SURV; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Douglas JM, 2005, SEX TRANSM DIS, V32, pS80, DOI 10.1097/01.olq.0000180571.48799.8d; Fenton KA, 2008, LANCET INFECT DIS, V8, P244, DOI 10.1016/S1473-3099(08)70065-3; Mahoney JF, 1944, J AMER MED ASSOC, V126, P63, DOI 10.1001/jama.1944.02850370001001; Moore JE, 1944, J AMER MED ASSOC, V126, P67, DOI 10.1001/jama.1944.02850370005002; PARRAN T, 1937, SHADOW LAND SYPHILLI; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Schmid GP, 2007, SEX TRANSM DIS, V34, pS5, DOI 10.1097/01.olq.0000261456.09797.1b; SPARLING PF, 2007, SEXUALLY TRANSMITTED, P661; Stokes JH, 1944, J AMER MED ASSOC, V126, P73, DOI 10.1001/jama.1944.02850370011003; Tramont E., 2005, PRINCIPLES PRACTICE, P276; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31	16	30	34	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					769	771		10.1001/jama.2009.143	http://dx.doi.org/10.1001/jama.2009.143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224755				2022-12-28	WOS:000263370100021
J	Strangfeld, A; Listing, J; Herzer, P; Liebhaber, A; Rockwitz, K; Richter, C; Zink, A				Strangfeld, Anja; Listing, Joachim; Herzer, Peter; Liebhaber, Anke; Rockwitz, Karin; Richter, Constanze; Zink, Angela			Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-alpha Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-NECROSIS-FACTOR; POSTHERPETIC NEURALGIA; MONOCLONAL-ANTIBODY; INFECTIONS; THERAPY; EPIDEMIOLOGY; METHOTREXATE; ETANERCEPT; INFLIXIMAB; ADALIMUMAB	Context The risk of bacterial infection is increased in patients treated with drugs that inhibit tumor necrosis factor alpha ( TNF- alpha). Little is known about the reactivation of latent viral infections during treatment with TNF- alpha inhibitors. Objective To investigate whether TNF- alpha inhibitors together as a class, or separately as either monoclonal anti-TNF-alpha antibodies (adalimumab, infliximab) or a fusion protein ( etanercept), are related to higher rates of herpes zoster in patients with rheumatoid arthritis. Design, Setting, and Patients Patients were enrolled in the German biologics register RABBIT, a prospective cohort, between May 2001 and December 2006 at the initiation of treatment with infliximab, etanercept, adalimumab, or anakinra, or when they changed conventional disease- modifying antirheumatic drug ( DMARD). Treatment, clinical status, and adverse events were assessed by rheumatologists at fixed points during follow- up. Main Outcome Measures Hazard ratio ( HR) of herpes zoster episodes following anti - TNF- alpha treatment. Study aims were to detect a clinically significant difference ( HR, 2.0) between TNF- alpha inhibitors as a class compared with DMARDs and to detect an HR of at least 2.5 for each of 2 types of TNF- alpha inhibitors, the monoclonal antibodies or the fusion protein, compared with conventional DMARDs. Results Among 5040 patients receiving TNF- alpha inhibitors or conventional DMARDs, 86 episodes of herpes zoster occurred in 82 patients. Thirty- nine occurrences could be attributed to treatment with anti - TNF- alpha antibodies, 23 to etanercept, and 24 to conventional DMARDs. The crude incidence rate per 1000 patient- years was 11.1 ( 95% confidence interval [ CI], 7.9- 15.1) for the monoclonal antibodies, 8.9 ( 95% CI, 5.6-13.3) for etanercept, and 5.6 ( 95% CI, 3.6- 8.3) for conventional DMARDs. Adjusted for age, rheumatoid arthritis severity, and glucocorticoid use, a significantly increased risk was observed for treatment with the monoclonal antibodies ( HR, 1.82 [ 95% CI, 1.05- 3.15]), although this risk was lower than the threshold for clinical significance. No significant associations were found for etanercept use ( HR, 1.36 [ 95% CI, 0.73-2.55]) or for anti - TNF- alpha treatment ( HR, 1.63 [ 95% CI, 0.97- 2.74]) as a class. Conclusion Treatment with monoclonal anti - TNF- alpha antibodies may be associated with increased risk of herpes zoster, but this requires further study.	[Strangfeld, Anja; Listing, Joachim; Zink, Angela] German Rheumatism Res Ctr, Epidemiol Unit, D-10117 Berlin, Germany; [Zink, Angela] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Strangfeld, A (corresponding author), German Rheumatism Res Ctr, Epidemiol Unit, Charitepl 1, D-10117 Berlin, Germany.	strangfeld@drfz.de						ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Furst DE, 2003, J RHEUMATOL, V30, P2563; GLYNN C, 1990, J ROY SOC MED, V83, P617, DOI 10.1177/014107689008301007; Gupta G, 2006, CLIN GASTROENTEROL H, V4, P1483, DOI 10.1016/j.cgh.2006.09.019; *INT C HARM, CLIN SAF DAT MAN DEF; Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lautenschlager J, 1997, Z RHEUMATOL, V56, P144, DOI 10.1007/s003930050030; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; LOCKSLEY RM, 1985, J INFECT DIS, V152, P1172, DOI 10.1093/infdis/152.6.1172; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Moreland LW, 2006, J RHEUMATOL, V33, P854; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pham Thao, 2005, Joint Bone Spine, V72 Suppl 1, pS1; Pope JE, 2004, J RHEUMATOL, V31, P274; Schrauder A, 2007, LANCET, V369, P1232, DOI 10.1016/S0140-6736(07)60567-4; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Strangfeld A, 2006, BEST PRACT RES CL RH, V20, P1181, DOI 10.1016/j.berh.2006.08.010; The British Society for Rheumatology, 2002, VACC IMM PERS GUID P; THEMEAU TM, 2000, MODELLING SURVIVAL D; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Woodworth TG, 2001, J RHEUMATOL, V28, P1163; Zink A, 2005, ANN RHEUM DIS, V64, P1274, DOI 10.1136/ard.2004.031476	38	396	413	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					737	744		10.1001/jama.2009.146	http://dx.doi.org/10.1001/jama.2009.146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224750	Bronze			2022-12-28	WOS:000263370100016
J	Laurance, J				Laurance, Jeremy			On Reflection Ticking the right boxes	LANCET			English	Editorial Material												J.Laurance@independent.co.uk						Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					537	537		10.1016/S0140-6736(09)60188-4	http://dx.doi.org/10.1016/S0140-6736(09)60188-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217977				2022-12-28	WOS:000263333600016
J	Bezier, A; Annaheim, M; Herbiniere, J; Wetterwald, C; Gyapay, G; Bernard-Samain, S; Wincker, P; Roditi, I; Heller, M; Belghazi, M; Pfister-Wilhem, R; Periquet, G; Dupuy, C; Huguet, E; Volkoff, AN; Lanzrein, B; Drezen, JM				Bezier, Annie; Annaheim, Marc; Herbiniere, Juline; Wetterwald, Christoph; Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick; Roditi, Isabel; Heller, Manfred; Belghazi, Maya; Pfister-Wilhem, Rita; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Volkoff, Anne-Nathalie; Lanzrein, Beatrice; Drezen, Jean-Michel			Polydnaviruses of Braconid Wasps Derive from an Ancestral Nudivirus	SCIENCE			English	Article							GENOME SEQUENCE; CHELONUS-INANITUS; VIRUS; DNA; EVOLUTION; REPLICATION; GENES; SYMBIOSIS; INSIGHTS; REVEALS	Many species of parasitoid wasps inject polydnavirus particles in order to manipulate host defenses and development. Because the DNA packaged in these particles encodes almost no viral structural proteins, their relation to viruses has been debated. Characterization of complementary DNAs derived from braconid wasp ovaries identified genes encoding subunits of a viral RNA polymerase and structural components of polydnavirus particles related most closely to those of nudiviruses- a sister group of baculoviruses. The conservation of this viral machinery in different braconid wasp lineages sharing polydnaviruses suggests that parasitoid wasps incorporated a nudivirus- related genome into their own genetic material. We found that the nudiviral genes themselves are no longer packaged but are actively transcribed and produce particles used to deliver genes essential for successful parasitism in lepidopteran hosts.	[Bezier, Annie; Herbiniere, Juline; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Drezen, Jean-Michel] Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France; [Annaheim, Marc; Wetterwald, Christoph; Roditi, Isabel; Pfister-Wilhem, Rita; Lanzrein, Beatrice] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick] Genoscope Ctr Natl Sequencage, CEA, F-91057 Evry, France; [Belghazi, Maya] Ctr Anal Proteom Marseille, Inst Federatif Rech J Roche IFR11, INSERM, Fac Med, F-13916 Marseille 20, France; [Volkoff, Anne-Nathalie] Univ Montpellier 2, INRA, UMR 1231, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; University of Bern; University of Bern; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier	Drezen, JM (corresponding author), Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, Parc Grandmont, F-37200 Tours, France.	drezen@univ-tours.fr	BEZIER, Annie/B-4429-2016; Dupuy, Catherine/AFK-5583-2022; Huguet, Elisabeth/D-3321-2009	BEZIER, Annie/0000-0002-2528-4260; Dupuy, Catherine/0000-0002-3947-3580; Huguet, Elisabeth/0000-0002-0096-0330; Heller, Manfred/0000-0002-6364-7325; Roditi, Isabel/0000-0003-2812-6513; Drezen, Jean-Michel/0000-0001-7578-635X	Agence Nationale de la Recherche (France); CNRS [GDR 2153, GDR 2157, IFR 136]; Swiss National Science Foundation [3100A0-103964, 3100A0-116067]	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Investigations of C. congregata and H. didymator were performed as part of the project EVPARASITOID supported by the agencies Agence Nationale de la Recherche ( France) and CNRS (GDR 2153, GDR 2157, and IFR 136). C. inanitus study was supported by the Swiss National Science Foundation ( grants 3100A0- 103964 and 116067 to B. L.). We thank E. Herniou for helpful discussions and C. Menoret and C. Labrousse for insect- rearing. Sequences have been deposited in the EMBL Nucleotide Sequence Database, accession numbers FM201559- 80, FM201582- 97, and FM877774 for the viral cDNAs and FM212911- 15 for the chromosomally integrated form of nudivirus- related genes.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Annaheim M, 2007, J GEN VIROL, V88, P450, DOI 10.1099/vir.0.82396-0; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Cheng CH, 2002, J VIROL, V76, P9024, DOI 10.1128/JVI.76.18.9024-9034.2002; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; GRANADOS RR, 1978, INTERVIROLOGY, V10, P309, DOI 10.1159/000148993; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Pasquier-Barre F, 2002, J GEN VIROL, V83, P2035, DOI 10.1099/0022-1317-83-8-2035; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; Raina AK, 2000, J INVERTEBR PATHOL, V76, P6, DOI 10.1006/jipa.2000.4942; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang YJ, 2008, J VIROL METHODS, V152, P106, DOI 10.1016/j.jviromet.2008.06.003; Wang YJ, 2007, J VIROL, V81, P5395, DOI 10.1128/JVI.02781-06; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Weber B, 2007, ARCH INSECT BIOCHEM, V66, P9, DOI 10.1002/arch.20190; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Wyder S, 2003, J INSECT PHYSIOL, V49, P491, DOI 10.1016/S0022-1910(03)00056-8	29	223	234	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					926	930		10.1126/science.1166788	http://dx.doi.org/10.1126/science.1166788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213916	Green Published			2022-12-28	WOS:000263295400040
J	Neumann, GA; Mazarico, E				Neumann, Gregory A.; Mazarico, Erwan			PLANETARY SCIENCE Seeing the Missing Half	SCIENCE			English	Editorial Material							LUNAR; MASCONS; BASINS		[Neumann, Gregory A.; Mazarico, Erwan] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Neumann, GA (corresponding author), NASA, Goddard Space Flight Ctr, Code 698, Greenbelt, MD 20771 USA.	gregory.a.neumann@nasa.gov; erwan.m.mazarico@nasa.gov	Mazarico, Erwan/N-6034-2014; Neumann, Gregory A/I-5591-2013	Mazarico, Erwan/0000-0003-3456-427X; Neumann, Gregory A/0000-0003-0644-9944				Araki H, 2009, SCIENCE, V323, P897, DOI 10.1126/science.1164146; Cameron A. G. W., 1976, LUNAR SCI, V7, P120; CONEL JE, 1968, SCIENCE, V162, P1403, DOI 10.1126/science.162.3860.1403; Haruyama J, 2009, SCIENCE, V323, P905, DOI 10.1126/science.1163382; HEAD JW, 1976, REV GEOPHYS, V14, P265, DOI 10.1029/RG014i002p00265; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Lemoine FGR, 1997, J GEOPHYS RES-PLANET, V102, P16339, DOI 10.1029/97JE01418; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Ono T, 2009, SCIENCE, V323, P909, DOI 10.1126/science.1165988; PHILLIPS RJ, 1973, P 4 LUN SCI C, P2821; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SOLOMON SC, 1980, REV GEOPHYS, V18, P107, DOI 10.1029/RG018i001p00107; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; WISE DU, 1970, J GEOPHYS RES, V75, P261, DOI 10.1029/JB075i002p00261	16	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					885	887		10.1126/science.1170655	http://dx.doi.org/10.1126/science.1170655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213904				2022-12-28	WOS:000263295400026
J	Mukundan, D; Jenkins, O				Mukundan, Deepa; Jenkins, Oliver			A Tuba Player with Air in the Parotid Gland	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mukundan, Deepa] Univ Toledo, Toledo, OH 43608 USA; [Jenkins, Oliver] NW Ohio ENT Consultants, Perrysburg, OH 43551 USA	University System of Ohio; University of Toledo	Mukundan, D (corresponding author), Univ Toledo, Toledo, OH 43608 USA.	deepa.mukundan@utoledo.edu	Mukundan, Deepa/AAA-1898-2020						0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					710	710		10.1056/NEJMicm0706236	http://dx.doi.org/10.1056/NEJMicm0706236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213684				2022-12-28	WOS:000263260500008
J	Kawase, T; Ohki, R; Shibata, T; Tsutsumi, S; Kamimura, N; Inazawa, J; Ohta, T; Ichikawa, H; Aburatani, H; Tashiro, F; Taya, Y				Kawase, Tatsuya; Ohki, Rieko; Shibata, Tatsuhiro; Tsutsumi, Shuichi; Kamimura, Naoko; Inazawa, Johji; Ohta, Tsutomu; Ichikawa, Hitoshi; Aburatani, Hiroyuki; Tashiro, Fumio; Taya, Yoichi			PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt	CELL			English	Article							GENOMIC HYBRIDIZATION ANALYSIS; PLECKSTRIN-HOMOLOGY DOMAINS; CANDIDATE MEDIATOR; KINASE B; P53; ACTIVATION; PATHWAY; LUNG; FAMILY; CANCER	p53 and Akt are critical players regulating tumorigenesis with opposite effects: whereas p53 transactivates target genes to exert its function as a tumor suppressor, Akt phosphorylates its substrates and transduces downstream survival signals. In addition, p53 and Akt negatively regulate each other to balance survival and death signals within a cell. We now identify PHLDA3 as a p53 target gene that encodes a PH domain-only protein. We find that PHLDA3 competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation. Ablation of endogenous PHLDA3 results in enhanced Akt activity and decrease of p53-dependent apoptosis. We also demonstrate the suppression of anchorage-independent cell growth by PHLDA3. Loss of the PHLDA3 genomic locus was frequently observed in primary lung cancers, suggesting a role of PHLDA3 in tumor suppression. Our results reveal a new mode of coordination between the p53 and Akt pathways.	[Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Canc Genom Project, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan; [Ohta, Tsutomu] Natl Canc Ctr, Res Inst, Ctr Med Genom, Chuo Ku, Tokyo 1040045, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Tsutsumi, Shuichi; Kamimura, Naoko; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Kawase, Tatsuya; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2708510, Japan; [Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] SORST JST, Kawaguchi, Saitama 3320012, Japan; [Taya, Yoichi] Natl Univ Singapore, Ctr Life Sci, Canc Res Ctr Excellence, Singapore 117456, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo University of Science; Japan Science & Technology Agency (JST); National University of Singapore	Ohki, R (corresponding author), Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	rohki@ncc.go.jp	Shibata, Tatsuhiro/ABA-8234-2020; Shibata, Tatsuhiro/AAO-1278-2021		Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science for Young Scientists	Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Atsushi Okabe for production of ChIP-chip and ChIP sequence data and Hiroko Meguro and Kaori Shiina for analysis of ChIP-chip and ChIP sequence samples. This study was supported by the program for the promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency ( to T. O. and H. I.), a Grant-in-Aid for Scientific Research and a grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to H. A.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to Y. T.), and a Grant-in-Aid for Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan ( to T. S. and Y. T.). T. K. is a recipient of a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kawase T, 2008, ONCOGENE, V27, P3797, DOI 10.1038/onc.2008.32; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Moore SM, 1998, CANCER RES, V58, P5239; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Peng WX, 2005, CANCER SCI, V96, P661, DOI 10.1111/j.1349-7006.2005.00092.x; Ren Y, 2003, ANTICANCER RES, V23, P3231; Righi L, 2007, VIRCHOWS ARCH, V451, pS51, DOI 10.1007/s00428-007-0445-0; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	37	151	160	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					535	550		10.1016/j.cell.2008.12.002	http://dx.doi.org/10.1016/j.cell.2008.12.002			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203586	Bronze			2022-12-28	WOS:000263120600022
J	Head, JJ; Bloch, JI; Hastings, AK; Bourque, JR; Cadena, EA; Herrera, FA; Polly, PD; Jaramillo, CA				Head, Jason J.; Bloch, Jonathan I.; Hastings, Alexander K.; Bourque, Jason R.; Cadena, Edwin A.; Herrera, Fabiany A.; Polly, P. David; Jaramillo, Carlos A.			Giant boid snake from the Palaeocene neotropics reveals hotter past equatorial temperatures	NATURE			English	Article							BODY-SIZE; GIGANTISM; CLIMATE; NUCLEAR; CO2	The largest extant snakes live in the tropics of South America and southeast Asia(1-3) where high temperatures facilitate the evolution of large body sizes among air- breathing animals whose body temperatures are dependant on ambient environmental temperatures ( poikilothermy)(4,5). Very little is known about ancient tropical terrestrial ecosystems, limiting our understanding of the evolution of giant snakes and their relationship to climate in the past. Here we describe a boid snake from the oldest known neotropical rainforest fauna from the Cerrejon Formation ( 58 - 60 Myr ago) in northeastern Colombia. We estimate a body length of 13 and a mass of 1,135 kg, making it the largest known snake(6-9). The maximum size of poikilothermic animals at a given temperature is limited by metabolic rate(4), and a snake of this size would require a minimum mean annual temperature of 30 - 34 degrees C to survive. This estimate is consistent with hypotheses of hot Palaeocene neotropics with high concentrations of atmospheric CO2 based on climate models(10). Comparison of palaeotemperature estimates from the equator to those from South American mid- latitudes indicates a relatively steep temperature gradient during the early Palaeogene greenhouse, similar to that of today. Depositional environments and faunal composition of the Cerrejon Formation indicate an anaconda- like ecology for the giant snake, and an earliest Cenozoic origin of neotropical vertebrate faunas.	[Head, Jason J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Bloch, Jonathan I.; Hastings, Alexander K.; Bourque, Jason R.; Cadena, Edwin A.; Herrera, Fabiany A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Cadena, Edwin A.; Herrera, Fabiany A.; Jaramillo, Carlos A.] Smithsonian Trop Res Inst, Balboa, Panama; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of Toronto; University Toronto Mississauga; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; Indiana University System; Indiana University Bloomington	Head, JJ (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	jason.head@utoronto.ca	Alberto, Edwin/O-7220-2018; Hastings, Alan/O-6864-2019; Polly, P. David/ABC-6597-2020	Alberto, Edwin/0000-0003-3038-567X; Hastings, Alan/0000-0002-0717-8026; Polly, P. David/0000-0001-7338-8526; jaramillo, carlos/0000-0002-2616-5079; Bloch, Jonathan/0000-0003-1484-6931; Head, Jason/0000-0002-2237-6901	National Science Foundation; Fondo para Investigaciones del Banco de la Republica de Colombia; Smithsonian Tropical Research Institute Paleobiology Fund; Florida Museum of Natural History; Geological Society of America Graduate Student Research Grant; National Sciences and Engineering Research Council of Canada Discovery Grant	National Science Foundation(National Science Foundation (NSF)); Fondo para Investigaciones del Banco de la Republica de Colombia; Smithsonian Tropical Research Institute Paleobiology Fund(Smithsonian InstitutionSmithsonian Tropical Research Institute); Florida Museum of Natural History; Geological Society of America Graduate Student Research Grant; National Sciences and Engineering Research Council of Canada Discovery Grant	We thank C. Bell, R. Ghent, E. Kowalski, A. M. Lawing, B. MacFadden, R. Reisz and S. Wing for advice and discussion, K. Seymour, K. Krysko, K. deQueiroz and G. Zug for access to comparative specimens, A. Rincon and M. Carvalho for fieldwork, J. Mason, K. Church, J. Mathis and J. Nestler for fossil preparation, and K. Krysko and J. Nestler for photographic assistance. We thank Carbones del Cerrejon, L. Teicher, F. Chavez, C. Montes and G. Hernandez for logistical support and access to the Cerrejon mine. This research was funded by the National Science Foundation, Fondo para Investigaciones del Banco de la Republica de Colombia, Smithsonian Tropical Research Institute Paleobiology Fund, the Florida Museum of Natural History, a Geological Society of America Graduate Student Research Grant to A.K.H., and a National Sciences and Engineering Research Council of Canada Discovery Grant to J. J. H.	ALBINO AM, 1991, CIENCIA HOY, V3, P58; Alexander G. J., 2007, BIOL BOAS PYTHONS, P51; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; CHAPPELL MA, 1987, J COMP PHYSIOL B, V157, P227, DOI 10.1007/BF00692367; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DIRKSEN L., 2002, ANAKONDAS MONOGRAPHI; Head J, 2004, J VERTEBR PALEONTOL, V24, p68A; Head JJ, 2007, BIOL LETTERS, V3, P296, DOI 10.1098/rsbl.2007.0069; HERRERA F, 2005, EOS T AM GEOPHY UN S, V86, P608; HOGAN KP, 1991, PLANT CELL ENVIRON, V14, P763, DOI 10.1111/j.1365-3040.1991.tb01441.x; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Iglesias A, 2007, GEOLOGY, V35, P947, DOI 10.1130/G23889A.1; Jaramillo CA, 2007, PALYNOLOGY, V31, P153, DOI 10.2113/gspalynol.31.1.153; Kowalski EA, 2003, P NATL ACAD SCI USA, V100, P167, DOI 10.1073/pnas.232693599; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Makarieva AM, 2005, OIKOS, V111, P425, DOI 10.1111/j.1600-0706.2005.14095.x; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2325, DOI 10.1098/rspb.2005.3223; Murphy J.C, 1997, TALES GIANT SNAKES H; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Polly PD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P197; RAGE JC, 1983, CR ACAD SCI II, V296, P1741; RIVAS J, 1999, LIFE HIST GREEN ANAC; Scanlon JD, 2006, NATURE, V439, P839, DOI 10.1038/nature04137; Scanlon JD, 2001, ALCHERINGA, V25, P425, DOI 10.1080/03115510108619232; Shellito CJ, 2003, PALAEOGEOGR PALAEOCL, V193, P113, DOI 10.1016/S0031-0182(02)00718-6; Shine R, 1998, FUNCT ECOL, V12, P248, DOI 10.1046/j.1365-2435.1998.00179.x; SLOAN LC, 2003, GEOLOGICAL SOC AM SP, V369, P25; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001	30	152	160	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					715	U4		10.1038/nature07671	http://dx.doi.org/10.1038/nature07671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194448				2022-12-28	WOS:000263064700039
J	Anstey, ML; Rogers, SM; Ott, SR; Burrows, M; Simpson, SJ				Anstey, Michael L.; Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm; Simpson, Stephen J.			Serotonin Mediates Behavioral Gregarization Underlying Swarm Formation in Desert Locusts	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHASE-CHANGE; CRUSTACEANS; AGGRESSION; PHYSIOLOGY; RECEPTOR; FIGHT	Desert locusts, Schistocerca gregaria, show extreme phenotypic plasticity, transforming between a little- seen solitarious phase and the notorious swarming gregarious phase depending on population density. An essential tipping point in the process of swarm formation is the initial switch from strong mutual aversion in solitarious locusts to coherent group formation and greater activity in gregarious locusts. We show here that serotonin, an evolutionarily conserved mediator of neuronal plasticity, is responsible for this behavioral transformation, being both necessary if behavioral gregarization is to occur and sufficient to induce it. Our data demonstrate a neurochemical mechanism linking interactions between individuals to large- scale changes in population structure and the onset of mass migration.	[Anstey, Michael L.; Rogers, Stephen M.; Simpson, Stephen J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Rogers, Stephen M.; Ott, Swidbert R.; Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Oxford; University of Cambridge; University of Sydney	Rogers, SM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	smr34@cam.ac.uk		Simpson, Stephen J./0000-0003-0256-7687; Ott, Swidbert/0000-0003-4278-2613	Biotechnology and Biological Sciences Research Council, UK; University Research Fellowship from the Royal Society, UK; Natural Sciences and Engineering Research Council of Canada; Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Research Fellowship from the Royal Society, UK(Royal Society of London); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Hope Studentship in Entomology from Jesus College; University of Oxford, UK; Australian Research Council Federation Fellowship(Australian Research Council)	We thank J. Niven, G. Sutton, and G. Sword for reading and commenting upon the manuscript; C. de la Riva at the Babraham Institute (UK) for technical support with the HPLC and K. Kendrick for permission to use the facility; T. Dodgson and E. Miller for locust rearing and technical support; and M. Ungless for advice and support to M. A. This work is supported by grants from the Biotechnology and Biological Sciences Research Council, UK (to M.B, S.S., and S.O.), and a University Research Fellowship from the Royal Society, UK, to S.O.M.A. was supported by the Natural Sciences and Engineering Research Council of Canada, an Overseas Research Student Award, UK, and the Hope Studentship in Entomology from Jesus College and the University of Oxford, UK. S.S. is supported by an Australian Research Council Federation Fellowship.	Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Molaei G, 2003, J INSECT PHYSIOL, V49, P1073, DOI 10.1016/j.jinsphys.2003.08.004; OSBORNE NN, 1974, BRAIN RES, V74, P366, DOI 10.1016/0006-8993(74)90593-9; PARKER D, 1995, J NEUROPHYSIOL, V73, P923, DOI 10.1152/jn.1995.73.3.923; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SLOLEY BD, 1988, J NEUROCHEM, V51, P535, DOI 10.1111/j.1471-4159.1988.tb01071.x; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; TYRER NM, 1984, J COMP NEUROL, V227, P313, DOI 10.1002/cne.902270303; Ureshi M, 2002, J COMP PHYSIOL A, V188, P767, DOI 10.1007/s00359-002-0364-0; Uvarov B., 1966, GRASSHOPPER LOCUSTS, V1; West-Eberhard Mary Jane, 2003, pi	30	251	259	2	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					627	630		10.1126/science.1165939	http://dx.doi.org/10.1126/science.1165939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179529				2022-12-28	WOS:000262862800041
J	Elias, DC; Nair, RR; Mohiuddin, TMG; Morozov, SV; Blake, P; Halsall, MP; Ferrari, AC; Boukhvalov, DW; Katsnelson, MI; Geim, AK; Novoselov, KS				Elias, D. C.; Nair, R. R.; Mohiuddin, T. M. G.; Morozov, S. V.; Blake, P.; Halsall, M. P.; Ferrari, A. C.; Boukhvalov, D. W.; Katsnelson, M. I.; Geim, A. K.; Novoselov, K. S.			Control of Graphene's Properties by Reversible Hydrogenation: Evidence for Graphane	SCIENCE			English	Article							ATOMIC-HYDROGEN; GRAPHITE; STORAGE; MEMBRANES; OXIDE	Although graphite is known as one of the most chemically inert materials, we have found that graphene, a single atomic plane of graphite, can react with atomic hydrogen, which transforms this highly conductive zero- overlap semimetal into an insulator. Transmission electron microscopy reveals that the obtained graphene derivative ( graphane) is crystalline and retains the hexagonal lattice, but its period becomes markedly shorter than that of graphene. The reaction with hydrogen is reversible, so that the original metallic state, the lattice spacing, and even the quantum Hall effect can be restored by annealing. Our work illustrates the concept of graphene as a robust atomic- scale scaffold on the basis of which new two- dimensional crystals with designed electronic and other properties can be created by attaching other atoms and molecules.	[Elias, D. C.; Nair, R. R.; Mohiuddin, T. M. G.; Halsall, M. P.; Geim, A. K.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Morozov, S. V.] Russian Acad Sci, Inst Microelect Technol, Chernogolovka 142432, Russia; [Blake, P.; Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Ferrari, A. C.] Univ Cambridge, Dept Engn, Cambridge CB3 0FA, England; [Boukhvalov, D. W.; Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	University of Manchester; Russian Academy of Sciences; University of Manchester; University of Cambridge; Radboud University Nijmegen	Novoselov, KS (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	Kostya@manchester.ac.uk	Nair, Rahul Raveendran/Z-1566-2019; Cunha Elias, Daniel/A-7494-2013; Boukhvalov, Danil/F-7517-2017; Geim, Andre K/J-7888-2012; Katsnelson, Mikhail I./D-4359-2012; Ghulam, Tariq/K-5875-2012; Morozov, Sergey V/H-3171-2014; Novoselov, Kostya S/G-9581-2014; Blake, Peter/E-8556-2010; Raveendran Nair, Rahul/G-5839-2010	Cunha Elias, Daniel/0000-0002-0878-1409; Geim, Andre K/0000-0003-2861-8331; Morozov, Sergey V/0000-0003-3075-7787; Novoselov, Kostya S/0000-0003-4972-5371; hai yan, he/0000-0003-0366-6185; Halsall, Matthew/0000-0001-7441-4247	Engineering and Physical Sciences Research Council (UK); Royal Society, the European Research Council; Office of Naval Research; Air Force Research Office of Scientific Research; National Council for Scientific and Technological Development (Brazil); EPSRC [EP/E051227/1, EP/G030480/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G030480/1, EP/E051227/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society, the European Research Council(Royal Society of LondonEuropean Research Council (ERC)); Office of Naval Research(Office of Naval Research); Air Force Research Office of Scientific Research; National Council for Scientific and Technological Development (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (UK), the Royal Society, the European Research Council (programs "Ideas" and "New and Emerging Science and Technology, "project "Structural Information of Biological Molecules at Atomic Resolution"), Office of Naval Research, and Air Force Research Office of Scientific Research. D. C. E. acknowledges financial support from the National Council for Scientific and Technological Development (Brazil). The authors are grateful to Nacional de Grafite for providing high- quality crystals of natural graphite.	Booth TJ, 2008, NANO LETT, V8, P2442, DOI 10.1021/nl801412y; Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Darkrim Lamari F, 2002, INT J HYDROGEN ENERG, V27, P193, DOI 10.1016/S0360-3199(01)00103-3; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715; Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c; Hornekaer L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156104; Khare BN, 2002, NANO LETT, V2, P73, DOI 10.1021/nl015646j; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Morozov SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016602; MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338; NEUMANN D, 1992, APPL PHYS A-MATER, V55, P489, DOI 10.1007/BF00348338; Nikitin A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225507; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pereira VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036801; Ruffieux P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245416; Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Wehling TO, 2008, NANO LETT, V8, P173, DOI [10.1021/nl072364w, 10.1021/nL072364w]; Yildirim T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075404; Zuttel A, 2002, INT J HYDROGEN ENERG, V27, P203, DOI 10.1016/S0360-3199(01)00108-2	30	3347	3432	24	1773	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					610	613		10.1126/science.1167130	http://dx.doi.org/10.1126/science.1167130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179524	Green Submitted			2022-12-28	WOS:000262862800036
J	Slutsky, AS; Hudson, LD; Dubler, NN; Weijer, C; Tonelli, MR				Slutsky, Arthur S.; Hudson, Leonard D.; Dubler, Nancy N.; Weijer, Charles; Tonelli, Mark R.			Care of an Unresponsive Patient with a Poor Prognosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVAL		[Slutsky, Arthur S.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hudson, Leonard D.] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Hudson, Leonard D.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dubler, Nancy N.] Montefiore Med Ctr, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON, Canada; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Tonelli, Mark R.] Univ Washington, Med Ctr, Dept Bioeth & Humanities, Seattle, WA 98195 USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Slutsky, AS (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur/M-3325-2019					Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; Berger JT, 2008, ANN INTERN MED, V149, P48, DOI 10.7326/0003-4819-149-1-200807010-00010; Buchanan AE, 1990, DECIDING OTHERS ETHI; Dubler N. N., 2004, BIOETHICS MEDIATION; DUBLER NN, 1995, KENNEDY INST ETHIC J, V5, P289; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Kapp M B, 1997, Univ Toledo Law Rev, V28, P521; LUCE JM, 1995, CRIT CARE MED, V23, P760, DOI 10.1097/00003246-199504000-00027; *PC, 1983, DEC FOR LIF SUST TRE; Reisfield GM, 2006, RESUSCITATION, V71, P152, DOI 10.1016/j.resuscitation.2006.02.022; Tonelli MR, 1997, J LAW MED ETHICS, V25, P22, DOI 10.1111/j.1748-720X.1997.tb01392.x; Toussaint LG, 2005, NEUROSURGERY, V57, P25, DOI 10.1227/01.NEU.0000163086.23124.70; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Weijer C, 1998, CAN MED ASSOC J, V159, P817	14	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					527	531		10.1056/NEJMclde0808330	http://dx.doi.org/10.1056/NEJMclde0808330			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179322				2022-12-28	WOS:000262812400017
J	Liu, YL				Liu, Yuanli			Reforming China's health care: for the people, by the people?	LANCET			English	Editorial Material							SYSTEM REFORM		[Liu, Yuanli] Harvard Univ, Sch Publ Hlth, China Initiat, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Liu, YL (corresponding author), Harvard Univ, Sch Publ Hlth, China Initiat, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	yuanliu@hsph.harvard.edu						Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; LIU Y, 2006, HARVARD CHINA REV, V3, P14; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; *STAT COUNC HEALTH, 2008, REC DEEP HLTH SYST R; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460	6	28	29	1	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					281	283		10.1016/S0140-6736(09)60080-5	http://dx.doi.org/10.1016/S0140-6736(09)60080-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167561	Bronze, Green Published			2022-12-28	WOS:000262728100009
J	MacDonald, R; Horton, R				MacDonald, Rhona; Horton, Richard			Trade and health: time for the health sector to get involved	LANCET			English	Editorial Material									[MacDonald, Rhona; Horton, Richard] The Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.							BLOUIN C, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61777-8; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; FIDLER DP, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61775-4; *G20 FIN MIN CENTR, 2008, COMM M MIN GOV SAO P; LEE K, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61776-6; *MED SANS FRONT, CAMP ACC ESS MED; *OXF, 2008, MARK ACC; *OXF, 2008, DUMP; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61780-8; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61778-X; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61779-1; STIGLIZ JE, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61772-9; *WORLD TRAD ORG, UND WTO AGR INT PROP; 2008, LANCET, V372, P1928; [No title captured]	15	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					273	274		10.1016/S0140-6736(08)61773-0	http://dx.doi.org/10.1016/S0140-6736(08)61773-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398JJ	19167062				2022-12-28	WOS:000262728100004
J	Schwartz, LM; Woloshin, S; Welch, HG				Schwartz, Lisa M.; Woloshin, Steven; Welch, H. Gilbert			Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials	ANNALS OF INTERNAL MEDICINE			English	Article							TO-CONSUMER ADVERTISEMENTS; PRESCRIPTION DRUGS; TELEPHONE SURVEY; NONRESPONSE; EXPERIENCE; RISK	Background: Direct-to-consumer prescription drug ads typically fail to provide fundamental information that consumers need to make informed decisions: data on how well the drug works. Objective: To see whether providing consumers with a drug facts box-a table quantifying outcomes with and without the drug improves knowledge and affects judgments about prescription medications. Design: Two randomized, controlled trials conducted between October 2006 and April 2007: a symptom drug box trial using direct-to-consumer ads for a histamine-2 blocker and a proton-pump inhibitor to treat heartburn, and a prevention drug box trial using direct-to-consumer ads for a statin and clopidogrel to prevent cardiovascular events. Setting: National sample of U. S. adults identified by random-digit dialing. Participants: Adults age 35 to 70 years who completed a mailed survey; the final samples comprised 231 participants with completed surveys in the symptom drug box trial (49% response rate) and 219 in the prevention drug box trial (46% response rate). Intervention: In both trials, the control group received 2 actual drug ads (including both the front page and brief summary). The drug box group received the same ads, except that the brief summary was replaced by a drug facts box. Measurements: Choice between drugs (primary outcome of the symptom drug box trial) and accurate perceptions of drug benefits and side effects (primary outcome of the prevention drug box trial). Results: In the symptom drug box trial, 70% of the drug box group and 8% of the control group correctly identified the PPI as being "a lot more effective" than the histamine-2 blocker (P < 0.001), and 80% and 38% correctly recognized that the side effects of the 2 drugs were similar (P < 0.001). When asked what they would do if they had bothersome heartburn and could have either drug for free, 68% of the drug box group and 31% of the control group chose the proton-pump inhibitor, the superior drug (P < 0.001). In the prevention drug box trial, the drug box improved consumers' knowledge of the benefits and side effects of a statin and clopidogrel. For example, 72% of the drug box group and 9% of the control group correctly quantified the benefit (absolute risk reduction) of the statin (P < 0.001). Most of the control participants overestimated this benefit, and 65% did so by a factor of 10 or more. Limitations: The trials tested drug boxes in only 4 direct-to-consumer ads. If other direct-to-consumer ads were to communicate outcome data better, the effect of the drug box would be reduced. Conclusion: A drug facts box improved U. S. consumers' knowledge of prescription drug benefits and side effects. It resulted in better choices between drugs for current symptoms and corrected the overestimation of benefit in the setting of prevention.	Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med Media, Hanover, NH USA; Vet Affairs Outcomes Grp, White River Jct, VT USA	Dartmouth College	Woloshin, S (corresponding author), Vet Affairs Outcomes Grp 111B, Dept Vet Affairs Med Ctr, White River Jct, VT 05009 USA.	steven.woloshin@dartmouth.edu			Robert Wood Johnson; National Cancer Institute [R01CA104721]; Attorney General Consumer and Prescriber Education; NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER	Robert Wood Johnson(Robert Wood Johnson Foundation (RWJF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Attorney General Consumer and Prescriber Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs. Schwartz and Woloshin were supported by Robert Wood Johnson Generalist Faculty Scholars Awards. The study was supported by the National Cancer Institute (grant R01CA104721) and the Attorney General Consumer and Prescriber Education grant program.	Avorn J, 2008, NEW ENGL J MED, V359, P991, DOI 10.1056/NEJMp0805922; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bell RA, 2000, J FAM PRACTICE, V49, P1092; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *COMM ASS US DRUG, 2006, FUT DRUG SAF PROM PR; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; Davis J, 2007, J HEALTH COMMUN, V12, P607, DOI 10.1080/10810730701615164; Davis JJ, 2007, HEALTH AFFAIR, V26, P863, DOI 10.1377/hlthaff.26.3.863; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; *I MED, 2007, UND BEN RISKS PHARM; Johnsson F, 2003, SCAND J GASTROENTERO, V38, P347, DOI 10.1080/00365520310002157; Kallen A, 2007, HEALTH AFFAIR, V26, P1392, DOI 10.1377/hlthaff.26.5.1392; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; National Center for Health Statistics, NAT HLTH NUTR EX SUR; *OR HLTH SCI U, DRUG EFF REV PROJ DE; RUSH DR, 1995, J FAM PRACTICE, V41, P126; Schwartz LM, 2007, MED DECIS MAKING, V27, P655, DOI 10.1177/0272989x07306786; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; The American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; *US FDA, 2004, GUID IND BRIEF SUMM; *US FDA, 2007, 020839 NDA US FDA; *US FDA, OFF MAN BUDG FORM PR; VANPINXTEREN B, 2001, COCHRANE DB SYST REV, P2095; Woloshin S, 2001, LANCET, V358, P1141, DOI 10.1016/S0140-6736(01)06254-7; WOLOSHIN S, 2004, HLTH AFFAIRS S   JAN; Woloshin S, 2008, KNOW YOUR CHANCES UN; Woloshin S, 2007, ANN INTERN MED, V146, P256, DOI 10.7326/0003-4819-146-4-200702200-00004; 2008, DTC PERSPECTIVES, V7, P10	31	186	186	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					516	W93		10.7326/0003-4819-150-8-200904210-00106	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00106			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437AD	19221371				2022-12-28	WOS:000265457000002
J	Sancho, D; Joffre, OP; Keller, AM; Rogers, NC; Martinez, D; Hernanz-Falcon, P; Rosewell, I; Sousa, CRE				Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Martinez, Dolores; Hernanz-Falcon, Patricia; Rosewell, Ian; Reis e Sousa, Caetano			Identification of a dendritic cell receptor that couples sensing of necrosis to immunity	NATURE			English	Article							ACTIVATION; ADJUVANTS; DANGER; CLEC9A; DEATH	Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair(1). In addition, antigens present in necrotic cells can sometimes provoke a specific immune response(2-4) and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection(5,6). In the mouse, the CD8 alpha(+) subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8(+) T cells against cell-associated antigens(7). Here we show that CD8 alpha(+) dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin(8-10), to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8 alpha(+) dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.	[Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; [Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, London Res Inst, Canc Res UK, FACS Lab, London WC2A 3PX, England; [Martinez, Dolores; Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, Trangen Serv, Potters Bar EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	Sousa, CRE (corresponding author), Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Martinez, Lola/ABG-2474-2020; Reis e Sousa, Caetano/O-1657-2014; Martinez, Lola/L-2308-2014; Joffre, Olivier P/K-1235-2014; Reis e Sousa, Caetano/ABD-7322-2021; Sancho, David/D-3433-2009	Reis e Sousa, Caetano/0000-0001-7392-2119; Martinez, Lola/0000-0001-6273-6724; Joffre, Olivier P/0000-0003-1168-8165; Reis e Sousa, Caetano/0000-0001-7392-2119; Sancho, David/0000-0003-2890-3984; Rogers, Neil/0000-0001-8977-7585	Cancer Research UK; EMBO [ALTF 336-2004]; European Community [MEIF-CT-2005-009205]	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); European Community(European Commission)	This work was funded by Cancer Research UK. D. S. was supported by an EMBO long-term fellowship (ALTF 336-2004) and by a Marie Curie Intra-European Fellowship within the sixth European Community Framework Programme (MEIF-CT-2005-009205). We thank E. Schweighoffer and V. Tybulewicz for fetal liver from Syk<SUP>-/-</SUP> embryos. We also thank N. Shastri for B3Z and BWZ cell lines and A. Eddaoudi for assistance with cell sorting. We are grateful to members of the Immunobiology Laboratory, Cancer Research UK, for advice and discussions and the Biological Resources staff for animal care and assistance with mouse experiments.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	26	501	523	4	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					899	903		10.1038/nature07750	http://dx.doi.org/10.1038/nature07750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19219027	Green Accepted			2022-12-28	WOS:000265182500045
J	Sung, JJY; Barkun, A; Kuipers, EJ; Mossner, J; Jensen, DM; Stuart, R; Lau, JY; Ahlbom, H; Kilhamn, J; Lind, T				Sung, Joseph J. Y.; Barkun, Alan; Kuipers, Ernst J.; Mossner, Joachim; Jensen, Dennis M.; Stuart, Robert; Lau, James Y.; Ahlbom, Henrik; Kilhamn, Jan; Lind, Tore		Peptic Ulcer Bleed Study Grp	Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PUMP INHIBITOR THERAPY; PLACEBO-CONTROLLED MULTICENTER; ENDOSCOPIC TREATMENT; COCHRANE-COLLABORATION; CONTINUOUS-INFUSION; ACID SUPPRESSION; INTRAGASTRIC PH; METAANALYSIS; OMEPRAZOLE; COAGULATION	Background: Use of proton-pump inhibitors in the management of peptic ulcer bleeding is controversial because discrepant results have been reported in different ethnic groups. Objective: To determine whether intravenous esomeprazole prevents recurrent peptic ulcer bleeding better than placebo in a multi-ethnic patient sample. Design: Randomized trial conducted between October 2005 and December 2007; patients, providers, and researchers were blinded to group assignment. Setting: 91 hospital emergency departments in 16 countries. Patients: Patients 18 years or older with peptic ulcer bleeding from a single gastric or duodenal ulcer showing high-risk stigmata. Intervention: Intravenous esomeprazole bolus, 80 mg, followed by 8-mg/h infusion, over 72 hours or matching placebo, each given after successful endoscopic hemostasis. Intervention was allocated by computer-generated randomization. After infusion, both groups received oral esomeprazole, 40 mg/d, for 27 days. Measurements: The primary end point was rate of clinically significant recurrent bleeding within 72 hours. Recurrent bleeding within 7 and 30 days, death, surgery, endoscopic re-treatment, blood transfusions, hospitalization, and safety were also assessed. Results: Of 767 patients randomly assigned, 764 provided data for an intention-to-treat analysis (375 esomeprazole recipients and 389 placebo recipients). Fewer patients receiving intravenous esomeprazole (22 of 375) had recurrent bleeding within 72 hours than those receiving placebo (40 of 389) (5.9% vs. 10.3%; difference, 4.4 percentage points [95% Cl, 0.6% to 8.3%]; P = 0.026). The difference in bleeding recurrence remained significant at 7 days and 30 days (P = 0.010). Esomeprazole also reduced endoscopic retreatment (6.4% vs. 11.6%; difference, 5.2 percentage points [95% Cl of difference, 1.1 percentage points to 9.2 percentage points]; P = 0.012), surgery (2.7% vs. 5.4%), and all-cause mortality rates (0.8% vs. 2.1%) more than placebo, although differences for the latter 2 comparisons were not significant. About 10% and 40% of patients in both groups reported serious and nonserious adverse events, respectively. Limitation: Endoscopic therapy was not completely standardized; some patients received epinephrine injection, thermal coagulation, or hemoclips alone, whereas others received combination therapy, but there were similar proportions with single therapy in each group. Conclusion: High-dose intravenous esomeprazole given after successful endoscopic therapy to patients with high-risk peptic ulcer bleeding reduced recurrent bleeding at 72 hours and had sustained clinical benefits for up to 30 days.	Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; McGill Univ, Ctr Hlth, Montreal, PQ, Canada; Erasmus MC Univ, Med Ctr, Rotterdam, Netherlands; Univ Leipzig, Med Klin & Poliklin 2, Leipzig, Germany; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Digest Dis Res Ctr, Ctr Ulcer Res & Educ, Los Angeles, CA USA; Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; AstraZeneca Res & Dev, Molndal, Sweden	Chinese University of Hong Kong; McGill University; Erasmus University Rotterdam; Erasmus MC; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Glasgow; AstraZeneca	Sung, JJY (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China.	joesung@cuhk.edu.hk	Kuipers, Ernst J/H-3293-2019; Lau, James Y. W./O-2612-2016; Sung, Joseph J. Y./R-3203-2018	Kuipers, Ernst J/0000-0002-0633-3098; Lau, James Y. W./0000-0003-0122-4068; Sung, Joseph J. Y./0000-0003-3125-5199	AstraZeneca Research and Development	AstraZeneca Research and Development(AstraZeneca)	Primary Funding Source: AstraZeneca Research and Development.	Andriulli A, 2005, AM J GASTROENTEROL, V100, P207, DOI 10.1111/j.1572-0241.2005.40636.x; Barkun A, 2004, AM J GASTROENTEROL, V99, P1238, DOI 10.1111/j.1572-0241.2004.30272.x; Barkun AN, 1999, ALIMENT PHARM THER, V13, P1565; Berstad A, 1997, SCAND J GASTROENTERO, V32, P396, DOI 10.3109/00365529709007691; British Society of Gastroenterology, 2007, UK COMP AUD UPP GAST; CHAIMOFF C, 1978, AM J SURG, V136, P257, DOI 10.1016/0002-9610(78)90241-6; COLLINS R, 1985, NEW ENGL J MED, V313, P660, DOI 10.1056/NEJM198509123131104; DeMuckadell OBS, 1997, SCAND J GASTROENTERO, V32, P320, DOI 10.3109/00365529709007679; FORREST JAH, 1974, LANCET, V2, P394; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; GREEN FW, 1978, GASTROENTEROLOGY, V74, P38; Hasselgren G, 1997, SCAND J GASTROENTERO, V32, P328, DOI 10.3109/00365529709007680; Jensen DM, 2006, AM J GASTROENTEROL, V101, P1991, DOI 10.1111/j.1572-0241.2006.00773.x; JENSEN DM, 2006, AM J GASTROENTEROL, V101, P2170; Khuroo MS, 2005, J GASTROEN HEPATOL, V20, P11, DOI 10.1111/j.1440-1746.2004.03441.x; Khuroo MS, 1997, NEW ENGL J MED, V336, P1054, DOI 10.1056/NEJM199704103361503; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; Leontiadis GI, 2005, ALIMENT PHARM THER, V21, P1055, DOI 10.1111/j.1365-2036.2005.02441.x; Leontiadis GI, 2005, BMJ-BRIT MED J, V330, P568, DOI 10.1136/bmj.38356.641134.8F; Leontiadis GI, 2007, MAYO CLIN PROC, V82, P286; Levine JE, 2002, ALIMENT PHARM THERAP, V16, P1137, DOI 10.1046/j.1365-2036.2002.01274.x; Li YY, 2000, J GASTROEN HEPATOL, V15, P148, DOI 10.1046/j.1440-1746.2000.02055.x; Lin HJ, 1998, ARCH INTERN MED, V158, P54, DOI 10.1001/archinte.158.1.54; Marmo R, 2007, AM J GASTROENTEROL, V102, P469; Marmo R, 2007, AM J GASTROENTEROL, V102, P279, DOI 10.1111/j.1572-0241.2006.01023.x; Netzer P, 1999, AM J GASTROENTEROL, V94, P351; PATCHETT SE, 1989, GUT, V30, P1704, DOI 10.1136/gut.30.12.1704; Sung JJY, 2008, ALIMENT PHARM THER, V27, P666, DOI 10.1111/j.1365-2036.2008.03631.x; Sung JJY, 2007, GUT, V56, P1364, DOI 10.1136/gut.2007.123976; VANRENSBURG CJ, 2004, CAN J GASTROENTE SSA, V18; Vreeburg EM, 2001, ALIMENT PHARM THER, V15, P639, DOI 10.1046/j.1365-2036.2001.00978.x; YAVORSKI RT, 1995, AM J GASTROENTEROL, V90, P568; Zargar SA, 2006, J GASTROEN HEPATOL, V21, P716, DOI 10.1111/j.1440-1746.2006.04292.x	35	131	152	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					455	+		10.7326/0003-4819-150-7-200904070-00105	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00105			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432EZ	19221370				2022-12-28	WOS:000265117600003
J	Van Mooy, BAS; Fredricks, HF; Pedler, BE; Dyhrman, ST; Karl, DM; Koblizek, M; Lomas, MW; Mincer, TJ; Moore, LR; Moutin, T; Rappe, MS; Webb, EA				Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Dyhrman, Sonya T.; Karl, David M.; Koblizek, Michal; Lomas, Michael W.; Mincer, Tracy J.; Moore, Lisa R.; Moutin, Thierry; Rappe, Michael S.; Webb, Eric A.			Phytoplankton in the ocean use non-phosphorus lipids in response to phosphorus scarcity	NATURE			English	Article							NITROGEN-FIXATION; N-P; LIMITATION; PHOSPHATE; GROWTH; BACTERIOPLANKTON; PROCHLOROCOCCUS; TRICHODESMIUM; BIOSYNTHESIS; AVAILABILITY	Phosphorus is an obligate requirement for the growth of all organisms; major biochemical reservoirs of phosphorus in marine plankton include nucleic acids and phospholipids(1-3). However, eukaryotic phytoplankton and cyanobacteria (that is, 'phytoplankton' collectively) have the ability to decrease their cellular phosphorus content when phosphorus in their environment is scarce(1,4,5). The biochemical mechanisms that allow phytoplankton to limit their phosphorus demand and still maintain growth are largely unknown. Here we show that phytoplankton, in regions of oligotrophic ocean where phosphate is scarce, reduce their cellular phosphorus requirements by substituting non-phosphorus membrane lipids for phospholipids. In the Sargasso Sea, where phosphate concentrations were less than 10 nmol l(-1), we found that only 1.3 +/- 0.6% of phosphate uptake was used for phospholipid synthesis; in contrast, in the South Pacific subtropical gyre, where phosphate was greater than 100 nmol l(-1), plankton used 17 +/- 6% (ref. 6). Examination of the planktonic membrane lipids at these two locations showed that classes of sulphur- and nitrogen-containing membrane lipids, which are devoid of phosphorus, were more abundant in the Sargasso Sea than in the South Pacific. Furthermore, these non-phosphorus, 'substitute lipids' were dominant in phosphorus-limited cultures of all of the phytoplankton species we examined. In contrast, the marine heterotrophic bacteria we examined contained no substitute lipids and only phospholipids. Thus heterotrophic bacteria, which compete with phytoplankton for nutrients in oligotrophic regions like the Sargasso Sea, appear to have a biochemical phosphorus requirement that phytoplankton avoid by using substitute lipids. Our results suggest that phospholipid substitutions are fundamental biochemical mechanisms that allow phytoplankton to maintain growth in the face of phosphorus limitation.	[Van Mooy, Benjamin A. S.; Fredricks, Helen F.; Pedler, Byron E.; Mincer, Tracy J.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Dyhrman, Sonya T.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Karl, David M.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Koblizek, Michal] Acad Sci Czech Republ, Inst Microbiol, Trebon, Czech Republic; [Koblizek, Michal] Univ S Bohemia, Inst Phys Biol, Nove Hrady, Czech Republic; [Lomas, Michael W.] Bermuda Inst Ocean Sci, St George, Bermuda; [Moore, Lisa R.] Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA; [Moutin, Thierry] Aix Marseille Univ, Ctr Oceanol Marseille, Lab Oceanog Phys & Biogeochim, Marseille, France; [Rappe, Michael S.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Webb, Eric A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Hawaii System; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Bermuda Institute of Ocean Sciences; University of Maine System; University of Southern Maine; UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; University of Southern California	Van Mooy, BAS (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	bvanmooy@whoi.edu	Koblizek, Michal/H-2851-2014; Karl, David/AFP-3837-2022	Mincer, Tracy/0000-0002-4644-5609; Moore, Lisa/0000-0002-4114-1518; Karl, David/0000-0002-6660-6721; Lomas, Michael/0000-0003-1209-3753; Pedler Sherwood, Byron/0000-0001-9578-0481; Webb, Eric/0000-0003-4085-7730	National Science Foundation [OCE-0646944, OCE-0451419, OCE-0326616, OCE-0453023, OCE-0453019, DEB-0207085]; Office of Naval Research [N00014-06-1-0134, GAAV-1QS500200570]; Centre National de la Recherche Scientifique; Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut des Sciences de l'Univers; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution Mary Sears Travel Fund	We thank the captains and crews of the RVs L'Atalante, Atlantic Explorer, Kilo Moana and Ka'imikai-o-Kanaloa. J. Dacey, R. Johnson, N. Levine, T. Gregory, D. Sadler, H. Claustre and A. Sciandra provided access and logistical support for our cruises. K. Bjorkman and P. Rimmelin provided phosphate data. N. Trowbridge, M. Brandon, S. Haley, E. Orchard and K. Roache-Johnson assisted with cultures. D. Glover provided input on data treatment and presentation. This research was supported by grants from the National Science Foundation (OCE-0646944 to B. A. S. V. M., OCE-0451419 to S. T. D., OCE-0326616 to D. M. K., OCE-0453023 to M. W. L., OCE-0453019 to L. R. M. and DEB-0207085 to M. S. R.), the Office of Naval Research (N00014-06-1-0134 to B. A. S. V. M.) and Czech Republic research grants (GACR-206/07/0241 and GAAV-1QS500200570 to M. K.). The BIOSOPE campaign was a contribution of the French LEFE-CYBER program funded by the Centre National de la Recherche Scientifique and the Institut des Sciences de l'Univers. Funding was also provided by the Gordon and Betty Moore Foundation, the Center for Microbial Oceanography: Research and Education, the Woods Hole Oceanographic Institution Ocean Life Institute and the Woods Hole Oceanographic Institution Mary Sears Travel Fund.	Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, 10.1029/2003EO180001]; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bjorkman KM, 2003, LIMNOL OCEANOGR, V48, P1049; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Krauk JM, 2006, AQUAT MICROB ECOL, V42, P243, DOI 10.3354/ame042243; Lomas MW, 2004, LIMNOL OCEANOGR, V49, P2303, DOI 10.4319/lo.2004.49.6.2303; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Mills MM, 2008, LIMNOL OCEANOGR, V53, P824, DOI 10.4319/lo.2008.53.2.0824; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moutin T, 2008, BIOGEOSCIENCES, V5, P95, DOI 10.5194/bg-5-95-2008; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SATO N, 2000, RECENT ADV BIOCH PLA; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Van Mooy BAS, 2008, BIOGEOSCIENCES, V5, P133, DOI 10.5194/bg-5-133-2008; Van Mooy BAS, 2008, LIMNOL OCEANOGR, V53, P78, DOI 10.4319/lo.2008.53.1.0078; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	30	505	517	17	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					69	72		10.1038/nature07659	http://dx.doi.org/10.1038/nature07659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19182781				2022-12-28	WOS:000263836000034
J	Hertz, N				Hertz, Noreena			Recession Watch: Cooperation must rule	NATURE			English	Editorial Material											Hertz, N (corresponding author), Erasmus Univ, Rotterdam Sch Management, NL-3000 DR Rotterdam, Netherlands.	n.hertz@jbs.cam.ac.uk						Mauss M., 1969, GIFT FORMS FUNCTIONS; McElvaine R.S., 1993, GREAT DEPRESSION AM	2	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2009	457	7232					962	963		10.1038/457962a	http://dx.doi.org/10.1038/457962a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HF	19225504				2022-12-28	WOS:000263425400022
J	Ricardo, S; Lehmann, R				Ricardo, Sara; Lehmann, Ruth			An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant	SCIENCE			English	Article							GENE ENCODES; A-FACTOR; P-GLYCOPROTEIN; MELANOGASTER; PROTEOLYSIS; SECRETION; MIGRATION; RAS; RHO	Directed cell migration, which is critical for embryonic development, leukocyte trafficking, and cell metastasis, depends on chemoattraction. 3-hydroxy-3-methylglutaryl coenzyme A reductase regulates the production of an attractant for Drosophila germ cells that may itself be geranylated. Chemoattractants are commonly secreted through a classical, signal peptide- dependent pathway, but a geranyl- modified attractant would require an alternative pathway. In budding yeast, pheromones produced by a-cells are farnesylated and secreted in a signal peptide- independent manner, requiring the adenosine triphosphate- binding cassette ( ABC) transporter Ste6p. Here we show that Drosophila germ cell migration uses a similar pathway, demonstrating that invertebrate germ cells, like yeast cells, are attracted to lipid- modified peptides. Components of this unconventional export pathway are highly conserved, suggesting that this pathway may control the production of similarly modified chemoattractants in organisms ranging from yeast to humans.	[Ricardo, Sara; Lehmann, Ruth] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Lehmann, R (corresponding author), NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Ricardo, Sara/I-1653-2015	Lehmann, Ruth/0000-0002-8454-5651; Ricardo, Sara/0000-0002-8605-2500	NIH [HD49100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD049100] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank P. Lopez and G. de la Cruz for FACS sorting; S. Michaelis for reagents and discussions; J. Treisman, Blomington stock center, and the Drosophila Genomics Resource Center for fly lines and reagents; the Lehmann Lab; and D. Siekhaus and S. Burden for comments on the manuscript. This work was supported by NIH grant HD49100. S. R. is a HHMI research associate; R. L. is an HHMI investigator and a member of the Kimmel Stem Cell Center.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Christensen PU, 1997, MOL GEN GENET, V255, P226, DOI 10.1007/s004380050493; Dean M, 2001, J LIPID RES, V42, P1007; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Magie CR, 1999, DEVELOPMENT, V126, P5353; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Settleman J, 2001, DEV CELL, V1, P321, DOI 10.1016/S1534-5807(01)00053-3; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612	21	83	84	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					943	946		10.1126/science.1166239	http://dx.doi.org/10.1126/science.1166239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213920	Green Accepted			2022-12-28	WOS:000263295400045
J	Inskip, HM; Crozier, SR; Godfrey, KM; Borland, SE; Cooper, C; Robinson, SM				Inskip, Hazel M.; Crozier, Sarah R.; Godfrey, Keith M.; Borland, Sharon E.; Cooper, Cyrus; Robinson, Sian M.		Southampton Womens Survey Study Gr	Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MODERATE ALCOHOL-CONSUMPTION; PRECONCEPTIONAL FOLIC-ACID; NEURAL-TUBE DEFECTS; UNINTENDED PREGNANCY; FERTILITY; TIME; HEALTH; BRITAIN	Objective To examine the extent to which women planning a pregnancy comply with recommendations for nutrition and lifestyle. Design Prospective cohort study. Setting Southampton, United Kingdom. Participants 12 445 non-pregnant women aged 20-34 recruited to the Southampton Women's Survey through general practices, 238 of whom became pregnant within three months of being interviewed. Main outcome measures Folic acid supplement intake, alcohol consumption, smoking, diet, and physical activity before pregnancy. Results The 238 women who became pregnant within three months of the interview were only marginally more likely to comply with recommendations for those planning a pregnancy than those who did not become pregnant in this period. Among those who became pregnant, 2.9% (95% confidence interval 1.2% to 6.0%) were taking 400 mu g or more of folic acid supplements a day and drinking four or fewer units of alcohol a week, compared with 0.66% (0.52% to 0.82%) of those who did not become pregnant. 74% of those who became pregnant were nonsmokers compared with 69% of those who did not become pregnant (P=0.08). Women in both groups were equally likely to consume five or more portions of fruit and vegetables a day (53% in each group, P=1.0), but only 57% of those who became pregnant had taken any strenuous exercise in the past three months compared with 64% in those who did not become pregnant (P=0.03). Conclusion Only a small proportion of women planning a pregnancy follow the recommendations for nutrition and lifestyle. Greater publicity for the recommendations is needed, but as many pregnancies are unplanned, improved nutrition and lifestyles of women of childbearing age is also required.	[Inskip, Hazel M.; Crozier, Sarah R.; Godfrey, Keith M.; Borland, Sharon E.; Cooper, Cyrus; Southampton Womens Survey Study Gr] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England	University of Southampton	Inskip, HM (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England.	hmi@mrc.soton.ac.uk	; Inskip, Hazel/L-5467-2018	Cooper, Cyrus/0000-0003-3510-0709; Inskip, Hazel/0000-0001-8897-1749; Godfrey, Keith/0000-0002-4643-0618; Crozier, Sarah/0000-0002-9524-1127; Robinson, Sian/0000-0003-1766-7269	UK Medical Research Council; University of Southampton; Dunhill Medical Trust; Medical Research Council [U1475000001, U1475000004] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Southampton; Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This component of the Southampton Women's Survey was funded by the UK Medical Research Council, the University of Southampton, and the Dunhill Medical Trust. None of the funders had any role in the design of this study; collection, analysis, and interpretation of the data; writing the report; or the decision to submit the article for publication.	Amitai Y, 2008, PREV MED, V46, P166, DOI 10.1016/j.ypmed.2007.09.005; Axmon A, 2005, FERTIL STERIL, V84, P966, DOI 10.1016/j.fertnstert.2005.04.030; Chapin RE, 2004, ENVIRON HEALTH PERSP, V112, P69, DOI 10.1289/ehp.6261; Coll O, 2004, EUR J OBSTET GYN R B, V115, P173, DOI 10.1016/j.ejogrb.2003.12.009; CROZIER SR, 2009, PAED PERINA IN PRESS; Custer M, 2008, PAEDIATR PERINAT EP, V22, P195, DOI 10.1111/j.1365-3016.2007.00896.x; D'Angelo Denise, 2007, Morbidity and Mortality Weekly Report, V56, P1; *FAM PLANN ASS, 2008, PREGN TRY GET PREGN; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; *FOOD STAND AG, 2008, EAT WELL BE WELL; FORSTER DA, 2007, MIDWIFERY, DOI DOI 10.1016/J.MIDW.2007.01.01; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goddard E, 2008, GEN HOUSEHOLD SURVEY; Goldberg BB, 2006, BIRTH DEFECTS RES A, V76, P193, DOI 10.1002/bdra.20239; Hellerstedt WL, 1998, AM J PUBLIC HEALTH, V88, P663, DOI 10.2105/AJPH.88.4.663; HERRICK K, 2003, MATERNAL INFANT HLTH; Howell F, 1997, LANCET, V350, P664, DOI 10.1016/S0140-6736(05)63357-0; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Jensen TK, 1998, BRIT MED J, V317, P505, DOI 10.1136/bmj.317.7157.505; Joffe M, 2000, LANCET, V355, P1961, DOI 10.1016/S0140-6736(00)02328-X; Joffe M, 1996, LANCET, V347, P1519, DOI 10.1016/S0140-6736(96)90673-X; Juhl M, 2001, HUM REPROD, V16, P2705, DOI 10.1093/humrep/16.12.2705; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Li ZW, 2007, PUBLIC HEALTH NUTR, V10, P471, DOI 10.1017/S1368980007223869; MCFADEN A, 2008, NICE MAT CHILD NUTR; McGovern E, 1997, BRIT J GEN PRACT, V47, P635; Morin P, 2002, PREV MED, V35, P143, DOI 10.1006/pmed.2002.1041; *NIH CLIN EXC PUBL, 2008, NIH CLIN EXC PUBL HL; *PAT UK, 2008, PLANN BEC PREGN; Perlow JH, 2001, AM J OBSTET GYNECOL, V184, P1263, DOI 10.1067/mob.2001.112974; Robinson S, 1996, EUR J CLIN NUTR, V50, P302; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; *SCI ADV COMM NUTR, 2006, FOL DIS PREV; Sillender M, 2000, J Obstet Gynaecol, V20, P271; Slama R, 2004, EPIDEMIOLOGY, V15, P458, DOI 10.1097/01.ede.0000129520.84568.87; Tam LE, 2005, J OBSTET GYNAECOL CA, V27, P232, DOI 10.1016/S1701-2163(16)30515-1; *US DHHS, 2008, HLTH PREGN; WALD N, 1993, ANN NY ACAD SCI, V678, P112; Wild J, 1997, LANCET, V350, P30, DOI 10.1016/S0140-6736(05)66239-3	39	130	133	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2009	338								b481	10.1136/bmj.b481	http://dx.doi.org/10.1136/bmj.b481			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZY	19213768	Green Published, hybrid			2022-12-28	WOS:000263976200007
J	Kluytmans, J; Struelens, M				Kluytmans, Jan; Struelens, Marc			Meticillin resistant Staphylococcus aureus in the hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MRSA INFECTIONS; UNITED-STATES; GUIDELINES; MANAGEMENT; DAPTOMYCIN; BACTEREMIA; VANCOMYCIN; COMMUNITY; EMERGENCE		[Kluytmans, Jan] Amphia Hosp Breda, Lab Microbiol & Infect Control, NL-4800 RK Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Med Microbiol & Infect Control, NL-1081 HV Amsterdam, Netherlands; [Struelens, Marc] Free Univ Brussels, Hop Erasme, Dept Microbiol, B-1070 Brussels, Belgium; [Struelens, Marc] Free Univ Brussels, Hop Erasme, Lab Reference Staphylocoques, B-1070 Brussels, Belgium; [Struelens, Marc] Univ Libre Bruxelles, Fac Med, Dept Microbiol & Immunol, B-1070 Brussels, Belgium	Amphia Hospital; Vrije Universiteit Amsterdam; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Kluytmans, J (corresponding author), Amphia Hosp Breda, Lab Microbiol & Infect Control, NL-4800 RK Breda, Netherlands.	jankluytmans@gmail.com		Struelens, Marc/0000-0001-5150-4944				Arbeit RD, 2004, CLIN INFECT DIS, V38, P1673, DOI 10.1086/420818; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Charbonneau P, 2006, CLIN INFECT DIS, V42, P778, DOI 10.1086/500319; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; de San N, 2007, J CLIN MICROBIOL, V45, P1098, DOI 10.1128/JCM.02208-06; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lewis JS, 2007, CURR OPIN INFECT DIS, V20, P568; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V62, DOI 10.1093/jac/dkn200; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	31	37	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2009	338								b364	10.1136/bmj.b364	http://dx.doi.org/10.1136/bmj.b364			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	415ZY	19213761				2022-12-28	WOS:000263976200004
J	Hemerly, AS; Prasanth, SG; Siddiqui, K; Stillman, B				Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce			Orc1 Controls Centriole and Centrosome Copy Number in Human Cells	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CYCLIN-E; DNA-REPLICATION; DUPLICATION; AMPLIFICATION; OVERDUPLICATION; LOCALIZATION; ACCUMULATION; CDK2-CYCLIN; LICENSES	Centrosomes, each containing a pair of centrioles, organize microtubules in animal cells, particularly during mitosis. DNA and centrosomes are normally duplicated once before cell division to maintain optimal genome integrity. We report a new role for the Orc1 protein, a subunit of the origin recognition complex ( ORC) that is a key component of the DNA replication licensing machinery, in controlling centriole and centrosome copy number in human cells, independent of its role in DNA replication. Cyclin A promotes Orc1 localization to centrosomes where Orc1 prevents Cyclin E- dependent reduplication of both centrioles and centrosomes in a single cell division cycle. The data suggest that Orc1 is a regulator of centriole and centrosome reduplication as well as the initiation of DNA replication.	[Hemerly, Adriana S.; Prasanth, Supriya G.; Siddiqui, Khalid; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hemerly, Adriana S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	Cold Spring Harbor Laboratory; Universidade Federal do Rio de Janeiro	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; /0000-0001-6448-0902	National Institutes of Health [CA13106]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Spector for critical reading of the manuscript, P. Wendel for technical support, and J. Salisbury and S. Doxsey for providing antibodies to centrin 2 and centriolin, respectively. This work was supported by a grant from the National Institutes of Health (CA13106), a fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to A.S.H., and a Special Fellow award from the Leukemia and Lymphoma Society to S.G.P.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Gillingham AK, 2000, EMBO REP, V1, P524; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	30	114	118	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					789	793		10.1126/science.1166745	http://dx.doi.org/10.1126/science.1166745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197067	Green Accepted			2022-12-28	WOS:000263066800049
J	Wilkinson, JJ; Stoffell, B; Wilkinson, CC; Jeffries, TE; Appold, MS				Wilkinson, Jamie J.; Stoffell, Barry; Wilkinson, Clara C.; Jeffries, Teresa E.; Appold, Martin S.			Anomalously Metal-Rich Fluids Form Hydrothermal Ore Deposits	SCIENCE			English	Article							ICP-MS; INCLUSIONS; GENESIS; GOLD; MINERALIZATION; MINERALS; BRINES; VEINS; MT	Hydrothermal ore deposits form when metals, often as sulfides, precipitate in abundance from aqueous solutions in Earth's crust. Much of our knowledge of the fluids involved comes from studies of fluid inclusions trapped in silicates or carbonates that are believed to represent aliquots of the same solutions that precipitated the ores. We used laser ablation inductively coupled plasma mass spectrometry to test this paradigm by analysis of fluid inclusions in sphalerite from two contrasting zinc- lead ore systems. Metal contents in these inclusions are up to two orders of magnitude greater than those in quartz- hosted inclusions and are much higher than previously thought, suggesting that ore formation is linked to influx of anomalously metal- rich fluids into systems dominated by barren fluids for much of their life.	[Wilkinson, Jamie J.; Stoffell, Barry; Wilkinson, Clara C.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Wilkinson, Jamie J.; Wilkinson, Clara C.; Jeffries, Teresa E.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Appold, Martin S.] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA	Imperial College London; Natural History Museum London; University of Missouri System; University of Missouri Columbia	Wilkinson, JJ (corresponding author), Univ Tasmania, Australian Res Council Ctr Excellence Ore Deposit, Private Bag 126, Hobart, Tas 7001, Australia.	j.wilkinson@imperial.ac.uk	Wilkinson, Jamie/P-3872-2019; Wilkinson, Jamie/E-7084-2012; Jeffries, Teresa/F-4415-2014	Wilkinson, Jamie/0000-0002-7706-6003; Jeffries, Teresa/0000-0001-6417-1704	Imperial College Albert Julius Bursary; National Environment Research Council [GR9/03047]	Imperial College Albert Julius Bursary; National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by an Imperial College Albert Julius Bursary to B. S. and National Environment Research Council grant GR9/03047. We thank B. Coles and R. Garcia-Sanchez for laboratory support and the Natural History Museum-Imperial College London Joint Analytical Facility for access to instrumentation. The constructive comments of three anonymous reviewers are appreciated.	Appold MS, 2004, ECON GEOL BULL SOC, V99, P185, DOI 10.2113/99.1.185; Barnes HL, 1998, SCIENCE, V279, P2064, DOI 10.1126/science.279.5359.2064; Benison KC, 1998, NATURE, V392, P911, DOI 10.1038/31917; CAMPBELL AR, 1990, GEOCHIM COSMOCHIM AC, V54, P673, DOI 10.1016/0016-7037(90)90363-P; CARPENTER AB, 1974, ECON GEOL, V69, P1191, DOI 10.2113/gsecongeo.69.8.1191; Everett CE, 1999, GEOL SOC SPEC PUBL, V155, P247, DOI 10.1144/GSL.SP.1999.155.01.18; Garven G, 1999, HYDROGEOL J, V7, P108, DOI 10.1007/s100400050183; HANOR JS, 1996, SOC EC GEOLOGISTS SP, V4, P483; Harris AC, 2003, SCIENCE, V302, P2109, DOI 10.1126/science.1089927; Heinrich CA, 2006, SCIENCE, V314, P263, DOI 10.1126/science.1134456; HODGSON CJ, 1993, SPECIAL PUBLICATION, V2, P1; Huston D.L, 1998, AGSO J AUST GEOL GEO, V17, P15; Jeffries TE, 1998, J ANAL ATOM SPECTROM, V13, P935, DOI 10.1039/a801328d; Kharaka Y.K., 1987, US APPL GEOCHEM, V2, P543, DOI DOI 10.1016/0883-2927(87)90008-4; Leach D.L., 1994, SEDIMENT HOSTED ZN P, P104; McKibben MA., 1997, GEOCHEMISTRY HYDROTH, V3, P877; Roedder E., 1984, REV MINERALOGY, V12; Rusk BG, 2004, CHEM GEOL, V210, P173, DOI 10.1016/j.chemgeo.2004.06.011; SAMSON IM, 1987, ECON GEOL, V82, P371, DOI 10.2113/gsecongeo.82.2.371; Seward T.M., 1997, GEOCHEMISTRY HYDROTH, P435; Simmons SF, 2006, SCIENCE, V314, P288, DOI 10.1126/science.1132866; Stoffell B, 2004, AM J SCI, V304, P533, DOI 10.2475/ajs.304.6.533; Stoffell B, 2008, ECON GEOL, V103, P1411, DOI 10.2113/gsecongeo.103.7.1411; Ulrich T, 1999, NATURE, V399, P676, DOI 10.1038/21406; Ulrich T, 2003, ORE GEOL REV, V22, P61, DOI 10.1016/S0169-1368(02)00109-9; VIETS JG, 1996, SOC EC GEOL SPEC PUB, V4, P465; VONDAMM KL, 1990, ANNU REV EARTH PL SC, V18, P173, DOI 10.1146/annurev.ea.18.050190.001133; Wilkinson JJ, 2001, LITHOS, V55, P229, DOI 10.1016/S0024-4937(00)00047-5; Wilkinson JJ, 2005, GEOLOGY, V33, P805, DOI 10.1130/G21740.1; Yardley BWD, 2005, ECON GEOL, V100, P613, DOI 10.2113/100.4.613; [No title captured]	31	138	151	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					764	767		10.1126/science.1164436	http://dx.doi.org/10.1126/science.1164436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197059				2022-12-28	WOS:000263066800041
J	Burns, A; Iliffe, S				Burns, Alistair; Iliffe, Steve			Alzheimer's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VASCULAR DEMENTIA; DIAGNOSIS; EFFICACY; RISK; METAANALYSIS; ASSOCIATION; CAREGIVERS; MANAGEMENT; DISORDERS; SYMPTOMS		[Burns, Alistair; Iliffe, Steve] Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England; [Burns, Alistair] Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England; [Iliffe, Steve] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of Manchester; Open University - UK; University of London; University College London	Burns, A (corresponding author), Univ Manchester, Psychiat Res Grp, Manchester M13 9PL, Lancs, England.	alistair.burns@manchester.ac.uk		Burns, Alistair/0000-0002-9837-0645; Iliffe, Stephen/0000-0003-2806-3997				BACKMAN, 2005, J INT MED, V256, P195; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; BIRKS J, 2008, COCHRANE DATABASE SY; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Burns A, 2002, BRIT MED J, V325, P1312, DOI 10.1136/bmj.325.7376.1312; BURNS A, 1990, BRIT J PSYCHIAT, V157, P72, DOI 10.1192/bjp.157.1.72; Burns A, 2006, J PSYCHOPHARMACOL, V20, P732, DOI 10.1177/0269881106068299; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chang CY, 2004, EXPERT REV MOL DIAGN, V4, P63, DOI 10.1586/14737159.4.1.63; Chong MS, 2003, ANN ACAD MED SINGAP, V32, P740; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P177, DOI 10.1348/014466504323088042; DUBOIS, 2007, LANCET, V6, P734; FARRER L, 1997, JAMA-J AM MED ASSOC, V278, P1249; Feldt T, 2005, EUR J MED RES, V10, P7; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finckh U, 2003, J NEURAL TRANSM, V110, P253, DOI 10.1007/s00702-002-0775-7; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Holmes C, 2004, NEUROLOGY, V63, P214, DOI 10.1212/01.WNL.0000129990.32253.7B; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; JORM AF, 2005, DEMENTIA, P369; KAUWE J, NEUROBIOLOGY; KAUWE J, 2007, NEUROBIOLOGY ALZHEIM, P59; KIVIPELTO M, 2006, LANCET NEUROL; LEROI I, 2005, DEMENTIA, P55; Matthews F, 2005, PLOS MED, V2, P1047, DOI 10.1371/journal.pmed.0020389; Matthews FE, 2007, INT J GERIATR PSYCH, V22, P627, DOI 10.1002/gps.1720; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McShane R, 1997, BMJ-BRIT MED J, V314, P266, DOI 10.1136/bmj.314.7076.266; MOL, 2006, INT J GERIATR PSYCH, V5, P432; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; *NICE SOC CAR I EX, 2006, SCIE GUID; O'Brien J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a602; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P1; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Spaan PEJ, 2003, J CLIN EXP NEUROPSYC, V25, P216, DOI 10.1076/jcen.25.2.216.13638; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; UNKENSTEIN A, 2005, DEMENTIA, P510; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; Vernooj-Dassen M, 2000, INT J AGING HUM DEV, V51, P259, DOI 10.2190/P8L1-N8QD-VTJ4-EURT; Waldemar G, 2007, INT J GERIATR PSYCH, V22, P47, DOI 10.1002/gps.1652; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1	51	525	549	1	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2009	338								b158	10.1136/bmj.b158	http://dx.doi.org/10.1136/bmj.b158			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	414OZ	19196745				2022-12-28	WOS:000263876400002
J	Friedland, JC; Lee, MH; Boettiger, D				Friedland, Julie C.; Lee, Mark H.; Boettiger, David			Mechanically Activated Integrin Switch Controls alpha(5)beta(1) Function	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; MEDIATED ADHESION; CRYSTAL-STRUCTURE; CELL-ADHESION; LIVING CELLS; CATCH BONDS; FORCE; FIBRONECTIN; ALPHA-V-BETA-3	The cytoskeleton, integrin- mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are often deranged in cancer. The connection between these mechanical elements and chemical signaling processes is not known. Here, we show that alpha 5 beta 1 integrin switches between relaxed and tensioned states in response to myosin II- generated cytoskeletal force. Force combines with extracellular matrix stiffness to generate tension that triggers the integrin switch. This switch directly controls the alpha(5)beta(1)- fibronectin bond strength through engaging the synergy site in fibronectin and is required to generate signals through phosphorylation of focal adhesion kinase. In the context of tissues, this integrin switch connects cytoskeleton and extracellular matrix mechanics to adhesion- dependent motility and signaling pathways.	[Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Friedland, Julie C.; Lee, Mark H.; Boettiger, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Boettiger, David] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Boettiger, D (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	boettige@upenn.edu			National Institutes of Health [GM57388]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM57388 from the National Institutes of Health to D. B. We thank S. Akiyama (NIH) for 13G12 antibody, H. Erickson (Duke) for mutant fibronectin constructs, and Qi Shi for technical assistance.	Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; WANG YL, 2007, SCI STKE, pE10; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	24	526	536	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2009	323	5914					642	644		10.1126/science.1168441	http://dx.doi.org/10.1126/science.1168441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179533				2022-12-28	WOS:000262862800045
J	Schrinner, M; Ballauff, M; Talmon, Y; Kauffmann, Y; Thun, J; Moller, M; Breu, J				Schrinner, Marc; Ballauff, Matthias; Talmon, Yeshayahu; Kauffmann, Yaron; Thun, Juergen; Moeller, Michael; Breu, Josef			Single Nanocrystals of Platinum Prepared by Partial Dissolution of Au-Pt Nanoalloys	SCIENCE			English	Article							SPHERICAL POLYELECTROLYTE BRUSHES; SHAPE-CONTROLLED SYNTHESIS; ELECTRON-TRANSFER REACTION; CATALYTIC-ACTIVITY; NANOPARTICLES; GOLD; SIZE; NANOPRISMS; OXIDATION; CLUSTERS	Small metal nanoparticles that are also highly crystalline have the potential for showing enhanced catalytic activity. We describe the preparation of single nanocrystals of platinum that are 2 to 3 nanometers in diameter. These particles were generated and immobilized on spherical polyelectrolyte brushes consisting of a polystyrene core ( diameter of similar to 100 nanometers) onto which long chains of a cationic polyelectrolyte were affixed. In a first step, a nanoalloy of gold and platinum ( a solid solution) was generated within the layer of cationic polyelectrolyte chains. In a second step, the gold was slowly and selectively dissolved by cyanide ions in the presence of oxygen. Cryogenic transmission electron microscopy, wide- angle x- ray scattering, and high-resolution transmission electron microscopy showed that the resulting platinum nanoparticles are faceted single crystals that remain embedded in the polyelectrolyte- chain layer. The composite systems of the core particles and the platinum single nanocrystals exhibit an excellent colloidal stability, as well as high catalytic activity in hydrogenation reactions in the aqueous phase.	[Schrinner, Marc; Ballauff, Matthias; Thun, Juergen; Moeller, Michael; Breu, Josef] Univ Bayreuth, D-95440 Bayreuth, Germany; [Talmon, Yeshayahu] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Kauffmann, Yaron] Technion Israel Inst Technol, Dept Mat Engn, IL-32000 Haifa, Israel	University of Bayreuth; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Ballauff, M (corresponding author), Univ Bayreuth, POB 101251, D-95440 Bayreuth, Germany.	Matthias.Ballauff@uni-bayreuth.de	Kauffmann, Yaron/B-7301-2013; Talmon, Yeshayahu/N-1076-2019; Ballauff, Matthias M/O-4593-2016; Breu, Josef/G-7472-2019; Ballauff, Matthias/AAZ-8185-2020	Talmon, Yeshayahu/0000-0002-9854-3972; Ballauff, Matthias M/0000-0003-0872-1438; Breu, Josef/0000-0002-2547-3950; Kauffmann, Yaron/0000-0002-0117-6222	Deutsche Forschungsgemeinschaft [SFB 481]; Bayreuth; BASF SE; Fonds der Chemischen Industrie; von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayreuth; BASF SE(BASF); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support by the Deutsche Forschungsgemeinschaft, SFB 481, Bayreuth; by the BASF SE; and by the Fonds der Chemischen Industrie is gratefully acknowledged. M. S. thanks the Minerva Foundation, the German Academic Exchange Service (DAAD), and the Technion Russell Berrie Nanotechnology Institute (RBNI) for the support during a stay at the Technion in Haifa. Y. T. thanks the von Humboldt Foundation for the support, through a von Humboldt-Meitner Prize, of the collaboration with the University of Bayreuth. Cryo-TEM was performed at the Hannah and George Krumholz Laboratory for Electron Microscopy of Soft Matter, part of the Technion Project on Complex Liquids, Microstructure, and Macromolecules. The HR-TEM work was done at the Electron Microscopy Center at the Department of Materials Engineering, the Technion.	Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Ballauff M, 2007, PROG POLYM SCI, V32, P1135, DOI 10.1016/j.progpolymsci.2007.05.002; BROOKSBANK D, 1968, J IRON STEEL I, V206, P595; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Ferrando R, 2008, CHEM REV, V108, P845, DOI 10.1021/cr040090g; Guo SJ, 2007, J PHYS CHEM C, V111, P17104, DOI 10.1021/jp075625z; Huheey J.E., 2004, INORGANIC CHEM PRINC, V4th; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Kinge S, 2006, APPL ORGANOMET CHEM, V20, P784, DOI 10.1002/aoc.1126; Koh S, 2007, J AM CHEM SOC, V129, P12624, DOI 10.1021/ja0742784; Lee H, 2006, ANGEW CHEM INT EDIT, V45, P7824, DOI 10.1002/anie.200603068; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Lu Y, 2007, J PHYS CHEM C, V111, P7676, DOI 10.1021/jp070973m; Mei Y, 2005, LANGMUIR, V21, P12229, DOI 10.1021/la052120w; Mei Y, 2007, CHEM MATER, V19, P1062, DOI 10.1021/cm062554s; Narayanan R, 2004, J AM CHEM SOC, V126, P7194, DOI 10.1021/ja0486061; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Narayanan R, 2003, J PHYS CHEM B, V107, P12416, DOI 10.1021/jp035647v; Pastoriza-Santos I, 2002, NANO LETT, V2, P903, DOI 10.1021/nl025638i; Ramirez E, 2007, ADV FUNCT MATER, V17, P2219, DOI 10.1002/adfm.200600633; Ren J, 2007, SMALL, V3, P1508, DOI 10.1002/smll.200700135; Schrinner M, 2008, ADV MATER, V20, P1928, DOI 10.1002/adma.200702421; Schrinner M, 2007, MACROMOL CHEM PHYS, V208, P1542, DOI 10.1002/macp.200700161; Snyder J, 2008, ADV MATER, V20, P4883, DOI 10.1002/adma.200702760; Sulman E, 2006, TOP CATAL, V39, P187, DOI 10.1007/s11244-006-0056-z; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Sun Y, 2007, J AM CHEM SOC, V129, P15465, DOI 10.1021/ja076177b; SWANSON T, 1953, NATL BUR STAND US CI, V31, P539; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194	30	243	247	3	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					617	620		10.1126/science.1166703	http://dx.doi.org/10.1126/science.1166703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179526				2022-12-28	WOS:000262862800038
J	Gustafsson, O; Krusa, M; Zencak, Z; Sheesley, RJ; Granat, L; Engstrom, E; Praveen, PS; Rao, PSP; Leck, C; Rodhe, H				Gustafsson, Orjan; Krusa, Martin; Zencak, Zdenek; Sheesley, Rebecca J.; Granat, Lennart; Engstrom, Erik; Praveen, P. S.; Rao, P. S. P.; Leck, Caroline; Rodhe, Henning			Brown Clouds over South Asia: Biomass or Fossil Fuel Combustion?	SCIENCE			English	Article							SULFUR-DIOXIDE EMISSIONS; INDIAN-OCEAN EXPERIMENT; BLACK CARBON; AEROSOL; CLIMATE; QUANTIFICATION; INVENTORY	Carbonaceous aerosols cause strong atmospheric heating and large surface cooling that is as important to South Asian climate forcing as greenhouse gases, yet the aerosol sources are poorly understood. Emission inventory models suggest that biofuel burning accounts for 50 to 90% of emissions, whereas the elemental composition of ambient aerosols points to fossil fuel combustion. We used radiocarbon measurements of winter monsoon aerosols from western India and the Indian Ocean to determine that biomass combustion produced two- thirds of the bulk carbonaceous aerosols, as well as one- half and two- thirds of two black carbon subfractions, respectively. These constraints show that both biomass combustion ( such as residential cooking and agricultural burning) and fossil fuel combustion should be targeted to mitigate climate effects and improve air quality.	[Gustafsson, Orjan; Krusa, Martin; Zencak, Zdenek; Sheesley, Rebecca J.] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Granat, Lennart; Engstrom, Erik; Leck, Caroline; Rodhe, Henning] Stockholm Univ, Dept Meteorol, S-10691 Stockholm, Sweden; [Praveen, P. S.] MCOH, Hanimaadhoo, Maldives; [Rao, P. S. P.] Indian Inst Trop Meteorol, Pune 411008, Maharashtra, India	Stockholm University; Stockholm University; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM)	Gustafsson, O (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	orjan.gustafsson@itm.su.se	Puppala, Siva/E-7795-2013; Sheesley, Rebecca/I-6655-2015	Puppala, Siva/0000-0002-6742-0398; Puppala, Siva Praveen/0000-0002-1352-3412; Sheesley, Rebecca/0000-0002-8187-0571	Maldives Meteorological Office; H. Nguyen of the international ABC program; Swedish Strategic Environmental Research Foundation; Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning; Swedish International Development Agency; Department for Research Co-Operation; Academy Researcher from the Swedish Royal Academy of Science	Maldives Meteorological Office; H. Nguyen of the international ABC program; Swedish Strategic Environmental Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning(Swedish Research Council Formas); Swedish International Development Agency; Department for Research Co-Operation; Academy Researcher from the Swedish Royal Academy of Science	This is a contribution of the Stockholm University Bert Bolin Centre for Climate Research. We gratefully acknowledge access to and support of the MCOH field site by the Maldives Meteorological Office and H. Nguyen of the international ABC program. We appreciate access to the thermo-optical analyzer at the Department of Applied Environmental Science, Stockholm University. We thank V. Ramanathan (University of California, San Diego, USA) and M. M. Sarin (Physical Research Laboratory, India) for useful discussions. This study was financed by the Swedish Strategic Environmental Research Foundation; the Swedish Research Council; the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning; and the Swedish International Development Agency, Department for Research Co-Operation. O.G. also acknowledges support as an Academy Researcher from the Swedish Royal Academy of Science.	Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Chung CE, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006356; Currie LA, 2002, J RES NATL INST STAN, V107, P279, DOI 10.6028/jres.107.022; Dickerson RR, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000501; Eglinton TI, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000269; Elmquist M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002629; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gustafsson O, 2001, GLOBAL BIOGEOCHEM CY, V15, P881, DOI 10.1029/2000GB001380; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Klinedinst DB, 1999, ENVIRON SCI TECHNOL, V33, P4146, DOI 10.1021/es990355m; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Levin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018477; Mandalakis M, 2005, ENVIRON SCI TECHNOL, V39, P2976, DOI 10.1021/es048184v; Mayol-Bracero OL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000039; Menon S, 2002, SCIENCE, V297, P2250, DOI 10.1126/science.1075159; Neususs C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000327; Novakov T, 2000, GEOPHYS RES LETT, V27, P4061, DOI 10.1029/2000GL011759; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Ramanathan V, 2007, NATURE, V448, P575, DOI 10.1038/nature06019; Reddy MS, 2002, ATMOS ENVIRON, V36, P699, DOI 10.1016/S1352-2310(01)00464-2; Reddy MS, 2002, ATMOS ENVIRON, V36, P677, DOI 10.1016/S1352-2310(01)00463-0; Rengarajan R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008150; Schwartz S.E., 2007, NATURE REPORTS CLIMA, V2, P23, DOI DOI 10.1038/CLIMATE.2007.22; Seinfeld J, 2008, NAT GEOSCI, V1, P15, DOI 10.1038/ngeo.2007.62; Stone EA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008118; Szidat S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028325; Venkataraman C, 2005, SCIENCE, V307, P1454, DOI 10.1126/science.1104359; Zencak Z, 2007, ATMOS ENVIRON, V41, P7895, DOI 10.1016/j.atmosenv.2007.06.006	33	485	505	11	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					495	498		10.1126/science.1164857	http://dx.doi.org/10.1126/science.1164857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164746				2022-12-28	WOS:000262587900040
J	Persad, G; Wertheimer, A; Emanuel, EJ				Persad, Govind; Wertheimer, Alan; Emanuel, Ezekiel J.			Principles for allocation of scarce medical interventions	LANCET			English	Article							INTENSIVE-CARE-UNIT; HEALTH-CARE; RENAL-TRANSPLANTATION; RESOURCE-ALLOCATION; LIFE EXPECTANCY; PUBLIC-HEALTH; FAIR PROCESS; OF-LIFE; REASONABLENESS; ACCOUNTABILITY	Allocation of very scarce medical interventions such as organs and vaccines is a persistent ethical challenge. We evaluate eight simple allocation principles that can be classified into four categories: treating people equally, favouring the worst-off, maximising total benefits, and promoting and rewarding social usefulness. No single principle is sufficient to incorporate all morally relevant considerations and therefore individual principles must be combined into multiprinciple allocation systems. We evaluate three systems: the United Network for Organ Sharing points systems, quality-adjusted life-years, and disability-adjusted life-years. We recommend an alternative system-the complete lives system-which prioritises younger people who have not yet lived a complete life, and also incorporates prognosis, save the most lives, lottery, and instrumental value principles.	[Persad, Govind; Wertheimer, Alan; Emanuel, Ezekiel J.] NIH, Dept Bioeth, Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.	eemanuel@nih.gov	Persad, Govind/K-2593-2019	Persad, Govind/0000-0002-9436-9209				Alexander GC, 2004, ARCH INTERN MED, V164, P593, DOI 10.1001/archinte.164.6.593; *AM MED ASS, ALL LTD MED RES; Anderson ES, 1999, ETHICS, V109, P287, DOI 10.1086/233897; [Anonymous], 1996, COST EFFECTIVENESS H; [Anonymous], THEORY JUSTICE; Arns W, 2007, NEPHROL DIAL TRANSPL, V22, P336, DOI 10.1093/ndt/gfl637; Arras John D, 2005, Yale J Biol Med, V78, P287; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Billittier AJ, 2005, J PUBLIC HEALTH MAN, V11, P267; Brock Dan W, 2003, Cost Eff Resour Alloc, V1, P4, DOI 10.1186/1478-7547-1-4; Brock DW, 2004, ETHICAL, LEGAL, AND SOCIAL ISSUES IN ORGAN TRANSPLANTATION, P41; Brock DW, 2001, J MED PHILOS, V26, P163, DOI 10.1076/jmep.26.2.163.3027; BROOME J, 1984, ETHICS, V95, P38, DOI 10.1086/292596; Burgess EW, 1942, AM J SOCIOL, V48, P343, DOI 10.1086/219181; Calabresi Guido, 1978, TRAGIC CHOICES CONFL; Callahan D., 1995, SETTING LIMITS MED G; Caplan A L, 1987, Health Prog, V68, P40; Childress JF, 2001, CAMB Q HEALTHC ETHIC, V10, P365, DOI 10.1017/S0963180101004054; Cookson R, 2000, J MED ETHICS, V26, P323, DOI 10.1136/jme.26.5.323; Crisp R., 2000, NICOMACHEAN ETHICS; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2005, LANCET, V366, P169, DOI 10.1016/S0140-6736(05)66518-X; Daniels N., 2004, ACHIEVE FAIR DISTRIB; Daniels N, 1988, AM I MY PARENTS KEEP; *DEP HHS, DRAFT GUID ALL TARG; Dworkin R., 2002, SOVEREIGN VIRTUE; Dworkin R., 1993, LIFES DOMINION; Elhauge Einer, 1994, Calif Law Rev, V82, P1449, DOI 10.2307/3480858; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; EMANUEL EJ, 2006, U TOR CTR ETH IN C I; Evans JG, 1997, BRIT MED J, V314, P822, DOI 10.1136/bmj.314.7083.822; Friedman A, 2008, BIOETHICS, V22, P101, DOI 10.1111/j.1467-8519.2007.00605.x; Glover J, 1977, CAUSING DEATH SAVING; HADORN DC, 1991, HASTINGS CENT REP, V21, pS11, DOI 10.2307/3563329; HARRIS J, 1987, J MED ETHICS, V13, P117, DOI 10.1136/jme.13.3.117; Harris J., 1985, VALUE LIFE; Hasman A, 2005, HEALTH CARE ANAL, V13, P261, DOI 10.1007/s10728-005-8124-2; HOPE T, 1993, BRIT MED J, V306, P379, DOI 10.1136/bmj.306.6874.379; Howard DH, 2001, TRANSPLANTATION, V72, P1169, DOI 10.1097/00007890-200109270-00037; Hsieh NH, 2006, PHILOS PUBLIC AFF, V34, P352, DOI 10.1111/j.1088-4963.2006.00074.x; JECKER NS, 1989, J AM GERIATR SOC, V37, P1067, DOI 10.1111/j.1532-5415.1989.tb06923.x; Jonsen A R, 1986, Law Med Health Care, V14, P172; Kamm F. M., 1993, MORTALITY MORTALITY, V1; Kappel Klemens, 1992, Bioethics, V6, P297, DOI 10.1111/j.1467-8519.1992.tb00208.x; Kind P., 1999, 172 U YORK YORK HLTH; LANGFORD MJ, 1992, J MED ETHICS, V18, P12, DOI 10.1136/jme.18.1.12; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; LANKEN PN, 1997, ETHICS ALLOCATING IN, P5; Liss PE, 2003, SCAND J PUBLIC HEALT, V31, P156, DOI 10.1080/14034940210165226; LO B, 2007, ETH LEG CONS MIT PAN; Macklin R., 2004, ETHICS EQUITY ACCESS; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; McGough LJ, 2005, AM J PUBLIC HEALTH, V95, P1173, DOI 10.2105/AJPH.2004.052738; McGregor M, 2003, CAN MED ASSOC J, V168, P433; McKerlie D, 2001, PHILOS PUBLIC AFF, V30, P152, DOI 10.1111/j.1088-4963.2001.00152.x; McKie J., 2005, NEGLECTED EQUITY I 1; Menzel P, 2002, SOC SCI MED, V55, P2149, DOI 10.1016/S0277-9536(01)00358-6; Mielke J, 2003, CRIT CARE MED, V31, P2764, DOI 10.1097/01.CCM.0000098440.74735.DE; Miller Leslie W., 1998, Transplantation (Baltimore), V66, P947, DOI 10.1097/00007890-199810150-00032; Morreim EH, 2005, AM J BIOETHICS, V5, P11, DOI 10.1080/15265160500194246; Morreim EH, 1995, HASTINGS CENT REP, V25, P5, DOI 10.2307/3527834; Murphy TF, 2004, AM J BIOETHICS, V4, pW28; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Mutinga N, 2005, AM J TRANSPLANT, V5, P1090, DOI 10.1111/j.1600-6143.2005.00802.x; Nagel Thomas, 2000, MORTAL QUESTIONS; *NAT I CLIN EXC, 2003, GUID METH TECHN APPR; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Organ Procurement and Transplantation Network, 2007, PUBL FOR DISC KIDN A; Parfit D, 1997, RATIO, V10, P202, DOI 10.1111/1467-9329.00041; Phillips S, 2006, ACAD EMERG MED, V13, P1103, DOI 10.1197/j.aem.2006.07.007; Pronovost P, 2001, CRIT CARE MED, V29, pN46, DOI 10.1097/00003246-200102001-00009; Ramsey Paul, 2002, PATIENT PERSON EXPLO, V2nd; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rawls John., 2001, LAW PEOPLES; RESCHER N, 1969, ETHICS, V79, P173, DOI 10.1086/291723; Richardson J, 1999, AGE WEIGHTING DISCOU; RIVLIN MM, 1995, BRIT MED J, V310, P1179, DOI 10.1136/bmj.310.6988.1179; Roosevelt F. D., 1937, 2 INAUGURAL ADDRESS; Rutecki GW, 1999, SEMIN DIALYSIS, V12, P38, DOI 10.1046/j.1525-139X.1999.t01-3-00004.x; SANDERS D, 1968, UCLA LAW REV, V15, P357; Schwappach David L B, 2002, Health Expect, V5, P210, DOI 10.1046/j.1369-6513.2002.00182.x; Sen A., 1973, EC INEQUALITY; Shaffer D., 2007, DEV PSYCHOL CHILDHOO; Silverman WA, 2001, BMJ-BRIT MED J, V323, P1467, DOI 10.1136/bmj.323.7327.1467; Stein MS, 2002, SOC PHILOS POLICY, V19, P212, DOI 10.1017/S0265052502192090; STEIN MS, 2002, SOC PHILOS POLICY, P19; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Tsuchiya A, 2003, SOC SCI MED, V57, P687, DOI 10.1016/S0277-9536(02)00418-5; Ubel PA, 2000, MED CARE, V38, P892, DOI 10.1097/00005650-200009000-00003; *UN NETW ORG SHAR, POL; Veatch RM, 2005, MT SINAI J MED, V72, P236; VEATCH RM, 2001, MED ETHICS, P7; Williams A, 1999, Ethical Theory Moral Pract, V2, P47, DOI 10.1023/A:1009922327634; Zink S, 2005, AM J BIOETHICS, V5, P6, DOI 10.1080/15265160590953085	96	512	520	2	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					423	431		10.1016/S0140-6736(09)60137-9	http://dx.doi.org/10.1016/S0140-6736(09)60137-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19186274	Green Submitted			2022-12-28	WOS:000262912100034
J	Watts, G				Watts, Geoff			Profile Ian Gilmore: President of the Royal College of Physicians	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					373	373		10.1016/S0140-6736(09)60122-7	http://dx.doi.org/10.1016/S0140-6736(09)60122-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19186262				2022-12-28	WOS:000262912100013
J	Liti, G; Carter, DM; Moses, AM; Warringer, J; Parts, L; James, SA; Davey, RP; Roberts, IN; Burt, A; Koufopanou, V; Tsai, IJ; Bergman, CM; Bensasson, D; O'Kelly, MJT; van Oudenaarden, A; Barton, DBH; Bailes, E; Ba, ANN; Jones, M; Quail, MA; Goodhead, I; Sims, S; Smith, F; Blomberg, A; Durbin, R; Louis, EJ				Liti, Gianni; Carter, David M.; Moses, Alan M.; Warringer, Jonas; Parts, Leopold; James, Stephen A.; Davey, Robert P.; Roberts, Ian N.; Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.; Bergman, Casey M.; Bensasson, Douda; O'Kelly, Michael J. T.; van Oudenaarden, Alexander; Barton, David B. H.; Bailes, Elizabeth; Ba, Alex N. Nguyen; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Blomberg, Anders; Durbin, Richard; Louis, Edward J.			Population genomics of domestic and wild yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; DIVERSITY; EVOLUTION; PARADOXUS; KUDRIAVZEVII; GENES; LIFE; WINE	Since the completion of the genome sequence of Saccharomyces cerevisiae in 1996 (refs 1, 2), there has been a large increase in complete genome sequences, accompanied by great advances in our understanding of genome evolution. Although little is known about the natural and life histories of yeasts in the wild, there are an increasing number of studies looking at ecological and geographic distributions(3,4), population structure(5-8) and sexual versus asexual reproduction(9,10). Less well understood at the whole genome level are the evolutionary processes acting within populations and species that lead to adaptation to different environments, phenotypic differences and reproductive isolation. Here we present one- to fourfold or more coverage of the genome sequences of over seventy isolates of the baker's yeast S. cerevisiae and its closest relative, Saccharomyces paradoxus. We examine variation in gene content, single nucleotide polymorphisms, nucleotide insertions and deletions, copy numbers and transposable elements. We find that phenotypic variation broadly correlates with global genome-wide phylogenetic relationships. S. paradoxus populations are well delineated along geographic boundaries, whereas the variation among worldwide S. cerevisiae isolates shows less differentiation and is comparable to a single S. paradoxus population. Rather than one or two domestication events leading to the extant baker's yeasts, the population structure of S. cerevisiae consists of a few well-defined, geographically isolated lineages and many different mosaics of these lineages, supporting the idea that human influence provided the opportunity for cross-breeding and production of new combinations of pre-existing variations.	[Carter, David M.; Moses, Alan M.; Parts, Leopold; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Liti, Gianni; Barton, David B. H.; Bailes, Elizabeth; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; [Moses, Alan M.; Ba, Alex N. Nguyen] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 2J4, Canada; [Warringer, Jonas; Blomberg, Anders] Univ Gothenburg, Lundberg Lab, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden; [James, Stephen A.; Davey, Robert P.; Roberts, Ian N.] Inst Food Res, Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; [Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Bergman, Casey M.; Bensasson, Douda] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [O'Kelly, Michael J. T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Wellcome Trust Sanger Institute; University of Nottingham; University of Toronto; University of Gothenburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Imperial College London; University of Manchester; Massachusetts Institute of Technology (MIT)	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1HH, England.	rd@sanger.ac.uk; ed.louis@nottingham.ac.uk	Warringer, Jonas/B-8520-2013; van Oudenaarden, Alexander/AAA-1705-2019; Bergman, Casey/F-7854-2010; Tsai, Isheng Jason/ABB-8273-2021; Quail, michael/ABE-6131-2020; Durbin, Richard/AAE-7178-2019; Roberts, Ian N/B-9743-2008; Louis, Edward/B-7920-2008; Liti, Gianni/I-9929-2014; Goodhead, Ian/ABC-9200-2020; Tsai, Isheng J/H-6606-2014	Warringer, Jonas/0000-0001-6144-2740; Bergman, Casey/0000-0002-5462-9854; Tsai, Isheng Jason/0000-0002-2123-5058; Durbin, Richard/0000-0002-9130-1006; Louis, Edward/0000-0003-1157-3608; Blomberg, Anders/0000-0002-1260-3920; Liti, Gianni/0000-0002-2318-0775; Burt, Austin/0000-0001-5146-9640; Bensasson, Douda/0000-0002-9015-2707; Davey, Robert/0000-0002-5589-7754; Goodhead, Ian/0000-0002-3110-9442; Parts, Leopold/0000-0002-2618-670X	The Wellcome Trust; Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC; Swedish Research Council; Swedish Foundation for Strategic Research; National Environment Research Council (NERC); Wellcome Trust; NERC; Canada Foundation for Innovation; National Science Foundation; National Institutes of Health; Hertz fellowship; Biotechnology and Biological Sciences Research Council [BB/F015216/1, BBS/E/F/00042258] Funding Source: researchfish; Natural Environment Research Council [NE/D008824/1] Funding Source: researchfish; BBSRC [BB/F015216/1] Funding Source: UKRI; NERC [NE/D008824/1] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertz fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all the members of the Sanger sequencing production teams for generating the sequence data. We thank members of the Durbin and Louis laboratories and C. Nieduszynski for comments and suggestions, L. Kruglyak and J. Schacherer for sharing their unpublished manuscript and R. Ames and S. Lovell for sharing unpublished results. We also thank the British Council and Chinese Academy of Sciences for providing the opportunity to design and develop this project. Research at the Wellcome Trust Sanger Institute ( D. M. C., A. M. M., L. P, M. J., M. A. Q., I. G., S. S., F. S. and R. D.) is supported by The Wellcome Trust. G. L., D. B. H. B., E. B. and E. J. L. were supported by the Wellcome Trust, the Royal Society and the Biotechnology and Biological Sciences Research Council ( BBSRC). S. A. J., R. P. D. and I. N. R. were supported by the BBSRC. A. B. and J. W. were supported by the Swedish Research Council and the Swedish Foundation for Strategic Research. A. B. and V. K. were supported by the National Environment Research Council (NERC) and I. J. T. was supported by the Wellcome Trust. D. B. was supported by NERC. A. M. M. was supported by the Canada Foundation for Innovation. M. J. T. O. and A. v. O. were supported by the National Science Foundation, the National Institutes of Health and a Hertz fellowship.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BULMER M, 1991, GENETICS, V129, P897; CARTER DM, 2005, SACCHAROMYCES GENOME; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pritchard JK, 2000, GENETICS, V155, P945; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; TAJIMA F, 1989, GENETICS, V123, P585; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105	29	1027	1042	3	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					337	341		10.1038/nature07743	http://dx.doi.org/10.1038/nature07743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212322	Green Submitted, Green Accepted			2022-12-28	WOS:000264285600041
J	Scheibert, J; Leurent, S; Prevost, A; Debregeas, G				Scheibert, J.; Leurent, S.; Prevost, A.; Debregeas, G.			The Role of Fingerprints in the Coding of Tactile Information Probed with a Biomimetic Sensor	SCIENCE			English	Article							TEXTURE; FINE; SKIN; DISCRIMINATION; PERCEPTION; RESOLUTION; MECHANICS; FILTER	In humans, the tactile perception of fine textures (spatial scale <200 micrometers) is mediated by skin vibrations generated as the finger scans the surface. To establish the relationship between texture characteristics and subcutaneous vibrations, a biomimetic tactile sensor has been designed whose dimensions match those of the fingertip. When the sensor surface is patterned with parallel ridges mimicking the fingerprints, the spectrum of vibrations elicited by randomly textured substrates is dominated by one frequency set by the ratio of the scanning speed to the interridge distance. For human touch, this frequency falls within the optimal range of sensitivity of Pacinian afferents, which mediate the coding of fine textures. Thus, fingerprints may perform spectral selection and amplification of tactile information that facilitate its processing by specific mechanoreceptors.	[Debregeas, G.] Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, F-75231 Paris 05, France; Univ Paris 07, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Debregeas, G (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, 24 Rue Lhomond, F-75231 Paris 05, France.	georges.debregeas@lps.ens.fr	Scheibert, Julien/C-5892-2009	Scheibert, Julien/0000-0002-9600-3796; LEURENT, Sebastien/0000-0003-3847-8352; Prevost, Alexis Michel/0000-0002-4588-3316; Debregeas, Georges/0000-0003-3698-4497	CNRS; EU-NEST; MONAT [contract 21, number 29000]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EU-NEST(European Commission); MONAT	This project was supported primarily by CNRS basic funding and in part by the EU-NEST (New and Emerging Science and Technology) program, MONAT (Measurement of Naturalness) project (contract 21, number 29000). We are grateful to D. Chatenay and L. Bourdieu for fruitful discussions and careful reading of the manuscript.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; CARTMILL M, 1979, AM J PHYS ANTHROPOL, V50, P497, DOI 10.1002/ajpa.1330500402; CAUNA N, 1954, ANAT RECORD, V119, P449, DOI 10.1002/ar.1091190405; Crowder R, 2006, SCIENCE, V312, P1478, DOI 10.1126/science.1129110; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; DARIANSMITH I, 1984, HDB PHYSL NERVOUS SY, V3, pCH17; FEARING RS, 1985, INT J ROBOT RES, V4, P40, DOI 10.1177/027836498500400304; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; HOWE RD, 1993, IEEE T ROBOTIC AUTOM, V9, P140, DOI 10.1109/70.238278; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Jones L.A., 2006, HUMAN HAND FUNCTION; Katz, 1989, THE WORLD OF TOUCH; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Maheshwari V, 2006, SCIENCE, V312, P1501, DOI 10.1126/science.1126216; MAKOUS JC, 1995, J NEUROSCI, V15, P2808; Rieke F., 1999, SPIKES EXPLORING NEU; Scheibert J, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/34003; SRINIVASAN MA, 1990, J NEUROPHYSIOL, V63, P1323, DOI 10.1152/jn.1990.63.6.1323; Wang Q, 2007, J BIOMECH, V40, P851, DOI 10.1016/j.jbiomech.2006.03.004; WIENER N, 1958, NONLINEAR PROBLEMS R	26	252	264	9	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1503	1506		10.1126/science.1166467	http://dx.doi.org/10.1126/science.1166467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19179493	Green Submitted			2022-12-28	WOS:000264101700048
J	Liaw, YF; Chu, CM				Liaw, Yun-Fan; Chu, Chia-Ming			Hepatitis B virus infection	LANCET			English	Review							E-ANTIGEN SEROCONVERSION; LIVER-DISEASE PROGRESSION; CORE PROMOTER MUTATIONS; HBEAG-POSITIVE PATIENTS; ACUTE VIRAL-HEPATITIS; TERM-FOLLOW-UP; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; GENOTYPE-C; PEGINTERFERON ALPHA-2A	Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma. An improved understanding of hepatitis B virology, immunology, and the natural course of chronic infection, has identified hepatitis B virus replication as the key driver of immune-mediated liver injury and disease progression. The approval of potent oral antiviral agents has revolutionised hepatitis B treatment since 1998. Conventional and pegylated interferon alfa and nucleoside and nucleotide analogues are widely authorised treatments, and monotherapy with these drugs greatly suppresses virus replication, reduces hepatitis activity, and halts disease progression. However, hepatitis B virus is rarely eliminated, and drug resistance is a major drawback during long term therapy. The development of new drugs and strategies is needed to improve treatment outcomes.	[Liaw, Yun-Fan; Chu, Chia-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Liaw, YF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, 199 Tung Hwa North Rd, Taipei, Taiwan.	liveryfl@so-net.net.tw	Liaw, Yun-Fan/B-4305-2009		Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	We thank Chang-Gung Medical Research Fund and the Prosperous Foundation, Taipei, Taiwan, for long term grant support: Elicit Donaldson and Eric Matluck for English editing; and Su-Chiung Chu for secretarial assistance.	Bertoletti A, 2003, ANTIVIR RES, V60, P61, DOI 10.1016/j.antiviral.2003.08.012; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Bonino F, 2003, J HEPATOL, V39, pS160, DOI 10.1016/S0168-8278(03)00319-2; Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077; BOTHA JF, 1984, LANCET, V1, P1210; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chen YC, 2007, HEPATOL INT, V1, P267, DOI 10.1007/s12072-007-5001-0; Chien RN, 1999, HEPATOLOGY, V30, P770, DOI 10.1002/hep.510300313; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; Chien RN, 2006, ANTIVIR THER, V11, P947; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chu CM, 2007, HEPATOL INT, V1, P311, DOI 10.1007/s12072-007-9002-9; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CJ, 2003, HEPATOLOGY, V38, P619, DOI 10.1053/jhep.2003.50352; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Chu CM, 2005, J HEPATOL, V43, P411, DOI 10.1016/j.jhep.2005.03.018; Chu CM, 2005, INFECTION, V33, P136, DOI 10.1007/s15010-005-4094-4; Chu CM, 2002, J CLIN MICROBIOL, V40, P16, DOI 10.1128/JCM.40.1.16-21.2002; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; CHU CM, 1985, HEPATOLOGY, V5, P431, DOI 10.1002/hep.1840050315; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Craxi A, 2003, J HEPATOL, V39, pS99, DOI 10.1016/S0168-8278(03)00154-5; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Duong TN, 2004, J MED VIROL, V72, P551, DOI 10.1002/jmv.20044; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Flink HJ, 2006, AM J GASTROENTEROL, V101, P2523, DOI 10.1111/j.1572-0241.2006.00812.x; Fontana RJ, 2002, GASTROENTEROLOGY, V123, P719, DOI 10.1053/gast.2002.35352; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Gish RG, 2006, CLIN GASTROENTEROL H, V4, P666, DOI 10.1016/j.cgh.2006.03.017; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hadziyannis SJ, 2007, HEPATOL INT, V1, P281, DOI 10.1007/s12072-007-9004-7; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hann HWL, 2003, LIVER TRANSPLANT, V9, P49, DOI 10.1053/jlts.2003.50005; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lampertico PF, 2007, GASTROENTEROLOGY, V133, P1445, DOI 10.1053/j.gastro.2007.08.079; Lau G, 2007, HEPATOL INT, V1, P316, DOI 10.1007/s12072-007-9006-5; Lau GKK, 2008, HEPATOL INT, V2, P152, DOI 10.1007/s12072-008-9056-3; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2006.01372.x; Liaw YF, 2006, ANTIVIR THER, V11, P669; Lin HH, 2003, J MED VIROL, V69, P466, DOI 10.1002/jmv.10332; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Manesis EK, 2006, J HEPATOL, V45, P343, DOI 10.1016/j.jhep.2006.07.001; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; MARCELLIN P, 2008, HEPATOL INT, V2, pA139; MARCELLIN P, 2008, HEPATOL INT, V2, pA114; McKnight C. A., 2007, Morbidity and Mortality Weekly Report, V56, P1164; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Papatheodoridis GV, 2005, HEPATOLOGY, V42, P121, DOI 10.1002/hep.20760; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Visvanathan K, 2006, SEMIN LIVER DIS, V26, P104, DOI 10.1055/s-2006-939755; Wasley Annemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; YF Liaw, 2006, ASIA PACIFIC POCKET; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2004, J HEPATOL, V41, P119, DOI 10.1016/j.jhep.2004.03.004; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2003, CLIN INFECT DIS, V36, P979, DOI 10.1086/374226; Yuen MF, 2003, HEPATOLOGY, V37, P562, DOI 10.1053/jhep.2003.50098; Yuen MF, 2002, J INFECT DIS, V186, P1335, DOI 10.1086/344327; Zacharakis GH, 2005, J MED VIROL, V77, P173, DOI 10.1002/jmv.20434; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6; [No title captured]	131	960	1052	5	217	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					582	592		10.1016/S0140-6736(09)60207-5	http://dx.doi.org/10.1016/S0140-6736(09)60207-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217993				2022-12-28	WOS:000263333600037
J	Cowan, N; Rouder, JN				Cowan, Nelson; Rouder, Jeffrey N.			Comment on "Dynamic Shifts of Limited Working Memory Resources in Human Vision"	SCIENCE			English	Editorial Material							SHORT-TERM-MEMORY; CAPACITY; STORAGE		[Cowan, Nelson; Rouder, Jeffrey N.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Cowan, N (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	CowanN@missouri.edu		Rouder, Jeffrey/0000-0003-2023-3891	NICHD NIH HHS [R01 HD-21338, R01 HD021338, R01 HD021338-22] Funding Source: Medline; NIMH NIH HHS [R01-MH071418] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD021338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071418] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan Nelson, 2005, WORKING MEMORY CAPAC; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Luck SJ, 1998, TRENDS COGN SCI, V2, P78, DOI 10.1016/S1364-6613(98)01143-7; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	10	48	49	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916								10.1126/science.1166478	http://dx.doi.org/10.1126/science.1166478			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213899	Green Accepted			2022-12-28	WOS:000263295400018
J	Lancrin, C; Sroczynska, P; Stephenson, C; Allen, T; Kouskoff, V; Lacaud, G				Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Allen, Terry; Kouskoff, Valerie; Lacaud, Georges			The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage	NATURE			English	Article							EMBRYONIC STEM-CELL; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; YOLK-SAC; COMMON PRECURSOR; TYROSINE KINASE; IN-VITRO; EXPRESSION; HEMANGIOBLAST; COMMITMENT	It has been proposed that during embryonic development haematopoietic cells arise from a mesodermal progenitor with both endothelial and haematopoietic potential called the haemangioblast(1,2). A conflicting theory instead associates the first haematopoietic cells with a phenotypically differentiated endothelial cell that has haematopoietic potential ( that is, a haemogenic endothelium) (3-5). Support for the haemangioblast concept was initially provided by the identification during mouse embryonic stem cell differentiation of a clonal precursor, the blast colony- forming cell (BL-CFC), which gives rise to blast colonies with both endothelial and haematopoietic components(6,7). Although recent studies have now provided evidence for the presence of this bipotential precursor in vivo(8,9), the precise mechanism for generation of haematopoietic cells from the haemangioblast still remains completely unknown. Here we demonstrate that the haemangioblast generates haematopoietic cells through the formation of a haemogenic endothelium intermediate, providing the first direct link between these two precursor populations. The cell population containing the haemogenic endothelium is transiently generated during BL-CFC development. This cell population is also present in gastrulating mouse embryos and generates haematopoietic cells on further culture. At the molecular level, we demonstrate that the transcription factor Tal1 ( also known as Scl; ref. 10) is indispensable for the establishment of this haemogenic endothelium population whereas the core binding factor Runx1 ( also known as AML1; ref. 11) is critical for generation of definitive haematopoietic cells from haemogenic endothelium. Together our results merge the two a priori conflicting theories on the origin of haematopoietic development into a single linear developmental process.	[Lancrin, Christophe; Sroczynska, Patrycja; Stephenson, Catherine; Lacaud, Georges] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Allen, Terry] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Struct Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Haematopoiesis Grp, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Paterson Institute for Cancer Research; University of Manchester; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Lacaud, G (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Biol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	glacaud@picr.man.ac.uk	lacaud, Georges/ABH-5215-2020; Lancrin, Christophe/AAG-8169-2019	Lancrin, Christophe/0000-0003-0028-7374; Lacaud, Georges/0000-0002-5630-2417	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank K. Labib, C. Miller and T. Somervaille for critical reading of the manuscript, J. Barry and M. Hughes for cell sorting, S. Bagley for help with the time-lapse photography, G. Ashton for help with preparation of sections, and L. Gautreau for advice with the OP9 cultures. Cancer Research UK supported this work.	Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Faloon P, 2000, DEVELOPMENT, V127, P1931; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hirai H, 2003, BLOOD, V101, P886, DOI 10.1182/blood-2002-02-0655; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MURRAY PDF, 1932, P R SOC LOND, V11, P497; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196	30	461	482	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					892	895		10.1038/nature07679	http://dx.doi.org/10.1038/nature07679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19182774	Green Accepted			2022-12-28	WOS:000263266700047
J	Reznick, DN; Ricklefs, RE				Reznick, David N.; Ricklefs, Robert E.			Darwin's bridge between microevolution and macroevolution	NATURE			English	Review							ECOLOGICAL CHARACTER DISPLACEMENT; DIVERSIFICATION RATES; ANGIOSPERM DIVERSIFICATION; MOLECULAR PHYLOGENIES; SPECIES RICHNESS; EXTINCTION RISK; FOSSIL RECORD; DIVERSITY; SPECIATION; BIRDS	Evolutionary biologists have long sought to understand the relationship between microevolution ( adaptation), which can be observed both in nature and in the laboratory, and macroevolution ( speciation and the origin of the divisions of the taxonomic hierarchy above the species level, and the development of complex organs), which cannot be witnessed because it occurs over intervals that far exceed the human lifespan. The connection between these processes is also a major source of conflict between science and religious belief. Biologists often forget that Charles Darwin offered a way of resolving this issue, and his proposal is ripe for re- evaluation in the light of recent research.	[Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of California System; University of California Riverside; University of Missouri System; University of Missouri Saint Louis	Reznick, DN (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	gupy@ucr.edu		reznick, david/0000-0002-1144-0568	National Science Foundation [DEB-0416085, DEB-0623632]	National Science Foundation(National Science Foundation (NSF))	We thank M. Clark, N. Hughes, D. Rabosky and J. Sachs for comments on the manuscript. D.N.R. is supported by grants from the National Science Foundation (grant numbers DEB-0416085 and DEB-0623632).	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; [Anonymous], 1861, ORIGIN SPECIES MEANS; Barraclough TG, 1998, PHILOS T R SOC B, V353, P241, DOI 10.1098/rstb.1998.0206; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chase J.M., 2009, ECOLOGICAL NICHES LI; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; Dobzhansky T., 1937; Freeman PW, 2000, EVOL ECOL RES, V2, P317; GOULD S J, 1977, Paleobiology, V3, P115; GOULD SJ, 1977, ONTONGENY PHYLOGENY; Gould SJ, 2002, STRUCTURE EVOLUTIONA; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; HARVEY PH, 1994, BIOESSAYS, V16, P767, DOI 10.1002/bies.950161012; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Judd WS, 1994, HARVARD PAPERS BOTAN, V1, P1; Lack D., 1947, DARWINS FINCHES; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; LIDGARD S, 1990, PALEOBIOLOGY, V16, P77, DOI 10.1017/S009483730000974X; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; LOSOS JB, 1990, EVOLUTION, V44, P558, DOI 10.1111/j.1558-5646.1990.tb05938.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacArthur R.H., 1972, pvii; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; MAYR E, 1994, PHILOS SCI, V61, P529, DOI 10.1086/289820; Mayr E., 1982, GROWTH BIOL THOUGHT; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; RICKLEFS RE, 1972, AM NAT, V106, P195, DOI 10.1086/282762; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Ricklefs Robert E., 2005, American Naturalist, V165, P651, DOI 10.1086/429676; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Ricklefs Robert E., 2005, P16; Ricklefs Robert E., 2009, P257; Rudwick M. J. S., 2005, BURSTING LIMITS TIME; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; Stanley S. M., 1979, MACROEVOLUTION PATTE; Vandermeer J.H., 1972, Annual Rev Ecol Syst, V3, P107, DOI 10.1146/annurev.es.03.110172.000543; Wallace A. R., 1858, J P LINN SOC ZOOL, V3, P53; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; WRIGHT S, 1982, EVOLUTION, V36, P427, DOI 10.1111/j.1558-5646.1982.tb05065.x	66	98	102	7	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					837	842		10.1038/nature07894	http://dx.doi.org/10.1038/nature07894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212402				2022-12-28	WOS:000263266700034
J	Duret, L; Galtier, N				Duret, Laurent; Galtier, Nicolas			Comment on "Human-Specific Gain of Function in a Developmental Enhancer"	SCIENCE			English	Editorial Material							BIASED GENE CONVERSION; HUMAN GENOME; RECOMBINATION RATES; EVOLUTION; MAP	Prabhakar et al. ( Reports, 5 September 2008, p. 1346) argued that the conserved noncoding sequence HACNS1 has undergone positive selection and contributed to human adaptation. However, the pattern of substitution in HACNS1 is more consistent with the neutral process of biased gene conversion ( BGC). The reported human- specific gain of function is likely due to the accumulation of deleterious mutations driven by BGC, not positive selection.	[Duret, Laurent] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Galtier, Nicolas] Univ Montpellier 2, CNRS, UMR5554, Inst Sci Evolut, F-34095 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Duret, L (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	duret@biomserv.univ-lyon1.fr		Duret, Laurent/0000-0003-2836-3463				Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Webster MT, 2005, MOL BIOL EVOL, V22, P1468, DOI 10.1093/molbev/msi136; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	13	28	28	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915								10.1126/science.1165848	http://dx.doi.org/10.1126/science.1165848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197042				2022-12-28	WOS:000263066800020
J	Hamdan, FF; Gauthier, J; Spiegelman, D; Noreau, A; Yang, Y; Pellerin, S; Dobrzeniecka, S; Cote, M; Perreault-Linck, E; Carmant, L; D'Anjou, G; Fombonne, E; Addington, AM; Rapoport, JL; Delisi, LE; Krebs, MO; Mouaffak, F; Joober, R; Mottron, L; Drapeau, P; Marineau, C; Lafreniere, RG; Lacaille, JC; Rouleau, GA; Michaud, JL				Hamdan, Fadi F.; Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Pellerin, Stephanie; Dobrzeniecka, Sylvia; Cote, Melanie; Perreault-Linck, Elizabeth; Carmant, Lionel; D'Anjou, Guy; Fombonne, Eric; Addington, Anjene M.; Rapoport, Judith L.; Delisi, Lynn E.; Krebs, Marie-Odile; Mouaffak, Faycal; Joober, Ridha; Mottron, Laurent; Drapeau, Pierre; Marineau, Claude; Lafreniere, Ronald G.; Lacaille, Jean Claude; Rouleau, Guy A.; Michaud, Jacques L.		Synapse Dis Grp	Mutations in SYNGAP1 in Autosomal nonsyndromic Mental Retardation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTORS; PROTEIN; TRAFFICKING; COMPLEXES; GENETICS; DEFECT	Although autosomal forms of nonsyndromic mental retardation account for the majority of cases of mental retardation, the genes that are involved remain largely unknown. We sequenced the autosomal gene SYNGAP1, which encodes a ras GTPAse-activating protein that is critical for cognition and synapse function, in 94 patients with nonsyndromic mental retardation. We identified de novo truncating mutations (K138X, R579X, and L813RfsX22) in three of these patients. In contrast, we observed no de novo or truncating mutations in SYNGAP1 in samples from 142 subjects with autism spectrum disorders, 143 subjects with schizophrenia, and 190 control subjects. These results indicate that SYNGAP1 disruption is a cause of autosomal dominant nonsyndromic mental retardation.	[Hamdan, Fadi F.; Pellerin, Stephanie; Carmant, Lionel; D'Anjou, Guy; Michaud, Jacques L.] CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Ctr Hosp, Res Ctr, Montreal, PQ, Canada; [Gauthier, Julie; Spiegelman, Dan; Noreau, Anne; Yang, Yan; Dobrzeniecka, Sylvia; Cote, Melanie; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurom, Dept Med, Montreal, PQ, Canada; [Drapeau, Pierre] Univ Montreal, Ctr Excellence Neurom, Grp Rech Syst Nerveux Cent, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Lacaille, Jean Claude] Univ Montreal, Ctr Excellence Neurom, Dept Physiol, Montreal, PQ, Canada; [Perreault-Linck, Elizabeth; Mottron, Laurent] Univ Montreal, Ctr Excellence Neurom, Ctr Rech Fernand Seguin, Hop Riviere Prairies, Montreal, PQ, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3H 1P3, Canada; [Joober, Ridha] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Addington, Anjene M.; Rapoport, Judith L.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Delisi, Lynn E.] Nathan S Kline Inst Psychiat Res, Ctr Adv Brain Imaging, Orangeburg, NY 10962 USA; [Krebs, Marie-Odile; Mouaffak, Faycal] Univ Paris 05, INSERM, Unite 894, Paris, France; [Krebs, Marie-Odile; Mouaffak, Faycal] Hop St Anne, F-75674 Paris, France	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Nathan Kline Institute for Psychiatric Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Michaud, JL (corresponding author), CHU St Justine, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	michaud@recherche-ste-justine.qc.ca	Krebs, Marie-Odile/O-2104-2017; Fombonne, Eric/M-4893-2018	Krebs, Marie-Odile/0000-0002-4715-9890; Fombonne, Eric/0000-0002-8605-3538; spiegelman, dan/0000-0003-4971-8868; Mottron, Laurent/0000-0001-5668-5422; MOUAFFAK, Faycal/0000-0002-6277-5755; Addington, Anjene/0000-0001-7770-299X	Canadian Institute of Health Research; Fonds de la Recherche en Sant; Genome Canada; Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002581] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sant; Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal; Clinical Investigatorship Award; CIHR (Institute of Genetics)(Canadian Institutes of Health Research (CIHR)); Fondation Pierre Deniker; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Canadian Institute of Health Research (CIHR) (to Drs. Lacaille, Rouleau, and Michaud), from Fonds de la Recherche en Sant, (to Dr. Michaud), and from Genome Canada and Genome Quebec and cofunding by Universite de Montreal for the Synapse to Diseases project (to Drs. Drapeau and Rouleau). Dr. Michaud is the recipient of a Clinical Investigatorship Award of the CIHR (Institute of Genetics). The schizophrenia series was collected partly through the Collaborative Network for Family Study in Psychiatry, which is supported by the Fondation Pierre Deniker.; No potential conflict of interest relevant to this article was reported.; We thank the patients and their parents for participating in this study; the members of the Synapse to Disease Group, including Edouard Henrion and Ousmane Diallo of the bioinformatics division and Sandra Laurent, Frederic Kuku, Joannie Duguay, Laurie Destroismaisons, Karine Lachapelle, Philippe Jolivet, Pascale Thibodeau, and Annie Raymond of the genetic screening division; Annie Levert and Judith St.-Onge for performing DNA extraction and paternity testing, respectively; and Pierre Lepage, Sebastien Brunet, and Hao Fan Yam of McGill University and Genome Quebec Innovation Centre sequencing group and Louis Letourneau and Louis Dumond Joseph of the bioinformatics group.	Angehagen M, 2005, J NEUROCHEM, V94, P1124, DOI 10.1111/j.1471-4159.2005.03259.x; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Li WD, 2001, J BIOL CHEM, V276, P21417, DOI 10.1074/jbc.M010744200; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	24	208	227	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					599	605		10.1056/NEJMoa0805392	http://dx.doi.org/10.1056/NEJMoa0805392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196676	Green Accepted			2022-12-28	WOS:000263028800006
J	Ludwig, DS; Pollack, HA				Ludwig, David S.; Pollack, Harold A.			Obesity and the Economy From Crisis to Opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONSEQUENCES		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Pollack, Harold A.] Univ Chicago, Ctr Hlth Adm Studies, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; University of Chicago	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Pollack, Harold A/A-1166-2007	Ludwig, David/0000-0003-3307-8544				*BUR LAB STAT, JUN 2008 CPI DET REP; Caroli M, 2004, INT J OBESITY, V28, pS104, DOI 10.1038/sj.ijo.0802802; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1808, DOI 10.1001/jama.300.15.1808; Marniemi J, 2002, J INTERN MED, V251, P35, DOI 10.1046/j.1365-2796.2002.00921.x; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Rose D, 1999, J NUTR, V129, p517S, DOI 10.1093/jn/129.2.517S; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; SHAND D, STANDARD POORS; Wang LY, 2003, OBES RES, V11, P1313, DOI 10.1038/oby.2003.178	14	79	79	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					533	535		10.1001/jama.2009.52	http://dx.doi.org/10.1001/jama.2009.52			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	402CS	19190318				2022-12-28	WOS:000262992400024
J	Venteicher, AS; Abreu, EB; Meng, ZJ; McCann, KE; Terns, RM; Veenstra, TD; Terns, MP; Artandi, SE				Venteicher, Andrew S.; Abreu, Eladio B.; Meng, Zhaojing; McCann, Kelly E.; Terns, Rebecca M.; Veenstra, Timothy D.; Terns, Michael P.; Artandi, Steven E.			A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis	SCIENCE			English	Article							SMALL NUCLEOLAR RNPS; DYSKERATOSIS-CONGENITA; RNA; ACCUMULATION; HOMOLOG; BODIES; PURIFICATION; RECRUITMENT; BIOGENESIS; SHARE	Telomerase is a ribonucleoprotein ( RNP) complex that synthesizes telomere repeats in tissue progenitor cells and cancer cells. Active human telomerase consists of at least three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA ( TERC), and dyskerin. Here, we identify a holoenzyme subunit, TCAB1 ( telomerase Cajal body protein 1), that is notably enriched in Cajal bodies, nuclear sites of RNP processing that are important for telomerase function. TCAB1 associates with active telomerase enzyme, established telomerase components, and small Cajal body RNAs that are involved in modifying splicing RNAs. Depletion of TCAB1 by using RNA interference prevents TERC from associating with Cajal bodies, disrupts telomerase- telomere association, and abrogates telomere synthesis by telomerase. Thus, TCAB1 controls telomerase trafficking and is required for telomere synthesis in human cancer cells.	[Venteicher, Andrew S.; McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Abreu, Eladio B.; Terns, Rebecca M.; Terns, Michael P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, Lab Proteom & Analyt Technol, Adv Technol Program, Sci Applicat Int Corp, Frederick, MD 21702 USA; [McCann, Kelly E.; Artandi, Steven E.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021; Terns, Michael/N-6435-2016	Venteicher, Andrew/0000-0003-0643-0493; 	Medical Scientist Training Program [GM07365]; NCI [CA104676, NO1-CO-12400, CA111691, CA125453]; Leukemia and Lymphoma Society Specialized Centers of Research [7007-09]; NATIONAL CANCER INSTITUTE [R01CA104676, R01CA111691, R01CA125453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Specialized Centers of Research(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Medical Scientist Training Program grant GM07365 (A.S.V.) and NCI grant CA104676 (M.P.T. and R.M.T.), with a Supplement to Promote Diversity in Health- Related Research (E.B.A.). This project has been funded in part with federal funds from the NCI under contract NO1-CO-12400 (T.D.V.). This work was supported by NCI grants CA111691 and CA125453 (S.E.A.) and by Leukemia and Lymphoma Society Specialized Centers of Research grant 7007-09 (S.E.A.).	Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hoareau-Aveilla C, 2006, RNA, V12, P832, DOI 10.1261/rna.2344106; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	23	376	398	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					644	648		10.1126/science.1165357	http://dx.doi.org/10.1126/science.1165357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179534	Green Accepted			2022-12-28	WOS:000262862800046
J	Arias, CA; Murray, BE				Arias, Cesar A.; Murray, Barbara E.			Antibiotic-Resistant Bugs in the 21st Century -- A Clinical Super-Challenge.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arias, Cesar A.; Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Murray, Barbara E.] Univ Texas Houston, Sch Med, Div Infect Dis, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Universidad El Bosque; University of Texas System; University of Texas Health Science Center Houston	Arias, CA (corresponding author), Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77025 USA.							Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; LAX E, 2004, MOLD FLOREYS COAT ST; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schwartz BS, 2008, ANN PHARMACOTHER, V42, P289, DOI 10.1345/aph.1K548	5	730	821	6	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					439	443		10.1056/NEJMp0804651	http://dx.doi.org/10.1056/NEJMp0804651			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179312				2022-12-28	WOS:000262812400002
J	Fidler, DP; Drager, N; Lee, K				Fidler, David P.; Drager, Nick; Lee, Kelley			Trade and Health 1 Managing the pursuit of health and wealth: the key challenges	LANCET			English	Article								This article forms part of a six-part Series on trade and health, and sets the stage for this Series by analysing key aspects of the relationship between trade and health. The Series takes stock of this relation and provides timely analysis of the key challenges facing efforts to achieve an appropriate balance between trade and health across a diverse range of issues. This introductory article reviews how trade and health have risen and expanded on global policy agendas in the past decade in unprecedented ways, describes how trade and health issues are respectively governed in international relations, examines the ongoing search for policy coherence between the two policy spheres, and highlights the topics of the remaining articles in the Series.	[Fidler, David P.] Indiana Univ, Sch Law, Ctr Amer & Global Secur, Bloomington, IN 47401 USA; [Drager, Nick] WHO, Dept Eth Equ Trade & Human Rights, CH-1211 Geneva, Switzerland; [Lee, Kelley] London Sch Hyg & Trop Med, Ctr Global Change & Hlth, London WC1, England	Indiana University System; Indiana University Bloomington; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Fidler, DP (corresponding author), Indiana Univ, Maurer Sch Law, Bloomington, IN 47405 USA.	dfidler@indiana.edu			NATIONAL CANCER INSTITUTE [R01CA091021] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA091021-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; [Anonymous], MEMB OBS; BARTLETT C, 2006, CULTURAL GOVERNANCE; BLOUIN C, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61777-8; *CONST WORLD HLTH, 1994, WORLD HLTH ORG BAS D, P1; CUERTO M, 2004, AM J PUBLIC HEALTH, V94, P1864; DOROLLE P, 1976, J INFECT DIS, V133, P478; Fidler D. P, 1999, INT LAW INFECT DIS; FINK C, 2007, TRADE DOHA DEV WINDO, P285; *GLOB FUND FIGHT A, GLOB FUND WORKS; Goodman NM, 1971, INT HLTH ORG THEIR W, V2nd; Howard-Jones N, 1975, SCI BACKGR INT SAN C; HOWARDJONES N, 1950, BRIT MED J, V1, P1032, DOI 10.1136/bmj.1.4661.1032; *INT FIN FAC IMM, WHY IFFIM; *INT LAB ORG, ORG HIST; LEE K, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61776-6; Sands Philippe, 2003, INT ENV LAW, P26; Smith R., 2008, HDB INT TRADE SERVIC, P437; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61780-8; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61778-X; SMITH R, 2009, LANCET          0122, DOI DOI 10.1016/S0140-6736(08)61779-1; *UN, 2003, INT C FIN DEV MONT C; WHO Regional Office for Europe, 2007, CHALLENGE OBESITY WH, DOI [10.1186/1479-5868-4-11, DOI 10.1186/1479-5868-4-11]; World Health Assembly, 2003, WHO FRAM CONV TOB CO; *WORLD HLTH ASS, 2005, WHA583 WHO; *WORLD TRAD ORG, GATT YEARS HAV MARR; *WORLD TRAD ORG, WTO BRIEF ORG 2; *WORLD TRAD ORG, 1999, RES UR ROUND MULT TR, P354; *WORLD TRAD ORG, ACC; *WORLD TRAD ORG, 1999, RES UR ROUND MULT TR, P284; World Trade Organization, 1999, RES UR ROUND MULT TR, P423	31	30	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					325	331		10.1016/S0140-6736(08)61775-4	http://dx.doi.org/10.1016/S0140-6736(08)61775-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19167061	Green Accepted			2022-12-28	WOS:000262728100028
J	Brandt, F; Etchells, SA; Ortiz, JO; Elcock, AH; Hartl, FU; Baumeister, W				Brandt, Florian; Etchells, Stephanie A.; Ortiz, Julio O.; Elcock, Adrian H.; Hartl, F. Ulrich; Baumeister, Wolfgang			The Native 3D Organization of Bacterial Polysomes	CELL			English	Article							COLI 70S RIBOSOME; TRIGGER FACTOR; NASCENT CHAIN; ESCHERICHIA-COLI; MESSENGER-RNA; ELECTRON TOMOGRAPHY; ANGSTROM RESOLUTION; INITIATION-FACTORS; PROTEIN-SYNTHESIS; BINDING-PROTEIN	Recent advances have led to insights into the structure of the bacterial ribosome, but little is known about the 3D organization of ribosomes in the context of translating polysomes. We employed cryoelectron tomography and a template-matching approach to map 70S ribosomes in vitrified bacterial translation extracts and in lysates of active E. coli spheroplasts. In these preparations, polysomal arrangements were observed in which neighboring ribosomes are densely packed and exhibit preferred orientations. Analysis of characteristic examples of polysomes reveals a staggered or pseudohelical organization of ribosomes along the mRNA trace, with the transcript being sequestered on the inside, the tRNA entrance sites being accessible, and the polypeptide exit sites facing the cytosol. Modeling of elongating nascent polypeptide chains suggests that this arrangement maximizes the distance between nascent chains on adjacent ribosomes, thereby reducing the probability of intermolecular interactions that would give rise to aggregation and limit productive folding.	[Brandt, Florian; Etchells, Stephanie A.; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Brandt, Florian; Ortiz, Julio O.; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Hartl, F. Ulrich; Baumeister, Wolfgang] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Elcock, Adrian H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Max Planck Society; Max Planck Society; University of Munich; University of Iowa	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; baumeist@biochem.mpg.de	Elcock, Adrian H./F-4799-2010; Hartl, F. Ulrich/Y-8206-2019	Ortiz, Julio/0000-0001-7470-5546; Elcock, Adrian/0000-0003-2820-1376	European Union; Deutsche Forschungsgemeinschaft [FOR 967]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank S. K. Lakshmipathy for providing the pBAD Luc-SecM-GFP construct. This work was supported by Framework 7 Program of the European Union, by "Fondation Fourmentin Guilbert,'' and by the Deutsche Forschungsgemeinschaft (FOR 967).	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Arnold TE, 1998, RNA, V4, P319; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bashan A, 2005, BIOCHEM SOC T, V33, P488, DOI 10.1042/BST0330488; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Evans MS, 2005, PROTEIN PEPTIDE LETT, V12, P189, DOI 10.2174/0929866053005908; Forster F, 2008, J STRUCT BIOL, V161, P276, DOI 10.1016/j.jsb.2007.07.006; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; FRIEDBERG I, 1975, FEBS LETT, V56, P108, DOI 10.1016/0014-5793(75)80121-9; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; Kopeina GS, 2008, NUCLEIC ACIDS RES, V36, P2476, DOI 10.1093/nar/gkm1177; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Madin K, 2004, FEBS LETT, V562, P155, DOI 10.1016/S0014-5793(04)00221-2; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; RICH A, 1963, SCI AM, V209, P44, DOI 10.1038/scientificamerican1263-44; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SLAYTER H, 1968, J CELL BIOL, V37, P583, DOI 10.1083/jcb.37.2.583; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; STAEHELIN T, 1963, NATURE, V199, P865, DOI 10.1038/199865a0; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; WARNER JR, 1962, SCIENCE, V138, P1399, DOI 10.1126/science.138.3548.1399; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOOLHEAD CA, 2004, NATURE, V444, P391	44	182	186	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					261	271		10.1016/j.cell.2008.11.016	http://dx.doi.org/10.1016/j.cell.2008.11.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167328	Bronze			2022-12-28	WOS:000262648800015
J	Etiope, G; Ciccioli, P				Etiope, Giuseppe; Ciccioli, Paolo			Earth's Degassing: A Missing Ethane and Propane Source	SCIENCE			English	Article							GEOLOGIC EMISSIONS; METHANE		[Etiope, Giuseppe] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Ciccioli, Paolo] CNR, Ist Met Chim, I-00016 Monterotondo, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR)	Etiope, G (corresponding author), Ist Nazl Geofis & Vulcanol, Sez Roma 2,Via V Murata 605, I-00143 Rome, Italy.	Etiope@ingv.it	Etiope, Giuseppe/H-3343-2011	Etiope, Giuseppe/0000-0001-8614-4221				Etiope G, 2004, ATMOS ENVIRON, V38, P3099, DOI 10.1016/j.atmosenv.2004.04.002; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Etiope G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033623; GRANIER C, 2005, GEIA ACCENT DATABASE; Olivier J. G. J., 2003, 3 POET; RUDOLPH J, 1995, J GEOPHYS RES-ATMOS, V100, P11369, DOI 10.1029/95JD00693; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Stein O, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008062	8	128	135	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					478	478		10.1126/science.1165904	http://dx.doi.org/10.1126/science.1165904			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164741				2022-12-28	WOS:000262587900034
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators I	CELL			English	Editorial Material							NUCLEATION; ARRAYS		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32 DE007306, 5T32DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Manning J, 2007, INT J BIOCHEM CELL B, V39, P7, DOI 10.1016/j.biocel.2006.08.012; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003	8	10	10	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					379	U189	380.e1	10.1016/j.cell.2009.01.010	http://dx.doi.org/10.1016/j.cell.2009.01.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19167337	Bronze, Green Accepted			2022-12-28	WOS:000262648800025
J	Okamoto, R; O'Brien, JL; Hofmann, HF; Nagata, T; Sasaki, K; Takeuchi, S				Okamoto, Ryo; O'Brien, Jeremy L.; Hofmann, Holger F.; Nagata, Tomohisa; Sasaki, Keiji; Takeuchi, Shigeki			An Entanglement Filter	SCIENCE			English	Article							STANDARD QUANTUM LIMIT; COMMUNICATION; PAIRS	The ability to filter quantum states is a key capability in quantum information science and technology, in which one- qubit filters, or polarizers, have found wide application. Filtering on the basis of entanglement requires extension to multi- qubit filters with qubit- qubit interactions. We demonstrated an optical entanglement filter that passes a pair of photons if they have the desired correlations of their polarization. Such devices have many important applications to quantum technologies.	[Okamoto, Ryo; Nagata, Tomohisa; Sasaki, Keiji; Takeuchi, Shigeki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; [Okamoto, Ryo; Nagata, Tomohisa; Takeuchi, Shigeki] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan; [O'Brien, Jeremy L.] Univ Bristol, Ctr Quantum Photon, HH Wills Phys Lab, Bristol BS8 1UG, Avon, England; [O'Brien, Jeremy L.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UG, Avon, England; [Hofmann, Holger F.] Hiroshima Univ, Grad Sch Adv Sci & Matter, Hiroshima 7398530, Japan	Hokkaido University; Osaka University; University of Bristol; University of Bristol; Hiroshima University	Takeuchi, S (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.	takeuchi@es.hokudai.ac.jp	Takeuchi, Shigeki/F-9807-2012; O'Brien, Jeremy L/A-6290-2008; OKAMOTO, RYO/A-5272-2012; Sasaki, Keiji/AAH-5161-2020	OKAMOTO, RYO/0000-0002-7172-6533; Sasaki, Keiji/0000-0003-2340-9477; O'Brien, Jeremy/0000-0002-3576-8285	Japan Science and Technology Agency; Ministry of Internal Affairs and Communication; Japan Society for the Promotion of Science; 21st Century Center of Excellence Program; Promoting Science and Technology, Japan; Engineering and Physical Sciences Research Council, UK; EPSRC [EP/F010524/1, EP/F008023/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F008023/1, EP/F010524/1] Funding Source: researchfish	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Internal Affairs and Communication; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promoting Science and Technology, Japan; Engineering and Physical Sciences Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Japan Science and Technology Agency, Ministry of Internal Affairs and Communication, Japan Society for the Promotion of Science, 21st Century Center of Excellence Program, Special Coordination Funds for Promoting Science and Technology, Japan, and Engineering and Physical Sciences Research Council, UK.	Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; BURNHAM DC, 1970, PHYS REV LETT, V25, P84, DOI 10.1103/PhysRevLett.25.84; D'Angelo M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.013602; Gansen EJ, 2007, NAT PHOTONICS, V1, P585, DOI 10.1038/nphoton.2007.173; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Gisin N, 2007, NAT PHOTONICS, V1, P165, DOI 10.1038/nphoton.2007.22; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; Hofmann HF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.147901; Kardynal BE, 2008, NAT PHOTONICS, V2, P425, DOI 10.1038/nphoton.2008.101; Kiesel N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210505; Kim JS, 1999, APPL PHYS LETT, V74, P902, DOI 10.1063/1.123404; Kwiat PG, 1999, PHYS REV LETT, V83, P4725, DOI 10.1103/PhysRevLett.83.4725; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Nielsen Michael A., 2002, QUANTUM COMPUTATION; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Okamoto R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210506; Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041; Pittman TB, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062311; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Resch KJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.203602; Sanaka K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.083601; Sanaka K, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.021801; Takeuchi S, 1999, APPL PHYS LETT, V74, P1063, DOI 10.1063/1.123482; Yamamoto T, 2003, NATURE, V421, P343, DOI 10.1038/nature01358	26	51	51	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					483	485		10.1126/science.1167182	http://dx.doi.org/10.1126/science.1167182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164743				2022-12-28	WOS:000262587900036
J	Farkouh, ME				Farkouh, Michael E.			Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-DOSE ASPIRIN; TRIAL		Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Farkouh, ME (corresponding author), Mt Sinai Sch Med, New York, NY USA.							Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-8	10.7326/0003-4819-150-2-200901200-02008	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172713				2022-12-28	WOS:000262655200026
J	Makari, G				Makari, George			On the shifting boundaries of medicine	LANCET			English	Editorial Material									[Makari, George] Cornell Univ, Weill Med Coll, Inst Hist Psychiat, New York, NY 10065 USA; [Makari, George] Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10065 USA	Cornell University; Cornell University	Makari, G (corresponding author), Cornell Univ, Weill Med Coll, Inst Hist Psychiat, New York, NY 10065 USA.	gjmakari@med.cornell.edu						Albury W.R., 2005, HLTH HIST, V7, P2; Bonner T., 1995, BECOMING PHYS MED ED; Bynum W. F., 1994, SCI PRACTICE MED 19; Bynum WF, 2006, WESTERN MEDICAL TRADITION, 1800-2000, P1; Conrad L.I., 2008, W MED TRADITION 800; Fleck L, 1979, GENESIS DEV SCI FACT, P1935; Jonsen A.R., 1998, BIRTH BIOETHICS; Makari George, 2008, REVOLUTION MIND; SIGERIST Henry E, 1951, HIST MED PRIMITIVE A, V1	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					206	207		10.1016/S0140-6736(09)60062-3	http://dx.doi.org/10.1016/S0140-6736(09)60062-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19165946				2022-12-28	WOS:000262537500014
J	Fejes-Toth, K; Sotirova, V; Sachidanandam, R; Assaf, G; Hannon, GJ; Kapranov, P; Foissac, S; Willingham, AT; Duttagupta, R; Dumais, E; Gingeras, TR				Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Hannon, Gregory J.; Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.		Affymetrix Cold Spring Harbor Lab	Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs	NATURE			English	Article							GENE-EXPRESSION; HUMAN GENOME; CELLS; IDENTIFICATION; TRANSCRIPTION; REVEAL; MAPS	The transcriptomes of eukaryotic cells are incredibly complex. Individual non- coding RNAs dwarf the number of protein- coding genes, and include classes that are well understood as well as classes for which the nature, extent and functional roles are obscure(1). Deep sequencing of small RNAs (, 200 nucleotides) from human HeLa and HepG2 cells revealed a remarkable breadth of species. These arose both from within annotated genes and from unannotated intergenic regions. Overall, small RNAs tended to align with CAGE ( cap- analysis of gene expression) tags(2), which mark the 5 ' ends of capped, long RNA transcripts. Many small RNAs, including the previously described promoter- associated small RNAs3, appeared to possess cap structures. Members of an extensive class of both small RNAs and CAGE tags were distributed across internal exons of annotated protein coding and noncoding genes, sometimes crossing exon - exon junctions. Here we show that processing of mature mRNAs through an as yet unknown mechanism may generate complex populations of both long and short RNAs whose apparently capped 5 ' ends coincide. Supplying synthetic promoter- associated small RNAs corresponding to the c-MYC transcriptional start site reduced MYC messenger RNA abundance. The studies presented here expand the catalogue of cellular small RNAs and demonstrate a biological impact for at least one class of non- canonical small RNAs.	[Fejes-Toth, Katalin; Sotirova, Vihra; Sachidanandam, Ravi; Assaf, Gordon; Gingeras, Thomas R.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Fejes-Toth, Katalin; Sotirova, Vihra; Assaf, Gordon; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Kapranov, Philipp; Foissac, Sylvain; Willingham, Aarron T.; Duttagupta, Radha; Dumais, Erica; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Affymetrix	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; gingeras@cshl.edu	Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Gingeras, Thomas/0000-0001-9106-3573; Foissac, Sylvain/0000-0002-2631-5356	Schering Foundation; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557] Funding Source: NIH RePORTER	Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Cardone, D. Rebolini, M. Kramer, and W. R. McCombie for Illumina sequencing. We wish to thank J. Brosius, J. Schmitz and T. Rozhdestvensky for their help with the small RNA cloning protocol and J. Dumais for technical assistance. K.F.-T. was in part supported by the Schering Foundation. This work was supported in part by grants from the NIH and was performed as part of the ENCODE consortium (G.J.H. and T.R.G.). G.J.H is an investigator of the Howard Hughes Medical Institute.	BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; EDDY S, 2006, UCSC GENOME BROWSER; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672	20	302	330	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1028	1032		10.1038/nature07759	http://dx.doi.org/10.1038/nature07759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19169241	Green Accepted, Green Published			2022-12-28	WOS:000263425400046
J	Visel, A; Blow, MJ; Li, ZR; Zhang, T; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Chen, F; Afzal, V; Ren, B; Rubin, EM; Pennacchio, LA				Visel, Axel; Blow, Matthew J.; Li, Zirong; Zhang, Tao; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Chen, Feng; Afzal, Veena; Ren, Bing; Rubin, Edward M.; Pennacchio, Len A.			ChIP-seq accurately predicts tissue-specific activity of enhancers	NATURE			English	Article							GENOME; CHROMATIN; SEQUENCE; VERTEBRATE; CONSTRAINT; PROMOTERS; DATABASE; IDENTIFICATION; COACTIVATOR; RECRUITMENT	A major yet unresolved quest in decoding the human genome is the identification of the regulatory sequences that control the spatial and temporal expression of genes. Distant- acting transcriptional enhancers are particularly challenging to uncover because they are scattered among the vast non- coding portion of the genome. Evolutionary sequence constraint can facilitate the discovery of enhancers, but fails to predict when and where they are active in vivo. Here we present the results of chromatin immunoprecipitation with the enhancer- associated protein p300 followed by massively parallel sequencing, and map several thousand in vivo binding sites of p300 in mouse embryonic forebrain, midbrain and limb tissue. We tested 86 of these sequences in a transgenic mouse assay, which in nearly all cases demonstrated reproducible enhancer activity in the tissues that were predicted by p300 binding. Our results indicate that in vivo mapping of p300 binding is a highly accurate means for identifying enhancers and their associated activities, and suggest that such data sets will be useful to study the role of tissue- specific enhancers in human biology and disease on a genome- wide scale.	[Visel, Axel; Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Zhang, Tao; Wright, Crystal; Chen, Feng; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Visel, Axel/A-9398-2009; Blow, Matthew/G-6369-2012; Ding, Cheng-Qiang/B-6287-2011	Visel, Axel/0000-0002-4130-7784; Blow, Matthew/0000-0002-8844-9149; Pennacchio, Len/0000-0002-8748-3732	Berkeley-PGA; National Heart, Lung, & Blood Institute; National Human Genome Research Institute; American Heart Association; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062859] Funding Source: NIH RePORTER	Berkeley-PGA; National Heart, Lung, & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Heart Association(American Heart Association); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank R. Hosseini and S. Phouanenavong for technical support, and J. Rubenstein, J. Long, J. Choi and Y. Zhu for help with microarray experiments. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. L. A. P. and E. M. R. were supported by the Berkeley-PGA, under the Programs for Genomic Applications, funded by National Heart, Lung, & Blood Institute, and L. A. P. by the National Human Genome Research Institute. A. V. was supported by an American Heart Association postdoctoral fellowship. B. R. was supported by grants from the National Human Genome Research Institute and the Ludwig Institute for Cancer Research.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	53	1193	1233	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					854	858		10.1038/nature07730	http://dx.doi.org/10.1038/nature07730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212405	Green Submitted, Green Accepted			2022-12-28	WOS:000263266700039
J	Teno, JM; Connor, SR				Teno, Joan M.; Connor, Stephen R.			Referring a Patient and Family to High-Quality Palliative Care at the Close of Life "We Met a New Personality ... With This Level of Compassion and Empathy"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPICE CARE; MEMBERS PERCEPTIONS; ILL PATIENTS	Palliative care services are increasingly available to primary care physicians for both expert consultations and services to seriously ill patients. The United States now has more than 1400 hospital- based palliative care teams and more than 4700 hospice programs. We use an illustrative case of a palliative care hospitalization and intervention for a middle- aged man with severe pain from spinal metastases to discuss 4 key questions that a primary care physician faces in caring for the seriously ill patient with difficult symptom management: ( 1) Should I refer a patient to a hospital- based palliative care team or to hospice services for difficult symptom management? ( 2) If the patient is referred to a hospital- based palliative care team, what should I, as the primary care physician, expect? ( 3) When should I refer to hospice services a patient initially referred to a hospital- based palliative care team? and ( 4) How can I choose a hospice program that will provide competent, coordinated, and compassionate patient- and family-centered care? Primary care physicians now may choose among hospice programs, and the programs may vary in their quality of care. Validated tools to measure patient and family perceptions of the quality of hospice care are now available but progress in defining and measuring the quality of hospice care is still needed before actionable information will be available to guide the choice of hospice programs for physicians and consumers.	[Teno, Joan M.] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Connor, Stephen R.] Natl Hospice & Palliat Care Org, Washington, DC USA	Brown University	Teno, JM (corresponding author), Brown Univ, Warren Alpert Sch Med, 2 Stimson Ave, Providence, RI 02912 USA.	Joan_Teno@brown.edu	Connor, Stephen R/B-3353-2009	Connor, Stephen R/0000-0003-0332-2067	Archstone Foundation	Archstone Foundation	The Perspectives on Care at the Close of Life section is made possible by a grant from the Archstone Foundation.	[Anonymous], NAT FRAM PREF PRACT; Carlson MDA, 2008, J PAIN SYMPTOM MANAG, V36, P107, DOI 10.1016/j.jpainsymman.2007.09.014; Casarett D, 2005, J AM GERIATR SOC, V53, P249, DOI 10.1111/j.1532-5415.2005.53110.x; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Connor SR, 2005, J PAIN SYMPTOM MANAG, V30, P9, DOI 10.1016/j.jpainsymman.2005.04.001; Connor SR, 2004, J PAIN SYMPTOM MANAG, V28, P316, DOI 10.1016/j.jpainsymman.2004.07.003; DY S, 2008, QUALITY MEASURES HOS; HANSON L, 2008, MEASURING QUALITY CA; Larson DG, 2000, JAMA-J AM MED ASSOC, V284, P1573, DOI 10.1001/jama.284.12.1573; Lorenz Karl A, 2002, J Palliat Med, V5, P507, DOI 10.1089/109662102760269742; Mitchell SL, 2007, J PAIN SYMPTOM MANAG, V34, P7, DOI 10.1016/j.jpainsymman.2007.01.003; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; *NAT CONS PROJ QUA, 2004, PRACT GUID QUAL PALL; *NAT HOSP FDN, SEL HOSP PROGR; *NAT QUAL FOR, 2006, PREV REV NAT QUAL FO; *ORG NHPCO, NHPCO FACTS FIG HOSP; Pan C X, 2001, J Palliat Med, V4, P315, DOI 10.1089/109662101753123922; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rhodes RL, 2007, J PAIN SYMPTOM MANAG, V34, P472, DOI 10.1016/j.jpainsymman.2007.06.004; Rickerson E, 2005, J AM GERIATR SOC, V53, P819, DOI 10.1111/j.1532-5415.2005.53259.x; SAUNDERS C, 2001, MONOGRAPH COMMEMORAT; Schoen C, 2008, HLTH AFFAIRS MILLWOO, V28, pw1, DOI DOI 10.1377/HLTHAFF.28.1.W1; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith Thomas J, 2005, J Palliat Med, V8, P736, DOI 10.1089/jpm.2005.8.736; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Teno JM, 2007, J PAIN SYMPTOM MANAG, V34, P120, DOI 10.1016/j.jpainsymman.2007.04.014; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; VONGUNTEN CF, 2001, CTR ADV PALLIATIVE C; World Health Organization, WHO DEF PALL CAR; 2008, FED REG, V73, P32089	32	34	34	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					651	659		10.1001/jama.2009.109	http://dx.doi.org/10.1001/jama.2009.109			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211472				2022-12-28	WOS:000263229000029
J	Carnaval, AC; Hickerson, MJ; Haddad, CFB; Rodrigues, MT; Moritz, C				Carnaval, Ana Carolina; Hickerson, Michael J.; Haddad, Celio F. B.; Rodrigues, Miguel T.; Moritz, Craig			Stability Predicts Genetic Diversity in the Brazilian Atlantic Forest Hotspot	SCIENCE			English	Article							RAIN-FOREST; CLIMATE DYNAMICS; LATE QUATERNARY; PHYLOGEOGRAPHY; CONSERVATION; BIODIVERSITY; SELECTION; AMAZONIA; ENDEMISM; REPTILES	Biodiversity hotspots, representing regions with high species endemism and conservation threat, have been mapped globally. Yet, biodiversity distribution data from within hotspots are too sparse for effective conservation in the face of rapid environmental change. Using frogs as indicators, ecological niche models under paleoclimates, and simultaneous Bayesian analyses of multispecies molecular data, we compare alternative hypotheses of assemblage- scale response to late Quaternary climate change. This reveals a hotspot within the Brazilian Atlantic forest hotspot. We show that the southern Atlantic forest was climatically unstable relative to the central region, which served as a large climatic refugium for neotropical species in the late Pleistocene. This sets new priorities for conservation in Brazil and establishes a validated approach to biodiversity prediction in other understudied, species- rich regions.	[Carnaval, Ana Carolina; Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hickerson, Michael J.] CUNY Queens Coll, Dept Biol, Flushing, NY 11367 USA; [Haddad, Celio F. B.] UNESP, Dept Zool, Inst Biociencias, BR-35264100 Rio Claro, SP, Brazil; [Rodrigues, Miguel T.] Univ Fed Sao Paulo, Dept Zool, Inst Biociencias, BR-05508090 Sao Paulo, SP, Brazil	University of California System; University of California Berkeley; City University of New York (CUNY) System; Queens College NY (CUNY); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Carnaval, AC (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	carnaval@berkeley.edu	Moritz, Craig/A-7755-2012; Rodrigues, Miguel T./F-8174-2012; Haddad, Célio F. B./C-4267-2012	Moritz, Craig/0000-0001-5313-7279; Rodrigues, Miguel T./0000-0003-3958-9919; Haddad, Célio F. B./0000-0002-7044-5764; Carnaval, Ana/0000-0002-4399-1313	NSF [DBI 0512013, DEB 0743648, DEB 416250, DEB 0817035]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank U. Caramaschi and H. Zaher for providing access to collections MNRJ and MZUSP; O. Peixoto, M. Gomes, A. Muri, R. Kautskyi, S. Lima, E. Santos, J. S. Filho, J. V. Filho, G. Barros, J. Queiroz, R. Araljo, L. Japp, H. Japp, J. Giovanelli, J. Alexandrino, L. Toledo, O. Araljo, G. Egito, J. Zina, D. Loebmann, D. Pavan, R. Amaro, V. Verdade, F. Curcio, M. Dixo, and J. Cassimiro for field work assistance; W. Monahan and R. Hijmans for discussions about the modeling work; L. Smith and D. Turong for DNA- sequencing assistance; R. Pereira, R. Damasceno, S. Rovito, J. Kolbe, S. Singhal, R. Puschendorf, and A. Pounds for discussions about earlier versions of the manuscript. Funding was provided by the NSF (awards DBI 0512013 to A.C.C., DEB 0743648 to M.J.H., DEB 416250 and DEB 0817035 to C.M.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grants to C.F.B.H. and M.T.R.). Sequences are deposited in GenBank (FJ502639-FJ502822). A.C.C. and C. M. designed the study; A.C.C., C.F.B.H., and M.T.R. collected the data; A.C.C., C.M. and M.J.H. analyzed the data; A.C.C. wrote the paper. All authors discussed the results and commented on earlier versions of the manuscript.	Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; BALLARD JWO, 1994, GENETICS, V138, P757; Behling H, 2002, PALAEOGEOGR PALAEOCL, V179, P227, DOI 10.1016/S0031-0182(01)00435-7; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Fay JC, 2000, GENETICS, V155, P1405; FROST DR, 2008, AMPHIBIAN SPECIES WO; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Haddad C.F.B., 2008, ANFIBIOS MATA ATLANT; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-322; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Ledru MP, 2007, DIVERS DISTRIB, V13, P761, DOI 10.1111/j.1472-4642.2007.00389.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1646/0006-3606(2000)032[0786:ITBAF]2.0.CO;2; Nei M., 1987, MOL EVOLUTIONARY GEN; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Rodrigues MT, 2005, CONSERV BIOL, V19, P659, DOI 10.1111/j.1523-1739.2005.00690.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Tajima F, 1996, GENETICS, V143, P1457; TAMURA K, 1992, MOL BIOL EVOL, V9, P678	30	756	778	1	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					785	789		10.1126/science.1166955	http://dx.doi.org/10.1126/science.1166955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197066				2022-12-28	WOS:000263066800048
J	Myers, MG				Myers, Martin G., Jr.			CELL BIOLOGY Moonlighting in Mitochondria	SCIENCE			English	Editorial Material							GRIM-19		[Myers, Martin G., Jr.] Univ Michigan, Div Endocrinol Diabet & Metab, Dept Internal Med, Ann Arbor, MI 48109 USA; [Myers, Martin G., Jr.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Myers, MG (corresponding author), Univ Michigan, Div Endocrinol Diabet & Metab, Dept Internal Med, Ann Arbor, MI 48109 USA.	mgmyers@umich.edu						Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	7	30	32	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					723	724		10.1126/science.1169660	http://dx.doi.org/10.1126/science.1169660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19197047				2022-12-28	WOS:000263066800028
J	Steigemann, P; Wurzenberger, C; Schmitz, MHA; Held, M; Guizetti, J; Maar, S; Gerlich, DW				Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.			Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization	CELL			English	Article							CHROMOSOME SEGREGATION; ANAPHASE BRIDGES; IN-VITRO; CYTOKINESIS; CELLS; CANCER; PHOSPHORYLATION; NONDISJUNCTION; LOCALIZATION; PROGRESSION	Genomic abnormalities are often seen in tumor cells, and tetraploidization, which results from failures during cytokinesis, is presumed to be an early step in cancer formation. Here, we report a cell division control mechanism that prevents tetraploidization in human cells with perturbed chromosome segregation. First, we found that Aurora B inactivation promotes completion of cytokinesis by abscission. Chromosome bridges sustained Aurora B activity to posttelophase stages and thereby delayed abscission at stabilized intercellular canals. This was essential to suppress tetraploidization by furrow regression in a pathway further involving the phosphorylation of mitotic kinesin-like protein 1 (Mklp1). We propose that Aurora B is part of a sensor that responds to unsegregated chromatin at the cleavage site. Our study provides evidence that in human cells abscission is coordinated with the completion of chromosome segregation to protect against tetraploidization by furrow regression.	[Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gerlich, DW (corresponding author), Swiss Inst Technol Zurich ETHZ, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	daniel.gerlich@bc.biol.ethz.ch	Gerlich, Daniel Wolfram W/A-6991-2016; Guizetti, Julien/AAF-3793-2020	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Guizetti, Julien/0000-0002-8762-4259; Guizetti, Julien/0000-0002-7735-4689				Acilan C, 2007, GENE CHROMOSOME CANC, V46, P522, DOI 10.1002/gcc.20425; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jensen CG, 1996, CARCINOGENESIS, V17, P2013, DOI 10.1093/carcin/17.9.2013; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Keppler A, 2006, BIOTECHNIQUES, V41, P167, DOI 10.2144/000112216; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PELIN K, 1992, TOXICOL IN VITRO, V6, P445, DOI 10.1016/0887-2333(92)90051-R; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	34	441	444	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					473	484		10.1016/j.cell.2008.12.020	http://dx.doi.org/10.1016/j.cell.2008.12.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203582	Bronze			2022-12-28	WOS:000263120600017
J	Wynshaw-Boris, A				Wynshaw-Boris, Anthony			Elongator Bridges Tubulin Acetylation and Neuronal Migration	CELL			English	Editorial Material							COMPLEX	Neuronal cell migration and maturation are crucial for the development of the mammalian cerebral cortex. In this issue, Creppe et al. ( 2009) now show that the multisubunit histone acetyltransferase Elongator may regulate migration and branch formation of cortical neurons in the developing mouse brain by acetylating alpha-tubulin.	[Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wynshaw-Boris, A (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA.	wynshawborist@peds.ucsf.edu						Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; PRAMPARO T, 2009, ENCY NEUROSCIENCE, V5, P495; SHEFFIELD VC, 2008, INBORN ERRORS DEV, P1371; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005	7	7	8	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					393	394		10.1016/j.cell.2009.01.024	http://dx.doi.org/10.1016/j.cell.2009.01.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203572	Bronze			2022-12-28	WOS:000263120600007
J	Love, GD; Grosjean, E; Stalvies, C; Fike, DA; Grotzinger, JP; Bradley, AS; Kelly, AE; Bhatia, M; Meredith, W; Snape, CE; Bowring, SA; Condon, DJ; Summons, RE				Love, Gordon D.; Grosjean, Emmanuelle; Stalvies, Charlotte; Fike, David A.; Grotzinger, John P.; Bradley, Alexander S.; Kelly, Amy E.; Bhatia, Maya; Meredith, William; Snape, Colin E.; Bowring, Samuel A.; Condon, Daniel J.; Summons, Roger E.			Fossil steroids record the appearance of Demospongiae during the Cryogenian period	NATURE			English	Article							BIOMARKERS; SPONGES; MARINE; ORIGIN; CLASSIFICATION; BILATERIANS; OXIDATION; EMBRYOS; OILS	The Neoproterozoic era ( 1,000 - 542 Myr ago) was an era of climatic extremes and biological evolutionary developments culminating in the emergence of animals ( Metazoa) and new ecosystems(1). Here we show that abundant sedimentary 24- isopropylcholestanes, the hydrocarbon remains of C-30 sterols produced by marine demosponges, record the presence of Metazoa in the geological record before the end of the Marinoan glaciation ( similar to 635 Myr ago). These sterane biomarkers are abundant in all formations of the Huqf Supergroup, South Oman Salt Basin, and, based on a new high-precision geochronology(2), constitute a continuous 100- Myr- long chemical fossil record of demosponges through the terminal Neoproterozoic and into the Early Cambrian epoch. The demosponge steranes occur in strata that underlie the Marinoan cap carbonate ( > 635 Myr ago). They currently represent the oldest evidence for animals in the fossil record, and are evidence for animals pre- dating the termination of the Marinoan glaciation. This suggests that shallow shelf waters in some late Cryogenian ocean basins (> 635 Myr ago) contained dissolved oxygen in concentrations sufficient to support basal metazoan life at least 100 Myr before the rapid diversification of bilaterians during the Cambrian explosion. Biomarker analysis has yet to reveal any convincing evidence for ancient sponges pre- dating the first globally extensive Neoproterozoic glacial episode ( the Sturtian, similar to 713 Myr ago in Oman(2)).	[Love, Gordon D.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Love, Gordon D.; Bradley, Alexander S.; Kelly, Amy E.; Bhatia, Maya; Bowring, Samuel A.; Condon, Daniel J.; Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 01239 USA; [Grosjean, Emmanuelle] Geosci Australia, Petr & Marine Div, Canberra, ACT 2601, Australia; [Stalvies, Charlotte] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fike, David A.; Grotzinger, John P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Meredith, William; Snape, Colin E.] Univ Nottingham, Sch Chem Environm & Min Engn, Nottingham NG7 2RD, England	University of California System; University of California Riverside; Massachusetts Institute of Technology (MIT); Geoscience Australia; Newcastle University - UK; California Institute of Technology; University of Nottingham	Love, GD (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	glove@ucr.edu	Fike, David A/D-3634-2011; Meredith, Will/N-3342-2019; Summons, Roger Everett/AAL-3789-2020; Bradley, Alexander/A-9391-2009; Meredith, Will/A-4745-2011; Condon, Daniel/A-4249-2008	Fike, David A/0000-0003-2848-0328; Meredith, Will/0000-0003-2978-1608; Bradley, Alexander/0000-0002-4044-2802; Meredith, Will/0000-0003-2978-1608; Condon, Daniel/0000-0002-9082-3283; Snape, Colin/0000-0002-6671-8766; Bhatia, Maya/0000-0002-5236-8689	Petroleum Development Oman (PDO); NASA Exobiology Program; NSF EAR Program; Agouron Institute; NASA Astrobiology Institute; NERC [bgs04003] Funding Source: UKRI; Natural Environment Research Council [bgs04003, NE/C517909/1] Funding Source: researchfish	Petroleum Development Oman (PDO); NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF EAR Program(National Science Foundation (NSF)); Agouron Institute(Pfizer); NASA Astrobiology Institute; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding support for this work came from Petroleum Development Oman (PDO), the NASA Exobiology Program, the NSF EAR Program, the Agouron Institute and the NASA Astrobiology Institute. We thank PDO for access to sample materials and Z. Rawahi and P. Taylor, in particular, for their input. C. Colonero, R. Kayser and A. Lewis provided laboratory assistance, including the maintenance of mass spectrometers at MIT.	BERGQUIST PR, 1991, BIOCHEM SYST ECOL, V19, P17, DOI 10.1016/0305-1978(91)90109-D; BERGQUIST PR, 1980, BIOCHEM SYST ECOL, V8, P423, DOI 10.1016/0305-1978(80)90045-9; Bowring SA, 2007, AM J SCI, V307, P1097, DOI 10.2475/10.2007.01; Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Droser ML, 2002, P NATL ACAD SCI USA, V99, P12572, DOI 10.1073/pnas.202322499; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; GRANTHAM PJ, 1988, J PETROL GEOL, V11, P61, DOI 10.1111/j.1747-5457.1988.tb00801.x; Hold IM, 1999, ORG GEOCHEM, V30, P1411, DOI 10.1016/S0146-6380(99)00115-1; Kodner RB, 2008, P NATL ACAD SCI USA, V105, P9897, DOI 10.1073/pnas.0803975105; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Love GD, 1995, ORG GEOCHEM, V23, P981, DOI 10.1016/0146-6380(95)00075-5; MCCAFFREY MA, 1994, GEOCHIM COSMOCHIM AC, V58, P529, DOI 10.1016/0016-7037(94)90481-2; MCCARRON GME, 2000, THESIS U OXFORD; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; MOLDOWAN JM, 1990, SCIENCE, V247, P309, DOI 10.1126/science.247.4940.309; Murray IP, 1998, ORG GEOCHEM, V29, P1487, DOI 10.1016/S0146-6380(98)00162-4; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; SILVA CJ, 1991, COMP BIOCHEM PHYS B, V99, P763, DOI 10.1016/0305-0491(91)90140-9; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Thiel V, 2002, NATURWISSENSCHAFTEN, V89, P60, DOI 10.1007/s00114-001-0284-9; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682	30	463	492	3	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					718	U5		10.1038/nature07673	http://dx.doi.org/10.1038/nature07673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19194449				2022-12-28	WOS:000263064700040
J	Krumholz, HM; Ross, JS				Krumholz, Harlan M.; Ross, Joseph S.			Relationships with the drug industry: More regulation, greater transparency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med,Sect Hlth Policy & Adm,Sch Publ Hlth, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Bronx, NY USA	Yale University; Yale University; Yale University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320				Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; *HARR INT, 9 ANN RQ REP 60 MOST; *HARR INT, PREST PAR HIGH PAY D; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; *PHARM RES MAN AM, 2008, PHRMA COD INT HEALTH; *US STAT SEN COMM, 2007, COMM STAFF REP CHAIR	7	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2009	338								b211	10.1136/bmj.b211	http://dx.doi.org/10.1136/bmj.b211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	414OX	19193612				2022-12-28	WOS:000263876200004
J	Lu, L; Chen, X; Huang, X; Lu, K				Lu, L.; Chen, X.; Huang, X.; Lu, K.			Revealing the Maximum Strength in Nanotwinned Copper	SCIENCE			English	Article							STRAIN-RATE SENSITIVITY; COHERENT TWIN BOUNDARIES; CENTERED-CUBIC METALS; NANOCRYSTALLINE COPPER; NANOSTRUCTURED METALS; MECHANICAL-PROPERTIES; TENSILE PROPERTIES; DISLOCATIONS; DEFORMATION; CU	The strength of polycrystalline materials increases with decreasing grain size. Below a critical size, smaller grains might lead to softening, as suggested by atomistic simulations. The strongest size should arise at a transition in deformation mechanism from lattice dislocation activities to grain boundary- related processes. We investigated the maximum strength of nanotwinned copper samples with different twin thicknesses. We found that the strength increases with decreasing twin thickness, reaching a maximum at 15 nanometers, followed by a softening at smaller values that is accompanied by enhanced strain hardening and tensile ductility. The strongest twin thickness originates from a transition in the yielding mechanism from the slip transfer across twin boundaries to the activity of preexisting easy dislocation sources.	[Lu, L.; Chen, X.; Lu, K.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Huang, X.] Tech Univ Denmark, Riso Natl Lab Sustainable Energy, Ctr Fundamental Res Met Struct Four Dimens, Dept Mat Res, DK-4000 Roskilde, Denmark	Chinese Academy of Sciences; Institute of Metal Research, CAS; Technical University of Denmark	Lu, L (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	llu@imr.ac.cn	Huang, Xiaoxu/AFV-2572-2022; Lu, Lei/E-3864-2012; Huang, Xiaoxu/N-2856-2017	Huang, Xiaoxu/0000-0002-4635-6112	National Natural Science Foundation of China [50431010, 50621091, 50725103, 50890171]; Ministry of Science and Technology of China [2005CB623604]; Danish National Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Danish National Research Foundation(Danmarks Grundforskningsfond)	Supported by National Natural Science Foundation of China grants 50431010, 50621091, 50725103, and 50890171, Ministry of Science and Technology of China grant 2005CB623604, and the Danish National Research Foundation through the Center for Fundamental Research: Metal Structures in Four Dimensions (X.H.). We thank N. Hansen, Z. Jin, W. Pantleon, and B. Ralph for stimulating discussions, X. Si and H. Ma for sample preparation, S. Zheng for TEM observations, and Y. Shen for conducting some of the tensile tests.	Champion Y, 2003, SCIENCE, V300, P310, DOI 10.1126/science.1081042; Chen J, 2006, SCRIPTA MATER, V54, P1913, DOI 10.1016/j.scriptamat.2006.02.022; Chen XH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2799087; Cheng S, 2005, ACTA MATER, V53, P1521, DOI 10.1016/j.actamat.2004.12.005; Dao M, 2006, ACTA MATER, V54, P5421, DOI 10.1016/j.actamat.2006.06.062; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Huang XX, 2006, SCIENCE, V312, P249, DOI 10.1126/science.1124268; Jin ZH, 2008, ACTA MATER, V56, P1126, DOI 10.1016/j.actamat.2007.11.020; Jin ZH, 2006, SCRIPTA MATER, V54, P1163, DOI 10.1016/j.scriptamat.2005.11.072; Koch CC, 2005, ADV ENG MATER, V7, P787, DOI 10.1002/adem.200500094; Konopka K, 2000, J MATER PROCESS TECH, V99, P255, DOI 10.1016/S0924-0136(99)00434-3; Li YS, 2008, ACTA MATER, V56, P230, DOI 10.1016/j.actamat.2007.09.020; Lu L, 2005, ACTA MATER, V53, P2169, DOI 10.1016/j.actamat.2005.01.031; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; MEYERS MA, 1999, MECH BEHAV MAT, P112; Misra A, 2005, ACTA MATER, V53, P221, DOI 10.1016/j.actamat.2004.09.018; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Rao SI, 2000, PHILOS MAG A, V80, P2011, DOI 10.1080/01418610008212148; Sanders PG, 1997, ACTA MATER, V45, P4019, DOI 10.1016/S1359-6454(97)00092-X; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Shen YF, 2005, SCRIPTA MATER, V52, P989, DOI 10.1016/j.scriptamat.2005.01.033; WANG YM, 2003, SCRIPTA MATER, V48, P1851; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254; Zhang X, 2004, ACTA MATER, V52, P995, DOI 10.1016/j.actamat.2003.10.033; Zhu T, 2007, P NATL ACAD SCI USA, V104, P3031, DOI 10.1073/pnas.0611097104	27	1492	1538	81	1417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					607	610		10.1126/science.1167641	http://dx.doi.org/10.1126/science.1167641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179523				2022-12-28	WOS:000262862800035
J	Gruber, J				Gruber, Jonathan			Health Care 2009: Universal Health Insurance Coverage or Economic Relief -- A False Choice.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gruber, Jonathan] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gruber, J (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Baucus M., 2008, CALL ACTION HLTH REF; Gruber J, 1999, J POLIT ECON, V107, P1249, DOI 10.1086/250096; Gruber J., 2007, PUBLIC FINANCE PUBLI; Gruber Jonathan, 2004, HLTH POLICY UNINSURE, P98	4	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					437	439		10.1056/NEJMp0810203	http://dx.doi.org/10.1056/NEJMp0810203			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399PS	19179311				2022-12-28	WOS:000262812400001
J	Ibrahim, HN; Foley, R; Tan, LP; Rogers, T; Bailey, RF; Guo, HF; Gross, CR; Matas, AJ				Ibrahim, Hassan N.; Foley, Robert; Tan, LiPing; Rogers, Tyson; Bailey, Robert F.; Guo, Hongfei; Gross, Cynthia R.; Matas, Arthur J.			Long-Term Consequences of Kidney Donation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-FUNCTION; FOLLOW-UP; UNILATERAL NEPHRECTOMY; BLOOD-PRESSURE; DONORS; TRANSPLANTATION; METAANALYSIS; HYPERTENSION; FILTRATION; RISK	Background: The long-term renal consequences of kidney donation by a living donor are attracting increased appropriate interest. The overall evidence suggests that living kidney donors have survival similar to that of nondonors and that their risk of end-stage renal disease (ESRD) is not increased. Previous studies have included relatively small numbers of donors and a brief follow-up period. Methods: We ascertained the vital status and lifetime risk of ESRD in 3698 kidney donors who donated kidneys during the period from 1963 through 2007; from 2003 through 2007, we also measured the glomerular filtration rate (GFR) and urinary albumin excretion and assessed the prevalence of hypertension, general health status, and quality of life in 255 donors. Results: The survival of kidney donors was similar to that of controls who were matched for age, sex, and race or ethnic group. ESRD developed in 11 donors, a rate of 180 cases per million persons per year, as compared with a rate of 268 per million per year in the general population. At a mean (+/-SD) of 12.2+/-9.2 years after donation, 85.5% of the subgroup of 255 donors had a GFR of 60 ml per minute per 1.73 m(sup 2) of body-surface area or higher, 32.1% had hypertension, and 12.7% had albuminuria. Older age and higher body-mass index, but not a longer time since donation, were associated with both a GFR that was lower than 60 ml per minute per 1.73 m(sup 2) and hypertension. A longer time since donation, however, was independently associated with albuminuria. Most donors had quality-of-life scores that were better than population norms, and the prevalence of coexisting conditions was similar to that among controls from the National Health and Nutrition Examination Survey (NHANES) who were matched for age, sex, race or ethnic group, and body-mass index. Conclusions: Survival and the risk of ESRD in carefully screened kidney donors appear to be similar to those in the general population. Most donors who were studied had a preserved GFR, normal albumin excretion, and an excellent quality of life. N Engl J Med 2009;360:459-69.	[Ibrahim, Hassan N.; Tan, LiPing; Rogers, Tyson] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bailey, Robert F.; Matas, Arthur J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [Guo, Hongfei] Univ Minnesota, Off Clin Res, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA; [Gross, Cynthia R.] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Foley, Robert] Chron Dis Res Grp, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ibrahim, HN (corresponding author), Univ Minnesota, Div Renal Dis & Hypertens, Suite 353,717 Delaware St SE, Minneapolis, MN 55414 USA.	ibrah007@umn.edu	matas, arthur/ABE-1018-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK013083] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000400, M01-RR00400] Funding Source: Medline; NIDDK NIH HHS [P01 DK013083, P01DK13083] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2007, US REN DAT SYST USRD; BAUDOIN P, 1993, AM J KIDNEY DIS, V21, P603, DOI 10.1016/S0272-6386(12)80032-1; BAY WH, 1987, ANN INTERN MED, V106, P719, DOI 10.7326/0003-4819-106-5-719; BOHANNON LL, 1988, J UROLOGY, V140, P810, DOI 10.1016/S0022-5347(17)41822-2; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BOURGOIGNIE JJ, 1989, KIDNEY INT, V36, pS86; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; DUNN JF, 1986, ANN SURG, V203, P637, DOI 10.1097/00000658-198606000-00008; Ellison MD, 2002, TRANSPLANTATION, V74, P1349, DOI 10.1097/00007890-200211150-00025; Fehrman-Ekholm I, 2006, TRANSPLANTATION, V82, P1646, DOI 10.1097/01.tp.0000250728.73268.e3; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Ibrahim HN, 2006, AM J TRANSPLANT, V6, P1479, DOI 10.1111/j.1600-6143.2006.01335.x; KAPLAN C, 1975, AM J PATHOL, V80, P227; KROHN AG, 1966, J AMER MED ASSOC, V196, P322, DOI 10.1001/jama.196.4.322; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; NARKUNBURGESS DM, 1993, KIDNEY INT, V43, P1110, DOI 10.1038/ki.1993.156; Ramcharan T, 2002, AM J TRANSPLANT, V2, P959, DOI 10.1034/j.1600-6143.2002.21013.x; ROBERTSON JL, 1986, KIDNEY INT, V29, P511, DOI 10.1038/ki.1986.29; SOBH M, 1989, International Urology and Nephrology, V21, P547, DOI 10.1007/BF02549594; THORNER PS, 1984, PEDIATRICS, V73, P806; TORRES VE, 1987, KIDNEY INT, V31, P1383, DOI 10.1038/ki.1987.153; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; WATNICK TJ, 1988, TRANSPLANTATION, V45, P59	29	749	770	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					459	469		10.1056/NEJMoa0804883	http://dx.doi.org/10.1056/NEJMoa0804883			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19179315	Green Accepted			2022-12-28	WOS:000262812400005
J	Pollard, RT; Salter, I; Sanders, RJ; Lucas, MI; Moore, CM; Mills, RA; Statham, PJ; Allen, JT; Baker, AR; Bakker, DCE; Charette, MA; Fielding, S; Fones, GR; French, M; Hickman, AE; Holland, RJ; Hughes, JA; Jickells, TD; Lampitt, RS; Morris, PJ; Nedelec, FH; Nielsdottir, M; Planquette, H; Popova, EE; Poulton, AJ; Read, JF; Seeyave, S; Smith, T; Stinchcombe, M; Taylor, S; Thomalla, S; Venables, HJ; Williamson, R; Zubkov, MV				Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Lucas, Mike I.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Baker, Alex R.; Bakker, Dorothee C. E.; Charette, Matthew A.; Fielding, Sophie; Fones, Gary R.; French, Megan; Hickman, Anna E.; Holland, Ross J.; Hughes, J. Alan; Jickells, Timothy D.; Lampitt, Richard S.; Morris, Paul J.; Nedelec, Florence H.; Nielsdottir, Maria; Planquette, Helene; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Thomalla, Sandy; Venables, Hugh J.; Williamson, Robert; Zubkov, Mike V.			Southern Ocean deep-water carbon export enhanced by natural iron fertilization	NATURE			English	Article							PHYTOPLANKTON BLOOM; CROZET PLATEAU; RADIUM ISOTOPES; CO2; SEQUESTRATION; RESPONSES; NORTH; SCALE; SI	The addition of iron to high- nutrient, low- chlorophyll regions induces phytoplankton blooms that take up carbon(1-3). Carbon export from the surface layer and, in particular, the ability of the ocean and sediments to sequester carbon for many years remains, however, poorly quantified(3). Here we report data from the CROZEX experiment(4) in the Southern Ocean, which was conducted to test the hypothesis that the observed north - south gradient in phytoplankton concentrations in the vicinity of the Crozet Islands is induced by natural iron fertilization that results in enhanced organic carbon flux to the deep ocean. We report annual particulate carbon fluxes out of the surface layer, at three kilometres below the ocean surface and to the ocean floor. We find that carbon fluxes from a highly productive, naturally iron-fertilized region of the sub- Antarctic Southern Ocean are two to three times larger than the carbon fluxes from an adjacent high-nutrient, low- chlorophyll area not fertilized by iron. Our findings support the hypothesis that increased iron supply to the glacial sub- Antarctic may have directly enhanced carbon export to the deep ocean(5). The CROZEX sequestration efficiency(6) ( the amount of carbon sequestered below the depth of winter mixing for a given iron supply) of 8,600 mol mol(-1) was 18 times greater than that of a phytoplankton bloom induced artificially by adding iron(7), but 77 times smaller than that of another bloom(8) initiated, like CROZEX, by a natural supply of iron. Large losses of purposefully added iron can explain the lower efficiency of the induced bloom(6). The discrepancy between the blooms naturally supplied with iron may result in part from an underestimate of horizontal iron supply.	[Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Natl Environm Res Council, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Pollard, Raymond T.; Salter, Ian; Sanders, Richard J.; Moore, C. Mark; Mills, Rachel A.; Statham, Peter J.; Allen, John T.; Holland, Ross J.; Hughes, J. Alan; Lampitt, Richard S.; Morris, Paul J.; Nielsdottir, Maria; Popova, Ekaterina E.; Poulton, Alex J.; Read, Jane F.; Seeyave, Sophie; Smith, Tania; Stinchcombe, Mark; Taylor, Sarah; Zubkov, Mike V.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Salter, Ian] Observ Oceanol, BP44, F-66651 Banyuls Sur Mer, France; [Lucas, Mike I.] Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; [Baker, Alex R.; Bakker, Dorothee C. E.; French, Megan; Jickells, Timothy D.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Charette, Matthew A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem MS25, Woods Hole, MA 02543 USA; [Fielding, Sophie; Venables, Hugh J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Fones, Gary R.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Hickman, Anna E.] Univ Liverpool, Dept Earth & Ocean Sci, Liverpool L69 3GP, Merseyside, England; [Nedelec, Florence H.] IFREMER, Lab Environm & Resources Normandie, F-14520 Port En Bessen, France; [Planquette, Helene] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Thomalla, Sandy; Williamson, Robert] Univ Cape Town, Dept Oceanog, ZA-7701 Rondebosch, South Africa	NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Southampton; University of Southampton; UDICE-French Research Universities; Sorbonne Universite; University of Cape Town; University of East Anglia; Woods Hole Oceanographic Institution; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Portsmouth; University of Liverpool; Ifremer; Rutgers State University New Brunswick; University of Cape Town	Sanders, RJ (corresponding author), Natl Environm Res Council, Natl Oceanog Ctr Southampton, European Way, Southampton SO14 3ZH, Hants, England.	rics@noc.soton.ac.uk	Allen, John Taylor/AHB-3419-2022; Hickman, Anna E/A-9351-2011; Salter, Ian/A-7404-2011; Sanders, Richard J/B-8717-2012; Fones, Gary/G-2489-2010; Mills, Rachel A/A-1150-2011; Salter, Ian/AAI-1015-2021; Charette, Matthew/I-9495-2012; Poulton, Alex J/A-9859-2012; Fielding, Sophie/E-5137-2012; Zubkov, Mikhail/AAW-9674-2020; Bakker, Dorothee C E/E-4951-2015; Baker, Alex R/D-1233-2011; Popova, Ekaterina E/B-4520-2012; Menet-Nedelec, Florence H. A./K-2262-2015; Seas, Deep/J-9245-2014; Thomalla, Sandy/AAS-4133-2021; Planquette, Helene/B-4990-2013	Allen, John Taylor/0000-0001-7357-6623; Sanders, Richard J/0000-0002-6884-7131; Fones, Gary/0000-0002-1999-0716; Mills, Rachel A/0000-0002-9811-246X; Poulton, Alex J/0000-0002-5149-6961; Fielding, Sophie/0000-0002-3152-4742; Zubkov, Mikhail/0000-0001-7723-6810; Bakker, Dorothee C E/0000-0001-9234-5337; Baker, Alex R/0000-0002-8365-8953; Popova, Ekaterina E/0000-0002-2012-708X; Menet-Nedelec, Florence H. A./0000-0002-0933-2509; French, Megan Anne/0000-0002-5837-1360; Salter, Ian/0000-0002-4513-0314; Hickman, Anna/0000-0002-2774-3934; Moore, Mark/0000-0002-9541-6046; Planquette, Helene/0000-0002-2235-5158; Seeyave, Sophie/0000-0002-4583-2869; Williamson, Robert/0000-0002-7288-1762	Natural Environment Research Council; Natural Environment Research Council [NE/F017359/1, soc010008, bas010017, NE/B502844/1, NE/C507353/1] Funding Source: researchfish; NERC [soc010008, bas010017, NE/F017359/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the operators, master and crew of RRS Discovery for their support. CROZEX was a component of Biophysical Interactions and Controls on Export Production, a five-year project at the National Oceanography Centre, Southampton, supported by the Natural Environment Research Council (NERC).	Bakker DCE, 2007, DEEP-SEA RES PT II, V54, P2174, DOI 10.1016/j.dsr2.2007.06.009; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437; Brown L, 2003, LIMNOL OCEANOGR, V48, P1831, DOI 10.4319/lo.2003.48.5.1831; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Charette MA, 2007, DEEP-SEA RES PT II, V54, P1989, DOI 10.1016/j.dsr2.2007.06.003; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Lucas M, 2007, DEEP-SEA RES PT II, V54, P2138, DOI 10.1016/j.dsr2.2007.06.017; Marsh R, 2007, DEEP-SEA RES PT II, V54, P2260, DOI 10.1016/j.dsr2.2007.06.004; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Mongin M, 2008, DEEP-SEA RES PT II, V55, P880, DOI 10.1016/j.dsr2.2007.12.039; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2066, DOI 10.1016/j.dsr2.2007.06.015; Morris PJ, 2007, DEEP-SEA RES PT II, V54, P2208, DOI 10.1016/j.dsr2.2007.06.002; Planquette H, 2007, DEEP-SEA RES PT II, V54, P1999, DOI 10.1016/j.dsr2.2007.06.019; PLANQUETTE HF, 2008, THESIS SOUTHAMPTON U; Pollard RT, 2007, DEEP-SEA RES PT II, V54, P1915, DOI 10.1016/j.dsr2.2007.06.012; Pollard R, 2007, DEEP-SEA RES PT II, V54, P1905, DOI 10.1016/j.dsr2.2007.07.023; Poulton AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002712; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P2085, DOI 10.1016/j.dsr2.2007.06.005; Sanders R, 2007, DEEP-SEA RES PT II, V54, P2191, DOI 10.1016/j.dsr2.2007.06.007; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; van Beek P, 2008, DEEP-SEA RES PT II, V55, P622, DOI 10.1016/j.dsr2.2007.12.025; Venables HJ, 2007, DEEP-SEA RES PT II, V54, P1949, DOI 10.1016/j.dsr2.2007.06.014; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Zhang Y, 2008, DEEP-SEA RES PT II, V55, P638, DOI 10.1016/j.dsr2.2007.12.029	32	249	253	1	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					577	U81		10.1038/nature07716	http://dx.doi.org/10.1038/nature07716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19177128				2022-12-28	WOS:000262852200040
J	Zhao, C; Chen, A; Jamieson, CH; Fereshteh, M; Abrahamsson, A; Blum, J; Kwon, HY; Kim, J; Chute, JP; Rizzieri, D; Munchhof, M; VanArsdale, T; Beachy, PA; Reya, T				Zhao, Chen; Chen, Alan; Jamieson, Catriona H.; Fereshteh, Mark; Abrahamsson, Annelie; Blum, Jordan; Kwon, Hyog Young; Kim, Jynho; Chute, John P.; Rizzieri, David; Munchhof, Michael; VanArsdale, Todd; Beachy, Philip A.; Reya, Tannishtha			Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; SONIC HEDGEHOG; RESISTANCE; GENE; PROLIFERATION; PROGENITORS; MECHANISMS; PATHWAYS; THERAPY	Although the role of Hedgehog (Hh) signalling in embryonic pattern formation is well established(1), its functions in adult tissue renewal and maintenance remain unclear, and the relationship of these functions to cancer development has not been determined. Here we show that the loss of Smoothened (Smo), an essential component of the Hh pathway(2), impairs haematopoietic stem cell renewal and decreases induction of chronic myelogenous leukaemia (CML) by the BCR-ABL1 oncoprotein(3). Loss of Smo causes depletion of CML stem cells-the cells that propagate the leukaemia-whereas constitutively active Smo augments CML stem cell number and accelerates disease. As a possible mechanism for Smo action, we show that the cell fate determinant Numb, which depletes CML stem cells, is increased in the absence of Smo activity. Furthermore, pharmacological inhibition of Hh signalling impairs not only the propagation of CML driven by wild-type BCR-ABL1, but also the growth of imatinib-resistant mouse and human CML. These data indicate that Hh pathway activity is required for maintenance of normal and neoplastic stem cells of the haematopoietic system and raise the possibility that the drug resistance and disease recurrence associated with imatinib treatment of CML4,5 might be avoided by targeting this essential stem cell maintenance pathway.	[Zhao, Chen; Chen, Alan; Fereshteh, Mark; Blum, Jordan; Kwon, Hyog Young; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Chute, John P.; Rizzieri, David] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy, Durham, NC 27710 USA; [Jamieson, Catriona H.; Abrahamsson, Annelie] Moores UCSD Canc Ctr Jolla, Stem Cell Res Program, Dept Med, La Jolla, CA 92093 USA; [Kim, Jynho; Beachy, Philip A.] Stanford Univ, Med Ctr, Howard Hughes Med Inst, Dept Dev Biol,Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Munchhof, Michael] Pfizer Labs, Div Med Chem, Groton, CT 06340 USA; [VanArsdale, Todd] Pfizer Labs, Div Oncol, La Jolla, CA 92121 USA	Duke University; Duke University; Howard Hughes Medical Institute; Stanford University; Pfizer; Pfizer	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Kwon, Hyog/T-7915-2019; Chen, Alan/HGD-3414-2022	Kwon, Hyog/0000-0003-1663-5118; 	CRI; EMF; Leukemia and Lymphoma Society; Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine; National Institutes of Health [DK63031, DK072234, AI067798]; Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072234, R01DK063031] Funding Source: NIH RePORTER	CRI; EMF; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Duke Molecular Cancer Biology Training; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lisa Stafford Memorial Prize; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank R. Wechsler-Reya for critical advice, D. Kioussis for Vav-Cre transgenic mice, A. M. Pendergast, A. Means and B. Hogan for review of the manuscript, S. Li for advice on mouse CML experiments, G. Daley, M. Azam and S. Li for the T315I BCR-ABL1 construct, B. Harvat for cell sorting, and J. Harris, B. Zimdahl, N. D'Amato and S. Honeycutt for experimental help. T. R. is a recipient of a CRI Investigator Award, an EMF New Scholar award and a Leukemia and Lymphoma Society Scholar Award, M. F. is supported by the Duke Molecular Cancer Biology Training grant and C. H. J. is funded by the California Institute of Regenerative Medicine and a sponsored research agreement with Pfizer. This work was also supported by National Institutes of Health grants DK63031, DK072234, AI067798 and the Lisa Stafford Memorial Prize to T. R.	Adams JM, 2007, SCIENCE, V318, DOI 10.1126/science.1149672; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	30	679	727	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					776	U117		10.1038/nature07737	http://dx.doi.org/10.1038/nature07737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19169242	Green Accepted			2022-12-28	WOS:000265193600044
J	Qi, XL; Li, RD; Zang, JD; Zhang, SC				Qi, Xiao-Liang; Li, Rundong; Zang, Jiadong; Zhang, Shou-Cheng			Inducing a Magnetic Monopole with Topological Surface States	SCIENCE			English	Article							HGTE QUANTUM-WELLS; PHASE-TRANSITION; GAUGE THEORY; SPIN; INSULATOR; PARTICLES	Existence of the magnetic monopole is compatible with the fundamental laws of nature; however, this elusive particle has yet to be detected experimentally. We show theoretically that an electric charge near a topological surface state induces an image magnetic monopole charge due to the topological magneto-electric effect. The magnetic field generated by the image magnetic monopole may be experimentally measured, and the inverse square law of the field dependence can be determined quantitatively. We propose that this effect can be used to experimentally realize a gas of quantum particles carrying fractional statistics, consisting of the bound states of the electric charge and the image magnetic monopole charge.	[Qi, Xiao-Liang; Li, Rundong; Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Zang, Jiadong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China	Stanford University; Fudan University	Zhang, SC (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	sczhang@stanford.edu	Li, Rundong/B-2748-2010; Qi, Xiaoliang/F-9245-2010; Zhang, Shou-Cheng/B-2794-2010	Qi, Xiaoliang/0000-0003-0388-5003; 	U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC03-76SF00515]	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank O. M. Auslaender, T. L. Hughes, S. Kivelson, and L. Luan for insightful discussions. This work is supported by the U.S. Department of Energy, Office of Basic Energy Sciences under contract DE-AC03-76SF00515.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Fradkin E, 1996, NUCL PHYS B, V474, P543, DOI 10.1016/0550-3213(96)00310-0; FRADKIN E, 1996, PHYS REV LETT, V543, P100; Fu L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195312; HASENFRATZ P, 1976, PHYS REV LETT, V36, P1119, DOI 10.1103/PhysRevLett.36.1119; HASENFRATZ P, 1976, NUCL PHYS B, V1119, P474; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; JACKIW R, 1976, PHYS REV LETT, V36, P1116, DOI 10.1103/PhysRevLett.36.1116; JACKIW R, 1976, PHYS REV LETT, V1116, P36; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Landau LD., 1984, ELECTRODYNAMICS CONT; LEINAAS JM, 1977, NUOVO CIMENTO B, V37, P1, DOI 10.1007/BF02727953; Madelung O., 1998, LANDOLTBORNSTEIN SUB, VI, P1; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; WILCZEK F, 1982, PHYS REV LETT, V49, P957, DOI 10.1103/PhysRevLett.49.957; WITTEN E, 1979, PHYS LETT B, V86, P283, DOI 10.1016/0370-2693(79)90838-4; Witten E., 1995, SELECTA MATH, V1, P383, DOI 10.1007/BF01671570; ZHANG SC, 1989, PHYS REV LETT, V62, P82, DOI 10.1103/PhysRevLett.62.82	24	733	741	8	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1184	1187		10.1126/science.1167747	http://dx.doi.org/10.1126/science.1167747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19179491	Green Submitted			2022-12-28	WOS:000263687600030
J	Lissenberg, CJ; Rioux, M; Shimizu, N; Bowring, SA; Mevel, C				Lissenberg, C. Johan; Rioux, Matthew; Shimizu, Nobumichi; Bowring, Samuel A.; Mevel, Catherine			Zircon Dating of Oceanic Crustal Accretion	SCIENCE			English	Article							MID-ATLANTIC RIDGE; TI-IN-ZIRCON; CORE COMPLEXES; BENEATH	Most of Earth's present- day crust formed at mid- ocean ridges. High- precision uranium- lead dating of zircons in gabbros from the Vema Fracture Zone on the Mid- Atlantic Ridge reveals that the crust there grew in a highly regular pattern characterized by shallow melt delivery. Combined with results from previous dating studies, this finding suggests that two distinct modes of crustal accretion occur along slow- spreading ridges. Individual samples record a zircon date range of 90,000 to 235,000 years, which is interpreted to reflect the time scale of zircon crystallization in oceanic plutonic rocks.	[Lissenberg, C. Johan; Mevel, Catherine] Inst Phys Globe, F-75252 Paris 05, France; [Lissenberg, C. Johan; Shimizu, Nobumichi] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Rioux, Matthew; Bowring, Samuel A.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	UDICE-French Research Universities; Universite Paris Cite; Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Lissenberg, CJ (corresponding author), Inst Phys Globe, 4 Pl Jussieu, F-75252 Paris 05, France.	lissenbergcj@cardiff.ac.uk	Rioux, Matthew/I-2500-2012; Lissenberg, Cornelis/A-9585-2010; lgm, ipgp/F-8820-2010	Lissenberg, Johan/0000-0001-7774-2297	Woods Hole Oceanographic Institution Deep Ocean Exploration Institute; NSF [OCE-0727914]	Woods Hole Oceanographic Institution Deep Ocean Exploration Institute; NSF(National Science Foundation (NSF))	Supported by a grant from the Woods Hole Oceanographic Institution Deep Ocean Exploration Institute (N.S., C.J.L.). U-Pb geochronology was supported in part by NSF grant OCE-0727914 ( S. A. B.). We thank H. Dick for discussions, J. Honnorez for providing CH78 cruise information, and two anonymous reviewers for their comments. Figure 1 was made using GeoMapApp. This is IPGP contribution 2457.	AUZENDE JM, 1989, NATURE, V337, P726, DOI 10.1038/337726a0; Blackman DK, 1998, J GEOPHYS RES-SOL EA, V103, P21315, DOI 10.1029/98JB01756; Bonatti E, 2005, EARTH PLANET SC LETT, V240, P642, DOI 10.1016/j.epsl.2005.10.010; Bonatti E, 2003, NATURE, V423, P499, DOI 10.1038/nature01594; Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P2699, DOI 10.1029/1999JB900379; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Cannat M, 1996, J GEOPHYS RES-SOL EA, V101, P2847, DOI 10.1029/95JB03116; Coogan LA, 2006, GEOLOGY, V34, P633, DOI 10.1130/G22737.1; deMartin BJ, 2007, GEOLOGY, V35, P711, DOI 10.1130/G23718A.1; Dick HJB, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001645; DICK HJB, 1991, P OC DRILL PROGR SCI, V0118; Dunn RA, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003473; Escartin J, 2008, NATURE, V455, P790, DOI 10.1038/nature07333; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Fu B, 2008, CONTRIB MINERAL PETR, V156, P197, DOI 10.1007/s00410-008-0281-5; Grimes CB, 2007, GEOLOGY, V35, P643, DOI 10.1130/G23603A.1; Grimes CB, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002063; John BE, 2004, EARTH PLANET SC LETT, V222, P145, DOI 10.1016/j.epsl.2004.02.014; Mattinson JM, 2005, CHEM GEOL, V220, P47, DOI 10.1016/j.chemgeo.2005.03.011; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Schwartz JJ, 2005, SCIENCE, V310, P654, DOI 10.1126/science.1116349; Tucholke BE, 1998, J GEOPHYS RES-SOL EA, V103, P9857, DOI 10.1029/98JB00167; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5	23	65	68	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1048	1050		10.1126/science.1167330	http://dx.doi.org/10.1126/science.1167330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19179492				2022-12-28	WOS:000263478400038
J	Thilker, DA; Donovan, J; Schiminovich, D; Bianchi, L; Boissier, S; de Paz, AG; Madore, BF; Martin, DC; Seibert, M				Thilker, David A.; Donovan, Jennifer; Schiminovich, David; Bianchi, Luciana; Boissier, Samuel; Gil de Paz, Armando; Madore, Barry F.; Martin, D. Christopher; Seibert, Mark			Massive star formation within the Leo 'primordial' ring	NATURE			English	Article							H-I CLOUD; M96 GROUP; ULTRAVIOLET EXTINCTION; INTERGALACTIC RING; NEUTRAL HYDROGEN; EVOLUTION; GALAXIES; SEARCH; RESOLUTION; DISKS	Few intergalactic, plausibly primordial clouds of neutral atomic hydrogen ( H I) have been found in the local Universe, suggesting that such structures have either dispersed, become ionized or produced a stellar population on gigayear timescales. The Leo ring(1,2), a massive (M-HI approximate to 1.8 x 10(9) M., M. denoting the solar mass), 200- kpc- wide structure orbiting the galaxies M105 and NGC 3384 with a 4- Gyr period, is a candidate primordial cloud. Despite repeated atttempts(3,4), it has previously been seen only from HI emission, suggesting the absence of a stellar population. Here we report the detection of ultraviolet light from gaseous substructures of the Leo ring, which we attribute to recent massive star formation. The ultraviolet colour of the detected complexes is blue, implying the onset of a burst of star formation or continuous star formation of moderate (similar to 10(8)-yr) duration. Measured ultraviolet visible photometry favours models with low metallicity (Z approximate to Z./ 50-Z./5, Z. denoting the solar metallicity), that is, a low proportion of elements heavier than helium, although spectroscopic confirmation is needed. We speculate that the complexes are dwarf galaxies observed during their formation, but distinguished by their lack of a dark matter component(5). In this regard, they resemble tidal dwarf galaxies, although without the enrichment preceding tidal stripping. If structures like the Leo ring were common in the early Universe, they may have produced a large, yet undetected, population of faint, metal- poor, halo- lacking dwarf galaxies.	[Thilker, David A.; Bianchi, Luciana] Johns Hopkins Univ, Ctr Astrophys Sci, Baltimore, MD 21218 USA; [Donovan, Jennifer; Schiminovich, David] Columbia Univ, Pupin Phys Labs, Dept Astron, New York, NY 10027 USA; [Boissier, Samuel] Lab Astrophys Marseille, F-13376 Marseille 12, France; [Gil de Paz, Armando] Univ Complutense Madrid, Dept Astrofis, Fac Ciencias Fis, E-28040 Madrid, Spain; [Madore, Barry F.; Seibert, Mark] Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; [Martin, D. Christopher] CALTECH, Pasadena, CA 91125 USA	Johns Hopkins University; Columbia University; UDICE-French Research Universities; Aix-Marseille Universite; Complutense University of Madrid; Carnegie Institution for Science; California Institute of Technology	Thilker, DA (corresponding author), Johns Hopkins Univ, Ctr Astrophys Sci, 3400 N Charles St, Baltimore, MD 21218 USA.	dthilker@pha.jhu.edu	Boissier, Samuel/AAA-8018-2022; Gil de Paz, Armando/J-2874-2016	Boissier, Samuel/0000-0002-9091-2366; Gil de Paz, Armando/0000-0001-6150-2854; Seibert, Mark/0000-0002-1143-5515				Adelman-McCarthy JK, 2008, ASTROPHYS J SUPPL S, V175, P297, DOI 10.1086/524984; Aloisi A, 2007, ASTROPHYS J, V667, pL151, DOI 10.1086/522368; Bekki K, 2005, MON NOT R ASTRON SOC, V363, pL21, DOI 10.1111/j.1745-3933.2005.00076.x; Boissier S, 2007, ASTROPHYS J SUPPL S, V173, P524, DOI 10.1086/516642; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; De Jong JTA, 2008, ASTROPHYS J, V680, P1112, DOI 10.1086/587835; de Paz AG, 2007, ASTROPHYS J, V661, P115, DOI 10.1086/513730; DONAHUE M, 1995, ASTROPHYS J, V450, pL45, DOI 10.1086/316771; KIBBLEWHITE EJ, 1985, MON NOT R ASTRON SOC, V213, P111, DOI 10.1093/mnras/213.2.111; MEURER G, ASTROPHYS J IN PRESS; Mihos JC, 2005, ASTROPHYS J, V631, pL41, DOI 10.1086/497030; Millis RL, 2002, ASTRON J, V123, P2083, DOI 10.1086/339481; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; PIERCE MJ, 1985, ASTRON J, V90, P450, DOI 10.1086/113750; REYNOLDS RJ, 1986, ASTROPHYS J, V309, pL9, DOI 10.1086/184750; ROOD HJ, 1985, ASTROPHYS J, V288, P535, DOI 10.1086/162819; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SCHNEIDER SE, 1983, ASTROPHYS J, V273, pL1, DOI 10.1086/184118; SCHNEIDER SE, 1989, ASTROPHYS J, V343, P94, DOI 10.1086/167687; SCHNEIDER SE, 1985, ASTROPHYS J, V288, pL33, DOI 10.1086/184416; SCHNEIDER SE, 1986, ASTRON J, V91, P13, DOI 10.1086/113975; SCHNEIDER SE, 1989, ASTRON J, V97, P666, DOI 10.1086/115012; Sil'chenko OK, 2003, ASTROPHYS J, V591, P185, DOI 10.1086/375315; SPITZER L, 1951, ASTROPHYS J, V113, P413, DOI 10.1086/145406; Thilker DA, 2007, ASTROPHYS J SUPPL S, V173, P538, DOI 10.1086/523853	29	33	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					990	993		10.1038/nature07780	http://dx.doi.org/10.1038/nature07780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225520				2022-12-28	WOS:000263425400037
J	Rousseau, P				Rousseau, Paul			Southern Comfort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					704	704		10.1001/jama.2009.142	http://dx.doi.org/10.1001/jama.2009.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224740				2022-12-28	WOS:000263370100001
J	Araki, H; Tazawa, S; Noda, H; Ishihara, Y; Goossens, S; Sasaki, S; Kawano, N; Kamiya, I; Otake, H; Oberst, J; Shum, C				Araki, H.; Tazawa, S.; Noda, H.; Ishihara, Y.; Goossens, S.; Sasaki, S.; Kawano, N.; Kamiya, I.; Otake, H.; Oberst, J.; Shum, C.			Lunar Global Shape and Polar Topography Derived from Kaguya-LALT Laser Altimetry	SCIENCE			English	Article							MOON	A global lunar topographic map with a spatial resolution of finer than 0.5 degree has been derived using data from the laser altimeter ( LALT) on board the Japanese lunar explorer Selenological and Engineering Explorer ( SELENE or Kaguya). In comparison with the previous Unified Lunar Control Network ( ULCN 2005) model, the new map reveals unbiased lunar topography for scales finer than a few hundred kilometers. Spherical harmonic analysis of global topographic data for the Moon, Earth, Mars, and Venus suggests that isostatic compensation is the prevailing lithospheric support mechanism at large scales. However, simple rigid support is suggested to dominate for the Moon, Venus, and Mars for smaller scales, which may indicate a drier lithosphere than on Earth, especially for the Moon and Venus.	[Araki, H.; Noda, H.] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Tazawa, S.; Ishihara, Y.; Goossens, S.; Sasaki, S.; Kawano, N.] Natl Inst Nat Sci, Natl Astron Observ Japan, Mizusawa, Iwate 0230861, Japan; [Kamiya, I.] Geog Survey Inst, Tsukuba, Ibaraki 3050811, Japan; [Otake, H.] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan; [Oberst, J.] German Aerosp Ctr DLR, D-12489 Berlin, Germany; [Shum, C.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Helmholtz Association; German Aerospace Centre (DLR); University System of Ohio; Ohio State University	Araki, H (corresponding author), Natl Inst Nat Sci, Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	arakih@miz.nao.ac.jp	Ishihara, Yoshiaki/A-8499-2011; Goossens, Sander J/K-2526-2015; Sasaki, Sho/S-3845-2019	Goossens, Sander J/0000-0002-7707-1128; Sasaki, Sho/0000-0002-7646-5248; Tazawa, Seiichi/0000-0002-2536-4623; Ishihara, Yoshiaki/0000-0002-0375-6300; Shum, C K/0000-0001-9378-4067	NEC Co. Ltd.; Grants-in-Aid for Scientific Research [20244073] Funding Source: KAKEN	NEC Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to express our great appreciation for the contributions of all staff engineers of NEC Co. Ltd. and the entire staff of the Kaguya (SELENE) project at JAXA in their development and operational support of LALT. We would also express our special thanks to M. Wieczorek for SHTOOLS on his Web site ( www.ipgp.jussieu.fr/similar to wieczor) used for the spherical harmonic analysis and F. Lemoine and his colleagues at NASA Goddard Space Flight Center for invaluable discussions on the orbit accuracy of the Kaguya main orbiter. Finally, we are grateful to the reviewers for their helpful review and comments and to editors for their careful checking of our manuscript. All of the science data obtained by the Kaguya mission will be made available to the public in a PDS-like format ( not PDS itself) via the Internet and/ or some other method on 1 November 2009. LALT data sets are summarized in table S1.	Araki H, 2008, ADV SPACE RES, V42, P317, DOI 10.1016/j.asr.2007.05.042; Archinal B. B. A., 2006, 20061367 US GEOL SUR, P2006; ARCHINAL BA, 2007, LUNAR PLANET SCI, V38, P1904; BUSSEY B, 2004, CLEMENTINE ATLAS MOO; Campbell BA, 2006, ICARUS, V180, P1, DOI 10.1016/j.icarus.2005.08.018; Mackwell SJ, 1998, J GEOPHYS RES-SOL EA, V103, P975, DOI 10.1029/97JB02671; MCCARTHY JJ, 2007, SOLVE PROGRAM USERS; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; NEUMANN GA, 2001, INT ARCH PHOTOGRAM 3, V34, P73; Pavlis D.E., 2006, GEODYN 2 SYSTEM DESC, P1; Seidelmann PK, 2007, CELEST MECH DYN ASTR, V98, P155, DOI 10.1007/s10569-007-9072-y; Smith DE, 1997, J GEOPHYS RES-PLANET, V102, P1591, DOI 10.1029/96JE02940; TSUBOKAWA T, 2002, P 23 INT S SPAC TECH, P1986; WATTS A.B, 2001, ISOSTASY FLEXURE LIT; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Wieczorek M., 2007, TREATISE GEOPHYS, V2, P165, DOI [10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6/00156-5, 10.1016/b978-044452748-6/00156-5]; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	17	201	237	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					897	900		10.1126/science.1164146	http://dx.doi.org/10.1126/science.1164146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213910				2022-12-28	WOS:000263295400032
J	Marques-Bonet, T; Kidd, JM; Ventura, M; Graves, TA; Cheng, Z; Hillier, LW; Jiang, ZS; Baker, C; Malfavon-Borja, R; Fulton, LA; Alkan, C; Aksay, G; Girirajan, S; Siswara, P; Chen, L; Cardone, MF; Navarro, A; Mardis, ER; Wilson, RK; Eichler, EE				Marques-Bonet, Tomas; Kidd, Jeffrey M.; Ventura, Mario; Graves, Tina A.; Cheng, Ze; Hillier, LaDeana W.; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Fulton, Lucinda A.; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Cardone, Maria Francesca; Navarro, Arcadi; Mardis, Elaine R.; Wilson, Richard K.; Eichler, Evan E.			A burst of segmental duplications in the genome of the African great ape ancestor	NATURE			English	Article							COPY NUMBER VARIATION; STRUCTURAL VARIATION; EVOLUTION	It is generally accepted that the extent of phenotypic change between human and great apes is dissonant with the rate of molecular change(1). Between these two groups, proteins are virtually identical(1,2), cytogenetically there are few rearrangements that distinguish ape - human chromosomes(3), and rates of single- base- pair change(4-7) and retrotransposon activity(8-10) have slowed particularly within hominid lineages when compared to rodents or monkeys. Studies of gene family evolution indicate that gene loss and gain are enriched within the primate lineage(11,12). Here, we perform a systematic analysis of duplication content of four primate genomes ( macaque, orang- utan, chimpanzee and human) in an effort to understand the pattern and rates of genomic duplication during hominid evolution. We find that the ancestral branch leading to human and African great apes shows the most significant increase in duplication activity both in terms of base pairs and in terms of events. This duplication acceleration within the ancestral species is significant when compared to lineage- specific rate estimates even after accounting for copy- number polymorphism and homoplasy. We discover striking examples of recurrent and independent gene- containing duplications within the gorilla and chimpanzee that are absent in the human lineage. Our results suggest that the evolutionary properties of copy- number mutation differ significantly from other forms of genetic mutation and, in contrast to the hominid slowdown of single- base- pair mutations, there has been a genomic burst of duplication activity at this period during human evolution.	[Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Navarro, Arcadi] UPF CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Ventura, Mario; Cardone, Maria Francesca] Univ Bari, Sez Genet, Dipartimento Anat Patol & Genet, I-70125 Bari, Italy; [Graves, Tina A.; Hillier, LaDeana W.; Fulton, Lucinda A.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Navarro, Arcadi] ICREA, Barcelona 08003, Spain; [Navarro, Arcadi] INB, Barcelona 08003, Spain	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universita degli Studi di Bari Aldo Moro; Washington University (WUSTL); ICREA	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Alkan, Can/D-2982-2009; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Marques-Bonet, Tomas/I-4618-2014; Marques-Bonet, Tomas/ABF-3734-2020; Cardone, Maria Francesca/G-8818-2012; Navarro, Arcadi/F-1592-2011; Girirajan, Santhosh/A-5280-2010; Ventura, Mario/E-6420-2011	Alkan, Can/0000-0002-5443-0706; Wilson, Richard K./0000-0002-1992-1358; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075; Cardone, Maria Francesca/0000-0002-7597-7313; Navarro, Arcadi/0000-0003-2162-8246; Ventura, Mario/0000-0001-7762-8777; Kidd, Jeffrey/0000-0002-9631-1465	NIH [HG002385, U54 HG003079]; Marie Curie fellowship; Departament d'Educacio i Universitats de la Generalitat de Catalunya; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002385] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie fellowship(European Commission); Departament d'Educacio i Universitats de la Generalitat de Catalunya(Generalitat de Catalunya); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ICREA(ICREA)	We thank H. Mefford, A. Itsara, G. Cooper, T. Brown and G. McVicker for comments during the preparation of this manuscript. The authors are also grateful to J. Sikela and L. Dumas for assistance with the comparison to cDNA microarray data sets. We are grateful to L. Faust, J. Rogers, Southwest National Primate Research Center (P51- RR013986) and P. Parham for providing some of the primate material used in this study and to M. Adams for providing the alignments for the positive selection analysis. We also thank the large genome sequencing centres for early access to the whole genome sequence data for targeted analysis of segmental duplications. This work was supported, in part, by an NIH grant HG002385 to E.E.E. and NIH grant U54 HG003079 to R.K.W. and E.R.M. INB is a platform of Genoma Espana. T.M.-B. is supported by a Marie Curie fellowship and by Departament d'Educacio i Universitats de la Generalitat de Catalunya. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GOODMAN M, 1961, HUM BIOL, V33, P131; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	30	167	169	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					877	881		10.1038/nature07744	http://dx.doi.org/10.1038/nature07744			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212409	Green Accepted			2022-12-28	WOS:000263266700044
J	Horton, R				Horton, Richard			The UK's NIHS and pharma: from schism to symbiosis	LANCET			English	Editorial Material									[Horton, Richard] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							GRIFFIN GE, 2009, TIMES           0114, P27; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; *HOUS COMM HLTH SE, 2005, INFL PHARM IND; Illing J., 2008, PREPARED MED GRADUAT; Richards M, 2008, IMPROVING ACCESS MED; Royal College of Physicians, 2009, INN HLTH PAT PHYS PH	6	8	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					435	436		10.1016/S0140-6736(09)60148-3	http://dx.doi.org/10.1016/S0140-6736(09)60148-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19200902	Green Submitted			2022-12-28	WOS:000263132800004
J	Kafri, R; Springer, M; Pilpel, Y				Kafri, Ran; Springer, Michael; Pilpel, Yitzhak			Genetic Redundancy: New Tricks for Old Genes	CELL			English	Editorial Material							DUPLICATED GENES; YEAST; EVOLUTION; GENOME	Many crucial components of signal transduction, developmental, and metabolic pathways have functionally redundant copies. Further, these redundancies show surprising evolutionary stability over prolonged time scales. We propose that redundancies are not just archeological leftovers of ancient gene duplications, but rather that synergy arising from feedback between redundant copies may serve as an information processing element that facilitates signal transduction and the control of gene expression.	[Kafri, Ran; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science	Kafri, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ran_kafri@hms.harvard.edu; pilpel@weizmann.ac.il						Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kirschner M, 2005, PLAUSIBILITY LIFE RE; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; TISCHLER J, 2006, MOL BIOL EVOL, V20, P772	15	125	126	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					389	392		10.1016/j.cell.2009.01.027	http://dx.doi.org/10.1016/j.cell.2009.01.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203571	Bronze			2022-12-28	WOS:000263120600006
J	Goldston, D				Goldston, David			Beware politicians bearing gifts	NATURE			English	Editorial Material									[Goldston, David] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Harvard University	Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com						Goldston D, 2007, NATURE, V447, P130, DOI 10.1038/447130a	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					649	649		10.1038/457649a	http://dx.doi.org/10.1038/457649a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	403EA	19194425	Bronze			2022-12-28	WOS:000263064700014
J	Tol, J; Koopman, M; Cats, A; Rodenburg, CJ; Creemers, GJM; Schrama, JG; Erdkamp, FLG; Vos, AH; van Groeningen, CJ; Sinnige, HAM; Richel, DJ; Voest, EE; Dijkstra, JR; Vink-Borger, ME; Antonini, NF; Mol, L; van Krieken, JHJM; Dalesio, O; Punt, CJA				Tol, Jolien; Koopman, Miriam; Cats, Annemieke; Rodenburg, Cees J.; Creemers, Geert J. M.; Schrama, Jolanda G.; Erdkamp, Frans L. G.; Vos, Allert H.; van Groeningen, Cees J.; Sinnige, Harm A. M.; Richel, Dirk J.; Voest, Emile E.; Dijkstra, Jeroen R.; Vink-Borger, Marianne E.; Antonini, Ninja F.; Mol, Linda; van Krieken, Johan H. J. M.; Dalesio, Otilia; Punt, Cornelis J. A.			Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III; COMBINATION CHEMOTHERAPY; PLUS OXALIPLATIN; 1ST-LINE THERAPY; FINAL REPORT; CAPECITABINE; IRINOTECAN; FLUOROURACIL; LEUCOVORIN	Background Fluoropyrimidine- based chemotherapy plus the anti - vascular endothelial growth factor ( VEGF) antibody bevacizumab is standard first- line treatment for metastatic colorectal cancer. We studied the effect of adding the anti - epidermal growth factor receptor ( EGFR) antibody cetuximab to a combination of capecitabine, oxaliplatin, and bevacizumab for metastatic colorectal cancer. Methods We randomly assigned 755 patients with previously untreated metastatic colorectal cancer to capecitabine, oxaliplatin, and bevacizumab ( CB regimen, 378 patients) or the same regimen plus weekly cetuximab ( CBC regimen, 377 patients). The primary end point was progression- free survival. The mutation status of the KRAS gene was evaluated as a predictor of outcome. Results The median progression- free survival was 10.7 months in the CB group and 9.4 in the CBC group ( P = 0.01). Quality- of- life scores were lower in the CBC group. The overall survival and response rates did not differ significantly in the two groups. Treated patients in the CBC group had more grade 3 or 4 adverse events, which were attributed to cetuximab- related adverse cutaneous effects. Patients treated with cetuximab who had tumors bearing a mutated KRAS gene had significantly decreased progression- free survival as compared with cetuximab- treated patients with wildtype - KRAS tumors or patients with mutated- KRAS tumors in the CB group. Conclusions The addition of cetuximab to capecitabine, oxaliplatin, and bevacizumab resulted in significantly shorter progression- free survival and inferior quality of life. Mutation status of the KRAS gene was a predictor of outcome in the cetuximab group. (ClinicalTrials. gov number, NCT00208546.).	[Tol, Jolien; Koopman, Miriam; Dijkstra, Jeroen R.; Vink-Borger, Marianne E.; van Krieken, Johan H. J. M.; Punt, Cornelis J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands; [Cats, Annemieke; Antonini, Ninja F.; Dalesio, Otilia] Netherlands Canc Inst, Amsterdam, Netherlands; [Rodenburg, Cees J.] Meander Med Ctr, Amersfoort, Netherlands; [Creemers, Geert J. M.] Catharina Hosp, Eindhoven, Netherlands; [Schrama, Jolanda G.] Spaarne Hosp, Hoofddorp, Netherlands; [Erdkamp, Frans L. G.] Maasland Hosp, Sittard, Netherlands; [Vos, Allert H.] Bernhoven Hosp, Oss, Netherlands; [van Groeningen, Cees J.] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Sinnige, Harm A. M.] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [Richel, Dirk J.] Amsterdam Med Ctr, Amsterdam, Netherlands; [Voest, Emile E.] Univ Utrecht, Med Ctr, Utrecht, Netherlands; [Mol, Linda] Ctr Comprehens Canc E, Nijmegen, Netherlands	Radboud University Nijmegen; Netherlands Cancer Institute; Meander Medisch Centrum; Catharina Hospital; Spaarne Hospital; Maasland Hospital; Vrije Universiteit Amsterdam; Jeroen Bosch Ziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Punt, CJA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	c.punt@onco.umcn.nl	Dijkstra, Jeroen R/N-4383-2015; van Krieken, Joannes H J M/D-4138-2009; Tol, J./L-4695-2015	van Krieken, Joannes H J M/0000-0001-6544-1040; Mol, Linda/0000-0002-4155-1605				BOKEMEYER C, 2007, EUR CANC C 2007 BARC; Bokemeyer C, 2008, J CLIN ONCOL, V26, P1783, DOI 10.1200/JCO.2007.15.2991; Ciardiello F, 2000, CLIN CANCER RES, V6, P3739; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Diaz-Rubio E, 2007, J CLIN ONCOL, V25, P4224, DOI 10.1200/JCO.2006.09.8467; HECHT JR, 2008, 2008 GASTR CANC S; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Jung YD, 2002, EUR J CANCER, V38, P1133, DOI 10.1016/S0959-8049(02)00013-8; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Nowacki M, 2007, P AN M AM SOC CLIN, V25, p164s; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Saltz LB, 2008, J CLIN ONCOL, V26, P511, DOI 10.1200/JCO.2007.15.0383; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; SCARTOZZI M, 2008, ANN ONCOL       1007; Seymour MT, 2007, LANCET, V370, P566; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Shaheen RM, 2001, BRIT J CANCER, V85, P584, DOI 10.1054/bjoc.2001.1936; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2008, ANN ONCOL, V19, P734, DOI 10.1093/annonc/mdm607; Tonra JR, 2006, CLIN CANCER RES, V12, P2197, DOI 10.1158/1078-0432.CCR-05-1682; Van Cutsem E, 2008, J CLIN ONCOL S, V26, p5s	27	1062	1165	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2009	360	6					563	572		10.1056/NEJMoa0808268	http://dx.doi.org/10.1056/NEJMoa0808268			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402QS	19196673	Green Published			2022-12-28	WOS:000263028800003
J	Kang, LY				Kang, Lydia Y.			The First Wake	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lkang@unmc.edu							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					467	468		10.1001/jama.2009.61	http://dx.doi.org/10.1001/jama.2009.61			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19190306				2022-12-28	WOS:000262992400001
J	Schwartz, MA				Schwartz, Martin A.			CELL BIOLOGY The Force Is with Us	SCIENCE			English	Editorial Material							CONTRACTILITY; FIBRONECTIN; BINDING		[Schwartz, Martin A.] Univ Virginia, Dept Microbiol, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Schwartz, Martin A.] Univ Virginia, Dept Cell Biol, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Schwartz, Martin A.] Univ Virginia, Dept Biomed Engn, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Schwartz, Martin A.] Univ Virginia, Mellon Urol Canc Res Inst, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Dept Microbiol, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu		schwartz, martin/0000-0002-2071-1243				Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	15	47	48	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					588	589		10.1126/science.1169414	http://dx.doi.org/10.1126/science.1169414			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179515				2022-12-28	WOS:000262862800026
J	Taylor, AF; Tinsley, MR; Wang, F; Huang, ZY; Showalter, K				Taylor, Annette F.; Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth			Dynamical Quorum Sensing and Synchronization in Large Populations of Chemical Oscillators	SCIENCE			English	Article							EMERGING COHERENCE; FISCHERI; WAVES; CELLS	Populations of certain unicellular organisms, such as suspensions of yeast in nutrient solutions, undergo transitions to coordinated activity with increasing cell density. The collective behavior is believed to arise through communication by chemical signaling via the extracellular solution. We studied large, heterogeneous populations of discrete chemical oscillators (similar to 100,000) with well- defined kinetics to characterize two different types of density- dependent transitions to synchronized oscillatory behavior. For different chemical exchange rates between the oscillators and the surrounding solution, increasing oscillator density led to ( i) the gradual synchronization of oscillatory activity, or ( ii) the sudden "switching on" of synchronized oscillatory activity. We analyze the roles of oscillator density and exchange rate of signaling species in these transitions with a mathematical model of the interacting chemical oscillators.	[Tinsley, Mark R.; Wang, Fang; Huang, Zhaoyang; Showalter, Kenneth] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Taylor, Annette F.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	West Virginia University; University of Leeds	Showalter, K (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	kshowalt@wvu.edu	Showalter, Kenneth/P-3460-2015; taylor, annette/Z-1062-2018	Showalter, Kenneth/0000-0003-3443-9911; taylor, annette/0000-0003-0071-8306	UK Engineering and Physical Sciences Research Council [GR/T11036/01]; NSF [CHE-0809058]; Engineering and Physical Sciences Research Council [GR/T11036/01] Funding Source: researchfish; Division Of Chemistry [0809058] Funding Source: National Science Foundation	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by UK Engineering and Physical Sciences Research Council grant GR/T11036/01 (A.F.T.) and by NSF grant CHE-0809058. We dedicate this paper to the memory of Anatol M. Zhabotinsky, a pioneer of modern research in oscillations and pattern formation in chemical systems.	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; ERMENTROUT GB, 1990, PHYSICA D, V41, P219, DOI 10.1016/0167-2789(90)90124-8; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Greenberg EP, 1997, ASM NEWS, V63, P371; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; MASELKO J, 1989, J PHYS CHEM-US, V93, P2774, DOI 10.1021/j100344a016; MASELKO J, 1989, NATURE, V339, P609, DOI 10.1038/339609a0; Patriquin GM, 2008, J BACTERIOL, V190, P662, DOI 10.1128/JB.01473-07; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; Toth R, 2006, J PHYS CHEM B, V110, P10170, DOI 10.1021/jp060732z; Winfree AT, 2002, SCIENCE, V298, P2336, DOI 10.1126/science.1072560; Yoshikawa K, 1998, J PHYS CHEM A, V102, P7649, DOI 10.1021/jp982136d; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; ZHABOTINSKY AM, 1993, J PHYS CHEM-US, V97, P7578, DOI 10.1021/j100131a030	20	314	318	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2009	323	5914					614	617		10.1126/science.1166253	http://dx.doi.org/10.1126/science.1166253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400JB	19179525				2022-12-28	WOS:000262862800037
J	Gotzsche, PC; Hartling, OJ; Nielsen, M; Brodersen, J; Jorgensen, KJ				Gotzsche, Peter C.; Hartling, Ole J.; Nielsen, Margrethe; Brodersen, John; Jorgensen, Karsten Juhl			Breast screening: the facts-or maybe not	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; WOMEN		[Gotzsche, Peter C.; Nielsen, Margrethe; Jorgensen, Karsten Juhl] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Hartling, Ole J.] Dept Nucl Med, Vejle Sygehus, Denmark; [Brodersen, John] Univ Copenhagen, Dept Gen Practice, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388; Brodersen, John Brandt/0000-0001-9369-3376	KraeftFonden	KraeftFonden	Production and distribution of our leaflet in Denmark was funded by KraeftFonden.	Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; Brodersen J., 2006, MEASURING PSYCHOSOCI; Brodersen J, 2007, VALUE HEALTH, V10, P294, DOI 10.1111/j.1524-4733.2007.00184.x; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; *DEP HLTH, 2006, NHS CANC SCREEN PROG; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; JORGENSEN KJ, BMJ IN PRESS; Perry N., 2006, EUROPEAN GUIDELINES; Raffle AE, 2007, SCREENING EVIDENCE P; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; Vainio H, 2002, IARC HDB CANC PREVEN, V7; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	18	76	77	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2009	338								b86	10.1136/bmj.b86	http://dx.doi.org/10.1136/bmj.b86			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405EL	19174442				2022-12-28	WOS:000263205400003
J	Campbell-Scherer, DL; Montori, VM				Campbell-Scherer, Denise L.; Montori, Victor M.			Rosuvastatin prevented major cardiovascular events in persons with elevated C-reactive protein	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Campbell-Scherer, Denise L.] Univ Michigan, Flint, MI 48503 USA; [Montori, Victor M.] Mayo Clin, Rochester, MN USA	University of Michigan System; University of Michigan; University of Michigan Flint; Mayo Clinic	Campbell-Scherer, DL (corresponding author), Univ Michigan, Flint, MI 48503 USA.							Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2							JC1-4	10.7326/0003-4819-150-2-200901200-02004	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19172709				2022-12-28	WOS:000262655200022
